Citrus Sinensis ID: 005582
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | 2.2.26 [Sep-21-2011] | |||||||
| F4I114 | 714 | Probable serine/threonine | yes | no | 0.875 | 0.845 | 0.640 | 0.0 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.608 | 0.734 | 0.637 | 1e-168 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.573 | 0.771 | 0.461 | 3e-98 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.472 | 0.628 | 0.514 | 4e-95 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.471 | 0.643 | 0.505 | 3e-94 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.471 | 0.633 | 0.5 | 2e-92 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.471 | 0.217 | 0.445 | 2e-76 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.471 | 0.218 | 0.445 | 4e-76 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.504 | 0.280 | 0.428 | 6e-76 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.471 | 0.219 | 0.442 | 9e-76 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/657 (64%), Positives = 492/657 (74%), Gaps = 53/657 (8%)
Query: 68 DVGSSDDGEKKVKLQRRST----------INV------QVAQPRMTRIVSVSNGERGAQV 111
D D+ EKKV L+R+S+ I V + QP+MTRI SVSNGERGAQV
Sbjct: 77 DAKKDDESEKKVNLERKSSRLVFQRRPTGIEVGANNIGTLQQPKMTRICSVSNGERGAQV 136
Query: 112 VAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRF 171
+AGWPSWL +VAGEAINGW+PRKADSFEKL+KIGQGTYSSVYKARDLE N+LVALKKVRF
Sbjct: 137 MAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRF 196
Query: 172 TNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG 231
NMDP+SVRFMAREIIILRRLDHPN+MKLEGLITSRVSGS+YL+FEYMEHDLAGLA+TPG
Sbjct: 197 ANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPG 256
Query: 232 VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291
+ F+EAQIKCYMKQLLHGLEHCHSRG+LHRDIKGSNLL+D+N LKIGDFGLANF++ Q
Sbjct: 257 INFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQ 316
Query: 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
KQPLTSRVVTLWYRPPELLLGSTDYG +VDLWS+GCILAELF GKPIMPGRTEVEQLHKI
Sbjct: 317 KQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKI 376
Query: 352 FKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411
FKLCGSPSEEYWK SKLPHATIFKPQQPYKRCVAETFK +PSSAL+L+++LL+ EP+ RG
Sbjct: 377 FKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARG 436
Query: 412 TASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGK 471
T +SAL++EFFTT PL DPSSLPKY P KE DVK ++++ +R + +S ++ +
Sbjct: 437 TTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDS-KQVSR 495
Query: 472 ESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQT 531
ESKAVPAPD+NAE TSIQKRQ Q N + S++FN ED+ S F IEP K G
Sbjct: 496 ESKAVPAPDSNAESLTSIQKRQGQHNQVSNSDKFNPGEDAAS-FRIEPLKSGTAKDGHTR 554
Query: 532 MKPTTVGAS-LNMTMDSDRN-------SRSYMHPGAAGLSRFANSVAVR-GGHSQLDCSN 582
++V + N+ M S R+ RS++ G A LSRF+NSVA R G H +
Sbjct: 555 YGVSSVNRNGENVMMGSSRSPRKELRTQRSFVQRGTAQLSRFSNSVAARDGSHFAI---- 610
Query: 583 RVNSQWSDDS---------GHEWSQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMH 633
N +W +DS G WSQ L+ K E KES T + KK RMH
Sbjct: 611 -ANPRWFEDSYNNNNGRQNGGAWSQRLV-------VKHKEFTKHKESITVN-GEKKERMH 661
Query: 634 YSGPILPPGGNLEEMLKEHERQIQQAVRRARGDKTKAQKNGESGQTQSLLHYGRNGR 690
SGP++ GGNL+EMLKEHERQIQ AVR+AR DK + G++ QTQ+ L NGR
Sbjct: 662 CSGPLVSAGGNLDEMLKEHERQIQLAVRKARVDKKTNR--GDNRQTQAFL--AANGR 714
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 591 bits (1524), Expect = e-168, Method: Compositional matrix adjust.
Identities = 272/427 (63%), Positives = 343/427 (80%), Gaps = 7/427 (1%)
Query: 98 RIVSVSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARD 157
R+ + S RG QV AGWPSWL+ GEA+NGWVPRKAD+FEK+DKIGQGTYS+VYKA+D
Sbjct: 78 RLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKD 137
Query: 158 LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217
+ K+VALKKVRF N++PESV+FMAREI++LRRLDHPN++KLEGL+TSR+S SLYLVF+
Sbjct: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQ 197
Query: 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILK 277
YM+HDLAGLA++P VKF+E+++KC M+QL+ GLEHCHSRG+LHRDIKGSNLLID G+LK
Sbjct: 198 YMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLK 257
Query: 278 IGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337
I DFGLA F + K+P+TSRVVTLWYR PELLLG+TDYG +DLWS+GCILAEL AG+P
Sbjct: 258 IADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRP 317
Query: 338 IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALS 397
IMPGRTEVEQLHKI+KLCGSPSE+YWK+ K H I+KP++PYKR + ETFKD P S+L
Sbjct: 318 IMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLP 377
Query: 398 LLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR--- 454
L+D LLS EPE R TAS+AL++EFFT++P C+P+ LPKYPPSKE D K RD++ RR
Sbjct: 378 LIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRA 437
Query: 455 GGGGKGRGLESIRKAGKESKAVPAPDANAELQTSIQKRQ--NQSNPKATSEQFNSDEDSG 512
+G G R + ++A+PAP+ANAELQ+++ +R+ +N K+ SE+F G
Sbjct: 438 ASKAQGDGARKNRHRDRSNRALPAPEANAELQSNVDRRRLITHANAKSKSEKFPPPHQDG 497
Query: 513 S--GFPI 517
G P+
Sbjct: 498 GAMGVPL 504
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (922), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 192/416 (46%), Positives = 250/416 (60%), Gaps = 20/416 (4%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIIL 189
W R D FEKL++IG+GTY VY A++ E N++VALKK+R N REI IL
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDNEREGFPITAIREIKIL 76
Query: 190 RRLDHPNIMKLEGLITS---------------RVSGSLYLVFEYMEHDLAGLAATPGVKF 234
++L H N+++L+ ++TS + GS+Y+VFEYM+HDL GLA PG++F
Sbjct: 77 KKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRF 136
Query: 235 TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294
T QIKCYM+QLL GL +CH +LHRDIKGSNLLID G LK+ DFGLA F
Sbjct: 137 TVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGN 196
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354
LT+RV+TLWYRPPELLLGST YG +VD+WS GCI AEL GKPI+ G+ E EQL KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFEL 256
Query: 355 CGSPSEEYWK-RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA 413
CG+P E W +K+P FKPQ+P KR V E+FK AL LL+ +L+ +P R +A
Sbjct: 257 CGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISA 316
Query: 414 SSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKES 473
AL E+F T PLPCDP SLPKY S EF K + +R+ R + ++ S
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQAEEAAKR--QKLQHPPPHS 374
Query: 474 KAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGG 529
+ P + Q + + + P A + + G G P P+ G N GG
Sbjct: 375 RLPPIQNPGQPHQIRPGQPMHNAPPVAAGPSHHYAKPRGPGGPNRYPQ--GGNQGG 428
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 349 bits (896), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 176/342 (51%), Positives = 220/342 (64%), Gaps = 16/342 (4%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIIL 189
W R D FEKL++IG+GTY VY AR+ E ++VALKK+R N REI IL
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDNEREGFPITAIREIKIL 76
Query: 190 RRLDHPNIMKLEGLITS---------------RVSGSLYLVFEYMEHDLAGLAATPGVKF 234
++L H N+++L+ ++TS + GS+Y+VFEYM+HDL GLA PG++F
Sbjct: 77 KKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRF 136
Query: 235 TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294
T QIKCYMKQLL GL +CH +LHRDIKGSNLLID G LK+ DFGLA F
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGN 196
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354
LT+RV+TLWYRPPELLLGST YG +VD+WS GCI AEL GKPI+PG+ E EQL KIF +
Sbjct: 197 LTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDV 256
Query: 355 CGSPSEEYWK-RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA 413
CG+P E W +K+P FKP + KR V E FK AL LL+ +L+ +P R +A
Sbjct: 257 CGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISA 316
Query: 414 SSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRG 455
AL E+F + PLPCDP SLPKY S EF K + R+
Sbjct: 317 QDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQA 358
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 3e-94, Method: Compositional matrix adjust.
Identities = 172/340 (50%), Positives = 222/340 (65%), Gaps = 15/340 (4%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIIL 189
W R D FEKL++IG+GTY VY A++++ ++VALKK+R N REI IL
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKIL 77
Query: 190 RRLDHPNIMKLEGLITS--------------RVSGSLYLVFEYMEHDLAGLAATPGVKFT 235
++L H N+++L+ ++TS + G +Y+VFEYM+HDL GLA PG++FT
Sbjct: 78 KKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFT 137
Query: 236 EAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295
QIKCYMKQLL GL +CH +LHRDIKGSNLLID G LK+ DFGLA + L
Sbjct: 138 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNL 197
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355
T+RV+TLWYRPPELLLG+T YG ++D+WS GCI AEL KPI+PG+ E EQL+KIF+LC
Sbjct: 198 TNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELC 257
Query: 356 GSPSEEYWK-RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS 414
GSP E+ W SK+P FKP +P KR V E F+ AL LL+ +L +P R +A
Sbjct: 258 GSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAK 317
Query: 415 SALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
AL E+F T PLPCDP SLP Y S EF K + +R+
Sbjct: 318 DALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQ 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 340 bits (873), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 170/340 (50%), Positives = 217/340 (63%), Gaps = 15/340 (4%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIIL 189
W R D FEKL++IG+GTY VY A++++ ++VALKK+R N REI IL
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKIL 77
Query: 190 RRLDHPNIMKLEGLITS--------------RVSGSLYLVFEYMEHDLAGLAATPGVKFT 235
++L H N++ L+ ++TS + G +Y+VFEYM+HDL GLA PG++FT
Sbjct: 78 KKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFT 137
Query: 236 EAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295
QIKCYMKQLL GL +CH +LHRDIKGSNLLID G LK+ DFGLA + L
Sbjct: 138 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNL 197
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355
T+RV+TLWYRPPELLLG+T YG ++D+WS GCI AEL GKPI+PG+TE EQL+KI++LC
Sbjct: 198 TNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELC 257
Query: 356 GSPSEEYWK-RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS 414
GSP E W SK+P K +P KR V E ++ AL LL+ +L +P R A
Sbjct: 258 GSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAK 317
Query: 415 SALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
AL E+F T PLPCDP SLP Y S EF K + R
Sbjct: 318 DALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRH 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 150/337 (44%), Positives = 205/337 (60%), Gaps = 12/337 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIII 188
W R D F+ + IG+GTY VYKA+D + +LVALKKVR N + E A REI I
Sbjct: 720 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 778
Query: 189 LRRLDHPNIMKLEGLITSRVS--------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIK 240
LR+L H +++ ++ ++T + G+ YLVFEYM+HDL GL + V F+E IK
Sbjct: 779 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 838
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+MKQL+ GL++CH + LHRDIK SN+L++ +G +K+ DFGLA + + +P T++V+
Sbjct: 839 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 898
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
TLWYRPPELLLG Y ++D+WS GCIL ELF KPI E+ QL I +LCGSP
Sbjct: 899 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 958
Query: 361 EYWKRS-KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
W KLP+ KP++ Y+R + E F IPS+AL LLD +L+ +P R TA LQ+
Sbjct: 959 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1018
Query: 420 EFFTTKPLP-CDPSSLPKYPPSKEFDVKLRDDDRRRG 455
+F L DP LP + E K R R+ G
Sbjct: 1019 DFLKDVELSKMDPPDLPHWQDCHELWSKKRRRQRQSG 1055
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 150/337 (44%), Positives = 204/337 (60%), Gaps = 12/337 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIII 188
W R D F+ + IG+GTY VYKA+D + +LVALKKVR N + E A REI I
Sbjct: 719 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 777
Query: 189 LRRLDHPNIMKLEGLITSRVS--------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIK 240
LR+L H +++ ++ ++T + G+ YLVFEYM+HDL GL + V F+E IK
Sbjct: 778 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 837
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+MKQL+ GLE+CH + LHRDIK SN+L++ +G +K+ DFGLA + + +P T++V+
Sbjct: 838 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 897
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
TLWYRPPELLLG Y ++D+WS GCIL ELF KPI E+ QL I +LCGSP
Sbjct: 898 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 957
Query: 361 EYWKRS-KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
W KLP+ KP++ Y+R + E F IPS+AL LLD +L+ +P R TA LQ+
Sbjct: 958 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1017
Query: 420 EFFTTKPLP-CDPSSLPKYPPSKEFDVKLRDDDRRRG 455
+F L P LP + E K R R+ G
Sbjct: 1018 DFLKDVELSKMAPPDLPHWQDCHELWSKKRRRQRQSG 1054
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 6e-76, Method: Compositional matrix adjust.
Identities = 156/364 (42%), Positives = 218/364 (59%), Gaps = 16/364 (4%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIII 188
W R D F+ + IG+GTY VYKA+D + +LVALKKVR N + E A REI I
Sbjct: 702 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 760
Query: 189 LRRLDHPNIMKLEGLITSRVS--------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIK 240
LR+L H +++ ++ ++T + G+ YLVFEYM+HDL GL + V+F+E IK
Sbjct: 761 LRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIK 820
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+MKQL+ GLE+CH + LHRDIK SN+L++ +G +K+ DFGLA + + +P T++V+
Sbjct: 821 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVI 880
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
TLWYRPPELLLG Y ++D+WS GCIL ELF KPI E+ QL I +LCGSP
Sbjct: 881 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 940
Query: 361 EYWKRS-KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
W KLP+ KP++ Y+R + E F +P+ AL LLD +L+ +P R TA LQ+
Sbjct: 941 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQS 1000
Query: 420 EFFTTKPLPCDPSS--LPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVP 477
+F + C ++ LP + E K R R+R G +I+ KES +VP
Sbjct: 1001 DFLKDVDV-CKMATPDLPHWQDCHELWSKKR--RRQRQSGIVLEEPPAIKAPRKESVSVP 1057
Query: 478 APDA 481
DA
Sbjct: 1058 GGDA 1061
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 9e-76, Method: Compositional matrix adjust.
Identities = 149/337 (44%), Positives = 204/337 (60%), Gaps = 12/337 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIII 188
W R D F+ + IG+GTY VYKA+D + +LVALKKVR N + E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 189 LRRLDHPNIMKLEGLITSRVS--------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIK 240
LR+L H +++ ++ ++T + G+ YLVFEYM+HDL GL + V F+E IK
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 833
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+MKQL+ GL++CH + LHRDIK SN+L++ +G +K+ DFGLA + + +P T++V+
Sbjct: 834 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 893
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
TLWYRPPELLLG Y ++D+WS GCIL ELF KPI E+ QL I +LCGSP
Sbjct: 894 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 953
Query: 361 EYWKRS-KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
W KLP+ KP++ Y+R + E F IPS+AL LLD +L+ +P R TA LQ+
Sbjct: 954 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1013
Query: 420 EFFTTKPLP-CDPSSLPKYPPSKEFDVKLRDDDRRRG 455
+F L P LP + E K R R+ G
Sbjct: 1014 DFLKDVELSKMAPPDLPHWQDCHELWSKKRRRQRQSG 1050
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | ||||||
| 359486237 | 741 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.923 | 0.638 | 0.0 | |
| 356541852 | 709 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.950 | 0.596 | 0.0 | |
| 15217565 | 714 | protein kinase-like protein [Arabidopsis | 0.875 | 0.845 | 0.640 | 0.0 | |
| 3482933 | 967 | Similar to cdc2 protein kinases [Arabido | 0.875 | 0.624 | 0.640 | 0.0 | |
| 334183391 | 692 | protein kinase-like protein [Arabidopsis | 0.973 | 0.971 | 0.585 | 0.0 | |
| 224119892 | 536 | predicted protein [Populus trichocarpa] | 0.752 | 0.968 | 0.687 | 0.0 | |
| 359495293 | 895 | PREDICTED: uncharacterized protein LOC10 | 0.9 | 0.693 | 0.566 | 0.0 | |
| 297741044 | 615 | unnamed protein product [Vitis vinifera] | 0.852 | 0.956 | 0.569 | 0.0 | |
| 449457023 | 707 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.953 | 0.547 | 0.0 | |
| 12321357 | 686 | CRK1 protein, putative [Arabidopsis thal | 0.965 | 0.970 | 0.577 | 0.0 |
| >gi|359486237|ref|XP_002264491.2| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] gi|297739502|emb|CBI29684.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 916 bits (2367), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/747 (63%), Positives = 558/747 (74%), Gaps = 63/747 (8%)
Query: 1 MGCICSKAIRAKKYIAKNNAKEKELTKRTNKRL-GSFKKENVTVVVETDGIGNESTTRLI 59
MGCICSK +Y+ KN A++KEL+K+++KRL S ++E V VVE G N++T RLI
Sbjct: 1 MGCICSKGSSVNEYVEKN-ARDKELSKKSSKRLVASSRREGV--VVEGYGGSNDATARLI 57
Query: 60 NDQSVADDDVGS------------SDDGEKKVKLQRRSTINV--QVAQPRMTRIVSVSNG 105
QS D+ + + D + +Q+ ST+ V QP+MTRIVS+ NG
Sbjct: 58 PTQSAEDNAASTPVSWDKRQKKSMAIDNSTRAAVQKPSTMEVGMNAGQPQMTRIVSMGNG 117
Query: 106 ERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVA 165
AQ AGWPSWLTAVA EAI+GWVPRKADSFE+LDKIGQGTYSSVYKARDLE K VA
Sbjct: 118 VEAAQAAAGWPSWLTAVAAEAIDGWVPRKADSFERLDKIGQGTYSSVYKARDLETGKTVA 177
Query: 166 LKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG 225
LKKVRF NMDPESVRFMAREI ILRRLDHPN+MKLEGLITSR+SGSLYLVFEYM+HDLAG
Sbjct: 178 LKKVRFANMDPESVRFMAREIHILRRLDHPNVMKLEGLITSRMSGSLYLVFEYMDHDLAG 237
Query: 226 LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN 285
LA++P +KFTE QIKCYM+QLL GLEHCHSRG+LHRDIKGSNLLID NG LKIGDFGLA
Sbjct: 238 LASSPKIKFTEPQIKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLIDNNGNLKIGDFGLAT 297
Query: 286 FFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEV 345
FF+ QKQPLTSRVVTLWYRPPELLLG+T YG +VDLWS+GCILAEL+AGKPIM GRTEV
Sbjct: 298 FFQPYQKQPLTSRVVTLWYRPPELLLGATSYGVAVDLWSAGCILAELYAGKPIMQGRTEV 357
Query: 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST 405
EQLH+IFKLCGSPSEEYWKR+KLPHATIFKPQ PY+RCVAETF D PS ALSL+D+LL+
Sbjct: 358 EQLHRIFKLCGSPSEEYWKRAKLPHATIFKPQHPYRRCVAETFSDFPSPALSLMDVLLAI 417
Query: 406 EPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKL--RDDDRRRGGGGKGRGL 463
EPE RG+ASSAL NEFFTTKPLPCD S+LPKYPPSKEFD KL + RRR G KGRG
Sbjct: 418 EPERRGSASSALHNEFFTTKPLPCDTSNLPKYPPSKEFDAKLREEEARRRRAAGSKGRGH 477
Query: 464 ESIRKAGKESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGI 523
ES RK +ESKAVPAPDANAELQ SIQKR+ QSNPK+ SE+F +ED GSGFPIEP KG
Sbjct: 478 ESTRKVSRESKAVPAPDANAELQVSIQKRREQSNPKSKSEKFIPEEDGGSGFPIEPTKGT 537
Query: 524 GRNA---GGQTMKPTTVGASLNMTMDSD-------------------RNSRSYMHPGAAG 561
RN G+++ PT G++ NM ++ D R +SY H G +
Sbjct: 538 TRNGFSHSGKSIHPTAFGSARNMDVNEDEAQMGPGRGSNSSRNGAELRIQKSYSHRGGSQ 597
Query: 562 LSRFANSVAVRGGHSQLDC--SNRVNSQWSDD---------------SGHEWSQNLLDRP 604
LS F+ SVAV+G S+ D N +N W ++ H+WS +LLDRP
Sbjct: 598 LSMFSGSVAVQGS-SRFDNDRENGMNRHWPEERCNARYNELGGAESSEKHQWSHHLLDRP 656
Query: 605 MSSYNKKGEKPSGKESKTQDFASKKTRMHYSGPILPPGGNLEEMLKEHERQIQQAVRRAR 664
SS+ KK E+PS K S + +A KK R+HYSGP++PPGGNLEEMLKEHE+QIQ AVR+AR
Sbjct: 657 KSSH-KKDEQPSEKGS-SMGYAPKKNRIHYSGPLMPPGGNLEEMLKEHEKQIQLAVRKAR 714
Query: 665 GDKTKAQKN-GESGQTQSLLHYGRNGR 690
DK K +K ++GQT+SLL +GRN R
Sbjct: 715 LDKVKTKKAYNDNGQTESLLPHGRNNR 741
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541852|ref|XP_003539386.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/722 (59%), Positives = 524/722 (72%), Gaps = 48/722 (6%)
Query: 1 MGCICSKAIRAKKYIAKNNAKEKELTKRTNKRLGSFKKEN---VTVVVETDGIGNESTTR 57
MGCICSK A +Y+A+N+AK++ + + G EN ++ + IG+ + T
Sbjct: 1 MGCICSKGKSADQYVAENHAKDRSSNTKHLRLGGRELTENDATAHLISNANAIGHGNGTE 60
Query: 58 LINDQSVADDDVGSSDDGEKKVKLQRRSTINVQVAQPRMTRIVSVSNGERGAQVVAGWPS 117
+ S + D+ G+K V + Q QP++ RI SV+ GERG QV+ GWPS
Sbjct: 61 ---EASTSSDE---HHQGDKNVN----ANATEQSPQPKVCRIFSVTGGERGGQVLTGWPS 110
Query: 118 WLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE 177
WLTAVAGEAI+GW+PR+ADSFEKLDKIGQGTYSSVY+ARDLE NK+VALKKVRF NMDPE
Sbjct: 111 WLTAVAGEAISGWIPRRADSFEKLDKIGQGTYSSVYRARDLETNKIVALKKVRFANMDPE 170
Query: 178 SVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEA 237
SVRFM+REII+LRRLDHPN+MKLEG+ITSR SGSLYL+FEYM+HDLAGLAA P +KFTEA
Sbjct: 171 SVRFMSREIIVLRRLDHPNVMKLEGMITSRFSGSLYLIFEYMDHDLAGLAAIPNIKFTEA 230
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297
QIKCYM+QLL GLEHCHSRG++HRDIKGSNLL+D NG LKIGDFGLA F+ S QPLTS
Sbjct: 231 QIKCYMQQLLRGLEHCHSRGVMHRDIKGSNLLLDSNGNLKIGDFGLAALFQPSHGQPLTS 290
Query: 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357
RVVTLWYRPPELLLG+TDYG +VDLWS+GCILAELF GKPIMPGRTEVEQLHKIFKLCGS
Sbjct: 291 RVVTLWYRPPELLLGATDYGVTVDLWSAGCILAELFVGKPIMPGRTEVEQLHKIFKLCGS 350
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417
PSEEYWK+SK PHAT+FKPQQPYK +++TFKDIPSSALSLL++LLS EP+ RGTAS AL
Sbjct: 351 PSEEYWKKSKPPHATVFKPQQPYKCVISQTFKDIPSSALSLLEVLLSVEPKDRGTASLAL 410
Query: 418 QNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDD-RRRGGGGKGRGLESIRKAGKESKAV 476
Q+EFFT PLPCDPS+LPKYPPSKEFD KLR+++ RR+ KG ES+ + +ESKAV
Sbjct: 411 QHEFFTAMPLPCDPSTLPKYPPSKEFDAKLREEETRRQRAVNKGYEHESVGRNFRESKAV 470
Query: 477 PAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNA---GGQTMK 533
P PDANAE Q ++ RQ Q N K ++++N +ED GF EP K + GQ++
Sbjct: 471 PIPDANAEFQATV-GRQGQCNSKCITKKYNPEEDGDYGFHREPAKSRALDVLSHSGQSVH 529
Query: 534 PTTVGASLNMTMDSD----------------RNSRSYMHPGAAGLSRFANSVAVRGGHSQ 577
P+ G+S NM + + R +SY A LSRF+NSVAV+G
Sbjct: 530 PSVYGSSRNMNLKEEDLTSPDHGFRSRKSELRKQKSYWQGSTAKLSRFSNSVAVQGD-PL 588
Query: 578 LDCS--NRVNSQWSDD-----SGHEW---SQNLLDRPMSSYNKKGEKPSGKESKTQDFAS 627
LD S + NSQW +D H+ S+ LLD + S K P GK+ + + +A+
Sbjct: 589 LDMSGDSSANSQWPEDQFGMRCSHQADGDSKQLLD-GLKSSQKNDFHPIGKD-RAKGYAN 646
Query: 628 KKTRMHYSGPILPPGGNLEEMLKEHERQIQQAVRRARGDKTKAQK-NGESGQTQSLLHYG 686
K RMH+SGP+L P NLEEMLKEHERQIQQAVR+AR K K +K + ESG T+SL H+
Sbjct: 647 KNARMHHSGPLLAPEDNLEEMLKEHERQIQQAVRKARLGKDKTKKADSESGLTESLFHHV 706
Query: 687 RN 688
RN
Sbjct: 707 RN 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15217565|ref|NP_172431.1| protein kinase-like protein [Arabidopsis thaliana] gi|443474272|sp|F4I114.1|Y1960_ARATH RecName: Full=Probable serine/threonine-protein kinase At1g09600 gi|332190346|gb|AEE28467.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/657 (64%), Positives = 492/657 (74%), Gaps = 53/657 (8%)
Query: 68 DVGSSDDGEKKVKLQRRST----------INV------QVAQPRMTRIVSVSNGERGAQV 111
D D+ EKKV L+R+S+ I V + QP+MTRI SVSNGERGAQV
Sbjct: 77 DAKKDDESEKKVNLERKSSRLVFQRRPTGIEVGANNIGTLQQPKMTRICSVSNGERGAQV 136
Query: 112 VAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRF 171
+AGWPSWL +VAGEAINGW+PRKADSFEKL+KIGQGTYSSVYKARDLE N+LVALKKVRF
Sbjct: 137 MAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRF 196
Query: 172 TNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG 231
NMDP+SVRFMAREIIILRRLDHPN+MKLEGLITSRVSGS+YL+FEYMEHDLAGLA+TPG
Sbjct: 197 ANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPG 256
Query: 232 VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291
+ F+EAQIKCYMKQLLHGLEHCHSRG+LHRDIKGSNLL+D+N LKIGDFGLANF++ Q
Sbjct: 257 INFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQ 316
Query: 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
KQPLTSRVVTLWYRPPELLLGSTDYG +VDLWS+GCILAELF GKPIMPGRTEVEQLHKI
Sbjct: 317 KQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKI 376
Query: 352 FKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411
FKLCGSPSEEYWK SKLPHATIFKPQQPYKRCVAETFK +PSSAL+L+++LL+ EP+ RG
Sbjct: 377 FKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARG 436
Query: 412 TASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGK 471
T +SAL++EFFTT PL DPSSLPKY P KE DVK ++++ +R + +S ++ +
Sbjct: 437 TTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDS-KQVSR 495
Query: 472 ESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQT 531
ESKAVPAPD+NAE TSIQKRQ Q N + S++FN ED+ S F IEP K G
Sbjct: 496 ESKAVPAPDSNAESLTSIQKRQGQHNQVSNSDKFNPGEDAAS-FRIEPLKSGTAKDGHTR 554
Query: 532 MKPTTVGAS-LNMTMDSDRN-------SRSYMHPGAAGLSRFANSVAVR-GGHSQLDCSN 582
++V + N+ M S R+ RS++ G A LSRF+NSVA R G H +
Sbjct: 555 YGVSSVNRNGENVMMGSSRSPRKELRTQRSFVQRGTAQLSRFSNSVAARDGSHFAI---- 610
Query: 583 RVNSQWSDDS---------GHEWSQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMH 633
N +W +DS G WSQ L+ K E KES T + KK RMH
Sbjct: 611 -ANPRWFEDSYNNNNGRQNGGAWSQRLV-------VKHKEFTKHKESITVN-GEKKERMH 661
Query: 634 YSGPILPPGGNLEEMLKEHERQIQQAVRRARGDKTKAQKNGESGQTQSLLHYGRNGR 690
SGP++ GGNL+EMLKEHERQIQ AVR+AR DK + G++ QTQ+ L NGR
Sbjct: 662 CSGPLVSAGGNLDEMLKEHERQIQLAVRKARVDKKTNR--GDNRQTQAFL--AANGR 714
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3482933|gb|AAC33218.1| Similar to cdc2 protein kinases [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2032), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/657 (64%), Positives = 492/657 (74%), Gaps = 53/657 (8%)
Query: 68 DVGSSDDGEKKVKLQRRST----------INV------QVAQPRMTRIVSVSNGERGAQV 111
D D+ EKKV L+R+S+ I V + QP+MTRI SVSNGERGAQV
Sbjct: 77 DAKKDDESEKKVNLERKSSRLVFQRRPTGIEVGANNIGTLQQPKMTRICSVSNGERGAQV 136
Query: 112 VAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRF 171
+AGWPSWL +VAGEAINGW+PRKADSFEKL+KIGQGTYSSVYKARDLE N+LVALKKVRF
Sbjct: 137 MAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRF 196
Query: 172 TNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG 231
NMDP+SVRFMAREIIILRRLDHPN+MKLEGLITSRVSGS+YL+FEYMEHDLAGLA+TPG
Sbjct: 197 ANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPG 256
Query: 232 VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291
+ F+EAQIKCYMKQLLHGLEHCHSRG+LHRDIKGSNLL+D+N LKIGDFGLANF++ Q
Sbjct: 257 INFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQ 316
Query: 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
KQPLTSRVVTLWYRPPELLLGSTDYG +VDLWS+GCILAELF GKPIMPGRTEVEQLHKI
Sbjct: 317 KQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKI 376
Query: 352 FKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411
FKLCGSPSEEYWK SKLPHATIFKPQQPYKRCVAETFK +PSSAL+L+++LL+ EP+ RG
Sbjct: 377 FKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARG 436
Query: 412 TASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGK 471
T +SAL++EFFTT PL DPSSLPKY P KE DVK ++++ +R + +S ++ +
Sbjct: 437 TTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDS-KQVSR 495
Query: 472 ESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQT 531
ESKAVPAPD+NAE TSIQKRQ Q N + S++FN ED+ S F IEP K G
Sbjct: 496 ESKAVPAPDSNAESLTSIQKRQGQHNQVSNSDKFNPGEDAAS-FRIEPLKSGTAKDGHTR 554
Query: 532 MKPTTVGAS-LNMTMDSDRN-------SRSYMHPGAAGLSRFANSVAVR-GGHSQLDCSN 582
++V + N+ M S R+ RS++ G A LSRF+NSVA R G H +
Sbjct: 555 YGVSSVNRNGENVMMGSSRSPRKELRTQRSFVQRGTAQLSRFSNSVAARDGSHFAI---- 610
Query: 583 RVNSQWSDDS---------GHEWSQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMH 633
N +W +DS G WSQ L+ K E KES T + KK RMH
Sbjct: 611 -ANPRWFEDSYNNNNGRQNGGAWSQRLV-------VKHKEFTKHKESITVN-GEKKERMH 661
Query: 634 YSGPILPPGGNLEEMLKEHERQIQQAVRRARGDKTKAQKNGESGQTQSLLHYGRNGR 690
SGP++ GGNL+EMLKEHERQIQ AVR+AR DK + G++ QTQ+ L NGR
Sbjct: 662 CSGPLVSAGGNLDEMLKEHERQIQLAVRKARVDKKTNR--GDNRQTQAFL--AANGR 714
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334183391|ref|NP_176083.2| protein kinase-like protein [Arabidopsis thaliana] gi|332195333|gb|AEE33454.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1947), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/710 (58%), Positives = 506/710 (71%), Gaps = 38/710 (5%)
Query: 1 MGCICSKAIRAKK-YIAKNNAKEKELTKRTNKRLGSFKKENVTVVVETDGIGNESTTRLI 59
MGCICSK +R YI N+ + + +K+ ++ +V GNE+T RLI
Sbjct: 1 MGCICSKGVRTNDDYIETNHVSIGKENPKASKKQSDSEETSVN--------GNEATLRLI 52
Query: 60 ND--QSVADDDVGSSDDGEKKVKLQRRS-------------TINVQVAQPRMTRIVSVSN 104
D + D+ + +K+ + +S NV QPRM+RI SVSN
Sbjct: 53 PDDVKDTFSDEEVEELEEKKESSFEMKSCESVLQKGNVLEIVDNVGPLQPRMSRIGSVSN 112
Query: 105 GERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLV 164
G+R A+V+AGWPSWL +VAGEAINGW+PR ADSFEKL+ IGQGTYSSVY+ARDLE N++V
Sbjct: 113 GDRAAKVIAGWPSWLVSVAGEAINGWIPRSADSFEKLEMIGQGTYSSVYRARDLETNQIV 172
Query: 165 ALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLA 224
ALKKVRF NMDPESVRFMAREIIILRRL+HPN+MKLEGLI S+ SGS+YL+FEYM+HDLA
Sbjct: 173 ALKKVRFANMDPESVRFMAREIIILRRLNHPNVMKLEGLIISKASGSMYLIFEYMDHDLA 232
Query: 225 GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
GLA+TPG+KF++AQIKCYMKQLL GLEHCHS G+LHRDIK SNLL+D N LKIGDFGL+
Sbjct: 233 GLASTPGIKFSQAQIKCYMKQLLLGLEHCHSCGVLHRDIKCSNLLLDRNNNLKIGDFGLS 292
Query: 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE 344
NF++ +KQPLTSRVVTLWYRPPELLLGSTDYG +VDLWS+GCILAELF GKP++PGRTE
Sbjct: 293 NFYRGQRKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPLLPGRTE 352
Query: 345 VEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLS 404
VEQ+HKIFKLCGSPSEEYW+RS+L HATIFKPQ PYKRCVA+TFKD+PSSAL+LL++LL+
Sbjct: 353 VEQMHKIFKLCGSPSEEYWRRSRLRHATIFKPQHPYKRCVADTFKDLPSSALALLEVLLA 412
Query: 405 TEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLE 464
EP+ RGTASSALQ+EFFTTKP P +PSSLP+Y P KEFD KLR+++ RR G + E
Sbjct: 413 VEPDARGTASSALQSEFFTTKPFPSEPSSLPRYQPRKEFDAKLREEEARRRKGSSSKQNE 472
Query: 465 SIRKAGKESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIG 524
R A +ESKAVPAP ANAEL SIQKR ++N + SE+FN + DSG+GF IEP KG
Sbjct: 473 QKRLA-RESKAVPAPSANAELLASIQKRLGETNRTSISEKFNPEGDSGNGFRIEPLKG-- 529
Query: 525 RNAGGQTMKPTTVGASLNMTMDSDRNSRSYMHPGAAGLSRFANSVAVRGGHSQLDCSNR- 583
N T G + R RSY+ G+ LSRF+NS+A SQ
Sbjct: 530 -NTAQNPYPIYTNGDNHPNGSSQLRTQRSYVQRGSGQLSRFSNSMAPTRDGSQFGSMRDA 588
Query: 584 -VNSQWSDDSGHEW--SQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMHYSGPILP 640
VN +W +D + SQ LL++P + K S KES K+ R+ YSGP++P
Sbjct: 589 IVNQRWLEDGSENFNLSQRLLEKP-NGIRKDDPSSSSKESIMGYDGEKRGRIQYSGPLIP 647
Query: 641 PGGNLEEMLKEHERQIQQAVRRARGDKTKAQKNGESGQTQSLLHYGRNGR 690
GNL+EMLKEHERQI AVRRA+ DK K N Q Q+L + NGR
Sbjct: 648 GEGNLDEMLKEHERQILLAVRRAQADKAKRDDN---RQAQTL--FPANGR 692
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119892|ref|XP_002331088.1| predicted protein [Populus trichocarpa] gi|222872816|gb|EEF09947.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/576 (68%), Positives = 441/576 (76%), Gaps = 57/576 (9%)
Query: 102 VSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENN 161
+SNGERGAQVVAGWPSWLT+VAGEAINGWVPR+ADSFEKLDKIGQGTYSSVYKARDLE N
Sbjct: 1 MSNGERGAQVVAGWPSWLTSVAGEAINGWVPRRADSFEKLDKIGQGTYSSVYKARDLETN 60
Query: 162 KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH 221
K VALKKV F NMDPESVRFMAREIIILRRLDHPN+MKLEG+I SR+SGSLYL+FEYMEH
Sbjct: 61 KTVALKKVCFANMDPESVRFMAREIIILRRLDHPNVMKLEGVIASRMSGSLYLIFEYMEH 120
Query: 222 DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281
DLAGL A+PG+KF+EAQIKCYM+QLLHGLEHCH+RGILHRDIKGSNLLID NG LKI DF
Sbjct: 121 DLAGLLASPGIKFSEAQIKCYMQQLLHGLEHCHNRGILHRDIKGSNLLIDSNGNLKIADF 180
Query: 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG 341
GLA FF QKQPLTSRVVTLWYRPPELLLG+T+YG SVDLWS+GCILAELF GK IMPG
Sbjct: 181 GLATFFSSPQKQPLTSRVVTLWYRPPELLLGATEYGVSVDLWSTGCILAELFVGKHIMPG 240
Query: 342 RTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDI 401
RTEVEQLHKIFKLCGSPS+EYWKRSKLPHATIFKPQ PYKRCV ETFKD PSSAL+LLD+
Sbjct: 241 RTEVEQLHKIFKLCGSPSDEYWKRSKLPHATIFKPQHPYKRCVTETFKDFPSSALALLDV 300
Query: 402 LLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDD--RRRGGGGK 459
LL+ EPE RGTA SAL +EFFTTKPLPCDPS+LPK+PP+KEFDVK RD+D RRR GGK
Sbjct: 301 LLAVEPEARGTALSALDSEFFTTKPLPCDPSTLPKHPPTKEFDVKFRDEDARRRRAAGGK 360
Query: 460 GRGLESIRKAGKESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEP 519
GRG ES R+ KESK +PA DANAELQ SIQKRQ QS + SE +N +ED S P+ P
Sbjct: 361 GRGYESTRRGSKESKVMPAADANAELQASIQKRQGQSKQISISEIYNHEEDGVSRSPVGP 420
Query: 520 PKGIGRNAGGQTMKPTTVGASLNMTMDSDRNSRSYMHPGAAGLSRFANSVAVRGGHSQLD 579
KG RN Y H G +G
Sbjct: 421 AKGTARNI--------------------------YSHSGQSG-----------------S 437
Query: 580 CSNRVNSQWSDDSGHEWSQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMHYSGPIL 639
+ R NS DDS H L RP S K G T +++KK+ +HYSGP++
Sbjct: 438 FNARYNSL--DDSSH----GLSGRPNFSNKKPG------LDSTTGYSTKKSHVHYSGPLV 485
Query: 640 PPGGNLEEMLKEHERQIQQAVRRARGDKTKAQKNGE 675
P GGN+EEMLKEHE+QIQ+AVR+AR DK ++ N E
Sbjct: 486 PRGGNIEEMLKEHEKQIQRAVRKARLDKNTSETNTE 521
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495293|ref|XP_002277016.2| PREDICTED: uncharacterized protein LOC100265500 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/711 (56%), Positives = 491/711 (69%), Gaps = 90/711 (12%)
Query: 1 MGCICSKAIRAKKYIAKNNAKEKELTKRTNKR-----LGSFKKENVTVVVETDGIGNEST 55
MGCICSK +Y+ N +EKE K NK S +E V G G
Sbjct: 230 MGCICSKEASVDEYV-DYNEREKEKGKELNKDSVQLVAPSTGEEFVMGPGGGGGHGRTGG 288
Query: 56 TRLINDQSVADDDVGSSD----DGEKKVKL---------QRRSTINVQ--VAQPRMTRIV 100
+ +S +VGS+ +GEKK QRR T++++ V M+RIV
Sbjct: 289 SVHPISKSALQGNVGSAPIRAMEGEKKAMTADRPTKASHQRRLTLDMENNVGPSPMSRIV 348
Query: 101 SVSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLEN 160
S+ NG +G Q+VAGWPSWL++VAGEAI GWVP + +S+EKLDKIGQGTYS+VY+ARDL++
Sbjct: 349 SMPNGAKGEQIVAGWPSWLSSVAGEAIQGWVPLRPESYEKLDKIGQGTYSTVYRARDLDS 408
Query: 161 NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220
K+VALKKVRF NMDPESVRFMAREI +LR+LDHPN+MKLEGLITSR SG+LYLVFEYME
Sbjct: 409 GKIVALKKVRFGNMDPESVRFMAREIHVLRKLDHPNVMKLEGLITSRTSGTLYLVFEYME 468
Query: 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGD 280
HDLAGL+ATPG+KFTE QIKCYM+QLL GLEHCHSRG+LHRDIKGSNLLID G+LKIGD
Sbjct: 469 HDLAGLSATPGIKFTEPQIKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLIDNKGVLKIGD 528
Query: 281 FGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP 340
FGLA+ F+ QPLTSRVVTLWYRPPELLLG+T YGASVDLWS+GCI+AELFAG PIMP
Sbjct: 529 FGLAS-FRSDPSQPLTSRVVTLWYRPPELLLGATKYGASVDLWSTGCIIAELFAGSPIMP 587
Query: 341 GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLD 400
G TEVEQ+HKIFKLCGSPSEEYW++SKL HA+ FKPQ PYKR +AETF++ PSSAL+L+D
Sbjct: 588 GSTEVEQIHKIFKLCGSPSEEYWQKSKLAHASSFKPQHPYKRRLAETFRNFPSSALALVD 647
Query: 401 ILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDD--RRRGGGG 458
+LLS EP+ RGTA+SAL++EFFTTKPLPCDPSSLPKY PSKE+D KLR+++ R+R
Sbjct: 648 VLLSVEPDARGTAASALKSEFFTTKPLPCDPSSLPKYVPSKEYDAKLRNEEARRQRAEAV 707
Query: 459 KGRGLESIRKAGKESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIE 518
KGRG ES+R+ ++SK VP P+ + Q S+ Q Q+N K SE++ EDSGS F +E
Sbjct: 708 KGRGAESVRRGSRQSKDVPTPEFKPQAQASL---QGQTNTKCISEKYKPGEDSGSNFRME 764
Query: 519 PPKG------------IGRNAGGQTMKPTTVGASLNM--TMDSDRNSR------SYMHPG 558
P +G I +NA G + K A L T DS RN S+M G
Sbjct: 765 PHRGTVPNGLSHSTLMINQNAVGSSEKKVEDEAQLGYGNTFDSSRNKVELRTHGSHMPHG 824
Query: 559 AAGLSRFANSVAVRGGHSQLDCSNRVNSQWSDDSGHEWSQNLLDRPMSSYNKKGEKPSGK 618
AAG+S +S ++K E+ SGK
Sbjct: 825 AAGVS------------------------------------------NSSHRKDERISGK 842
Query: 619 ESKTQDFASKKTRMHYSGPILPPGGNLEEMLKEHERQIQQAVRRARGDKTK 669
ES T + KK RMHYSGP++P GGN+EEMLK+HERQIQ+AVR+AR DKT+
Sbjct: 843 ESVT-GYVPKKNRMHYSGPLMPSGGNIEEMLKDHERQIQEAVRKARIDKTQ 892
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741044|emb|CBI31356.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/693 (56%), Positives = 481/693 (69%), Gaps = 105/693 (15%)
Query: 1 MGCICSKAIRAKKYIAKNNAKEKELTKRTNKRLGSFKKENVTVVVETDGIGNESTTRLIN 60
MGCICSK +Y+ N +EKE K NK ++V +V + G E T
Sbjct: 1 MGCICSKEASVDEYV-DYNEREKEKGKELNK-------DSVQLVAPS--TGEEPT----- 45
Query: 61 DQSVADDDVGSSDDGEKKVKLQRRSTINVQ--VAQPRMTRIVSVSNGERGAQVVAGWPSW 118
K QRR T++++ V M+RIVS+ NG +G Q+VAGWPSW
Sbjct: 46 -----------------KASHQRRLTLDMENNVGPSPMSRIVSMPNGAKGEQIVAGWPSW 88
Query: 119 LTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES 178
L++VAGEAI GWVP + +S+EKLDKIGQGTYS+VY+ARDL++ K+VALKKVRF NMDPES
Sbjct: 89 LSSVAGEAIQGWVPLRPESYEKLDKIGQGTYSTVYRARDLDSGKIVALKKVRFGNMDPES 148
Query: 179 VRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQ 238
VRFMAREI +LR+LDHPN+MKLEGLITSR SG+LYLVFEYMEHDLAGL+ATPG+KFTE Q
Sbjct: 149 VRFMAREIHVLRKLDHPNVMKLEGLITSRTSGTLYLVFEYMEHDLAGLSATPGIKFTEPQ 208
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298
IKCYM+QLL GLEHCHSRG+LHRDIKGSNLLID G+LKIGDFGLA+ F+ QPLTSR
Sbjct: 209 IKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLIDNKGVLKIGDFGLAS-FRSDPSQPLTSR 267
Query: 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358
VVTLWYRPPELLLG+T YGASVDLWS+GCI+AELFAG PIMPG TEVEQ+HKIFKLCGSP
Sbjct: 268 VVTLWYRPPELLLGATKYGASVDLWSTGCIIAELFAGSPIMPGSTEVEQIHKIFKLCGSP 327
Query: 359 SEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
SEEYW++SKL HA+ FKPQ PYKR +AETF++ PSSAL+L+D+LLS EP+ RGTA+SAL+
Sbjct: 328 SEEYWQKSKLAHASSFKPQHPYKRRLAETFRNFPSSALALVDVLLSVEPDARGTAASALK 387
Query: 419 NEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDD--RRRGGGGKGRGLESIRKAGKESKAV 476
+EFFTTKPLPCDPSSLPKY PSKE+D KLR+++ R+R KGRG ES+R+ ++SK V
Sbjct: 388 SEFFTTKPLPCDPSSLPKYVPSKEYDAKLRNEEARRQRAEAVKGRGAESVRRGSRQSKDV 447
Query: 477 PAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKG------------IG 524
P P+ + Q S+ Q+N K SE++ EDSGS F +EP +G I
Sbjct: 448 PTPEFKPQAQASL-----QTNTKCISEKYKPGEDSGSNFRMEPHRGTVPNGLSHSTLMIN 502
Query: 525 RNAGGQTMKPTTVGASLNM--TMDSDRNSR------SYMHPGAAGLSRFANSVAVRGGHS 576
+NA G + K A L T DS RN S+M GAAG+S
Sbjct: 503 QNAVGSSEKKVEDEAQLGYGNTFDSSRNKVELRTHGSHMPHGAAGVS------------- 549
Query: 577 QLDCSNRVNSQWSDDSGHEWSQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMHYSG 636
+S ++K E+ SGKES T + KK RMHYSG
Sbjct: 550 -----------------------------NSSHRKDERISGKESVT-GYVPKKNRMHYSG 579
Query: 637 PILPPGGNLEEMLKEHERQIQQAVRRARGDKTK 669
P++P GGN+EEMLK+HERQIQ+AVR+AR DKT+
Sbjct: 580 PLMPSGGNIEEMLKDHERQIQEAVRKARIDKTQ 612
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457023|ref|XP_004146248.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449526203|ref|XP_004170103.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/720 (54%), Positives = 497/720 (69%), Gaps = 46/720 (6%)
Query: 1 MGCICSK--AIRAKKYIAKNNAKEKELTKRTNKRLGSFKKENVTVVVETDGIGNESTTRL 58
MGC+C K AI K ++ K + RL S +E + GN++ L
Sbjct: 1 MGCVCCKPSAIEDSKESPRDRVSSKTSSDLRVARLTSSSREEAYRAKDQYD-GNDARVTL 59
Query: 59 INDQSVADDDVGSSDDGEKKVKLQRRSTINVQVAQPRMTRIVSVSNGERGAQVVAGWPSW 118
I+ Q + + K+ K++ ++ P M RI + G+ + AGWP W
Sbjct: 60 IDKQVNGSGRLPGENCERKREKME-----HMTAQHPSMGRIPKAAEGD---HIAAGWPPW 111
Query: 119 LTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES 178
L AVAGEAI GW+PR+ADSFEKLDKIGQGTYS+VY+ARDL+ K+VALKKVRF N++PES
Sbjct: 112 LAAVAGEAIRGWLPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 171
Query: 179 VRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQ 238
VRFMAREI ILRRLDHPN++KLEGL+TSR+S SLYLVFEYMEHDLAGLA+ PGVKFTEAQ
Sbjct: 172 VRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGVKFTEAQ 231
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298
+KCYM+QLL GL+HCHS G+LHRDIKGSNLLID +GILKI DFGLA+FF Q QPLTSR
Sbjct: 232 VKCYMQQLLRGLDHCHSHGVLHRDIKGSNLLIDNHGILKIADFGLASFFDIHQNQPLTSR 291
Query: 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358
VVTLWYRPPELLLG+T YG +VDLWS+GCILAEL+AGKPIMPGRTEVEQLHKIFKLCGSP
Sbjct: 292 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 351
Query: 359 SEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
SE+YW++S+LPHATIFKPQQPY+RCVA+TFKD P+ AL+L++ LLS +P RG+A+ AL+
Sbjct: 352 SEDYWRKSRLPHATIFKPQQPYRRCVADTFKDFPAPALALIETLLSIDPADRGSAALALK 411
Query: 419 NEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGG--GGKGRGLESIRKAGKESKAV 476
+EFF+ KPLPCDPSSLPKYPPSKEFD K+RD++ RR G G KG L+ RK ++S+AV
Sbjct: 412 SEFFSAKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGAVGSKGHRLDLQRK-DRDSRAV 470
Query: 477 PAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQTM---- 532
PAPDANAEL +S+QKRQ S+ K+ SE+FN + SGFPI+PP+ + G + M
Sbjct: 471 PAPDANAELASSMQKRQGLSSSKSRSEKFNPHPEEASGFPIDPPRP---SQGAERMDSQV 527
Query: 533 ---KPTTVGASLNMTMDSDRNSRSYMHPG--AAGLSRFANS--VAVRGGHSQLDCSNRVN 585
K + L + SR+ P + G FA S VA R DC + +
Sbjct: 528 RHPKKASHSGPLAQRAAWAKASRNPDDPPKISTGTETFATSGLVAARRSMLAEDCREKSD 587
Query: 586 SQWSD---------DSGHEWSQN--LLDRPMSSYNKKG----EKPSGKESKTQDFASKKT 630
S + S E S++ L D+ S+++ G E+ S K+ + SK
Sbjct: 588 SSQGEVQKLIGRFPGSFKETSESSMLPDQKFSNHSIAGSHDKERSSTKDPIVVGYGSKGH 647
Query: 631 RMHYSGPILPPGGNLEEMLKEHERQIQQAVRRARGDKTKAQK---NGESGQTQSLLHYGR 687
++HYSGP+L P GN+++MLK+H+R IQ+AVRRAR DK K +K +G+ T SL GR
Sbjct: 648 KIHYSGPLLVPSGNMDQMLKDHDRHIQEAVRRARLDKAKVRKIQADGKQISTNSLFVSGR 707
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12321357|gb|AAG50753.1|AC079733_21 CRK1 protein, putative [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/710 (57%), Positives = 500/710 (70%), Gaps = 44/710 (6%)
Query: 1 MGCICSKAIRAKK-YIAKNNAKEKELTKRTNKRLGSFKKENVTVVVETDGIGNESTTRLI 59
MGCICSK +R YI N+ + + +K+ ++ +V GNE+T RLI
Sbjct: 1 MGCICSKGVRTNDDYIETNHVSIGKENPKASKKQSDSEETSVN--------GNEATLRLI 52
Query: 60 ND--QSVADDDVGSSDDGEKKVKLQRRS-------------TINVQVAQPRMTRIVSVSN 104
D + D+ + +K+ + +S NV QPRM+RI SVSN
Sbjct: 53 PDDVKDTFSDEEVEELEEKKESSFEMKSCESVLQKGNVLEIVDNVGPLQPRMSRIGSVSN 112
Query: 105 GERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLV 164
G+R A+V+AGWPSWL +VAGEAINGW+PR ADSFEKL+ IGQGTYSSVY+ARDLE N++V
Sbjct: 113 GDRAAKVIAGWPSWLVSVAGEAINGWIPRSADSFEKLEMIGQGTYSSVYRARDLETNQIV 172
Query: 165 ALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLA 224
ALKKVRF NMDPESVRFMAREIIILRRL+HPN+MKLEGLI S+ SGS+YL+FEYM+HDLA
Sbjct: 173 ALKKVRFANMDPESVRFMAREIIILRRLNHPNVMKLEGLIISKASGSMYLIFEYMDHDLA 232
Query: 225 GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
GLA+TPG+KF++AQ QLL GLEHCHS G+LHRDIK SNLL+D N LKIGDFGL+
Sbjct: 233 GLASTPGIKFSQAQ------QLLLGLEHCHSCGVLHRDIKCSNLLLDRNNNLKIGDFGLS 286
Query: 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE 344
NF++ +KQPLTSRVVTLWYRPPELLLGSTDYG +VDLWS+GCILAELF GKP++PGRTE
Sbjct: 287 NFYRGQRKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPLLPGRTE 346
Query: 345 VEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLS 404
VEQ+HKIFKLCGSPSEEYW+RS+L HATIFKPQ PYKRCVA+TFKD+PSSAL+LL++LL+
Sbjct: 347 VEQMHKIFKLCGSPSEEYWRRSRLRHATIFKPQHPYKRCVADTFKDLPSSALALLEVLLA 406
Query: 405 TEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLE 464
EP+ RGTASSALQ+EFFTTKP P +PSSLP+Y P KEFD KLR+++ RR G + E
Sbjct: 407 VEPDARGTASSALQSEFFTTKPFPSEPSSLPRYQPRKEFDAKLREEEARRRKGSSSKQNE 466
Query: 465 SIRKAGKESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIG 524
R A +ESKAVPAP ANAEL SIQKR ++N + SE+FN + DSG+GF IEP KG
Sbjct: 467 QKRLA-RESKAVPAPSANAELLASIQKRLGETNRTSISEKFNPEGDSGNGFRIEPLKG-- 523
Query: 525 RNAGGQTMKPTTVGASLNMTMDSDRNSRSYMHPGAAGLSRFANSVAVRGGHSQLDCSNR- 583
N T G + R RSY+ G+ LSRF+NS+A SQ
Sbjct: 524 -NTAQNPYPIYTNGDNHPNGSSQLRTQRSYVQRGSGQLSRFSNSMAPTRDGSQFGSMRDA 582
Query: 584 -VNSQWSDDSGHEW--SQNLLDRPMSSYNKKGEKPSGKESKTQDFASKKTRMHYSGPILP 640
VN +W +D + SQ LL++P + K S KES K+ R+ YSGP++P
Sbjct: 583 IVNQRWLEDGSENFNLSQRLLEKP-NGIRKDDPSSSSKESIMGYDGEKRGRIQYSGPLIP 641
Query: 641 PGGNLEEMLKEHERQIQQAVRRARGDKTKAQKNGESGQTQSLLHYGRNGR 690
GNL+EMLKEHERQI AVRRA+ DK K N Q Q+L + NGR
Sbjct: 642 GEGNLDEMLKEHERQILLAVRRAQADKAKRDDN---RQAQTL--FPANGR 686
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| F4I114 | Y1960_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6407 | 0.8753 | 0.8459 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00035300001 | SubName- Full=Chromosome undetermined scaffold_77, whole genome shotgun sequence; (687 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 690 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-157 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-120 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-113 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-111 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-104 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-104 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-99 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-95 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-94 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-89 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-88 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-87 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-87 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-86 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-84 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-83 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-79 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-78 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-77 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-77 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-77 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-77 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-77 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-75 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-73 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-72 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-69 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-67 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-65 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-65 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-64 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-64 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-63 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-63 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-61 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-59 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-58 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-57 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-56 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-56 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-56 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-54 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-53 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-48 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-48 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-47 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-47 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-46 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-45 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-45 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-44 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-43 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-40 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-38 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-37 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-37 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-25 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-21 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 455 bits (1172), Expect = e-157
Identities = 166/287 (57%), Positives = 213/287 (74%), Gaps = 2/287 (0%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+EK+ +IG+GTY VYKAR+ + +LVALKK+R N REI +L++L HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
++L+ ++TS+ GS+Y+VFEYM+HDL GL +P VKFTE+QIKCYMKQLL GL++ HS G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYG 317
ILHRDIKGSN+LI+ +G+LK+ DFGLA + T+RV+TLWYRPPELLLG+T YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 318 ASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW-KRSKLPHATIFKP 376
VD+WS GCILAELF GKPI G TE+EQL KIF+LCGSP++E W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 377 QQPYKRCVAETFKD-IPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
++PYKR + E FK I SAL LLD LL+ +P+ R +A ALQ+E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 359 bits (925), Expect = e-120
Identities = 126/290 (43%), Positives = 175/290 (60%), Gaps = 13/290 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD----PESVRFMAREIIILRRLD 193
+EKL+K+G+GTY VYKARD + ++VALKK+R N + ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
HPNI+KL +I + LYLVFEY + DL + IK M QLL GL +C
Sbjct: 57 HPNIVKLLDVIHT--ERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS ILHRD+K N+LI+ +G+LK+ DFGLA F + T VVTLWYR PE+LLGS
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHAT 372
Y +VD+WS GCI AE+ GKP+ PG +E++QL KIF++ G+P+EE W +KLP
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
P+ P K + + + + LL +L P R +A AL++ +F
Sbjct: 234 PTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 342 bits (879), Expect = e-113
Identities = 133/302 (44%), Positives = 181/302 (59%), Gaps = 9/302 (2%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN--MDPESVRFMA-REIIILRRLDH 194
+EK K+G+GTY+ VYKARD E ++VA+KK++ + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
PNI+ L + + ++ LVFE+ME DL + + T A IK YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S ILHRD+K +NLLI +G+LK+ DFGLA F S + +T +VVT WYR PELL G+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVVTRWYRAPELLFGAR 178
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATI 373
YG VD+WS GCI AEL P +PG ++++QL KIF+ G+P+EE W + LP
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSS 433
FKP P + + F AL LL LL+ P R TA AL++ +F+ P P PS
Sbjct: 239 FKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
Query: 434 LP 435
LP
Sbjct: 297 LP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-111
Identities = 145/312 (46%), Positives = 199/312 (63%), Gaps = 12/312 (3%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN----MDPESVRFMAREIII 188
R FEKL++IG+GTY VY+ARD + ++VALKKVR N + S+R EI +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----EITL 59
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
L L HPNI++L+ ++ + S++LV EY E DLA L F+E+Q+KC M QLL
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
GL++ H I+HRD+K SNLL+ G LKI DFGLA + K P+T +VVTLWYR PE
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPE 178
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SK 367
LLLG T Y ++D+W+ GCILAEL A KP++PG++E+EQL I +L G+P+E W S
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238
Query: 368 LPHATIFK-PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426
LP F P+QPY + F + + L LL+ LL +P+ R TA AL++ +F KP
Sbjct: 239 LPLVGKFTLPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297
Query: 427 LPCDPSSLPKYP 438
LPC+P +P +P
Sbjct: 298 LPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 320 bits (821), Expect = e-104
Identities = 138/307 (44%), Positives = 185/307 (60%), Gaps = 19/307 (6%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRL 192
K +E L K+G+GT+ VYKAR ++ ++VALKK+ N + + A REI IL++L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKL 64
Query: 193 DHPNIMKLEGLI------TSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
HPN++ L + + R GS+Y+V YM+HDL+GL P VK TE+QIKCYM QL
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP----------LT 296
L G+ + H ILHRDIK +N+LID GILKI DFGLA + P T
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG 356
+ VVT WYRPPELLLG Y +VD+W GC+ AE+F +PI+ G+++++QLH IFKLCG
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 357 SPSEEYWKR-SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415
+P+EE W LP Y R + E F + L LL LLS +P R TAS
Sbjct: 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304
Query: 416 ALQNEFF 422
AL++ +F
Sbjct: 305 ALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 318 bits (817), Expect = e-104
Identities = 144/302 (47%), Positives = 192/302 (63%), Gaps = 11/302 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIII 188
W R D F+ + +IG+GTY VYKARD + +LVALKKVR N + E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 189 LRRLDHPNIMKLEGLITSRV--------SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIK 240
LR+L+H NI+ L+ ++T + G+ YLVFEYM+HDL GL + V F+E IK
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+MKQLL GL +CH + LHRDIK SN+L++ G +K+ DFGLA + + +P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
TLWYRPPELLLG YG ++D+WS GCIL ELF KPI E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 361 EYWKR-SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
W KLP+ KP++ Y+R + E F IP+ AL LLD +L+ +P R TA AL +
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 420 EF 421
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 307 bits (788), Expect = 1e-99
Identities = 132/297 (44%), Positives = 188/297 (63%), Gaps = 12/297 (4%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF---MAREIIIL 189
R D +EKL++I +GTY VY+ARD + ++VALKK++ M+ E F REI IL
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINIL 58
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+L HPNI+ ++ ++ +Y+V EY+EHDL L T F ++++KC M QLL G
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
+ H H ILHRD+K SNLL++ GILKI DFGLA + S +P T VVTLWYR PEL
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPEL 177
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKL 368
LLG+ +Y ++D+WS GCI AEL KP+ PG++E++QL+KIFKL G+P+E+ W S+L
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 369 PHATIFKPQ-QPYKRCVAETFKDIPSS--ALSLLDILLSTEPEVRGTASSALQNEFF 422
P A PY + + + F + S LL+ LL+ +P R +A AL++ +F
Sbjct: 238 PGAKKKTFTKYPYNQ-LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = 1e-95
Identities = 142/311 (45%), Positives = 183/311 (58%), Gaps = 14/311 (4%)
Query: 125 EAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA- 183
+ + +EKL KIGQGT+ V+KAR + ++VALKKV N + E A
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITAL 59
Query: 184 REIIILRRLDHPNIMKL------EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEA 237
REI IL+ L H N++ L + +R GS YLVFE+ EHDLAGL + VKFT +
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF---KCSQKQP 294
+IK MK LL+GL + H ILHRD+K +N+LI +GILK+ DFGLA F K S+
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354
T+RVVTLWYRPPELLLG DYG +D+W +GCI+AE++ PIM G TE QL I +L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 355 CGSPSEEYW-KRSKLPHATIFKPQQPYKRCVAETFKDIPSS--ALSLLDILLSTEPEVRG 411
CGS + E W KL + Q KR V E K AL L+D LL +P R
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299
Query: 412 TASSALQNEFF 422
A +AL ++FF
Sbjct: 300 DADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 291 bits (748), Expect = 6e-94
Identities = 126/286 (44%), Positives = 170/286 (59%), Gaps = 4/286 (1%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++KL KIG+GTY VYKARD ++VA+KK++ + REI +L+ L+HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
+KL + + G LYLVFE+M+ DL L E+ IK Y+ QLL GL CHS G
Sbjct: 61 IKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYG 317
ILHRD+K NLLI+ G+LK+ DFGLA F S +P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 318 ASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATIFKP 376
VD+WS GCI AEL + +P+ PG++E++QL KIF+ G+P E W + + L F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ + + F + AL LL +L +P R TA AL + +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 2e-89
Identities = 111/286 (38%), Positives = 157/286 (54%), Gaps = 33/286 (11%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+E L+K+G+G++ VY ARD + KLVA+K ++ + + R + REI IL++L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
++L + LYLV EY E DL L G + +E + + Y++Q+L LE+ HS+
Sbjct: 60 VRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSK 116
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
GI+HRD+K N+L+D +G +K+ DFGLA +K LT+ V T Y PE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 317 GASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376
G +VD+WS G IL EL GKP PG +QL ++FK G P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP----------- 219
Query: 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
DI A L+ LL +PE R TA ALQ+ FF
Sbjct: 220 -----------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 2e-88
Identities = 116/292 (39%), Positives = 163/292 (55%), Gaps = 13/292 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD---PESVRFMAREIIILRRLDH 194
++ L +IG+G + V+KA+D E + VALKKV ++ P REI L+ H
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQH 58
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
P ++KL L LV EYM DL+ + EAQ+K YM+ LL G+ + H
Sbjct: 59 PYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
+ GI+HRD+K +NLLI +G+LKI DFGLA F + + + +V T WYR PELL G+
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHAT- 372
Y VDLW+ GCI AEL G P+ PG ++EQL +F+ G+P+EE W + LP
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236
Query: 373 -IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
F +P + E F D AL LL LL +P R +A+ AL++ +FT
Sbjct: 237 ITFPESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 3e-87
Identities = 127/295 (43%), Positives = 179/295 (60%), Gaps = 22/295 (7%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDHPN 196
++K++KIG+GTY VYKARD ++VALKK+R D E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPN 59
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
I++L ++ S LYLVFE+++ DL + ++P IK Y+ QLL G+ +CHS
Sbjct: 60 IVRLLDVVHS--ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL---TSRVVTLWYRPPELLLG 312
+LHRD+K NLLID G LK+ DFGLA F P+ T VVTLWYR PE+LLG
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGV----PVRTYTHEVVTLWYRAPEILLG 173
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHA 371
S Y VD+WS GCI AE+ +P+ PG +E++QL +IF+ G+P E+ W + LP
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD- 232
Query: 372 TIFKPQQPYKRCVAETF-KDIPS---SALSLLDILLSTEPEVRGTASSALQNEFF 422
+KP P + + K +P+ L LL +L +P R +A +ALQ+ +F
Sbjct: 233 --YKPTFP--KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 5e-87
Identities = 127/296 (42%), Positives = 171/296 (57%), Gaps = 20/296 (6%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD---PESVRFMAREIIILRRLD- 193
+E+L +IG+G Y +VYKARDL + VALKKVR + P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 194 --HPNIMKL----EGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQL 246
HPNI++L G T R L LVFE+++ DLA L+ P IK M+QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L G++ HS I+HRD+K N+L+ +G +KI DFGLA + S + LTS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRA 174
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE+LL S+ Y VD+WS GCI AELF +P+ G +E +QL KIF + G PSEE W R+
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ F P R +I L LL +L+ P R +A ALQ+ +F
Sbjct: 234 VSLPRSSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 275 bits (704), Expect = 1e-86
Identities = 124/326 (38%), Positives = 180/326 (55%), Gaps = 34/326 (10%)
Query: 138 FEKLDK-IGQGTYSSVYKARDLENNKLVALKKVRFT-----------NMDPESVRFMA-R 184
+ + +G+GTY V KA D K+VA+KKV+ + + F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGS-LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYM 243
E+ I+ + H NIM GL+ V G + LV + M DL + ++ TE+Q+KC +
Sbjct: 70 ELKIMNEIKHENIM---GLVDVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCIL 125
Query: 244 KQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS--------QKQP- 294
Q+L+GL H +HRD+ +N+ I+ GI KI DFGLA + +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 295 ----LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHK 350
+TS+VVTLWYR PELL+G+ Y +VD+WS GCI AEL GKP+ PG E++QL +
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 351 IFKLCGSPSEEYW-KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV 409
IF+L G+P+E+ W + KLP T F P++P + + F + A+ LL LL P
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLE 303
Query: 410 RGTASSALQNEFFTTKPLPCDPSSLP 435
R +A AL++E+F + PLPCDPS LP
Sbjct: 304 RISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 9e-84
Identities = 106/287 (36%), Positives = 144/287 (50%), Gaps = 29/287 (10%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+E L K+G G++ +VYKA+ K+VA+K ++ + + + REI ILRRL HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
++L LYLV EY E DL + G +E + K Q+L GLE+ HS
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
GI+HRD+K N+L+D NG++KI DFGLA S LT+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 317 GASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK-LCGSPSEEYWKRSKLPHATIFK 375
G VD+WS G IL EL GKP G ++QL I + L + K S
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS--------- 227
Query: 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
A L+ L+ +P R TA LQ+ +F
Sbjct: 228 --------------SGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 1e-83
Identities = 116/315 (36%), Positives = 167/315 (53%), Gaps = 13/315 (4%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
IG G Y V A D + VA+KK+ D + + REI +LR L H NI+ L +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 204 ITSRVS---GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
+ +Y+V E ME DL + +P T+ I+ ++ Q+L GL++ HS ++H
Sbjct: 68 LRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIH 126
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--LTSRVVTLWYRPPELLLGSTDYGA 318
RD+K SN+L++ N LKI DFGLA + + LT VVT WYR PELLL S+ Y
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378
++D+WS GCI AEL KP+ PGR ++QL+ I ++ G+PSEE K A +
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL 246
Query: 379 PY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPK 436
P K+ +++ F A+ LL+ +L +P+ R TA AL + + L DP P
Sbjct: 247 PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL--AQLH-DPEDEPV 303
Query: 437 YPPSKEFDVKLRDDD 451
P FD DDD
Sbjct: 304 AKPP--FDFDFFDDD 316
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 2e-79
Identities = 116/291 (39%), Positives = 172/291 (59%), Gaps = 12/291 (4%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE--SVRFMAREIIILRRLDH 194
+F++L+K+G+GTY++VYK R+ ++VALK++ ++D E + REI +++ L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKH 57
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK--FTEAQIKCYMKQLLHGLEH 252
NI++L +I L LVFEYM+ DL T GV+ +K + QLL G+
Sbjct: 58 ENIVRLHDVI--HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
CH +LHRD+K NLLI+ G LK+ DFGLA F ++ VVTLWYR P++LLG
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVVTLWYRAPDVLLG 174
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHA 371
S Y S+D+WS GCI+AE+ G+P+ PG +QL KIF++ G+P+E W S+LP
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
P+ P + + + F + LL LL PE+R +A ALQ+ +F
Sbjct: 235 KPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 2e-78
Identities = 122/288 (42%), Positives = 170/288 (59%), Gaps = 6/288 (2%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
+EKL+KIG+GTY +V+KA++ E +++VALK+VR + D REI +L+ L H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
I++L ++ S L LVFEY + DL + +K +M QLL GL CHS
Sbjct: 61 IVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
+LHRD+K NLLI+ NG LK+ DFGLA F + ++ VVTLWYRPP++L G+ Y
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLY 177
Query: 317 GASVDLWSSGCILAELF-AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATIF 374
S+D+WS+GCI AEL AG+P+ PG +QL +IF+L G+P+EE W SKLP +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
V K + S+ LL LL P R +A ALQ+ +F
Sbjct: 238 PMYPATTSLVNVVPK-LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 250 bits (639), Expect = 1e-77
Identities = 130/298 (43%), Positives = 171/298 (57%), Gaps = 15/298 (5%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
D++EKL+KIG+GTY VYKARD KLVALKK R MD E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRL-EMDEEGIPPTALREISLLQMLSE 59
Query: 195 -PNIMKL---EGLITSRVSGSLYLVFEYMEHDLA----GLAATPGVKFTEAQIKCYMKQL 246
I++L E + SLYLVFEY++ DL PG IK +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
L G+ HCH G++HRD+K NLL+D G+LKI D GL F K T +VTLWYR
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYR 178
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PE+LLGST Y VD+WS GCI AE+ +P+ PG +E++QL IFKL G+P+E+ W
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 366 -SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
SKL F +P ++ D+ L LL +L +P R +A +AL + +F
Sbjct: 239 VSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 4e-77
Identities = 122/292 (41%), Positives = 173/292 (59%), Gaps = 14/292 (4%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDHP 195
+F+K++KIG+GTY VYKAR+ ++VALKK+R + + E V A REI +L+ L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+KL +I + LYLVFE++ DL + A+P IK Y+ QLL GL CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S +LHRD+K NLLI+ G +K+ DFGLA F + T VVTLWYR PE+LLG
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK 176
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLP-HAT 372
Y +VD+WS GCI AE+ + + PG +E++QL +IF+ G+P E W + LP +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236
Query: 373 IFK--PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
F +Q + + V +D LL +L +P R +A +AL + FF
Sbjct: 237 SFPKWARQDFSKVVPPLDED----GRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 6e-77
Identities = 109/291 (37%), Positives = 158/291 (54%), Gaps = 7/291 (2%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +E L +G+G Y V K R+ ++VA+KK + + D + + RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+ L R G LYLVFEY+E L L A+PG ++ Y+ QLL + +CH
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCH 117
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S I+HRDIK N+L+ +G+LK+ DFG A + PLT V T WYR PELL+G T
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS-PSEEYWKRSKLPHATI 373
+YG VD+W+ GCI+AEL G+P+ PG ++++QL+ I K G P S P
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 374 FK-PQQPYKRCVAETFKDIPSS-ALSLLDILLSTEPEVRGTASSALQNEFF 422
P+ + + SS AL L L +P+ R T LQ+ +F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 6e-77
Identities = 114/291 (39%), Positives = 175/291 (60%), Gaps = 14/291 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKV--RFTNMDPESVRFMAREIIILRRL-DH 194
++ + ++G GT+ SVY AR+ E +LVA+KK+ +F + + E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHC 253
PNI+KL+ + R + LY VFEYME +L L G F+E+ I+ + Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
H G HRD+K NLL+ ++KI DFGLA + + P T V T WYR PE+LL S
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRAPEILLRS 173
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS-KLPHAT 372
T Y + VD+W+ GCI+AEL+ +P+ PG +E++QL+KI + G+P+++ W KL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 373 IFK-PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
F+ PQ + + + A+ L+ +L +P+ R TAS ALQ+ +F
Sbjct: 234 GFRFPQFAPTS-LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 8e-77
Identities = 119/297 (40%), Positives = 174/297 (58%), Gaps = 16/297 (5%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRL 192
K ++++KLDK+G+G+Y++VYK R +LVALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDL 60
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
H NI+ L +I ++ + L LVFEY++ DL G + ++ ++ QLL GL +
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
CH R +LHRD+K NLLI G LK+ DFGLA K + ++ VVTLWYRPP++LLG
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYW-KRSKLPH 370
ST+Y S+D+W GCI E+ G+P+ PG T+V +QLHKIF++ G+P+EE W S P
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 371 ATIFKPQQ-----PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
FKP P D L L EP+ R +A+ A+++ +F
Sbjct: 238 ---FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 3e-75
Identities = 126/291 (43%), Positives = 178/291 (61%), Gaps = 9/291 (3%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
D +EK++KIG+GTY VYKARD N+ +ALKK+R D E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQH 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHC 253
NI++L+ ++ S LYLVFEY++ DL + ++P IK Y+ Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHS--EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 254 HSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
HS +LHRD+K NLLID LK+ DFGLA F + T VVTLWYR PE+LLG
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLG 177
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHA 371
S Y VD+WS GCI AE+ KP+ PG +E+++L KIF++ G+P+EE W + LP
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
P+ P K +A + + + LL +L +P R TA +AL++E+F
Sbjct: 238 KSAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 2e-73
Identities = 117/291 (40%), Positives = 177/291 (60%), Gaps = 13/291 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDHPN 196
+ K++KIG+GTY VYK R+ + ++VA+KK+R + + E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPN 60
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQ-IKCYMKQLLHGLEHCH 254
I+ L+ ++ LYL+FE++ DL L + P ++ +A+ +K Y+ Q+L G+ CH
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
SR +LHRD+K NLLID G++K+ DFGLA F + T VVTLWYR PE+LLGS
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEVLLGSP 177
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATI 373
Y VD+WS G I AE+ KP+ G +E++QL +IF++ G+P+E+ W + LP
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD--- 234
Query: 374 FKPQQP--YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+K P K + K++ L LL+ +L +P R +A AL + +F
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 2e-72
Identities = 109/316 (34%), Positives = 157/316 (49%), Gaps = 32/316 (10%)
Query: 138 FEKLDKIGQGTYSSVYKARDLEN--NKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
+E IG+GTY VYKA+ K A+KK + + A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGL----AATPGVKFTEAQIKCYMKQLLHGL 250
N++ L + S+YL+F+Y EHDL + V + +K + Q+L+G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 251 EHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQPLTSR--VVTLWY 304
+ HS +LHRD+K +N+L+ G++KIGD GLA F K VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---------VEQLHKIFKLC 355
R PELLLG+ Y ++D+W+ GCI AEL +PI GR +QL +IF++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 356 GSPSEEYWKR-SKLPH----ATIFKPQQPYKRCV----AETFKDIPSSALSLLDILLSTE 406
G+P+E+ W K+P FK + Y E K S LL LL +
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 407 PEVRGTASSALQNEFF 422
P R TA AL++ +F
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 7e-69
Identities = 121/331 (36%), Positives = 171/331 (51%), Gaps = 36/331 (10%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKV--RFTNMDPESVRFMAREIIILRRL-DH 194
+E L K+G+G Y V+KA D ++VALKK+ F N F REI+ L+ L DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDL-----AGLAATPGVKFTEAQIKCYMKQLLHG 249
PNI+KL +I + +YLVFEYME DL A + + + M QLL
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-------LEDVHKRYIMYQLLKA 119
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC---SQKQP-LTSRVVTLWYR 305
L++ HS ++HRD+K SN+L++ + +K+ DFGLA + + P LT V T WYR
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK- 364
PE+LLGST Y VD+WS GCIL E+ GKP+ PG + + QL KI ++ G PS E +
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 365 -RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF-- 421
+S + ++ + E AL LL LL P R TA AL++ +
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 422 -FTTKPLPCDPSSLPKYPPSKEFDVKLRDDD 451
F +PS P P + + + DD
Sbjct: 300 QFH------NPSDEPVLP----YPITIPLDD 320
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 3e-67
Identities = 108/290 (37%), Positives = 155/290 (53%), Gaps = 19/290 (6%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALK--KVRFTNMDPESVRFMAREIIILRRL-DHPNI 197
L KIG+GT+S V KA+ + K A+K K F +++ + REI LRRL HPNI
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
++L ++ R +G L LVFE M+ +L L E ++K YM QLL L+H H G
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKC---SQKQPLTSRVVTLWYRPPELLLGST 314
I HRDIK N+LI + ILK+ DFG C K P T + T WYR PE LL
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG-----SCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY-WKRSKLPHATI 373
YG +D+W+ GC+ E+ + P+ PG E++Q+ KI + G+P E K K H
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 374 -FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
F ++ + + + + L LL LL+ +P+ R TA AL++ +F
Sbjct: 235 NFPSKKG--TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-65
Identities = 123/293 (41%), Positives = 163/293 (55%), Gaps = 14/293 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL---DH 194
+E + +IG G Y +VYKARD + VALK VR + RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 195 PNIMKLEGLI-TSRV--SGSLYLVFEYMEHDL-AGLAATPGVKFTEAQIKCYMKQLLHGL 250
PNI++L + TSR + LVFE+++ DL L P IK M+Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
+ H+ I+HRD+K N+L+ G +K+ DFGLA + C + LT VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVL 179
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS-KLP 369
L ST Y VD+WS GCI AE+F KP+ G +E +QL KIF L G P E+ W R LP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
F P+ P R V +I S LL +L+ P R +A ALQ+ FF
Sbjct: 239 RGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 2e-65
Identities = 111/325 (34%), Positives = 160/325 (49%), Gaps = 27/325 (8%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
++ ++ IG G Y V A D + K VA+KK+ P + RE+ ILR H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 196 NIMKLEGLITSRVS--GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
NI+ + ++ + +Y+V + ME DL + + TE I+ ++ QLL GL++
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI 123
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP---LTSRVVTLWYRPPELL 310
HS ++HRD+K SNLL++ + L+IGDFG+A S + +T V T WYR PELL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS---- 366
L +Y ++D+WS GCI AE+ + + PG+ V QL I + GSPSEE R
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 367 ------KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
LP K P+ + F AL LL +L +PE R T ALQ+
Sbjct: 244 VRKYIQNLPR----KQPVPWS----KIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295
Query: 421 FFTTKPLPCDPSSLPKYPPSKEFDV 445
F DP P PP +FD
Sbjct: 296 FLAQYH---DPDDEPTCPPPFDFDF 317
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 119/296 (40%), Positives = 175/296 (59%), Gaps = 17/296 (5%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K +++ KLDK+G+GTY++V+K R LVALK++R + + + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 194 HPNIMKLEGLI-TSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
H NI+ L +I T R L LVFEY++ DL G + +K +M QLL GL +
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
CH R ILHRD+K NLLI+ G LK+ DFGLA K + ++ VVTLWYRPP++LLG
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372
ST+Y +D+W GCIL E+ G+P+ PG T E+LH IF+L G+P+EE W P T
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGIT 232
Query: 373 IFKPQQPY--KRCVAETFKD----IPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ + Y + A+ + + + + LL LL E + R +A +AL++ +F
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 3e-64
Identities = 107/298 (35%), Positives = 157/298 (52%), Gaps = 23/298 (7%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +EKL KIG+G+Y V+K R+ E ++VA+KK + DP + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATP-GVKFTEAQIKCYMKQLLHGLEHC 253
N++ L + R L+LVFEY +H L L P GV E IK + Q L + C
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVP--EHLIKKIIWQTLQAVNFC 116
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
H +HRD+K N+LI G +K+ DFG A T V T WYR PELL+G
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGD 175
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS---------PSEEYWK 364
T YG VD+W+ GC+ AEL G+P+ PG+++V+QL+ I K G + +++K
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+P +P + F +I S ALS L L +P R + L++ +F
Sbjct: 236 GLSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 116/291 (39%), Positives = 168/291 (57%), Gaps = 7/291 (2%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K +++ KLDK+G+GTY++VYK R + LVALK++R + + + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
H NI+ L +I + SL LVFEY++ DL G +K ++ QLL GL +C
Sbjct: 63 HANIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
H R +LHRD+K NLLI+ G LK+ DFGLA K + ++ VVTLWYRPP++LLGS
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK--RSKLPHA 371
TDY +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+EE W S
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ P+ C+ + S LL LL E R +A A+++ +F
Sbjct: 240 SYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 6e-63
Identities = 121/298 (40%), Positives = 174/298 (58%), Gaps = 20/298 (6%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLD 193
A S+ L+K+G+G+Y++VYK N +LVALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEH 252
H NI+ L +I ++ +L VFEYM DLA + PG ++ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTK--ETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAY 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
H + ILHRD+K NLLI Y G LK+ DFGLA K Q +S VVTLWYRPP++LLG
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVLLG 177
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKR-SKLPH 370
+TDY +++D+W +GCI E+ G+P PG ++V EQL KI+ + G P+E+ W SKLP+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 371 ATIFKPQQPYKRCVAETFKDI------PSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+KP+ + C + + + P A L +L P+ R +A AL + +F
Sbjct: 238 ---YKPEW-FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-62
Identities = 113/310 (36%), Positives = 165/310 (53%), Gaps = 16/310 (5%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR--FTN-MDPESVRFMAREIIILRRLDHPNIMKL 200
IG+G Y V A++ E N+ VA+KK+ F N +D + REI +LR LDH N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLRHLDHENVIAI 69
Query: 201 EGLIT---SRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
+ ++ +Y+V+E M+ DL + + ++ + ++ QLL GL++ HS
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYG 317
+LHRD+K SNLL++ N LKI DFGLA + +T VVT WYR PELLL ++Y
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLNCSEYT 187
Query: 318 ASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377
++D+WS GCI AEL KP+ PG+ V QL I +L GSPSEE + A +
Sbjct: 188 TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247
Query: 378 QPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLP 435
PY ++ A F A+ LL+ +L +P R T AL + + L DPS P
Sbjct: 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA--SLH-DPSDEP 304
Query: 436 KYPPSKEFDV 445
FD
Sbjct: 305 VCQTPFSFDF 314
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 9e-61
Identities = 79/191 (41%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
+G+G + +VY ARD + K VA+K ++ + + REI IL++L+HPNI+KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 204 ITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRD 262
LYLV EY E L L K +E +I + Q+L GLE+ HS GI+HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 263 IKGSNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVD 321
+K N+L+D NG +K+ DFGL+ S K L + V T Y PE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 322 LWSSGCILAEL 332
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 1e-59
Identities = 110/300 (36%), Positives = 172/300 (57%), Gaps = 21/300 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K +++ KL+K+G+GTY++V+K R LVALK++R + + + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
H NI+ L ++ + SL LVFEY++ DL G + +K ++ Q+L GL +C
Sbjct: 63 HANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
H R +LHRD+K NLLI+ G LK+ DFGLA K + ++ VVTLWYRPP++LLGS
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW---------K 364
++Y +D+W GCI E+ +G+P+ PG T ++LH IF+L G+P+EE W K
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424
P +KP QP + + + LL L E + R +A A+++ +F +
Sbjct: 240 NYNFPK---YKP-QPLINHAPR----LDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 111/328 (33%), Positives = 159/328 (48%), Gaps = 11/328 (3%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
++ L IG+G Y V A VA+KK+ R + REI ILRR H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKH 62
Query: 195 PNIMKLEGLITSRVSGSL---YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
NI+ + +I S Y+V E ME DL L T + I+ ++ Q+L GL+
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLK 120
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--LTSRVVTLWYRPPEL 309
+ HS +LHRD+K SNLL++ N LKI DFGLA LT V T WYR PE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
+L S Y ++D+WS GCILAE+ + +P+ PG+ + QL+ I + G+PS+E
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 370 HATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427
A + P+K V + F + AL LLD +L+ P R T AL + +
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300
Query: 428 PCD-PSSLPKYPPSKEFDVKLRDDDRRR 454
P D P + +P E L + +
Sbjct: 301 PSDEPVAEEPFPFDFELFDDLPKEKLKE 328
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 1e-57
Identities = 123/306 (40%), Positives = 175/306 (57%), Gaps = 26/306 (8%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRL 192
KADS+EKL+K+G+G+Y++VYK + N KLVALK +R + E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTAIREASLLKGL 60
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLE 251
H NI+ L +I ++ +L LVFEY+ DL + PG +K ++ QLL GL
Sbjct: 61 KHANIVLLHDIIHTK--ETLTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLS 117
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ H R ILHRD+K NLLI G LK+ DFGLA K ++ VVTLWYRPP++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKR-SKLP 369
GST+Y +D+W GCI E+ G PG +++ QL +IF + G+P+E+ W LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236
Query: 370 HATIFKPQQPYKRCVAETFKDIPSS---------ALSLLDILLSTEPEVRGTASSALQNE 420
H FKP+ R + K++ + A L LL P+ R +A +AL +E
Sbjct: 237 H---FKPE----RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289
Query: 421 FFTTKP 426
+F+ P
Sbjct: 290 YFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 104/313 (33%), Positives = 158/313 (50%), Gaps = 12/313 (3%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D ++ L +G G Y V A D + + VA+KK+ + RE+ +L+ +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 196 NIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
N++ L + T S +YLV M DL + K ++ I+ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLK 132
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ HS GI+HRD+K SN+ ++ + LKI DFGLA + +T V T WYR PE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDE--MTGYVATRWYRAPEIML 188
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +VD+WS GCI+AEL GK + PG ++QL +I L G+P EE ++ A
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 372 TIFKPQQPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
+ P K+ E F A+ LL+ +L +P+ R TA+ AL + + P
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308
Query: 430 DPSSLPKYPPSKE 442
D P Y S E
Sbjct: 309 DEPVAPPYDQSFE 321
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 3e-56
Identities = 101/290 (34%), Positives = 166/290 (57%), Gaps = 11/290 (3%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDHPN 196
+E L +G+G+Y V K + E ++VA+KK + D + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
++ L + R LYLVFE+++H L L P E++++ Y+ Q+L G+E CHS
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS 118
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
I+HRDIK N+L+ +G++K+ DFG A + T V T WYR PELL+G T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTK 177
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE---EYWKRSKLPHAT 372
YG +VD+W+ GC++ E+ G+P+ PG ++++QL+ I K G+ E ++++ L A
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FAG 236
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ P+ + + F + L L L +P+ R ++S L +EFF
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 4e-56
Identities = 89/295 (30%), Positives = 139/295 (47%), Gaps = 44/295 (14%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
+ + + +G+G++ SVY A D + +L+A+K V + E + + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 197 IMKLEGLITSRVSGSLYLVFEYM-EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
I++ G +L + EY+ L+ L G K E I+ Y +Q+L GL + HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGST 314
GI+HRDIKG+N+L+D +G++K+ DFG A + T V T ++ PE++ G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
+YG + D+WS GC + E+ GKP W P A ++
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP------------------------WSELGNPMAALY 214
Query: 375 K-------PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
K P+ P + + A L L +P+ R TA LQ+ F
Sbjct: 215 KIGSSGEPPEIP---------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 4e-56
Identities = 125/297 (42%), Positives = 169/297 (56%), Gaps = 21/297 (7%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENN-KLVALKKVRFTNMDPESVRFMAREIIILRRLD--- 193
+E + +IG+G Y V+KARDL+N + VALK+VR + RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 194 HPNIMKLEGLIT-SRV--SGSLYLVFEYMEHDLAGL---AATPGVKFTEAQIKCYMKQLL 247
HPN+++L + T SR L LVFE+++ DL PGV TE IK M QLL
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP-TET-IKDMMFQLL 120
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
GL+ HS ++HRD+K N+L+ +G +K+ DFGLA + S + LTS VVTLWYR P
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAP 178
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS- 366
E+LL S+ Y VDLWS GCI AE+F KP+ G ++V+QL KI + G P EE W R
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 367 KLPHATIF-KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
LP K QP ++ V DI LL L+ P R +A SAL + +F
Sbjct: 238 ALPRQAFHSKSAQPIEKFVT----DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 2e-54
Identities = 113/332 (34%), Positives = 171/332 (51%), Gaps = 27/332 (8%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNK--LVALKKVRFTNMDPESV--RFMAREIIILRRL- 192
+E + ++GQG Y V AR+ E ++ VA+KK+ TN+ + + + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKI--TNVFSKKILAKRALRELKLLRHFR 59
Query: 193 DHPNIMKLEGL--ITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
H NI L + + LYL E ME DL + + G T+A + ++ Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGL 118
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-----NFFKCSQKQPLTSRVVTLWYR 305
++ HS +LHRD+K NLL++ + LKI DFGLA N + + +T V T WYR
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--MTEYVATRWYR 176
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PE++L Y ++D+WS GCILAEL KP+ G+ V+QL++I ++ G+P EE R
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 366 SKLPHATIF---KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
P A + P P K F + AL LL+ LL+ +P R + AL++ +
Sbjct: 237 IGSPKAQNYIRSLPNIPKKP-FESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295
Query: 423 TTKPLPCDPSSLPKYPPSKEFDV-----KLRD 449
P D K P F+ +LRD
Sbjct: 296 AIWHDPDDEPVCQK-PFDFSFESEDSMEELRD 326
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 6e-53
Identities = 107/317 (33%), Positives = 162/317 (51%), Gaps = 16/317 (5%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ L +G G + V ARD + VA+KK+ P + RE+ +L+ L H NI
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQ-IKCYMKQLLHGLEHCHSR 256
+ L + S + +Y V E + DL L + + E Q I+ ++ Q+L GL++ HS
Sbjct: 72 ISLSDIFISPLE-DIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
G++HRD+K SN+LI+ N LKI DFGLA Q +T V T +YR PE++L Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 317 GASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376
VD+WS+GCI AE+ GKP+ PG+ V Q I L G+P ++ + F
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 377 QQPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSL 434
P +E FK+ SA+ LL+ +L +P+ R +A+ AL + + P DP+
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL--APYH-DPTDE 300
Query: 435 PKYPPSKEFDVKLRDDD 451
P ++FD D D
Sbjct: 301 PV--AEEKFDWSFNDAD 315
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 8e-53
Identities = 114/325 (35%), Positives = 170/325 (52%), Gaps = 23/325 (7%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ L +G G+ V+ A D + +K VA+KK+ T DP+SV+ REI I+RRLDH NI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 198 MKLEGLITSRVS------------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQ 245
+K+ ++ S S+Y+V EYME DLA + +E + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG--PLSEEHARLFMYQ 122
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFF--KCSQKQPLTSRVVTL 302
LL GL++ HS +LHRD+K +N+ I+ +LKIGDFGLA S K L+ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
WYR P LLL +Y ++D+W++GCI AE+ GKP+ G E+EQ+ I + EE
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 363 WKR--SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
+ +P +P +R + + + AL L+ +L+ P R TA AL +
Sbjct: 243 RNELLNVIPSFVRNDGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301
Query: 421 FFTTKPLPCD-PSSLPKYPPSKEFD 444
+ + P D P SL + E D
Sbjct: 302 YMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 7e-52
Identities = 93/295 (31%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+E + +IG+G++ VY R + KL LK++ +NM + E+ IL++L+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 198 MKL-EGLITSRVSGSLYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLLHGLEH 252
+K E G L +V EY + DL+ G F E QI + QL L++
Sbjct: 62 IKYYESFEEK---GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLL 311
HSR ILHRDIK N+ + NG++K+GDFG++ S L VV T +Y PEL
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSPELCQ 176
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y D+WS GC+L EL K G +E KI
Sbjct: 177 NKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-------------------- 215
Query: 372 TIFKPQQPYKRCVAETFKDIP---SSALS-LLDILLSTEPEVRGTASSALQNEFF 422
+ + IP SS L L+ LL +PE R + + LQ+ F
Sbjct: 216 ------------LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 91/285 (31%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
FE L+KIG+G + VYKAR K VA+K ++ + E + EI IL++ HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
+K G L++V E+ L L + TE+QI K+LL GLE+ HS
Sbjct: 60 VKYYGSYL--KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
GI+HRDIK +N+L+ +G +K+ DFGL+ S + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 317 GASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376
D+WS G EL GKP ++ L KI + + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------ATNGPPGLRNP 220
Query: 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
++ ++ FKD L L PE R TA L++ F
Sbjct: 221 EK-----WSDEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 92/227 (40%), Positives = 130/227 (57%), Gaps = 4/227 (1%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ FE L +G+G Y V K R E ++VA+KK + + + E RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
NI++L+ R G LYLVFEY+E ++ L +++ Y+ QL+ + CH
Sbjct: 61 NIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
I+HRDIK NLLI +N +LK+ DFG A T V T WYR PELLLG+
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP- 177
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS-PSEE 361
YG +VD+WS GCIL EL G+P+ PG +E++QL I K+ G P+E+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (440), Expect = 3e-48
Identities = 103/334 (30%), Positives = 143/334 (42%), Gaps = 40/334 (11%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHP 195
S+ L K+G+G++ VY ARD KLVALK + + V REI IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 196 -NIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPG--VKFTEAQIKCYMKQLLHGLE 251
NI+KL GSLYLV EY++ L L G +E++ + Q+L LE
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 252 HCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQ-----KQPLTSRVVTLWYR 305
+ HS+GI+HRDIK N+L+D +G ++K+ DFGLA ++ V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 306 PPELLLGSTD--YGASVDLWSSGCILAELFAGKPIMPGRTE---VEQLHKIFKLCGSPSE 360
PE+LLG + +S D+WS G L EL G P G Q KI +PS
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
P I +A LL LL+ +P+ R ++SS L ++
Sbjct: 236 ASPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 421 FFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
L S P
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEA 310
|
Length = 384 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 5e-48
Identities = 111/315 (35%), Positives = 168/315 (53%), Gaps = 40/315 (12%)
Query: 143 KIGQGTYSSVYKAR--DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
K+G+GTY VYKA+ D ++++ ALK++ T + + REI +LR L HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 201 EGLITSRVSGSLYLVFEYMEHDL--------AGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
+ + S ++L+F+Y EHDL A A V+ +K + Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 253 CHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQPLTSR---VVTLWYR 305
H+ +LHRD+K +N+L+ G +KI D G A F S +PL VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYR 182
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---------VEQLHKIFKLCG 356
PELLLG+ Y ++D+W+ GCI AEL +PI R E +QL +IF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 357 SPSEEYWKR-SKLP-HATIFKP--QQPYKRC----VAETFKDIP-SSALSLLDILLSTEP 407
P+++ W+ K+P H+T+ K + Y C E K P S A LL LL+ +P
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 408 EVRGTASSALQNEFF 422
R T+ A+Q+ +F
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 114/331 (34%), Positives = 175/331 (52%), Gaps = 21/331 (6%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRRLDHP 195
++ + IG+G+Y V A D + VA+KK+ F ++ ++ R + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHP 59
Query: 196 NIMKLEGLI---TSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
+I++++ ++ + R +Y+VFE ME DL + T + ++ QLL L++
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKY 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN--FFKCSQKQPLTSRVVTLWYRPPELL 310
H+ + HRD+K N+L + + LKI DFGLA F T V T WYR PEL
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 311 LGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
GS + Y ++D+WS GCI AE+ GKP+ PG+ V QL I L G+PS E R +
Sbjct: 179 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 369 PHATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426
A + K+ V ++ F + AL LL+ LL+ +P+ R TA AL + +F K
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF--KG 295
Query: 427 LPC---DPSSLPKYPPSKEFD-VKLRDDDRR 453
L +PS+ P EF+ +L +D R
Sbjct: 296 LAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 105/331 (31%), Positives = 174/331 (52%), Gaps = 19/331 (5%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+P + + L ++G G Y SV A D + VA+KK+ + RE+ +L+
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 191 RLDHPNIMKLEGLITSRVSG----SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+ H N++ L + TS VSG YLV YM+ DL + G +E +++ + Q+
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQM 126
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L GL++ HS GI+HRD+K NL ++ + LKI DFGLA +T VVT WYR
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRA 182
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE++L Y +VD+WS GCI+AE+ GK + G+ ++QL +I K+ G P E+ ++
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242
Query: 367 KLPHATIF---KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
+ A + P+ P ++ + F A+ LL+ +L + + R TA+ AL++ +F
Sbjct: 243 EDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
Query: 424 TKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
+ + + Y S E + KL D+ ++
Sbjct: 302 SFRDADEETEQQPYDDSLENE-KLSVDEWKK 331
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 103/318 (32%), Positives = 163/318 (51%), Gaps = 15/318 (4%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
VP + ++ L +G G Y SV A D + VA+KK+ R RE+ +L+
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 191 RLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+ H N++ L + T S +YLV M DL + K ++ ++ + QL
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQL 127
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L GL++ HS GI+HRD+K SN+ ++ + L+I DFGLA +T V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRA 183
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE++L Y +VD+WS GCI+AEL GK + PG ++QL +I ++ G+PS E K+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 367 KLPHATIFKPQQPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424
HA + P+ ++ + + F+ A+ LL+ +L + + R +AS AL + +F+
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 425 KPLPCDPSSLPKYPPSKE 442
P D Y S E
Sbjct: 304 YHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 73/199 (36%), Positives = 114/199 (57%), Gaps = 10/199 (5%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
D IG+G + VYK +LE VA+K++ + E+++ + +EI +L+ L HPNI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 202 GLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
G I S SLY++ EY E+ L + G F E+ + Y+ Q+L GL + H +G++H
Sbjct: 66 GSI--ETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASV 320
RDIK +N+L +G++K+ DFG+A + S V T ++ PE++ S GAS
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS---GAST 178
Query: 321 --DLWSSGCILAELFAGKP 337
D+WS GC + EL G P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 108/317 (34%), Positives = 164/317 (51%), Gaps = 44/317 (13%)
Query: 143 KIGQGTYSSVYKAR--DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
K+G+GTY VYKA+ D ++ K ALK++ T + + REI +LR L HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 201 EGLITSRVSGSLYLVFEYMEHDL--------AGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
+ + S ++L+F+Y EHDL A A ++ + +K + Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 253 CHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQPLTSR---VVTLWYR 305
H+ +LHRD+K +N+L+ G +KI D G A F S +PL VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYR 182
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---------VEQLHKIFKLCG 356
PELLLG+ Y ++D+W+ GCI AEL +PI R E +QL +IF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 357 SPSEEYWKR-SKLPHATIFKPQQPYKRCV---------AETFKDIP-SSALSLLDILLST 405
P+++ W+ K+P Q+ ++R E K P S LL LL+
Sbjct: 243 FPADKDWEDIRKMPEYPTL--QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM 300
Query: 406 EPEVRGTASSALQNEFF 422
+P R T+ ALQ+ +F
Sbjct: 301 DPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 12/311 (3%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D + L ++G G Y +V A D VA+KK+ + RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 196 NIMKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
N++ L + T +S YLV +M DL L K +E +I+ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLK 132
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ H+ GI+HRD+K NL ++ + LKI DFGLA +T VVT WYR PE++L
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVIL 188
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +VD+WS GCI+AE+ GKP+ G ++QL +I K+ G+PS+E+ ++ + A
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 372 TIFKPQQP--YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
+ + P K+ + A+++L+ +L + E R TA+ AL + +F P
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
Query: 430 DPSSLPKYPPS 440
D + P Y S
Sbjct: 309 DETEAPPYDDS 319
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 8e-44
Identities = 100/323 (30%), Positives = 154/323 (47%), Gaps = 21/323 (6%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ ++ L +G G Y SV A D + VA+KK+ + RE+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 196 NIMKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
N++ L + T S +YLV M DL + K T+ ++ + Q+L GL+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 134
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ HS I+HRD+K SNL ++ + LKI DFGLA +T V T WYR PE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 190
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +VD+WS GCI+AEL G+ + PG ++QL I +L G+P E K+ A
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 372 TIFKPQQPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
+ K A F A+ LL+ +L + + R TA+ AL + +F
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH--- 307
Query: 430 DPSSLPKYPP------SKEFDVK 446
DP P P S++ +
Sbjct: 308 DPDDEPVADPYDQSFESRDLLID 330
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 91/291 (31%), Positives = 145/291 (49%), Gaps = 38/291 (13%)
Query: 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
++ +KIG GT+ VY A +L+ +L+A+K++R + DP++++ +A E+ +L L HPN++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 199 KLEGLITSRVSGSLYLVFEY-MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
K G+ R +Y+ EY L L G E I+ Y QLL GL + HS G
Sbjct: 63 KYYGVEVHR--EKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL----WYRPPELLLGS 313
I+HRDIK +N+ +D+NG++K+GDFG A K + + V +L Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 314 TD--YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI-FKLCGSPSEEYWKRSKLPH 370
+G + D+WS GC++ E+ GK E++ +I F +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGAGH------------ 223
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
KP P + LD L ++P+ R TAS LQ+ F
Sbjct: 224 ----KPPIP-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 97/282 (34%), Positives = 152/282 (53%), Gaps = 9/282 (3%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK-LEG 202
IG G + V+ D + K VALKK+ + S + + RE+ +L H N++ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 203 LITSRVS--GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
L + +Y+V E M+ DL + +P + +K ++ Q+L GL++ HS GILH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASV 320
RDIK NLL++ N +LKI DFGLA + + + +T VVT +YR PE+L+GS Y ++V
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV 186
Query: 321 DLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380
D+WS GCI AEL + + ++ ++QL I L G+PS E RS A + P+
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM-RSACEGARAHILRGPH 245
Query: 381 K-RCVAETFK---DIPSSALSLLDILLSTEPEVRGTASSALQ 418
K + + A+ LL +L +P+ R +A+ AL
Sbjct: 246 KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 92/315 (29%), Positives = 132/315 (41%), Gaps = 63/315 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
D F+ IG+G++S+V A++ E NK A+K K + + +E+ L RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV--LTRL 58
Query: 193 D-HPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+ HP I+KL T + +LY V EY + +L G E + Y ++L L
Sbjct: 59 NGHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLAL 115
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF---------------KCSQKQPL 295
E+ HS+GI+HRD+K N+L+D + +KI DFG A SQ +
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 296 TSR----VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
R V T Y PELL G S DLW+ GCI+ ++ GKP G E KI
Sbjct: 176 RRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 352 FKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411
KL EY P + P A L++ LL +P+ R
Sbjct: 235 LKL------EY----SFPP-------------------NFPPDAKDLIEKLLVLDPQDRL 265
Query: 412 TASSALQN----EFF 422
+ FF
Sbjct: 266 GVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 89/300 (29%), Positives = 136/300 (45%), Gaps = 37/300 (12%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++ L+KIG+G VYKA D K VA+KK+R + E + EI+I++ HPNI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
+ + V L++V EYM+ L + V+ E QI +++L GLE+ HS+
Sbjct: 78 VDYYD--SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
++HRDIK N+L+ +G +K+ DFG A +K S V T ++ PE++ DY
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVVGTPYWMAPEVIKRK-DY 193
Query: 317 GASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376
G VD+WS G + E+ G+P P L +F + +K P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEP--P-YLREPPLRALFLI----------TTKGI------P 234
Query: 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPK 436
+ FKD L+ L +PE R +A LQ+ F C
Sbjct: 235 PLKNPEKWSPEFKD-------FLNKCLVKDPEKRPSAEELLQHPFLKK---ACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 76/223 (34%), Positives = 115/223 (51%), Gaps = 11/223 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+E L+ IG+G++ +V K R + K++ K++ + NM + + + E+ ILR L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLLHGLEHC 253
++ I R + +LY+V EY E DLA L E I + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 254 HSRG-----ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
H+R +LHRD+K +N+ +D N +K+GDFGLA + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
L + Y D+WS GC++ EL A P R +++ KI
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 91/291 (31%), Positives = 135/291 (46%), Gaps = 38/291 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
E++ +GQG+ VYK R K+ ALKK+ + D E + + RE+ LR + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
++K G G + +V EYM+ LA L G K E + +Q+L GL++ H
Sbjct: 60 YVVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH 116
Query: 255 S-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
+ R I+HRDIK SNLLI+ G +KI DFG++ + + Q T V T+ Y PE + G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGE 175
Query: 314 TDYGASVDLWSSGCILAELFAGK-PIMPGRTE--VEQLHKIFKLCGSPSEEYWKRSKLPH 370
+ Y + D+WS G L E GK P +P E + I C P
Sbjct: 176 S-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPP----------- 220
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
P P + E F+D + L +P+ R +A+ LQ+ F
Sbjct: 221 -----PSLPAEEFSPE-FRDF-------ISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 84/283 (29%), Positives = 140/283 (49%), Gaps = 38/283 (13%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDP---ESVRFMAREIIILRRLDHPNIMKL 200
+G G++ SVY+ +L++ A+K+V + E+V+ + +EI +L +L HPNI++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 201 EGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
G T R +LY+ E + LA L G F E I+ Y +Q+L GLE+ H R +
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDYGA 318
HRDIKG+N+L+D NG++K+ DFG+A K + + ++ PE++ YG
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378
+ D+WS GC + E+ GKP +++E + +FK+ S P
Sbjct: 182 AADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKEL---------------PPI 223
Query: 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
P + A + L +P +R TA+ L++ F
Sbjct: 224 P---------DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-38
Identities = 105/309 (33%), Positives = 158/309 (51%), Gaps = 30/309 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
IG G++ VY+A ++ ++ VA+KKV DP+ + RE++I++ L+H NI+ L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 204 ITS----RVSGSLYL----------VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+ + +++L V +YM+H A P +K Y QL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
L + HS+ I HRD+K NLLID N LK+ DFG A Q+ S + + +YR PE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
L+LG+T+Y +DLWS GCI+AE+ G PI G++ V+QL +I ++ G+P+E+ K
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
+A I P K K P A++ + L EP R AL + FF P
Sbjct: 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360
Query: 429 CDPSSLPKY 437
C LPKY
Sbjct: 361 C--IKLPKY 367
|
Length = 440 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 78/205 (38%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIILRRLDH 194
+F+ KIG+G +S VYKA L + ++VALKKV+ F MD ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 195 PNIMK-LEGLITSRVSGSLYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLLHG 249
PN++K L I + L +V E + DL+ + E I Y QL
Sbjct: 62 PNVIKYLASFIEN---NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
LEH HS+ I+HRDIK +N+ I G++K+GD GL FF S+ S V T +Y PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPER 177
Query: 310 LLGSTDYGASVDLWSSGCILAELFA 334
+ Y D+WS GC+L E+ A
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 7/210 (3%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
+G+G++ V R + KL A+K ++ + + V E IL R++HP I+KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 203 LITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ LYLV EY +L + G +F+E + + Y +++ LE+ HS GI++R
Sbjct: 61 AFQTE--EKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVD 321
D+K N+L+D +G +K+ DFGLA S+ + T Y PE+LLG YG +VD
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVD 175
Query: 322 LWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
WS G +L E+ GKP E KI
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 90/291 (30%), Positives = 142/291 (48%), Gaps = 41/291 (14%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKV--------RFTNMDPESVRFMAREIIILRRLDHP 195
IG+GTY VY A ++ +++A+K+V R + + V+ + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI++ G T+ S++L EY+ + T G +F E ++ + +Q+L GL + H
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH 125
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGL----ANFFKCSQKQPLTSRVVTLWYRPPELL 310
S+GILHRD+K NLL+D +GI KI DFG+ + + Q + V W P +
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV--FWMAPEVIH 183
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
S Y A VD+WS GC++ E+FAG+ P E E + +FKL G+ +P
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL-GNKR----SAPPIP- 234
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
+ ++ AL L+ + P+ R TA LQ+ F
Sbjct: 235 --------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 91/305 (29%), Positives = 154/305 (50%), Gaps = 30/305 (9%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++ L IG G V A D + VA+KK+ + + RE+++++ ++H NI
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 198 MKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L + T + S +YLV E M+ +L + + ++ + Q+L G++H
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHL 134
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS GI+HRD+K SN+++ + LKI DFGLA +T VVT +YR PE++LG
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG- 191
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y +VD+WS GCI+ E+ G + PG ++Q +KI + G+PS+E+ R + P
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ-PTVRN 250
Query: 374 FKPQQPYKRCVAETFKDI-----------------PSSALSLLDILLSTEPEVRGTASSA 416
+ +P + +F+++ S A LL +L +PE R + A
Sbjct: 251 YVENRP--KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308
Query: 417 LQNEF 421
LQ+ +
Sbjct: 309 LQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 101/330 (30%), Positives = 163/330 (49%), Gaps = 29/330 (8%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+++L IG G V A D VA+KK+ + + RE+++L+ ++H NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 198 MKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L + T + S +YLV E M+ A L ++ ++ + Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS GI+HRD+K SN+++ + LKI DFGLA +T VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILG- 196
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR--SKLPHA 371
Y +VD+WS GCI+ EL G I G ++Q +K+ + G+PS E+ R + +
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 372 TIFKPQQPYKRCVAETFKD--IP----------SSALSLLDILLSTEPEVRGTASSALQN 419
+PQ P E F D P S A LL +L +P+ R + AL++
Sbjct: 257 VENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 420 EFFTTKPLPCDPSSLPKYPPSKEFDVKLRD 449
+ T P + + PP + +D +L +
Sbjct: 316 PYITVWYDPAEAEA----PPPQIYDAQLEE 341
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 95/324 (29%), Positives = 158/324 (48%), Gaps = 23/324 (7%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++ L IG G V A D + VA+KK+ + + RE+++++ ++H NI
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 198 MKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L + T + S +Y+V E M+ A L ++ ++ + Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS GI+HRD+K SN+++ + LKI DFGLA S +T VVT +YR PE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 199
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y +VD+WS GCI+ E+ G + PG ++Q +K+ + G+P E+ K+ + T
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 374 FKPQQPYKRCVAET-FKDI------------PSSALSLLDILLSTEPEVRGTASSALQNE 420
+ + Y E F D+ S A LL +L + R + ALQ+
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 421 FFTTKPLPCDPSSLPKYPPSKEFD 444
+ P + + P P K+ D
Sbjct: 320 YINVWYDPSEAEAPPPKIPDKQLD 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 100/335 (29%), Positives = 169/335 (50%), Gaps = 35/335 (10%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++ L IG G V A D ++ VA+KK+ + + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 198 MKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L + T + S +YLV E M+ A L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS GI+HRD+K SN+++ + LKI DFGLA S +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y +VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P E+ K+ + P
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRN 251
Query: 374 FKPQQPYKRCVAETFKDI----------------PSSALSLLDILLSTEPEVRGTASSAL 417
+ +P + TF + S A LL +L +P R + AL
Sbjct: 252 YVENRP--KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
Query: 418 QNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDR 452
Q+ + + DP+ + + PP + +D +L D+R
Sbjct: 310 QHPYIN---VWYDPAEV-EAPPPQIYDKQL--DER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ F+ L+K+G+G+Y SVYKA E ++VA+K V ++ + + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQE-IIKEISILKQCDSP 58
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAG----LAATPGVKFTEAQIKCYMKQLLHGLE 251
I+K G + L++V ME+ AG + TE +I + Q L GLE
Sbjct: 59 YIVKYYGSY--FKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELL 310
+ HS +HRDIK N+L++ G K+ DFG++ + + + V+ T ++ PE++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKP 337
Y D+WS G E+ GKP
Sbjct: 172 QEI-GYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 83/304 (27%), Positives = 136/304 (44%), Gaps = 54/304 (17%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD--PESVRFMAREIIILRRLD 193
D +E ++ IG G + VY A L NN+ VA+K++ +++ SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 194 HPNIMKLEGLITSRVSG-SLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLH 248
HPN++K TS V G L+LV Y+ D+ + G EA I +K++L
Sbjct: 58 HPNVVKYY---TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLK 113
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL-ANFFK--CSQKQPLTSRVVTLWYR 305
GLE+ HS G +HRDIK N+L+ +G +KI DFG+ A+ ++ + V T +
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIF-------KLCGSP 358
PE++ Y D+WS G EL G P K L P
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAA--PY-------SKYPPMKVLMLTLQNDP 224
Query: 359 SEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
L +K +++F+ ++ + L +P R TA L+
Sbjct: 225 -------PSLETGADYKK-------YSKSFRK-------MISLCLQKDPSKRPTAEELLK 263
Query: 419 NEFF 422
++FF
Sbjct: 264 HKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 87/266 (32%), Positives = 128/266 (48%), Gaps = 27/266 (10%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES---VRFMAREIIILRRLDHPNIMKL 200
+GQG + VY D++ + +A+K+V F PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 201 EGLITSRVSGSLYLVFEYME----HD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
G + R +L + EYM D L A TE + Y +Q+L G+E+ HS
Sbjct: 70 YGCL--RDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILEGVEYLHS 122
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFK--CSQKQPLTSRVVTLWYRPPELLLGS 313
I+HRDIKG+N+L D G +K+GDFG + + CS + S T ++ PE++ G
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
YG D+WS GC + E+ KP E E + IFK+ P+ P A
Sbjct: 183 G-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLL 399
F +R E K P SA LL
Sbjct: 239 F-----LRRTFVENAKKRP-SAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 12/219 (5%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
F+ L K+G+G+Y SVYK + L +N+ ALK+V +M + EI IL ++HPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 198 MKL-EGLITSRVSGSLYLVFEYME-HDLAGL---AATPGVKFTEAQIKCYMKQLLHGLEH 252
+ E + L +V EY DL+ E +I QLL GL+
Sbjct: 62 ISYKEAFLDGN---KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
H + ILHRD+K +N+L+ N ++KIGD G++ K +K +++ T Y PE+ G
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGIS---KVLKKNMAKTQIGTPHYMAPEVWKG 175
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
Y D+WS GC+L E+ P R+ + +K+
Sbjct: 176 -RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 82/266 (30%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESV--RFMAREIIILRRLDHPNIMKL- 200
I +G Y V+ A+ + A+K ++ +M ++ + + E IL + P ++KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVKLY 59
Query: 201 EGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
+ +LYLV EY+ DLA L G E + Y+ +++ LE+ HS GI+
Sbjct: 60 YSFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGII 115
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANF------FKCSQKQPLTSRVV-TLWYRPPELLLG 312
HRD+K N+LID NG LK+ DFGL+ + + R+V T Y PE++LG
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI------FKLCGSPSEEYWKR- 365
+ +VD WS GCIL E G P G T E I + S+E
Sbjct: 176 Q-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDI 391
SKL P KR A++ ++I
Sbjct: 235 SKLLV------PDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRRLDH 194
+ +E + +IG GTY VYKARD+ +LVA+K + ++P + + +EI +L+ H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRH 59
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
PNI+ G R L++V EY D+ + P +E QI ++ L GL
Sbjct: 60 PNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGL 114
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL-ANFFKCSQKQPLTSRVVTLWYRPPEL 309
+ H G +HRDIKG+N+L+ +G +K+ DFG+ A K+ S + T ++ PE+
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPYWMAPEV 172
Query: 310 LL--GSTDYGASVDLWSSGCILAELFAGKPIM 339
Y D+W+ G EL +P M
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 79/249 (31%), Positives = 127/249 (51%), Gaps = 16/249 (6%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+E + KIG+G++ +Y A+ +++ +K++ T M + +E+I+L ++ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
+ + + +G L++V EY + DL + GV F+E QI + Q+ GL+H H
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 256 RGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
R ILHRDIK N+ + NG + K+GDFG+A S + T V T +Y PE + +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPE-ICQNR 177
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG------SPSEEYWKRSKL 368
Y D+WS GC+L EL K G + QL + K+C SP+ RS +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQGYFAPISPNFSRDLRSLI 234
Query: 369 PHATIFKPQ 377
P+
Sbjct: 235 SQLFKVSPR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 138 FEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
E K+G+G + VYK VA+K ++ + E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
HPNI++L G+ T LY+V EYM DL G K T + Q+ G+E+
Sbjct: 60 HPNIVRLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF-FKCSQKQPLTSRVVTL-WYRPPELL 310
S+ +HRD+ N L+ N ++KI DFGL+ ++ + + + W PE L
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESL 176
Query: 311 LGSTDYGASVDLWSSGCILAELF 333
S D+WS G +L E+F
Sbjct: 177 KDGKFTSKS-DVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
+G+GTY VY ARDL +A+K++ + V+ + EI + L H NI++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 204 ITSRVSGSLYLVFEYMEH----DLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRG 257
S + +F ME L+ L + +K E I Y KQ+L GL++ H
Sbjct: 73 --SDSENGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 258 ILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELL-LGST 314
I+HRDIKG N+L++ Y+G++KI DFG + + + P T TL Y PE++ G
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 315 DYGASVDLWSSGCILAELFAGKP 337
YGA D+WS GC + E+ GKP
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 82/232 (35%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRF---TNMDPESV-RFMAREIIILRRLDHPNIMK 199
+G G +SS Y+ARD++ L+A+K+V + T+ + E V + +EI ++ RL+HP+I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
+ G + L E+M ++ L + G F EA I Y +QLL GL + H I
Sbjct: 68 MLG--ATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 259 LHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCS-------QKQPLTSRVVTLWYRPPELL 310
+HRD+KG+NLLID G L+I DFG A Q Q L T+ + PE+L
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG----TIAFMAPEVL 180
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC---GSPS 359
G YG S D+WS GC++ E+ KP L IFK+ +PS
Sbjct: 181 RGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 76/231 (32%), Positives = 124/231 (53%), Gaps = 20/231 (8%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-------VRFMAREIIILRRLDHPN 196
IG G++ SVY + + +L+A+K+V ++ S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
I++ G +S + L + EY+ +A L G F E ++ +++Q+L GL + H+
Sbjct: 68 IVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLHN 124
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGL-----ANFFKCSQKQPLTSRVVTLWYRPPELL 310
RGI+HRDIKG+N+L+D G +KI DFG+ AN S ++++ PE +
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-V 183
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361
+ T Y D+WS GC++ E+ GK P + QL IFK+ + S E
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 18/208 (8%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP--ESVRFMAREIIILRRLD 193
+ F L+ IG+G++ VYKA D N++VA+K + +++ + + + +EI L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAEDEIEDIQQEIQFLSQCR 57
Query: 194 HPNIMKLEGLITSRVSGS-LYLVFEYMEHDLAGLAAT---PGVKFTEAQIKCYMKQLLHG 249
P I K G S + GS L+++ EY G PG K E I ++++L G
Sbjct: 58 SPYITKYYG---SFLKGSKLWIIMEYCG---GGSCLDLLKPG-KLDETYIAFILREVLLG 110
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
LE+ H G +HRDIK +N+L+ G +K+ DFG++ + + T V T ++ PE+
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEV 169
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKP 337
+ S Y D+WS G EL G+P
Sbjct: 170 IKQS-GYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 72/237 (30%), Positives = 108/237 (45%), Gaps = 25/237 (10%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P FE ++ IG+GTY VYKAR + +LVA+K ++ + + E ILR+
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRK 58
Query: 192 L-DHPNIMKLEGLITSRVS----GSLYLVFEYMEH----DLAGLAATPGVKFTEAQIKCY 242
+HPNI G + L+LV E DL G + E I
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+++ L GL + H ++HRDIKG N+L+ N +K+ DFG++ + + T + T
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTP 177
Query: 303 WYRPPELLLGS----TDYGASVDLWSSGCILAELFAGKP----IMPGRTEVEQLHKI 351
++ PE++ Y A D+WS G EL GKP + P R L KI
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 76/289 (26%), Positives = 126/289 (43%), Gaps = 43/289 (14%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRLDH 194
FE L IG+G + V + + K+ A+K K + SVR + E IL+ L+H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--GSVRNVLNERRILQELNH 59
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAG---LAATPGVKFTEAQIKCYMKQLLHGLE 251
P ++ L + + ++YLV + + L G + VKF+E Q+K ++ +++ LE
Sbjct: 60 PFLVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALE 114
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ HS+GI+HRDIK N+L+D G + I DF +A TS T Y PE+L
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLC 172
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +VD WS G E GK G + + ++ + +
Sbjct: 173 -RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR------------TIRDQI-RAKQETAD 218
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-GTASSALQN 419
++ + A+ ++ LL +P+ R G L+N
Sbjct: 219 VLYPATW-------------STEAIDAINKLLERDPQKRLGDNLKDLKN 254
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 139 EKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
K+G+G + VYK + VA+K ++ + + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
PN++KL G+ T LY+V EYME DL K + + + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL-WYRPPELLLG 312
S+ +HRD+ N L+ N ++KI DFGL+ + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKE 177
Query: 313 STDYGASVDLWSSGCILAELF 333
+ + D+WS G +L E+F
Sbjct: 178 GK-FTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 139 EKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
K+G+G + VYK VA+K ++ + + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLHGLEH 252
PNI+KL G+ T L +V EYM DL L + + + + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRVVTLWYRPPELLL 311
S+ +HRD+ N L+ N ++KI DFGL+ + + + ++ W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 312 GSTDYGASVDLWSSGCILAELF 333
+ + D+WS G +L E+F
Sbjct: 178 EGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 75/204 (36%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIILRRLDHP 195
+F+ KIG+G +S VY+A L + K VALKKV+ F MD ++ + +EI +L++L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 196 NIMK-LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVK---FTEAQIKCYMKQLLHGL 250
N++K L+ I L +V E + DL+ + + E + Y QL +
Sbjct: 63 NVIKYLDSFIED---NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
EH HSR ++HRDIK +N+ I G++K+GD GL FF S+ S V T +Y PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-R 177
Query: 311 LGSTDYGASVDLWSSGCILAELFA 334
+ Y D+WS GC+L E+ A
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 142 DKIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
K+G+G + VYK + + VA+K ++ + E + +E ++++L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 199 KLEGLITSRVSGSLYLVFEYMEH-DL-------AGLAATPGVK-FTEAQIKCYMKQLLHG 249
+L G+ T LYLV EYME DL + +P + + + Q+ G
Sbjct: 60 RLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCSQKQPLTSRVVTLW 303
+E+ S+ +HRD+ N L+ + ++KI DFGL+ ++++ L R W
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELF 333
PE L + + D+WS G +L E+F
Sbjct: 174 M-APESLKDGI-FTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 90/304 (29%), Positives = 140/304 (46%), Gaps = 50/304 (16%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P+K + + +KIGQG +VY A D+ + VA+K++ + + + EI+++R
Sbjct: 17 PKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRE 72
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT---EAQIKCYMKQLLH 248
HPNI+ L + V L++V EY LAG + T V T E QI ++ L
Sbjct: 73 NKHPNIVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVTLWY 304
LE HS ++HRDIK N+L+ +G +K+ DFG C+Q P S+ V T ++
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-----CAQITPEQSKRSTMVGTPYW 181
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE++ YG VD+WS G + E+ G+P + L+ I
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------- 227
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT- 423
AT P+ ++ F+D L+ L + E RG+A LQ+ F
Sbjct: 228 ------ATNGTPELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLKI 274
Query: 424 TKPL 427
KPL
Sbjct: 275 AKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 63/197 (31%), Positives = 107/197 (54%), Gaps = 6/197 (3%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ K+ KIG+G++ + E+ K +K++ + M P+ +E+ +L + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DL-AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
++ + + +G+LY+V +Y E DL + A GV F E QI + Q+ L+H H
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
R ILHRDIK N+ + +G +K+GDFG+A + + T + T +Y PE + +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPE-ICENRP 177
Query: 316 YGASVDLWSSGCILAEL 332
Y D+W+ GC+L E+
Sbjct: 178 YNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/287 (26%), Positives = 119/287 (41%), Gaps = 36/287 (12%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ + +G+G + R E++ LV K+V T + + R EI+IL L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
+ +L + EY L + G F E + Y+ Q++ + + H
Sbjct: 62 IAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
GILHRDIK N+ + G++K+GDFG++ S+ + V T +Y PEL G
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQG-VK 177
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375
Y D+W+ GC+L EL L + F +P K + + +
Sbjct: 178 YNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIVQGNYTPV-- 221
Query: 376 PQQPYKRCVAETFKDIPSSAL-SLLDILLSTEPEVRGTASSALQNEF 421
+ SS L SL+ LL +PE R TA L
Sbjct: 222 -------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 85/314 (27%), Positives = 135/314 (42%), Gaps = 53/314 (16%)
Query: 131 VPRKADSFEKLD---KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREII 187
V D LD KIG+G+ V A D + VA+KK+ + F E++
Sbjct: 11 VVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVV 68
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGV---KFTEAQIKCYMK 244
I+R HPNI+++ + V L++V E++E G A T V + E QI
Sbjct: 69 IMRDYQHPNIVEMYS--SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCL 122
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VV 300
+L L H++G++HRDIK ++L+ +G +K+ DFG C+Q R V
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF-----CAQVSKEVPRRKSLVG 177
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
T ++ PE ++ YG VD+WS G ++ E+ G+P ++ + +I
Sbjct: 178 TPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--------- 227
Query: 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
R LP P + + S LD +L +P R TA+ L +
Sbjct: 228 ----RDNLP---------PKLK----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270
Query: 421 FFTTKPLPCDPSSL 434
F PSS+
Sbjct: 271 FLA---KAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 70/221 (31%), Positives = 104/221 (47%), Gaps = 12/221 (5%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
FE L+KIG+G++ V+K + ++ A+K++ + M+ E +L +LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 198 MK-LEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
++ E + G L +V EY E H L L G E Q+ + Q+L GL H
Sbjct: 62 IRYYESFLDK---GKLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
HS+ ILHRDIK NL +D +KIGD G+A + T V T +Y PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE-LCE 174
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
Y D+W+ G +L E GK + + KI +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 9/221 (4%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES---VRFMAREIIILRRLDHPNIMKL 200
+GQG + VY D++ + +A K+V+F PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
G + R +L + EYM TE+ + Y +Q+L G+ + HS I+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFK--CSQKQPLTSRVVTLWYRPPELLLGSTDYGA 318
RDIKG+N+L D G +K+GDFG + + C + S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGR 188
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS 359
D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 79/246 (32%), Positives = 119/246 (48%), Gaps = 31/246 (12%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
KIG+G +S VY+A L + VALKKV+ F MD ++ +EI +L++L+HPN++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 202 GLITSRVSGSLYLVFEYMEH-DLAGLAATPGVK---FTEAQIKCYMKQLLHGLEHCHSRG 257
L +V E + DL+ + + E + Y QL LEH HSR
Sbjct: 69 ASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYG 317
++HRDIK +N+ I G++K+GD GL FF S+ S V T +Y PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 318 ASVDLWSSGCILAELFAGK----------------------PIMPGRTEVEQLHKIFKLC 355
D+WS GC+L E+ A + P +P E+L ++ +C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244
Query: 356 GSPSEE 361
+P E
Sbjct: 245 INPDPE 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 140 KLDKIGQGTYSSVYKAR-DLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ ++G+G + V R D + VA+K + + + + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHE 66
Query: 196 NIMKLEGLITSRVSGSLYLVFEY-----MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
NI+K +G+ SL L+ EY + L + ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-----KQPLTSRVVTLWYR 305
++ S+ +HRD+ N+L++ ++KI DFGLA + K+P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELF 333
PE L S AS D+WS G L ELF
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 71/201 (35%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES--VRFMAREIIILRRLDHPNIM 198
L I +G + SVY A+ A+K ++ ++M ++ A I++ + + P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 199 KLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
KL S+ LYLV EY+ D A L T G E K Y+ +++ G+E H RG
Sbjct: 61 KLYYSFQSK--DYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDY 316
I+HRDIK NLLID G LK+ DFGL S+ + V T Y PE +LG D
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGL------SRNGLENKKFVGTPDYLAPETILGVGDD 171
Query: 317 GASVDLWSSGCILAELFAGKP 337
S D WS GC++ E G P
Sbjct: 172 KMS-DWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFM------AREIIIL 189
D FE + +G G++ V R + K ALK + + + E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI-----LSKAKIVKLKQVEHVLNEKRIL 55
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYME-------HDLAGLAATPGVKFTEAQIKCY 242
+ + HP ++ L G + + +LYLV EY+ +G +F E + Y
Sbjct: 56 QSIRHPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFY 106
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
Q++ LE+ HS I++RD+K NLL+D +G +KI DFG A + R TL
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTL 158
Query: 303 W----YRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337
Y PE++L S YG +VD W+ G ++ E+ AG P
Sbjct: 159 CGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR----FTNMDPESVRFMAREIIILRRLDHPNIMK 199
+G G + V + N+ ALK V+ E + E IL +HP I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 200 LEGLITSRVSGSLYLVFEYME--------HDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
L T + +Y++ EY D F E + Y+ ++ E
Sbjct: 58 LYR--TFKDKKYIYMLMEYCLGGELWTILRDRG--------LFDEYTARFYIACVVLAFE 107
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELL 310
+ H+RGI++RD+K NLL+D NG +K+ DFG A K QK T T Y PE++
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEII 164
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKP 337
L Y SVD WS G +L EL G+P
Sbjct: 165 LNK-GYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 9/221 (4%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES---VRFMAREIIILRRLDHPNIMKL 200
+GQG + VY D + + +A+K+V+F PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
G + + +L + E+M TE + Y +Q+L G+ + HS I+H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFK--CSQKQPLTSRVVTLWYRPPELLLGSTDYGA 318
RDIKG+N+L D G +K+GDFG + + C + S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGR 188
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS 359
D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 189 KADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 94/320 (29%), Positives = 131/320 (40%), Gaps = 65/320 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRRLD 193
D FE + IG+G + V+ RD + ++ A+K +R ++M + A E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA-ERDILADAD 59
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
P I+KL + + LYLV EYM DL L V F E + Y+ +L+ L+
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDS 116
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLA--------NFFKCSQKQPLTSR------ 298
H G +HRDIK N+LID +G +K+ DFGL + + L R
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 299 --------------VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE 344
V T Y PE+L G T YG D WS G IL E+ G P T
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 345 VEQLHKIFKLCGSPSEEYWKRS-KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILL 403
E +KI WK S + P + A+ L+ LL
Sbjct: 236 QETYNKIIN---------WKESLRFPPD-----------------PPVSPEAIDLICRLL 269
Query: 404 STEPEVR-GTASSALQNEFF 422
+PE R G+ + FF
Sbjct: 270 -CDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFT-NMDPESVRFMAREIIILRRLDHPN 196
F L +IG G++ +VY ARD+ N++VA+KK+ ++ E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
++ +G + +LV EY + + E +I L GL + HS
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD- 315
+HRDIK N+L+ G +K+ DFG A S P S V T ++ PE++L +
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSA-----SLVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 316 -YGASVDLWSSGCILAELFAGKP 337
Y VD+WS G EL KP
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 10/217 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRRLDHPN 196
F L +IG G++ +VY ARD+ N+++VA+KK+ ++ E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
++ G + +LV EY + L E +I L GL + HS
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD- 315
++HRD+K N+L+ G++K+GDFG A+ P V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189
Query: 316 -YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
Y VD+WS G EL KP + + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 77/236 (32%), Positives = 118/236 (50%), Gaps = 18/236 (7%)
Query: 116 PSWLTAVAGEAINGWVPRKADSFEKLDK---IGQGTYSSVYKARDLENNKLVALKKVRFT 172
S ++ + + +G P A S +L++ IG G +VYK +L ALK V +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 173 NMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGV 232
N + R + REI ILR ++HPN++K + +G + ++ E+M D L T
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFM--DGGSLEGTHIA 165
Query: 233 KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292
E + +Q+L G+ + H R I+HRDIK SNLLI+ +KI DFG++ +
Sbjct: 166 D--EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222
Query: 293 QPLTSRVVTLWYRPPE-----LLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGR 342
P S V T+ Y PE L G+ D G + D+WS G + E + G+ P GR
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 90/304 (29%), Positives = 144/304 (47%), Gaps = 50/304 (16%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P+K + + +KIGQG +VY A D+ + VA++++ + + + EI+++R
Sbjct: 18 PKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRE 73
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT---EAQIKCYMKQLLH 248
+PNI+ L + V L++V EY LAG + T V T E QI ++ L
Sbjct: 74 NKNPNIVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVTLWY 304
LE HS ++HRDIK N+L+ +G +K+ DFG C+Q P S+ V T ++
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-----CAQITPEQSKRSTMVGTPYW 182
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE++ YG VD+WS G + E+ G+P + L+ I G+P
Sbjct: 183 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP------ 234
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT- 423
+ Q P K ++ F+D L+ L + E RG+A LQ++F
Sbjct: 235 ----------ELQNPEK--LSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 424 TKPL 427
KPL
Sbjct: 276 AKPL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 50/304 (16%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P+K + + +KIGQG +V+ A D+ + VA+K++ + + + EI++++
Sbjct: 17 PKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKE 72
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT---EAQIKCYMKQLLH 248
L +PNI+ L + V L++V EY LAG + T V T EAQI ++ L
Sbjct: 73 LKNPNIVNF--LDSFLVGDELFVVMEY----LAGGSLTDVVTETCMDEAQIAAVCRECLQ 126
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL----WY 304
LE H+ ++HRDIK N+L+ +G +K+ DFG C+Q P S+ T+ ++
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF-----CAQITPEQSKRSTMVGTPYW 181
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE++ YG VD+WS G + E+ G+P + L+ I G+P
Sbjct: 182 MAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP------ 233
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT- 423
+ Q P K ++ F+D L+ L + E RG+A LQ+ F
Sbjct: 234 ----------ELQNPEK--LSPIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLKL 274
Query: 424 TKPL 427
KPL
Sbjct: 275 AKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 10/217 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFT-NMDPESVRFMAREIIILRRLDHPN 196
F L +IG G++ +VY ARD+ N++VA+KK+ ++ E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
++ +G + +LV EY + L E +I L GL + HS
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD- 315
++HRDIK N+L+ G +K+ DFG A S P S V T ++ PE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSA-----SIASPANSFVGTPYWMAPEVILAMDEG 199
Query: 316 -YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
Y VD+WS G EL KP + + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
F KL++IG+G++ V+K D ++VA+K + + E + + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 198 MKLEGLITSRVSGS-LYLVFEYME--HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
K G S + G+ L+++ EY+ L L A P F E QI +K++L GL++ H
Sbjct: 65 TKYYG---SYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLH 118
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S +HRDIK +N+L+ G +K+ DFG+A +Q + T W P ++ +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIQQS 176
Query: 315 DYGASVDLWSSGCILAELFAGKP 337
Y + D+WS G EL G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 36/294 (12%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
D +E + ++G G + VYKA+ E A K ++ + + E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-ELEDFMV-EIDILSECKH 61
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
PNI+ L L+++ E+ + L + TE QI+ +Q+L L
Sbjct: 62 PNIVGLYE--AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS ++HRD+K N+L+ +G +K+ DFG++ K S Q + + T ++ PE++
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVACE 178
Query: 314 TD----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
T Y D+WS G L EL +P P E+ + + K+ S
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP---------- 225
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
T+ +P + +F D S L +P+ R TA+ L++ F +
Sbjct: 226 -PTLDQP-----SKWSSSFNDFLKSC-------LVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 16/223 (7%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRF--TNMDPESVRFMAREIIILRRLDHP 195
+ L +G+G++ + + +++ A+K++R ++ E R +E ++L ++ HP
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR---KEAVLLAKMKHP 58
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
NI+ + + G LY+V EY + + + G F E I + Q+ G++H
Sbjct: 59 NIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
H + +LHRDIK N+ + NG +K+GDFG A T V T +Y PPE + +
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPE-IWEN 174
Query: 314 TDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLC 355
Y D+WS GCIL EL K P + + I K+C
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 86/304 (28%), Positives = 140/304 (46%), Gaps = 50/304 (16%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P+K + + +KIGQG +VY A D+ + VA+K++ + + + EI+++R
Sbjct: 17 PKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRE 72
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT---EAQIKCYMKQLLH 248
+PNI+ L + V L++V EY LAG + T V T E QI ++ L
Sbjct: 73 NKNPNIVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL----WY 304
L+ HS ++HRDIK N+L+ +G +K+ DFG C+Q P S+ T+ ++
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-----CAQITPEQSKRSTMVGTPYW 181
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE++ YG VD+WS G + E+ G+P + L+ I
Sbjct: 182 MAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------- 227
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT- 423
AT P+ ++ F+D L+ L + + RG+A LQ+ F
Sbjct: 228 ------ATNGTPELQNPERLSAVFRD-------FLNRCLEMDVDRRGSAKELLQHPFLKL 274
Query: 424 TKPL 427
KPL
Sbjct: 275 AKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 71/230 (30%), Positives = 112/230 (48%), Gaps = 25/230 (10%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES------VRFMAREIIILRRLDHPNI 197
+G+G + VY D + + +A+K+V F DP+S V + EI +L+ L H I
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPF---DPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 198 MKLEGLITSRVSGSLYLVFEYM-----EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
++ G + L + EYM + L A TE + Y +Q+L G+ +
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-----LTENVTRRYTRQILQGVSY 121
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK--CSQKQPLTSRVVTLWYRPPELL 310
HS I+HRDIKG+N+L D G +K+GDFG + + C + S T ++ PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
G YG D+WS C + E+ KP E E + IFK+ P++
Sbjct: 182 SGE-GYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 66/233 (28%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D E L ++G G V K K++A+K +R ++ + + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAAT-PGVK--FTEAQIKCYMKQLLHGLEH 252
I+ G +G + + EYM D L V+ E + +L GL +
Sbjct: 60 YIVGFYG--AFYNNGDISICMEYM--DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 253 CHS-RGILHRDIKGSNLLIDYNGILKIGDFG--------LANFFKCSQKQPLTSRVVTLW 303
H I+HRD+K SN+L++ G +K+ DFG LA F V T
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----------VGTSS 164
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELFAGK-----PIMPGRTEVEQLHKI 351
Y PE + G DY D+WS G L EL G+ P E L I
Sbjct: 165 YMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLEN-NKLVALKKVRFTNMD--------PESVRFMAREI- 186
+ L+ +G G + VYK R N L+ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCY 242
II +L HPNI++ + LY+V + +E + +FTE +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 243 MKQLLHGLEHCH-SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP---LTSR 298
Q++ L + H + I+HRD+ +N+++ + + I DFGLA QKQP LTS
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSV 173
Query: 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337
V T+ Y PE ++ + YG D+W+ GCIL ++ +P
Sbjct: 174 VGTILYSCPE-IVKNEPYGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 19/232 (8%)
Query: 132 PRKADSFEK---------LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRF 181
P AD F K L +IG G++ +VY A + N++VA+KK+ ++ E +
Sbjct: 8 PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67
Query: 182 MAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKC 241
+ +E+ L++L HPN ++ +G + +LV EY + L E +I
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 242 YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVT 301
L GL + HS ++HRDIK N+L+ G +K+ DFG A S+ P S V T
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGT 180
Query: 302 LWYRPPELLLGSTD--YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
++ PE++L + Y VD+WS G EL KP + + L+ I
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 78/305 (25%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 145 GQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLI 204
+ K + N LVA+KK+ + E ++ + +EII R+L HPNI+
Sbjct: 11 EDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV--- 65
Query: 205 TSRVSGS-LYLVFEYMEH----DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
TS + S LY+V M + DL L E I +K +L+ L++ HS+G +
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQ-----PLTSRVVTLWYRPPELL--- 310
HR +K S++L+ +G + + + + K ++Q S V L + PE+L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183
Query: 311 -LGSTDYGASVDLWSSGCILAEL------FAGKPIMPGRTE-----VEQLHKIFKLCGSP 358
G Y D++S G EL F P E V L
Sbjct: 184 LQG---YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 359 SEEYWKRSKLPHATIFKPQQ-PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417
RS H PY R +E F +++ L +PE R +AS L
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ-------FVELCLQRDPESRPSASQLL 293
Query: 418 QNEFF 422
+ FF
Sbjct: 294 NHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES--VRFMAREIIILRRLDH- 194
+++L+ IG+G Y +VY+ + + ++VALK + N+D V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQS 59
Query: 195 --PNIMKLEGLITSRVSG-SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
PNI K G S + G L+++ EY E G E I ++++L L+
Sbjct: 60 QPPNITKYYG---SYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALK 115
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ H G++HRDIK +N+L+ G +K+ DFG+A + + T V T ++ PE++
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVIT 174
Query: 312 GSTDYGASVDLWSSGCILAELFAGKP 337
Y D+WS G + E+ G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
F KL++IG+G++ VYK D ++VA+K + + E + + +EI +L + D P I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 198 MKLEGLITSRVSGS-LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
+ G S + G+ L+++ EY+ A PG E I ++++L GL++ HS
Sbjct: 65 TRYYG---SYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSE 120
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
+HRDIK +N+L+ G +K+ DFG+A +Q + T W P + + D+
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 317 GASVDLWSSGCILAELFAGKP 337
A D+WS G EL G+P
Sbjct: 181 KA--DIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
F KL+KIG+G++ V+K D K+VA+K + + E + + +EI +L + D P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
K G + L+++ EY+ A PG E QI ++++L GL++ HS
Sbjct: 65 TKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK 121
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYG 317
+HRDIK +N+L+ +G +K+ DFG+A +Q + + V T ++ PE++ S Y
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSA-YD 179
Query: 318 ASVDLWSSGCILAELFAGKP 337
+ D+WS G EL G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +L ++G+G SV K R + ALK + T+ +P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL-------LH 248
I+K G S S+ + EY E G + K + + K L L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCE---GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
GL + HSR I+HRDIK SN+L+ G +K+ DFG++ S T T +Y PE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPE 173
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGK-PIMP 340
+ G Y + D+WS G L E+ + P P
Sbjct: 174 RIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREII-----ILR 190
D E++ +G GT+ V+ RD + ALK + PE +R + + +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+ HP I++L T LY++ EY+ +L G +F+ + Y +++
Sbjct: 57 EVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCA 113
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW----YR 305
LE+ HS+ I++RD+K N+L+D G +K+ DFG A + L R TL Y
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEYL 165
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
PE ++ S + +VD W+ G ++ E+ G P KI
Sbjct: 166 APE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 74/235 (31%), Positives = 120/235 (51%), Gaps = 20/235 (8%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIIL 189
+ D++E ++ IG+GTY VYK + ++ L A+K + +++D E + E IL
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNIL 72
Query: 190 RRL-DHPNIMKLEGLITSR---VSGSLYLVFEY-----MEHDLAGLAATPGVKFTEAQIK 240
+ L +HPN++K G+ V G L+LV E + + GL G + EA I
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMIS 131
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+ L GL+H H+ I+HRD+KG+N+L+ G +K+ DFG++ ++ + TS V
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VG 190
Query: 301 TLWYRPPELLLGS----TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
T ++ PE++ Y A D+WS G EL G P + V+ L KI
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 75/295 (25%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
E KIG+G+ V AR+ + + VA+K + + F E++I+R H N+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAAT---PGVKFTEAQIKCYMKQLLHGLEHCH 254
+++ + V L+++ E+++ G A T + E QI + +L L + H
Sbjct: 81 VEMYK--SYLVGEELWVLMEFLQ----GGALTDIVSQTRLNEEQIATVCESVLQALCYLH 134
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGS 313
S+G++HRDIK ++L+ +G +K+ DFG + S+ P +V T ++ PE ++
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPE-VISR 191
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
T YG VD+WS G ++ E+ G+P + V+ + ++ + S P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPPKLKN 239
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
P R L+ +L+ EP+ R TA L + F LP
Sbjct: 240 AHKISPVLR--------------DFLERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+EK+ +G+G + V+ R + KLV +K++ M + E +L+ L HPNI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 198 MK-LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVK-FTEAQIKCYMKQLLHGLEHCH 254
++ E + + +L +V EY LA E I + Q+L L H H
Sbjct: 62 IEYYENFLEDK---ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 255 SRGILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
++ ILHRD+K N+L+D + ++KIGDFG++ S K + V T Y PEL G
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGK 176
Query: 314 TDYGASVDLWSSGCILAEL 332
Y D+W+ GC+L EL
Sbjct: 177 P-YNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 11/208 (5%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRRLDH 194
+ FE + +IG GTY VYKAR++ +L A+K ++ ++P E + +EII+++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
NI+ G R L++ E+ L + G +E+QI ++ L GL +
Sbjct: 66 SNIVAYFGSYLRR--DKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL 122
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL--LL 311
HS+G +HRDIKG+N+L+ NG +K+ DFG++ + + S + T ++ PE+ +
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR-KSFIGTPYWMAPEVAAVE 181
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIM 339
Y D+W+ G EL +P M
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 143 KIGQGTYSSVYKARD---LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199
++G+G++ +VY +D + +L LK++ ++P +E +L +LDHP I+K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 200 LEGLITSRVSGSLYLVFEYME-HDL---AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
R + ++ EY E DL G +E Q+ + QLL G+ + H
Sbjct: 67 FHASFLER--DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFF--KCSQKQPLTSRVVTLWYRPPELLLGS 313
R ILHRD+K N+ + N +LKIGDFG++ C T T +Y PE L
Sbjct: 125 RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKH 179
Query: 314 TDYGASVDLWSSGCILAEL 332
Y + D+WS GCIL E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 41/284 (14%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
KIG+G+ V A + K VA+KK+ + F E++I+R H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 203 LITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT---EAQIKCYMKQLLHGLEHCHSRGIL 259
+ V L++V E++E G A T V T E QI +L L + H++G++
Sbjct: 87 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDYGA 318
HRDIK ++L+ +G +K+ DFG + S++ P +V T ++ PE ++ YG
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPE-VISRLPYGT 197
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378
VD+WS G ++ E+ G+P ++ + +I R LP P+
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------RDNLP------PR- 237
Query: 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
V ++ K + S LD++L EP R TA LQ+ F
Sbjct: 238 -----VKDSHK-VSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRLDH 194
F+ L ++GQG Y V+ A+ + ++VALK K ++ VR + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN--EVRHVLTERDILTTTKS 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
++KL L + LYL EY+ D L GV +E + YM ++ ++
Sbjct: 61 EWLVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDAL 117
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT---SRVVTLWYRPPELL 310
H G +HRD+K N LID +G +K+ DFGL+ K +T S V + Y PE+L
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVTYANSVVGSPDYMAPEVL 170
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRT 343
G Y +VD WS GC+L E G P G T
Sbjct: 171 RG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+E + ++G GTY VYKAR+L +L A+K ++ D S+ + +EI +++ H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNI 68
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
+ G SR L++ EY L + G +E QI ++ L GL + HS+
Sbjct: 69 VAYFGSYLSR--EKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK 125
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD- 315
G +HRDIKG+N+L+ NG +K+ DFG+A + + S + T ++ PE+ +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEKNG 184
Query: 316 -YGASVDLWSSGCILAELFAGKPIM 339
Y D+W+ G EL +P M
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 47/257 (18%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
D FE + IG+G + V + + + A+KK+R + M + E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK---FTEAQIKCYMKQLLHGLE 251
P ++KL + + LYL+ EY+ G T +K FTE + + Y+ + + ++
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEYLP---GGDMMTLLMKKDTFTEEETRFYIAETILAID 115
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-------------------- 291
H G +HRDIK NLL+D G +K+ DFGL K S
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 292 KQPLTS-RVVTLW----------------YRPPELLLGSTDYGASVDLWSSGCILAELFA 334
+P++S R W Y PE+ L T Y D WS G I+ E+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLV 234
Query: 335 GKPIMPGRTEVEQLHKI 351
G P E KI
Sbjct: 235 GYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 89/306 (29%), Positives = 145/306 (47%), Gaps = 50/306 (16%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +E + ++G G + VYKA++ E L A K + T + E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMV-EIEILATCNHP 69
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH---DLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
I+KL G G L+++ E+ D L G+ TE QI+ +Q+L L++
Sbjct: 70 YIVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVICRQMLEALQY 125
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGL-ANFFKCSQKQPLTSRVVTLWYRPPELLL 311
HS I+HRD+K N+L+ +G +K+ DFG+ A K Q++ S + T ++ PE+++
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVM 183
Query: 312 GST------DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
T DY A D+WS G L E+ I P E+ + + K+ +
Sbjct: 184 CETMKDTPYDYKA--DIWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------K 229
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF--- 422
S+ P + QP K + F+D L L PE R +A+ L++ F
Sbjct: 230 SEPPTLS-----QPSKWSM--EFRD-------FLKTALDKHPETRPSAAQLLEHPFVSSV 275
Query: 423 -TTKPL 427
+ +PL
Sbjct: 276 TSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 73/240 (30%), Positives = 118/240 (49%), Gaps = 21/240 (8%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIILR 190
P +D++E ++ IG+GTY V+K + +N A+K + ++D E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 191 RL-DHPNIMKLEGLITSR--VSG-SLYLVFEYME----HDLAGLAATPGVKFTEAQIKCY 242
L DHPN++K G+ + +G L+LV E DL G + E I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ + L GL+H H +HRD+KG+N+L+ G +K+ DFG++ ++ + TS
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 303 WYRPP----ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358
W P E L ST Y A D+WS G EL G P + ++ + +FK+ +P
Sbjct: 190 WMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 20/205 (9%)
Query: 141 LDKIGQGTYSSVYKAR--DLENN--KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
+ ++G+G + SV R L++N ++VA+KK++ + E +R REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
I+K +G+ S +L LV EY+ + L + ++ Y Q+ G+E+ S
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-----KQPLTSRVVTLWYRPPELL 310
+ +HRD+ N+L++ +KIGDFGL + ++P S + WY P L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPESL- 183
Query: 311 LGSTDYGASV--DLWSSGCILAELF 333
T+ SV D+WS G +L ELF
Sbjct: 184 ---TESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+KIG+G + VYK L+ N VA+K R T +F+ +E IL++ DHPNI+KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH-------GLEHCH 254
G+ + +Y+V E + G + ++ + ++ +K+LL G+E+
Sbjct: 59 GVCVQKQP--IYIVMELV----PGGSLLTFLRKKKNRLT--VKKLLQMSLDAAAGMEYLE 110
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLA-----NFFKCSQKQPLTSRVVTLWYRPPEL 309
S+ +HRD+ N L+ N +LKI DFG++ + S ++ W P L
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG---LKQIPIKWTAPEAL 167
Query: 310 LLGSTDYGASVDLWSSGCILAELFAG 335
G Y + D+WS G +L E F+
Sbjct: 168 NYGR--YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
KIG+G+ V A + KLVA+KK+ + F E++I+R H N++++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 203 LITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT---EAQIKCYMKQLLHGLEHCHSRGIL 259
+ V L++V E++E G A T V T E QI +L L H++G++
Sbjct: 85 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVTLWYRPPELLLGSTD 315
HRDIK ++L+ ++G +K+ DFG C+Q R V T ++ PE L+
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGF-----CAQVSKEVPRRKSLVGTPYWMAPE-LISRLP 192
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375
YG VD+WS G ++ E+ G+P ++ + I R LP
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP------ 233
Query: 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
P+ V+ + K LD LL +P R TA+ L++ F P
Sbjct: 234 PKLKNLHKVSPSLK-------GFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDHPNIMKLEG 202
+G+G + V + K+ A KK+ + MA E IL ++ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 203 LITSRVSGSLYLV--------FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
++ L + + G F EA+ Y Q++ GLEH H
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEHLH 112
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
R I++RD+K N+L+D +G ++I D GLA K + + R T Y PE+L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
Y SVD ++ GC L E+ AG+ R E + ++ + + EY
Sbjct: 171 -YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 17/228 (7%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKL-VALKKVRFTNMDPESVRFMAREII 187
W +PR +S + K+G G + V+ N VA+K ++ M PE+ +E
Sbjct: 1 WEIPR--ESLKLERKLGAGQFGEVWMG--TWNGTTKVAVKTLKPGTMSPEA---FLQEAQ 53
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQ 245
I+++L H +++L + + +Y+V EYM L L + G K Q+ Q
Sbjct: 54 IMKKLRHDKLVQLYAVCSEE--EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ 111
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT-SRVVTLWY 304
+ G+ + SR +HRD+ N+L+ N + KI DFGLA + + ++ W
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
P G + D+WS G +L E+ G+ PG T E L ++
Sbjct: 172 APEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 84/306 (27%), Positives = 133/306 (43%), Gaps = 44/306 (14%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL-DHPNIMK 199
IG+G + VY R + K+ A+K K R E++ R ++ L D P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
+ + L + + M DL + GV F+EA+++ Y +++ GLEH H+R +
Sbjct: 62 MSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGA 318
++RD+K +N+L+D +G ++I D GLA F S+K+P S V T Y PE+L Y +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEVLQKGVAYDS 175
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378
S D +S GC+L +L G SP ++ + K +
Sbjct: 176 SADWFSLGCMLFKLLRGH--------------------SPFRQHKTKDKHEIDRMTLTMA 215
Query: 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVR-----GTASSALQNEFFTTKPLPCDPSS 433
E SLL+ LL + R A ++ FF + L
Sbjct: 216 V------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF--RSLDWQMVF 267
Query: 434 LPKYPP 439
L KYPP
Sbjct: 268 LQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 87/305 (28%), Positives = 140/305 (45%), Gaps = 49/305 (16%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +E + ++G G + VYKA++ E ++A KV T + E +M EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKET-GVLAAAKVIDTKSEEELEDYMV-EIDILASCDHP 62
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGV-----KFTEAQIKCYMKQLLHGL 250
NI+KL L +L+++ E+ AG A + TE QI+ KQ L L
Sbjct: 63 NIVKL--LDAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL-ANFFKCSQKQPLTSRVVTLWYRPPEL 309
+ H I+HRD+K N+L +G +K+ DFG+ A + Q++ S + T ++ PE+
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEV 174
Query: 310 LLGSTD----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
++ T Y D+WS G L E+ I P E+ + + K+ +
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------K 222
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT-- 423
S+ P T+ +P + + FKD L L + R T + LQ+ F T
Sbjct: 223 SEPP--TLAQPSR-----WSSEFKD-------FLKKCLEKNVDARWTTTQLLQHPFVTVN 268
Query: 424 -TKPL 427
KP+
Sbjct: 269 SNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 83/326 (25%), Positives = 138/326 (42%), Gaps = 27/326 (8%)
Query: 137 SFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRR 191
+FE L +G G Y V+ R + + KL A+K ++ + ++V E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 192 L-DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+ P ++ L + L+L+ +Y+ F+E +++ Y +++ L
Sbjct: 61 VRQSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
EH H GI++RDIK N+L+D G + + DFGL+ F +K+ S T+ Y PE++
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKP--IMPGR--TEVEQLHKIFKLCGS-PSEEYWKR 365
G +G +VD WS G ++ EL G + G T+ E +I K PS +
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 366 SKLPHATIFKPQQPYKRCVAET-----------FKDIPSSALSLLDILLSTEPEVRG-TA 413
L H + K P KR A FK + AL+L + P +R
Sbjct: 239 QDLLHKLLRK--DPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELD 296
Query: 414 SSALQNEFFTTKPLPCDPSSLPKYPP 439
EF +P+ + P
Sbjct: 297 VGNFAEEFTNLEPVYSPAGTPPSGAR 322
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 9/223 (4%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
F+ +G+G + V R+ + A+K ++ + + E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P I +L+ +LYLV EY DL L +F E + Y+ +L+ +
Sbjct: 61 PWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL-- 311
H G +HRDIK N+LID G +K+ DFG A ++ V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 312 ---GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
G YG D WS G I E+ G+ T + + I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR----DLENNK-LVALKKVRFTNMDPESVRFMAREIII 188
+ D+ ++G+G + V+ + EN+K LVA+K ++ T + F RE +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-REAEL 61
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL----------AGLAATPGVKFTEA 237
L H NI+K G+ T +VFEYMEH DL A +P E
Sbjct: 62 LTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 238 QIKCYMK---QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQ 293
+ ++ Q+ G+ + S+ +HRD+ N L+ Y+ ++KIGDFG++ + + +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 294 PLTSRVVTLWYRPPELLLGSTDYG---ASVDLWSSGCILAELFA-GK 336
++ + + PPE S Y D+WS G +L E+F GK
Sbjct: 180 VGGHTMLPIRWMPPE----SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+G+G++ V+ A N+ A+K ++ MD + M + ++ +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
T + +L+ V EY+ KF + Y +++ GL+ HS+GI++R
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP----PELLLGSTDYG 317
D+K N+L+D +G +KI DFG+ C + ++ T P PE+LLG Y
Sbjct: 121 DLKLDNILLDTDGHIKIADFGM-----CKENMLGDAKTCTFCGTPDYIAPEILLGQK-YN 174
Query: 318 ASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
SVD WS G +L E+ G+ G E E I
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D E LD++G+G Y SVYK +A+K++R +D + E+ IL + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHD-----LAGLAATPGVKFTEAQIKCYMKQLLHGL 250
I+ G + G++Y+ EYM+ AG AT G+ E ++ ++ GL
Sbjct: 60 YIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIP--EDVLRRITYAVVKGL 115
Query: 251 -----EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRVVTLWY 304
EH I+HRD+K +N+L++ NG +K+ DFG++ N K + + Y
Sbjct: 116 KFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS----Y 167
Query: 305 RPPELL--LGSTD---YGASVDLWSSGCILAELFAGKPIMPGRT 343
PE + G Y D+WS G + E+ G+ P T
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-VRFMAREIIILRRLDHPNIMKLEG 202
IG+G++ V + R + ++ ALK +R ++ S V E +L +++ P I+ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 203 LITSRVSGSLYLVFEYME-----HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
S LYLV ++ H L +F ++ + Y +LL LE+ H
Sbjct: 61 SFQSP--EKLYLVLAFINGGELFHHLQREG-----RFDLSRARFYTAELLCALENLHKFN 113
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW----YRPPELLLGS 313
+++RD+K N+L+DY G + + DFGL C + T Y PELLLG
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGL-----CKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 314 TDYGASVDLWSSGCILAELFAGKP 337
Y +VD W+ G +L E+ G P
Sbjct: 169 -GYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 40/234 (17%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-VRFMAREIIILRRLDH 194
F+K+ +G+G V+ R KL ALK + M + V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 195 PNIMKLEGLI-TSRVSGSLYLVFEY-MEHDL-AGLAATPGVKFTEAQIKCYMKQLLHGLE 251
P + L T L LV +Y +L L PG +E + Y ++L LE
Sbjct: 61 PFLPTLYASFQTETY---LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR------------- 298
+ H GI++RD+K N+L+ +G + + DF L+ + + P S+
Sbjct: 118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLS--KQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 299 -----------------VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG 335
V T Y PE++ G +G++VD W+ G +L E+ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 141 LDKIGQGTYSSVYKARDL---ENNKLVALK-------KVRFTNMDPESVRF-MAREIIIL 189
L +GQG++ V+ R + + +L A+K KVR + VR M R+I L
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR------DRVRTKMERDI--L 52
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
++HP I+KL + G LYL+ +++ + V FTE +K Y+ +L
Sbjct: 53 AEVNHPFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 110
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
L+H HS GI++RD+K N+L+D G +K+ DFGL+ ++ S T+ Y PE
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE- 168
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
++ + S D WS G ++ E+ G G+ E + I K
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+G+G++ V A ++L A+K ++ D + M + ++ HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 202 GLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
++ L+ V EY+ DL G +F E + + Y +++ GL+ H RGI++
Sbjct: 63 SCFQTK--DRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW------YRPPELLLGST 314
RD+K N+L+D G +KI DFG+ C K+ + V T Y PE+L
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGM-----C--KEGILGGVTTSTFCGTPDYIAPEILSY-Q 171
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
YG +VD W+ G +L E+ AG+ G E E I
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 65/197 (32%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL-DHPNIMK 199
IG+G + VY R + K+ A+K K R E++ R ++ L D P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
+ L + + M DL + GV F+E +++ Y +++ GLEH H+R +
Sbjct: 62 MT--YAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFV 118
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGA 318
++RD+K +N+L+D +G ++I D GLA F S+K+P S V T Y PE+L T Y +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEVLQKGTAYDS 175
Query: 319 SVDLWSSGCILAELFAG 335
S D +S GC+L +L G
Sbjct: 176 SADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKV--RFTNMDPESVRFMAREIIILRRL--DHPNIMK 199
IG+GT+ VY+ R + ++ A+K + + E + I++R L + P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 200 LEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
L+ + + LYLV +YM +F+E + K Y+ +L+ LEH H I+
Sbjct: 61 LK--FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV------TLWYRPPELLLGS 313
+RD+K N+L+D G + + DFGL+ K LT T Y PE+LL
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-------KANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 314 TDYGASVDLWSSGCILAELFAG 335
Y VD WS G ++ E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 138 FEKLDKIGQGTYSSV----YKARDLENNKLVALKKVRFTNMDPES----VRFMAREIIIL 189
+++ +G+G + V Y + VA+K ++ PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEIL 60
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH 248
R L H NI+K +G+ T + L+ E++ L K Q Y Q+
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-----KQPLTSRVVTLW 303
G+++ SR +HRD+ N+L++ +KIGDFGL + + K L S V W
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FW 178
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELF 333
Y PE L+ S Y AS D+WS G L EL
Sbjct: 179 Y-APECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 12/224 (5%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +IG G + V+ LE K VA+K +R M E E ++ +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
+++L G+ T R + LVFE+MEH L+ KF++ + + G+ +
Sbjct: 60 KLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S ++HRD+ N L+ N ++K+ DFG+ F Q T + + PE+ S
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS- 176
Query: 315 DYGASVDLWSSGCILAELFA-GKPIMPGRTE---VEQLHKIFKL 354
Y + D+WS G ++ E+F+ GK R+ VE ++ F+L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 164 VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD- 222
VA+K +R M + F+ E ++ +L HPN+++L G+ T + +++V EYM +
Sbjct: 31 VAIKMIREGAMSEDD--FI-EEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVTEYMANGC 85
Query: 223 -LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281
L L G K + + +E+ S G +HRD+ N L+ + ++K+ DF
Sbjct: 86 LLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDF 144
Query: 282 GLANF-----FKCSQ--KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA 334
GLA + + SQ K P+ + PPE+ + + + D+WS G ++ E+F+
Sbjct: 145 GLARYVLDDQYTSSQGTKFPVK-------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFS 196
Query: 335 -GKPIMPGRTE---VEQLHKIFKL 354
GK + VE + ++L
Sbjct: 197 EGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 144 IGQGTYSSVYKARDLENN-KLVALKKVRFTNMDPESV-------RFMAREIIILRRLDHP 195
+G+G Y +VY L N +L+A+K+V +D +V + E+ +L+ L H
Sbjct: 8 LGKGAYGTVYCG--LTNQGQLIAVKQVE---LDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK----FTEAQIKCYMKQLLHGLE 251
NI++ G + S+++ F + G + + + E Y KQ+L G+
Sbjct: 63 NIVQYLGTCLDDNTISIFMEF------VPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF-----KCSQKQPLTSRVVTLWYRP 306
+ H+ ++HRDIKG+N+++ NGI+K+ DFG A + L S T ++
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKP 337
PE ++ + YG D+WS GC + E+ GKP
Sbjct: 177 PE-VINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 9/205 (4%)
Query: 138 FEKLDKIGQGTYSSVYKARDLEN---NKLVA---LKKVRFTNMDPESVRFMAREIIILRR 191
FE L +G G Y V+ R + KL A LKK + ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
P ++ L + L+L+ +Y+ FTE++++ Y+ +++ L+
Sbjct: 62 RRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
H H GI++RDIK N+L+D G + + DFGL+ F +++ S T+ Y PE++
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 312 GSTD-YGASVDLWSSGCILAELFAG 335
G + + +VD WS G + EL G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 5e-17
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
A FE ++ +G GTY VYK R ++ +L A+K + T + E ++ +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 195 -PNIMKLEGLITSR----VSGSLYLVFEYMEH----DLAGLAATPGVKFTEAQIKCYMKQ 245
NI G + + L+LV E+ DL + T G E I ++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 119
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVT 301
+L GL H H ++HRDIKG N+L+ N +K+ DFG++ +Q R + T
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGT 174
Query: 302 LWYRPPELLLGSTD----YGASVDLWSSGCILAELFAGKP 337
++ PE++ + Y DLWS G E+ G P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
A FE ++ +G GTY VYK R ++ +L A+K + T + E ++ EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 195 -PNIMKLEGLITSRV----SGSLYLVFEYMEH----DLAGLAATPGVKFTEAQIKCYMKQ 245
NI G + L+LV E+ DL + T G E I ++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL--VKNTKGNALKEDWIAYICRE 129
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVT 301
+L GL H H+ ++HRDIKG N+L+ N +K+ DFG++ +Q R + T
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGT 184
Query: 302 LWYRPPELLLGSTD----YGASVDLWSSGCILAELFAGKP 337
++ PE++ + Y D+WS G E+ G P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMARE 185
PR ++ E + IGQG + V++AR E +VA+K ++ F RE
Sbjct: 2 YPR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 58
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME--------------------HDLAG 225
++ DHPNI+KL G+ V + L+FEYM H +
Sbjct: 59 AALMAEFDHPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 226 LAATPGVK--FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL 283
+ + C KQ+ G+ + R +HRD+ N L+ N ++KI DFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 284 ------ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA 334
A+++K S+ + R + PPE + Y D+W+ G +L E+F+
Sbjct: 177 SRNIYSADYYKASENDAIPIR-----WMPPESIF-YNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 80/291 (27%), Positives = 121/291 (41%), Gaps = 50/291 (17%)
Query: 144 IGQGTYSSVYKARDLENNKLVA---LKK-VRFTNMDPESVRFMAREIIILRRLDHPNIMK 199
+G+G++ V A N+ A LKK V + D E + R ++ L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT-MVERRVLALA-WEHPFLTH 60
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
L T + L+ V EY+ DL + G +F EA+ + Y +++ GL+ H +GI
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGI 117
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW----YRPPELLLGST 314
++RD+K N+L+D +G +KI DFG+ C + + T Y PE+L G
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
Y SVD WS G +L E+ G+ G E E I + PH
Sbjct: 173 -YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-------------LNDRPH---- 214
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-GTASSALQNEFFTT 424
+ R I A L L +P R G Q+ FF
Sbjct: 215 -----FPRW-------ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 138 FEKLDKIGQGTYSSV----YKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
+K+ +G+G + V Y + ++VA+K ++ ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEH 252
H NI+K +G + + L L+ EY+ L L P K AQ+ + +Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV------TLWYRP 306
HS+ +HRD+ N+L+D + ++KIGDFGLA K + RV WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA---KAVPEGHEYYRVREDGDSPVFWY-A 178
Query: 307 PELLLGSTDYGASVDLWSSGCILAELF 333
E L + AS D+WS G L EL
Sbjct: 179 VECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 12/223 (5%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
PR+ F K+G G + V++ +N VA+K ++ ++ + +E+ L+R
Sbjct: 4 PRE--EFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDL--LKQQDFQKEVQALKR 58
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATP-GVKFTEAQIKCYMKQLLHG 249
L H +++ L + + +Y++ E ME L +P G A + Q+ G
Sbjct: 59 LRHKHLISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
+ + + +HRD+ N+L+ + + K+ DFGLA K ++ W P
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 310 LLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
G+ + D+WS G +L E+F G+ PG E +I
Sbjct: 177 SHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 144 IGQGTYSSVYKARDL---ENNKLVA---LKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+G+G Y V++ R + + K+ A LKK ++ A E IL + HP I
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 198 MKLEGLITSRVSGSLYLVFEY-------MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+ L + + G LYL+ EY M + G+ F E Y+ ++ L
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-------FMEDTACFYLSEISLAL 113
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV------TLWY 304
EH H +GI++RD+K N+L+D G +K+ DFGL C K+ + V T+ Y
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL-----C--KESIHEGTVTHTFCGTIEY 166
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
PE+L+ S +G +VD WS G ++ ++ G P + + KI K
Sbjct: 167 MAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
+G+G+Y V R + K +KK+ N + +E +L +L HPNI
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 204 ITSRVS-----GSLYLVFEYMEH-DL-AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
+ R S G LY+V + E DL L G E Q+ + Q+ L++ H +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
ILHRD+K N+ + I+K+GD G+A + +Q ++ + T +Y PE L + Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPY 179
Query: 317 GASVDLWSSGCILAEL 332
D+W+ GC + E+
Sbjct: 180 NYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 60/226 (26%), Positives = 111/226 (49%), Gaps = 27/226 (11%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
VPR ++ + + K+G G + V+ + VA+K ++ +M PE+ F+A E +++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
+L HP +++L ++T +Y++ EYME+ + L G+K T ++ Q+
Sbjct: 57 QLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-------KQPLTSRVVT 301
G+ + +HRD++ +N+L+ KI DFGLA + ++ K P+
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----- 168
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVE 346
W P + G+ + D+WS G +L E+ G+ PG T E
Sbjct: 169 -WTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 120 TAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDP 176
+ W K FE + +G G++ V A+ + A LKK M
Sbjct: 5 YMFTKPDTSSW---KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM-- 59
Query: 177 ESVRFMAREIIILRRLDHPNIMK-LEGLITSRVSGSLYLVFEY-MEHDLAGLAATPGVKF 234
+ V+ +A+E IL L HP I+ + +Y + E+ + +L G +F
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDEN---RVYFLLEFVVGGELFTHLRKAG-RF 115
Query: 235 TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294
K Y +L+ E+ HS+ I++RD+K NLL+D G +K+ DFG A +
Sbjct: 116 PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KK 167
Query: 295 LTSRVVTLW----YRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337
+ R TL Y PE ++ S +G +VD W+ G +L E AG P
Sbjct: 168 VPDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVR----FTNMDPESVRFMAREIIILRRLD 193
F L +G+G + V A + +L A+K ++ + ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEY------MEHDLAGLAATPGVKFTEAQIKCYMKQLL 247
HP ++ L + + V EY M H + F+E + Y ++
Sbjct: 61 HPFLVNLFACF--QTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFYAACVV 111
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP- 306
GL++ H I++RD+K NLL+D G +KI DFGL C + R T P
Sbjct: 112 LGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEGMGFGDRTSTFCGTPE 166
Query: 307 ---PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE 346
PE+L T Y +VD W G ++ E+ G+ PG E E
Sbjct: 167 FLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 75/258 (29%), Positives = 108/258 (41%), Gaps = 48/258 (18%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDHPN 196
F K+ IG G + V R ++ N L A+K +R + + + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
++KL + + +LY V +Y+ D+ L G+ F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFF------KCSQK----------------- 292
G +HRDIK N+LID +G +K+ DFGL F K QK
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 293 ------QPLTSR-------------VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
+PL R V T Y PE+LL T Y D WS G IL E+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 334 AGKPIMPGRTEVEQLHKI 351
G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 20/235 (8%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDHP 195
+F +G+G + V + K+ A KK+ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME--------HDLAGLAATPGVKFTEAQIKCYMKQLL 247
++ L ++ +L LV M +++ PG F E + Y ++
Sbjct: 61 FVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYNMG----NPG--FDEERAVFYAAEIT 112
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
GLE H I++RD+K N+L+D G ++I D GLA + + + + RV T+ Y P
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
E ++ + Y S D W GC++ E+ GK R E + ++ + EEY
Sbjct: 171 E-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 13/226 (5%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W + R S + L K+G G + V++ N VA+K ++ MDP+ F+ E I
Sbjct: 1 WEIDRT--SIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKD--FL-AEAQI 54
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQL 246
+++L HP +++L + T + +Y+V E M++ L L G Q+ Q+
Sbjct: 55 MKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
G+ + ++ +HRD+ N+L+ N I K+ DFGLA K + + +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
PE L + D+WS G +L E+ G+ PG T E L ++
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKV-RFTNMDPESVRFMAREIIILRRL 192
KA+ F+ + IG+G + V R + ++ A+K + +F + F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
+ I++L LY+V EYM DL L + + E + Y +++ L+
Sbjct: 101 NSEWIVQLHYAFQD--DKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTAEVVLALD 156
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
HS G +HRD+K N+L+D +G LK+ DFG + + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 312 ---GSTDYGASVDLWSSGCILAELFAGKP 337
G YG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 74/240 (30%), Positives = 104/240 (43%), Gaps = 26/240 (10%)
Query: 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270
LY V EY+ DL G KF E Q Y ++ GL H RGI++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 271 DYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELLLGSTDYGASVDLWSSGCI 328
D G +KI DFG+ K +T+R T Y PE ++ YG SVD W+ G +
Sbjct: 135 DSEGHIKIADFGMC---KEHMVDGVTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVL 190
Query: 329 LAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK---PQQPYKR--C 383
L E+ AG+P G E E I + + Y K +I K + P KR C
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSIME----HNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246
Query: 384 VAETFKDIPSSA---------LSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSL 434
E +DI A L +I +P+V G + F +P+ P L
Sbjct: 247 GPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQL 306
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 55/310 (17%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM----DPESVRFMAREIIILRR 191
+ FE + I G Y +VY R E + A+KK+ N+ + V F+ R+I L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDI--LTF 57
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
++P ++ + ++ L +V EY+E D A L G + + Y + + L
Sbjct: 58 AENPFVVSMFCSFETK--RHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVLAL 114
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA---------NFFKCS----QKQPLTS 297
E+ H+ GI+HRD+K NLLI G +K+ DFGL+ N ++ ++ L
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 298 RVV-TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG 356
+V T Y PE++L YG VD W+ G IL E G G T E ++
Sbjct: 175 QVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI---- 229
Query: 357 SPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-GTASS 415
S++ I P E + +P+ A L+ LL P R GT +
Sbjct: 230 --SDD-----------IEWP---------EGDEALPADAQDLISRLLRQNPLERLGTGGA 267
Query: 416 A--LQNEFFT 423
Q+ FF
Sbjct: 268 FEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 137 SFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRR 191
+FE L +G G Y V+ R + ++ KL A+K ++ + ++ E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 192 LDH-PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+ P ++ L + L+L+ +Y+ + +F E +++ Y +++ L
Sbjct: 61 IRQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
EH H GI++RDIK N+L+D NG + + DFGL+ F + + S T+ Y P+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 311 L-GSTDYGASVDLWSSGCILAELFAG 335
G + +VD WS G ++ EL G
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 51/148 (34%), Positives = 73/148 (49%), Gaps = 4/148 (2%)
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMK 244
E +LRRL HP ++ L L V G LV DL AQ+ +
Sbjct: 210 EARLLRRLSHPAVLAL--LDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLW 303
QLL +++ H GI+HRDIK N+L++ + +GDFG A F + S P + T+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAE 331
PE+L G Y SVD+WS+G ++ E
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIIL 189
W + + IG+G + V D K VA+K ++ + ++ F+A E ++
Sbjct: 1 WAINSKE-LKLGATIGKGEFGDVMLG-DYRGQK-VAVKCLKDDSTAAQA--FLA-EASVM 54
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVK-FTEAQIKCYMKQLL 247
L HPN+++L G++ LY+V EYM L + G T AQ + +
Sbjct: 55 TTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
G+E+ + +HRD+ N+L+ + + K+ DFGLA K + + + ++ W P
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPE 169
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA 334
L + D+WS G +L E+++
Sbjct: 170 ALREKK--FSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 72/264 (27%), Positives = 111/264 (42%), Gaps = 52/264 (19%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDHPN 196
F K+ +G G + V AR ++ L A+K +R + + V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
+++L + + +LY V +Y+ D+ L G+ F E + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFF---------------------------- 287
G +HRDIK N+LID +G +K+ DFGL F
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 288 ----KCSQK-QPLTSR-------------VVTLWYRPPELLLGSTDYGASVDLWSSGCIL 329
+C + +PL R V T Y PE+LL T Y D WS G IL
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 330 AELFAGKPIMPGRTEVEQLHKIFK 353
E+ G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 75/240 (31%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270
LY V EY+ DL G KF E Y ++ GL HS+GI++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 271 DYNGILKIGDFGLA--NFFKCSQKQPLTSRVV--TLWYRPPELLLGSTDYGASVDLWSSG 326
D G +KI DFG+ N F T+R T Y PE++ YG SVD W+ G
Sbjct: 135 DAEGHIKIADFGMCKENIF-----GGKTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAFG 188
Query: 327 CILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK---PQQPYKR- 382
+L E+ AG+P G E E +F+ + Y K +I K + P KR
Sbjct: 189 VLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
Query: 383 -CVAETFKDIPSSA---------LSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPS 432
C +DI A L +I +P+V+G S+ ++FFT +P P
Sbjct: 245 GCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPP 304
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 8/192 (4%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
K+G G Y VY+ + + VA+K ++ M+ E F+ +E +++ + HPN+++L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHPNLVQLLG 69
Query: 203 LITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYM-KQLLHGLEHCHSRGILH 260
+ T Y++ E+M + +L + A + YM Q+ +E+ + +H
Sbjct: 70 VCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASV 320
RD+ N L+ N ++K+ DFGL+ + + PE L + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKS 186
Query: 321 DLWSSGCILAEL 332
D+W+ G +L E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 71/242 (29%), Positives = 107/242 (44%), Gaps = 43/242 (17%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P + E L +IG GT VYK R + ++A+K++R T E+ R + ++L+
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYME------------------HDLAGLAATPGVK 233
D P I+K G + VF ME D+ G K
Sbjct: 71 HDCPYIVKCYGYFITDSD-----VFICMELMSTCLDKLLKRIQGPIPEDILG-------K 118
Query: 234 FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293
T A +K LH L+ H G++HRD+K SN+L+D +G +K+ DFG++ S+ +
Sbjct: 119 MTVAIVKA-----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171
Query: 294 PLTSRVVTLWYRPPELLLGST---DYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLH 349
++ Y PE + Y D+WS G L EL G+ P +TE E L
Sbjct: 172 TRSAGCAA--YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT 229
Query: 350 KI 351
KI
Sbjct: 230 KI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
++IG+G + V+ R +N VA+K R T + P+ +E IL++ HPNI++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 202 GLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
G+ T + +Y+V E ++ D T G + ++ ++ G+E+ S+ +H
Sbjct: 60 GVCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS------RVVTLWYRPPELLLGST 314
RD+ N L+ +LKI DFG++ ++ + + ++ W P L G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR- 172
Query: 315 DYGASVDLWSSGCILAELFA 334
Y + D+WS G +L E F+
Sbjct: 173 -YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 9/207 (4%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKV-RFTNMDPESVRFMAREIIILRRL 192
KA+ ++ + IG+G + V R + K+ A+K + +F + F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
+ P +++L + LY+V EYM DL L + V E K Y +++ L+
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLALD 156
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
HS G++HRD+K N+L+D +G LK+ DFG + + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 312 ---GSTDYGASVDLWSSGCILAELFAG 335
G YG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 18/231 (7%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR +S + + K+G G + V+ N K VA+K ++ M PES E I++
Sbjct: 3 IPR--ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
+L H +++L +++ +Y+V EYM L L G + Q+
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT-SRVVTLWYRPP 307
G+ + +HRD++ +N+L+ + KI DFGLA + ++ ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GK---PIMPGRTEVEQLHKIFKL 354
L G + D+WS G +L EL G+ P M R +EQ+ + +++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 22/226 (9%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+ IG+G + +V + + VA+K ++ D + F+ E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGEYT--GQKVAVKNIK---CDVTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 202 GLITSRVSGSLYLVFEYMEH-DLAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
G+I + LY+V E M +L T G + Q+ + + G+E+ S+ ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGAS 319
HRD+ N+L+ +G+ K+ DFGLA + S++ W P L + +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHKK--FSSK 177
Query: 320 VDLWSSGCILAELF----AGKPIMPGRTEVEQLHKIFKLCGSPSEE 361
D+WS G +L E+F A P M + E + K +++ P E
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 5/133 (3%)
Query: 230 PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289
PG F E + Y ++L GLE H ++RD+K N+L+D G ++I D GLA K
Sbjct: 97 PG--FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKI 152
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLH 349
+ + + RV T+ Y PE +L + Y S D W GC++ E+ G+ GR E +
Sbjct: 153 PEGESIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211
Query: 350 KIFKLCGSPSEEY 362
++ + E Y
Sbjct: 212 EVDRRVLETEEVY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-15
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 181 FMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEA--- 237
+ EI+ L RL+H NI+K+E ++ R + Y++ + + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 238 -QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296
Q + MKQLL +E+ H + ++HRDIK N+ ++ +G + +GDFG A F+ ++
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP----GRTEVEQLHKIF 352
V T+ PE+L G Y D+WS G IL ++ + P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 353 KLCGSPSEEY 362
EE+
Sbjct: 385 DSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 42/246 (17%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
A+ + L +IG+G + +V K + ++A+K++R T + E R + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGV--------------KFTEAQIK 240
P I+K G + G ++ E M+ L V K A +K
Sbjct: 63 PYIVKFYGALFRE--GDCWICMELMDISLDKFYKY--VYEVLKSVIPEEILGKIAVATVK 118
Query: 241 C--YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298
Y+K+ L I+HRD+K SN+L+D NG +K+ DFG+ Q ++
Sbjct: 119 ALNYLKEELK---------IIHRDVKPSNILLDRNGNIKLCDFGI-----SGQLVDSIAK 164
Query: 299 VVTLWYRP---PELLLGSTDYGASV--DLWSSGCILAELFAGKPIMPGRTEV-EQLHKIF 352
RP PE + S G V D+WS G L E+ GK P V +QL ++
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
Query: 353 KLCGSP 358
K G P
Sbjct: 225 K--GDP 228
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 63/258 (24%), Positives = 111/258 (43%), Gaps = 28/258 (10%)
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGSLY-LVFEYMEHDLAGLAATPGVKFTEAQIKCYM 243
E ++L+ ++HP++++++ + VSG++ +V + DL Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTL---VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 244 KQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TL 302
KQ+L GL + H++ I+HRD+K N+ I+ + IGD G A + P + T+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA---QFPVVAPAFLGLAGTV 220
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFA----------GKPIMPGRTEVEQLHKIF 352
PE +L Y + D+WS+G +L E+ A P ++ L KI
Sbjct: 221 ETNAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 353 KLCGSPSEEYWKR--SKLPHATIFKP---QQPYKR--CVAETFKDIPSSALSLLDILLST 405
EE+ + S+L I +QPY R C ++P L+ +L+
Sbjct: 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV--NLPIDGEFLVHKMLTF 337
Query: 406 EPEVRGTASSALQNEFFT 423
+ +R +A L F
Sbjct: 338 DAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 12/226 (5%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D E ++++G+G Y V K R + ++A+K++R T E R + I +R +D P
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGL---AATPGVKFTEAQIKCYMKQLLHGLEH 252
+ G + G +++ E M+ L G+ E + ++ LE+
Sbjct: 61 YTVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 253 CHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
HS+ ++HRD+K SN+LI+ NG +K+ DFG++ + S + T Y PE +
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERIN 176
Query: 312 GSTD---YGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFK 353
+ Y D+WS G + EL G+ P +T +QL ++ +
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 17/302 (5%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K D FE++ ++G G V K + + + L+ +K+ + P + RE+ +L +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQH-KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P I+ G S G + + E+M+ + E + +L GL +
Sbjct: 62 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 254 HSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
+ I+HRD+K SN+L++ G +K+ DFG++ S S V T Y PE L G
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 176
Query: 313 STDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
T Y D+WS G L EL G+ PI P + ++L IF G P + PH+
Sbjct: 177 -THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD--GEEGEPHS 228
Query: 372 TIFKPQQPYKRCVAETFKDIPSSAL-SLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430
+P+ P + P+ A+ LLD +++ P + F K L +
Sbjct: 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288
Query: 431 PS 432
P+
Sbjct: 289 PA 290
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 144 IGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
IG G + V + R K VA+K ++ + D + + F+ E I+ + DHPNI++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAG--LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
EG++T S + ++ EYME+ L G KFT Q+ ++ + G+++
Sbjct: 71 EGVVTK--SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYRPPELLLGSTDY 316
+HRD+ N+L++ N + K+ DFGL+ + S+ T ++ W P + +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--F 185
Query: 317 GASVDLWSSGCILAEL--FAGKP 337
++ D+WS G ++ E+ + +P
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 164 VALKKVRFTNMDPESVRFMAR---EIIILRRLDHPNIMKLEGLITSRVS--GSLYLVFEY 218
VA+K +R PE AR E + RL HPNI+ L + S + G L+ VFEY
Sbjct: 6 VAIKLLR--TDAPEEEHQRARFRRETALCARLYHPNIVAL---LDSGEAPPGLLFAVFEY 60
Query: 219 ME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI-- 275
+ L + A G + M Q+L L H++GI+HRD+K N+++ G+
Sbjct: 61 VPGRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 276 -LKIGDFGLANF---FKCSQKQPLTSR---VVTLWYRPPELLLGSTDYGASVDLWSSGCI 328
K+ DFG+ + + LT + T Y PE L G S DL++ G I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWGLI 178
Query: 329 LAELFAGKPIMPGRTEVEQLHK 350
E G+ ++ G + E L++
Sbjct: 179 FLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 74/292 (25%), Positives = 118/292 (40%), Gaps = 58/292 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
D FE L IG+G + V + + + A+K +R +M + E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
++K+ + + +LYL+ E++ D+ L +E + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAI 117
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGL------------------------------ 283
H G +HRDIK NLL+D G +K+ DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 284 ----ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIM 339
A +K +++Q S V T Y PE+ + T Y D WS G I+ E+ G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 340 PGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDI 391
T P E Y K +F P+ P ++E KD+
Sbjct: 237 CSET--------------PQETYRKVMNWKETLVFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRRL-DHPNIMKL 200
IG+G+Y+ V R + ++ A+K V+ N D E + ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
+ L+ V EY+ K E + Y ++ L + H RGI++
Sbjct: 62 HSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDYGAS 319
RD+K N+L+D G +K+ D+G+ + + TS T Y PE+L G DYG S
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFS 176
Query: 320 VDLWSSGCILAELFAGK 336
VD W+ G ++ E+ AG+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 140 KLDK-IGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
K++K IG G + V R K VA+K ++ + + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+ LEG++T S + +V EYME+ L +FT Q+ ++ + G+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR--VVTLWYRPPELLLG 312
G +HRD+ N+L++ N + K+ DFGL+ + + T+R + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 313 STDYGASVDLWSSGCILAELFA 334
+ ++ D+WS G ++ E+ +
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 9/207 (4%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKV-RFTNMDPESVRFMAREIIILRRL 192
KA+ +E + IG+G + V R K+ A+K + +F + F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
+ P +++L + LY+V EYM DL L + V E + Y +++ L+
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EKWARFYTAEVVLALD 156
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
HS G +HRD+K N+L+D +G LK+ DFG + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 312 ---GSTDYGASVDLWSSGCILAELFAG 335
G YG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+ +G G +VYKA L +++A+K + ++ E + + E+ IL + D P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 201 EG--LITSRVS--------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
G + +R+S GSL + + EH L +A ++ GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------------VVKGL 108
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
+ S ILHRD+K SN+L++ G +K+ DFG++ S + V T Y PE +
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---KTYVGTNAYMAPERI 165
Query: 311 LGSTDYGASVDLWSSGCILAELFAGK 336
G YG D+WS G EL G+
Sbjct: 166 SGE-QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLD-HPNIMKLE 201
IG+G+Y+ V R +N+++ A+K V+ + D E + ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ + L+LV EY+ K E + Y ++ L H RGI++R
Sbjct: 63 SCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQ----KQPLTSRVVTLWYRPPELLLGSTDYG 317
D+K N+L+D +G +K+ D+G+ C + ++ T Y PE+L G +YG
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYG 174
Query: 318 ASVDLWSSGCILAELFAGK 336
SVD W+ G ++ E+ AG+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 137 SFEKLDK-IGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRL 192
S K+++ IG G + V + R K VA+K ++ + + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
DHPNI+ LEG++T S + ++ E+ME+ L +FT Q+ ++ + G++
Sbjct: 63 DHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP-----LTSRVVTLWYRP 306
+ +HRD+ N+L++ N + K+ DFGL+ F + P L ++ W P
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFA 334
+ + ++ D+WS G ++ E+ +
Sbjct: 181 EAIAY--RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 58/292 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
+ FE L IG+G + V + + + A+K +R +M + E V + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
++K+ +++ LYL+ E++ D+ L TE + + Y+ + + ++
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSI 117
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGL------------------------------ 283
H G +HRDIK NLL+D G +K+ DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 284 ----ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIM 339
A +K +++Q S V T Y PE+ + T Y D WS G I+ E+ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 340 PGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDI 391
T P E Y K IF P+ P ++E KD+
Sbjct: 237 CSET--------------PQETYKKVMNWKETLIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 15/225 (6%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR++ E K+GQG + V+ VA+K ++ M PE+ +E +++
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
+L H +++L +++ +Y+V EYM L L G Q+ Q+
Sbjct: 57 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT-SRVVTLWYRPP 307
G+ + +HRD++ +N+L+ N + K+ DFGLA + ++ ++ W P
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/222 (25%), Positives = 108/222 (48%), Gaps = 19/222 (8%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR++ EK K+G G + V+ A ++ K VA+K ++ +M SV E +++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
L H ++KL ++T +Y++ E+M L L + G K ++ + Q+
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
G+ R +HRD++ +N+L+ + + KI DFGLA + ++ + + PE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 309 LLLGSTDYGA---SVDLWSSGCILAELFA-GKPIMPGRTEVE 346
+ ++G+ D+WS G +L E+ G+ PG + E
Sbjct: 174 ----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 5/194 (2%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRF-TNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
+G+GT+ V R+ + A+K +R + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 203 LITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRD 262
+ L V EY + FTE + + Y +++ LE+ HSR +++RD
Sbjct: 63 AFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 263 IKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDL 322
IK NL++D +G +KI DFGL S + + T Y PE +L DYG +VD
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 323 WSSGCILAELFAGK 336
W G ++ E+ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 51/182 (28%), Positives = 95/182 (52%), Gaps = 16/182 (8%)
Query: 164 VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD- 222
VA+K ++ +M + E ++ +L H +++L G+ T + +Y+V EYM +
Sbjct: 31 VAIKMIKEGSMSEDE---FIEEAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGC 85
Query: 223 LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG 282
L G +F +Q+ K + G+ + S+ +HRD+ N L+D G +K+ DFG
Sbjct: 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG 145
Query: 283 LANFFKCSQKQPLTSRVVTLW---YRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPI 338
L+ + + TS V + + + PPE+LL S + + D+W+ G ++ E+++ GK
Sbjct: 146 LSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGK-- 199
Query: 339 MP 340
MP
Sbjct: 200 MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 19/302 (6%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K D FEK+ ++G G V+K + + L+ +K+ + P + RE+ +L +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSH-KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P I+ G S G + + E+M+ + E + ++ GL +
Sbjct: 62 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 254 HSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
+ I+HRD+K SN+L++ G +K+ DFG++ S S V T Y PE L G
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 176
Query: 313 STDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
T Y D+WS G L E+ G+ PI P + ++L +F G P E S+
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMF---GCPVEGDPAESETSP- 229
Query: 372 TIFKPQQPYKRCVAETFKDIPSSAL-SLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430
+P+ P + + P A+ LLD +++ P + + + F K L +
Sbjct: 230 ---RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 431 PS 432
P+
Sbjct: 287 PA 288
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 234 FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293
F E ++ Q++ L+ HSR ++HRD+K +N+ + GI+K+GDFG + + S
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 294 PLTSRVV-TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIF 352
+ S T +Y PE L Y D+WS G IL EL LH+ F
Sbjct: 226 DVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT-------------LHRPF 271
Query: 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT 412
K PS+ ++ ++ P+ V+ K +LLD LLS P +R T
Sbjct: 272 K---GPSQR-----EIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALRPT 316
Query: 413 ASSALQNEFF 422
L EF
Sbjct: 317 TQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-13
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 33/233 (14%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
+ + +E + KIG G + V+ + + K + + + + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEY-----MEHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
H NI++ ++ + LY++ E+ + ++ G K E I +QLLH
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-KIEEHAIVDITRQLLH 129
Query: 249 GLEHCHS-------RGILHRDIKGSNLLI---------------DYNG--ILKIGDFGLA 284
L +CH+ +LHRD+K N+ + + NG I KIGDFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGST-DYGASVDLWSSGCILAELFAGK 336
+ S V T +Y PELLL T Y D+W+ GCI+ EL +GK
Sbjct: 190 K--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 17/220 (7%)
Query: 142 DKIGQGTYSSVYKAR-DLENNKL--VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
K+G G++ V + K+ VA+K ++ + F+ +E I+ LDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 199 KLEGLITSRVSGSLYLVFEYMEHDLAGLAAT---PGVKFTEAQIKC-YMKQLLHGLEHCH 254
+L G++ ++ L +V E L L + C Y Q+ +G+ +
Sbjct: 60 RLYGVV---LTHPLMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYRPPELLLG 312
S+ +HRD+ N+L+ + +KIGDFGL ++ + V + PE L
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 313 STDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
T AS D+W G L E+F G+ G + + L KI
Sbjct: 175 RTFSHAS-DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 10/214 (4%)
Query: 144 IGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+G+G++ V AR E+ +L A LKK D + I+ L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
+ L+ V E++ +F EA+ + Y ++ L H +GI++
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDYGAS 319
RD+K N+L+D+ G K+ DFG+ + K TS T Y PE +L YG S
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 320 VDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
VD W+ G +L E+ G E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 42/132 (31%), Positives = 70/132 (53%), Gaps = 3/132 (2%)
Query: 234 FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293
F E + Y ++ GLE H I++RD+K N+L+D +G ++I D GLA + Q
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQ 156
Query: 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
+ RV T+ Y PE ++ + Y S D W+ GC+L E+ AG+ R + + ++ +
Sbjct: 157 TIKGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215
Query: 354 LCGSPSEEYWKR 365
L EEY ++
Sbjct: 216 LVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 141 LDKIGQGTYSSVYKARDLENNK-----LVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
L+++G+G + VYK N+ VA+K ++ F +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR-QEAELMSDLQHP 68
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DL----------AGLAATPGVKFTEAQIKC--- 241
NI+ L G+ T + +FEY+ H DL + + A G + ++ + C
Sbjct: 69 NIVCLLGVCTKEQPTCM--LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 242 --YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL------ANFFKCSQKQ 293
Q+ G+E+ S +HRD+ N L+ +KI DFGL A++++ K
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA 334
L R W P +L G + D+WS G +L E+F+
Sbjct: 187 LLPVR----WMPPEAILYGK--FTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 29/300 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+G+G++ V A + A+K ++ +D + M + ++ ++P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 202 GLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
T + L+ V E++ DL G +F + Y +++ GL+ HS+GI++
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP----PELLLGSTDY 316
RD+K N+++D +G +KI DFG+ C + +R T P PE+L G Y
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGM-----CKENVFGDNRASTFCGTPDYIAPEILQG-LKY 173
Query: 317 GASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW--KRSKLPHATIF 374
SVD WS G +L E+ G+ G E E I +P W K SK +F
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLF 231
Query: 375 KPQQPYKRC-------VAETFKDIPSSALSLLDILLSTEPEVRGTAS-SALQNEFFTTKP 426
+ + P +R FK I +AL ++ +P+V+ + S EF + KP
Sbjct: 232 E-RDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKP 290
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 42/232 (18%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
+G+G + V+K L++ VA+K + ++F++ E IL++ DHPNI+KL G+
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 204 ITSRVSGSLYLVFEYMEHDLAGLAATPGVKF----TEAQIKCYMKQLLH-------GLEH 252
T R +Y+V E + PG F + + + KQL+ G+ +
Sbjct: 61 CTQR--QPIYIVMELV----------PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN------FFKCSQKQPLTSRVVTLWYRP 306
S+ +HRD+ N L+ N +LKI DFG++ + KQ + W P
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIKWTAP 163
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFA----GKPIMPGRTEVEQLHKIFKL 354
L G Y + D+WS G +L E F+ P M + EQ+ K +++
Sbjct: 164 EALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 69/259 (26%), Positives = 106/259 (40%), Gaps = 54/259 (20%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDHPN 196
F K+ +G G + V A ++ + L A+K +R + ++ V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
++KL + +LY V +Y+ D+ L V F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS------------------------- 290
G +HRDIK N+LID +G +K+ DFGL F+ +
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 291 ---------------------QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCIL 329
Q+ S V T Y PE+LL Y D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 330 AELFAGKP--IMPGRTEVE 346
E+ G+P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 164 VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD- 222
VA+K + M E F+ E ++ +L HP +++L G+ T + LY+V E+ME+
Sbjct: 31 VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVTEFMENGC 85
Query: 223 -LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281
L L G K ++ + + + G+E+ +HRD+ N L+ G++K+ DF
Sbjct: 86 LLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDF 144
Query: 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMP 340
G+ + + + + + PPE+ S Y + D+WS G ++ E+F GK MP
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLE 201
IG+G+Y+ V + ++ A+K ++ + D E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 202 GLI--TSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
SR L+ V E++ K E + Y ++ L H RGI+
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---KQPLTSRVV-TLWYRPPELLLGSTD 315
+RD+K N+L+D G +K+ D+G+ C + TS T Y PE+L G D
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGM-----CKEGIRPGDTTSTFCGTPNYIAPEILRGE-D 172
Query: 316 YGASVDLWSSGCILAELFAGK 336
YG SVD W+ G ++ E+ AG+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 144 IGQGTYSSVYKARDLENNKL---VALKKV-RFTNMDPESVRFMAREIIILRRLDHPNIMK 199
IG+G + VY ++++ A+K + R T++ E V +E II++ HPN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLS 60
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
L G I GS +V YM+H DL + T + + Q+ G+E+ S+
Sbjct: 61 LLG-ICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCSQKQPLTSRVVTLWYRPPELLLG 312
+HRD+ N ++D + +K+ DFGLA ++ +++ W L
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--GAKLPVKWMALES--LQ 175
Query: 313 STDYGASVDLWSSGCILAELFA-GKPIMP 340
+ + D+WS G +L EL G P P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
+G+GT+ V R+ K A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 203 LITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ + L V EY +L + V F+E + + Y +++ L + HS +++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW----YRPPELLLGSTDYG 317
D+K NL++D +G +KI DFGL C + + + T Y PE +L DYG
Sbjct: 120 DLKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPE-VLEDNDYG 173
Query: 318 ASVDLWSSGCILAELFAGK 336
+VD W G ++ E+ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 143 KIGQGTYSSVYKARDL----ENNK-LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++G+G + V+ A E +K LVA+K ++ + + + RE +L L H +I
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DASDNARKDFHREAELLTNLQHEHI 69
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DL----------AGLAA--TPGVKFTEAQIKCYMK 244
+K G+ L +VFEYM+H DL A L A + T++Q+ +
Sbjct: 70 VKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRVVTLW 303
Q+ G+ + S+ +HRD+ N L+ N ++KIGDFG++ + + + ++ +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELF 333
+ PPE ++ + D+WS G +L E+F
Sbjct: 188 WMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 14/220 (6%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR +S + + K+G G + V+ N+ VA+K ++ M SV+ E +++
Sbjct: 3 IPR--ESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM---SVQAFLEEANLMK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
L H +++L ++T +Y++ EYM L L + G K ++ + Q+
Sbjct: 57 TLQHDKLVRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT-SRVVTLWYRPP 307
G+ + + +HRD++ +N+L+ + + KI DFGLA + ++ ++ W P
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVE 346
+ GS + D+WS G +L E+ GK PG + +
Sbjct: 175 AINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 144 IGQGTYSSVYKA--RDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNI 197
+G+G + V KA L+N VA+K ++ + + ++ E+ +++ + H NI
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 198 MKLEGLITSRVSGSLYLVFEY----------------MEHDLAGLAATPGVKFTEAQIKC 241
+ L G+ T G LY+V EY E+ P T+ +
Sbjct: 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 242 YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ--KQPLTSRV 299
+ Q+ G+E S+ +HRD+ N+L+ + ++KI DFGLA ++ R+
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQLHKIFK 353
W P L Y D+WS G +L E+F G P PG VE+L K+ K
Sbjct: 197 PVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 5/194 (2%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRF-TNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
+G+GT+ V R+ + K A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 203 LITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRD 262
+ + L V EY+ + F+E + + Y +++ L++ HS I++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 263 IKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDL 322
+K NL++D +G +KI DFGL + + + T Y PE +L DYG +VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 323 WSSGCILAELFAGK 336
W G ++ E+ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 14/224 (6%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRRLDHPNIMKLE 201
IG+G++ V A+ + A+K ++ + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ + + LY V +Y+ F E + + Y ++ + + HS I++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDYGASV 320
D+K N+L+D G + + DFGL + + + TS T Y PE +L Y +V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTV 177
Query: 321 DLWSSGCILAELFAGKPIMPGRTEVEQ-----LHKIFKLCGSPS 359
D W G +L E+ G P R +V Q LHK +L G +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAR-EIIILRRLDHPNIMKLEG 202
+G+G + V + K+ A KK+ + +S MA E IL +++ P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 203 LITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTE-AQIKCYMKQLLHGLEHCHSRGILH 260
S+ L LV M DL G + E ++ Y Q+ G+ H HS I++
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASV 320
RD+K N+L+D G ++ D GLA + + +T R T Y PE+L Y V
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP-YSYPV 175
Query: 321 DLWSSGCILAELFAGKPIMPGRTEVEQLHK 350
D ++ GC + E+ AG+ P + E++ K
Sbjct: 176 DWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR---DLENNKL-VALKKVRFTNMDPESVRFMAREIIIL 189
K EK+ +G G + +VYK + E K+ VA+K +R P++ + + E ++
Sbjct: 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVM 63
Query: 190 RRLDHPNIMKLEGL-ITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
+DHP++++L G+ ++S+V L+ + M L + + Q+
Sbjct: 64 ASVDHPHVVRLLGICLSSQVQ----LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYR 305
G+ + + ++HRD+ N+L+ +KI DFGLA +K+ +V W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 306 PPELLLGSTDYGASVDLWSSGCILAEL--FAGKP 337
+L Y D+WS G + EL F KP
Sbjct: 180 LESILHR--IYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 17/193 (8%)
Query: 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270
LY V EY+ DL G +F E Y ++ GL HS+GI++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 271 DYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELLLGSTDYGASVDLWSSGCI 328
D G +KI DFG+ K + +T++ T Y PE ++ YG SVD W+ G +
Sbjct: 135 DSEGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVL 190
Query: 329 LAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP---QQPYKR--C 383
L E+ AG+ G E E I + + Y K I K + P KR C
Sbjct: 191 LYEMLAGQAPFEGEDEDELFQSIME----HNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246
Query: 384 VAETFKDIPSSAL 396
E +DI A
Sbjct: 247 GPEGERDIKEHAF 259
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 10/226 (4%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK--KVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
IG+G++ V A+ + K A+K + + E MA ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ + + LY V +++ F E + + Y ++ L + HS I++R
Sbjct: 63 --YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVD 321
D+K N+L+D G + + DFGL +Q T+ T Y PE++ Y +VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNTVD 178
Query: 322 LWSSGCILAELFAGKPIMPGRTEVEQ----LHKIFKLCGSPSEEYW 363
W G +L E+ G P R E LHK L S W
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 183 AREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCY 242
A E ILR ++HP+I++L+G T L L Y LAA + + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNIAICD--ILAI 187
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ +L +++ H I+HRDIK N+ I++ G + +GDFG A F T+
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGK 336
PE LL YG +VD+WS+G +L E+
Sbjct: 248 ATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 80/332 (24%), Positives = 127/332 (38%), Gaps = 43/332 (12%)
Query: 143 KIGQG--TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+IG+G +SVY AR LV ++ N E ++ + E+++ HPNIM
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAG--LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
+ T L+++ +M + A L +EA I + L GL + H G
Sbjct: 65 WTVFT--TGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFF---KCSQKQ------PLTSRVVTLWYRPPEL 309
+HR+IK S++LI +G++ + GL++ + + QK P S V W P L
Sbjct: 123 IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
Y D++S G EL G+ P L K+ SP +
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP----LDITTF 236
Query: 369 PH---------------------ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEP 407
P A +R + K + +L+++ L +P
Sbjct: 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296
Query: 408 EVRGTASSALQNEFFTTKPLPCDPSSLPKYPP 439
E R +ASS L + FF S L PP
Sbjct: 297 EKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 143 KIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199
IG+G + VY+ EN K+ VA+K + +F+ E I+R+ DHP+I+K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 200 LEGLITSRVSGSLYLVFE-YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
L G+IT +++V E +L A + Y QL L + S+
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLA 284
+HRDI N+L+ +K+GDFGL+
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK-----KVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
IG+G++ V A+ + K A+K + E MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNVLLKNVKHPFLV 59
Query: 199 KLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
L + + + LY V +Y+ F E + + Y ++ L + HS I
Sbjct: 60 GLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW----YRPPELLLGST 314
++RD+K N+L+D G + + DFGL C + + T Y PE+L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGL-----CKEGIEHSKTTSTFCGTPEYLAPEVLR-KQ 171
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
Y +VD W G +L E+ G P R E I
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 14/215 (6%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRRLDHPNIMKLE 201
IG+G++ V AR K A+K ++ + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ + + LY V +Y+ F E + + Y ++ L + HS I++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW----YRPPELLLGSTDYG 317
D+K N+L+D G + + DFGL C + T Y PE +L Y
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL-----CKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYD 174
Query: 318 ASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIF 352
+VD W G +L E+ G P R E I
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 64/266 (24%), Positives = 102/266 (38%), Gaps = 56/266 (21%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
+ F + IG+G + V + + K+ A+K + + M + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK---FTEAQIKCYMKQLLHGLE 251
P ++ L + + + LYL+ E++ G T +K F+E + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLP---GGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN-FFKCSQ----KQPLTSRVVT----- 301
H G +HRDIK N+LID G +K+ DFGL+ F K ++ L +
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 302 --------------------LW----------------YRPPELLLGSTDYGASVDLWSS 325
W Y PE+ L YG D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSL 234
Query: 326 GCILAELFAGKPIMPGRTEVEQLHKI 351
G I+ E G P E KI
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+G+G++ V A +++ A LKK D + I+ L HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
+ L+ V EY+ KF E + + Y ++ L H G+++
Sbjct: 62 HC--CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW------YRPPELLLGST 314
RD+K N+L+D G K+ DFG+ K+ + + V T Y PE +L
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMC-------KEGILNGVTTTTFCGTPDYIAPE-ILQEL 171
Query: 315 DYGASVDLWSSGCILAELFAGKP 337
+YG SVD W+ G ++ E+ AG+P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 15/225 (6%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR++ + K+GQG + V+ K VA+K ++ M PE+ +E I++
Sbjct: 3 IPRESLRLDV--KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMK 56
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
+L H ++ L +++ +Y+V E+M L L G Q+ Q+
Sbjct: 57 KLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT-SRVVTLWYRPP 307
G+ + +HRD++ +N+L+ N + KI DFGLA + ++ ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 37/245 (15%)
Query: 164 VALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH- 221
VA+K ++ T E M+ E+ I+ L +H NI+ L G T + G + ++ EY +
Sbjct: 68 VAVKMLKPTAHSSEREALMS-ELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYG 124
Query: 222 DLAGLAATPGVKF-TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGD 280
DL F T + + Q+ G+ S+ +HRD+ N+L+ + I+KI D
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184
Query: 281 FGLA-------NFF-KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL 332
FGLA N+ K + + P+ W P + Y D+WS G +L E+
Sbjct: 185 FGLARDIMNDSNYVVKGNARLPVK------WMAPESIFNCV--YTFESDVWSYGILLWEI 236
Query: 333 FA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY---KRCVAETF 388
F+ G PG + +K+ K E ++ ++ HA P + Y K C
Sbjct: 237 FSLGSNPYPGMPVDSKFYKLIK-------EGYRMAQPEHA----PAEIYDIMKTCWDADP 285
Query: 389 KDIPS 393
P+
Sbjct: 286 LKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 19/185 (10%)
Query: 163 LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH- 221
LVA+K +R F+ +EI I+ RL +PNI++L G+ S L ++ EYME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 222 DLAGLAATPGV--KFTEAQ-IKC-------YMK-QLLHGLEHCHSRGILHRDIKGSNLLI 270
DL + + FT A I YM Q+ G+++ S +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 271 DYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELLLGSTDYGASVDLWSSGCI 328
+ +KI DFG++ + R V W +LLG + + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVT 220
Query: 329 LAELF 333
L E+F
Sbjct: 221 LWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 44/121 (36%), Positives = 64/121 (52%), Gaps = 6/121 (4%)
Query: 230 PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289
PG F E + Y Q++ GLEH H R I++RD+K N+L+D +G ++I D GLA K
Sbjct: 92 PG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLH 349
Q + T + PELL G +Y SVD ++ G L E+ A + P R E++
Sbjct: 150 GQSKT-KGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARG--PFRARGEKVE 205
Query: 350 K 350
Sbjct: 206 N 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKA----RDLENNKL-VALKKVRFTNMDPESVRFMARE 185
VPR DS L +G G + VY+ RD + +L VA+K + + + + F+ E
Sbjct: 3 VPR--DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-ME 59
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLA----ATPGVKFTEAQIK 240
+I+ + +H NI++L G+ R+ +++ E M DL P +
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSSLT--- 114
Query: 241 CYMKQLLH-------GLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLA-NFFKC 289
MK LL G ++ +HRDI N L+ G + KI DFG+A + ++
Sbjct: 115 --MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQL 348
S + ++ + + PPE L + + D+WS G +L E+F+ G PGRT E +
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 143 KIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRF-MAREIIILRRLDHPN 196
++G+G + V+ A ++ LVA+K ++ + ES R RE +L L H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQH 68
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DL---------------AGLAATPGVKFTEAQIK 240
I++ G+ T L +VFEYM H DL G PG + T Q+
Sbjct: 69 IVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG-QLTLGQML 125
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCSQKQP 294
Q+ G+ + S +HRD+ N L+ ++KIGDFG++ ++++ +
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
L R + PPE +L + D+WS G +L E+F
Sbjct: 186 LPIR-----WMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 132 PRKADSFEKLDKIGQGTYSSVY--KARDLENNK--------------LVALKKVRFTNMD 175
PRK +F+ +K+G+G + V+ +A +E LVA+K +R + +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59
Query: 176 PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME----------HDLAG 225
+ +EI I+ RL PNI++L L S L ++ EYME H+
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 226 LAATPGVKFTEAQIKCYMK-QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
A V +M Q+ G+++ S +HRD+ N L+ N +KI DFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 285 ------NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
++++ + L R W +LLG + + D+W+ G L E+
Sbjct: 178 RNLYSGDYYRIQGRAVLPIR----WMSWESILLGK--FTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 30/231 (12%)
Query: 144 IGQGTYSSVYK--ARDL----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+G G + VY+ A D+ VA+K +R D E F+ E ++ +HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 198 MKLEGLITSRVSGSLYLVFEYME-----HDLAGLAA----TPGVKFTE-AQIKCYMKQLL 247
+KL G+ ++ Y++ E ME L P + E I + +
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNG-----ILKIGDFGLA-NFFKCSQKQPLTSRVVT 301
LE H +HRD+ N L+ G ++KIGDFGLA + +K + ++
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
+ + PE LL + D+WS G ++ E+ G+ P E L +
Sbjct: 177 VRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
+ + E + +G G SV K + + ++A KKV + + RE+ I+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
P I+ G + ++ + E+M+ L + G + ++ GL +
Sbjct: 62 SPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTY 118
Query: 253 CHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
++ I+HRDIK SN+L++ G +K+ DFG++ S V T Y PE +
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSPERIQ 175
Query: 312 GSTDYGASVDLWSSGCILAELFAGK 336
G Y D+WS G + EL GK
Sbjct: 176 GG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 144 IGQGTYSSVYKARDLENN---KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+G G + SV K L + VA+K ++ ++ F+ RE ++ +LDHP I++L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVRL 61
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKF-------TEAQIKCYMKQLLHGLEHC 253
G+ L LV E LA L P +K+ + +K Q+ G+ +
Sbjct: 62 IGVC---KGEPLMLVME-----LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAYL 111
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLA-------NFFKCSQ--KQPLTSRVVTLWY 304
S+ +HRD+ N+L+ KI DFG++ ++++ + + PL WY
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------WY 165
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFA--GKPI--MPGRTEVEQLHKIFKLCGSPSE 360
P + G + + D+WS G L E F+ KP M G + L +L P E
Sbjct: 166 APECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-PRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 43/273 (15%)
Query: 144 IGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199
+G+G + V+ A+ + E + + L K D RE+ + R+L H N+++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 200 LEGLITSRVSGSLYLVFEYME-HDL-----AGLAATPGVK---FTEAQIKCYMKQLLHGL 250
L GL R + Y++ EY + DL A + +K + Q Q+ G+
Sbjct: 73 LLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
+H + +HRD+ N L+ +K+ L+ S+ L + ++ L + PE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK--- 367
D+ D+WS G ++ E+F T+ E G EE R +
Sbjct: 191 Q-EDDFSTKSDVWSFGVLMWEVF---------TQGELPFY-----GLSDEEVLNRLQAGK 235
Query: 368 ----LPHATIFKPQQPYK---RCVAETFKDIPS 393
+P P + YK RC A KD PS
Sbjct: 236 LELPVPEGC---PSRLYKLMTRCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYK--ARDLENNKL---VALKKVRFTNMDPESVRFMA 183
W +PR + + ++GQG++ VY+ A+ + + VA+K V E + F+
Sbjct: 1 WELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN 58
Query: 184 REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAA-------TPGVKF 234
E +++ + ++++L G++ S +L +V E M DL L + PG+
Sbjct: 59 -EASVMKEFNCHHVVRLLGVV-STGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 235 TEAQIKCYMK-QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFF 287
Q M ++ G+ + ++ +HRD+ N ++ + +KIGDFG+ +++
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL--FAGKP 337
+ K L R W P L G + D+WS G +L E+ A +P
Sbjct: 176 RKGGKGLLPVR----WMAPESLKDGV--FTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 26/188 (13%)
Query: 163 LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH- 221
LVA+K +R D F+ +E+ IL RL PNI +L G+ V L ++ EYME+
Sbjct: 48 LVAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGV--CTVDPPLCMIMEYMENG 104
Query: 222 DL-----AGLAATPG----VKFTEAQIKCYM-KQLLHGLEHCHSRGILHRDIKGSNLLID 271
DL +A T G K YM Q+ G+ + S +HRD+ N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 272 YNGILKIGDFGL------ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSS 325
N +KI DFG+ +++++ + PL R W +LLG + D+W+
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTKSDVWAF 218
Query: 326 GCILAELF 333
G L E+
Sbjct: 219 GVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 12/225 (5%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKV-RFTNMDPESVRFMAREIIILRRLDH 194
+ FE L IG+G + V + +K+ A+K + ++ + E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEY-MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
I L +LYLV +Y + DL L + + E + Y+ +++ ++
Sbjct: 61 QWITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELLL 311
H +HRDIK N+L+D NG +++ DFG + K + + S V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 312 GSTD----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIF 352
D YG D WS G + E+ G+ + VE KI
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 140 KLDKI-GQGTYSSVYKAR---DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
KL KI G+G + SV + + D + VA+K ++ + E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 196 NIMKLEGL-ITSRVSGSL---YLVFEYMEHD------LAGLAATPGVKFTEAQIKCYMKQ 245
N+MKL G+ + + ++ +M+H L K + +M
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ G+E+ +R +HRD+ N ++ + + + DFGL+
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 14/225 (6%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRRLD 193
D FE + IG+G + V + ++ A+K + M E+ F E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR-EERNVLVNGD 59
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEY-MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
I L LYLV +Y + DL L + + E + Y+ +++ +
Sbjct: 60 CQWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELL 310
H +HRDIK N+L+D NG +++ DFG + K +Q + S V T Y PE+L
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 311 LGSTD----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
D YG D WS G + E+ G+ + VE KI
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR-DLENNKLVALKKVRFTNM-DPESVRFMAREIIILRR 191
K + F + +G G++ V A E+ VA+K+ + + + V + E IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY 87
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAAT---PGVKFTEAQIKC-YMKQLL 247
++HP + L G + + LYLV E++ + G T +F + C Y Q++
Sbjct: 88 INHPFCVNLYG--SFKDESYLYLVLEFV---IGGEFFTFLRRNKRFPN-DVGCFYAAQIV 141
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP- 306
E+ S I++RD+K NLL+D +G +K+ DFG A + +R TL P
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPE 193
Query: 307 ---PELLLGSTDYGASVDLWSSGCILAELFAGKP 337
PE+LL + +G + D W+ G + E+ G P
Sbjct: 194 YIAPEILL-NVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 82/320 (25%), Positives = 134/320 (41%), Gaps = 61/320 (19%)
Query: 142 DKIGQGTYSSVYKARDLENNKL---VALKKVR-FTNMDPESVRFMAREIIILRRL-DHPN 196
D IG+G + V KAR ++ + L A+K+++ + + D R A E+ +L +L HPN
Sbjct: 13 DVIGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPN 69
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH---------------DLA-GLAATPGVKFTEAQIK 240
I+ L G R G LYL EY H D A +A + + Q+
Sbjct: 70 IINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+ + G+++ + +HRD+ N+L+ N + KI DFGL+ + K+ + R+
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLP 186
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAEL--FAGKPIMPGRTEVEQLHKIFKLCGSP 358
W L + Y + D+WS G +L E+ G P CG
Sbjct: 187 VRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------YCGMT 228
Query: 359 SEEYWKRSKLPHATIFKPQQPYKRCVAETF-------KDIPSSALSLLDILLSTEP--EV 409
E ++ KLP ++ ++P C E + ++ P S IL+S E
Sbjct: 229 CAELYE--KLPQG--YRLEKPLN-CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
Query: 410 RGTASSALQNEFFTTKPLPC 429
R T + E FT + C
Sbjct: 284 RKTYVNTTLYEKFTYAGIDC 303
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 143 KIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++G+G + V+ A ++ LVA+K ++ + + RE +L L H +I
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGV--------KFTEAQIKCYMKQLLH 248
+K G+ L +VFEYM+H DL G + +A+ + + Q+LH
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 249 -------GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRVV 300
G+ + S+ +HRD+ N L+ N ++KIGDFG++ + + + ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
+ + PPE ++ + D+WS G IL E+F
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D FEKL ++G G V K + ++A K + + P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSP 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH---DL----AGLAATPGV-KFTEAQIK--CYMKQ 245
I+ G S G + + E+M+ D AG + K + A ++ Y+++
Sbjct: 60 YIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG--------LANFFKCSQKQPLTS 297
I+HRD+K SN+L++ G +K+ DFG +AN F
Sbjct: 118 ---------KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---------- 158
Query: 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PI-MPGRTEVEQLH 349
V T Y PE L G T Y D+WS G L E+ G+ PI P E+E +
Sbjct: 159 -VGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 47/164 (28%), Positives = 66/164 (40%), Gaps = 25/164 (15%)
Query: 184 REIIILRRLDHPNIMKLEGLITSRVSGSLY-LVFEYMEHDLAGLAATPGVKFTEAQIKCY 242
REI IL+ + H I+ L I + S +V + DL FT
Sbjct: 135 REIDILKTISHRAIINL---IHAYRWKSTVCMVMPKYKCDL----------FTYVDRSGP 181
Query: 243 M---------KQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQK 292
+ ++LL L + H RGI+HRD+K N+ +D +GDFG A
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK 336
TL PELL Y A D+WS+G +L E+
Sbjct: 242 PQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 37/239 (15%)
Query: 144 IGQGTYSSVYKARDLENNK-------LVALKKVRFTNMDPESVRFMAREIIILRRL-DHP 195
+G+G + V A L +K VA+K ++ + + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 196 NIMKLEGLITSRVSGSLYLVFEY-----------------MEHDLAGLAATPGVKFTEAQ 238
NI+ L G T G LY++ EY ME+ +A P + T
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSY-DIARVPDEQMTFKD 138
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ--KQPLT 296
+ Q+ G+E+ S+ +HRD+ N+L+ N ++KI DFGLA K+
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQLHKIFK 353
R+ W P L Y D+WS G ++ E+F G P PG VE+L K+ K
Sbjct: 199 GRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
IG+G + V D NK VA+K ++ D + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLG-DYRGNK-VAVKCIK---NDATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 204 ITSRVSGSLYLVFEYM-EHDLAGLAATPG--VKFTEAQIKCYMKQLLHGLEHCHSRGILH 260
I G LY+V EYM + L + G V + +K + + +E+ + +H
Sbjct: 68 IVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAMEYLEANNFVH 125
Query: 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASV 320
RD+ N+L+ + + K+ DFGL +Q T ++ W P L +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EKKFSTKS 180
Query: 321 DLWSSGCILAELFA-GK---PIMPGRTEVEQLHKIFKL 354
D+WS G +L E+++ G+ P +P + V ++ K +K+
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 55/305 (18%)
Query: 144 IGQGTYSSVYKARDLENNK-------LVALKKVRFTNMDPESVRFMAREIIILRRLD-HP 195
+G+G + V +A +K VA+K ++ D + ++ E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS-EMELMKLIGKHK 78
Query: 196 NIMKLEGLITSRVSGSLYLVFEYM------EHDLAGLAATP-----GVKFTEAQ------ 238
NI+ L G+ T G LY++ EY E A P K E Q
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCSQK 292
+ C Q+ G+E+ SR +HRD+ N+L+ + ++KI DFGLA +++ K
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY----K 191
Query: 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQL-- 348
+ R+ W P L Y D+WS G ++ E+F G P PG VE+L
Sbjct: 192 KTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSP-YPG-IPVEELFK 247
Query: 349 -----HKIFKLCGSPSEEYWKRSKLPHATIFKPQQP-YKRCVAETFKDIPSSALSLLDIL 402
H++ K E Y + HA Q+P +K+ V K + + + LD+
Sbjct: 248 LLREGHRMDKPSNCTHELYMLMRECWHAV--PTQRPTFKQLVEALDKVLAAVSEEYLDLS 305
Query: 403 LSTEP 407
+ E
Sbjct: 306 MPFEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 5/133 (3%)
Query: 230 PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289
PG F E + Y +L GLE I++RD+K N+L+D G ++I D GLA +
Sbjct: 97 PG--FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQI 152
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLH 349
+ + + RV T+ Y PE ++ + Y S D W GC++ E+ G+ R E +
Sbjct: 153 PEGETVRGRVGTVGYMAPE-VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE 211
Query: 350 KIFKLCGSPSEEY 362
++ + EEY
Sbjct: 212 EVDRRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 54/272 (19%)
Query: 142 DKIGQGTYSSVYKAR-DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMK 199
D IG+G + V +A + K+ A K+ R A E+ +L +L HPNI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 200 LEGLITSRVSGSLYLVFEY---------------MEHDLA-----GLAATPGVKFTEAQI 239
L G +R G LY+ EY +E D A G A+T T Q+
Sbjct: 68 LLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST----LTSQQL 121
Query: 240 KCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299
+ + G+++ + +HRD+ N+L+ N KI DFGL+ + K+ + R+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRL 180
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAEL--FAGKPIMPGRTEVEQLHKIFKLCGS 357
W L + Y D+WS G +L E+ G P CG
Sbjct: 181 PVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP----------------YCGM 222
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFK 389
E ++ KLP ++ ++P + C E ++
Sbjct: 223 TCAELYE--KLPQG--YRMEKP-RNCDDEVYE 249
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 14/219 (6%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL-EG 202
+G G +V A+ + + + A+K V M E+ L D +I+K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 203 LITSRVSGS-----LYLVFEY-----MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
+ LV +Y + ++ A T F E + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHH 158
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLL 311
HS+ ++HRDIK +N+L+ NG++K+GDFG + + + + T +Y PE+
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHK 350
Y D++S G +L EL K G E +HK
Sbjct: 219 -RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 52/221 (23%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 141 LDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
++++G+ + +YK +++ +LVA+K ++ N +P+ +E ++ L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPN 68
Query: 197 IMKLEGLITSRVSGSLYLVFEYME-------------HDLAGLAA----TPGVKFTEAQI 239
I+ L G++T + ++FEY+ H G ++ T
Sbjct: 69 IVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 240 KCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL------ANFFKCSQKQ 293
Q+ G+E+ S +H+D+ N+LI +KI D GL A++++ K
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA 334
L R W P ++ G + + D+WS G +L E+F+
Sbjct: 187 LLPIR----WMPPEAIMYGK--FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRF-TNMDPESVRFMAREIIILRRLDHPNIMKLEG 202
+G+GT+ V ++ + A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 203 LITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHR 261
+ + L V EY + F+E + + Y +++ L++ HS + +++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELLLGSTDYGAS 319
D+K NL++D +G +KI DFGL K K T + T Y PE +L DYG +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRA 176
Query: 320 VDLWSSGCILAELFAGK 336
VD W G ++ E+ G+
Sbjct: 177 VDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 32/183 (17%)
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFT-------EAQIKCY 242
H NI+ L G T G LY++ EY + PG+ ++ E Q+
Sbjct: 77 HKNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 243 -----MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCSQ 291
Q+ G+E+ S+ +HRD+ N+L+ + ++KI DFGLA +++
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY---- 190
Query: 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHK 350
K+ R+ W P L Y D+WS G +L E+F G PG VE+L K
Sbjct: 191 KKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFK 247
Query: 351 IFK 353
+ K
Sbjct: 248 LLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 36/223 (16%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESV--RFMAREIIILRRLDHP 195
++ + IG+G VY A D ++ VALKK+R + + RF+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME-----HDLAGLAATPGVKFTEAQIKCYMKQLL--- 247
I+ + + + +Y Y+E L + + E K + L
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIF 119
Query: 248 ----HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF----------FKCSQKQ 293
+E+ HS+G+LHRD+K N+L+ G + I D+G A F ++
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 294 PLTSR-------VVTLWYRPPELLLGSTDYGASVDLWSSGCIL 329
S V T Y PE LLG S D+++ G IL
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 7/174 (4%)
Query: 163 LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222
VA+ +R D + F+A E + L + DH NI++LEG+IT ++ +V EYM +
Sbjct: 35 PVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNG 91
Query: 223 -LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281
L + Q+ + L G+++ G +H+ + +L++ + + KI F
Sbjct: 92 ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF 151
Query: 282 GLANFFKCSQ-KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA 334
K ++ + LW P + + ++ D+WS G ++ E+ +
Sbjct: 152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 31/243 (12%)
Query: 134 KADSFEKLDKIGQGTYSSVYKA---RDLENNKL-VALKKVRFTNMDPESVRFMAREIIIL 189
K +++ +G G + +VYK + E K+ VA+K + T +V FM E +I+
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIM 63
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLH 248
+DHP++++L G+ +S ++ LV + M H L + + Q+
Sbjct: 64 ASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ--------PLTSRVV 300
G+ + R ++HRD+ N+L+ +KI DFGLA + +K+ P+ +
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 301 T-LWYRPPELLLGSTDYGASVDLWSSGCILAEL--FAGKPI--MPGRTEVEQLHKIFKLC 355
+ YR + D+WS G + EL F GKP +P R + L K +L
Sbjct: 181 ECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231
Query: 356 GSP 358
P
Sbjct: 232 QPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 143 KIGQGTYSSVYKA--RDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
++G G + +V K + ++ K VA+K ++ N DP + RE ++++LD+P I+++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKF-------TEAQIKCYMKQLLHGLEHC 253
G+ + S LV E LA L P KF TE I + Q+ G+++
Sbjct: 62 IGICEAE---SWMLVME-----LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLA-------NFFKCSQ--KQPLTSRVVTLWY 304
+HRD+ N+L+ KI DFGL+ N++K K P+ WY
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------WY 165
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFA 334
P + + + D+WS G ++ E F+
Sbjct: 166 APE--CMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 9/147 (6%)
Query: 212 LYLVFEY-MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270
LYLV +Y + DL L + + E + Y+ +++ ++ H G +HRDIK N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 271 DYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPELLL----GSTDYGASVDLWS 324
D NG +++ DFG + + + S V T Y PE+L G YG D WS
Sbjct: 136 DKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193
Query: 325 SGCILAELFAGKPIMPGRTEVEQLHKI 351
G + E+ G+ + VE KI
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 5/143 (3%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEG 202
I +G + VY R N+KL A+K V+ +M + V + E L P I+ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 203 LITSRVSGSLYLVFEYM-EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ S + ++YLV EY+ D+ L G F E Y+ ++ L++ H GI+HR
Sbjct: 72 SLQS--ANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 262 DIKGSNLLIDYNGILKIGDFGLA 284
D+K N+LI G +K+ DFGL+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 50/240 (20%)
Query: 141 LDK-IGQGTYSSVYKARDLENNKL-----VALKKVRFTNMDPESVRFMAREIIILRRLDH 194
L K +G+G + V KA VA+K ++ N +R + E +L++++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNH 62
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-------------DLAGLAA----------TPG 231
P+++KL G + G L L+ EY ++ + L + P
Sbjct: 63 PHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 232 VK-FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------ 284
+ T + + Q+ G+++ ++HRD+ N+L+ +KI DFGL+
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 285 -NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL--FAGKPIMPG 341
++ K S+ R+ W L Y D+WS G +L E+ G P PG
Sbjct: 181 DSYVKRSK-----GRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 50/214 (23%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 144 IGQGTYSSVYKARDLENNKL--VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+G+G + SV + + +++ + VA+K ++ + E + ++ DHPN+M+L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 202 GLITSRVSGSLY----LVFEYMEH-DL------AGLAATPGVKFTEAQIKCYMKQLLHGL 250
G+ V Y ++ +M+H DL + L P T+ +K +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN--FFKCSQKQPLTSRVVTLWYRPPE 308
E+ S+ +HRD+ N +++ N + + DFGL+ + +Q +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 309 LLLGSTDYGASVDLWSSGCILAELFA-GKPIMPG 341
L Y D+WS G + E+ G+ PG
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 36/185 (19%)
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFT-------------E 236
H NI+ L G T G LY++ EY + PG+++ +
Sbjct: 83 HKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCS 290
+ C Q+ G+E+ S+ +HRD+ N+L+ + ++KI DFGLA +++
Sbjct: 141 DLVSCAY-QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 196
Query: 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQL 348
K+ R+ W P L Y D+WS G +L E+F G P PG VE+L
Sbjct: 197 -KKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEEL 251
Query: 349 HKIFK 353
K+ K
Sbjct: 252 FKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 44/198 (22%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 144 IGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
IG G + V++ + VA+K ++ + + F++ E I+ + H NI++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 201 EGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
EG++T ++ EYME+ L +F+ Q+ ++ + G+++ +
Sbjct: 72 EGVVTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS---RVVTLWYRPPELLLGSTDY 316
HRD+ N+L++ N K+ DFGL+ + + T+ ++ W P + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA--IAYRKF 187
Query: 317 GASVDLWSSGCILAELFA 334
++ D+WS G ++ E+ +
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 144 IGQGTYSSVYKAR-DLENNKL--VALKKVR---FTNMDPESVRFMAREIIILRRLDHPNI 197
+G+G + SV +A+ E+ VA+K ++ F++ D E F+ RE ++ DHPN+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE--EFL-REAACMKEFDHPNV 63
Query: 198 MKLEGL-ITSRVSGSL---YLVFEYMEH-DL------AGLAATPGVKFTEAQIKCYMKQL 246
+KL G+ + SR G L ++ +M+H DL + + P + ++ +M +
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-FMIDI 122
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ--KQPLTSRVVTLWY 304
G+E+ S+ +HRD+ N +++ N + + DFGL+ +Q S++ W
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAEL 332
L Y D+W+ G + E+
Sbjct: 183 ALES--LADNVYTTHSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 141 LDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
++++G+ + VYK E + VA+K ++ P F E ++ RL HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF-KHEAMMRSRLQHP 68
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH--------------DLAGLAATPGVKFT--EAQI 239
NI+ L G++T L ++F Y H D+ VK T A
Sbjct: 69 NIVCLLGVVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 240 KCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL------ANFFKCSQKQ 293
+ Q+ G+E S ++H+D+ N+L+ +KI D GL A+++K
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA 334
L R W P ++ G + D+WS G +L E+F+
Sbjct: 187 LLPIR----WMSPEAIMYGK--FSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYKA---RDLENNKL-VALKKVRFTNMDPESVRFMAREIIIL 189
K F+K+ +G G + +VYK + E K+ VA+K++R P++ + + E ++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVM 63
Query: 190 RRLDHPNIMKLEGL-ITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLL 247
+D+P++ +L G+ +TS V L+ + M L + + Q+
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK--QPLTSRVVTLWYR 305
G+ + R ++HRD+ N+L+ +KI DFGLA +K +V W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 306 PPELLLGSTDYGASVDLWSSGCILAEL--FAGKP 337
+L Y D+WS G + EL F KP
Sbjct: 180 LESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRV 299
CY Q+ G+E SR +HRD+ N+L+ N ++KI DFGLA + +K S
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFK 353
+ L + PE + Y D+WS G +L E+F+ G PG E+ + K
Sbjct: 238 LPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 122 VAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF 181
V GE I+ R F+ L +G+GT+ V +A D + + A+K VR N+ P+ R
Sbjct: 119 VLGEDIDVSTQR----FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR--NV-PKYTRD 171
Query: 182 MAREIIILRRL------DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFT 235
EI + ++ D +MK++ + +G + +V L G F+
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGHMCIVMPKYGPCLLDWIMKHG-PFS 229
Query: 236 EAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGI----------------LKI 278
+ + Q L++ H+ ++H D+K N+L++ + ++I
Sbjct: 230 HRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289
Query: 279 GDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPI 338
D G C ++ T+ V T YR PE++LG + S D+WS GCI+ EL+ GK +
Sbjct: 290 CDLGGC----CDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLL 344
Query: 339 MPGRTEVEQLHKIFK-LCGSPSE 360
+E LH + K L PSE
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 70/275 (25%), Positives = 112/275 (40%), Gaps = 60/275 (21%)
Query: 142 DKIGQGTYSSVYKA---RD-LENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPN 196
D IG+G + V KA +D L + + K + D R A E+ +L +L HPN
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPN 57
Query: 197 IMKLEGLITSRVSGSLYLVFEY---------------MEHDLA-----GLAATPGVKFTE 236
I+ L G R G LYL EY +E D A A+T +
Sbjct: 58 IINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST----LSS 111
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296
Q+ + + G+++ + +HRD+ N+L+ N + KI DFGL+ + K+ +
Sbjct: 112 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 170
Query: 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL--FAGKPIMPGRTEVEQLHKIFKL 354
R+ W L + Y + D+WS G +L E+ G P
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------Y 212
Query: 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFK 389
CG E ++ KLP ++ ++P C E +
Sbjct: 213 CGMTCAELYE--KLPQG--YRLEKP-LNCDDEVYD 242
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 11/183 (6%)
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
PN++ L I S S++LV ++ E + + E +K + +++ L+ H
Sbjct: 45 PNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH 102
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR-VVTLWYRPPELLLGS 313
GI+ RD+ +N+L+D G +++ F + S+ + V Y PE + G
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPE-VGGI 156
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
++ + D WS G IL EL GK ++ H + SEE RS L
Sbjct: 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEE--ARSLLQQLLQ 214
Query: 374 FKP 376
F P
Sbjct: 215 FNP 217
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 46/219 (21%)
Query: 143 KIGQGTYSSV----YKARDLENNKLVALKKVRFTNMDPESVR-FMAREIIILRRLDHPNI 197
++G G + V YK R + + VA+K ++ N + +SVR M RE I+ +LD+P I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID--VAIKVLK--NENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKF--------TEAQIKCYMKQLLHG 249
+++ G+ + +L LV E +A P KF T + + M Q+ G
Sbjct: 58 VRMIGVCEAE---ALMLVME-----MAS--GGPLNKFLSGKKDEITVSNVVELMHQVSMG 107
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-------NFFKCSQ--KQPLTSRVV 300
+++ + +HRD+ N+L+ KI DFGL+ +++K K PL
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK---- 163
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFA--GKP 337
WY P + + + D+WS G + E F+ KP
Sbjct: 164 --WYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 142 DKIGQGTYSSVY--KARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199
D+IG G + V +A + V +K++R + E + F+ +E+ R L+HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH----GLEHCH 254
G + LV E+ DL + + K ++++ GL H
Sbjct: 60 CLGQCIESIP--YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFFKCSQKQPLTSRVVTLWYRPPE 308
+H D+ N + + +KIGD+GLA +++ V L + PE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC-----HAVPLRWLAPE 172
Query: 309 LL------LGSTDYGASVDLWSSGCILAELF 333
L+ L D ++WS G + ELF
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 3/103 (2%)
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRV 299
CY Q+ G+E SR +HRD+ N+L+ N ++KI DFGLA + +K
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPG 341
+ L + PE + Y D+WS G +L E+F+ G PG
Sbjct: 243 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 81/343 (23%), Positives = 133/343 (38%), Gaps = 65/343 (18%)
Query: 139 EKLDKIGQG--TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
E L IG+G +V AR + V ++++ E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH----DLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
I+ + L++V +M + DL G+ +E I ++ +L L++
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGM--SELAIAYILQGVLKALDY 116
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGL-ANFFKCSQKQ--------PLTSRVVTLW 303
H G +HR +K S++LI +G K+ GL +N + Q P S V W
Sbjct: 117 IHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PI--MPGRTEVEQLHKIFKLCGS--- 357
P L Y A D++S G EL G P MP T++ + KL G+
Sbjct: 175 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQM----LLEKLNGTVPC 229
Query: 358 -------PSEEYWKR----------------SKLPHATIFKPQQPYKRCVAETFKDIPSS 394
P+EE + S + PY R + F
Sbjct: 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH----- 284
Query: 395 ALSLLDILLSTEPEVRGTASSALQNEFFTT-KPLPCDPSSLPK 436
++ L P+ R +AS+ L + FF K + +LP+
Sbjct: 285 --HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 32/206 (15%)
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMK---Q 245
R L HPNI++ G + LVFEY E DL + +Q+ + +
Sbjct: 50 RILQHPNILQCLGQCVEAIP--YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF-FKCSQKQPLTSRVVTLWY 304
+ G+ H H LH D+ N + + +K+GD+G+ +K + + V L +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 305 RPPELL------LGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQLHKIFKLCG 356
PEL+ L + + ++W+ G L ELF A +P ++ E L+ + K
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP-YSHLSDREVLNHVIKD-- 224
Query: 357 SPSEEYWKRSKLPHATIFKPQ--QPY 380
++ KL FKPQ PY
Sbjct: 225 -------QQVKL-----FKPQLELPY 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 25/46 (54%), Positives = 31/46 (67%)
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
IK M+Q+L GL H GI+HRDIK NLL+ +G +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 32/223 (14%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYK--ARDL---ENNKLVALKKVRFTNMDPESVRFMARE 185
V R + L ++GQG++ VY+ ARD+ E VA+K V + E + F+ E
Sbjct: 3 VSR--EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NE 59
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL--AATPGVKFTEAQIKCY 242
+++ ++++L G++ S+ +L +V E M H DL + P + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 243 MKQLLH-------GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL------ANFFKC 289
+++++ G+ + +++ +HRD+ N ++ ++ +KIGDFG+ ++++
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL 332
K L R W P L G + S D+WS G +L E+
Sbjct: 178 GGKGLLPVR----WMAPESLKDGV--FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYK---ARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
K +K+ +G G + +VYK D EN K+ KV N P++ + + E ++
Sbjct: 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64
Query: 191 RLDHPNIMKLEGL-ITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLH 248
+ P + +L G+ +TS V LV + M + L + + + Q+
Sbjct: 65 GVGSPYVCRLLGICLTSTVQ----LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYRP 306
G+ + ++HRD+ N+L+ +KI DFGLA + + +V W
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 307 PELLLGSTDYGASVDLWSSGCILAEL--FAGKPI--MPGRTEVEQLHKIFKLCGSP 358
+L + D+WS G + EL F KP +P R + L K +L P
Sbjct: 181 ESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRVVTLW 303
Q+ +G+E S+ +HRD+ N+LI ++KI DFGLA + + S S + L
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQLHKIFKLCGSPSEE 361
+ PE + + Y D+WS G +L E+F G P P EQ + + +
Sbjct: 307 WMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFY-------NAIKR 357
Query: 362 YWKRSKLPHAT--IFKPQQPYKRCVAETFKDIPS 393
++ +K HA+ I++ Q +C E F+ P
Sbjct: 358 GYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 3/103 (2%)
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRV 299
Y Q+ G+E SR +HRD+ N+L+ N ++KI DFGLA + +K
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPG 341
+ L + PE + Y D+WS G +L E+F+ G PG
Sbjct: 237 LPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 30/204 (14%)
Query: 151 SVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210
+V K R L LVA+K +R F+ +E+ IL RL PNI++L G+
Sbjct: 40 NVRKGRPL----LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 211 SLYLVFEYMEH-DL------------------AGLAATPGVKFTEAQIKCYMKQLLHGLE 251
L ++ EYME+ DL A A + + + Q+ G++
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPPEL 309
+ S +HRD+ N L+ N +KI DFG++ + R V W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 310 LLGSTDYGASVDLWSSGCILAELF 333
L+G + + D+W+ G L E+
Sbjct: 213 LMGK--FTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 33/202 (16%)
Query: 151 SVYKARDLENNKLVALKKV-RFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209
S+YK NNK V ++ +F + EI LRR+D NI+K+ G I V
Sbjct: 35 SIYKGI--FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 210 G--SLYLVFEY-----------MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH-S 255
L L+ EY E DL + K A I C GL + +
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDKEKDL-----SFKTKLDMA-IDC-----CKGLYNLYKY 141
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS-T 314
++++ + L+ N LKI GL P V + Y ++L +
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFS 197
Query: 315 DYGASVDLWSSGCILAELFAGK 336
+Y D++S G +L E+F GK
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298
IK MK +L LE+ H GI H DIK N+++D N I D+G+A+ F K S+
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCI 328
+R T Y A +D + C+
Sbjct: 188 EQKDLHR-------GTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 30/217 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKA----RDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
D D + +GT+ ++ + V +K V+ + V + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYG 64
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYME--------HDLAGLAATPGVKFTEAQIKCYM 243
L H NI+ + + ++++ YM A + Q+
Sbjct: 65 LSHQNILPI-LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 244 KQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-----NFFKC---SQKQPL 295
Q+ G+ + H RG++H+DI N +ID +KI D L+ + C ++ +P+
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL 332
W L+ + +Y ++ D+WS G +L EL
Sbjct: 184 K------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 45/213 (21%), Positives = 89/213 (41%), Gaps = 15/213 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYKA---RDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
K KL +G G + +V+K + ++ K+ K ++ + + ++ +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLH 248
LDH I++L G+ SL LV + L + ++ + Q+
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAK 120
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVT--LWYRP 306
G+ + ++HR++ N+L+ + I++I DFG+A+ K+ S T W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 307 PELLLGSTDYGASVDLWSSGCILAEL--FAGKP 337
+L G Y D+WS G + E+ + +P
Sbjct: 181 ESILFGR--YTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 5/112 (4%)
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL--TSRVVTL 302
Q+ G+ S+ +HRD+ N+L+ + I KI DFGLA + + +R+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFK 353
W P + + Y D+WS G +L E+F+ G PG + +K+ K
Sbjct: 282 WMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 242 YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPLTSRVV 300
+ Q+ G+E S+ +HRD+ N+L+ I+KI DFGLA + S S +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPG 341
+ + PE + + Y D+WS G +L E+F+ G PG
Sbjct: 302 PVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 7e-05
Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 27/131 (20%)
Query: 233 KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQ 291
K +EA++K ++QL+ L H I+H DIK N+L D + + D+GL
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-------- 156
Query: 292 KQPLTSRVV--------TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGR 342
+++ TL Y PE + G +Y S D W+ G + EL GK P
Sbjct: 157 -----CKIIGTPSCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 343 TE---VEQLHK 350
E +E L K
Sbjct: 211 DEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 5/112 (4%)
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL--TSRVVTL 302
Q+ G++ S+ +HRD+ N+L+ + KI DFGLA + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFK 353
W P + Y D+WS G +L E+F+ GK PG + +K+ K
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 46/233 (19%), Positives = 85/233 (36%), Gaps = 43/233 (18%)
Query: 144 IGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMA--REIIILRRLDHPN 196
+GQGT++++YK DL+ V + + +A ++ +L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKC--------YMKQLLH 248
++KL G+ V +V EY++ P F + KQL
Sbjct: 63 LVKLYGVC---VRDENIMVEEYVKFG-------PLDVFLHREKNNVSLHWKLDVAKQLAS 112
Query: 249 GLEHCHSRGILHRDIKGSNLLI-------DYNGILKIGDFGLANFFKCSQKQPLTSRVVT 301
L + + ++H ++ G N+L+ Y +K+ D G+ RV
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-----ITVLSREERVER 167
Query: 302 LWYRPPELLLG---STDYGASVDLWSSGCILAELFAGKPI-MPGRTEVEQLHK 350
+ + PE + S A D WS G L E+ + + + E+
Sbjct: 168 IPWIAPECIRNGQASLTIAA--DKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 25/73 (34%), Positives = 38/73 (52%), Gaps = 3/73 (4%)
Query: 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID- 271
Y V Y+ + L G++ I+ M+Q+L L+ HS GI+HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 272 YNGILKIGDFGLA 284
+G KI D G A
Sbjct: 291 GSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 25/187 (13%)
Query: 164 VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF------- 216
V +K++R + E ++F+ E R L H N+++ G T L + F
Sbjct: 25 VVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGIL 276
Y+ TP T ++ C ++ GL H H +H D+ N L+ + +
Sbjct: 84 GYLRSCRKAELMTPDPT-TLQRMAC---EIALGLLHLHKNNFIHSDLALRNCLLTADLTV 139
Query: 277 KIGDFGLANFFKCSQKQPLTSRVVTLW----YRPPELL------LGSTDYGASVDLWSSG 326
KIGD+GL++ K+ LW + PEL+ L D ++WS G
Sbjct: 140 KIGDYGLSH---NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG 196
Query: 327 CILAELF 333
+ ELF
Sbjct: 197 VTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 8/77 (10%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGL 203
I +G + YK + ++N +K++ N P S EI + +L HPNI+KL GL
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKLIGL 751
Query: 204 ITSRVSGSLYLVFEYME 220
S YL+ EY+E
Sbjct: 752 CRSEKGA--YLIHEYIE 766
|
Length = 968 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 47/211 (22%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 143 KIGQGTYSSVYKA------RDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
++GQG++ VY+ +D E VA+K V E + F+ E +++ + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKD-EPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHH 70
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGL--AATPGVKFTEAQIKCYMKQLLH------ 248
+++L G++ S+ +L ++ DL + P ++ Q +K+++
Sbjct: 71 VVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 249 -GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL------ANFFKCSQKQPLTSRVVT 301
G+ + ++ +HRD+ N ++ + +KIGDFG+ ++++ K L R
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAEL 332
W P L G + D+WS G +L E+
Sbjct: 187 -WMSPESLKDGV--FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.3 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.25 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.19 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.09 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.01 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.82 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.07 | |
| PLN02236 | 344 | choline kinase | 95.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.57 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.44 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.06 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.71 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.07 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.07 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 89.39 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-88 Score=726.09 Aligned_cols=429 Identities=66% Similarity=1.107 Sum_probs=397.9
Q ss_pred eEeecCCCccccccccCCcchhhhhhhccccCCcCCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHH
Q 005582 98 RIVSVSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE 177 (690)
Q Consensus 98 ~~~s~~~~~~~~~~~~~~p~~~~~~~~e~~~~~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~ 177 (690)
+..++......++++++||.|+....++++.+|.++..+.|+.+++||+|+||.||+|++..||+.||+|+++..+.++.
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~ 158 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG 158 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc
Confidence 44555566667899999999999999999999999999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005582 178 SVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257 (690)
Q Consensus 178 ~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~g 257 (690)
....+.|||.||++|+||||++|.++.+++..+.+|||||||++||..++..++..|++.++++||+||+.||.|||++|
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 89999999999999999999999999999877899999999999999999999999999999999999999999999999
Q ss_pred CccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCC
Q 005582 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337 (690)
Q Consensus 258 IvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~ 337 (690)
|+|||||++|||||.+|.+||+|||||+++.......+|+.+.|+||+|||+|+|...|+.++|+||+||||.||++|+|
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 99999999999999999999999999999998888889999999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHh
Q 005582 338 IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417 (690)
Q Consensus 338 pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 417 (690)
+|+|.++++|+++|+++||+|++++|+..++|.+..+++..+|++++.+.+..++..+++|+..||.+||.+|.||.++|
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCCCCCCCCCCCCCCCCcccccccchhhhhcCCCCCCCcchhhhhhccCCCCcCCcccchhhHHHHHhhhcCCC
Q 005582 418 QNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAELQTSIQKRQNQSN 497 (690)
Q Consensus 418 ~hpwf~~~p~~~~p~~lp~~p~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (690)
+|+||++.|++|+|+.||.|+++.+++.|.++++++++......... ..+..+.+++.|.+.++++.+.+.+++ ++|
T Consensus 399 ~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~~-~~~~~~~~r~~p~~~~~~~~~~~~~~~--~~n 475 (560)
T KOG0600|consen 399 QSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRRI-RERGDRGSRAIPAQPANAESQASPQRR--KSN 475 (560)
T ss_pred cCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhccccccccccc-ccccccccCCCCCCCCCHHHhcccccc--ccC
Confidence 99999999999999999999999999999999887776533322222 123356788999999999999999877 688
Q ss_pred CCCccccCCCCCCCCCCcCCCCCCCCCCCCCCC
Q 005582 498 PKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQ 530 (690)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (690)
..+.+++|+|+++.+.||+++|++.. .+..+.
T Consensus 476 ~~~~s~kf~p~~~~~~~~~~~~~~~~-~~~~~~ 507 (560)
T KOG0600|consen 476 SRSNSEKFPPPEQDGVGFPIGPSRRS-QSKGPS 507 (560)
T ss_pred CcCcccCCCCccccccCcccCCcccc-CCCCcc
Confidence 99999999987655599999998776 444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-62 Score=504.34 Aligned_cols=309 Identities=43% Similarity=0.760 Sum_probs=274.7
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
++..+.|++++.|++|+||.||+|+++.|++.||+|+++........--.-+|||.+|.+++|||||.+.++.....-+.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 56778999999999999999999999999999999999865433333334579999999999999999999999877788
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|||||||++||..++..-..+|...++++++.|++.||+|||.++|+||||||+|+|++..|.+||+|||||+.+.. .
T Consensus 152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-p 230 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-P 230 (419)
T ss_pred eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC-C
Confidence 999999999999999888777899999999999999999999999999999999999999999999999999999864 3
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
..++|..+.|.||+|||+|+|...|++++|+||+|||+.||++++|+|+|..+.+|+.+||+++|+|++..|+.....+.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999997654443
Q ss_pred c--ccCCCCccchhhhhhcCC--CchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCCCCCCCCCCCCcc
Q 005582 372 T--IFKPQQPYKRCVAETFKD--IPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKE 442 (690)
Q Consensus 372 ~--~~~~~~p~~~~~~e~~~~--~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~p~~lp~~p~~~~ 442 (690)
- ...+..||. .+...|.. ++....+|+..||.+||.+|.||.|+|+|+||...|+|++|..+|.+|...+
T Consensus 311 ~k~~~f~~~pyn-~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 311 VKKMTFSEHPYN-NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred hhccccCCCCch-hhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 2 223334443 33334443 5599999999999999999999999999999999999999999999987543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-61 Score=480.56 Aligned_cols=297 Identities=45% Similarity=0.769 Sum_probs=267.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|..+++||+|.||.||+|++..||+.||||+++..+..........|||+.|+.++|+||+.|+++|.. .+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 47999999999999999999999999999999999887655555668899999999999999999999977 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
+|||+.+|...+......|+..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+... ....
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p-~~~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP-NRIQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC-Cccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998643 4455
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh-cCCCccccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~-~~l~~~~~~ 374 (690)
+..+.|.||+|||+++|+..|+..+||||+|||++||+.|.|+|+|.++.+|+..||..+|+|.++.|+. ..+|.+..+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 6669999999999999999999999999999999999999999999999999999999999999999987 456665554
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCCCCCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKY 437 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~p~~lp~~ 437 (690)
. +.|.. .....|+..+++++||+.+||.+||.+|+||.|+|+|+||++.|.|+.++.+|.-
T Consensus 239 ~-~~P~~-~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 239 Q-QFPKP-PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred h-cCCCC-ccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 4 11111 1223678899999999999999999999999999999999999999998877653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-58 Score=470.06 Aligned_cols=286 Identities=33% Similarity=0.582 Sum_probs=252.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
+.|+.+.++|+|+||.||+|+++.||+.||||++.-...++...+-.+|||.+|++|.|+|+|.|+++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 47999999999999999999999999999999998766666666778899999999999999999999976 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||||++..+..+......++...++.|+.|++.|+.|||+++||||||||+||||+.+|.+||||||+|+.+.. .....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999988776666799999999999999999999999999999999999999999999999999998864 56678
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc-cc-c
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH-AT-I 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~-~~-~ 373 (690)
|.++.|.||+|||++.|...|+..+||||+||++.||++|.|+|+|.++.+++..|.+.+|.............+ .. .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 999999999999999999999999999999999999999999999999999999999999987765443221111 11 1
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
..|...-.+.+...+++++.-++||+++||..||.+|++++|+|.|+||..
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 123333345567778899999999999999999999999999999999943
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-58 Score=492.68 Aligned_cols=286 Identities=40% Similarity=0.685 Sum_probs=255.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|.++++||.|+||.||+|..+.+|..||||+++.....-+... -+||++.|++|+ |||||+|.+++.+.+ ..+|+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~-~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDND-RILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccC-ceEee
Confidence 589999999999999999999999999999999986654433333 368999999999 999999999998853 38999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||||+.+|.+++..++..|++..++.|+.||+.||+|+|.+|+.||||||+||||.....+||+|||||+.+. ...+
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--SkpP 165 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--SKPP 165 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--cCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999875 3567
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh-cCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~-~~l~~~~~ 373 (690)
+|.++.|.||+|||+|+....|+.++|||++|||++|+.+-+|+|+|.++.+++.+|+..+|+|..+.|.. ..+.....
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 89999999999999999989999999999999999999999999999999999999999999999999986 33333333
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
|....--...+...+++.+.++.+||..||.|||.+||||.|+|+||||+..
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 3333333334566677899999999999999999999999999999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=463.53 Aligned_cols=294 Identities=36% Similarity=0.586 Sum_probs=254.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeec---cCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR---VSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~---~~~~l 212 (690)
..|..++.||.|+||.|+.|.+..+|+.||||++..........++..||+++|+.++|+||+.+++++..+ .-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 357778999999999999999999999999999974444566778899999999999999999999998762 24678
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC-C
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS-Q 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~-~ 291 (690)
|+|+|+|+.+|...+... ..|++..+..+++||+.||.|+|+.+|+||||||.|||++.++.+||||||||+..... .
T Consensus 102 YiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 999999998888877654 35999999999999999999999999999999999999999999999999999987543 2
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
...+|.++.|.||+|||+++....|+.++||||+||||+|||+|+++|+|.+..+|+..|+..+|+|+++.+.......+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 34578999999999999999989999999999999999999999999999999999999999999999998876543322
Q ss_pred cccCCC--CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCC
Q 005582 372 TIFKPQ--QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430 (690)
Q Consensus 372 ~~~~~~--~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~ 430 (690)
..+... ..-+..+...|++.++.+++||.+||.+||.+|+|++|+|+||||.....|.+
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 222111 11122356678899999999999999999999999999999999988754443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-54 Score=447.40 Aligned_cols=291 Identities=43% Similarity=0.749 Sum_probs=254.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEeecc----CC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN-IMKLEGLITSRV----SG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~----~~ 210 (690)
..|+.+++||+|+||+||+|+++.+|+.||+|+++....++..-....+|+.+|+.|+|+| |+.|++++.... ..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4688899999999999999999999999999999977554333345689999999999999 999999998742 13
Q ss_pred eEEEEEeccccchhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 211 SLYLVFEYMEHDLAGLAATPG---VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~---~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
.+||||||++.+|...+.... ..++...++.+++||+.||.|||+++|+||||||+||||+.+|.+||+|||+|+.+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 799999999999887766544 35788999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc-
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS- 366 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~- 366 (690)
.- ....++..++|.||+|||+++|...|+..+||||+|||++||++++++|+|.++.+++..|+..+|+|+++.|+..
T Consensus 171 ~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 171 SI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred cC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 42 2345788899999999999999989999999999999999999999999999999999999999999999999863
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
.++......+.+.-.+.+....+..++++.+|+.+||+++|.+|.||..+|.||||...+.
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 4455444444444355566677778899999999999999999999999999999987644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=453.30 Aligned_cols=263 Identities=30% Similarity=0.441 Sum_probs=222.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH-----HHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-----ESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~-----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|++||++|+|||||+++++|..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 356889999999999999999999999999999998654322 1234468999999999999999999999884
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC---CceEeeccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN---GILKIGDFGLANF 286 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~---g~vKL~DFGlA~~ 286 (690)
+..|||||||+|+.+....-.++.+.+..-+.+++||+.||.|||++||+||||||+||||+.+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 6789999999987665555555689999999999999999999999999999999999999876 7999999999998
Q ss_pred cccCCCCCcccccccccCcCCccccCC--CCCCCcceeecchhHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHh
Q 005582 287 FKCSQKQPLTSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYW 363 (690)
Q Consensus 287 ~~~~~~~~~~~~~gT~~Y~APEvl~g~--~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~w 363 (690)
.. ....+.+.||||.|.|||++.+. ..|..++||||||||||-+|+|.+||.+..... ..++|.+.-...-...
T Consensus 329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~- 405 (475)
T KOG0615|consen 329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ- 405 (475)
T ss_pred cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh-
Confidence 75 45678899999999999999652 235568999999999999999999998765444 5666655322222223
Q ss_pred hhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 364 ~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
|..+++++++||++||..||++|||++|+|+||||+..|
T Consensus 406 ------------------------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 ------------------------WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ------------------------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 456899999999999999999999999999999998764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=455.38 Aligned_cols=259 Identities=30% Similarity=0.463 Sum_probs=232.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.+|...+.||+|||+.||.+++..+|+.||+|++.+..+ .......+.+||+|.+.|+|||||+++++|++ .+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 579999999999999999999999999999999986544 34556778999999999999999999999998 589999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|+|+|..+.+..+.+....|+|.++++|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+... .+.
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc-ccc
Confidence 9999998887777778889999999999999999999999999999999999999999999999999999988644 344
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
..+.||||.|.|||++.. ..++..+||||+|||||.||+|+|||...+-.+++.+|...-..
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~----------------- 236 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS----------------- 236 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-----------------
Confidence 567899999999999985 67999999999999999999999999999999999998652111
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
.+..++.++.+||..||+.||.+|||++++|.|+||+..-.
T Consensus 237 ------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 237 ------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred ------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 12368999999999999999999999999999999966533
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=433.57 Aligned_cols=281 Identities=40% Similarity=0.637 Sum_probs=241.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC---eE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG---SL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~---~l 212 (690)
-.|...+.+|.|+||.||+|....+++.||||++-.... .--+|++||+.++|||||+|+.+|....+. .+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 368999999999999999999999999999999864322 124799999999999999999988776554 45
Q ss_pred EEEEeccccchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-CceEeeccccccccc
Q 005582 213 YLVFEYMEHDLAGLAAT---PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFK 288 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~---~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~~~~ 288 (690)
.+|||||+.+|...+.. .+..++.-.++.|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 78999999988877653 35579999999999999999999999999999999999999965 999999999999886
Q ss_pred cCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
. +++..++..|.+|+|||+++|...|+.++||||.||+++||+.|+++|+|.+..+|+..|++.+|+|+.+....+..
T Consensus 178 ~--~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 K--GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred c--CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 4 45568899999999999999999999999999999999999999999999999999999999999999998765443
Q ss_pred CcccccCCCCccchhhhh-hcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAE-TFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e-~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.. ..++........+.+ ..+..++++.+|+.++|.++|.+|.|+.|+|.||||...
T Consensus 256 ~y-~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 256 NY-TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cc-ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 22 222222222222323 457889999999999999999999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=424.05 Aligned_cols=260 Identities=30% Similarity=0.449 Sum_probs=229.7
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..++|+++++||+|+||+||+++...|++.||+|++++...- ...+..+..|..||..++||.||.|+..|++ ...+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeE
Confidence 357899999999999999999999999999999999876553 3467788999999999999999999888877 5899
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|||+||+.|+.+...+...+.|++..++.|+.+|+.||.|||+.|||||||||+|||||.+|+++|+||||++.... ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence 99999999988888888778999999999999999999999999999999999999999999999999999986432 23
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
....+.|||+.|||||++.+. .|+..+|+|||||++||||+|.+||.+.+....+.+|.+.-.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~---------------- 242 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL---------------- 242 (357)
T ss_pred CccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC----------------
Confidence 344568999999999999984 799999999999999999999999999999999999876210
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC----CHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG----TASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp----Ta~e~L~hpwf~~~ 425 (690)
......++.++++||++||..||++|. .+.++-+||||...
T Consensus 243 ------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 243 ------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 011123789999999999999999995 78999999999763
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-51 Score=386.17 Aligned_cols=285 Identities=41% Similarity=0.736 Sum_probs=253.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|..+++||+|.||+||+|++..+++.||+|.++....++..-...++||-+|+.|.|.|||+|+++..+ +..+-+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 5788899999999999999999999999999999887666656678999999999999999999999876 57899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
|||..++......-++.+....++.++.|++.||.|||+++++||||||.|+||+.+|.+||+|||+++.+.-. .....
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-vrcys 159 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYS 159 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEeee
Confidence 99999999888887889999999999999999999999999999999999999999999999999999987532 22345
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhc-CCCccccc
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS-KLPHATIF 374 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~-~l~~~~~~ 374 (690)
..+.|.||++|.++.|..-|+...|+||.|||+.||.. |+|+|+|.+..+++.+||..+|+|+++.|+.. ++|.+..
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~- 238 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP- 238 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc-
Confidence 66889999999999999999999999999999999975 89999999999999999999999999999863 4443322
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.|.-|-.-.|....+.++...++|+.++|..+|.+|++|+.+|+||||++-
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 233333456777888999999999999999999999999999999999763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=419.96 Aligned_cols=257 Identities=30% Similarity=0.429 Sum_probs=226.1
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++.+.+..||+|..|+||+++++.|++.+|+|++. .+.++...+++.+|++||+.++||+||.+|+.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 357889999999999999999999999999999994 45677788899999999999999999999999998532 6999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+++.++.+....+.++|..+..++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+..+
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999888887777789999999999999999999996 89999999999999999999999999999887644
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGR-----TEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~-----~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
...+++||..|||||-+.+ ..|+.++||||||+.++||.+|+.||+.. +..+++..|+. .|+..
T Consensus 233 ~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~------- 301 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPR------- 301 (364)
T ss_pred hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCC-------
Confidence 4568899999999999988 57999999999999999999999999874 45666666643 11111
Q ss_pred CcccccCCCCccchhhhhhcC-CCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFK-DIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
... .+++++++||..||.+||.+|||+.|+|+|||++..
T Consensus 302 ------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 302 ------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred ------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 012 378999999999999999999999999999999864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=437.52 Aligned_cols=283 Identities=30% Similarity=0.509 Sum_probs=235.6
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-C-----CCeeeeeeeEeeccCC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-H-----PNIMKLEGLITSRVSG 210 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-H-----pnIv~l~~~~~~~~~~ 210 (690)
+|++++.||+|+||.|.+|++..|++.||||+++.. .........||.||..|+ | -|||+++++|..+ +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--N 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--c
Confidence 689999999999999999999999999999999743 456666788999999996 3 5899999999984 8
Q ss_pred eEEEEEeccccchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC--ceEeecccccccc
Q 005582 211 SLYLVFEYMEHDLAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG--ILKIGDFGLANFF 287 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~-~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g--~vKL~DFGlA~~~ 287 (690)
++|||+|+++.+|..++.... ..|+...++.++.||+.||.+||+.||||+|||||||||...+ .|||+|||.|...
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999999999999887653 3599999999999999999999999999999999999998644 8999999999765
Q ss_pred ccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
. +....++.+++|+|||+|+| ..|+.++||||||||++||++|.|+|+|.++.+++..|++.+|.|+.......+
T Consensus 342 ~----q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 S----QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred C----Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 3 33447899999999999999 579999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccC--------------------------------CCCc-cchhhhhhcC-CCchhHHHHHHHhccCCCCCCCCH
Q 005582 368 LPHATIFK--------------------------------PQQP-YKRCVAETFK-DIPSSALSLLDILLSTEPEVRGTA 413 (690)
Q Consensus 368 l~~~~~~~--------------------------------~~~p-~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa 413 (690)
-.....-. ...| ..+.+...+. .-...+.+||.+||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 11100000 0011 1222222222 334568999999999999999999
Q ss_pred HHHhcCcCCCCCCCCC
Q 005582 414 SSALQNEFFTTKPLPC 429 (690)
Q Consensus 414 ~e~L~hpwf~~~p~~~ 429 (690)
.++|+||||+...+..
T Consensus 497 ~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 497 AQALNHPFLTGTSLER 512 (586)
T ss_pred HHHhcCcccccccccc
Confidence 9999999999765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=428.00 Aligned_cols=262 Identities=33% Similarity=0.495 Sum_probs=224.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.++|+++..||+|+||.||+|+.+.||..||+|++++..+ ....+..++.|-.||...++|+||+|+..|++ ..++|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LY 217 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLY 217 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeE
Confidence 4689999999999999999999999999999999998765 35677889999999999999999999888877 58999
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC--
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-- 291 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~-- 291 (690)
|||||++|+-..-++.....|++..+++|+.+++.||..||..|||||||||+|+|||..|++||+||||+.-+....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999986554444445589999999999999999999999999999999999999999999999999996443200
Q ss_pred --------------------CC------------------------CcccccccccCcCCccccCCCCCCCcceeecchh
Q 005582 292 --------------------KQ------------------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGC 327 (690)
Q Consensus 292 --------------------~~------------------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~ 327 (690)
.. ...+.+|||.|+|||+|++ ..|+..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHH
Confidence 00 0113489999999999998 46999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh-cCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCC
Q 005582 328 ILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTE 406 (690)
Q Consensus 328 iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~-~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~D 406 (690)
|+||||.|.|||.+++..++..+|.. |.. +..|. -..++.+++|||.+||+ |
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP~-----------------~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFPE-----------------EVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCCC-----------------cCcccHHHHHHHHHHhc-C
Confidence 99999999999999999999999975 432 11111 12467899999999999 9
Q ss_pred CCCCCC---HHHHhcCcCCCCCC
Q 005582 407 PEVRGT---ASSALQNEFFTTKP 426 (690)
Q Consensus 407 P~kRpT---a~e~L~hpwf~~~p 426 (690)
|.+|.- ++|+.+||||....
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCC
Confidence 999975 99999999998753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=430.04 Aligned_cols=261 Identities=34% Similarity=0.465 Sum_probs=227.8
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCC
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 210 (690)
+...+|.+.+.||+|+|++|++|+++.+++.||||++.+..+- +..++.+.+|-.+|.+| .||.|++|+..|.+ ..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--cc
Confidence 4467999999999999999999999999999999999765442 33455678899999999 89999999877776 57
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+|+||++++.+..++.+-+.|++..+++|+.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 89999999997554444455568999999999999999999999999999999999999999999999999999987643
Q ss_pred CCC------------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 005582 291 QKQ------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358 (690)
Q Consensus 291 ~~~------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p 358 (690)
... ...++|||..|.+||+|.. ...++.+|||+||||||+||.|.|||.+.++..++.+|+++-..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~- 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE- 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-
Confidence 322 1256899999999999976 56899999999999999999999999999999999999885322
Q ss_pred ChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 359 SEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 359 ~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
..+++++.+.+||+++|..||.+|+|+.++.+||||...
T Consensus 306 ----------------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 306 ----------------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ----------------------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 235688999999999999999999999999999999764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=406.35 Aligned_cols=292 Identities=38% Similarity=0.643 Sum_probs=240.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN----KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
..|+.+..||+|+||.||+|....++ +.+|||+++-...........-||+.+++.|+||||+.|..+|... +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 36999999999999999999654443 3799999985533333334567899999999999999999998874 678
Q ss_pred EEEEEeccccchhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC----CceEeecccc
Q 005582 212 LYLVFEYMEHDLAGLAATP----GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN----GILKIGDFGL 283 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~----~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~----g~vKL~DFGl 283 (690)
+||+|||.+++|+..+... ...++...++.++.||+.|+.|||++.|+||||||.||||..+ |.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 9999999999999887542 3468999999999999999999999999999999999999887 8999999999
Q ss_pred ccccccCCCC--CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC---------hHHHHHHHH
Q 005582 284 ANFFKCSQKQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT---------EVEQLHKIF 352 (690)
Q Consensus 284 A~~~~~~~~~--~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~---------~~e~l~kI~ 352 (690)
++.+...-.. .....++|.||+|||+|+|...|+.++|||++|||+.||||-+|+|.|.. ..+++.+|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9998643221 23456789999999999999999999999999999999999999998743 478999999
Q ss_pred HHhCCCChhHhhhc-CCCccccc--CCC-Cccchh----hhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 353 KLCGSPSEEYWKRS-KLPHATIF--KPQ-QPYKRC----VAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 353 ~~~g~p~~~~w~~~-~l~~~~~~--~~~-~p~~~~----~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+++|.|++..|+.. ++|+.... ... .-+..+ +.+..+.-++.+.+||.+||.+||.+|+||+++|+|+||+.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 99999999999864 44544111 011 111121 23344555677999999999999999999999999999999
Q ss_pred CCCC
Q 005582 425 KPLP 428 (690)
Q Consensus 425 ~p~~ 428 (690)
.++|
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 8765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=404.65 Aligned_cols=283 Identities=40% Similarity=0.708 Sum_probs=236.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|+++++||.|+||.||+|.+..++..||+|+++..... .....+.+|+.+|+.++||||+++++++.. .+.+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 35799999999999999999999999999999998754322 223456789999999999999999999876 468999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-Ccc
Confidence 9999999888777665556899999999999999999999999999999999999999999999999999765322 223
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc-
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI- 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~- 373 (690)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.|+.+.|+.........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3456789999999998876678999999999999999999999999999999999999999999999997543221110
Q ss_pred -cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 374 -FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 374 -~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
..+... ...+....+.++.++++||.+||.+||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccC-CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 011110 111223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=409.86 Aligned_cols=266 Identities=30% Similarity=0.456 Sum_probs=230.5
Q ss_pred CcCCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 130 ~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
+..+...+|.+...||.|+||+||+|+++.++..||||.+.+........+.+..||.||+.|+|||||.|++++.. .
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~ 81 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--D 81 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--C
Confidence 44566779999999999999999999999999999999999887778888889999999999999999999999987 5
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC------CceEeecccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN------GILKIGDFGL 283 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~------g~vKL~DFGl 283 (690)
+.+|||||||+|+.+..++...+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 7999999999976666555555689999999999999999999999999999999999999875 4699999999
Q ss_pred ccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Q 005582 284 ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363 (690)
Q Consensus 284 A~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w 363 (690)
|+.+.. .....+.||+|.|||||++.. ..|+.|+|+||+|+|||+|++|++||...+..+.+..|-+....
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~------ 232 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI------ 232 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc------
Confidence 999863 344677899999999999965 57999999999999999999999999999998888765431110
Q ss_pred hhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 364 ~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
+......++....+|+-.+|..+|..|.+..+.+.|+++...|
T Consensus 233 --------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 --------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred --------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 0111123556677999999999999999999999999998765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=414.63 Aligned_cols=266 Identities=32% Similarity=0.466 Sum_probs=228.2
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH------------HHHHHHHHHHHHHHhCCCCCeeee
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP------------ESVRFMAREIIILRRLDHPNIMKL 200 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~------------~~~~~~~rEi~iL~~L~HpnIv~l 200 (690)
...++|+++..||+|.||.|-+|++..+++.||||++.+..... ...+.+.+||.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34689999999999999999999999999999999997553311 123578999999999999999999
Q ss_pred eeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeec
Q 005582 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGD 280 (690)
Q Consensus 201 ~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~D 280 (690)
+++..++..+.+|||+|||..+-..+.-.....|++.+++.|+++++.||.|||.+|||||||||+|+||+.+|+|||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 99999998999999999999876665544443399999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC----CCcccccccccCcCCccccC---CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHH
Q 005582 281 FGLANFFKCSQK----QPLTSRVVTLWYRPPELLLG---STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353 (690)
Q Consensus 281 FGlA~~~~~~~~----~~~~~~~gT~~Y~APEvl~g---~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~ 353 (690)
||.+..+..... ..+...+|||.|+|||++.+ ....+.+.||||+||+||+|+.|+.||.++...++..+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 999987633221 23555799999999999977 33457899999999999999999999999999999999976
Q ss_pred HhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 354 LCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 354 ~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.- ......+.+...++|||.+||++||++|+|+.++..|||.+..
T Consensus 334 ~p---------------------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DP---------------------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred Cc---------------------------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 21 0111234678899999999999999999999999999999764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=399.15 Aligned_cols=294 Identities=46% Similarity=0.759 Sum_probs=248.4
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeec------
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR------ 207 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~------ 207 (690)
....|+.+.+||+|.||.||+|+...+|+.||+|++-..+.....-...++|+.+|..|.|+|++.|+++|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34579999999999999999999999999999998765443333344568999999999999999999987542
Q ss_pred cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 208 VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 208 ~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
....+||||.+|+++|..++......|+..+++.++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 23469999999999999999988889999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCC---CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 288 KCSQK---QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 288 ~~~~~---~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
....+ ...+.++.|+||++||+++|...|+++.|||..|||+.||+++.|+|.|+++..++..|..+||+.+.+.|+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 54332 347788999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred hc-CCCccccc--C--CCCccchhhhhhcC--CCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 365 RS-KLPHATIF--K--PQQPYKRCVAETFK--DIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 365 ~~-~l~~~~~~--~--~~~p~~~~~~e~~~--~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
.. ++|-.... . +... .+.+.+..+ .-++++.+|++.||.+||.+|++++++|.|.||..+|.|
T Consensus 255 ~~d~lpL~~sie~ePl~~~~-~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQ-KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccchHHHhccCCCCCcch-hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 63 22221111 1 1111 112222222 125689999999999999999999999999999988765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=397.07 Aligned_cols=284 Identities=35% Similarity=0.580 Sum_probs=234.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 47999999999999999999999999999999998654444455678899999999999999999999876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++++..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999998887766556799999999999999999999999999999999999999999999999999987654333334
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc---c
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA---T 372 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~---~ 372 (690)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||++.+..+.+..+....+..+...+........ .
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 45678999999999977 4589999999999999999999999999998888888888888877666543211100 0
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.+................++..+.+||.+||.+||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000111122234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.73 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=228.7
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..++|+++..||.|+||.|.+++++.+|..||+|++.+... .-.+++...+|..+|+.+.||++++|++.|.+ .+.+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeE
Confidence 45789999999999999999999999999999999986543 34566778999999999999999999887776 6899
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||||++|+.+..++.+..+|++..+++|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999998888888888999999999999999999999999999999999999999999999999999988742
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
...+.||||.|+|||++.. ..|+.++|+|||||++|||+.|.+||...+...++++|+..--.
T Consensus 197 -rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--------------- 259 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--------------- 259 (355)
T ss_pred -cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc---------------
Confidence 2456899999999999986 67999999999999999999999999999999999999862111
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.+..+++++++||++||+.|-.+|. ...++..||||...
T Consensus 260 --------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 260 --------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred --------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 1235789999999999999999993 56789999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=399.78 Aligned_cols=287 Identities=37% Similarity=0.621 Sum_probs=232.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999998754322 223346789999999999999999999876 468999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...... ...
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-Ccc
Confidence 9999999998877766667999999999999999999999999999999999999999999999999999754322 223
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhcCCCcc-c
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKRSKLPHA-T 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~w~~~~l~~~-~ 372 (690)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..++...+.+....|........ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 4456789999999998776678999999999999999999999998854 4567888888889888888765321111 0
Q ss_pred ccCCCCccchhhhhhcC--CCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFK--DIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~--~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
...........+...+. .++..+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000001111122222 356789999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=398.89 Aligned_cols=304 Identities=46% Similarity=0.827 Sum_probs=254.1
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
+..++|++.+.||.|+||.||+|.+..+|+.||+|+++...........+.+|+.+|++++|+||+++++++.....+.+
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 34578999999999999999999999999999999997554333333345689999999999999999999887545678
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+||||+.+++..++......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 9999999998877766555679999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC-Ccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL-PHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l-~~~ 371 (690)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.... +..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 2233445688999999987766789999999999999999999999999999999999999999998888865322 221
Q ss_pred cccC-CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCCCCCCCCCC
Q 005582 372 TIFK-PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYP 438 (690)
Q Consensus 372 ~~~~-~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~p~~lp~~p 438 (690)
..+. ...++ ..+...+..+++.+.+||.+||.+||++|||+.++|.||||...++|+.|..+|.+|
T Consensus 243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 243 GKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 2221 11122 223344556789999999999999999999999999999999999999999888875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=422.47 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=231.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFT-NMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.-|++.+.||.|+-|.|-+|++..||+.+|||++.+. .........+.+||-||+.|.||||++||++++. ..++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEE
Confidence 4578999999999999999999999999999999866 4444555678999999999999999999999987 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|+||++++-++.++...++|++.++..|+.||+.|+.|||..+|+||||||+|+|||..+.+||+|||+|..-. .+.-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKL 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--CCcc
Confidence 99999987776666666689999999999999999999999999999999999999999999999999997643 3456
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
+.+.||+|.|.|||++.|..+.+.++||||+|||||.||+|+.||.+++-...+.++....
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------------- 228 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------------- 228 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-------------------
Confidence 7889999999999999998888999999999999999999999999988888888886521
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
.+...+++.++.+||.+||+.||++|+|.+|+++|||+...+-
T Consensus 229 ----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 229 ----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 2334679999999999999999999999999999999987544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=412.84 Aligned_cols=258 Identities=31% Similarity=0.474 Sum_probs=223.9
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccC
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD---PESVRFMAREIIILRRLD-HPNIMKLEGLITSRVS 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~ 209 (690)
....|.+.+.||+|+||+|++|.+..++..||||++...... ......+.+|+.+++.+. ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 456899999999999999999999999999999987654221 123456779999999998 99999999999884
Q ss_pred CeEEEEEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-CceEeecccccccc
Q 005582 210 GSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFF 287 (690)
Q Consensus 210 ~~l~LV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~~~ 287 (690)
..+||||||+.| +|++.+.. .+++.+..++.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 569999999997 66666666 6789999999999999999999999999999999999999999 99999999999877
Q ss_pred ccCCCCCcccccccccCcCCccccCCC-CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGST-DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~-~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
. .....+...|||+.|+|||++.+.. +-+.++||||+||+||.|++|..||...+...++.+|.+..-.
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~--------- 241 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK--------- 241 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc---------
Confidence 4 3455678899999999999998865 4468999999999999999999999998888888887552110
Q ss_pred CCCcccccCCCCccchhhhhhcCCC-chhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDI-PSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~-~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
....+ +.++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 242 --------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 --------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11224 899999999999999999999999999999997
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=400.48 Aligned_cols=290 Identities=33% Similarity=0.525 Sum_probs=234.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC---CeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---GSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~~l~ 213 (690)
+|++.++||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999999999999999987543333444568899999999999999999998765322 3589
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~- 292 (690)
+|||||++++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999998877766543 4699999999999999999999999999999999999999999999999999976532211
Q ss_pred -CCcccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 293 -QPLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 -~~~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
......++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....|.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 123456789999999998642 468999999999999999999999999999999999999999998887665432111
Q ss_pred cccc--CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 371 ATIF--KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 371 ~~~~--~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
...+ .........+...++.+++.+.+||.+||..||.+|||++++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 00000111123445678899999999999999999999999999999987533
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=388.79 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=229.5
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
+..+.|++.+.||+|.|+.||++.+..+|+.+|+|++..........+.+.+|+.|-+.|.||||++|++.+.. .+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--ccee
Confidence 34678999999999999999999999999999999998766666677889999999999999999999998776 4788
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc---CCceEeecccccccccc
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY---NGILKIGDFGLANFFKC 289 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~---~g~vKL~DFGlA~~~~~ 289 (690)
|||||+|+|+.+..-+-...-+++..+..+++||+++|.|||.+||||||+||+|+||-. .--+||+|||+|..+.
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999998655443333356899999999999999999999999999999999999953 3479999999998876
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.......++|||.|||||++.. ..|+..+|||+.|||||-||.|.+||.+.+....++.|.+.-.-.+..+
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~------- 235 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE------- 235 (355)
T ss_pred -CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc-------
Confidence 5667888999999999999876 5799999999999999999999999999999999999987433333323
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
|+++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 236 ------------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 236 ------------------WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ------------------cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 4679999999999999999999999999999999965
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=387.85 Aligned_cols=280 Identities=40% Similarity=0.670 Sum_probs=228.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcC-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEeec---cC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNMDPESVRFMAREIIILRRL---DHPNIMKLEGLITSR---VS 209 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~---~~ 209 (690)
+|++++.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 79999999999999999999854 578999999876544333334466788877766 699999999988531 23
Q ss_pred CeEEEEEeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
..+|+||||+.+++...+... ...+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 568999999998887766542 3458999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC-
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK- 367 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~- 367 (690)
.. .......+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+.+|+..++.+....|....
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 162 FQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred CC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 32 23345678999999999876 468999999999999999999999999999999999999999988887775422
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
++.. .+... -...+....+.++..+.+||.+||..||++|||+.++|+||||
T Consensus 239 ~~~~-~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQ-AFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccch-hccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111 11110 0112333456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=392.19 Aligned_cols=249 Identities=31% Similarity=0.500 Sum_probs=214.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|+++++||.|+||.||++.+..+|+.||+|.++...++....+.+..|+.+|++|+|||||++++.-..+....++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 47999999999999999999999999999999999888888888999999999999999999999984333334558999
Q ss_pred Eeccccchh-hhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccccCCCcceeeccCCceEeecccccccc
Q 005582 216 FEYMEHDLA-GLA---ATPGVKFTEAQIKCYMKQLLHGLEHCHS--RG--ILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 216 ~Ey~~g~Ll-~~~---~~~~~~l~e~~i~~i~~qIl~gL~yLHs--~g--IvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
||||+++-+ ..+ ......+++..+|.++.|++.||.+||+ .+ |+||||||.||+|+.+|.|||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999997544 332 2345579999999999999999999999 45 999999999999999999999999999988
Q ss_pred ccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
.. ......+.+|||+||+||++.+ ..|+.++||||+||++|||+.-.+||.|++-.+...+|...-.+|-.
T Consensus 179 ~s-~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p------- 249 (375)
T KOG0591|consen 179 SS-KTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP------- 249 (375)
T ss_pred cc-hhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc-------
Confidence 63 3455678999999999999987 57999999999999999999999999999888888887653221110
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA 413 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa 413 (690)
. ..++.++..||..|+..||+.||+.
T Consensus 250 -----------------~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 -----------------D---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -----------------H---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 0 2367889999999999999999986
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=391.82 Aligned_cols=288 Identities=36% Similarity=0.670 Sum_probs=238.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|.++++||+|+||.||+|.+..++..||||.++..... .....+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 36899999999999999999999999999999998754322 223346789999999999999999999876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-TKT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC-ccc
Confidence 9999999888877666667899999999999999999999999999999999999999999999999999765322 122
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.+....|+..........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 33456799999999987766789999999999999999999999999999999999999999999988875432211100
Q ss_pred CCCCcc-chhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 375 KPQQPY-KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 375 ~~~~p~-~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.....+ ...+....+.++.++.+||.+||..||.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000000 1112233456889999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=414.46 Aligned_cols=282 Identities=33% Similarity=0.521 Sum_probs=228.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc------
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV------ 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~------ 208 (690)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 357999999999999999999999999999999885332 12457999999999999999998875421
Q ss_pred CCeEEEEEeccccchhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-ceEeeccccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAA---TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLA 284 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~---~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-~vKL~DFGlA 284 (690)
...+|+||||+++++...+. .....+++..++.++.||+.||.|||+.||+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 12478999999998765543 3455799999999999999999999999999999999999999665 7999999999
Q ss_pred cccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 285 ~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
+.+... ......++|+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+..+++.++++.+|.|..+.+.
T Consensus 219 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 876432 233456789999999998876679999999999999999999999999999999999999999999887765
Q ss_pred hcCCCcccccCCCCccchhhhhh-cCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAET-FKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~-~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
... +..............+... ....+.++++||.+||.+||.+|||+.|+|+||||...
T Consensus 297 ~~~-~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 297 EMN-PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred Hhc-hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 432 1111111000011111122 23578899999999999999999999999999999764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=405.28 Aligned_cols=289 Identities=32% Similarity=0.493 Sum_probs=236.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC---CeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---GSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~~l~ 213 (690)
+|++++.||+|+||.||+|.+..+++.||||++.....+......+.+|+.+|+.++||||+++++++..... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999999999999987543344455678899999999999999999999876421 2689
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+.+++...+... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999998887766543 47999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc---
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH--- 370 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~--- 370 (690)
.....++|+.|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|...+|.++.+.+.......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 45566789999999999886678999999999999999999999999999999999999999998876653211000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
........+............+..+.+||.+||.+||.+|||+.++|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000001111111223345688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=397.40 Aligned_cols=290 Identities=30% Similarity=0.506 Sum_probs=233.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999999999999999765444455667889999999999999999999876432 24
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 6899999999988776643 4789999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC--
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL-- 368 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l-- 368 (690)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+++..++.|..++++....
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 22345678999999999977 5689999999999999999999999999999999999999999988776654221
Q ss_pred -------CcccccCCCCccc----hhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCC
Q 005582 369 -------PHATIFKPQQPYK----RCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430 (690)
Q Consensus 369 -------~~~~~~~~~~p~~----~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~ 430 (690)
+....+.....+. ..........+..+++||.+||..||.+|||+.++|+||||..+..+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 329 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 329 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence 1100000000000 0011112234578999999999999999999999999999987544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=395.70 Aligned_cols=286 Identities=31% Similarity=0.500 Sum_probs=231.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999999999999999999765444555667889999999999999999999886532 13
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 175 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT- 175 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc-
Confidence 5799999999988776543 488999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.|...+++......
T Consensus 176 -~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 -NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred -CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 223345678999999999977 468999999999999999999999999999999999999999998877654321000
Q ss_pred -----ccccCCCCccchhh--------hhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 371 -----ATIFKPQQPYKRCV--------AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 371 -----~~~~~~~~p~~~~~--------~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.....+...+...+ .......++.+.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 00000000011000 111223567899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=379.63 Aligned_cols=281 Identities=40% Similarity=0.677 Sum_probs=228.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEeec---cCC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL---DHPNIMKLEGLITSR---VSG 210 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~---~~~ 210 (690)
+|++++.||+|+||.||+|.+..+++.||||.++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999999875433322233455677777665 799999999987642 134
Q ss_pred eEEEEEeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 211 SLYLVFEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
.+++||||+.+++...+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999999877765442 33589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.++|.+....+.+.+++...+.+....|......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 22344578999999999876 45899999999999999999999999999999999999999998888777542111
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
....+.+. ....+....+.++..+.+||.+||++||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111111 1122344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=410.06 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=227.8
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccC
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVS 209 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~ 209 (690)
....++|.++.+||+|+||+|+++..+.+++.||||++++..+ ..+.++.++.|..|+.... ||.++.|+..|+. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 3456899999999999999999999999999999999998765 4667888899999998885 9999999998887 5
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
.++|+||||+.|+.+..+ .....|++..+++|+..|+.||+|||++||||||||.+|||||.+|++||+||||++....
T Consensus 442 ~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 899999999999874433 3445799999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
......+.||||.|+|||++.+ ..|+.++|+|||||+|||||.|.+||+|+++.+....|+..--.
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~------------ 586 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR------------ 586 (694)
T ss_pred -CCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 2334567899999999999987 57999999999999999999999999999999999998752110
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
....++.++.+++++||..||++|.. ++++..||||...
T Consensus 587 -----------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 587 -----------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred -----------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 12347899999999999999999986 5889999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=403.82 Aligned_cols=282 Identities=24% Similarity=0.340 Sum_probs=221.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
..+|++++.||+|+||.||+|.+..+++.||||+... ..+.+|+.+|+.|+||||++++++|.. ....|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 3579999999999999999999999999999997532 236789999999999999999999876 468899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||++.+++...+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..........
T Consensus 161 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 9999998887766543 368999999999999999999999999999999999999999999999999997543333333
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGR-------TEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~-------~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+. +...++..|+...|.++.+++....
T Consensus 240 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 445689999999999876 46899999999999999999999776543 2456778888888876654321100
Q ss_pred CCcccc------cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 368 LPHATI------FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 368 l~~~~~------~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
...... .....+..+........++.++.+||.+||++||.+||||.|+|+||||+..+.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000000 0000010010011123467789999999999999999999999999999886543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=401.31 Aligned_cols=255 Identities=33% Similarity=0.485 Sum_probs=227.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+........+.+.+|+.|++.|+|||||.+++.|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57899999999999999999999999999999999887777788899999999999999999999999987 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
.||+.|+|...+... +.|+|+.++.++.+++.||.|||+++|+|||+||.||||+..|++|+||||+|+.... ....+
T Consensus 80 te~a~g~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL 157 (808)
T ss_pred ehhhhhhHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence 999999777666554 5899999999999999999999999999999999999999999999999999987653 34456
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
++.-|||.|||||++.+ ..|+..+|+||||||+|||++|+|||....-......|...- ..|
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~-----v~~------------ 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP-----VKP------------ 219 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC-----CCC------------
Confidence 77789999999999986 679999999999999999999999999877777777665410 001
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
...++..+..||+.+|.+||.+|.|-.++|.|||+..
T Consensus 220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 1357899999999999999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=391.35 Aligned_cols=261 Identities=31% Similarity=0.482 Sum_probs=212.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|...+.||+|+||.||++.+..+|..+|||.+...... ..+.+.+|+.+|++|+|||||+++|.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 3678899999999999999999999999999999866322 26778999999999999999999997554322368999
Q ss_pred EeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeecccccccccc--CC
Q 005582 216 FEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKC--SQ 291 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~~~~--~~ 291 (690)
|||+.++.+..+... ++.|++..++.|.+||++||.|||++|||||||||+||||+. +|.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999998766555444 337999999999999999999999999999999999999999 79999999999987763 22
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........||+.|||||++........++|||||||++.||+||++||... ...+.+..|.... .
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----------~--- 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----------S--- 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----------C---
Confidence 233456789999999999985222345999999999999999999999873 3333333332110 0
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.......++.++++||.+||..||.+||||+++|+|||.+..
T Consensus 241 -------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 241 -------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 012234589999999999999999999999999999999764
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=385.39 Aligned_cols=278 Identities=36% Similarity=0.641 Sum_probs=219.3
Q ss_pred EeeeeccCceEEEEEEEc--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 141 LDKIGQGTYSSVYKARDL--ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
..+||+|+||.||+|.+. .+++.||||.+...... ..+.+|+.+|+.++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 358999999999999965 46789999998754322 336789999999999999999999877656789999999
Q ss_pred cccchhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee----ccCCceEeeccccccc
Q 005582 219 MEHDLAGLAAT--------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANF 286 (690)
Q Consensus 219 ~~g~Ll~~~~~--------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl----d~~g~vKL~DFGlA~~ 286 (690)
+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99987765432 12358999999999999999999999999999999999999 4567999999999987
Q ss_pred cccCCC--CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 005582 287 FKCSQK--QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---------VEQLHKIFKLC 355 (690)
Q Consensus 287 ~~~~~~--~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~---------~e~l~kI~~~~ 355 (690)
+..... ......++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+... .+++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643221 2234567899999999998766789999999999999999999999976442 46788999999
Q ss_pred CCCChhHhhhcCC-Cccccc--------CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 356 GSPSEEYWKRSKL-PHATIF--------KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 356 g~p~~~~w~~~~l-~~~~~~--------~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
|.|....|..... +..... .........+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999888865321 111000 000011111111222346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=380.27 Aligned_cols=282 Identities=41% Similarity=0.707 Sum_probs=235.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||.|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++.+ .+.+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4889999999999999999999999999999997654433334557789999999999999999999876 46899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+++++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+... .....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VRCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-CCCcC
Confidence 99999888877665567999999999999999999999999999999999999999999999999999765432 22234
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhHhhhcC-CCccccc
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKRSK-LPHATIF 374 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~p-F~g~~~~e~l~kI~~~~g~p~~~~w~~~~-l~~~~~~ 374 (690)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..++..++.+....|.... .+.. ..
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY-KP 236 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc-cc
Confidence 456789999999988766689999999999999999998755 67788888999999999998888776432 1121 11
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.+..+....+.+..+.+++.+.+||.+||..||.+|||++++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 122222223344556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=404.48 Aligned_cols=256 Identities=30% Similarity=0.526 Sum_probs=224.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
..|....+||+|+.|.||.|....+++.||||.+...... ..+.+.+|+.+|+.++|+|||.+++-|.. .+.+|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEEE
Confidence 4688999999999999999999999999999999866532 33458899999999999999999998776 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||||+|+.+..+.... .|+|.++.+++++++.||.|||.+||+|||||.+|||++.+|.+||+|||++..+..... .-
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 9999998877776654 599999999999999999999999999999999999999999999999999988865443 45
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
.+.+|||+|||||++.. ..|++++||||||++++||+-|+|||...+....+..|.. .|.|.-..
T Consensus 427 ~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~------------- 491 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKN------------- 491 (550)
T ss_pred ccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCC-------------
Confidence 67799999999999976 5799999999999999999999999998888777777754 44442221
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
...+++.+++||++||+.||.+|+||.|+|+||||..
T Consensus 492 ------------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 492 ------------PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 3468999999999999999999999999999999954
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=381.29 Aligned_cols=286 Identities=39% Similarity=0.698 Sum_probs=236.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++++.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+|+.++||||+++++++.. .+.+|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999998754322 223456789999999999999999999876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKT 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC-CCc
Confidence 9999999888877666667899999999999999999999999999999999999999999999999999764322 122
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc-cc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA-TI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~-~~ 373 (690)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.+....|+....... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 33456789999999988766789999999999999999999999999999999999999999998888865311110 00
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+........++......+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111111122233344578899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=376.79 Aligned_cols=283 Identities=38% Similarity=0.700 Sum_probs=232.9
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++++.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 5889999999999999999999999999999987654443344567889999999999999999999886 57899999
Q ss_pred eccccchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.+++...+.. .+..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-ccc
Confidence 9999877766543 2357999999999999999999999999999999999999999999999999999765422 222
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+.+..|+..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 33456789999999987766689999999999999999999999999999999999999999888888864321111000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.........+......+++++.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000011112333456689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=390.48 Aligned_cols=285 Identities=33% Similarity=0.560 Sum_probs=232.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|.+++.||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36899999999999999999999999999999998754433344556779999999999999999999876421 24
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|++++++.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 94 EVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred cEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 5799999998777665532 3699999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+.......
T Consensus 171 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 171 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 23456789999999999876678999999999999999999999999999999999999988888777654322111
Q ss_pred ccccCCC--CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 ATIFKPQ--QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~--~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
...+... ......+...+...++.+.+||.+||..||.+|||+.++|.||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 1100000 001112333455677889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=390.45 Aligned_cols=288 Identities=31% Similarity=0.496 Sum_probs=232.5
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----C
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----S 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~ 209 (690)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346899999999999999999999999999999999765545555667889999999999999999999886532 2
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
..+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 45799999999988776643 588999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC-
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL- 368 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l- 368 (690)
. ......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+..+.+....-
T Consensus 172 ~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 172 S--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred c--cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 2 22345678999999999876 4689999999999999999999999999999999999999999887776643210
Q ss_pred --------CcccccCCCCcc----chhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 369 --------PHATIFKPQQPY----KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 369 --------~~~~~~~~~~p~----~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
+..........+ ...........+..+.+||.+||..||++|||+.|+|+||||.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 000000000000 00011112335678899999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=385.94 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=229.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.+|++.+.||+|.||.|-+|.+...|+.||||.+++..+ +....-.+.+||+||..|+||||+.++++|.. .+.+.|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEEE
Confidence 479999999999999999999999999999999998766 45667789999999999999999999999987 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||..++.+..+......|++.+++.|++||..|+.|||.++++|||||.+|||||.++++||+||||+..+. ....
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~--~~kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--DKKF 208 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc--cccH
Confidence 99999988777777777799999999999999999999999999999999999999999999999999999875 3566
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
++++||+|-|.+||++.|..+-++.+|.|||||+||.|+.|..||.|.+....+.+|... .+
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--aY---------------- 270 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--AY---------------- 270 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--cc----------------
Confidence 889999999999999999877799999999999999999999999999988887777541 11
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
.-+.-|.++.-||+.||..||++|.|++++-.|-|..
T Consensus 271 ------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 ------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0134578899999999999999999999999999974
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=392.49 Aligned_cols=260 Identities=34% Similarity=0.490 Sum_probs=226.8
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l 212 (690)
...|++.+.||.|.||.||+|.++.||+.||+|++.+.... ......+.+|+.||++|. |||||.++++|.+. ..+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence 45799999999999999999999999999999999866542 234567899999999998 99999999999884 689
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC----CceEeeccccccccc
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN----GILKIGDFGLANFFK 288 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~----g~vKL~DFGlA~~~~ 288 (690)
|+|||+|.|+.+...+... .+++..+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++..+.
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999986555444333 49999999999999999999999999999999999999643 579999999999876
Q ss_pred cCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
. ...+...+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.+..+...+|...-...+.
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~-------- 259 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS-------- 259 (382)
T ss_pred C--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC--------
Confidence 4 556778899999999999875 57999999999999999999999999999998888887663332222
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
+.|++++..+.+||+.||..||.+|+|+.++|+|||++..
T Consensus 260 -----------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 260 -----------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred -----------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 3457789999999999999999999999999999999875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.55 Aligned_cols=285 Identities=39% Similarity=0.673 Sum_probs=238.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||.|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5899999999999999999999999999999998765444555678899999999999999999999876 57899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+.++|...+......+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99966776666555567999999999999999999999999999999999999999999999999999876543333344
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC-CcccccC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL-PHATIFK 375 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l-~~~~~~~ 375 (690)
...++.+|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+.+..+...++.+....|+.... +......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 567899999999987766689999999999999999999999999999999999999999998877765321 1111110
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
........+...+++.+..+.+||.+||..||.+|||++++|.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 011111123445667889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=384.45 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=210.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999975432 23445567899999999999999999998876 578999999999
Q ss_pred cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccc
Q 005582 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300 (690)
Q Consensus 221 g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~g 300 (690)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccceec
Confidence 876655555556899999999999999999999999999999999999999999999999999975422 1223445679
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
|+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+....+..+... .+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~---------------------- 212 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EI---------------------- 212 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CC----------------------
Confidence 999999999876 56899999999999999999999999887766655554321 00
Q ss_pred chhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 381 KRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 381 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....+++.+.+||.+||..||.+|| ++.++|+||||...
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 01234788999999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=383.31 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=218.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|..++||||+++++++.. .+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 3799999999999999999999999999999999754322 2345568899999999999999999998876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999998866665555555799999999999999999999999999999999999999999999999999976542 3
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....++|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 218 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------------- 218 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------
Confidence 3456789999999999874 789999999999999999999999999887777666543111000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.+. .......++.++.+||.+||..+|.+|||+.++++||||...
T Consensus 219 ~~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 219 RPV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 000013578899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=384.67 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=215.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. .+.+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEE
Confidence 4689999999999999999999999999999999975432 22345668899999999999999999999877 57899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999987655544444557899999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|... .+
T Consensus 172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~--------------- 232 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL--------------- 232 (329)
T ss_pred -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc---------------
Confidence 234578999999999876 45899999999999999999999999988877666665431 10
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTT 424 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~ 424 (690)
.....++..+.+||.+||..||.+|++ ++++|.||||..
T Consensus 233 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 233 ------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 001236788999999999999999997 799999999976
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=388.87 Aligned_cols=261 Identities=30% Similarity=0.444 Sum_probs=215.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 479999999999999999999999999999999975432 23445667899999999999999999999887 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ- 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~- 293 (690)
||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999988665554444557999999999999999999999999999999999999999999999999998754321100
Q ss_pred ------------------------------------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCC
Q 005582 294 ------------------------------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337 (690)
Q Consensus 294 ------------------------------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~ 337 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 0113468999999999876 568999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC---HH
Q 005582 338 IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT---AS 414 (690)
Q Consensus 338 pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~ 414 (690)
||.+.+..+.+..+....... .. + ....+++.+.+||.+||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~--------~~----------~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETL--------QF----------P-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCcc--------CC----------C-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999988777766664311000 00 0 011468899999999997 9999998 99
Q ss_pred HHhcCcCCCCC
Q 005582 415 SALQNEFFTTK 425 (690)
Q Consensus 415 e~L~hpwf~~~ 425 (690)
++|+||||...
T Consensus 292 ~ll~h~~~~~~ 302 (364)
T cd05599 292 EIKSHPFFKGV 302 (364)
T ss_pred HHhcCCCcCCC
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.39 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=214.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 479999999999999999999999999999999975432 22345568899999999999999999988876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999987655544444557999999999999999999999999999999999999999999999999999765421
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... +
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~---------------- 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--L---------------- 215 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--c----------------
Confidence 234578999999999876 468999999999999999999999999988777666664310 0
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+|++ +.++++||||+..
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 011345788999999999999999995 9999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=380.70 Aligned_cols=272 Identities=26% Similarity=0.404 Sum_probs=223.4
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
+...+.|++...||.|..++||+|+...++..||||++.....+. .+..+.+|++.|+.++||||++++..|.. +..
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~ 98 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSE 98 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEe--cce
Confidence 445679999999999999999999999999999999998765543 37889999999999999999999998887 578
Q ss_pred EEEEEeccccchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 212 LYLVFEYMEHDLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
+|+||.||.++.+..+... ...|.|..|..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999998655444331 12399999999999999999999999999999999999999999999999998766543
Q ss_pred CCCC---CcccccccccCcCCccc-cCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Q 005582 290 SQKQ---PLTSRVVTLWYRPPELL-LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365 (690)
Q Consensus 290 ~~~~---~~~~~~gT~~Y~APEvl-~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~ 365 (690)
.... .+...++|++|||||++ .....|+.|+||||||++..||.+|..||........+.. ++-+.|+....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~t-- 254 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLLT-- 254 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCccc--
Confidence 3321 12456899999999995 4456799999999999999999999999988776665443 33344432110
Q ss_pred cCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 366 ~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
. ..-.+..+.++..++.+|..||..||.+||||+++|+|+||+..
T Consensus 255 ~---------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 255 S---------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred c---------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0 00122345677899999999999999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=400.02 Aligned_cols=283 Identities=23% Similarity=0.324 Sum_probs=221.5
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC------CCeeeeeeeEeec
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH------PNIMKLEGLITSR 207 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H------pnIv~l~~~~~~~ 207 (690)
..++|+++++||+|+||.||+|.+..+++.||||+++... .....+..|+.++..+.| ++|+.++++|...
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4578999999999999999999999999999999996432 223345667777777654 5688999888764
Q ss_pred cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCC------------
Q 005582 208 VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNG------------ 274 (690)
Q Consensus 208 ~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g------------ 274 (690)
..++|||||++.++++..+... ..+++..++.++.||+.||.|||+ .|||||||||+||||+.++
T Consensus 204 -~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 204 -TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred -CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4689999999988888776554 479999999999999999999998 5999999999999998765
Q ss_pred ----ceEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHH
Q 005582 275 ----ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHK 350 (690)
Q Consensus 275 ----~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~k 350 (690)
.+||+|||++... ....+..++|+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..
T Consensus 282 ~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCceEEECCCCccccC----ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999988543 223456789999999999987 4699999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHhhhcCCCcccc-cC----CCCcc-chhhhhh-----c--CCCchhHHHHHHHhccCCCCCCCCHHHHh
Q 005582 351 IFKLCGSPSEEYWKRSKLPHATI-FK----PQQPY-KRCVAET-----F--KDIPSSALSLLDILLSTEPEVRGTASSAL 417 (690)
Q Consensus 351 I~~~~g~p~~~~w~~~~l~~~~~-~~----~~~p~-~~~~~e~-----~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 417 (690)
|.+.+|.++..++.......... +. ....+ ...+... + ...++.+.+||.+||.+||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 99999988776543221111000 00 00000 0000000 0 01246788999999999999999999999
Q ss_pred cCcCCCCCC
Q 005582 418 QNEFFTTKP 426 (690)
Q Consensus 418 ~hpwf~~~p 426 (690)
+||||....
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998753
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.96 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=212.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 68999999999999999999999999999999975432 33455678999999999999999999999886 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC---
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK--- 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~--- 292 (690)
|||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99998765554444455799999999999999999999999999999999999999999999999999864321100
Q ss_pred -------------------------------------------CCcccccccccCcCCccccCCCCCCCcceeecchhHH
Q 005582 293 -------------------------------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCIL 329 (690)
Q Consensus 293 -------------------------------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL 329 (690)
......+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 00124579999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccC--CC
Q 005582 330 AELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST--EP 407 (690)
Q Consensus 330 ~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~--DP 407 (690)
|||++|.+||.+.+..+...++....... .. .....+++++.+||.+||.. +|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~-----------------~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTL--------HI-----------------PPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcccccc--------CC-----------------CCCCCCCHHHHHHHHHHccCcccc
Confidence 99999999999888766666554311100 00 01134789999999997655 44
Q ss_pred CCCCCHHHHhcCcCCCCC
Q 005582 408 EVRGTASSALQNEFFTTK 425 (690)
Q Consensus 408 ~kRpTa~e~L~hpwf~~~ 425 (690)
..|+|+.++|.||||+..
T Consensus 294 ~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 294 LGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cCCCCHHHHhcCcccCCC
Confidence 559999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.58 Aligned_cols=260 Identities=30% Similarity=0.416 Sum_probs=212.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|+++++||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||++++++|.+ .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 69999999999999999999999999999999975432 23445678899999999999999999999887 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC---
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK--- 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~--- 292 (690)
||||.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99998765544444445789999999999999999999999999999999999999999999999999854321000
Q ss_pred -------------------------------------------CCcccccccccCcCCccccCCCCCCCcceeecchhHH
Q 005582 293 -------------------------------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCIL 329 (690)
Q Consensus 293 -------------------------------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL 329 (690)
......+||+.|+|||++.+ ..|+.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 00123478999999999876 4689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC
Q 005582 330 AELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV 409 (690)
Q Consensus 330 ~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k 409 (690)
|||++|++||.+.+..+...++....... .. .....+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~-----------------p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSL--------HI-----------------PPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCc--------CC-----------------CCcccCCHHHHHHHHHHc-cCHhH
Confidence 99999999999988777666665311100 00 012357889999999987 59999
Q ss_pred CCC---HHHHhcCcCCCCC
Q 005582 410 RGT---ASSALQNEFFTTK 425 (690)
Q Consensus 410 RpT---a~e~L~hpwf~~~ 425 (690)
|++ ++++++||||...
T Consensus 293 R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred cCCCCCHHHHhcCCCcCCc
Confidence 997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=370.58 Aligned_cols=290 Identities=43% Similarity=0.734 Sum_probs=238.6
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD---PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
+|++.+.||.|+||.||+|.+..+++.||||++...... ......+..|+.+++.++|+||+++++++.+ .+.+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999889999999999865433 2334557789999999999999999999887 57899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+.++|...+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..+.... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999666666665544479999999999999999999999999999999999999999999999999998765322 2
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC-Cccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL-PHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l-~~~~ 372 (690)
......+++.|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+.+.+++..++.+....|..... +...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 233445688999999987666789999999999999999999999999999999999999888888877754221 1111
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDP 431 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~p 431 (690)
..... ........+...+..+.+||.+||.+||.+|||+.++|.|+||+..+.+..+
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 238 EFKPF--PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred ccccc--CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 11111 1112233456778999999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.52 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=211.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+|..++|+||+.+++++.. .+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 488999999999999999999999999999998754332 2233457789999999999999999998876 4689999
Q ss_pred Eeccccchhhh-hc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLAGL-AA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll~~-~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++.+.. +. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.. ..
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GE 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--CC
Confidence 99999765543 32 2234689999999999999999999999999999999999999999999999999976532 22
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 2345678999999999976 4689999999999999999999999988765443333333221110
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||.+||| ++++++||||...
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 0112457889999999999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=386.99 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=213.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975432 23345678899999999999999999998876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC--
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999998865555444456799999999999999999999999999999999999999999999999999976432110
Q ss_pred --------------------------------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCC
Q 005582 293 --------------------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP 340 (690)
Q Consensus 293 --------------------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~ 340 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01124579999999999976 468999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCC---CCCCHHHHh
Q 005582 341 GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE---VRGTASSAL 417 (690)
Q Consensus 341 g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~---kRpTa~e~L 417 (690)
+.+..+.+.+|....... . +. ....+++.+.+||.+|+. +|. .||++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------~------------~p-----~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETL--------I------------FP-----PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCcc--------c------------CC-----CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 988887777775411110 0 00 012367899999999886 455 458999999
Q ss_pred cCcCCCCC
Q 005582 418 QNEFFTTK 425 (690)
Q Consensus 418 ~hpwf~~~ 425 (690)
+||||...
T Consensus 292 ~hp~f~~~ 299 (363)
T cd05628 292 TNPFFEGV 299 (363)
T ss_pred CCCCCCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=383.90 Aligned_cols=261 Identities=32% Similarity=0.456 Sum_probs=216.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||++...... ......+..|+.+|..++||||+++++++.+ .+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 4799999999999999999999999999999999754322 2445668899999999999999999998876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC---
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ--- 291 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~--- 291 (690)
||||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999875544444334679999999999999999999999999999999999999999999999999998765332
Q ss_pred -------------------------CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHH
Q 005582 292 -------------------------KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE 346 (690)
Q Consensus 292 -------------------------~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e 346 (690)
.......++|+.|+|||++.+. .++.++|||||||+||+|++|+.||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 1123345789999999999874 68999999999999999999999999988777
Q ss_pred HHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-HHHHhcCcCCCCC
Q 005582 347 QLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-ASSALQNEFFTTK 425 (690)
Q Consensus 347 ~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-a~e~L~hpwf~~~ 425 (690)
...++....... .+ .....+++.+.+||..||. ||.+|++ +.++|+||||...
T Consensus 238 ~~~~i~~~~~~~--------~~-----------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESL--------RF-----------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcc--------cC-----------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 666665411100 00 0012368999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=381.88 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=217.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|.+.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.. .+.+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 479999999999999999999999999999999986433 23345668899999999999999999998876 478999
Q ss_pred EEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||++++.+ ..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999987544 444444357999999999999999999999999999999999999999999999999999876543332
Q ss_pred CcccccccccCcCCccccC-----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 294 PLTSRVVTLWYRPPELLLG-----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g-----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.....++|+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+....+.+|....... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------~~ 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--------KF 230 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--------CC
Confidence 3334578999999999863 3457899999999999999999999999888777777665421000 00
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.....++..+.+||..||. ||.+|||+.+++.||||...
T Consensus 231 -----------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 231 -----------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 0113478899999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.48 Aligned_cols=277 Identities=35% Similarity=0.640 Sum_probs=217.0
Q ss_pred eeeeccCceEEEEEEEcC--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLE--NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
.+||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 589999999999999653 668999999875432 23467899999999999999999998766567899999999
Q ss_pred ccchhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee----ccCCceEeecccccccc
Q 005582 220 EHDLAGLAAT--------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFF 287 (690)
Q Consensus 220 ~g~Ll~~~~~--------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl----d~~g~vKL~DFGlA~~~ 287 (690)
++++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9987766432 12358899999999999999999999999999999999999 56679999999999876
Q ss_pred ccCCC--CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC---------hHHHHHHHHHHhC
Q 005582 288 KCSQK--QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT---------EVEQLHKIFKLCG 356 (690)
Q Consensus 288 ~~~~~--~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~---------~~e~l~kI~~~~g 356 (690)
..... ......++|+.|+|||++.+...++.++|||||||++|||++|++||.... ...++.+++..+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43322 123456789999999999876678999999999999999999999997543 2467788999999
Q ss_pred CCChhHhhhcCCC-cccc----cC----CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 357 SPSEEYWKRSKLP-HATI----FK----PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 357 ~p~~~~w~~~~l~-~~~~----~~----~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.+....|...... .... +. ................+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 9988888653211 1000 00 00001111111122356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.59 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=211.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|.++++||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||++++++|.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 479999999999999999999999999999999875432 23445678899999999999999999999876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ- 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~- 293 (690)
||||+.++.+..+......+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999987655544444557999999999999999999999999999999999999999999999999999643211000
Q ss_pred ---------------------------------------------CcccccccccCcCCccccCCCCCCCcceeecchhH
Q 005582 294 ---------------------------------------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCI 328 (690)
Q Consensus 294 ---------------------------------------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~i 328 (690)
.....+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0013578999999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCC
Q 005582 329 LAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE 408 (690)
Q Consensus 329 L~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~ 408 (690)
||||++|.+||.+.+..+.+..|...... ..++ ....++..+.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~~~p-----------------~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRET--------LYFP-----------------DDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCc--------cCCC-----------------CCCCCCHHHHHHHHHHhc-CHh
Confidence 99999999999988877776666531100 0000 012467899999999998 777
Q ss_pred CC---CCHHHHhcCcCCCC
Q 005582 409 VR---GTASSALQNEFFTT 424 (690)
Q Consensus 409 kR---pTa~e~L~hpwf~~ 424 (690)
+| +|+.++|.||||..
T Consensus 292 ~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hcCCCCCHHHHhcCCCcCC
Confidence 75 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=365.93 Aligned_cols=261 Identities=31% Similarity=0.423 Sum_probs=229.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC------HHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD------PESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~------~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
+.|+..+.||.|..++|.+|.+..+|+.+|+|++...... .+..+...+|+.||+++ .||+|+.|.++|..
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 3688889999999999999999999999999999754331 22334567899999998 69999999999987
Q ss_pred CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
...+++|||+|..+.+..++.....+++...+.+++||++|+.|||.++||||||||+|||++++.++||+|||+|..+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 46789999999988888888888899999999999999999999999999999999999999999999999999998875
Q ss_pred cCCCCCcccccccccCcCCcccc-----CCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLL-----GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~-----g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w 363 (690)
. ...+...||||.|+|||.+. +...|+..+|+|++|||||.||.|.|||......-.+..|+..-.....+.
T Consensus 175 ~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe- 251 (411)
T KOG0599|consen 175 P--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE- 251 (411)
T ss_pred C--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc-
Confidence 4 45688899999999999874 345699999999999999999999999999888888888877444433333
Q ss_pred hhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 364 ~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
|.+++..+++||.+||+.||.+|.|++|+|.||||...
T Consensus 252 ------------------------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 252 ------------------------WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ------------------------hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 46789999999999999999999999999999999553
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=369.67 Aligned_cols=287 Identities=43% Similarity=0.753 Sum_probs=237.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.+|+.++||||+++++++.....+.+||
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45799999999999999999999999999999999865444333445678999999999999999999988754578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999988777766555569999999999999999999999999999999999999999999999999998765321 22
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC-CCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK-LPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~-l~~~~~ 373 (690)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.|....|.... ++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3445678899999998775567899999999999999999999999999999999999999999888886532 222211
Q ss_pred cCCCCccchhhhhhcCC--CchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 374 FKPQQPYKRCVAETFKD--IPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~--~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
..........+...++. +++.+.+||.+||..||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111222333444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=370.18 Aligned_cols=288 Identities=46% Similarity=0.804 Sum_probs=237.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc------
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV------ 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~------ 208 (690)
.++|++.++||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57999999999999999999999999999999998755433333345678999999999999999999876532
Q ss_pred CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
...+|+||||+.+++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999998888777666689999999999999999999999999999999999999999999999999997654
Q ss_pred cCCC----------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 005582 289 CSQK----------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358 (690)
Q Consensus 289 ~~~~----------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p 358 (690)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..++..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 112344668899999998776668999999999999999999999999999999999999999988
Q ss_pred ChhHhhhcCCCcc-cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 359 SEEYWKRSKLPHA-TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 359 ~~~~w~~~~l~~~-~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.+..|........ ............+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8877764332221 111111122233444566778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=367.68 Aligned_cols=282 Identities=40% Similarity=0.719 Sum_probs=231.3
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++++.||.|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++.+ .+.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4899999999999999999999999999999987554333344568899999999999999999999876 57899999
Q ss_pred eccccchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHDLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||+.+++...+.. ....+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..+... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-cccc
Confidence 9998877665543 3456899999999999999999999999999999999999999999999999999765422 2223
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC-Cccccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL-PHATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l-~~~~~~ 374 (690)
....+++.|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+.+++...+.+....|..... +.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3446788999999987766678999999999999999999999999999999999999999888777653211 111010
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.+.. ....+....+.++..+++||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKW-ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccc-cccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1111 1122333445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.12 Aligned_cols=261 Identities=29% Similarity=0.391 Sum_probs=212.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++.+.. .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 379999999999999999999999999999999864322 12334567899999999999999999999876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC--
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+.....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999998765554444455789999999999999999999999999999999999999999999999999854321000
Q ss_pred ----------------------------------------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHH
Q 005582 293 ----------------------------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL 332 (690)
Q Consensus 293 ----------------------------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~EL 332 (690)
......+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence 00123578999999999876 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-
Q 005582 333 FAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG- 411 (690)
Q Consensus 333 ltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp- 411 (690)
++|++||.+.+..+....+....... . ......++..+.+||.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~------------------~-------~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTL------------------H-------IPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccc------------------c-------CCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999988776665553210000 0 0012357889999999987 5999999
Q ss_pred --CHHHHhcCcCCCCC
Q 005582 412 --TASSALQNEFFTTK 425 (690)
Q Consensus 412 --Ta~e~L~hpwf~~~ 425 (690)
|+.++|+||||...
T Consensus 292 ~~t~~ell~h~~~~~~ 307 (376)
T cd05598 292 KNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCHHHHhCCCCcCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=384.20 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=218.8
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 446789999999999999999999999999999999975322 22334557889999999999999999998876 578
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+||||||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999987655544433 368999999999999999999999999999999999999999999999999998764333
Q ss_pred CCCcccccccccCcCCccccCC---CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLTSRVVTLWYRPPELLLGS---TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~---~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.......+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+....+.+|........ +
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~----- 268 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---F----- 268 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---C-----
Confidence 2233456799999999998653 2478999999999999999999999999888777777654211000 0
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC--CCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV--RGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..+|.+ |+|++++|+||||+..
T Consensus 269 -----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 269 -----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 012347899999999999999988 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=359.28 Aligned_cols=256 Identities=31% Similarity=0.457 Sum_probs=224.6
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHH-HHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESV-RFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~-~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..++|++.+.||.|.||.||+|+...++-.||+|++.+.++....+ ..+.+|++|.+.|+||||++++++|.+ ...+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--ccee
Confidence 3579999999999999999999999999999999998776543333 468899999999999999999999988 5789
Q ss_pred EEEEeccccchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 213 YLVFEYMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
||++||...+.+.-.+. +...|++...+.|+.|++.||.|||..+||||||||+|+|++..|.+||+|||.+....+
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999998765443333 666799999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
..-...|||..|.+||+..+ ..++..+|+|++|++.||+|.|.+||...+..+++.+|.+.--.
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------------- 240 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------------- 240 (281)
T ss_pred --CCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-------------
Confidence 23356799999999999987 56899999999999999999999999999999999998763211
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
....++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 241 ----------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ----------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 12468899999999999999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=381.53 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=215.7
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCC-eEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENN-KLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg-~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
..++|.+.+.||+|+||.||+|.+..++ ..||+|++..... .......+.+|+.+|+.++||||+++++++.. .+.
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 4568999999999999999999876554 7899999875432 23345668899999999999999999999977 478
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+||||||+.++.+..++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+..
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999998766555555555799999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.....
T Consensus 184 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 245 (340)
T PTZ00426 184 --RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------------- 245 (340)
T ss_pred --CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 2235678999999999976 4689999999999999999999999998887776666643110
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+|+ |+.++++||||...
T Consensus 246 --------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 246 --------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 01234678899999999999999995 89999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=375.75 Aligned_cols=269 Identities=27% Similarity=0.363 Sum_probs=225.9
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..+.|++++.||.|.-|+||+|....++..+|||++.+..+. .....+...|-+||+.++||.++.||..|+. ...+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~ 152 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYS 152 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--ccee
Confidence 456899999999999999999999999999999999876553 4456678889999999999999999999987 5789
Q ss_pred EEEEeccccchhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc-
Q 005582 213 YLVFEYMEHDLAGLAA--TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC- 289 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~--~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~- 289 (690)
|+|||||.|+-+..+. +++..|++..+++|+.+|+.||+|||-.|||+|||||+||||-++|++.|+||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999986655433 4567799999999999999999999999999999999999999999999999998743210
Q ss_pred --------------------------------C-C---------------------CCCcccccccccCcCCccccCCCC
Q 005582 290 --------------------------------S-Q---------------------KQPLTSRVVTLWYRPPELLLGSTD 315 (690)
Q Consensus 290 --------------------------------~-~---------------------~~~~~~~~gT~~Y~APEvl~g~~~ 315 (690)
. . .....+.|||-.|+|||++.| ..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G 311 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG 311 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence 0 0 011224688999999999988 46
Q ss_pred CCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhH
Q 005582 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSA 395 (690)
Q Consensus 316 ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~ 395 (690)
.+.++|+|+|||+|||||.|..||.|.+..+++.+|+..--. +| ..+.++..+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~----------Fp-----------------~~~~vs~~a 364 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK----------FP-----------------EEPEVSSAA 364 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc----------CC-----------------CCCcchhHH
Confidence 899999999999999999999999999999999998752111 00 112567899
Q ss_pred HHHHHHhccCCCCCCCC----HHHHhcCcCCCCCCCCCCCC
Q 005582 396 LSLLDILLSTEPEVRGT----ASSALQNEFFTTKPLPCDPS 432 (690)
Q Consensus 396 ~dLI~~mL~~DP~kRpT----a~e~L~hpwf~~~p~~~~p~ 432 (690)
+|||++||.+||.+|.. |+|+-+||||.....+.-..
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRC 405 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhcCccccCCChhheec
Confidence 99999999999999998 99999999998754443333
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=378.45 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=209.2
Q ss_pred CcEEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 210 (690)
+|++++.||+|+||.||++++. .+++.||+|++..... .......+..|+.+|..+ +||||+++++++.. .+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999999864 4789999999975322 223345678899999999 59999999988876 47
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 89999999998655544444457999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........+||+.|+|||++.+...++.++|||||||++|||++|..||...........+.......
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 226 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC------------ 226 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC------------
Confidence 33334456799999999999875568999999999999999999999997543221111111100000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
. ......++..+.+||.+||..||.+|| ++.++|+||||+..
T Consensus 227 ------~-------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 227 ------D-------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred ------C-------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 011234788999999999999999999 88999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=367.52 Aligned_cols=290 Identities=48% Similarity=0.860 Sum_probs=239.8
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV---- 208 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---- 208 (690)
...++|++.+.||+|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999999999999999999765433333445778999999999999999999887642
Q ss_pred ----CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccc
Q 005582 209 ----SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 209 ----~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
.+.+|+||||+++++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 2378999999999888777665557999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 285 ~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
..+............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 87654433333444568889999988765567899999999999999999999999999999999999999988887775
Q ss_pred hcCC-CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 365 RSKL-PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 365 ~~~l-~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.... +............+.+...+..++..+.+||..||..||.+|||+.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 4321 111111112222233444566789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=374.43 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=208.9
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++.. .+.+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975422 33445667899999999999999999998876 47899999999987
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccc
Q 005582 223 LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302 (690)
Q Consensus 223 Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~ 302 (690)
.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccCCc
Confidence 66555545567999999999999999999999999999999999999999999999999999754322 22234567899
Q ss_pred cCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccch
Q 005582 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKR 382 (690)
Q Consensus 303 ~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~ 382 (690)
.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------------------------- 209 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------------------------- 209 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------------------------
Confidence 9999999976 568999999999999999999999999887766665554310
Q ss_pred hhhhhcCCCchhHHHHHHHhccCCCCCCC---CHHHHhcCcCCCCC
Q 005582 383 CVAETFKDIPSSALSLLDILLSTEPEVRG---TASSALQNEFFTTK 425 (690)
Q Consensus 383 ~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---Ta~e~L~hpwf~~~ 425 (690)
......+++.+.+||.+||..||.+|| ++.++|.||||...
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 001235788999999999999999997 58999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=362.10 Aligned_cols=285 Identities=57% Similarity=0.986 Sum_probs=241.8
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.....+.+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999866433344556789999999999999999999987643368999999
Q ss_pred ccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccc
Q 005582 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 218 y~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
|+++++...+......+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++...........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99998887776665679999999999999999999999999999999999999999999999999998775443333445
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC-CCcccccCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK-LPHATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~-l~~~~~~~~ 376 (690)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+...++.+....|.... +.....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 5678899999988776668999999999999999999999999999999999999999999888876432 222223333
Q ss_pred CCccchhhhhhcCCC-chhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 377 QQPYKRCVAETFKDI-PSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~-~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
..+....+.+.+... +..+.++|.+||..||.+|||+.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 444444455556665 8999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=367.65 Aligned_cols=318 Identities=24% Similarity=0.282 Sum_probs=248.3
Q ss_pred CCCCcEEE-eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccC--
Q 005582 134 KADSFEKL-DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVS-- 209 (690)
Q Consensus 134 ~~~~Y~~~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~-- 209 (690)
-+++|.+- ++||-|-.|.|..|.++.|++.+|+|++... ...++|+++--.. .|||||.++++|.....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45678776 4789999999999999999999999998632 2256788775554 69999999999876433
Q ss_pred CeEEEEEeccccchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc---CCceEeeccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY---NGILKIGDFGLA 284 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~---~g~vKL~DFGlA 284 (690)
..+.||||+|+|+.+...+.. ...|+|.++..+++||..|+.|||+.+|.||||||+|+|... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 467899999998766544433 345999999999999999999999999999999999999975 458999999999
Q ss_pred cccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCh
Q 005582 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE----VEQLHKIFKLCGSPSE 360 (690)
Q Consensus 285 ~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~----~e~l~kI~~~~g~p~~ 360 (690)
+.... ...+.+.|.||+|.|||++ |...|+..+|+||+|||+|-||+|.|||..... ...-.+|...-..+++
T Consensus 212 K~t~~--~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQE--PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccCC--CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 87542 4557888999999999987 556799999999999999999999999987553 2233344333223333
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCCCCCCCCCCCCC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPS 440 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~~p~~lp~~p~~ 440 (690)
+. |..+++.++|||+.||..+|.+|.|+++++.|||++..+. +|..|..
T Consensus 289 pE-------------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~------vp~tpl~ 337 (400)
T KOG0604|consen 289 PE-------------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA------VPQTPLS 337 (400)
T ss_pred hh-------------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc------CCCCCch
Confidence 33 4568899999999999999999999999999999987532 4455555
Q ss_pred cccccccchhhhhcCCCCCCCcchhhhhhccCCCCcCCcccchhhHHHHHhh
Q 005582 441 KEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAELQTSIQKR 492 (690)
Q Consensus 441 ~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (690)
...-.+...+.+..-..+....++.+|......+..+.-+.|+.++....+.
T Consensus 338 t~~~l~~a~e~w~dvqeem~~~lA~mrv~~~~v~ik~l~~~nn~Ll~krrk~ 389 (400)
T KOG0604|consen 338 TSRMLKEAVEAWDDVQEEMTETLATMRVDPLQVQIKPLGSSNNPLLRKRRKK 389 (400)
T ss_pred hhhhcchhhhhhHHHHHHHHHHHHhcccCcceeEEeeccccCcHHHHHHHHh
Confidence 4433333333344344455566778888877788888888999888766544
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.77 Aligned_cols=281 Identities=37% Similarity=0.603 Sum_probs=228.5
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEEEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
|+++++||+|+||.||+|.+..+++.||+|+++....+.... ...+|+.++.++. |+||+++++++.+...+.+|+||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678999999999999999999999999999987543332222 3457999999985 99999999998875447899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+.++++..+......+++..++.++.||+.||.|||+.||+||||+|+|||++. +.+||+|||++..+... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99999888877665557999999999999999999999999999999999999999 99999999999866432 2234
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...+++.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+..+....+.+....+..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999987665667899999999999999999999999999999999999988888775543221111111111
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.......+......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111112233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.31 Aligned_cols=284 Identities=38% Similarity=0.676 Sum_probs=229.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++.+.||.|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 46899999999999999999999889999999998754322 122346789999999999999999999876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-SKT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC-Ccc
Confidence 9999999887776655557899999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhcCCCcc-c
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKRSKLPHA-T 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~w~~~~l~~~-~ 372 (690)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+++..+.+..+.+....|........ .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2334568899999998775668999999999999999999999998766 6778888889999988888865322111 1
Q ss_pred ccCCCCccchhhhhhcCCCc--hhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 373 IFKPQQPYKRCVAETFKDIP--SSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~--~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
...........+...+..++ ..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11111111112233334455 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=376.21 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=209.5
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
+.||+|+||.||++.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 368999999999999999999999999975432 23445677899999999999999999998876 578999999999
Q ss_pred cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccc
Q 005582 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300 (690)
Q Consensus 221 g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~g 300 (690)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......++
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 8766655555567999999999999999999999999999999999999999999999999998754221 222345678
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~---------------------- 212 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DI---------------------- 212 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--Cc----------------------
Confidence 999999999876 46899999999999999999999999887766555544220 00
Q ss_pred chhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCC
Q 005582 381 KRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTT 424 (690)
Q Consensus 381 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~ 424 (690)
.....++..+.+||.+||..||.+|+ |+.++|+|+||..
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred -----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 01235788999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=381.93 Aligned_cols=265 Identities=26% Similarity=0.364 Sum_probs=216.7
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
...++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ .+.
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCE
Confidence 345789999999999999999999999999999999875322 22334567899999999999999999999876 578
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+||||+.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999999987655444433 368999999999999999999999999999999999999999999999999998764333
Q ss_pred CCCcccccccccCcCCccccCC---CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLTSRVVTLWYRPPELLLGS---TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~---~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|........ |
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~----- 268 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---F----- 268 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---C-----
Confidence 3233456799999999998653 2378999999999999999999999999888777777754211110 0
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC--CCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV--RGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hpwf~~~ 425 (690)
.....++..+.+||..||..+|.+ |+|+.++|+||||+..
T Consensus 269 -----------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 269 -----------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 001246889999999999865544 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=359.19 Aligned_cols=283 Identities=35% Similarity=0.612 Sum_probs=227.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++...||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 47999999999999999999999899999999987543333334457899999999999999999999876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||++++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+..... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998887766666799999999999999999999999999999999999999999999999999987643221 23
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh---hcCCCccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK---RSKLPHAT 372 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~---~~~l~~~~ 372 (690)
....++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+........ ........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 345678899999998775668999999999999999999999999988888887777665543332111 00000000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
. .+.......+...+..++..+.+||.+||..||++|||+.++|.||||
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 S-IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred c-CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000111233456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.98 Aligned_cols=282 Identities=38% Similarity=0.708 Sum_probs=234.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++++.||.|+||.||+|.+..+|..||||++...... .....+.+|+.+++.++||||+++++++.. .+.+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 589999999999999999999999999999999765432 234456789999999999999999999887 47889999
Q ss_pred eccccchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHDLAGLAATPG--VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~--~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.+++...+.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999998877665433 468999999999999999999999999999999999999999999999999997654321 22
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|++||++.+...++.++|||||||++|+|++|++||.+.+..+.+.+++...+.|....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 33456789999999987766689999999999999999999999999999999999999999999988875442221111
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.............++.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111111122233445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=374.63 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=210.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
+.||+|+||.||++.+..+|..||+|++..... .......+.+|+.+|+.++||||++++++|.. .+.+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 369999999999999999999999999975422 23345567889999999999999999998876 478999999999
Q ss_pred cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccc
Q 005582 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300 (690)
Q Consensus 221 g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~g 300 (690)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......++
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 8766655555557999999999999999999999999999999999999999999999999998753221 222345678
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------ 212 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 999999999876 4689999999999999999999999988777666655532100
Q ss_pred chhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 381 KRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 381 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....+++.+.+||.+||..||.+|+ ++.++|+|+||...
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 01234788999999999999999998 99999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=362.81 Aligned_cols=289 Identities=47% Similarity=0.737 Sum_probs=230.5
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc-----
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----- 208 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----- 208 (690)
..++|++..+||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 456899999999999999999999999999999998754333333345678999999999999999999876532
Q ss_pred -CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 209 -SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 209 -~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
....|+||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 2457999999999888877766667999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCC---CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 288 KCSQKQ---PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 288 ~~~~~~---~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
...... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...+|..+.+.|+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 432221 22345678899999998776668899999999999999999999999999888888888889888777665
Q ss_pred hcCCCcc-cccCCCCccchhhhhhc--CCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 365 RSKLPHA-TIFKPQQPYKRCVAETF--KDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 365 ~~~l~~~-~~~~~~~p~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
....... ............+.... ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 4311110 00000111111111111 1245788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.68 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=211.1
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHH---HhCCCCCeeeeeeeEeeccCCeEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIIL---RRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL---~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
|++++.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++ +.++||||+++++++.. .+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 7889999999999999999999999999999975432 223345566776665 46689999999999876 57899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence 99999998766555443 36999999999999999999999999999999999999999999999999998754321 22
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------------- 218 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 2345678999999999876 5689999999999999999999999999888777766643110
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 01234688999999999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=378.92 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=213.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||+|.+..+++.||||+++.... .......+..|+.+|..++||||+++++.+.+ .+.+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999975322 23445678899999999999999999998876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC--
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999865555544455799999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCC
Q 005582 293 --------------------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP 340 (690)
Q Consensus 293 --------------------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~ 340 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 01124578999999999876 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC---CHHHHh
Q 005582 341 GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG---TASSAL 417 (690)
Q Consensus 341 g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---Ta~e~L 417 (690)
+.+..+.+.+|....... . +. ....++..+.+||.+|+ .||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------~------------~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETL--------V------------FP-----PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCce--------e------------cC-----CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 988877776665310000 0 00 01236789999999987 4999998 589999
Q ss_pred cCcCCCCC
Q 005582 418 QNEFFTTK 425 (690)
Q Consensus 418 ~hpwf~~~ 425 (690)
+||||...
T Consensus 292 ~hp~f~~~ 299 (360)
T cd05627 292 SHPFFEGV 299 (360)
T ss_pred cCCCCCCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.23 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=212.4
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCC-CeeeeeeeEeeccCCeEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHP-NIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~Hp-nIv~l~~~~~~~~~~~l~L 214 (690)
+|++++.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+.|+ +|+.+++++.. .+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 58999999999999999999999999999999975422 234456678899999999765 57888888876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCc
Confidence 9999987666555444557999999999999999999999999999999999999999999999999998653221 222
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 345678999999999976 4689999999999999999999999999887777766643110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-----HHHhcCcCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-----SSALQNEFFTT 424 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hpwf~~ 424 (690)
.....++..+.+||.+||..||.+|+++ .++++||||..
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 -----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0113467899999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=371.26 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=213.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||++.+..+++.||||++..... .......+.+|+.++..++|+||+.+++++.. .+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975322 23345567889999999999999999998876 578999
Q ss_pred EEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||+.++ |...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999775 44444443557999999999999999999999999999999999999999999999999999766433332
Q ss_pred CcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 294 PLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.....++|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..|.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------- 227 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------
Confidence 2334578999999999863 3457889999999999999999999999888777766664311100
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC--CCCHHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV--RGTASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hpwf~~~ 425 (690)
. +......++..+.+||.+||..++.+ |+++.++|+||||...
T Consensus 228 ---------~----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 228 ---------Q----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ---------c----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0 01112347899999999999765544 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=370.53 Aligned_cols=284 Identities=24% Similarity=0.315 Sum_probs=215.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++++.||+|+||.||++.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. .+.+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999987542 34455678999999999999999999999877 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999866655555555799999999999999999999986 6999999999999999999999999999765322
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc-CCCcc-
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS-KLPHA- 371 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~-~l~~~- 371 (690)
.....++|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...........+... ..+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2334578999999999876 46899999999999999999999999877655433222110000000000000 00000
Q ss_pred -ccc----CCCCccc---h----hhhhh-----cCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 372 -TIF----KPQQPYK---R----CVAET-----FKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 372 -~~~----~~~~p~~---~----~~~e~-----~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
... ....+.. . .+... ...+++++.+||.+||.+||++|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 0000000 0 00000 12467899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=371.26 Aligned_cols=287 Identities=31% Similarity=0.507 Sum_probs=231.0
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|++++.||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||++++++|.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 35899999999999999999999999999999998754444455566788999999999999999999886432 23
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
..|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999988776643 2899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.++...+|.|+.+++.......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred --CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22334567899999999877 568999999999999999999999999999999999999999999887654321110
Q ss_pred cccc-----CCCCccchhh---------hhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 371 ATIF-----KPQQPYKRCV---------AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 371 ~~~~-----~~~~p~~~~~---------~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
.... ....++...+ .......+..+++||.+||..||.+|||+.++|.||||..+-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0000 0000111110 1112245677999999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=357.58 Aligned_cols=285 Identities=35% Similarity=0.641 Sum_probs=235.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+|+.++|+||+++++++.. .+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 37999999999999999999999999999999987654444455678999999999999999999999977 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||++++++..+......+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999988877666656799999999999999999999999999999999999999999999999999987754443344
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc-cccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH-ATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~-~~~~ 374 (690)
...+++.+|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+...++......+....... ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 556789999999999875478999999999999999999999999998888888888888876665543322110 0000
Q ss_pred C-CCCccchhhhhhcCC-CchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 K-PQQPYKRCVAETFKD-IPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~-~~~p~~~~~~e~~~~-~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
. +.......+...++. ++..+.+||.+||..||++|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 011111122223333 48999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=361.08 Aligned_cols=286 Identities=42% Similarity=0.715 Sum_probs=230.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccC---Ce
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVS---GS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~---~~ 211 (690)
++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998755433333456788999999995 6999999998876321 23
Q ss_pred EEEEEeccccchhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeeccccccc
Q 005582 212 LYLVFEYMEHDLAGLAATP----GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANF 286 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~----~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~ 286 (690)
+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999999877765432 346899999999999999999999999999999999999998 89999999999976
Q ss_pred cccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 287 FKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 287 ~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
+... ........++++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.++...|...
T Consensus 161 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIP-VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCC-ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 5322 122334467899999999877666899999999999999999999999999999999999998888888777532
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
.........+.. ....+....+.++..+.+||.+||..||.+|||+.++|.||||.
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111110000110 01112233457899999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=361.08 Aligned_cols=286 Identities=42% Similarity=0.753 Sum_probs=233.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++...||.|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 57999999999999999999999899999999987654443444567899999999999999999999876 4789999
Q ss_pred EeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+++++...+... ...+++..++.++.||+.||.|||+++|+|+||+|+|||++. ++.+||+|||++...... ..
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VR 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-cc
Confidence 999998877765443 334688899999999999999999999999999999999985 567999999999765322 22
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC-CCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK-LPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~-l~~~~ 372 (690)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|.... ++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23445678999999998775668999999999999999999999999999999999999999999888886421 11111
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
...+..+ ........+.++..+.+||.+||+.||++||++.++|+||||...
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 1111111 112223346688999999999999999999999999999999764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=373.14 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=208.8
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
+.||+|+||.||++.+..+|+.||+|++..... .......+.+|+.++..++||||+++++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 368999999999999999999999999975432 23345567889999999999999999998876 478999999999
Q ss_pred cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 221 g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
++.+.........+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 87666555555679999999999999999999997 79999999999999999999999999998754321 22334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------------- 213 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 8999999999876 4689999999999999999999999988776655555432100
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~ 424 (690)
.....+++.+.+||.+||..||.+|+ ++.++|+||||..
T Consensus 214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 01134688999999999999999997 9999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=358.00 Aligned_cols=284 Identities=38% Similarity=0.629 Sum_probs=225.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+++|.+++.||+|+||.||+|.+..++..||||.+...... .....+.+|+.+|+.++|+||+++++++.. .+..|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999998754322 223346789999999999999999999876 468999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++..... ...
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-CCC
Confidence 9999998888776655556889999999999999999999999999999999999999999999999999754321 222
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhcC-CCccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKRSK-LPHAT 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~w~~~~-l~~~~ 372 (690)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+.++....|.|.+..|.... ++...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3345678999999998775568899999999999999999999997654 457778888888888777665422 11111
Q ss_pred ccCCCCccchhhhhhcC--CCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 373 IFKPQQPYKRCVAETFK--DIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~--~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
...........+...+. ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 11000111111112222 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=368.40 Aligned_cols=296 Identities=40% Similarity=0.744 Sum_probs=240.3
Q ss_pred CCCcEEE-eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHH------------HHHHHHHHHHHHHhCCCCCeeeee
Q 005582 135 ADSFEKL-DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE------------SVRFMAREIIILRRLDHPNIMKLE 201 (690)
Q Consensus 135 ~~~Y~~~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~------------~~~~~~rEi~iL~~L~HpnIv~l~ 201 (690)
.++|..+ ..||.|+||.||+|.+..+++.||||++........ ....+.+|+.+|+.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 3577654 679999999999999999999999999875432210 012467899999999999999999
Q ss_pred eeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecc
Q 005582 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 202 ~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DF 281 (690)
+++.. .+.+|+||||+.+++...+.. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+||
T Consensus 87 ~~~~~--~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVE--GDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEec--CCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99876 478999999999887776644 346899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-------------CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHH
Q 005582 282 GLANFFKCSQ-------------KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQL 348 (690)
Q Consensus 282 GlA~~~~~~~-------------~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l 348 (690)
|++..+.... ........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997654111 112233456889999999987666899999999999999999999999999999999
Q ss_pred HHHHHHhCCCChhHhhhcC-CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 349 HKIFKLCGSPSEEYWKRSK-LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 349 ~kI~~~~g~p~~~~w~~~~-l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
..++..++.|....|.... ++....+... ....+...+...+..+.+||..||..||++|||++++|.||||+..+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999999999887775432 1111111111 112233445677899999999999999999999999999999999998
Q ss_pred CCCCCCCC
Q 005582 428 PCDPSSLP 435 (690)
Q Consensus 428 ~~~p~~lp 435 (690)
++++..+|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 88876544
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=358.95 Aligned_cols=284 Identities=32% Similarity=0.608 Sum_probs=229.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++.. .+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 47999999999999999999998899999999987554433345567899999999999999999999876 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++++..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998877665555568999999999999999999999999999999999999999999999999998764332 334
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc--cc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA--TI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~--~~ 373 (690)
....++..|+|||++.+...++.++|||||||++|+|++|+++|.+.+..+.+..+....+............... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 4566789999999987756688999999999999999999999999888888888887766543322111000000 00
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
..+...........++.++..+.+|+.+||..||.+|||+.++|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0111111122333456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.11 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=209.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975422 233455677899998876 79999999999876 57899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 98666555545557999999999999999999999999999999999999999999999999998754322 22334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------------- 213 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 8999999999876 5689999999999999999999999999888777776643100
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH------HHHhcCcCCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA------SSALQNEFFTTK 425 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa------~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+|+++ +++++||||...
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 0012367899999999999999999998 999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.08 Aligned_cols=266 Identities=26% Similarity=0.359 Sum_probs=216.5
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 345799999999999999999999999999999999875322 22334567889999999999999999998876 578
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999987655544433 358999999999999999999999999999999999999999999999999998765333
Q ss_pred CCCcccccccccCcCCccccCC---CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLTSRVVTLWYRPPELLLGS---TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~---~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.......+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+....+.+|........ +
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~----- 268 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F----- 268 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C-----
Confidence 2233456799999999998653 2378999999999999999999999999888777777654211100 0
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC--CCCHHHHhcCcCCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV--RGTASSALQNEFFTTKP 426 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hpwf~~~p 426 (690)
.....++..+.+||..||..++.+ |++++++++|+||...+
T Consensus 269 -----------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 269 -----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred -----------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 012357899999999999844433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=369.64 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=209.1
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 368999999999999999999999999975432 234455677899999876 89999999999887 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence 98666544444557999999999999999999999999999999999999999999999999999754322 22234567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|....-.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL---------------------- 214 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999999888877776541100
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCC-------CHHHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRG-------TASSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-------Ta~e~L~hpwf~~ 424 (690)
....++..+.+||.+||..||.+|+ ++.++++||||..
T Consensus 215 -------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 215 -------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 0123678899999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=373.36 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=207.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|+++++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++.. .+.+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 467999999999999999999999999999999986443 33445678899999999999999999999876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... ...
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDP 224 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-ccc
Confidence 9999998765322 24578888999999999999999999999999999999999999999999999876422 222
Q ss_pred cccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 295 LTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
....++|..|+|||++.. ...++.++|||||||++|||++|+.||......+....+.......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------------ 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------------
Confidence 345678999999998743 2335678999999999999999999997433222211111110000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.......++..+.+||.+||..||++|||+.|+|+||||....
T Consensus 293 -------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 -------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0011235788999999999999999999999999999998753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=368.54 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=208.9
Q ss_pred EeeeeccCceEEEEEEEc---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 141 LDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++.||+|+||.||++++. .+++.||||++..... .......+..|+.+|+.++||||++++++|.. .+.+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 367999999999999864 4788999999975432 12334457789999999999999999999876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence 999998766555555567899999999999999999999999999999999999999999999999998754322 2223
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
...++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+.... .
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~----------------- 217 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--L----------------- 217 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C-----------------
Confidence 34578999999999876 458999999999999999999999999888777666654310 0
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....+++.+.+||.+||..||.+|| ++.+++.||||...
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 01234678999999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=357.46 Aligned_cols=281 Identities=41% Similarity=0.749 Sum_probs=230.4
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|++.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. .+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999997654333344567889999999999999999999876 478999999
Q ss_pred ccccchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 218 YMEHDLAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 218 y~~g~Ll~~~~~~~-~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
|+++.+...+.... ..+++..+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++..+... .....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VRTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-ccccC
Confidence 99887766654432 36899999999999999999999999999999999999999999999999999765322 22233
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC-cccccC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP-HATIFK 375 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~-~~~~~~ 375 (690)
...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+.++++..+.+....|...... ......
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 4466889999999877556789999999999999999999999999999999999999999988887543221 111111
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
+... ........+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111 112223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=366.97 Aligned_cols=290 Identities=35% Similarity=0.542 Sum_probs=233.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc---CCe
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV---SGS 211 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ 211 (690)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 468999999999999999999999999999999986432 2234456788999999999999999999876532 246
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+|+||+.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999999988766643 369999999999999999999999999999999999999999999999999997654322
Q ss_pred CC--CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 292 KQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 292 ~~--~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.. .....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++.+.|......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 2234578999999998876566899999999999999999999999999988889999998998887776543221
Q ss_pred cccccCCCCc--cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 370 HATIFKPQQP--YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 370 ~~~~~~~~~p--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
....+....+ ....+....+.++..+.+||.+||+.||.+|||+.++|+||||....-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 1111100000 111122334567889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=369.11 Aligned_cols=293 Identities=34% Similarity=0.566 Sum_probs=237.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeec--cCCeEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR--VSGSLY 213 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~--~~~~l~ 213 (690)
++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 589999999999999999999999999999999875543334556678899999999999999999987643 235789
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~- 292 (690)
+||||+.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 99999998777666443 4699999999999999999999999999999999999999999999999999976543222
Q ss_pred --CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 293 --QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 --~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
......+++.+|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....|.|+...+....-..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 122345789999999998765568999999999999999999999999999999999999999998877654321110
Q ss_pred cccc--CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCC
Q 005582 371 ATIF--KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429 (690)
Q Consensus 371 ~~~~--~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~ 429 (690)
.... .....-...+...++.++..+.+||.+||+.||.+|||+.++|.||||...+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 0000 0000001112344567899999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=366.84 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=212.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+|+++..||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ +|++|+.+++++.. .+.+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 58899999999999999999999999999999975432 223345567788888887 58899999998876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CCc
Confidence 9999987655544444457999999999999999999999999999999999999999999999999999754321 222
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..|.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 345678999999999876 5689999999999999999999999999888777776654110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-----HHHhcCcCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-----SSALQNEFFTT 424 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hpwf~~ 424 (690)
.....++..+.+||.+||..||.+|+++ .++++||||..
T Consensus 219 -----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 219 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 0113478899999999999999999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=372.70 Aligned_cols=251 Identities=30% Similarity=0.413 Sum_probs=211.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeE-EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKL-VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~-VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+.+...||.|+||+||++.+. |.. ||||++.....+......+.+|+.+|.+|+|||||+|+|++..+. ..++||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iV 118 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIV 118 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEE
Confidence 4556667999999999999884 555 999999876665555778999999999999999999999998752 269999
Q ss_pred EeccccchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccCCCcceeeccCC-ceEeeccccccccccCC
Q 005582 216 FEYMEHDLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRG-ILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~g-IvHrDLKp~NILld~~g-~vKL~DFGlA~~~~~~~ 291 (690)
||||.++.+..++.. ...|+...+..|+.||+.|+.|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999998877665544 568999999999999999999999999 99999999999999998 99999999998765322
Q ss_pred CCCcccccccccCcCCccccC-CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLG-STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g-~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+.........+....-.|.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~----------- 266 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP----------- 266 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 45566889999999999985 35799999999999999999999999999888555555543211111
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++.+..|+..|+..||.+||+..+++.
T Consensus 267 ----------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ----------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11237889999999999999999999999865
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=366.95 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=213.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|+++++||+|+||.||++.+..+++.||+|++..... .......+..|+.++..++|+||+.+++++.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 479999999999999999999999999999999864321 22334457889999999999999999998876 478999
Q ss_pred EEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||+.++ |...+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999865 44444443457999999999999999999999999999999999999999999999999999765433222
Q ss_pred CcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 294 PLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+.+|.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 227 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------
Confidence 2334578999999999862 3458999999999999999999999999988777777665311000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC--CCCHHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV--RGTASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hpwf~~~ 425 (690)
+ +......++..+.+||.+||..++.. |+|++++++||||...
T Consensus 228 ---------~----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 228 ---------Q----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------c----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 0 11112457899999999999765554 6899999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=366.49 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=205.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||+++.... .......+..|..++..+ +||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975422 223344556677777654 89999999998876 57899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 887665555445579999999999999999999999999999999999999999999999999997643222 2334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~--------------------- 213 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P--------------------- 213 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 8999999999976 458999999999999999999999999988776666553210 0
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-HHHhcCcCCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-SSALQNEFFTTK 425 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+||++ .+++.||||...
T Consensus 214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 0012367889999999999999999986 488899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=368.28 Aligned_cols=251 Identities=28% Similarity=0.421 Sum_probs=208.9
Q ss_pred eeeeccCceEEEEEEEc---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
+.||+|+||.||++++. .+|+.||+|++............+.+|+.+|++++||||+++++++.. .+.+||||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 57999999999999863 578999999998654333344557789999999999999999999876 5789999999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccc
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 298 (690)
+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCceecc
Confidence 987655444444557999999999999999999999999999999999999999999999999999765432 1223456
Q ss_pred cccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCC
Q 005582 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378 (690)
Q Consensus 299 ~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~ 378 (690)
++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------------------- 215 (318)
T cd05582 159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------------------- 215 (318)
T ss_pred cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 78999999999876 4689999999999999999999999998887777666643110
Q ss_pred ccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 379 p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||+.||.+||| +.+++.||||...
T Consensus 216 -------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 216 -------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 012346889999999999999999999 7889999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=366.71 Aligned_cols=291 Identities=36% Similarity=0.593 Sum_probs=235.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC---CeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---GSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~~l 212 (690)
++|.+...||.|+||.||+|.+..+++.||||.+............+.+|+.+|+.++||||+++++++..... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 47999999999999999999999999999999987543333345567789999999999999999998765321 358
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||||+.+++...+... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 999999998877766543 479999999999999999999999999999999999999999999999999998664322
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....|.+..+.|.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 23345677999999999876456899999999999999999999999999988889999999998877765322111111
Q ss_pred ccCCCCcc--chhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 373 IFKPQQPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 373 ~~~~~~p~--~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
.+....+. .......++.++..+.+||.+||..||.+|||+.++|+||||.....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 10000000 011223456789999999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=372.64 Aligned_cols=276 Identities=23% Similarity=0.333 Sum_probs=212.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
..|++++.||+|+||.||+|.+..++..||+|+..... ...|+.+|+.++||||+++++++.. ....|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEEE
Confidence 47999999999999999999999999999999854322 3569999999999999999999887 4678999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--APAF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--Cccc
Confidence 99999998888776667899999999999999999999999999999999999999999999999999975321 1223
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCC-CCCCCCC---------hHHHHHHHHHHhCCCChhHhhh
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRT---------EVEQLHKIFKLCGSPSEEYWKR 365 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~-~pF~g~~---------~~e~l~kI~~~~g~p~~~~w~~ 365 (690)
....+|+.|+|||++.+ ..|+.++|||||||++|||+++. ++|.... ....+..++..++..+..+...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 45678999999999977 46899999999999999999864 4444321 1334555556555544332210
Q ss_pred cC--CCcc-cc--cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 366 SK--LPHA-TI--FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 366 ~~--l~~~-~~--~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.. +... .. .....++.........+++.++.+||.+||..||.+||||.|+|+||||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 0000 00 000011111111112357788999999999999999999999999999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.76 Aligned_cols=286 Identities=37% Similarity=0.629 Sum_probs=226.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcC--CCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLE--NNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~--tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.|++..+||+|+||.||+|.+.. ++..||||.+..... .......+.+|+.+++.++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 899999999986331 122335578899999999999999999999886557899
Q ss_pred EEEeccccchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc----CCceEeecccccc
Q 005582 214 LVFEYMEHDLAGLAAT----PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY----NGILKIGDFGLAN 285 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~----~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~----~g~vKL~DFGlA~ 285 (690)
+||||++++++..+.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999887765532 2236899999999999999999999999999999999999999 9999999999998
Q ss_pred ccccCCCC--CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 005582 286 FFKCSQKQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---------VEQLHKIFKL 354 (690)
Q Consensus 286 ~~~~~~~~--~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~---------~e~l~kI~~~ 354 (690)
.+...... .....++|++|+|||++.+...++.++|||||||++|+|++|++||.+... ...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 76433221 123446789999999987766789999999999999999999999987653 3467788888
Q ss_pred hCCCChhHhhhc-CCCcccc---cCCCCccc----hhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 355 CGSPSEEYWKRS-KLPHATI---FKPQQPYK----RCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 355 ~g~p~~~~w~~~-~l~~~~~---~~~~~p~~----~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
++.+....|... .++.... .....++. ..+.+.+...+..+.+||.+||..||++|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 888877776532 1111111 00111111 11122223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=365.90 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=206.0
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREII-ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+|+.||||++..... .......+..|.. +++.++||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 1223344555555 5678999999999998876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcccccc
Confidence 9876655555556799999999999999999999999999999999999999999999999999875422 122334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------ 212 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 8999999999876 568999999999999999999999999887776666654310
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH----HHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA----SSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hpwf~~ 424 (690)
....+.++..+.+||.+||..||.+||++ .+++.||||..
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 01123568899999999999999999998 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=365.68 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=205.5
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+|+.||||+++.... .......+..|+.++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 369999999999999999999999999975422 123344567788888765 89999999999876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++...... .......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccC
Confidence 98655544444557999999999999999999999999999999999999999999999999998753211 22344567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... .+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~--------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP--------------------- 213 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---------------------
Confidence 8999999999976 46899999999999999999999999988776665554321 00
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-HHHhcCcCCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-SSALQNEFFTTK 425 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-~e~L~hpwf~~~ 425 (690)
.....++.++.+||.+||..||.+|+|+ +++++||||...
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0012367889999999999999999998 588899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=377.57 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=230.1
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|+.+++||.|+||.+++++++..++.|+||++..........+...+|+.+++++.|||||.+.+.|... +..+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 3589999999999999999999999999999999998877666666789999999999999999999999873 344999
Q ss_pred EEeccccchhhhh-cC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEHDLAGLA-AT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~-~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||+||+|+.+... .. ++..|++..+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999998766543 33 34679999999999999999999999999999999999999999999999999999886543
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
....+.+||+.|++||++.+ .+|+.++|||||||++|||++-++.|.+.+....+.+|+..+..|-.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 34567899999999999987 67999999999999999999999999999999999999886644422
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
...+.+++.||..||..+|..||++.++|.+|.+..
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 346789999999999999999999999999988764
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=357.46 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=203.5
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||+|+||+||++.+..+++.||+|++...... ......+..|+.+|+.++||||+++++++.. ...+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 69999999999999999999999998754332 2234567789999999999999999988876 46799999999986
Q ss_pred hhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccc
Q 005582 223 LAGLAA----TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298 (690)
Q Consensus 223 Ll~~~~----~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 298 (690)
.+.... .....+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++..+.... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccccc
Confidence 554332 234569999999999999999999999999999999999999999999999999997664322 223345
Q ss_pred cccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCC
Q 005582 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378 (690)
Q Consensus 299 ~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~ 378 (690)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......+
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 217 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------------------- 217 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-------------------
Confidence 78999999999987 4689999999999999999999999987543322222221110000
Q ss_pred ccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 379 p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
......++..+.+|+.+||..||.+|| |++++|+||||+..
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 218 ------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 011235788999999999999999999 89999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=351.53 Aligned_cols=259 Identities=32% Similarity=0.495 Sum_probs=212.9
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|++.+.||+|+||+||++.+..+++.||+|++..............+|+.++++++||||+++++++.. ...+|+|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 789999999999999999999999999999998765444444455679999999999999999999987 578999999
Q ss_pred ccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 218 YMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 218 y~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
|+.++ +...+. ....+++..+..++.||+.||.+||+.||+|+||||+|||++.++.++|+|||++..+ ........
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~ 156 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFN 156 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBS
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99994 444444 4457899999999999999999999999999999999999999999999999999754 12233455
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...+|+.|+|||++.....++.++|||||||++|+|++|..||......+....+.+.........+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 224 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------------ 224 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------------
Confidence 67789999999998734678999999999999999999999999875444444444332221111110
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....+..+.+||..||+.||.+|||+.++++||||
T Consensus 225 ----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ----------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 011224789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=379.89 Aligned_cols=276 Identities=24% Similarity=0.333 Sum_probs=212.1
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
...|.+...||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|||||++++++.. .+..||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 3479999999999999999999999999999996432 225689999999999999999998876 478899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||++.++++..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99999998888776655579999999999999999999999999999999999999999999999999998764322221
Q ss_pred -cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCC-CCCCCC------hHHHHHHHHHHhCCCChhHhh--
Q 005582 295 -LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP-IMPGRT------EVEQLHKIFKLCGSPSEEYWK-- 364 (690)
Q Consensus 295 -~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~-pF~g~~------~~e~l~kI~~~~g~p~~~~w~-- 364 (690)
....+||+.|+|||++.+ ..++.++||||||||||||++|.. +|.... ...++.+++...+....++-.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 234578999999999977 468999999999999999999875 443321 234555565544432211100
Q ss_pred ------hcCCCcccccCCCCccc-hhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 365 ------RSKLPHATIFKPQQPYK-RCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 365 ------~~~l~~~~~~~~~~p~~-~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.... .... .....+. ..+ ..+..++..+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~-~~~~-~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRH-RAAR-NRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHh-hhhc-ccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000 0000 0000000 011 112356778999999999999999999999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=364.59 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=213.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||++++..+++.||||++..... .......+..|+.++..++|+||+.+++++.. .+.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999875321 22334557889999999999999999999876 578999
Q ss_pred EEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||+.++.+ ..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999987544 444443457999999999999999999999999999999999999999999999999999776433222
Q ss_pred CcccccccccCcCCccccCC----CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 294 PLTSRVVTLWYRPPELLLGS----TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~----~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+.+.+|......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----------- 227 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-----------
Confidence 22345789999999998642 357889999999999999999999999888777766664311000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC--CCCHHHHhcCcCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV--RGTASSALQNEFFTT 424 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hpwf~~ 424 (690)
+ +...+.+++..+.+||.+||..++.+ |++++++++|+||..
T Consensus 228 ---------~----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 228 ---------Q----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred ---------c----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 0 01113457889999999999976654 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=378.78 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=219.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
..|..++.||.|+||.||+|.+..+++.||||++..... ...+..+.+|+.+|.+++++||.++|+.|.. +..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 368889999999999999999999999999999987654 3456778999999999999999999998887 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||||.|+....++..+..+.+..+..++++++.||.|||..+.+|||||+.||||..+|.+||+|||++..+.......
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999998887777777777999999999999999999999999999999999999999999999999998776544443
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
...+|||+|||||++.+ ..|+.++||||||++.+||++|.||+......-.+..|-+
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------------- 225 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------------- 225 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------------
Confidence 67899999999999985 6799999999999999999999999986554222111110
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.. ...+ -.++++.+++|+..||++||+.||||.++|+|+|++.
T Consensus 226 ~~---PP~L---~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 SA---PPRL---DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CC---CCcc---ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 00 0011 1257889999999999999999999999999999987
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.35 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=211.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+|+.++||||+++++.+.. .+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 488999999999999999999999999999999754322 2233456789999999999999999998876 4689999
Q ss_pred Eeccccchhhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLAGLAA-T-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~-~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++.+.... . ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.. ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GE 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC--CC
Confidence 9999876554332 2 234689999999999999999999999999999999999999999999999999976532 22
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 2344578999999999876 4689999999999999999999999998766544444332111000
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||.+|| +++++++||||...
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 011234788899999999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=364.80 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=202.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..+ +||||++++++|.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 368999999999999999999999999986432 234456688999999998 79999999999876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 98665544444557999999999999999999999999999999999999999999999999998753211 22334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE--------VEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~--------~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+.+.+..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----------------- 219 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------------
Confidence 8999999999976 5689999999999999999999999963211 1111111100
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC------HHHHhcCcCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT------ASSALQNEFFTT 424 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hpwf~~ 424 (690)
........++..+.+||.+||..||.+|+| +.++++||||..
T Consensus 220 -----------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 220 -----------KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -----------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 000112346788999999999999999987 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.66 Aligned_cols=282 Identities=43% Similarity=0.731 Sum_probs=235.9
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|++...||.|+||.||+|.+..+++.||+|++............+..|+.+++.++|+||+++++++.+ .+.+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 677889999999999999999999999999998654334445567889999999999999999999876 478999999
Q ss_pred ccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccc
Q 005582 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 218 y~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
|+++++...+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCc
Confidence 99988777776654579999999999999999999999999999999999999999999999999998764322 23344
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~ 377 (690)
...+..|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+.++...++.+.+..|..............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 55688999999987755789999999999999999999999999999999999999999999988875432211111111
Q ss_pred CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 378 QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 378 ~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
..........++.++..+.++|..||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111122334566778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=373.72 Aligned_cols=278 Identities=24% Similarity=0.322 Sum_probs=217.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEc--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL--ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.+|+++..||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.|+||||+++++++.. ...+|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 162 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KSTVC 162 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence 47999999999999999999754 356889999876321 24689999999999999999998876 47899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+|||++.+++...+ .....+++..++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||++..+......
T Consensus 163 lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 99999999888776 33457999999999999999999999999999999999999999999999999999766433222
Q ss_pred -CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 294 -PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 -~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~---~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.....++|+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.. ....+..|++.++..+.++.......
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2235678999999999876 468999999999999999999999997754 45677778877776544332110000
Q ss_pred ------cc-cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 370 ------HA-TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 370 ------~~-~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.. ....+.......+. -..++.++.+||.+||..||.+|||+.++|.||||...|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHHhhcccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00 00000001111110 124577899999999999999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.08 Aligned_cols=285 Identities=26% Similarity=0.411 Sum_probs=234.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--------CCCeeeeeeeEee-
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD--------HPNIMKLEGLITS- 206 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HpnIv~l~~~~~~- 206 (690)
.+|.+.++||+|.|++||+|+|..+.+.||+|+++... ...+..+.||++|+++. ..+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 48999999999999999999999999999999998543 34455788999999982 3579999999865
Q ss_pred -ccCCeEEEEEeccccchhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceee-------------
Q 005582 207 -RVSGSLYLVFEYMEHDLAGLAATPGV-KFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLI------------- 270 (690)
Q Consensus 207 -~~~~~l~LV~Ey~~g~Ll~~~~~~~~-~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILl------------- 270 (690)
+++.++|||||+++.+||.++...+. .++...++.|++|||.||.|||. .||||.||||+||||
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 45679999999999999999876543 49999999999999999999997 599999999999999
Q ss_pred --------------------------------------------------------------------------------
Q 005582 271 -------------------------------------------------------------------------------- 270 (690)
Q Consensus 271 -------------------------------------------------------------------------------- 270 (690)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred -----------------------cc--------------------------------------------------CCceE
Q 005582 271 -----------------------DY--------------------------------------------------NGILK 277 (690)
Q Consensus 271 -----------------------d~--------------------------------------------------~g~vK 277 (690)
+. +-.||
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 00 00378
Q ss_pred eeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCC------ChHHHHHHH
Q 005582 278 IGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGR------TEVEQLHKI 351 (690)
Q Consensus 278 L~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~------~~~e~l~kI 351 (690)
|+|||.|.++ ...++..+.|..|+||||++|. .|++.+||||++|++|||+||..+|... .+.+.+..|
T Consensus 395 IaDlGNACW~----~khFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWV----HKHFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhh----hhhhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 9999999654 4567788899999999999995 6999999999999999999999999632 367889999
Q ss_pred HHHhCCCChh----------HhhhcCCCcccccCCCCccchhhhhhcCC---CchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 352 FKLCGSPSEE----------YWKRSKLPHATIFKPQQPYKRCVAETFKD---IPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 352 ~~~~g~p~~~----------~w~~~~l~~~~~~~~~~p~~~~~~e~~~~---~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
++++|..+.. ++++............+|+.+.+.+.+.- ...++.+||.-||+++|++||||.++|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 9999976654 34433323333334557777777776642 2346788999999999999999999999
Q ss_pred CcCCCCCCCC
Q 005582 419 NEFFTTKPLP 428 (690)
Q Consensus 419 hpwf~~~p~~ 428 (690)
|||+...+.|
T Consensus 550 hPwLn~~~~~ 559 (590)
T KOG1290|consen 550 HPWLNPVAGP 559 (590)
T ss_pred CccccCCCCC
Confidence 9999987665
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.73 Aligned_cols=258 Identities=27% Similarity=0.474 Sum_probs=234.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+.-|.+.+.||+|.|+.|-+|++.-||..||||++.+..++.-....+.+|+..|+.+.|||||+||+++.. ...+||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEE
Confidence 346899999999999999999999999999999999988887777889999999999999999999999876 468999
Q ss_pred EEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee-ccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI-DYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl-d~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+|+-++ +|.+++++....+.+..++.|+.||+.|+.|||...+|||||||+|+.+ ..-|.|||+|||++..|.+ .
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--G 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--G 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC--c
Confidence 9999886 7888888888889999999999999999999999999999999999876 4679999999999998864 4
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
..++..||++.|-|||+|+|..+..+++||||||||||.|++|++||...++.+.+..|+.+-.+
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------------- 237 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------------- 237 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---------------
Confidence 56889999999999999999887788999999999999999999999999999999999874322
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
....++.+.++||..||.-||.+|.|.+++..|+|++..
T Consensus 238 --------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 238 --------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred --------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 234578899999999999999999999999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.05 Aligned_cols=289 Identities=37% Similarity=0.582 Sum_probs=238.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc---CCeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV---SGSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~l~ 213 (690)
+|++...||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999889999999998754433455567889999999999999999999887642 24789
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~- 292 (690)
+||||+.+++...+... ..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999998777666543 3899999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 293 -QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 -~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
.......+|++|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.++...|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2244567799999999998755789999999999999999999999999999999999999999998877653222111
Q ss_pred cccCC--CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 372 TIFKP--QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 372 ~~~~~--~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
..+.. .......+...++.++..+.+||.+||++||.+|||++++|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 11111 01111223344567899999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.64 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=208.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..+ +||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999985432 233455677899999888 79999999999876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccccee
Confidence 98766555555557999999999999999999999999999999999999999999999999998653221 22234457
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------------- 213 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 8999999999976 4689999999999999999999999998877666555532100
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-----HHHhcCcCCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-----SSALQNEFFTTK 425 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+|||+ .+++.||||...
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0113467899999999999999999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=366.58 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=204.0
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL---DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
||+|+||.||+|.+..+++.||||++..... .......+..|..++..+ +||||+.+++++.. ...+||||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999865332 122334456677777765 69999999998876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCcc
Confidence 88655544445567999999999999999999999999999999999999999999999999999754322 22234567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..|... .. .++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------~~~---------- 217 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KV--------RFP---------- 217 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CC--------CCC----------
Confidence 8999999999977666899999999999999999999999988766655554321 00 000
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCC----CHHHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRG----TASSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp----Ta~e~L~hpwf~~ 424 (690)
...++..+.+||.+||..||.+|| ++.++++||||..
T Consensus 218 --------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 218 --------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred --------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 123678999999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.93 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=211.6
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~L 214 (690)
+|++...||+|+||.||+|.+..+|+.||||++..... .......+..|+.++..+. |++|+++++++.. .+.+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 47899999999999999999999999999999975422 2334456778999998886 5677888888776 468999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-Ccc
Confidence 9999987665555555557999999999999999999999999999999999999999999999999999754322 122
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..|.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 334578999999999876 5689999999999999999999999999887776666654110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
.....++..+.+|+.+||..||.+|++ ..++++||||...
T Consensus 219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 012346788999999999999999997 5799999999763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=346.05 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=210.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD---PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
+.|.+.+.||+|+||.||.|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4689999999999999999999999999999998755432 2234568899999999999999999999887 4689
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+||||+.++.+.........+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999998765554444445789999999999999999999999999999999999999999999999999976543221
Q ss_pred CCc--ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 293 QPL--TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 ~~~--~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
... ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 111 34567889999999987 45899999999999999999999999876555444433221000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......++..+.+||..||..+|.+|||+.++|+|+||
T Consensus 226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01123578889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.66 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986432 234455678899998877 89999999999877 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccccc
Confidence 98766555555557999999999999999999999999999999999999999999999999999754221 22234567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT--------EVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~--------~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+.+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------------- 219 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------------- 219 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------------
Confidence 8999999999976 468999999999999999999999995211 01111111100
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC------HHHHhcCcCCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT------ASSALQNEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hpwf~~~ 425 (690)
........++..+.+||.+||..||.+|+| +.++++||||...
T Consensus 220 -----------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 220 -----------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred -----------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 000112357788999999999999999998 5899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.64 Aligned_cols=289 Identities=38% Similarity=0.620 Sum_probs=235.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++++ +||||+++++++.......+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4689999999999999999999988999999999865433334445677899999999 999999999998765456789
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~- 292 (690)
+||||+.+++...+... .+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++..+.....
T Consensus 86 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999998777665443 688999999999999999999999999999999999999999999999999987654322
Q ss_pred ---CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 293 ---QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 293 ---~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+.++....+.+....|.....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 22344578999999999877667889999999999999999999999999999999999998888877665432211
Q ss_pred ccccc--CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 370 HATIF--KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~--~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
....+ .....-.......++.++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 10000 000111112234456689999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=364.40 Aligned_cols=289 Identities=34% Similarity=0.571 Sum_probs=236.9
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC----
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---- 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---- 209 (690)
..++|++...||.|+||.||+|.+..++..||||++............+.+|+.+++.+.||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999999999999999987543344455667889999999999999999987765321
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
..+|+|+||++++|...+.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 34899999998877766654 3699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+++..|......
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 171 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred ----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2345577899999999876556889999999999999999999999999999999999999998888777654322
Q ss_pred cccccCCCC--ccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 370 HATIFKPQQ--PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 370 ~~~~~~~~~--p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
....+.... .-...+...+..++..+.+||.+||..||.+|||+.++|+||||.....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 211111000 01112334455678999999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.30 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=205.6
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREII-ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+|+.||||++..... .......+..|.. +++.++||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 368999999999999999999999999975422 2233344556655 5677999999999998876 57899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..... ........+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCccccc
Confidence 9876655555566899999999999999999999999999999999999999999999999999875322 122334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------ 212 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------ 212 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 8999999999876 468999999999999999999999999887776666554310
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH----HHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA----SSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hpwf~~ 424 (690)
....+.++..+.+||.+||..||.+||++ .+++.||||..
T Consensus 213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 00123467889999999999999999987 59999999976
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.09 Aligned_cols=282 Identities=44% Similarity=0.763 Sum_probs=235.1
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|++...||.|++|.||+|.+..+++.+++|.+............+.+|+.+|+.++|+||+++++++.. ...+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 677889999999999999998899999999987665444455678899999999999999999999876 478999999
Q ss_pred ccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccc
Q 005582 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 218 y~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
|+.+++...+......+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||.+..+.... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998888777665689999999999999999999999999999999999999999999999999998765432 23334
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc-ccccCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH-ATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~-~~~~~~ 376 (690)
..++..|+|||.+.+...++.++|+|||||++|+|++|+++|++.+..+.+.++...++.+....|....... ......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999998875578999999999999999999999999999999999999999988887776432200 000000
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
............+.++..+.+||..||..||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0011111233445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.92 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=204.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||+++.... ..........|..++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999975422 122344566788888764 99999999999877 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceeeec
Confidence 87655554444457899999999999999999999999999999999999999999999999998754221 12234567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... .+.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~-------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPC-------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC--------------------
Confidence 8999999999876 46899999999999999999999999988776665554321 000
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHH-HHhcCcCCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS-SALQNEFFTTK 425 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~-e~L~hpwf~~~ 425 (690)
....++..+.+||.+||..||.+||++. ++++||||...
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 215 -------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 0123678899999999999999999996 89999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=361.54 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=205.3
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHH-HHHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREI-IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi-~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||+|++...... ......+..|. .+++.++||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999999754321 12223344444 45778999999999998876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 98766655555567899999999999999999999999999999999999999999999999999754321 22334567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------ 212 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence 8999999999876 568999999999999999999999999888777766664310
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHH----HHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS----SALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~----e~L~hpwf~~ 424 (690)
....+.++..+.+||.+||..||.+|+++. ++++|+||..
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 001245788999999999999999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=360.86 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=203.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREII-ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+. +++.++||||+++++++.. .+.+||||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 1222334555554 6788999999999998876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
+++.+.........+++..++.++.||+.||.|||+.||+||||||+||||+.+|.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 98766555555567999999999999999999999999999999999999999999999999998753221 12234567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------------- 212 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--------------------- 212 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C---------------------
Confidence 8999999999876 56899999999999999999999999988766665555321 0
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH----HHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA----SSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hpwf~~ 424 (690)
....+..+..+.+||.+||..||.+|+++ .++++|+||..
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 00123467889999999999999999876 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=359.71 Aligned_cols=284 Identities=33% Similarity=0.573 Sum_probs=230.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|.+...||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35899999999999999999999899999999998754333334456789999999999999999999886532 13
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+|+||+..++.... +..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 57999999987655443 23589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....|.+...+++......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 23345678999999998765568999999999999999999999999998888999999988888777665433221
Q ss_pred ccccCCC--CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 ATIFKPQ--QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~--~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
...+... ......+...++.++..+.+||.+||+.||.+|||+.++|.||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 1111000 001122233456678899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.35 Aligned_cols=290 Identities=34% Similarity=0.533 Sum_probs=242.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC---Ce
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---GS 211 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~~ 211 (690)
.-+.+.-+.||.|+||.||.+.|..+|+.||+|++......-...+.+.+|+++|..+.|.|++..+++.....- ..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 345666788999999999999999999999999986433233445678899999999999999999988765432 35
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+|+|+|..+|...+..+. .|+.+.++-+++||+.||+|||+.+|+||||||.|+|++.+..+||||||||+......
T Consensus 132 iYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 79999999999888777665 79999999999999999999999999999999999999999999999999999988777
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC---
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL--- 368 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l--- 368 (690)
...++..+.|-+|+|||+++|...|+.++||||+|||+.|||..+-+|...+..+++..|..++|+|+.+.++...-
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999988763211
Q ss_pred CcccccCCCCccchhhhhhc--CCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETF--KDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.+.....+..|....+...- .+-..++.+++..||.+||.+|.+.+++|.|+|....
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111111222211111111 1334578999999999999999999999999998653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.19 Aligned_cols=285 Identities=33% Similarity=0.563 Sum_probs=230.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC----C
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS----G 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 210 (690)
.++|.+++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 468999999999999999999999999999999986543333444567899999999999999999998865321 2
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+++++...... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~- 170 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS- 170 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-
Confidence 4699999997766655543 3689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+.++++..+.++..++.......
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 22345678999999998765568899999999999999999999999999888899998888887776655432211
Q ss_pred ccccCC--CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 ATIFKP--QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~--~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
...+.. .......+....+.++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 111000 0000112233456788899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.46 Aligned_cols=283 Identities=24% Similarity=0.356 Sum_probs=212.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++.++||.|+||.||++.+..++..||+|.+.... .......+.+|+.+|+.++||||++++++|.. .+.+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence 368999999999999999999999999999999987542 34455678899999999999999999999987 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999998765555444445789999999999999999999985 7999999999999999999999999999765322
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHH--HhCCCChhHhhhcCCCcc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK--LCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~--~~g~p~~~~w~~~~l~~~ 371 (690)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ..++. ..+.+..........+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCcc
Confidence 2234578999999999876 4689999999999999999999999987654332 22221 111111100000000000
Q ss_pred -------cccCCCCccchh----hhhh-----cCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 372 -------TIFKPQQPYKRC----VAET-----FKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 372 -------~~~~~~~p~~~~----~~e~-----~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
....+....... +... ...++.++.+||.+||++||.+|||+.++|.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000000000 0000 01356789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=379.38 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=217.9
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC----
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---- 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---- 209 (690)
..++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999999999999999998776666667778899999999999999999887754321
Q ss_pred --CeEEEEEeccccchh-hhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccc
Q 005582 210 --GSLYLVFEYMEHDLA-GLAA---TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 210 --~~l~LV~Ey~~g~Ll-~~~~---~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGl 283 (690)
..+++||||+.++.+ ..+. .....+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 147899999997544 3332 2234699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Q 005582 284 ANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362 (690)
Q Consensus 284 A~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 362 (690)
++.+..... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..+.....
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------ 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence 987643222 22345678999999999976 4689999999999999999999999998887766666543110
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
......+++.+.+||..||..||.+|||+.++|+|||+..
T Consensus 263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 0112457889999999999999999999999999999864
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.70 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=211.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|++++.||.|+||.||++.+..+++.||+|++............+.+|+.++++++|+||+++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999976555555566788999999999999999999877542 45689999
Q ss_pred eccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.++.+ ..+.. ....+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-~~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc-CCc
Confidence 99987544 33332 2346899999999999999999999999999999999999999999999999999876432 223
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~---------------- 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L---------------- 219 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------------
Confidence 344567899999999876 468899999999999999999999998877655544443210 0
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......+++.+.+||.+||..||.+|||+.++|+||||
T Consensus 220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00113477899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.98 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=203.6
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++.++ +||||+.+++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999985432 234456688999999988 69999999998876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 88666554444457999999999999999999999999999999999999999999999999999753221 22234567
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~------~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.... ..+.+.++... .+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP--------------- 219 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC---------------
Confidence 8999999999876 568999999999999999999999996422 11222222110 00
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC------HHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT------ASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||.+|++ ..+++.||||...
T Consensus 220 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 220 -----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 0112346788999999999999999998 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.31 Aligned_cols=286 Identities=36% Similarity=0.591 Sum_probs=223.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC------
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS------ 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~------ 209 (690)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 589999999999999999999999999999999875543 344567899999999999999999987665321
Q ss_pred ------CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeeccc
Q 005582 210 ------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFG 282 (690)
Q Consensus 210 ------~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFG 282 (690)
..+|+||||+++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35799999999877665543 36899999999999999999999999999999999999984 5689999999
Q ss_pred cccccccCCC--CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 283 LANFFKCSQK--QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 283 lA~~~~~~~~--~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
++..+..... ......+++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....++.....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9976532211 11223467889999998876567899999999999999999999999999888888877765554443
Q ss_pred hHhhhc--CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 361 EYWKRS--KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 361 ~~w~~~--~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
..+... .++.. ...........+....+.++.++.+||.+||..||.+|||+.++|.||||+...
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 241 EDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 322211 00000 000111111223334567889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.84 Aligned_cols=289 Identities=33% Similarity=0.535 Sum_probs=230.4
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----C
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----S 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~ 209 (690)
..++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999999999999999999999999999754433344556789999999999999999999886421 2
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
..+|++++++.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 45799999997777655543 3589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
......+|++|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+....+......
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 173 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred ----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 2344577899999999877566899999999999999999999999998888888888888887776665432211
Q ss_pred cccccCC--CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 370 HATIFKP--QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 370 ~~~~~~~--~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
....+.. .......+...+...++.+.+||..||..||.+|||+.++|.||||.....|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0000000 0000111222233568889999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=371.16 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=221.4
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|.-+..||.|+||.||.|++..+.+.||||++.+.... .+.+..++.|+.+|++|.|||+|.+.++|.- ....|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence 477888999999999999999999999999999877653 5667889999999999999999999998876 4678999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||||-|+-.+++.-...+|.+.+|..|..+.+.||.|||+++.||||||..||||++.|.|||+|||.|.... +.
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----PA 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----PA 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----ch
Confidence 9999986666555555689999999999999999999999999999999999999999999999999997654 45
Q ss_pred ccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 296 TSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.+++|||+|||||+++. ...|+-++||||||++..||...+||+...+....++.|...- +|+-.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLq------------ 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQ------------ 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCC------------
Confidence 67899999999999863 4469999999999999999999999998888888888886521 11100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
-...+..++.|++.||.+-|..|||++++|.|+|...
T Consensus 247 --------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 247 --------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred --------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1345778999999999999999999999999999965
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=393.21 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=215.6
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
...++|+++..||+|+||.||+|.+..++..||+|++............+..|+.+|+.|+|||||+++++|.......+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999999999999999998766666666778999999999999999999999877656789
Q ss_pred EEEEeccccchh-hhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccccCCCcceeecc---------
Q 005582 213 YLVFEYMEHDLA-GLAAT---PGVKFTEAQIKCYMKQLLHGLEHCHSR-------GILHRDIKGSNLLIDY--------- 272 (690)
Q Consensus 213 ~LV~Ey~~g~Ll-~~~~~---~~~~l~e~~i~~i~~qIl~gL~yLHs~-------gIvHrDLKp~NILld~--------- 272 (690)
||||||+.++.+ .++.. ....|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999997544 43322 234699999999999999999999985 4999999999999964
Q ss_pred --------CCceEeeccccccccccCCCCCcccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCC
Q 005582 273 --------NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRT 343 (690)
Q Consensus 273 --------~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~ 343 (690)
.+.+||+|||++..+... ......++|+.|+|||++.+. ..++.++||||||||||+|++|..||...+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999999765422 223455789999999998652 458899999999999999999999998766
Q ss_pred hHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 344 EVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 344 ~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
....+..++... + . ......+..+.+||..||.++|.+|||+.|+|.|+||.
T Consensus 248 ~~~qli~~lk~~--p------------------~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 248 NFSQLISELKRG--P------------------D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cHHHHHHHHhcC--C------------------C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 655544433210 0 0 00134578899999999999999999999999999997
Q ss_pred CC
Q 005582 424 TK 425 (690)
Q Consensus 424 ~~ 425 (690)
..
T Consensus 300 ~i 301 (1021)
T PTZ00266 300 NV 301 (1021)
T ss_pred hc
Confidence 64
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=352.68 Aligned_cols=290 Identities=35% Similarity=0.539 Sum_probs=231.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCC--CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeec--cCCe
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLEN--NKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSR--VSGS 211 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~t--g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~--~~~~ 211 (690)
+|++.+.||+|+||.||++.+..+ +..||||++............+.+|+.+++.+ +||||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999888 89999999874433333455678899999999 599999999875432 2346
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+++||++++|...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 899999999887776654 3479999999999999999999999999999999999999999999999999998664322
Q ss_pred C---CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 K---QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~---~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
. ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++..+|.+..+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123457899999999887656789999999999999999999999999999999999999999888776654332
Q ss_pred CcccccCC--CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 369 PHATIFKP--QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 369 ~~~~~~~~--~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
+....+.. ...-...+...++.++..+.+||.+||..||.+|||+.++|.||||..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 21111000 000011222334567889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.13 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=207.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|++.+.||+|+||.||++.+..+++.||||.+...... ......+.+|+.+|+.++|+||+.+++.+.. .+.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 478899999999999999999999999999998754332 2334456789999999999999999998876 4689999
Q ss_pred Eeccccchhh-hhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLAG-LAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll~-~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++.+. .+. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--Q 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--c
Confidence 9999875443 332 23346899999999999999999999999999999999999999999999999999765322 2
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 2334578999999999976 4589999999999999999999999987543211111111000000
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
......+++.+.+||..||..||.+||| +.++++||||...
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 -----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0112457888999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=350.62 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=226.9
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..++|+.+++||+|.||.|.+|+.+.+++.||||++++.-+ ..+.+...+.|-.+|+...||.+..|...|+. .+.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceE
Confidence 34789999999999999999999999999999999987643 45667778899999999999999999877766 5899
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+||||+.|+.+...+.....|++...++|-..|+.||.|||+++||+||||.+|+|||.+|++||+||||++.-- ...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 9999999999888877777789999999999999999999999999999999999999999999999999997532 234
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+....+..|+..- .
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed----------~------ 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED----------L------ 385 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh----------c------
Confidence 45678999999999999975 689999999999999999999999999888777766665411 1
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....++++++.||..+|..||.+|. .|.|+.+|+||...
T Consensus 386 -------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 386 -------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred -------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 11246899999999999999999997 48999999999763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=396.00 Aligned_cols=279 Identities=29% Similarity=0.398 Sum_probs=234.8
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
...++|++++.||.|+||.|.+++++.|++.||+|++.+-.+ .......|+.|-.||..-+.+-|+.|+..|.+ ..+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccc
Confidence 456899999999999999999999999999999999976432 23345568899999999999999999888887 589
Q ss_pred EEEEEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+|||||.| ||+.++..-. ++++..+++|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.++.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999986 5666666555 8999999999999999999999999999999999999999999999999999888766
Q ss_pred CCCCcccccccccCcCCcccc----CCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 291 QKQPLTSRVVTLWYRPPELLL----GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~----g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
+.-.....||||.|.+||+|. +...|+..+|+||+||++||||.|..||..++-++++.+|+..-.. .
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~--------l 300 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES--------L 300 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh--------c
Confidence 666667789999999999984 2256999999999999999999999999999999999999874110 0
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC---HHHHhcCcCCCCCCCCCCCCCCCCCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT---ASSALQNEFFTTKPLPCDPSSLPKYPPS 440 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hpwf~~~p~~~~p~~lp~~p~~ 440 (690)
.+| ...++|..+++||.++|+ +|+.|.. ++++-.||||...+.-.-....|++-|.
T Consensus 301 ~FP-----------------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 301 SFP-----------------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred CCC-----------------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 111 013489999999999996 7999998 9999999999886543333444555443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.33 Aligned_cols=265 Identities=28% Similarity=0.368 Sum_probs=216.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.+.||+|+||.||+|.+..+++.||||.+....... .....+..|+.+|+.++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 37999999999999999999999999999999998654432 355678899999999999999999998876 578999
Q ss_pred EEeccccchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.++.+..+.. .+..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999998754443332 345799999999999999999999999999999999999999999999999999875532211
Q ss_pred C----------------------------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh
Q 005582 293 Q----------------------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE 344 (690)
Q Consensus 293 ~----------------------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~ 344 (690)
. .....++|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 1113467889999999876 4589999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC----HHHHhcCc
Q 005582 345 VEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT----ASSALQNE 420 (690)
Q Consensus 345 ~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT----a~e~L~hp 420 (690)
...+.++...-.. + .....++..+.+||.+||..||++||| ++++|.||
T Consensus 238 ~~~~~~~~~~~~~-----~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVT-----F----------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCcc-----C----------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 7666655421000 0 001226889999999999999999999 99999999
Q ss_pred CCCCCCCCCC
Q 005582 421 FFTTKPLPCD 430 (690)
Q Consensus 421 wf~~~p~~~~ 430 (690)
||+....+.-
T Consensus 291 ~~~~~~~~~~ 300 (316)
T cd05574 291 FFRGVNWALI 300 (316)
T ss_pred hhhcCChhhc
Confidence 9988654443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.88 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=211.9
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|+..+.||+|+||+||+|.+..+++.||+|.+...... ......+.+|+.+|+.++|+||+.+++++.. .+.+|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 378899999999999999999999999999998754332 2233457789999999999999999988876 4789999
Q ss_pred Eeccccchhhh-hcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLAGL-AAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll~~-~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++.+.. +.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 99999765543 322 2346999999999999999999999999999999999999999999999999999765322 2
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 2345578999999999876 46899999999999999999999999887765555544332111100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~~ 425 (690)
.....++..+.+|+..||..||.+||| +.+++.|+||...
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 112356788999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=374.69 Aligned_cols=260 Identities=29% Similarity=0.414 Sum_probs=219.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
+-|+|+..||.|+||.||+|.++.++-..|.|++... ..+....++-||.||..++||+||+|++.|.. .+.+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEE
Confidence 4588999999999999999999999999999998643 35677888999999999999999999998876 4789999
Q ss_pred Eeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
.|||.|+-.+.++ .-+..|++.++..+++|+|.||.|||+++|||||||..|||++.+|.++|+|||.+.... .....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 9999998765443 334579999999999999999999999999999999999999999999999999985432 22334
Q ss_pred cccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 295 LTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
-.+++|||+|||||+++. ..+|++++||||||++|.||..+.||...-+..-.+-+|.+.. |+ ..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PP-TL-------- 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP-TL-------- 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CC-cc--------
Confidence 567899999999999853 5679999999999999999999999998888777777775521 10 00
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
-.....+..+.|||.+||.+||..||+++++|+||||+..|
T Consensus 256 ---------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 256 ---------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred ---------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 01223567899999999999999999999999999998753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=339.84 Aligned_cols=280 Identities=42% Similarity=0.684 Sum_probs=224.9
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEeeccC---Ce
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL---DHPNIMKLEGLITSRVS---GS 211 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~~~---~~ 211 (690)
|++...||.|+||.||+|.+..+++.||||+++...........+.+|+.+++++ +||||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7789999999999999999988899999999975544333344566788887766 69999999999877421 23
Q ss_pred EEEEEeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
+|++|||+.+++...+... ...+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998776655432 236899999999999999999999999999999999999999999999999999776432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.+++...+.+....|.......
T Consensus 161 --~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 --MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred --cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22234457889999999977 458999999999999999999999999999999999999888877766664322111
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
...+. ...........+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11110 111112234445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=372.05 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=213.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC-CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN-NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t-g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
..|.+.+.||.|+||.||+|.+..+ +..||+|++... +......+.+|+.+|+.++||||+++++++.. .+.+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEE
Confidence 4599999999999999999998877 788999977533 23444567889999999999999999999887 478999
Q ss_pred EEeccccchhhh-h---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 215 VFEYMEHDLAGL-A---ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 215 V~Ey~~g~Ll~~-~---~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
||||+.++.+.. + ......+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999998755432 2 223457899999999999999999999999999999999999999999999999999876433
Q ss_pred CC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 291 QK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 291 ~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------------ 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD------------ 289 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 22 12345678999999999876 56899999999999999999999999988877766666431100
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.....++..+.+||.+||..||.+|||+.++|.|+|+..
T Consensus 290 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 ----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 001246788999999999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.23 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=198.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.++||+|+||.||+|.+. .++..||||++.... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 368999999999999999999752 345789999987432 334456788999999999 899999999988753
Q ss_pred CCeEEEEEeccccchhh-hhcCC---------------------------------------------------------
Q 005582 209 SGSLYLVFEYMEHDLAG-LAATP--------------------------------------------------------- 230 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~-~~~~~--------------------------------------------------------- 230 (690)
.+.+|+||||++++.+. .+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45789999999875443 32211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-CcccccccccCc
Q 005582 231 ----GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYR 305 (690)
Q Consensus 231 ----~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~ 305 (690)
...+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.+...... ......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 124788899999999999999999999999999999999999999999999999765322111 112234567899
Q ss_pred CCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhh
Q 005582 306 PPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCV 384 (690)
Q Consensus 306 APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~ 384 (690)
|||++.+ ..|+.++|||||||+||||++ |.+||.+....+.+...+.. +..
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~-------------------------- 295 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR-------------------------- 295 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------
Confidence 9999876 468999999999999999997 99999886544433333221 100
Q ss_pred hhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 385 AETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 385 ~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0012346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.25 Aligned_cols=285 Identities=33% Similarity=0.549 Sum_probs=232.0
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
..++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||++++++|... ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEE
Confidence 46789999999999999999999999999999999865443334456678999999999999999999988653 45789
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+++++...+.. ..+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.++|+|||++.....
T Consensus 87 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 9999998877665543 3588899999999999999999999999999999999999999999999999975432
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+.+|.++++.+..........
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 22345678899999998765678999999999999999999999999999888888888899998877665322111100
Q ss_pred cCCC--CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 374 FKPQ--QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~--~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
+... ........+.++.++..+.+||.+||+.+|++|||++++|.||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0000 000111223445688999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=334.58 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=212.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4889999999999999999999999999999998665556667778999999999999999999999876 47899999
Q ss_pred eccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.++.+ ..+.. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99987544 43333 24578999999999999999999999999999999999999999999999999998765322 22
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP----------------- 219 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 334567899999999876 45889999999999999999999999888766655554331000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....++..+.++|.+||..+|++||++.++|+|||+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 -----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0112467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.23 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=199.7
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||+|+||.||++.+..+|+.||+|++...... ......+..|+.+|+.++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 69999999999999999999999998653322 1223345679999999999999999998876 47899999999876
Q ss_pred hhh-hhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccc
Q 005582 223 LAG-LAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300 (690)
Q Consensus 223 Ll~-~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~g 300 (690)
.+. .+. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+... .......+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 553 332 23335889999999999999999999999999999999999999999999999999766422 22344578
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+....-..
T Consensus 157 ~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05607 157 TNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------------------- 213 (277)
T ss_pred CCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------------
Confidence 9999999998774 48999999999999999999999997654322111221110000
Q ss_pred chhhhhhcCCCchhHHHHHHHhccCCCCCCCCH----HHHhcCcCCCCCC
Q 005582 381 KRCVAETFKDIPSSALSLLDILLSTEPEVRGTA----SSALQNEFFTTKP 426 (690)
Q Consensus 381 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hpwf~~~p 426 (690)
.+......++.++.+||.+||..||.+|||+ .+++.|+||....
T Consensus 214 --~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 214 --EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred --ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 0000123578899999999999999999999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.41 Aligned_cols=281 Identities=22% Similarity=0.323 Sum_probs=206.3
Q ss_pred EEeeeecc--CceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 140 KLDKIGQG--TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 140 ~~~~LG~G--~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
++++||+| +|++||++.+..+|+.||||++............+.+|+.+++.++||||+++++++.. .+.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56789999 77899999999999999999997665555566678899999999999999999999987 478999999
Q ss_pred ccccchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC--
Q 005582 218 YMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-- 293 (690)
Q Consensus 218 y~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~-- 293 (690)
|++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+||+.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999765544332 2335899999999999999999999999999999999999999999999999875433211110
Q ss_pred ----CcccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---------
Q 005582 294 ----PLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS--------- 359 (690)
Q Consensus 294 ----~~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~--------- 359 (690)
.....+++..|+|||++.+. ..|+.++|||||||++|||++|+.||........+..... +..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 11223567789999998753 3589999999999999999999999987655443333221 1111
Q ss_pred -hhHhhh-cC------CCcccccC-CCCc-cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 360 -EEYWKR-SK------LPHATIFK-PQQP-YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 360 -~~~w~~-~~------l~~~~~~~-~~~p-~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
++.... .. ........ .... ...........+++.+.+||.+||++||++|||++++|+||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000 00 00000000 0000 000111122346788999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=340.23 Aligned_cols=280 Identities=38% Similarity=0.668 Sum_probs=227.9
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEEEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
|.+.+.||.|+||.||+|.+..+++.||||.+...... .......+|+..++.+. ||||+++++++.. .+..|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 67889999999999999999889999999998654322 12223457999999999 9999999999877 57899999
Q ss_pred eccccchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHDLAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~-~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||+.+++...+.... ..+++..+..++.||+.+|.|||++||+|+||+|+|||++.++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999888777665543 46899999999999999999999999999999999999999999999999999866432 223
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc-cccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH-ATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~-~~~~ 374 (690)
....++..|+|||++.+...++.++|+|||||++++|++|++||++.+..+.+.++....+.+....|....... ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 446678999999998765668999999999999999999999999999999999999999998887775422111 0000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.........+...++..+..+.+||.+||..||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000011111233344557899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=347.94 Aligned_cols=280 Identities=26% Similarity=0.341 Sum_probs=212.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 47999999999999999999999999999999987432 34455668899999999999999999999877 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||++++.+..+......+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++...... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999986665555444679999999999999999999998 59999999999999999999999999998765322 2
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....++++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+... ...++........ +...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGE--AKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCcccccc--ccCCcccccCCC
Confidence 234578899999999876 458999999999999999999999998766433 2333221111000 000000000000
Q ss_pred CCC-C--ccch----hhhh-----hcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 375 KPQ-Q--PYKR----CVAE-----TFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~-~--p~~~----~~~e-----~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
... . .... ...+ ....++.++.+||.+||..||++|||+.++|+||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000 0 0000 0000 011367789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=339.01 Aligned_cols=259 Identities=29% Similarity=0.473 Sum_probs=207.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD---PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
.+|+..+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3789999999999999999999999999999998754322 2345668899999999999999999998876545778
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC-
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ- 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~- 291 (690)
|++|||+.++.+.........+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999876555444444568999999999999999999999999999999999999999999999999997653211
Q ss_pred -CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 -KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 -~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||........+..+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~---------- 227 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN---------- 227 (266)
T ss_pred cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC----------
Confidence 111223457889999999876 4689999999999999999999999987654444333221 1100
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
+ .....++..+.+|| .||..+|.+|||+.++|+||||+
T Consensus 228 -----~---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 -----P---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -----C---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 01123577888898 57778999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=336.34 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=213.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999998899999999987554333 56778999999999999999999998876 5789999
Q ss_pred EeccccchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 216 FEYMEHDLAGLAATP---GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~---~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|||+.++.+...... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999987655444322 24689999999999999999999999999999999999999999999999999977654322
Q ss_pred C---CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 293 Q---PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 293 ~---~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
. .....+++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++... .+ ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~-~~-------- 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DP-PS-------- 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CC-CC--------
Confidence 2 1233467899999999876556899999999999999999999999877665554444331 00 00
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
+.. ...+..+++.+.+||.+||..||.+|||+.++|+||||
T Consensus 227 ----------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 ----------LET--GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----------cCC--ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000 00134678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.26 Aligned_cols=267 Identities=28% Similarity=0.404 Sum_probs=222.2
Q ss_pred cCCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 131 ~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.|..-+.|..-.+||+|+||.||-|+-..||+.||+|++.+..+. .......++|-.||.+++.+.||.|-..|.. .
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--k 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--K 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--C
Confidence 456678899999999999999999999999999999998655432 2223346789999999999999999777766 4
Q ss_pred CeEEEEEeccccchhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGV--KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~--~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
+.+||||..|+|+-+...+.+-+ .|++..+.+|+.+|+.||.+||..+||+|||||+|||||+.|++.|+|+|||..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 78999999999987766554433 6999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
. ...+....+||..|||||++.+.. |+.+.|+|||||+||||+.|+.||....+..--..|-+..-..++
T Consensus 338 ~--~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~------- 407 (591)
T KOG0986|consen 338 P--EGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE------- 407 (591)
T ss_pred C--CCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh-------
Confidence 4 456678889999999999998755 999999999999999999999999875543332222221111111
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCCCC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTKPL 427 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~p~ 427 (690)
+....+++++++|.+.+|..||.+|. +++++-+||||++..+
T Consensus 408 ------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 408 ------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred ------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 12356899999999999999999997 5679999999998544
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=341.29 Aligned_cols=258 Identities=28% Similarity=0.375 Sum_probs=212.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
-|++++.||+|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 368889999999999999999999999999998643 24456678899999999999999999999876 47899999
Q ss_pred eccccchhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||+.++.+... ......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 99998766544 333457999999999999999999999999999999999999999999999999999765322 2223
Q ss_pred ccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 296 TSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
....+|+.|+|||++.. ...++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------------
Confidence 34568899999999842 3457889999999999999999999998877666655554311000
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||.+|||++++|+||||...
T Consensus 228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00113467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.76 Aligned_cols=259 Identities=28% Similarity=0.421 Sum_probs=211.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
+.|+++++||.|+||.||+|.+..+++.||+|.+... +......+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEE
Confidence 5799999999999999999999999999999998643 34556678899999999999999999999876 4689999
Q ss_pred Eeccccchhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||+.++.+..+ ......+++..+..++.||+.+|.|||+.||+||||||+|||++.++.++|+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 999998766543 333456899999999999999999999999999999999999999999999999998654321 222
Q ss_pred cccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 295 LTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++... .++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~---------- 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT---------- 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCcc----------
Confidence 334567899999999853 234788999999999999999999999876655544443221 0000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||++|||+.++|+||||...
T Consensus 235 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 235 --------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred --------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00123467789999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=341.03 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=207.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++.. .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 36889999999999999999999999999999987542 34445678899999999999999999999887 4778999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||++++.+.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+... ..
T Consensus 78 ~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 78 TEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred EecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 9999998775542 5789999999999999999999999999999999999999999999999999765422 23
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhcCCCccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ---LHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~---l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
...++|..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+. ...+........
T Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------- 216 (279)
T cd06619 151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------------- 216 (279)
T ss_pred cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------------
Confidence 44678999999999876 4689999999999999999999999965321110 001111100000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.+ ......+++.+.+||.+||..||.+||++.++|+||||...
T Consensus 217 -----~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 -----PP-----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -----CC-----CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00 00013467889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=351.52 Aligned_cols=280 Identities=26% Similarity=0.455 Sum_probs=222.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--C----CeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH--P----NIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--p----nIv~l~~~~~~~~ 208 (690)
.++|.++..+|+|+||.|..+++..++..||||+++... ...+..+-||.+|.+|.+ | -+|.+.++|.-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 568999999999999999999999999999999997442 233345679999999943 2 26777777766
Q ss_pred CCeEEEEEeccccchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc---------------
Q 005582 209 SGSLYLVFEYMEHDLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY--------------- 272 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~--------------- 272 (690)
.+++|||||.++-++.+.+.. .-.+|+..+++.+..||+.++.|||+.+++|.||||+|||+..
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 589999999999888877765 3457999999999999999999999999999999999999842
Q ss_pred -----CCceEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHH
Q 005582 273 -----NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ 347 (690)
Q Consensus 273 -----~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~ 347 (690)
+..++|+|||.|+... +.....+.|..|+|||+++| -.++..+||||+||||+||.+|..+|++.++.|.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceec----cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2368999999997643 23356788999999999998 4699999999999999999999999999999999
Q ss_pred HHHHHHHhCCCChhHhhhc---------CCCcc---------cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCC
Q 005582 348 LHKIFKLCGSPSEEYWKRS---------KLPHA---------TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV 409 (690)
Q Consensus 348 l~kI~~~~g~p~~~~w~~~---------~l~~~---------~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k 409 (690)
+..+-..+|..+.....+. ++... ..+.+..|....... -...-..+.|||++||.+||.+
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHHHHHHHHHHccCccc
Confidence 9999999997766544322 11110 111122222222111 1112345899999999999999
Q ss_pred CCCHHHHhcCcCCCCC
Q 005582 410 RGTASSALQNEFFTTK 425 (690)
Q Consensus 410 RpTa~e~L~hpwf~~~ 425 (690)
|+|+.|+|.||||+..
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 9999999999999753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.64 Aligned_cols=283 Identities=32% Similarity=0.508 Sum_probs=236.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~~ 211 (690)
.+|.-+..+|.|.- .|..|.|..+++.||+|++..........++..+|+.++..+.|+||++++.+|+... ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 37888999999998 8999999999999999998765444555677889999999999999999999997642 246
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+|||||..++-..+.. .+....+.+++.|+++|++|||+.||+||||||+||+|..++.+||.|||+|+..+..
T Consensus 96 ~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 899999999998887763 5788899999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC----
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK---- 367 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~---- 367 (690)
-.++.+++|.+|+|||++.+.. |...+||||+|||+.||++|.-+|+|.+..++..+|...+|+|.+.++....
T Consensus 172 -~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 3578899999999999999854 9999999999999999999999999999999999999999999999876421
Q ss_pred -----CCcccccCCCCccchh----hhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 368 -----LPHATIFKPQQPYKRC----VAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 368 -----l~~~~~~~~~~p~~~~----~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.+.+..+.....++.. ..+..+.-...+++|+.+||..||++|.++.++|+||||+-|
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 2222222111111111 111112234568999999999999999999999999999855
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.41 Aligned_cols=264 Identities=31% Similarity=0.508 Sum_probs=215.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 213 (690)
-..|+++++||.||.+.||++.. .+...||+|++.....+...+..+.+||.+|.+| .|.+||+|++|-.. ++.+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lY 436 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLY 436 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEE
Confidence 35699999999999999999985 4556788888887778888899999999999999 69999999998766 58999
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||||-+.||...+......++...+++|..|++.++.++|.+||||.||||.|+|+- .|.+||+|||+|..+..+...
T Consensus 437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9999999999999888777777779999999999999999999999999999999984 689999999999887655443
Q ss_pred C-cccccccccCcCCccccCC----------CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Q 005582 294 P-LTSRVVTLWYRPPELLLGS----------TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362 (690)
Q Consensus 294 ~-~~~~~gT~~Y~APEvl~g~----------~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 362 (690)
. ..+.+||+.||+||.+... ...+.++||||||||||+|+.|++||..- ..++.++.... .|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI~-~P---- 588 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAIT-DP---- 588 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhhc-CC----
Confidence 2 4467999999999998531 12568999999999999999999999632 12233332211 11
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCc--hhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCCC
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIP--SSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~--~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~~ 429 (690)
...+ .|+.++ .++.++++.||..||.+|||+.++|+|||++..|.|.
T Consensus 589 -------~~~I-------------efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~ 637 (677)
T KOG0596|consen 589 -------NHEI-------------EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV 637 (677)
T ss_pred -------Cccc-------------cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence 1111 122222 2389999999999999999999999999998765543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=338.34 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=205.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc----C
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV----S 209 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~----~ 209 (690)
.+.|++.+.||.|+||.||+|.+..+++.||+|.+..... ....+.+|+.++..+ +||||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3579999999999999999999999999999999875432 234578899999998 7999999999987532 2
Q ss_pred CeEEEEEeccccchhhh-hcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 210 GSLYLVFEYMEHDLAGL-AAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~-~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
..+|+||||+.++.+.. +.. ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998754443 333 2346899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w 363 (690)
.... .......+++.|+|||++.+ ...|+.++|||||||++|+|++|..||...........+.. .+
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~----- 232 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP----- 232 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC-----
Confidence 4321 22344678899999999863 23588899999999999999999999976554333322211 00
Q ss_pred hhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 364 ~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.. ......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 233 ----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ----------------AP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------------CC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 00112467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.41 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=213.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+|++++||||+++++++.. .+.+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 479999999999999999999999999999999875432 23445678899999999999999999999876 578999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999976555444444457999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+......++.. +.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~---------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKV---------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc----------------
Confidence 234568899999999876 4578999999999999999999999988775555555432 110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..||.+|+ +++++++||||...
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 01134578999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.55 Aligned_cols=255 Identities=30% Similarity=0.528 Sum_probs=208.3
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-------PESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-------~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
+|.+...||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 367788999999999999999889999999998754332 1233568899999999999999999999876 4
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
+..++||||+.+..+..+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..+..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 68899999998866655555455789999999999999999999999999999999999999999999999999987642
Q ss_pred CCC-----CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 290 SQK-----QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 290 ~~~-----~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
... .......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+.++....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---------
Confidence 211 11123457889999999876 458899999999999999999999998766554444332200
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.......++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 229 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 -------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.75 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=204.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHH-HHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII-LRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~i-L~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.+.||+|+||.||++.+..+|+.||||.+......... ..+..|+.+ ++.++||||+++++++.. .+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 4799999999999999999999999999999998765433333 345556665 667799999999999876 467999
Q ss_pred EEeccccchhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 215 VFEYMEHDLAGLAA---TPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~---~~~~~l~e~~i~~i~~qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
||||+++++..++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999987655432 2345799999999999999999999997 9999999999999999999999999999765322
Q ss_pred CCCCcccccccccCcCCccccCC---CCCCCcceeecchhHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhHhhhc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGS---TDYGASVDLWSSGCILAELFAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~---~~ys~~sDIWSlG~iL~ELltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
...+...++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+... ..+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------- 226 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP------- 226 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-------
Confidence 112335678899999988642 34788999999999999999999998642 333333333220 000
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.. ....++..+.+||.+||..+|.+|||+.+++.||||...
T Consensus 227 ----------~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 227 ----------QL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ----------CC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00 012367889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=338.62 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=205.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++...||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEE
Confidence 479999999999999999999999999999999875432 234457899999999999999999999876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||++++.+..+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKR 163 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-ccc
Confidence 9999986665444444578999999999999999999999999999999999999999999999999998664221 122
Q ss_pred ccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 296 TSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....+++.|+|||.+.+ ...++.++|||||||++|+|++|.+||......+....+....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------ 225 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN------------------ 225 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC------------------
Confidence 34567899999998753 3447889999999999999999999986544332222111100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpw 421 (690)
+.+.. + .....++..+.+||.+||..||++|||++++|+|+|
T Consensus 226 ~~~~~-----~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 226 FQPPK-----L-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCC-----C-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000 0 011246789999999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.58 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=213.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++++.||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 45799999999999999999999889999999998743 34455678899999999999999999999876 478999
Q ss_pred EEeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||++++.+..+. .....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQ 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc-cc
Confidence 99999986655443 43457999999999999999999999999999999999999999999999999998765322 22
Q ss_pred CcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 294 PLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
......+|+.|+|||++.. ...++.++|||||||++|+|++|++||.+.+....+.++... .++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------- 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP---------- 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC----------
Confidence 2234568899999999752 244788999999999999999999999887665555444321 000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
. ......++..+.+||..||..||.+|||+.++|+|+||...
T Consensus 227 ~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 T--------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred C--------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0 00113467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=373.79 Aligned_cols=284 Identities=24% Similarity=0.337 Sum_probs=208.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCC-CeEEEEEEe--------------e-cCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLEN-NKLVALKKV--------------R-FTNMDPESVRFMAREIIILRRLDHPNIM 198 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~t-g~~VAIK~i--------------~-~~~~~~~~~~~~~rEi~iL~~L~HpnIv 198 (690)
.++|++++.||+|+||.||+|..... +..+++|.+ . ...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999876432 222222211 0 0111223445678999999999999999
Q ss_pred eeeeeEeeccCCeEEEEEeccccchhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 199 KLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 199 ~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~----~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
++++++.. .+..|+|++++.++++..+.... .......++.++.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999987 46789999999988877654321 2244677889999999999999999999999999999999999
Q ss_pred ceEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCC-C--CChHHHHHHH
Q 005582 275 ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP-G--RTEVEQLHKI 351 (690)
Q Consensus 275 ~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~-g--~~~~e~l~kI 351 (690)
.+||+|||++..+...........+||+.|+|||++.+ ..|+.++|||||||+||||++|..++. + .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998775433333345689999999999977 468999999999999999999985433 2 3455677777
Q ss_pred HHHhCCCChhH-------hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 352 FKLCGSPSEEY-------WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 352 ~~~~g~p~~~~-------w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+..++.+..++ |...... ........+...+. ...++.++.+||.+||.+||.+|||+.|+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~--~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSA--EIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhh--hcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 77666544332 1110000 00000011111111 1246788999999999999999999999999999976
Q ss_pred C
Q 005582 425 K 425 (690)
Q Consensus 425 ~ 425 (690)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 4
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.71 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=206.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 47999999999999999999999999999999987543 2334457889999999999999999998876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||++++.+..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence 999998655554444557999999999999999999999999999999999999999999999999998765422 2223
Q ss_pred ccccccccCcCCcccc--CCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 296 TSRVVTLWYRPPELLL--GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~--g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....+++.|+|||++. ....++.++|+|||||++|+|++|.+||........+..+......+ ..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--~~----------- 230 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP--PK----------- 230 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC--Cc-----------
Confidence 4457899999999874 22458899999999999999999999987655433332221100000 00
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpw 421 (690)
+ .....++..+.+||.+||..||++|||+.++|+|||
T Consensus 231 ----------~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 ----------L-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----------c-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 001235778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=341.54 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=210.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++++.||+|+||.||++.+..++..||+|.+... ........+.+|+.+|++++||||+++++.+.. .+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 4789999999999999999999989999999998753 234455678899999999999999999998876 4789999
Q ss_pred EeccccchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 216 FEYMEHDLAGLAATP---GVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~---~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|||+.++.+..+... ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999998666554433 2368999999999999999999997 59999999999999999999999999999765322
Q ss_pred CCCcccccccccCcCCccccCCC-----CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGST-----DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~-----~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
.....++++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 223346788999999985432 368899999999999999999999976554443333322111110
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++.++.+||.+||..+|.+|||+.+++.||||...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 01123478899999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=332.15 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=212.9
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++++.||.|+||.||++.+..++..||+|.+............+..|+.+++.++||||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58899999999999999999999999999999987666666667788999999999999999999988765567789999
Q ss_pred eccccchh-hhhcC---CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 217 EYMEHDLA-GLAAT---PGVKFTEAQIKCYMKQLLHGLEHCH-----SRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~---~~~~l~e~~i~~i~~qIl~gL~yLH-----s~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
||+.++.+ ..+.. ....+++..++.++.||+.||.||| +.+|+|+||+|+|||++.++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99987544 33322 2457999999999999999999999 999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
.... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+... ..
T Consensus 161 ~~~~-~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 227 (265)
T cd08217 161 GHDS-SFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KF--------- 227 (265)
T ss_pred cCCc-ccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--CC---------
Confidence 5332 11334578999999999876 45889999999999999999999999887754444333210 00
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......++..+.+|+.+||..+|.+|||+.++|+|||+
T Consensus 228 -----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 -----------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 01123467899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.13 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=212.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 37899999999999999999999999999999987553 23445567899999999999999999998876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
+||+.++.+....... .+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+.... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999986555444433 78999999999999999999999999999999999999999999999999998765332 223
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+.... ++
T Consensus 156 ~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~---------------- 216 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PP---------------- 216 (274)
T ss_pred ccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CC----------------
Confidence 345678899999998774 48999999999999999999999998766544443332210 00
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
. +. ...++..+.++|.+||..||++|||+.++++||||+..
T Consensus 217 -~------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 -S------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -C------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0 00 01267889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.22 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=210.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.. .+.+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 589999999999999999999988999999999975532 345678899999999999999999998876 5789999
Q ss_pred EeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||++++.+..+... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 999998766554433 3679999999999999999999999999999999999999999999999999997654321 12
Q ss_pred cccccccccCcCCccccCC--CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 295 LTSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~--~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.....++..|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+.......+......+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------------- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------------
Confidence 2345678899999998653 2578899999999999999999999988776555444332100000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpw 421 (690)
.......++..+.+||.+||..||..|||+.++|.|+|
T Consensus 225 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 -----------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00001235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=329.66 Aligned_cols=254 Identities=29% Similarity=0.496 Sum_probs=215.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++++.||.|+||.||.+.+..++..|++|.+............+.+|+.+|++++|+||+++++++.+ .+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999998766566666778899999999999999999999987 47899999
Q ss_pred eccccc-hhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHD-LAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~-Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.++ |...+... ...+++..+..++.|++.+|.|||+.||+|+||+|+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SM 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-cc
Confidence 999875 44444332 4568999999999999999999999999999999999999999999999999998764332 12
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.. +.+.
T Consensus 158 ~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------------- 219 (256)
T cd08221 158 AETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT--------------- 219 (256)
T ss_pred ccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC---------------
Confidence 3455789999999998764 578999999999999999999999998877776666643 1110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....++..+.++|.+||..||.+|||+.++|+|+|+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0013467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=330.51 Aligned_cols=281 Identities=32% Similarity=0.560 Sum_probs=229.2
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l 212 (690)
..++|++++++|.|.|+.||.|.+..+.+.++||+++. -..+.+.+||+||..|. ||||++|+++..++.+...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 45799999999999999999999999999999999873 34556899999999996 9999999999999888888
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-CceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~~~~~~~ 291 (690)
.|||||+++.-...+.. .|+...++.|+.+|+.||.|||++||+|||+||.|++||.. -.++|+|+|||.++.+.
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 99999999744333322 58889999999999999999999999999999999999964 58999999999988643
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChh-HhhhcC--
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEE-YWKRSK-- 367 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~-~pF~g~~~~e~l~kI~~~~g~p~~~-~w~~~~-- 367 (690)
....-.+.+.+|--||++..-..|+.+.|+|||||+|+.|+..+ |.|.|.+..+|+.+|.+.+|+..-. +..+..
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 33455678999999999998888999999999999999999876 6678999999999999999974332 222222
Q ss_pred CCcccc----cCCCCccchhhhhhcC-CCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 368 LPHATI----FKPQQPYKRCVAETFK-DIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 368 l~~~~~----~~~~~p~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+++... .....+..+.+...-. -.+++++|||+++|..|-..|+||.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 221111 1112222222222222 34689999999999999999999999999999964
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.02 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=208.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM---DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
.+|++.+.||+|+||.||.+.+..++..||||.+..... .......+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 379999999999999999999999999999999864332 23445678899999999999999999998876545678
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+||||+.++.+.........+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999998765554444445689999999999999999999999999999999999999999999999999976532111
Q ss_pred --CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 293 --QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 --~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||........+.++. ..+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC----------
Confidence 12234567889999999876 458999999999999999999999998765544433322 11100
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
......++..+.++|.+|| .+|.+|||++++++|||+.
T Consensus 228 --------------~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 0012346778999999999 4999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.33 Aligned_cols=262 Identities=28% Similarity=0.356 Sum_probs=212.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++++.||+|+||.||++.+..+++.||||.+...... ......+.+|+.+++.++||||+++++.+.. .+.+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 4799999999999999999999999999999998755332 2344567899999999999999999998876 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ- 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~- 293 (690)
||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||+++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999998666555544557999999999999999999999999999999999999999999999999998642111000
Q ss_pred -------------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 294 -------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 294 -------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Confidence 1112356788999999876 4689999999999999999999999998776665555443110000
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC---HHHHhcCcCCCCCC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT---ASSALQNEFFTTKP 426 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hpwf~~~p 426 (690)
.....++..+.+||.+||..||++||| +.++|+||||...+
T Consensus 237 -------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 237 -------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred -------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 001246888999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.27 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=210.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.+.. ....|+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEe
Confidence 5899999999999999999999999999999998754432 34567899999999999999999998876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~ 173 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-ccc
Confidence 999988655554433 358999999999999999999999999999999999999999999999999987654222 122
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+... +.+.
T Consensus 174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------------- 235 (296)
T cd06654 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE---------------- 235 (296)
T ss_pred CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC----------------
Confidence 34578899999999876 45789999999999999999999999877654443332210 1000
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
......++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 236 ---------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ---------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 0012346788999999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=333.10 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=209.6
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc--
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV-- 208 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~-- 208 (690)
+...++|++.+.||.|+||.||+|.+..+++.|++|++.... .....+.+|+.+++.+ .|+||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 345679999999999999999999998899999999987543 2345688999999999 7999999999987643
Q ss_pred --CCeEEEEEeccccchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccc
Q 005582 209 --SGSLYLVFEYMEHDLAGLAAT----PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG 282 (690)
Q Consensus 209 --~~~l~LV~Ey~~g~Ll~~~~~----~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFG 282 (690)
...+|+||||++++.+..+.. ....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 356899999999854433322 23579999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 005582 283 LANFFKCSQKQPLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358 (690)
Q Consensus 283 lA~~~~~~~~~~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p 358 (690)
++....... .......+++.|+|||++.. ...++.++|||||||+||+|++|.+||........+.++.... +
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~ 235 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--P 235 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--C
Confidence 997654222 22334568899999998753 2347889999999999999999999998765555544443210 0
Q ss_pred ChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 359 SEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 359 ~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
. . + .....++..+.+||.+||..||.+|||+.++++|||+
T Consensus 236 -~----------------~------~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 -P----------------T------L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -C----------------C------C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0 0 0012367789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.49 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=208.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD----PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
+|.+...||.|+||.||+|.+ .++..||||.+...... ......+.+|+.+|+.++|+||+++++++.+ .+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 477889999999999999986 57889999998754322 2334568899999999999999999999877 4789
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC-
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ- 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~- 291 (690)
|+||||+.++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999886666555544578999999999999999999999999999999999999999999999999987653211
Q ss_pred ----CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 292 ----KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 292 ----~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM--------- 227 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC---------
Confidence 112234567899999999876 468899999999999999999999998766554443332211100
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......++..+.+||.+||..+|.+|||+.++|.||||
T Consensus 228 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 -----------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01123478889999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=330.45 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=211.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||+|+||.||++.+..+|+.||||.+............+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 5899999999999999999999999999999998655455556678999999999999999999999876 47899999
Q ss_pred eccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.++ +...+.. ....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..+.... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 999874 4444433 23358899999999999999999999999999999999999999999999999997654321 11
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+...++... ..+
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------------- 219 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP--------------- 219 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCC---------------
Confidence 223457888999999876 45889999999999999999999999877766666555431 110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....++..+.+||.+||..+|.+||++.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.73 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=211.1
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
+.||+|+|+.|-.|....+|..||||++.+.. .....++.+|++++.++ .|+||+.|+++|.+ +..+|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEeccc
Confidence 47999999999999999999999999998663 34556789999999999 69999999999988 578999999999
Q ss_pred cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC---ceEeeccccccccccC------C
Q 005582 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCS------Q 291 (690)
Q Consensus 221 g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g---~vKL~DFGlA~~~~~~------~ 291 (690)
|+.+-..+.....|++.++..++++|+.||.|||.+||.||||||+|||..... -+|||||.|..-+... .
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 876555555556899999999999999999999999999999999999997654 5899999988644321 1
Q ss_pred CCCcccccccccCcCCcccc----CCCCCCCcceeecchhHHHHHHhCCCCCCCCCh---------------HHHHHHHH
Q 005582 292 KQPLTSRVVTLWYRPPELLL----GSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---------------VEQLHKIF 352 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~----g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~---------------~e~l~kI~ 352 (690)
...+.+.+|+..|||||+.. ....|+..+|+||||||||-||+|.+||.|.-. ...++.|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22356778899999999863 356799999999999999999999999987532 22333333
Q ss_pred HHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 353 ~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
+.-...++ +.|..++.++.+||..||..||..|.+|.++|+|||++..
T Consensus 320 EGkYeFPd-------------------------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 320 EGKYEFPD-------------------------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred ccCCcCCh-------------------------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 32222333 3456799999999999999999999999999999999863
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.66 Aligned_cols=256 Identities=27% Similarity=0.484 Sum_probs=213.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|++...||.|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 479999999999999999999999999999999875432 234567899999999999999999999876 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++.+..+.... .+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-SKR 172 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc-ccC
Confidence 9999987766555433 68999999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....+..+... +.+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------------
Confidence 34567899999999876 45889999999999999999999999988776655544321 1100
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
......+++.+.+||.+||..||.+|||+.+++.||||..
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 235 ---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 0012347788999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=328.09 Aligned_cols=259 Identities=32% Similarity=0.530 Sum_probs=211.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|.+.+.||+|+||.||++.+..++..||+|.+............+.+|+.+++.++|+||+++++++.. .+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5889999999999999999998899999999998765555577889999999999999999999998765 57899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC--
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP-- 294 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~-- 294 (690)
||+.++.+..+......+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999987666665555568999999999999999999999999999999999999999999999999998765332221
Q ss_pred -cccccccccCcCCccccCCC--CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 295 -LTSRVVTLWYRPPELLLGST--DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 295 -~~~~~gT~~Y~APEvl~g~~--~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|..||.+............. +..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------------ 225 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP------------ 225 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC------------
Confidence 11346788999999987632 3789999999999999999999999765432222211111 1100
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.. .....++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 226 -----~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----PI-------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----CC-------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0122457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=361.66 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=230.3
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
+.....|.++.+||+|.|+.|.+|++..++..||||.+.+...+....+.+.+|+.+|+.|+|||||+|+.+... ...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~ 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EAT 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cce
Confidence 345668999999999999999999999999999999999998888877789999999999999999999999887 478
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+||||+.++.+..++...+.+.+..++.++.|++.+++|||+++|||||||++||||+.+.++||+|||++..+. .
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--c
Confidence 99999999988777777767788889999999999999999999999999999999999999999999999999986 3
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
...+.+.||++.|.|||++.|..+.++.+|+||+|++||.|+.|..||.|.+-.+.-.+.+.
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------------------ 269 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------------------ 269 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------------------
Confidence 45678899999999999999988889999999999999999999999999775544333221
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.+... .--++.+..+||+++|.++|.+|++++++..|.|....
T Consensus 270 --gk~rI---------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 270 --GKYRI---------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred --eeecc---------cceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 01111 12367889999999999999999999999999999764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.32 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=210.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|.+++.||+|+||.||++.+..++..||||.+..... .....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEe
Confidence 589999999999999999999999999999999975433 233557899999999999999999999876 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||++++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~ 172 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 172 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cCc
Confidence 999998766555443 358999999999999999999999999999999999999999999999999997654322 222
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------------- 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------------- 234 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC----------------
Confidence 34567899999999876 5688999999999999999999999987654433222211 11110
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 ---------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred ---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 00123467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.14 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=205.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeec----cCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSR----VSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~----~~~ 210 (690)
+.|++...||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +||||+++++++... ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 57999999999999999999999999999999986432 3345578899999998 799999999988542 245
Q ss_pred eEEEEEeccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 211 SLYLVFEYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
.+|+||||+.++.+ .++.. ....+++..++.++.||+.||.|||+.||+|+||+|+||||+.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 78999999987544 43332 23458899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
... .......+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.... +
T Consensus 173 ~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~------ 243 (282)
T cd06636 173 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--P------ 243 (282)
T ss_pred ccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--C------
Confidence 221 22334568899999998853 2457889999999999999999999997665444333321100 0
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000123478899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=334.34 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=207.9
Q ss_pred CcCCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeec-
Q 005582 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSR- 207 (690)
Q Consensus 130 ~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~- 207 (690)
+.+...++|+++..||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 35566789999999999999999999999999999999886432 2224577899999999 799999999987532
Q ss_pred --cCCeEEEEEeccccchhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecc
Q 005582 208 --VSGSLYLVFEYMEHDLAGLA----ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 208 --~~~~l~LV~Ey~~g~Ll~~~----~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DF 281 (690)
.++.+|+||||++++.+..+ ......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 24678999999987655432 223456899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 005582 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357 (690)
Q Consensus 282 GlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~ 357 (690)
|++..+... ........+++.|+|||++.+ ...++.++|||||||++|+|++|+.||........+.++... .
T Consensus 169 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~ 245 (286)
T cd06638 169 GVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--P 245 (286)
T ss_pred CceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--C
Confidence 999766432 122234568999999998753 234788999999999999999999999876554433322110 0
Q ss_pred CChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 358 p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
+. .. .....++..+.+||.+||..||++|||+.++|+|+||
T Consensus 246 ~~------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PP------------TL------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CC------------cc------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 00 0012346789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=333.03 Aligned_cols=260 Identities=31% Similarity=0.517 Sum_probs=208.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD----PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
+|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+|+.++|+||+++++++.. .+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 478889999999999999999999999999998754321 2245678899999999999999999999876 4789
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-ceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-~vKL~DFGlA~~~~~~~ 291 (690)
++||||+.++.+..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++ .++|+|||++..+....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999876655554455789999999999999999999999999999999999998776 69999999997664321
Q ss_pred C---CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 K---QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~---~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
. .......+|..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+....-..
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---------- 227 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC----------
Confidence 1 11123467889999999876 468999999999999999999999997554333333222210000
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
........+++.+.++|..||..||.+|||+.++|+||||+
T Consensus 228 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 --------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00011234678999999999999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=326.84 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=210.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||+|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+++++.+.. .+.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999999999999998766555666788999999999999999999998875 57899999
Q ss_pred eccccchhh-hhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-CceEeeccccccccccCCCC
Q 005582 217 EYMEHDLAG-LAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 217 Ey~~g~Ll~-~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~~~~~~~~~ 293 (690)
||+.++.+. .+... ...+++..+..++.||+.+|.|||++||+|+||+|+|||++.+ +.++|+|||++...... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--S 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--c
Confidence 999875444 43332 3458999999999999999999999999999999999999855 46899999999876432 2
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------
Confidence 2234567889999999876 45889999999999999999999999887766655554321100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....++..+.+||..||..||.+|||+.++|+||||
T Consensus 220 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=327.93 Aligned_cols=255 Identities=30% Similarity=0.503 Sum_probs=209.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM---DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
+|+..+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+.+|+.++|+||+++++++.. ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 47788999999999999999988999999999875432 23455678899999999999999999998876 47899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+++..+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999986655555445568999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......+++.|+|||.+.....++.++|+|||||++|+|++|.+||......+...++......
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 220 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------------- 220 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC----------------
Confidence 2345668899999999866434889999999999999999999999776644444333210000
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......++..+.+||.+||..+|.+|||+.++|.||||
T Consensus 221 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 -----------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=332.79 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=207.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC--------HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD--------PESVRFMAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~--------~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
+|.+.+.||.|+||.||+|.+..+|+.||||.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 578899999999999999999889999999988643211 1123567889999999999999999998876
Q ss_pred CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
.+.+++||||+.++.+.........+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 47899999999886665554444579999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCC-CcccccccccCcCCccccCCC-CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 289 CSQKQ-PLTSRVVTLWYRPPELLLGST-DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 289 ~~~~~-~~~~~~gT~~Y~APEvl~g~~-~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
..... ......++..|+|||++.+.. .++.++|+|||||++|+|++|..||......+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 22111 123345788999999986543 47899999999999999999999997655444333322110000
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
. ........++..+.+||..||..||.+|||+.++|+||||
T Consensus 232 ------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 ------------P---IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------------c---CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 0011234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.62 Aligned_cols=260 Identities=29% Similarity=0.455 Sum_probs=207.8
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc---C
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV---S 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~---~ 209 (690)
..++|.+...||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++.... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4678999999999999999999999999999999986432 2234567899999999 8999999999987532 2
Q ss_pred CeEEEEEeccccchhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAA----TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~----~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
+.+|+||||+.++.+..+. .....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999875554332 234578999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCcccccccccCcCCccccCCC----CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 005582 286 FFKCSQKQPLTSRVVTLWYRPPELLLGST----DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361 (690)
Q Consensus 286 ~~~~~~~~~~~~~~gT~~Y~APEvl~g~~----~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~ 361 (690)
.+..... ......++..|+|||++.... .++.++|||||||++|+|++|++||...+....+..+... .+
T Consensus 177 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~--- 250 (291)
T cd06639 177 QLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PP--- 250 (291)
T ss_pred hcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CC---
Confidence 6543221 122346788999999875422 3688999999999999999999999877665555443221 00
Q ss_pred HhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 362 ~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
+. . .....++..+.+||.+||..||++|||+.++|+||||+
T Consensus 251 -------~~--~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 -------PT--L------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------CC--C------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 0 00123566899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=338.41 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=213.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
..|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 469999999999999999999988999999999875433 34455678899999999999999999999887 467899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 999999988877765555799999999999999999999999999999999999999999999999999976532
Q ss_pred cccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 295 LTSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+... ..+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~-------------- 232 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------------- 232 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCC--------------
Confidence 223567889999998852 345889999999999999999999999887765554443210 000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
. . ....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 233 ----~--~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 233 ----T--L------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----C--C------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0 0 011256789999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=336.85 Aligned_cols=244 Identities=22% Similarity=0.209 Sum_probs=202.2
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeEee--ccCCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRRLDHPNIMKLEGLITS--RVSGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~--~~~~~l~LV~Ey 218 (690)
..||+|+++.||+|.+ +|+.||||+++...... ...+.+.+|+.+|++++||||+++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 78999999997654332 335678899999999999999999999876 334578999999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCCCccc
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
+.++.+..+......+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..+... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 9987666665555679999999999999999999998 49999999999999999999999999999765321 234
Q ss_pred ccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 298 RVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
.++|+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+..+.+..+......++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 5678999999998652 4689999999999999999999999998877766666543211110
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+..+.+||.+||+.||.+|||+.++|+
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01246788999999999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=348.33 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=211.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
-|.++.+||+|+||.||+|.++.+|..||||++... ...+.+..||.|+++++.|+||++||.|.. ...+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeeh
Confidence 488999999999999999999999999999998753 456778999999999999999999997654 36799999
Q ss_pred eccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.+.. +.+..++.+|++.++..+++..+.||+|||...-||||||..||||+.+|+.||+|||.|-.+... ...-
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhh
Confidence 99996544 455566778999999999999999999999999999999999999999999999999999765422 2223
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
...+|||+|||||++.. ..|+.++||||||++..||..|+|||..-... ..||-.-..|+..
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPT-------------- 248 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPT-------------- 248 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCC--------------
Confidence 45789999999999975 56999999999999999999999999753322 2232211112111
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
|++ ....+.++.|||+.||.+.|++|-||.++++|||++..+
T Consensus 249 ----F~K-----PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 249 ----FKK-----PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ----CCC-----hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 110 123567899999999999999999999999999998754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=355.25 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=217.3
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
+.||+|-||+||-|++.++|+.||||++.+..........+++|+.||+.++||.||.|.-.|+. .+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcc
Confidence 68999999999999999999999999998776665566779999999999999999999888877 4789999999999
Q ss_pred chhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC---ceEeeccccccccccCCCCCccc
Q 005582 222 DLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 222 ~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g---~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
+.+..++. ..+.|++...++++.||+.||.|||..+|+|+||||+||||.... .+||||||+|+++.. ...-.+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFRrs 725 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFRRS 725 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhhhh
Confidence 99988765 356899999999999999999999999999999999999997643 899999999999863 444567
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~ 377 (690)
.+|||.|+|||+|.. ..|+...|+||+|||+|--|+|..||..+. +.-.+|.....-++...
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~P--------------- 787 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNP--------------- 787 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCc---------------
Confidence 899999999999976 579999999999999999999998887543 33334433222222222
Q ss_pred CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 378 QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 378 ~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
|..++..++|||..+|+..-.+|.|.++.|.|||++.+
T Consensus 788 ----------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 788 ----------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ----------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 45689999999999999999999999999999999875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.77 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=209.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 489999999999999999999989999999999754432 3456778999999999999999999998865 5789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++.+.........+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999987665555444689999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~--~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+. .+.+...... .
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 34567889999999876 4589999999999999999999999987664 2222221110 0
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH--HHHhcCcCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA--SSALQNEFF 422 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa--~e~L~hpwf 422 (690)
.......++..+.++|.+||..||.+||++ .++++||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001123467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=340.55 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=211.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|.....||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++||||+++++.+.. .+..|+||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEE
Confidence 4566778999999999999998899999999986432 3345568899999999999999999998876 57899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+... .....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRK 176 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-cccCc
Confidence 99998766655443 36899999999999999999999999999999999999999999999999999765322 22233
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...+++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+.......
T Consensus 177 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 237 (292)
T cd06658 177 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------ 237 (292)
T ss_pred eeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------------
Confidence 4578899999999866 468999999999999999999999998877665544432211000
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
+ .....++..+.+||..||..||.+|||+.++|+||||...+.|
T Consensus 238 -------~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 238 -------V-KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred -------c-ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0 0012367789999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=328.48 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=207.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||.|+||.||+|.+..++..|++|.+.... ....+.+|+.+++.++||||+++++++.. ...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEE
Confidence 58999999999999999999998889999999986432 25678999999999999999999999887 4789999
Q ss_pred Eeccccchhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
+||+.+..+..+ ......+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999998655443 33455789999999999999999999999999999999999999999999999999987643321 2
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.. ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--------------- 216 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPP--------------- 216 (256)
T ss_pred cccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCC---------------
Confidence 233457889999999876 4689999999999999999999999987655433322211 000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
. .......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 217 ---~-----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 217 ---P-----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ---C-----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 000123467889999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=331.75 Aligned_cols=251 Identities=18% Similarity=0.245 Sum_probs=202.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+|..++||||+++++++.. .+.+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 47999999999999999999864 456799999987543 23445568899999999999999999999876 4789
Q ss_pred EEEEeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
||||||++++.+..+. .....+++..++.++.||+.||.|||+.||+||||||+||||+.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999987665443 334578999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------------
Confidence 111112234678999999876 568999999999999999775 99999988877666655321100
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+..||..+|.+|||+.++++
T Consensus 228 ---------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ---------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=351.49 Aligned_cols=280 Identities=31% Similarity=0.506 Sum_probs=227.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeEeeccC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD------HPNIMKLEGLITSRVS 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~------HpnIv~l~~~~~~~~~ 209 (690)
.+|.+....|+|-|++|..|.+..-|..||||+|+... ...+.=++|++||++|+ .-|+++|+..|.. .
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--k 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--K 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--c
Confidence 47999999999999999999999999999999998543 23344578999999994 4688999888876 4
Q ss_pred CeEEEEEeccccchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-CceEeeccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANF 286 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~~ 286 (690)
+++|||||.+.-+|...+.+- +..|....++.|+.||+.||.+|-..||+|.||||+||||++. ..+||||||.|..
T Consensus 507 nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 899999999998888776653 3458888999999999999999999999999999999999975 5899999999977
Q ss_pred cccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 287 FKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 287 ~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
.. ....+.+.++.+|+|||+++| ..|+...|+||+||+||||.||+-+|+|.+...+|.-.+.+-|..+.....+.
T Consensus 587 ~~---eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 587 AS---ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cc---cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 64 345677888999999999999 56999999999999999999999999999999999999999999887665432
Q ss_pred CCC-----ccccc-----------------CCCCccchhhhhh-----c----CCCchhHHHHHHHhccCCCCCCCCHHH
Q 005582 367 KLP-----HATIF-----------------KPQQPYKRCVAET-----F----KDIPSSALSLLDILLSTEPEVRGTASS 415 (690)
Q Consensus 367 ~l~-----~~~~~-----------------~~~~p~~~~~~e~-----~----~~~~~~~~dLI~~mL~~DP~kRpTa~e 415 (690)
.+. ....| ....|.+....+. + ..+-..+.+||++||.+||++|.|+.+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 221 10000 1112211111111 1 112246899999999999999999999
Q ss_pred HhcCcCCCC
Q 005582 416 ALQNEFFTT 424 (690)
Q Consensus 416 ~L~hpwf~~ 424 (690)
+|.||||+.
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999975
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.81 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=206.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|+....||+|+||.||++.+..+++.||||.+...... .....+.+|+.++.++. ||||+++++++.. .+..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4677889999999999999999999999999998754433 44556889999999996 9999999998876 467899
Q ss_pred EEeccccchhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCcceeeccCCceEeecccccccccc
Q 005582 215 VFEYMEHDLAGLA----ATPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 215 V~Ey~~g~Ll~~~----~~~~~~l~e~~i~~i~~qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
+|||+..++..+. ......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999987554332 12335799999999999999999999985 999999999999999999999999999976542
Q ss_pred CCCCCcccccccccCcCCccccCC--CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~--~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
. .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+........
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 230 (288)
T cd06616 161 S--IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI------ 230 (288)
T ss_pred C--CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc------
Confidence 2 122334678899999998765 3689999999999999999999999976542 222222211110000
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
........++..+.+||.+||..||.+|||+.+++.||||..
T Consensus 231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 231 ---------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ---------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000111347889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.36 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=211.3
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|+.++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.+++.++||||+++++++.+ .+..|+||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEE
Confidence 58889999999999999999988999999999875432 3445678899999999999999999999877 57899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||++++.+..+... .++++.++..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+.... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence 99998665554443 368999999999999999999999999999999999999999999999999997664322 2233
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.. +.+
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~------------------ 218 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP------------------ 218 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC------------------
Confidence 4567889999999876 4589999999999999999999999987665444332211 000
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
......++..+.+||.+||..+|.+|||+.++|+|+||...+
T Consensus 219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 219 --------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred --------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 011234678899999999999999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.13 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=207.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 368889999999999999999999999999999876543 3455678899999999999999999999877 4789999
Q ss_pred Eeccccchhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||+.+..+. .+......+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999965444 443333679999999999999999999999 9999999999999999999999999999876542211
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT-----EVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~-----~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.. .+.
T Consensus 157 --~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~--------- 221 (265)
T cd06605 157 --KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP--------- 221 (265)
T ss_pred --hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC---------
Confidence 12667889999999876 468999999999999999999999987542 2222222211 000
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
+. +. ...++..+.+||..||..||.+|||+.+++.||||+.+
T Consensus 222 -------~~------~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -------PR------LP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -------CC------CC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 00 01167889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.00 Aligned_cols=249 Identities=30% Similarity=0.411 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+|+||||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 6899999999999998999999999975543 23445678999999999999999999998876 47799999999876
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccc
Q 005582 223 LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302 (690)
Q Consensus 223 Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~ 302 (690)
.+.........+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 665554444568999999999999999999999999999999999999999999999999998764322 223456789
Q ss_pred cCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT--EVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 303 ~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~--~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
.|++||++.+ ..++.++|+|||||++|+|++|..||.... ..+.+.++......+
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 9999999865 458999999999999999999999998766 444444443200000
Q ss_pred chhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCC
Q 005582 381 KRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTT 424 (690)
Q Consensus 381 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~ 424 (690)
......+..+.+||.+||..||.+||| +.|+++||||..
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 001234788999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.59 Aligned_cols=258 Identities=20% Similarity=0.261 Sum_probs=197.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC----------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE----------------NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~ 199 (690)
++|++.++||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 579999999999999999997532 34579999987542 3445567889999999999999999
Q ss_pred eeeeEeeccCCeEEEEEeccccchhhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 005582 200 LEGLITSRVSGSLYLVFEYMEHDLAGLAATP-------------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILH 260 (690)
Q Consensus 200 l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~-------------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvH 260 (690)
+++++.. .+..||||||+.++.+..++.. ...+++..+..++.||+.||.|||+.||+|
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999877 4678999999987544332211 124678889999999999999999999999
Q ss_pred ccCCCcceeeccCCceEeeccccccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh--CCC
Q 005582 261 RDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA--GKP 337 (690)
Q Consensus 261 rDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt--G~~ 337 (690)
|||||+||||+.++.+||+|||++..+....... .....++..|+|||++.+ ..++.++|||||||++|||++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999997654322211 122345778999999876 458999999999999999987 557
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHh
Q 005582 338 IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417 (690)
Q Consensus 338 pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 417 (690)
||.+.+..+.+..+....-..... . .....+.++..+.+||..||..||.+|||+.++.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQ-----------V----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhcccc-----------c----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 787766655555443311100000 0 0011234678999999999999999999999995
Q ss_pred c
Q 005582 418 Q 418 (690)
Q Consensus 418 ~ 418 (690)
+
T Consensus 300 ~ 300 (304)
T cd05096 300 A 300 (304)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.84 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=213.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
-|...++||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 37778899999999999999999999999999875433 33445668899999999999999999999887 4778999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++++..+......+++..+..++.||+.+|.|||++||+|+||+|+|||++.++.+||+|||++.... ..
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PA 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CC
Confidence 9999998888776666679999999999999999999999999999999999999999999999999986432 22
Q ss_pred ccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 296 TSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+... ..+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------- 239 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT-------------- 239 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCC--------------
Confidence 34567889999999842 245888999999999999999999999887766666555321 0000
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.....++..+.+||.+||..+|.+|||+.++|.||||...
T Consensus 240 ------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 240 ------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0113456789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.24 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=208.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|.+.+.||.|+||.||++.+..+|..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4889999999999999999999999999999997654443445567899999999999999999998876 47899999
Q ss_pred eccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-ceEeeccccccccccCCCC
Q 005582 217 EYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-~vKL~DFGlA~~~~~~~~~ 293 (690)
||+.+..+ ..+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||++...... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-ME 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC-cc
Confidence 99987544 43332 233589999999999999999999999999999999999999886 5699999999776432 22
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 2233467889999998866 458899999999999999999999998776655544433210
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
+....+.++..+.++|.+||..+|++|||+.++|.||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 001123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.97 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=211.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
-|+....||+|+||.||+|.+..+++.||||.+..... .....+.+|+.++..++||||+++++++.. .+..|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEE
Confidence 35556689999999999999988999999999865432 234557899999999999999999998876 57899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99998766555443 368999999999999999999999999999999999999999999999999997654221 2233
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
..++++.|+|||++.+ ..++.++|||||||++|||++|++||...+..+.+..+.. .+. ..
T Consensus 176 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~~-------------- 236 (297)
T cd06659 176 SLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-PK-------------- 236 (297)
T ss_pred ceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-CC--------------
Confidence 4678999999999876 4589999999999999999999999987776665544321 000 00
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~~ 428 (690)
......++..+.+||..||..+|.+|||+.++++||||....+|
T Consensus 237 --------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 237 --------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred --------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 01123467889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.61 Aligned_cols=257 Identities=26% Similarity=0.481 Sum_probs=209.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEeeccCCeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD---HPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~l~ 213 (690)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. ||||+++++++.. ....|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 5888999999999999999999999999999987543 2344556789999999996 9999999998876 57899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+||||+.++.+..+.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 999999886555544443 78999999999999999999999999999999999999999999999999998765433 2
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+... .+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~--------------- 219 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP--------------- 219 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CC---------------
Confidence 2344578899999999876566899999999999999999999999876543332211100 00
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
+. + ....++.++.+||..||..||.+|||+.+++.|+||+..
T Consensus 220 --~~------~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 220 --PR------L--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred --CC------C--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 00 0 011267889999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.67 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=196.6
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHH---hCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILR---RLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~---~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
.||+|+||.||++.+..+++.||+|.+....... .......+|..+++ ..+||||+.+++++.. .+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999999999999999987543321 11223344544443 4479999999998876 4689999999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccc
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 298 (690)
+.++.+.........+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+... .....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCc
Confidence 998766655555557999999999999999999999999999999999999999999999999999755322 22345
Q ss_pred cccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE--QLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 299 ~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e--~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
.+|+.|+|||++.+...++.++|||||||++|+|++|..||.+..... .+..+.. ..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~------------------ 214 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TV------------------ 214 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cC------------------
Confidence 689999999998654568999999999999999999999997643221 1111110 00
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
-......++..+.+||.+||..||.+|+ |+.++++||||...
T Consensus 215 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 215 -------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred -------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 0011245788999999999999999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=328.52 Aligned_cols=262 Identities=27% Similarity=0.374 Sum_probs=206.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|+..+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+++|+.++||||++++++|.....+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999999999999999875432 3445668899999999999999999999876556689999
Q ss_pred Eeccccchhhh----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 216 FEYMEHDLAGL----AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 216 ~Ey~~g~Ll~~----~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|||++++.+.. .......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99998754432 22334568999999999999999999999999999999999999999999999999987653221
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHhhhc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE-----VEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~-----~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+.. .... .
T Consensus 160 ---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-~---- 227 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNP-E---- 227 (287)
T ss_pred ---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCch-h----
Confidence 123456889999999876 5689999999999999999999999986522 222222111 0000 0
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+ .... ..-...++.+.+||.+||..||.+|||+.|+++||||..
T Consensus 228 -~------------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 228 -L------------KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -h------------ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 0 0000 000124678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=324.12 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=209.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN---MDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.++++++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 37999999999999999999999999999999886432 123455678899999999999999999999877555678
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC-
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ- 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~- 291 (690)
++||||+.++.+.........+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999876554444444468999999999999999999999999999999999999999999999999997654211
Q ss_pred -CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 -KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 -~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........++..|+|||++.+ ..++.++|+|||||++|+|++|++||........+.++. ..+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCCC---------
Confidence 112234568899999999876 457899999999999999999999998765554444332 211100
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....++..+.++|..||. +|..|||+.++|.|||.
T Consensus 229 ---------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ---------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1124577899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.86 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=197.8
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH-HHHHHHHHH---HHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMARE---IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~~~~rE---i~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
.||+|+||.||+|.+..+++.||||.+....... ........| +.+++..+||||+.+++++.. .+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999999999999999987654321 111122333 344555689999999998886 4689999999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccc
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 298 (690)
+.++.+.........+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 998766665555567999999999999999999999999999999999999999999999999999765322 12345
Q ss_pred cccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCC
Q 005582 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378 (690)
Q Consensus 299 ~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~ 378 (690)
+++..|+|||++.+...++.++|||||||++|+|++|+.||.+........ +.......
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-------------------- 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-------------------- 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhcc--------------------
Confidence 789999999998765568999999999999999999999998753221111 11100000
Q ss_pred ccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 379 p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
.......++..+.+||.+||..||.+|| |+.++++||||...
T Consensus 215 -----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 215 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred -----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0011234678999999999999999999 99999999999774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.52 Aligned_cols=253 Identities=30% Similarity=0.530 Sum_probs=207.5
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
-+||+|.||+||.|+|..|...+|||-+... +...++-+..||.+-++|.|.|||+++|.+.. ++.+-|+||-++|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPG 656 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCC
Confidence 3799999999999999999999999998533 34566778999999999999999999998765 5788999999998
Q ss_pred chhh-hhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeec-cCCceEeeccccccccccCCCCCccc
Q 005582 222 DLAG-LAATPGVKF--TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 222 ~Ll~-~~~~~~~~l--~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld-~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
+.+. ++...-++| .+..+-+|.+||++||.|||++.|||||||.+|+||+ ..|.+||+|||.++.+..- +....+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 7664 444455567 8889999999999999999999999999999999997 5899999999999887532 223446
Q ss_pred ccccccCcCCcccc-CCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 298 RVVTLWYRPPELLL-GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~-g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
+.||+.|||||++. |...|+.++|||||||++.||.||+|||... |+|..-.++. ..++.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-------------gspqAAMFkV------GmyKv 796 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-------------GSPQAAMFKV------GMYKV 796 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-------------CChhHhhhhh------cceec
Confidence 78999999999994 5567999999999999999999999999743 2222222211 11111
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
-. +....++.+++.||.+|+.+||.+||+|.++|++||++..
T Consensus 797 HP-------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 797 HP-------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CC-------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 11 2234577889999999999999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.48 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=205.6
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.+..++.||+|-||.||+|.+.. ...||+|.++...+.+ ..+.+|++||++|+|+|||+|++++... +.+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEEE
Confidence 46678899999999999999843 3479999998765443 3467999999999999999999999873 5799999
Q ss_pred eccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||..+ |+..+.. .+..+...+...|+.|||+|++||+++++|||||...||||+++..+||+|||||+....+....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 999975 5555554 45679999999999999999999999999999999999999999999999999999655433333
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....-....|.|||.+.. ..++.++|||||||+||||+| |+.|+++.+..+.+..+-+..--
T Consensus 361 ~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl---------------- 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL---------------- 423 (468)
T ss_pred cCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC----------------
Confidence 333333456999999976 459999999999999999999 88999999999998888652211
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
..+..+|+.+-+|+..|+..+|++|||.+.+..
T Consensus 424 ------------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 424 ------------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 123568999999999999999999999986643
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=322.66 Aligned_cols=256 Identities=30% Similarity=0.454 Sum_probs=211.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||.|+||.||+|.+..+++.|+||++...... .....+.+|+.++..++|+||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 3689999999999999999999999999999998765432 445678899999999999999999999876 4789999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||+.++.+..+......+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 9999976555554444679999999999999999999999 9999999999999999999999999999987643222 2
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~---~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.... ..+....+.. ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------------ 220 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------------ 220 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------------
Confidence 224567889999999876 468999999999999999999999998764 2222222221 000
Q ss_pred cccCCCCccchhhhhhcCC-CchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKD-IPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~-~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
...... ++..+.+||..||..+|.+|||+.++|+||||+.
T Consensus 221 -------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 221 -------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 001123 6889999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.24 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=210.3
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|.....||.|++|.||++.+..+++.|+||++.... ......+.+|+.+++.++||||+++++++.. .+..|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 5666789999999999999998899999999986432 2334567899999999999999999998876 57889999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+.++.+...... ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99987666554444 4689999999999999999999999999999999999999999999999999875532211 223
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+... ..+.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~----------------- 234 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK----------------- 234 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------------
Confidence 4568899999999876 45899999999999999999999999887766665554331 0000
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..||.+|||+.++|+|+||...
T Consensus 235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 235 --------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred --------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 00112367889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=318.02 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=212.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.++++++||||+++++++.. .+.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4889999999999999999998899999999998766555666789999999999999999999998876 47899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+++..+..+......+++..++.++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccc
Confidence 9999866655544446799999999999999999999999999999999999999999999999999987654322 123
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+....+.++... .
T Consensus 158 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------------- 215 (254)
T cd06627 158 SVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-D-------------------- 215 (254)
T ss_pred ccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-C--------------------
Confidence 45678899999998764 4889999999999999999999999876654443333210 0
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.......++..+.++|.+||..+|++|||+.++|.||||
T Consensus 216 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 -------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001123567899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.84 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=203.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN-----KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CC
Confidence 47999999999999999999876555 789999987443 34445668899999999999999999998876 46
Q ss_pred eEEEEEeccccchh-hhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 211 SLYLVFEYMEHDLA-GLAATP---------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll-~~~~~~---------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
..|++|||+.++.+ ..+... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 78999999987544 333221 14588899999999999999999999999999999999999999
Q ss_pred ceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005582 275 ILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIF 352 (690)
Q Consensus 275 ~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~ 352 (690)
.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....|.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976533221 12334456888999999876 458999999999999999998 999998877766555543
Q ss_pred HHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 353 ~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.... ......++.++.+|+..||+.||.+|||+.+++++
T Consensus 241 ~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2100 00123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.76 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=200.7
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||+|+||+||+|.+..+|+.||+|.+...... ......+..|+.+|+.++||||+++++++.. .+.+|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 68999999999999999999999998754322 2234456789999999999999999998876 47899999999975
Q ss_pred hhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccc
Q 005582 223 LAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300 (690)
Q Consensus 223 Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~g 300 (690)
.+...+.. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..... ........+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccC
Confidence 55433322 23689999999999999999999999999999999999999999999999999976542 222334567
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....-.
T Consensus 157 ~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------- 212 (277)
T cd05577 157 TPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----------------------- 212 (277)
T ss_pred CCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------------
Confidence 8899999998764 4899999999999999999999999775542222222110000
Q ss_pred chhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 381 KRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 381 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
........+++.+.+||.+||..||.+|| ++.+++.||||...
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 00111245688999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=324.00 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=200.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
+.+.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.. .+.+|+|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEE
Confidence 44555678999999999999998899999999886443 3455678899999999999999999999876 4789999
Q ss_pred Eeccccchhhh-hcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeeccccccccccCC
Q 005582 216 FEYMEHDLAGL-AATPGVKF--TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 216 ~Ey~~g~Ll~~-~~~~~~~l--~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~~~~~~ 291 (690)
|||+.++.+.. +......+ ++..+..++.||+.||.|||+.||+||||||+||||+. ++.++|+|||++..+...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI- 162 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC-
Confidence 99998755544 43333345 88889999999999999999999999999999999986 679999999999765422
Q ss_pred CCCcccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........+++.|+|||++.+. ..++.++|||||||++|+|++|.+||................
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 227 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--------------- 227 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------
Confidence 2223344678999999998553 347899999999999999999999997543221111000000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.........++..+.+|+.+||+.+|.+|||+.+++.||||
T Consensus 228 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 -----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00011123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.54 Aligned_cols=255 Identities=33% Similarity=0.489 Sum_probs=209.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 213 (690)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||+++++++.. .+.+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 479999999999999999999999999999999875432 2344567889999999998 9999999998876 47899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~- 292 (690)
+||||+.++.+.........+++..++.++.||+.||.|||+.|++|+||+|+||+|+.++.++|+|||++..+.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999996644443333444799999999999999999999999999999999999999999999999999976643221
Q ss_pred ------------------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 005582 293 ------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 293 ------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~ 354 (690)
.......++..|+|||++.+ ..++.++|||||||++++|++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 11223456889999998876 45889999999999999999999999987765555444321
Q ss_pred hCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH----HHHhcCcCC
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA----SSALQNEFF 422 (690)
Q Consensus 355 ~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hpwf 422 (690)
.. .....+++.+.+||..||+.||.+|||+ .++|+||||
T Consensus 238 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EY-----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC-----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 00 0113458889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.88 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=209.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEE
Confidence 357999999999999999999999999999999987543 23445678899999999999999999999887 478999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||+.++.+..+......+++..+..++.+|+.+|.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999987776655555579999999999999999999997 699999999999999999999999999986543211
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhhhcCCC
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE----QLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e----~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
....+++..|+|||++.+. .++.++|||||||++|+|++|..||......+ ....++.... ..+..
T Consensus 159 -~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~---- 228 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQE---- 228 (284)
T ss_pred -cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH----HHhhc----
Confidence 2245789999999998764 68999999999999999999999998655421 1111111000 00000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
. .+. + ....++..+.+||.+||..||.+|||+.++++|+||...
T Consensus 229 ~----~~~------~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 229 P----PPR------L--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred c----CCC------C--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 000 0 011267789999999999999999999999999999664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=318.99 Aligned_cols=254 Identities=33% Similarity=0.514 Sum_probs=212.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|.+.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|||++++++.+.. ....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5889999999999999999999899999999998766555666778999999999999999999998876 47899999
Q ss_pred eccccchh-hhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 217 EYMEHDLA-GLAATP---GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~~---~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||++++.+ ..+... ...+++..+..++.+|+.||.|||+.||+|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99997544 433332 3679999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 220 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---------------- 220 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------------
Confidence 12234567889999998876 4589999999999999999999999987765544444322100
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......++..+.++|..||..+|++|||+.++|+||||
T Consensus 221 ------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=320.80 Aligned_cols=250 Identities=27% Similarity=0.481 Sum_probs=206.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||.|+||.||++.+..++..||+|.++... .......+.+|+.+++.++||||+++++.+.. .+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 5889999999999999999999999999999987543 23455678899999999999999999999876 57899999
Q ss_pred eccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||+.++ +...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+... ...
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-ccc
Confidence 999864 5444432 3446899999999999999999999999999999999999999999999999999766432 222
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+....+..+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----------------- 218 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 334568899999999876 45899999999999999999999999887765555544321000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.....++..+.+||.+||..||.+|||+.++|.-
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112367789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=332.64 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=213.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|...+.||+|+||.||++.+..++..||||++..... .......+.+|+.+|+.++||||+++++++.. ....|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEE
Confidence 48899999999999999999999999999999875433 23445678899999999999999999999877 4678999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++++..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..... .
T Consensus 104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~ 178 (317)
T cd06635 104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----A 178 (317)
T ss_pred EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----c
Confidence 99999988777765566799999999999999999999999999999999999999999999999999865432 2
Q ss_pred ccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 296 TSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+......+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------------- 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------
Confidence 34567889999999742 2458899999999999999999999998876666555554311100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.....++..+.+||.+||..+|.+|||+.++++|+|+-.
T Consensus 244 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 ------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 001235678999999999999999999999999999955
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=373.86 Aligned_cols=264 Identities=31% Similarity=0.480 Sum_probs=208.6
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeec----
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR---- 207 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~---- 207 (690)
.|...+|+.+..||+||||.||+++++-+|..||||++.... .......+.+|+..|.+|+|||||+++..+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 356788999999999999999999999999999999998765 566677899999999999999999986544000
Q ss_pred ------------------------------------------------------------------------c-------
Q 005582 208 ------------------------------------------------------------------------V------- 208 (690)
Q Consensus 208 ------------------------------------------------------------------------~------- 208 (690)
+
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred --------------------------C--------CeEEEEEeccccchhhhhcCCCCCC-CHHHHHHHHHHHHHHHHHH
Q 005582 209 --------------------------S--------GSLYLVFEYMEHDLAGLAATPGVKF-TEAQIKCYMKQLLHGLEHC 253 (690)
Q Consensus 209 --------------------------~--------~~l~LV~Ey~~g~Ll~~~~~~~~~l-~e~~i~~i~~qIl~gL~yL 253 (690)
. ..+||-||||+..++..+...+... .....|.++++|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 1279999999999999888776544 4778999999999999999
Q ss_pred HhCCCccccCCCcceeeccCCceEeeccccccccc-----------------cCCCCCcccccccccCcCCccccCCC--
Q 005582 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK-----------------CSQKQPLTSRVVTLWYRPPELLLGST-- 314 (690)
Q Consensus 254 Hs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~-----------------~~~~~~~~~~~gT~~Y~APEvl~g~~-- 314 (690)
|++|||||||||.||+|+.++.|||+|||+|+... .......|+.+||..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998721 01112578889999999999997755
Q ss_pred CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchh
Q 005582 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSS 394 (690)
Q Consensus 315 ~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~ 394 (690)
.|+.|+||||||||||||+. ||. +..|....+..+- . ..+|.. ...+..--+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR-~--------g~iP~~-------------~~f~~~~~~~ 846 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLR-K--------GSIPEP-------------ADFFDPEHPE 846 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcc-c--------CCCCCC-------------cccccccchH
Confidence 69999999999999999994 354 3333333332211 1 111110 0111122245
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 395 ALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 395 ~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
-..+|..||+.||.+||||.|+|++.||.
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 66799999999999999999999999995
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.73 Aligned_cols=259 Identities=32% Similarity=0.526 Sum_probs=210.9
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++||||+++++.+.......+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47889999999999999999988999999999986655456677889999999999999999999988763236899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-Cc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-PL 295 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~-~~ 295 (690)
||+.+..+..+......+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99976555544444448999999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....++..|+|||.+.+. .++.++|||||||++|+|++|..||..... ....+......
T Consensus 161 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~------------------ 219 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSS------------------ 219 (260)
T ss_pred cCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcccc------------------
Confidence 345678899999998763 489999999999999999999999987652 11222211100
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.........++..+.+||.+||..||.+|||+.++|.||||
T Consensus 220 ------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 ------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00011223458899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.97 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=207.2
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|+..+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEE
Confidence 57788899999999999999989999999999875432 3345678899999999999999999999876 46899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 99998666555443 368999999999999999999999999999999999999999999999999997664321 1222
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...++..|+|||++.+ ..++.++|+|||||++|||++|.+||...........+.. +.+
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~------------------ 218 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSP------------------ 218 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc--CCC------------------
Confidence 3457889999999876 4688999999999999999999999876544333222111 000
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
......++..+.+||.+||..+|.+|||+.++|+||||..
T Consensus 219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 219 --------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred --------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 0011246788999999999999999999999999999965
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=323.01 Aligned_cols=250 Identities=30% Similarity=0.414 Sum_probs=200.1
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHH-HhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIIL-RRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL-~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||.|+||.||+|.+..+++.||||.+...... ......+..|..++ ..++||||+++++++.. .+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5689999999999999999999999998754322 22233345555544 45589999999999876 47899999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 299 (690)
.++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9876665555555799999999999999999999999999999999999999999999999999875432 22345
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.......+...... |
T Consensus 155 ~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~---------------- 212 (260)
T cd05611 155 GTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----W---------------- 212 (260)
T ss_pred CCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----C----------------
Confidence 78899999998774 4899999999999999999999999887766555544321000 0
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCC---HHHHhcCcCCCC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGT---ASSALQNEFFTT 424 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hpwf~~ 424 (690)
.......++..+.++|.+||..||++||| ++|+|.||||..
T Consensus 213 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 213 ----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 00112357899999999999999999995 479999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.53 Aligned_cols=248 Identities=22% Similarity=0.364 Sum_probs=200.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||++... .+..+|+|.+...... ...+.+|+.+|+.++||||+++++++.. .+.+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 46999999999999999999864 4567999988644332 2457889999999999999999998876 4679999
Q ss_pred Eeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||+.++ |...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999865 444444334468999999999999999999999999999999999999999999999999997654322222
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------------- 221 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence 223334567999999876 468999999999999999999 899998888777766664311000
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+..+.+|+.+||..||.+|||+.++++
T Consensus 222 -------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01124678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.98 Aligned_cols=279 Identities=24% Similarity=0.338 Sum_probs=204.0
Q ss_pred eeeecc--CceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQG--TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G--~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
..||.| +||+||++.+..+|+.||||++..........+.+.+|+.+++.++||||++++++|.. .+.+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 356666 99999999999999999999998665555666788999999999999999999999987 47799999999
Q ss_pred ccchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC---
Q 005582 220 EHDLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--- 294 (690)
Q Consensus 220 ~g~Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~--- 294 (690)
.++.+..+... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 97544433322 2358999999999999999999999999999999999999999999999998654322111100
Q ss_pred ---cccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 295 ---LTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 295 ---~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..++..... ..|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY---SPLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC---CCccccccch
Confidence 0112345679999998763 34789999999999999999999999887766555444432111 0110000000
Q ss_pred cc-----------------ccCC----CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 AT-----------------IFKP----QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~-----------------~~~~----~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.. .... ..............++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 0000 0000000011123467789999999999999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=323.12 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=202.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+|+.++||||+++++++.. .+.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 36899999999999999999999999999999986432 334568899999999999999999998876 4678999
Q ss_pred Eeccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++.+ ..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999986544 44332 2345899999999999999999999999999999999999999999999999999776432222
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.......++.|+|||++.+ ..++.++|||||||++|||++ |.+||++.+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----------------- 222 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------------
Confidence 1222233567999998876 568999999999999999998 999999877655544442210
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
. ......++..+.+||.+||..||++|||+.++++.
T Consensus 223 --~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 --R---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred --C---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0 01123578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.82 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=210.1
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 468999999999999999999998899999999986433 2334567899999999999999999999877 467899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|+||+.++.+..+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+..... .
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999886555444332 588999999999999999999999999999999999999999999999999876543222 2
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+..+.+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------------
Confidence 234467889999999876 4689999999999999999999999987665444332211 00000
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.+||..||..+|.+|||+.++|.|+||...
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00122467789999999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.11 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=202.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.+.||.|+||.||+|.+..+++.||||.+.... .+......+.+|+.+|+.++||||+++++++.. .+.+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 47999999999999999999999999999999887533 244555678899999999999999999999876 468999
Q ss_pred EEeccccchhh-hhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 215 VFEYMEHDLAG-LAA---TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 215 V~Ey~~g~Ll~-~~~---~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
||||++++.+. ++. .....+++..+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999975443 321 23345899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
. .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ...+...+...+.++.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------- 228 (267)
T ss_pred h-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC---------
Confidence 1 12234567889999999876 4588999999999999999999999865432 1222222221111110
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 229 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012357889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.93 Aligned_cols=255 Identities=28% Similarity=0.462 Sum_probs=209.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
-|++++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 47889999999999999999988999999999865432 3445678899999999999999999999876 47899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
||+.++.+..+... ..+++..+..++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++..+... .....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRN 159 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-hhhhc
Confidence 99998666555443 36899999999999999999999999999999999999999999999999999765432 11223
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+... .+
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------ 218 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP------------------ 218 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC------------------
Confidence 3467889999999875 45788999999999999999999999876654444333210 00
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.++|..||..+|.+||++.++|+||||...
T Consensus 219 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 --------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred --------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00123467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.89 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=197.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLEN-----NKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+|+.+ +|+||+++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 45799999999999999999986443 3579999997543 234456788999999999 89999999999876
Q ss_pred CCeEEEEEeccccchhh-hhcC----------------------------------------------------------
Q 005582 209 SGSLYLVFEYMEHDLAG-LAAT---------------------------------------------------------- 229 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~-~~~~---------------------------------------------------------- 229 (690)
.+.+||||||+.++.+. .+..
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 46899999999875433 2211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc-cc
Q 005582 230 -----------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL-TS 297 (690)
Q Consensus 230 -----------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~-~~ 297 (690)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+........ ..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 112478889999999999999999999999999999999999999999999999976543221111 12
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+......+
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------------------ 334 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------------------ 334 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------------------
Confidence 234567999999876 468999999999999999997 999998765444333333211000
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 335 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ---------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ---------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=343.38 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred CCcEEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVS 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~ 209 (690)
++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|..+ +||||+++++++.. .
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 4799999999999999999974 3467789999987443 233445688999999999 89999999999876 4
Q ss_pred CeEEEEEeccccc-hhhhhcCC----------------------------------------------------------
Q 005582 210 GSLYLVFEYMEHD-LAGLAATP---------------------------------------------------------- 230 (690)
Q Consensus 210 ~~l~LV~Ey~~g~-Ll~~~~~~---------------------------------------------------------- 230 (690)
+..|+|||||.++ |...+...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 6789999999864 33333211
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 231 ----------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 231 ----------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1247888999999999999999999999999999999999999999999999997654322111
Q ss_pred -cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 295 -LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 295 -~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+......+.+++.....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------- 335 (375)
T cd05104 272 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR--------------- 335 (375)
T ss_pred ccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc---------------
Confidence 112234567999999876 468999999999999999998 88999876544433333321000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
+ ......+.++.+||..||..||.+|||+.++++.
T Consensus 336 ---~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 ---M---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ---C---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 0012356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.45 Aligned_cols=253 Identities=19% Similarity=0.260 Sum_probs=200.2
Q ss_pred cEEEeeeeccCceEEEEEEEcCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC----C
Q 005582 138 FEKLDKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS----G 210 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 210 (690)
|.+.+.||+|+||.||+|....+ +..||||.++...........+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987543 4789999998655555566778999999999999999999998765321 2
Q ss_pred eEEEEEeccccchhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccc
Q 005582 211 SLYLVFEYMEHDLAGLAA------TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~------~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
..++||||+.++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999875543332 12236899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhH
Q 005582 285 NFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEY 362 (690)
Q Consensus 285 ~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 362 (690)
+.+...... .......+..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~---- 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--NR---- 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC----
Confidence 866432211 1112234678999998865 568999999999999999999 88999887766655444321 00
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......++..+.+||.+||..||.+|||+.+++.+
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.37 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=206.6
Q ss_pred CcEEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 210 (690)
.|++.+.||.|+||.||+|.+. .+|..||+|.+..... .......+.+|+.+|+.+ +|+||+.+++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999874 4789999999875322 122345678899999999 69999999988876 46
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+.++.+...+.....+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 88999999998655554444457899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.........++..|+|||++.+. ..++.++|||||||++|+|++|..||...........+...+-..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----------- 227 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence 33333455688999999998653 347889999999999999999999997543322222222211000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-----CHHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hpwf~~~ 425 (690)
..+ ....++..+.+||.+||..||.+|| ++.+++.||||+..
T Consensus 228 -------~~~-------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 228 -------EPP-------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred -------CCC-------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 000 1234678899999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.51 Aligned_cols=249 Identities=21% Similarity=0.381 Sum_probs=201.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|+++++||+|+||.||+|.+ .++..||+|.+.... .....+.+|+.+++.++|+||+++++++.. .+..|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 45899999999999999999986 456779999876432 234568899999999999999999988876 467899
Q ss_pred EEecccc-chhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEH-DLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g-~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.+ ++...+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999976 44444432 345688999999999999999999999999999999999999999999999999987643222
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22223345678999999876 458899999999999999998 99999987776665555321100
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+.+||..+|++|||++++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.06 Aligned_cols=273 Identities=23% Similarity=0.312 Sum_probs=199.2
Q ss_pred CceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhhh
Q 005582 148 TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLA 227 (690)
Q Consensus 148 ~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~ 227 (690)
+++.||.+.+..+++.||||++............+.+|+.+|+.++||||+++++++.. .+.+|++|||+.++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 44556666666799999999998765556677789999999999999999999999876 4678999999997655544
Q ss_pred cCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC------CCccccc
Q 005582 228 ATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK------QPLTSRV 299 (690)
Q Consensus 228 ~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~------~~~~~~~ 299 (690)
... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+..+..... .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 332 34689999999999999999999999999999999999999999999999999865532211 1122345
Q ss_pred ccccCcCCccccCC-CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc-----
Q 005582 300 VTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI----- 373 (690)
Q Consensus 300 gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~----- 373 (690)
++..|+|||++.+. ..|+.++|||||||++|+|++|..||........+.... .+.... .+.....+....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCcc-ccccCchhhhcCCcCcc
Confidence 67889999998653 358899999999999999999999998765544332222 122111 000000000000
Q ss_pred ---cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 374 ---FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 374 ---~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.................++..+.+||..||.+||++|||+.++|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000000000111122356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.85 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=211.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+.|...+.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEE
Confidence 458888999999999999999999999999999875432 33445667899999999999999999999877 467899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+.+++...+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++.....
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 999999888777665556789999999999999999999999999999999999999999999999999976542
Q ss_pred cccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 295 LTSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+.+..+.... .+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-------------- 232 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP-------------- 232 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CC--------------
Confidence 234567889999999753 2357889999999999999999999998766555444433210 00
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
......++..+.+||.+||..+|.+|||+.+++.|+||...
T Consensus 233 ------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 ------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00012467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=338.13 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=199.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVS 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~ 209 (690)
++|++.+.||+|+||.||+|.+.. +++.||+|+++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 489999999999999999997533 45789999987443 334456678899999999 899999999988753 5
Q ss_pred CeEEEEEeccccchhhhhcCC-----------------------------------------------------------
Q 005582 210 GSLYLVFEYMEHDLAGLAATP----------------------------------------------------------- 230 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~----------------------------------------------------------- 230 (690)
..+|+||||+.++.+..++..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 678999999997544332211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-CcccccccccCcCC
Q 005582 231 --GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPP 307 (690)
Q Consensus 231 --~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~AP 307 (690)
...+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++..+...... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 125889999999999999999999999999999999999999999999999999876432211 12233456789999
Q ss_pred ccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhh
Q 005582 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAE 386 (690)
Q Consensus 308 Evl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e 386 (690)
|++.+ ..++.++|||||||+||||++ |.+||.+....+.+...+... .. ..
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--------------------------~~ 296 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-TR--------------------------MR 296 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-CC--------------------------CC
Confidence 99877 568999999999999999998 999998755444333332210 00 00
Q ss_pred hcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 387 TFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 387 ~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.....++++.+|+.+||+.+|++|||+.++++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=324.34 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=202.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.+|.+.+.||+|+||.||+|.+.. ++..||||++.... ..+....+.+|+.+|+.+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--GD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CC
Confidence 479999999999999999998743 46789999987543 23345678999999999999999999999877 47
Q ss_pred eEEEEEeccccchhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCce
Q 005582 211 SLYLVFEYMEHDLAGLAATP--------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGIL 276 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~--------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~v 276 (690)
..|+||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 89999999987655443321 2358899999999999999999999999999999999999999999
Q ss_pred EeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 005582 277 KIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 277 KL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~ 354 (690)
+|+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976432211 11223345788999999876 468999999999999999998 99999887776655554321
Q ss_pred hCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 355 ~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. ......++..+.+||.+||..||.+|||+.|+++
T Consensus 241 --~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 --RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 0011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.69 Aligned_cols=252 Identities=34% Similarity=0.512 Sum_probs=207.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||.|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 48899999999999999999988999999999975442 355678899999999999999999998876 47789999
Q ss_pred eccccchhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHDLAGL-AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~Ll~~-~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||+++..+.. +......+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999655444 433335799999999999999999999999999999999999999999999999999977653321 3
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....++..|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+.. ...+ ..
T Consensus 155 ~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~-~~-------------- 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP-GL-------------- 217 (253)
T ss_pred cceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC-Cc--------------
Confidence 445678899999998764 488999999999999999999999987655544443322 0000 00
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpw 421 (690)
+ ....++..+.+||..||..||.+|||+.++|+|||
T Consensus 218 ---~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 ---R-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---C-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 00124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.10 Aligned_cols=251 Identities=32% Similarity=0.501 Sum_probs=204.1
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||.|+||.||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999988999999999875433 23455678899999999999999999988876 57899999999875
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-------CCc
Q 005582 223 LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-------QPL 295 (690)
Q Consensus 223 Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-------~~~ 295 (690)
.+..+......+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 5544443334799999999999999999999999999999999999999999999999999876432211 122
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
....++..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.. +.. .|
T Consensus 159 ~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~---~~------------ 220 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKI---EW------------ 220 (265)
T ss_pred cCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc---CC------------
Confidence 334678899999998764 488999999999999999999999988776665555432 100 00
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH---HHHhcCcCCCC
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA---SSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa---~e~L~hpwf~~ 424 (690)
+ ....++..+.+||..||+.+|.+|||+ .++|+||||+.
T Consensus 221 ---~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 221 ---P-------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred ---C-------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 0 001257899999999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.23 Aligned_cols=252 Identities=29% Similarity=0.454 Sum_probs=209.9
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.++||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4899999999999999999999999999999998765555556677899999999999999999998876 47899999
Q ss_pred eccccchhhhhc-C---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 217 EYMEHDLAGLAA-T---PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 217 Ey~~g~Ll~~~~-~---~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||+.+..+.... . ....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999875443322 2 2346899999999999999999999999999999999999999999999999999876533
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 218 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---------------- 218 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 2233567889999999876 5688999999999999999999999988776554444322100
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
......++.++.++|.+||..+|.+|||+.++|+||++
T Consensus 219 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 ------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.34 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=193.7
Q ss_pred CCcEEEeee--eccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKI--GQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~L--G~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 212 (690)
+.|++.+.+ |.|+||.||++.+..++..+|+|.+....... .|+.+...+ +||||+++++.|.. .+.+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCee
Confidence 456676666 99999999999999999999999987543221 122222222 79999999999887 4689
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-ceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-~vKL~DFGlA~~~~~~~ 291 (690)
|+||||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998754444444444899999999999999999999999999999999999999998 9999999999765422
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~-l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ..
T Consensus 164 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------------ 225 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK------------ 225 (267)
T ss_pred ----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc------------
Confidence 23467899999999976 4589999999999999999999999986543321 11111100 00
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-HHHHhcCcCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-ASSALQNEFFT 423 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-a~e~L~hpwf~ 423 (690)
....++.+++.+.+||..||+.||.+|++ ++++|+||||.
T Consensus 226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 00112358899999999999999999996 59999999996
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.89 Aligned_cols=251 Identities=20% Similarity=0.327 Sum_probs=199.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeE----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKL----VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~----VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
.+|++++.||+|+||.||+|.+..++.. ||||+++.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CC
Confidence 4799999999999999999998666654 899998643 234455678899999999999999999998875 35
Q ss_pred EEEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.++|+||+.++ +.+.+......+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999875 44555444456889999999999999999999999999999999999999999999999999876533
Q ss_pred CCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 291 QKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.... ......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+. ..++.....+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---------- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL---------- 230 (316)
T ss_pred CcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC----------
Confidence 2211 122334678999999876 468999999999999999998 9999987665443 3332211000
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......+..+.+|+..||..||.+|||+.+++.+
T Consensus 231 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 -----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=351.99 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=217.2
Q ss_pred EEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN--MDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 139 ~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+...+||+|+|-+||+|.|..+|..||.-.++... ..+...+++..|+.+|+.|.|||||++++.|.+.....+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34468999999999999999999999965554333 2466678999999999999999999999999987777899999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCcceeecc-CCceEeeccccccccccCCCC
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~g--IvHrDLKp~NILld~-~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|++..+.+..+..+...+....++.|++||+.||.|||++. |||||||.+||||+. .|.|||+|+|||+.... .
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---S 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc---c
Confidence 99999999888888788999999999999999999999985 999999999999985 58999999999988753 3
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
...+.+|||.|||||++. ..|+..+||||||++|+||+|+..||..-....++++-+.. |..+.-+
T Consensus 200 ~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~sl----------- 265 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAAL----------- 265 (632)
T ss_pred ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHHh-----------
Confidence 445689999999999986 46999999999999999999999999877666665554331 2222211
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.+--.+++++||.+||.. ...|+||.|+|.||||....
T Consensus 266 --------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 266 --------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred --------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 122368899999999999 99999999999999998863
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.29 Aligned_cols=254 Identities=17% Similarity=0.272 Sum_probs=199.6
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 3468999999999999999999864 245789999986432 22344567899999999999999999998865
Q ss_pred CCeEEEEEeccccchhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEe
Q 005582 209 SGSLYLVFEYMEHDLAGLAATP----------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKI 278 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~----------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL 278 (690)
....|+||||+.++.+..+... ...+++..+..++.||+.||.|||+.||+|+||||+||||+.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 4678999999987554433221 123577889999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 005582 279 GDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCG 356 (690)
Q Consensus 279 ~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g 356 (690)
+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+... +
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~ 238 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-G 238 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999765322211 1122345778999999876 458999999999999999999 78999887766555544321 0
Q ss_pred CCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 357 SPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 357 ~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.+ .....++..+.+||.+||..||.+|||+.+++++
T Consensus 239 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0113467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.09 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=209.5
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|....+||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++|+||+++++++.. .+..|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444578999999999999999999999999986432 2344568899999999999999999999887 578999999
Q ss_pred ccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccc
Q 005582 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 218 y~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
|+.++.+..+... ..+++..++.++.||+.+|.|||+.||+|+||+|+|||++.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9998766655543 368999999999999999999999999999999999999999999999999987654221 22234
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~ 377 (690)
..+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....+.+..+.... + .
T Consensus 176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~-----------~------- 234 (292)
T cd06657 176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--P-----------P------- 234 (292)
T ss_pred cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--C-----------c-------
Confidence 567899999998865 457899999999999999999999998877665544432211 0 0
Q ss_pred CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 378 QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 378 ~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.+ .....++..+.+||.+||..||.+|||+.++|.||||....
T Consensus 235 -----~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 -----KL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -----cc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00 01234678899999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=337.14 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=221.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l 212 (690)
+.+|.++.+||+|+||.|.+|..+.+.+.||||++++... ..+.++-.+.|-.+|.... -|.+++|+..|+. -+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence 3579999999999999999999999999999999987643 3445556677888887774 5788899988876 4789
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+||||+.|+-+-..+..-+.|.+..+.+|+..|+-||-|||++|||+||||.+|||||.+|++||+|||+++.-- ...
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FDG 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-cCC
Confidence 9999999987666666666789999999999999999999999999999999999999999999999999997532 223
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
....+.||||.|+|||++.- .+|+.++|+||+||+|||||.|++||.|.++.+....|....-+
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs--------------- 568 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS--------------- 568 (683)
T ss_pred cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc---------------
Confidence 44567899999999999975 67999999999999999999999999999999999999763222
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-----HHHhcCcCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-----SSALQNEFFTT 424 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hpwf~~ 424 (690)
..+.++.++.++++.+|.+.|.+|..+ .++-.||||..
T Consensus 569 --------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 569 --------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred --------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 135688999999999999999999865 67889999976
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.43 Aligned_cols=252 Identities=19% Similarity=0.277 Sum_probs=198.1
Q ss_pred EEEeeeeccCceEEEEEEEcCCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CCeE
Q 005582 139 EKLDKIGQGTYSSVYKARDLENNK--LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SGSL 212 (690)
Q Consensus 139 ~~~~~LG~G~fG~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~~l 212 (690)
.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.+|+.++||||+++++++.... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999877765 6999998765555566778899999999999999999999764321 2356
Q ss_pred EEEEeccccchhh-hhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccc
Q 005582 213 YLVFEYMEHDLAG-LAA-----TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~-~~~-----~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
++||||+.++.+. .+. .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 8999999865443 321 1233589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 287 FKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 287 ~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
+....... ......++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~------ 232 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NR------ 232 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CC------
Confidence 64322111 112234678999999876 568999999999999999999 88999887665554444320 00
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......++..+.+||.+||..||++|||+.+++++
T Consensus 233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 --------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=362.68 Aligned_cols=149 Identities=30% Similarity=0.437 Sum_probs=130.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.++|.++++||+|+||.||+|.+..+++.||||+++.... .......+..|+.++..++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999975433 34455678899999999999999999988876 57899
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccc
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
|||||+.++.+..++.....+++..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999875554444444578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.22 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=194.0
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
+.||+|+||.||+|.+..+++.||+|.+... ...+....+.+|+.+|+.++||||+++++++.. ...+|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3689999999999999999999999987643 234555678999999999999999999999876 4678999999987
Q ss_pred chhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc-cccc
Q 005582 222 DLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL-TSRV 299 (690)
Q Consensus 222 ~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~-~~~~ 299 (690)
+.+. .+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 5444 4444445689999999999999999999999999999999999999999999999999976432111110 1112
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCC
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~ 378 (690)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 2456999999876 458999999999999999998 88888766654443333221000
Q ss_pred ccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 379 p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+..+.+|+.+||..||.+|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.40 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=201.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEc----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCc
Confidence 57999999999999999999853 456789999987433 34455678899999999999999999998876 467
Q ss_pred EEEEEeccccc-hhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 212 LYLVFEYMEHD-LAGLAATP----------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 212 l~LV~Ey~~g~-Ll~~~~~~----------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
.|+||||+.++ |...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 89999999875 43333211 12478889999999999999999999999999999999999999
Q ss_pred ceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005582 275 ILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIF 352 (690)
Q Consensus 275 ~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~ 352 (690)
.+||+|||+++.+..... .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976543221 11233345677999999876 458999999999999999998 999998877655555443
Q ss_pred HHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 353 ~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.. .. ......+++.+.+|+..||..||.+||++.+++++
T Consensus 241 ~~-~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KR-QL---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cC-Cc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 21 00 00123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=316.93 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=199.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||+|.+. +++.||||.++.... ....+.+|+.++++++||||+++++++.. .+.+|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeee
Confidence 57999999999999999999964 567899999875432 23457889999999999999999998876 4678999
Q ss_pred Eecccc-chhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEH-DLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g-~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.+ +|...+... +..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999965 555554332 346899999999999999999999999999999999999999999999999999876522211
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------------- 223 (261)
T ss_pred ccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 1122223457999998876 568999999999999999999 99999988776666555321100
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+.+||..||.+|||+.++++
T Consensus 224 -------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 001246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.41 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=202.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
++|++.+.||+|+||.||+|.+..+ ...||||++.... .......+.+|+.+|+.++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence 5799999999999999999988644 4689999987543 34445568899999999999999999998876 4678
Q ss_pred EEEEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||+.++.+ ..+......+++..+..++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++..+....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999987544 4444444579999999999999999999999999999999999999999999999999998774221
Q ss_pred CCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 292 KQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 292 ~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----------- 228 (266)
T ss_pred cceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 111 112234578999999876 468999999999999999998 999998776665555543210000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.....+..+.+|+..||..+|.+|||+.+++++
T Consensus 229 -----------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 -----------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.55 Aligned_cols=260 Identities=18% Similarity=0.291 Sum_probs=202.3
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 34689999999999999999997542 35689999886443 22334457889999999999999999998876
Q ss_pred CCeEEEEEeccccchhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEe
Q 005582 209 SGSLYLVFEYMEHDLAGLAATP----------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKI 278 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~----------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL 278 (690)
.+..|+||||+.++.+...... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 4678999999986544433321 123567788999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 005582 279 GDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCG 356 (690)
Q Consensus 279 ~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g 356 (690)
+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+... +
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~ 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-G 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999765322211 1122344677999999876 458999999999999999998 78899887766655444321 0
Q ss_pred CCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc------CcCCCCC
Q 005582 357 SPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ------NEFFTTK 425 (690)
Q Consensus 357 ~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~------hpwf~~~ 425 (690)
.+ ......++.+.+|+.+||+.||.+|||+.++++ ||||...
T Consensus 239 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 239 YL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 00 011245788999999999999999999999987 9999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.06 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=208.3
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCe
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 211 (690)
...++|++.+.||+|+||.||+|.+..+++.||||.++..... .....+..|+.++..+ .||||+++++++.. ...
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~ 88 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSD 88 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CCe
Confidence 3457899999999999999999999888999999999755432 2344566777777666 59999999999876 468
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+||||+.+.+..+.......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+...
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99999999887766665544579999999999999999999997 59999999999999999999999999999765422
Q ss_pred CCCCcccccccccCcCCccccCC---CCCCCcceeecchhHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGS---TDYGASVDLWSSGCILAELFAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~---~~ys~~sDIWSlG~iL~ELltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||.... ..+.+..++.... +
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~-------- 237 (296)
T cd06618 169 K--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-P-------- 237 (296)
T ss_pred C--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-C--------
Confidence 1 22334567889999998653 247889999999999999999999997533 2333443332100 0
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
..+ ....++..+.+||.+||..||.+|||+.++++|+||...
T Consensus 238 ----------~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 238 ----------SLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred ----------CCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 000 011467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.39 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=200.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLEN-----NKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||.||++.+... ...||+|.+.... .......+.+|+.++..+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 45899999999999999999987643 3789999987543 334456688999999999 89999999998876
Q ss_pred CCeEEEEEeccccchhhhhc----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc
Q 005582 209 SGSLYLVFEYMEHDLAGLAA----------------TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY 272 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~----------------~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~ 272 (690)
.+.+|+||||+.++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 46799999999875443332 22446899999999999999999999999999999999999999
Q ss_pred CCceEeeccccccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHH
Q 005582 273 NGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHK 350 (690)
Q Consensus 273 ~g~vKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~k 350 (690)
++.+||+|||+++.+....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999998764322111 122234567999998866 568999999999999999997 9999988766555444
Q ss_pred HHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 351 IFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 351 I~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
+..... + ......+..+.+|+.+||..||.+|||+.++|++
T Consensus 247 ~~~~~~-------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR-------------------M---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc-------------------C---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 322000 0 0112457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.54 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=198.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||+|.+. ++..||+|.+....... ..+.+|+.+|+.++|+||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 57999999999999999999864 56679999987544332 357899999999999999999988743 568999
Q ss_pred Eeccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++.+ ..+.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999987544 44433 2345899999999999999999999999999999999999999999999999999776432222
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--------------- 222 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2222334567999998865 468999999999999999999 89999988777666655321000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+..+.+|+.+||..||.+|||+.++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 -------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 012356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.09 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=211.3
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
..+.|++...||+|+||.||++.+..++..|++|++..... ....+.+|+.+|+.++|+||+++++++.. ...+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEE
Confidence 45679999999999999999999988899999999975432 45567899999999999999999999887 47899
Q ss_pred EEEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 214 LVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 214 LV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
+|+||+++..+ +.+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 99999996444 4444333379999999999999999999999999999999999999999999999999987654221
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------- 235 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP------------- 235 (286)
T ss_pred hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-------------
Confidence 12223456789999999876 45899999999999999999999999877665544443321 0000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
......++..+.+||..||+.+|.+|||+.++|.|+||..
T Consensus 236 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 ------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0011236788999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.40 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=197.3
Q ss_pred eeeccCceEEEEEEE--cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 143 KIGQGTYSSVYKARD--LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~--~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
.||+|+||.||+|.+ ..++..||||+++....+......+.+|+.+|+.++||||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4578999999987665555566778999999999999999999998753 56799999999
Q ss_pred cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC--cccc
Q 005582 221 HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--LTSR 298 (690)
Q Consensus 221 g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~--~~~~ 298 (690)
++.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 76554444444579999999999999999999999999999999999999999999999999998764332211 1222
Q ss_pred cccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCC
Q 005582 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377 (690)
Q Consensus 299 ~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~ 377 (690)
.+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+..... +
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~------------------- 217 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M------------------- 217 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-------------------
Confidence 33578999998865 468899999999999999998 9999988777666555432100 0
Q ss_pred CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 378 QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 378 ~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+++.+.+||..||..||..|||+.++..
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 012347889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.98 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=197.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.++||+|+||.||+|.+..+ ..||||++...... ...+.+|+.+++.++||||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 4799999999999999999988655 45999998754332 2457889999999999999999987643 568999
Q ss_pred Eeccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++ +...+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999874 4444433 2345889999999999999999999999999999999999999999999999999766433222
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 222 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---------------
Confidence 2223345678999998865 458999999999999999999 88899887766665554321000
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 223 -------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.38 Aligned_cols=252 Identities=34% Similarity=0.511 Sum_probs=201.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... +......+.+|+.++++++|+||+++++++.. .+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 579999999999999999999988999999999875433 33446678899999999999999999999876 468899
Q ss_pred EEeccccchh-hhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 215 VFEYMEHDLA-GLAA---TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 215 V~Ey~~g~Ll-~~~~---~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
||||+.++.+ ..+. .....+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999987544 3332 23446899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHhhhcCC
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~--~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... .
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~----------- 224 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--D----------- 224 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--C-----------
Confidence 2 12234567889999999876 4589999999999999999999999865431 1111111110 0
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+ + +. ....++..+.++|.+||..+|.+|||+.++++
T Consensus 225 -----~-~--~~------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 -----Y-P--PL------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----C-C--CC------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 0 00 01246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.13 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=200.6
Q ss_pred CCcEEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
++|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.+|+.++||||+++++++.. .+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 4799999999999999999985 235677999988643 24455678899999999999999999999876 47
Q ss_pred eEEEEEeccccchhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceE
Q 005582 211 SLYLVFEYMEHDLAGLAATP-------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILK 277 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~-------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vK 277 (690)
.+|+||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 89999999987655433321 12489999999999999999999999999999999999999999999
Q ss_pred eeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 005582 278 IGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLC 355 (690)
Q Consensus 278 L~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~ 355 (690)
|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~- 238 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG- 238 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999976532211 11223345678999999876 568999999999999999998 89999887776666655431
Q ss_pred CCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 356 g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
... .....++..+.+|+.+||+.||.+|||+.+++.
T Consensus 239 -~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 -RVL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -CcC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 100 011246788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=347.71 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=206.9
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCe
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 211 (690)
...+.|++...||.|+|+.|-.+.+..+++..++|++..... ...+|+.++... +||||+++.+++.+ ..+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED--GKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC--Cce
Confidence 357789999999999999999999999999999999975522 234577666555 89999999999987 578
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee-ccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI-DYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl-d~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+|||++.|+.+...+.....+. ..+..|+++|+.++.|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999976655444333344 7888899999999999999999999999999999 68999999999999876543
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
+...+.|..|.|||++.. ..|+.++||||||++||+||+|+.||...... ..|...++.++..
T Consensus 470 ----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc---------
Confidence 455678999999999874 67999999999999999999999999865544 2333333333221
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
..++..+++||..||++||.+|+|+.+++.||||...
T Consensus 533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 3489999999999999999999999999999999443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=316.77 Aligned_cols=252 Identities=18% Similarity=0.290 Sum_probs=200.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLEN-----NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence 35899999999999999999987643 4889999986443 23344567899999999999999999999876 4
Q ss_pred CeEEEEEeccccchhh-hhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEee
Q 005582 210 GSLYLVFEYMEHDLAG-LAAT---------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIG 279 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~-~~~~---------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~ 279 (690)
...|+||||+.++.+. .+.. ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 7789999999865443 3321 12247888999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 005582 280 DFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGS 357 (690)
Q Consensus 280 DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~ 357 (690)
|||+++.+..... .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.. +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~ 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GG 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CC
Confidence 9999976543221 12233456788999999865 458999999999999999998 9999988776655544431 10
Q ss_pred CChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 358 p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. .....++..+.+||.+||..+|.+|||+.+++.
T Consensus 239 ~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HL--------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 011235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=376.48 Aligned_cols=261 Identities=32% Similarity=0.549 Sum_probs=221.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+-+|....+||.|.||.||.|.+..+|...|+|-++...........+.+|+.+|..|+|||+|+++|+-.++ +.+||
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHH
Confidence 3467788899999999999999999999999999987766666677789999999999999999999997774 67899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC--
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
.||||+++.+..+...+...++...+.|..|++.||.|||++|||||||||.||||+.+|.+|++|||.|..+.....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999998888887777788999999999999999999999999999999999999999999999999988765421
Q ss_pred -CCcccccccccCcCCccccCCC--CCCCcceeecchhHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhcCC
Q 005582 293 -QPLTSRVVTLWYRPPELLLGST--DYGASVDLWSSGCILAELFAGKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 293 -~~~~~~~gT~~Y~APEvl~g~~--~ys~~sDIWSlG~iL~ELltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
..+...+||+.|||||++.|.. ...-+.|||||||++.||+||+.||...+. ...+.++-.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--------------- 1456 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--------------- 1456 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc---------------
Confidence 2355788999999999998743 456789999999999999999999975443 333333321
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
..+|+.| ..++++..+||+.||.-||.+|+|+.|+|+|-|-...
T Consensus 1457 ----gh~Pq~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1457 ----GHKPQIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ----cCCCCCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 1122222 2388999999999999999999999999999997653
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=315.58 Aligned_cols=247 Identities=23% Similarity=0.425 Sum_probs=200.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|+++++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++||||+++++++.. +.+|+|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence 5899999999999999999985 56788999998754433 3457889999999999999999998743 568999
Q ss_pred Eeccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.++ +...+.. .+..+++.++..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999864 4444332 3457899999999999999999999999999999999999999999999999999776532222
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------------- 222 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---------------
Confidence 2233345678999999876 458899999999999999999 99999988766655554321100
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+||.+||..+|++|||+++++.
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 012346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=312.28 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred eeeeccCceEEEEEEEcCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 3689999999999998766 8899999997654333 46678999999999999999999998876 5789999999
Q ss_pred cccc-hhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 219 MEHD-LAGLAATP--------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 219 ~~g~-Ll~~~~~~--------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
+.++ |...+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9654 44444443 36799999999999999999999999999999999999999999999999999987653
Q ss_pred CCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 290 SQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 290 ~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
... .......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~~--------- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GYR--------- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC---------
Confidence 321 123344568899999998764 68999999999999999999 6999998876665555432 000
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......++..+.++|.+||..||.+|||+.+++.+
T Consensus 226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 -----------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01123458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.26 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=199.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|.+++.||+|+||.||++.+. .+..||||.+...... ...+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEE
Confidence 46999999999999999999864 3456999998754332 3457889999999999999999999876 4678999
Q ss_pred Eeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||+.++.+ ..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999987544 4443334478999999999999999999999999999999999999999999999999997654322211
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------
Confidence 222334577999999876 458999999999999999998 99999877766655555331100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......+..+.+|+..||..||.+|||+.+++.+
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0012357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.69 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=201.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCC----------------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN----------------KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg----------------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~ 199 (690)
.+|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 47999999999999999999876543 568999987543 3355667889999999999999999
Q ss_pred eeeeEeeccCCeEEEEEeccccchhhhhcCCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcce
Q 005582 200 LEGLITSRVSGSLYLVFEYMEHDLAGLAATPGV-----------KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNL 268 (690)
Q Consensus 200 l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~-----------~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NI 268 (690)
+++++.. .+.+++||||+.++.+..++.... .+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999876 478899999998754443332222 689999999999999999999999999999999999
Q ss_pred eeccCCceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh--CCCCCCCCChH
Q 005582 269 LIDYNGILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA--GKPIMPGRTEV 345 (690)
Q Consensus 269 Lld~~g~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt--G~~pF~g~~~~ 345 (690)
|++.++.++|+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999976532221 11223455778999999876 458999999999999999998 67788776665
Q ss_pred HHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 346 e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+.+..+....... .. .........++.++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~--------~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDD--------GR-------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccc--------cc-------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5555543311100 00 0000112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.33 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=198.6
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEEE
Confidence 6889999999999999999875 5668999998654332 2346789999999999999999998876 46789999
Q ss_pred eccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||++++ |.+.+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999875 4444444344789999999999999999999999999999999999999999999999999976542211111
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 159 ~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd05059 159 QGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL----------------- 220 (256)
T ss_pred CCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-----------------
Confidence 12223457999999876 468999999999999999999 89999887766655554321100
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......+..+.+|+.+||..+|++|||+.++++.
T Consensus 221 -----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 -----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0113468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.96 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=204.4
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
+...+|++.++||.|+||.||+|.+.. +..||+|++.... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCe
Confidence 344579999999999999999999876 8899999987543 2234568899999999999999999998876 4678
Q ss_pred EEEEeccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 213 YLVFEYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 213 ~LV~Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
|+||||+.++ |...+.. .+..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999874 4444433 3446899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 158 ~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 223 (261)
T cd05148 158 VY-LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------ 223 (261)
T ss_pred cc-cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC------------
Confidence 11 1223345678999999876 468999999999999999998 89999888776666655431100
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+++.+||..||.+|||+.++++
T Consensus 224 ----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ----------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=324.55 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=196.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeE--EEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCe
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKL--VALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~--VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 211 (690)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.+|.++ +||||+++++++.. .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 45899999999999999999998777754 577766532 2344556788999999999 89999999999876 467
Q ss_pred EEEEEeccccc-hhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCc
Q 005582 212 LYLVFEYMEHD-LAGLAATP---------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI 275 (690)
Q Consensus 212 l~LV~Ey~~g~-Ll~~~~~~---------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~ 275 (690)
+|+||||+.++ |...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 99999999864 44443221 235889999999999999999999999999999999999999999
Q ss_pred eEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 005582 276 LKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 276 vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~ 354 (690)
+||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999986432111 1111223567999998865 458999999999999999998 99999877765544433110
Q ss_pred hCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 355 ~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
. .+ .....++..+.+||.+||..+|.+|||+.++|.+
T Consensus 240 ~------~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y------RL----------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C------cC----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 0112367889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=333.88 Aligned_cols=266 Identities=26% Similarity=0.306 Sum_probs=194.8
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
.++++|.....||+|+||.||+|.- .+|..||||++....... ...|.+|+.+|.+++|||+|+|+|||.+.. ...
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~-~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGG-EHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCC-ceE
Confidence 4567899999999999999999995 566899999887544322 445999999999999999999999999742 168
Q ss_pred EEEEeccccchhhhh-cCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---CccccCCCcceeeccCCceEeecccccccc
Q 005582 213 YLVFEYMEHDLAGLA-ATPGV-KFTEAQIKCYMKQLLHGLEHCHSRG---ILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~-~~~~~-~l~e~~i~~i~~qIl~gL~yLHs~g---IvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
+||+|||..+.+... ..... .|+|..+..|+.+++.||.|||... |||||||++|||||+++.+||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 999999997655444 33333 8999999999999999999999954 999999999999999999999999999665
Q ss_pred ccCCCCCcccc-cccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh--HHHHHHH-HHHhCCCChhHh
Q 005582 288 KCSQKQPLTSR-VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE--VEQLHKI-FKLCGSPSEEYW 363 (690)
Q Consensus 288 ~~~~~~~~~~~-~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~--~e~l~kI-~~~~g~p~~~~w 363 (690)
... ....... .||..|+|||++.. ...+.++|||||||+|+||+||+.+...... ...+... ... |
T Consensus 228 ~~~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~--------~ 297 (361)
T KOG1187|consen 228 PEG-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL--------L 297 (361)
T ss_pred Ccc-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH--------H
Confidence 421 1111222 78999999999875 4689999999999999999999987764321 1101111 111 1
Q ss_pred hhcCCCcccccCCC-CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 364 KRSKLPHATIFKPQ-QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 364 ~~~~l~~~~~~~~~-~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
...++......... ..+... ..-..+..+...|+..+|..||++.|+++
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~------~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDE------KEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HCcchhheeCCCccCCCCChH------HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11111000000000 011000 01123778889999999999999999755
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.33 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=199.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 3579999999999999999999876 77899999886432 23344568889999999999999999998876 3
Q ss_pred CeEEEEEeccccchh-hhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC---ceEee
Q 005582 210 GSLYLVFEYMEHDLA-GLAATPG------VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIG 279 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll-~~~~~~~------~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g---~vKL~ 279 (690)
+..|+||||+.++.+ ..+.... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 568999999986544 4432221 2589999999999999999999999999999999999998765 69999
Q ss_pred ccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 005582 280 DFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGS 357 (690)
Q Consensus 280 DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~ 357 (690)
|||++..+...... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+... +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 99999865322111 1112233567999999876 458999999999999999997 99999987766554443221 00
Q ss_pred CChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 358 p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
+ .....++..+.+|+.+||..||++|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.31 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=197.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNK--LVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 212 (690)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++.. .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999877764 4688887632 2334456788999999999 79999999998876 4678
Q ss_pred EEEEeccccc-hhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCce
Q 005582 213 YLVFEYMEHD-LAGLAATP---------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGIL 276 (690)
Q Consensus 213 ~LV~Ey~~g~-Ll~~~~~~---------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~v 276 (690)
|+||||+.++ |...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 9999999865 44443221 1258899999999999999999999999999999999999999999
Q ss_pred EeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 005582 277 KIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLC 355 (690)
Q Consensus 277 KL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~ 355 (690)
||+|||++...... ........+..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+...++....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999998643211 01111222456999999876 458999999999999999997 999998877666555442210
Q ss_pred CCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 356 g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
. ......++..+.+||.+||..||.+|||++++++.
T Consensus 236 ~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00123477899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.65 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=201.1
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.+.||.|+||.||+|.+..++..||||.+..... +......+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 478999999999999999999989999999998875432 33445678899999999999999999999876 468999
Q ss_pred EEeccccchhh-hhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 215 VFEYMEHDLAG-LAA---TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 215 V~Ey~~g~Ll~-~~~---~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
||||+.++.+. .+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999975443 332 23446899999999999999999999999999999999999999999999999998766432
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhhhcCC
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~--e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
. .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.... +....+.. ...+
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~---------- 226 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP---------- 226 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCC----------
Confidence 2 22334568899999999876 45889999999999999999999999765431 11111111 0000
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+ .....++..+.+||.+||..||.+|||+.++++
T Consensus 227 ----------~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 ----------P------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------C------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 011346788999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.01 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=201.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN-----NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.+|++.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.++..++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--Q 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--C
Confidence 3688899999999999999987543 5789999987443 233456688999999999999999999998763 6
Q ss_pred eEEEEEeccccchhhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 211 SLYLVFEYMEHDLAGLAAT----------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~----------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
.+++++||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 7899999998754433321 123588889999999999999999999999999999999999999
Q ss_pred ceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005582 275 ILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIF 352 (690)
Q Consensus 275 ~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~ 352 (690)
.+||+|||+++....... .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876533221 11223345788999999876 458999999999999999998 888998877766666554
Q ss_pred HHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 353 ~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
..... ....+++..+.+|+..||+.||.+|||+.+++..
T Consensus 241 ~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 31100 0123578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.10 Aligned_cols=251 Identities=19% Similarity=0.297 Sum_probs=199.2
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.++|+++++||.|+||.||+|.+..++. .||+|++.... .......+.+|+.++..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 3589999999999999999999877776 48999986432 34455678899999999999999999998865 4
Q ss_pred eEEEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 211 SLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 211 ~l~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
..+++|||++++ +...+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999864 5555544445799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 290 SQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 290 ~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||.......... ++.....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcC---------
Confidence 2221 1122234678999999876 468999999999999999998 889987665444333 22211110
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+..+.+||..||..||.+|||+.+++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346778999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.32 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=201.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeee-eEeeccC----
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEG-LITSRVS---- 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~-~~~~~~~---- 209 (690)
.++++.+.|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|+.|. |+|||.+++ ....+..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4789999999999999999999888899999998654 6788889999999999996 999999999 3322211
Q ss_pred CeEEEEEeccc-cchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCcceeeccCCceEeecccccc
Q 005582 210 GSLYLVFEYME-HDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 210 ~~l~LV~Ey~~-g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~g--IvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
-.++|+||||. |+|++++..+ ...|++.++..|+.|+++|+.+||... |||||||-|||||+.+|..||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 35789999999 5777776532 234999999999999999999999998 9999999999999999999999999996
Q ss_pred ccccCCCCC--------cccccccccCcCCcccc--CCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 005582 286 FFKCSQKQP--------LTSRVVTLWYRPPELLL--GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355 (690)
Q Consensus 286 ~~~~~~~~~--------~~~~~gT~~Y~APEvl~--g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~ 355 (690)
......... -....-|+.|+|||++. .....+.|+|||+|||+||-|+....||.+.-... |+.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln-- 268 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN-- 268 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe--
Confidence 432211110 01123489999999973 33568999999999999999999999998653221 111
Q ss_pred CCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcC
Q 005582 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421 (690)
Q Consensus 356 g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpw 421 (690)
|.+ . ...++.++..+.+||..||+.||.+||++.|++.+-+
T Consensus 269 g~Y--------~-----------------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 269 GNY--------S-----------------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccc--------c-----------------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 100 0 0113567889999999999999999999999987544
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.32 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=201.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++.+.||.|+||.||+|.+. ++..||||.+...... ...+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 468999999999999999999974 5678999998754432 3457899999999999999999998875 467899
Q ss_pred EEeccccchh-hhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEHDLA-GLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll-~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.++.+ ..+.. .+..+++..+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999987544 44433 234689999999999999999999999999999999999999999999999999977643221
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
........+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------- 224 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 11222234567999999876 468999999999999999998 999999887777666654321100
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+..+.+++.+||..+|.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 ---------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.56 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=203.2
Q ss_pred CcEEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 210 (690)
+|++.+.||+|+||.||++.+. .+++.||||.++.... .......+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999864 4678999999875322 123345678899999999 69999999988866 46
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+.++.+.........+++..++.++.||+.+|.|||+.+|+|+||+|.|||++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 88999999987655544444457899999999999999999999999999999999999999999999999999776433
Q ss_pred CCCCcccccccccCcCCccccCCC-CCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGST-DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~-~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.........++..|+|||.+.+.. .++.++|||||||++|+|++|..||...........+.+..-. .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~---- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-------S---- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------c----
Confidence 222223346789999999986532 3688999999999999999999999644322111121111000 0
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC---HHHHhcCcCCCCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT---ASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hpwf~~~ 425 (690)
.......++..+.+||.+||+.||++||| +.++|+||||+..
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 00012346788999999999999999998 5677999999774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.04 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=193.9
Q ss_pred eeeeccCceEEEEEEEcCCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDLENN---KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
++||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+|+.++||||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876554 78999998755433 445678899999999999999999998753 568999999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc--
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT-- 296 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~-- 296 (690)
+.++.+...+.....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 987544444444447999999999999999999999999999999999999999999999999999876433221111
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccC
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~ 375 (690)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+... .+
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~~----------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ER----------------- 216 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--Cc-----------------
Confidence 1112457999999876 458999999999999999998 99999877665544443221 00
Q ss_pred CCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 376 ~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.46 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=198.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++...||+|+||.||+|.+..+ ..||+|.+..... ....+.+|+.+++.++||||+++++++.. +..|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 4799999999999999999987554 4599998864432 23457889999999999999999988743 568999
Q ss_pred Eecccc-chhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEH-DLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g-~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.+ +|...+.. ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999987 45555533 2345889999999999999999999999999999999999999999999999999766433222
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... .+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM-------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--------------
Confidence 2223345678999998876 458999999999999999999 899999887766655543210 00
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+.+||..||.+|||++++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.03 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=199.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||.||++.+ ..++..||||.++... .......+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 35799999999999999999975 2356689999987543 234456788999999999 89999999998876
Q ss_pred CCeEEEEEeccccchh-hhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccc
Q 005582 209 SGSLYLVFEYMEHDLA-GLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll-~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
.+.+|+||||+.++.+ ..+... ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 4679999999986544 444332 23489999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 287 FKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 287 ~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+.++......+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM------ 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC------
Confidence 5432211 1112345678999999876 458999999999999999998 999998776655444433210000
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+..+.+|+.+||..+|++|||+.++++
T Consensus 264 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 ---------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=329.54 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 35899999999999999999984 3567899999997543 234456788999999999 689999999988654
Q ss_pred CCeEEEEEeccccchhhhhcCC----------------------------------------------------------
Q 005582 209 SGSLYLVFEYMEHDLAGLAATP---------------------------------------------------------- 230 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~---------------------------------------------------------- 230 (690)
...+|+||||++++.+..+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999997544332211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC-Ccccccc
Q 005582 231 ---------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVV 300 (690)
Q Consensus 231 ---------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~-~~~~~~g 300 (690)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... ......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678888999999999999999999999999999999999999999999999765322111 1122334
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||++......+...+.....+
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 301 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 301 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------------
Confidence 667999999876 468999999999999999997 899998754433332222110000
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......++.+.+++..||..||.+|||+.++++|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011256789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.96 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=202.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
++|+..+.||+|+||.||+|.+..++. .||+|++.... .......+..|+.+++.++||||+++++++.. .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCc
Confidence 578999999999999999999876554 79999986443 23445678899999999999999999999876 4678
Q ss_pred EEEEeccccchhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||++++.+..+ ......+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999998655444 3444578999999999999999999999999999999999999999999999999997664322
Q ss_pred CCCccc--ccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLTS--RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~~--~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
...... ...++.|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....|......|
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 230 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---------- 230 (268)
T ss_pred ccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----------
Confidence 222111 122457999999876 458999999999999999997 999998877766666554311100
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+..+.+|+.+||..||.+||++.++++
T Consensus 231 ------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.08 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=200.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 4689999999999999999987544 3578999876432 34455678899999999999999999998765 457
Q ss_pred EEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||+.++ +...+......+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 8999999865 444444434468999999999999999999999999999999999999999999999999997664332
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------- 227 (270)
T ss_pred ceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-------------
Confidence 211222233567999998865 468999999999999999986 99999988776665554321000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.....++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 ---------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0124568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.58 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=198.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.+|.+...||+|+||.||+|.+. .++..|++|.+.... ......+.+|+.+++.++||||+++++++.. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--GD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CC
Confidence 46899999999999999999853 355679999876332 3344568899999999999999999999876 46
Q ss_pred eEEEEEeccccchhhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 211 SLYLVFEYMEHDLAGLAAT----------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~----------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
..++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 7899999998755443332 123489999999999999999999999999999999999999999
Q ss_pred ceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005582 275 ILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIF 352 (690)
Q Consensus 275 ~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~ 352 (690)
.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999976533221 11223455788999999876 468999999999999999999 999998777665544432
Q ss_pred HHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 353 ~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. .. ......++..+.+|+.+||..||.+|||+.++++
T Consensus 240 ~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QG--RV--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CC--CC--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 20 00 0011236788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.93 Aligned_cols=246 Identities=31% Similarity=0.474 Sum_probs=202.2
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
||.|+||.||++.+..+++.||+|.+...... ......+..|+.+++.++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 68999999999999888999999998765432 3355678899999999999999999988876 57899999999654
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccc
Q 005582 223 LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302 (690)
Q Consensus 223 Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~ 302 (690)
.+.........+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 444433344468999999999999999999999999999999999999999999999999997764321 2234456788
Q ss_pred cCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccch
Q 005582 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKR 382 (690)
Q Consensus 303 ~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~ 382 (690)
.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. +.+
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------------------ 210 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL------------------------ 210 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC------------------------
Confidence 9999999876 4578899999999999999999999987766444444432 000
Q ss_pred hhhhhcCCCchhHHHHHHHhccCCCCCCCCH---HHHhcCcCC
Q 005582 383 CVAETFKDIPSSALSLLDILLSTEPEVRGTA---SSALQNEFF 422 (690)
Q Consensus 383 ~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa---~e~L~hpwf 422 (690)
.....++..+.+||.+||..||+.|||+ +++++||||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.18 Aligned_cols=262 Identities=29% Similarity=0.460 Sum_probs=214.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.-|..++.||-|+||.|.+++..+|...||+|.+++.. +....+..+..|-.||..-+.+-||+||..|.+ .+++|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEE
Confidence 35899999999999999999999999999999997653 245667778899999999999999999887777 588999
Q ss_pred EEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc----
Q 005582 215 VFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC---- 289 (690)
Q Consensus 215 V~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~---- 289 (690)
||+|+.| ++..+++.-+ -|.|..+++|+.+|.+|+++.|..|+|||||||+|||||.+|++||+||||++-+.=
T Consensus 707 VMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999987 4556666544 799999999999999999999999999999999999999999999999999864420
Q ss_pred ----CCC-------C--------------------------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHH
Q 005582 290 ----SQK-------Q--------------------------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAEL 332 (690)
Q Consensus 290 ----~~~-------~--------------------------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~EL 332 (690)
... + ...+.+||+.|+|||+|.. ..|+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 000 0 0113478999999999986 5799999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC-
Q 005582 333 FAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG- 411 (690)
Q Consensus 333 ltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp- 411 (690)
+.|++||...+..+...+|+. |...- . .....+++.++++||.+|. .+++.|.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~l-----~-----------~~~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNFL-----H-----------IPYQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhcc-----c-----------cccccccCHHHHHHHHHHh-cChhhhhc
Confidence 999999998887776666543 32110 0 0112578999999999875 4788887
Q ss_pred --CHHHHhcCcCCCCCCC
Q 005582 412 --TASSALQNEFFTTKPL 427 (690)
Q Consensus 412 --Ta~e~L~hpwf~~~p~ 427 (690)
-++++-.||||+...+
T Consensus 919 kng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred ccchhhhhcCccccccch
Confidence 4678999999987543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=336.73 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=206.7
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
..+.+.+...||+|.||+||+|.+. | .||||+++.....++..+.|.+|+.+|++-+|.||+-+.|++..+ .+.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLA 463 (678)
T ss_pred CHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---cee
Confidence 3456778899999999999999984 3 499999999888889999999999999999999999999999863 359
Q ss_pred EEEeccccchhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC-C
Q 005582 214 LVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS-Q 291 (690)
Q Consensus 214 LV~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~-~ 291 (690)
||+-+|+|..|. .+......|.....+.|++||+.|+.|||.++|||||||..||||.+++.|||+||||+..-.-. .
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999996554 44455567999999999999999999999999999999999999999999999999999653222 2
Q ss_pred CCCcccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 292 KQPLTSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
...+...-+...|||||++.. ..+|++.+|||||||++|||++|..||........+-.+=...+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l------------- 610 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL------------- 610 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-------------
Confidence 223444556778999999853 45799999999999999999999999984433222111111000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
...+.....+.+.++++|+..|+.++++.||+..++|.
T Consensus 611 -----------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 611 -----------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11122334567889999999999999999999999987
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.43 Aligned_cols=250 Identities=19% Similarity=0.283 Sum_probs=196.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
++|++++.||+|+||.||+|.+..++. .|++|.+... ........+..|+.++..++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence 579999999999999999999877776 4777776532 223344567889999999999999999998743 45
Q ss_pred EEEEEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.++|+||+.+ +|...+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999986 455555454557999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 291 QKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+........ ++.....++
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--------- 231 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERLA--------- 231 (279)
T ss_pred CcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC---------
Confidence 2221 223345678999999876 458999999999999999998 999998876544322 222110000
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+..+.+++..||..||.+|||+.++++
T Consensus 232 ------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 ------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01124567899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.38 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=198.7
Q ss_pred CCcEEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.+|.+..+||+|+||.||++.. ..++..||+|.+... .......+.+|+.+++.++|+||+++++++.. .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 4788999999999999999974 235678999987643 34455678999999999999999999998876 46
Q ss_pred eEEEEEeccccchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCc
Q 005582 211 SLYLVFEYMEHDLAGLAATPG---------------VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI 275 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~---------------~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~ 275 (690)
..|+||||+.++.+..+.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 789999999875544332211 35889999999999999999999999999999999999999999
Q ss_pred eEeeccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 005582 276 LKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFK 353 (690)
Q Consensus 276 vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~ 353 (690)
+||+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999755322111 1122334678999999876 458999999999999999998 8999987776665555432
Q ss_pred HhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 354 LCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 354 ~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. +. .....+++.+.+||.+||+.||.+|||+.+++.
T Consensus 240 ~~--~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GR--EL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred Cc--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 10 00 011346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.17 Aligned_cols=265 Identities=24% Similarity=0.393 Sum_probs=196.7
Q ss_pred CCcEEEeeeeccCceEEEEEE----EcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
.+|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 479999999999999999997 3457889999998643 3445567889999999999999999999876554567
Q ss_pred EEEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+||||+.++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999865 44444444456899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCC--cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh---hHhhh
Q 005582 291 QKQP--LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE---EYWKR 365 (690)
Q Consensus 291 ~~~~--~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~---~~w~~ 365 (690)
.... ......+..|+|||++.+ ..++.++|||||||++|||++|..++..... ..... .+.... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~ 235 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRM----MGNDKQGQMIVYHL 235 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhh----cccccccccchHHH
Confidence 2111 111223456999999876 4589999999999999999998776543321 11111 111000 00000
Q ss_pred cCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 366 ~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. ..... ........++..+.+||.+||..+|++|||+.++++
T Consensus 236 ~~-----~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IE-----LLKNN-----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HH-----HHhcC-----CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 00000 000112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.84 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=200.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
++|+++..||.|+||.||+|+... +.+.||+|.+.... .......+.+|+.+|++++||||+++++++.+ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 479999999999999999999653 35689999876432 23345678899999999999999999998866 46
Q ss_pred eEEEEEeccccchhhhhcCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecc
Q 005582 211 SLYLVFEYMEHDLAGLAATPGV---------KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~---------~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DF 281 (690)
..|+||||++++.+..+..... .+++..+..++.||+.||.|||+.+|+||||||+||||+.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 7899999999755544333222 5899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 282 GlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
|++...............++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+......+..+.. +..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--~~~-- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--GKL-- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc--CCc--
Confidence 99875433222233444567789999988763 57899999999999999999 7888877655544443321 000
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.| .....++..+.++|.+||..||.+|||+.+++..
T Consensus 237 -~~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -EL----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -CC----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.05 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=201.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN---KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
.+|++.+.||+|+||.||+|.+..++ ..||+|.++... .......+.+|+.+|++++||||+++++++.. .+.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 47999999999999999999876444 379999987543 33445678899999999999999999999876 4678
Q ss_pred EEEEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||++++.+ ..+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999987544 4444444578999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcc--cccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLT--SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~--~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
....+ ....+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-----------
Confidence 21111 1223567999999876 468999999999999999886 99999887766555554321100
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+.+||..+|.+|||+.++++
T Consensus 229 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 -----------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 001246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=355.48 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=200.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++|++.++||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 479999999999999999999999999999999975432 23345678899999999999999999998876 478999
Q ss_pred EEeccccchhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccc
Q 005582 215 VFEYMEHDLAGLAATP-----------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~-----------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGl 283 (690)
||||++|+.+..+... ...++...+..++.||+.||.|||+.||+||||||+||||+.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998654433211 12356678889999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-----------------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHH
Q 005582 284 ANFFKCSQK-----------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE 346 (690)
Q Consensus 284 A~~~~~~~~-----------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e 346 (690)
+........ ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986621110 01123478999999999877 468999999999999999999999998754433
Q ss_pred HHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 347 QLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 347 ~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.... .....|.. ...+..+++.+.+++.+||..||.+|++..+.|.+
T Consensus 239 i~~~--~~i~~P~~------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYR--DVILSPIE------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hhccChhh------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2211 00000000 00124578899999999999999999988777654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.56 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=197.0
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeecc
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|+.+. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 4689999999999999999998743 34579999997543 2344567899999999996 9999999999876
Q ss_pred CCeEEEEEeccccchh-hhhcCC---------------------------------------------------------
Q 005582 209 SGSLYLVFEYMEHDLA-GLAATP--------------------------------------------------------- 230 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll-~~~~~~--------------------------------------------------------- 230 (690)
.+.+|||||||.++.+ ..+...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 4789999999986533 222110
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc
Q 005582 231 --------------------------------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY 272 (690)
Q Consensus 231 --------------------------------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~ 272 (690)
...+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788889999999999999999999999999999999999
Q ss_pred CCceEeeccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHH
Q 005582 273 NGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHK 350 (690)
Q Consensus 273 ~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~k 350 (690)
++.+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||++......+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999865432211 1223346778999999876 468999999999999999997 8899987654333333
Q ss_pred HHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 351 IFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 351 I~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.+.....+ .....++..+.+||.+||..||++|||+.++.+
T Consensus 352 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22210000 011346788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.47 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=198.6
Q ss_pred CcEEEeeeeccCceEEEEEEE----cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 137 SFEKLDKIGQGTYSSVYKARD----LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~----~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
-|.+++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+|+.+.||||+++++++.......+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478999999999999999974 4578899999986443 34445678999999999999999999998877544678
Q ss_pred EEEEeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999876554443 333468999999999999999999999999999999999999999999999999998764322
Q ss_pred CC--CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 292 KQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 292 ~~--~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.. ......++..|+|||++.+ ..++.++|||||||++|+|+++..++..... .+.+..+....+..... ..
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~~ 236 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVTR-LV 236 (284)
T ss_pred cceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHHH-HH
Confidence 11 1123455678999999876 4689999999999999999998765432211 11111111111100000 00
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
. ..... ........++..+.+||.+||..||.+|||+.+++++
T Consensus 237 ~--~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 R--VLEEG-----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred H--HHHcC-----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 00000 0011234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.28 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=194.8
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .+..|+||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999985 568899999986443 33444568899999999999999999999876 4678999999987
Q ss_pred chh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccc
Q 005582 222 DLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300 (690)
Q Consensus 222 ~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~g 300 (690)
+.+ ..+......+++..+..++.||+.+|.|||++|++|+||||+|||++.++.++|+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 544 4444444568999999999999999999999999999999999999999999999999997543222111122233
Q ss_pred cccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCc
Q 005582 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQP 379 (690)
Q Consensus 301 T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p 379 (690)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 567999999875 458899999999999999998 9999988776655544432100
Q ss_pred cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 380 YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 380 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......++..+.+|+.+||..+|++|||+.++++.
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00123467899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.73 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=197.1
Q ss_pred CCc-EEEeeeeccCceEEEEEE----EcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSF-EKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y-~~~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
++| .+++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 355 899999999999998865 33578899999987543 233445678999999999999999999988765456
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+||||+.++.+....... .+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 789999999987665544333 5999999999999999999999999999999999999999999999999999866432
Q ss_pred CCC--CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCChhHhhhcC
Q 005582 291 QKQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL-CGSPSEEYWKRSK 367 (690)
Q Consensus 291 ~~~--~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~-~g~p~~~~w~~~~ 367 (690)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+... .+......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~-- 235 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIE-- 235 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhh--
Confidence 211 1122334667999998876 45899999999999999999999887643321 1111110 00000000000
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
....... ......++..+.+|+..||..||++|||+.+++.
T Consensus 236 ---~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 ---LLERGMR-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ---hhhcCCC-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 0112457789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.98 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=198.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC--------------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeee
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN--------------NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t--------------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~ 201 (690)
++|++.+.||+|+||.||+|.+..+ ...||||+++.. ........+.+|+.+|+.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4899999999999999999987543 235899998743 2344556788999999999999999999
Q ss_pred eeEeeccCCeEEEEEeccccchhhhhc-CCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCccee
Q 005582 202 GLITSRVSGSLYLVFEYMEHDLAGLAA-TPG-----------VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLL 269 (690)
Q Consensus 202 ~~~~~~~~~~l~LV~Ey~~g~Ll~~~~-~~~-----------~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NIL 269 (690)
+++.. .+..|+||||+.++.+..+. ... ..+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 84 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99876 46789999999875443332 211 13688899999999999999999999999999999999
Q ss_pred eccCCceEeeccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh--CCCCCCCCChHH
Q 005582 270 IDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA--GKPIMPGRTEVE 346 (690)
Q Consensus 270 ld~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt--G~~pF~g~~~~e 346 (690)
++.++.+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999765322211 1222344678999999876 458999999999999999988 667888776665
Q ss_pred HHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 347 QLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 347 ~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.+..+.+....... .......+.+++.+.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGR---------------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccc---------------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55544331110000 0000112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.35 Aligned_cols=277 Identities=23% Similarity=0.308 Sum_probs=189.6
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCC----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEe----
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLEN----NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLIT---- 205 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~t----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~---- 205 (690)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... ......+ .+....+.++..++..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 467999999999999999999999888 89999998763321 1111111 122222333333222211
Q ss_pred eccCCeEEEEEeccccchhhhhc-CCCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q 005582 206 SRVSGSLYLVFEYMEHDLAGLAA-TPGV-------------------KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKG 265 (690)
Q Consensus 206 ~~~~~~l~LV~Ey~~g~Ll~~~~-~~~~-------------------~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp 265 (690)
......+||||||+.++.+..+. .... ......+..++.||+.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 12346789999999876543332 2111 122345678999999999999999999999999
Q ss_pred cceeecc-CCceEeeccccccccccCCCCCcccccccccCcCCccccCCC---------------------CCCCcceee
Q 005582 266 SNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST---------------------DYGASVDLW 323 (690)
Q Consensus 266 ~NILld~-~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~---------------------~ys~~sDIW 323 (690)
+||||+. ++.+||+|||+|+.+...........++|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 689999999999876544333445678899999999764321 244567999
Q ss_pred cchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhc
Q 005582 324 SSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILL 403 (690)
Q Consensus 324 SlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL 403 (690)
|||||||||+++. |+..+....+.+++..++.... .|.....+. ....... ..+.+......+.+||.+||
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~-----~~~~~~~-~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLV-AWRKLVEPR-----ASPDLRR-GFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHH-HHHHhhccc-----cchhhhh-hhhhccccchHHHHHHHHHc
Confidence 9999999999854 5566667777777776665433 333211110 0000000 11222334456789999999
Q ss_pred cCCCCCCCCHHHHhcCcCCCCC
Q 005582 404 STEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 404 ~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
.+||.+|||+.++|+||||+..
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCC
Confidence 9999999999999999999874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.63 Aligned_cols=253 Identities=27% Similarity=0.474 Sum_probs=202.0
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN---MDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
+|.+.+.||+|+||.||++.+..++..+++|+++... ........+..|+.+++.++||||+++++++.+ ....|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 5889999999999999999998877777777765322 223334456789999999999999999998876 46789
Q ss_pred EEEeccccchhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 214 LVFEYMEHDLAGLAA----TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~----~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
+||||+.++.+.... .....+++..++.++.||+.||.|||+.||+|+||+|+||+++. +.++|+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999875554322 23457999999999999999999999999999999999999975 6799999999976643
Q ss_pred CCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~ 369 (690)
.. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.. +.++
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~---------- 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP---------- 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC----------
Confidence 22 12223457889999998865 4578899999999999999999999987766555544432 1000
Q ss_pred cccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
.....++.++.+||.+||..||++||++.++|+||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0113467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.25 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=197.9
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcC-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEee
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLE-------NNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITS 206 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 206 (690)
.++|.+.+.||+|+||.||++.+.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3689999999999999999998643 23579999987542 234455688899999999 79999999999876
Q ss_pred ccCCeEEEEEeccccc-hhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee
Q 005582 207 RVSGSLYLVFEYMEHD-LAGLAATP---------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270 (690)
Q Consensus 207 ~~~~~l~LV~Ey~~g~-Ll~~~~~~---------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl 270 (690)
.+.+|+||||+.++ |...+... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 --DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 46799999999874 44444321 1248889999999999999999999999999999999999
Q ss_pred ccCCceEeeccccccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHH
Q 005582 271 DYNGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQL 348 (690)
Q Consensus 271 d~~g~vKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l 348 (690)
+.++.+||+|||++..+....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999997654221111 112233568999999876 458999999999999999998 88999876654443
Q ss_pred HHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 349 ~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
..+.. +.. .+....++..+.+||.+||..+|.+|||+.+++++
T Consensus 253 ~~~~~--~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKE--GHR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHc--CCC--------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33321 000 01123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.99 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=199.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.++|+++..||.|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 358999999999999999999874 367899999987432 34445668899999999999999999998876 4
Q ss_pred CeEEEEEeccccchh-hhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcc
Q 005582 210 GSLYLVFEYMEHDLA-GLAAT---------------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSN 267 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll-~~~~~---------------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~N 267 (690)
..+|+||||+.++.+ ..+.. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 678999999997544 33321 11247888999999999999999999999999999999
Q ss_pred eeeccCCceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChH
Q 005582 268 LLIDYNGILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEV 345 (690)
Q Consensus 268 ILld~~g~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~ 345 (690)
||++.++.++|+|||++..+..... ........++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876532211 11122334667999999876 468999999999999999998 88888877766
Q ss_pred HHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 346 e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+.+..+..... ......++..+.+||.+||..||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 65554432100 0012346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.06 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=197.8
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++.+.||.|+||.||+|.. .|+.||||.+.... .....+.+|+.+++.++|+||+++++++.+ .+..|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 35799999999999999999986 47899999987543 245678899999999999999999999876 577999
Q ss_pred EEecccc-chhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEH-DLAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g-~Ll~~~~~~~-~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.+ ++...+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 9999996 4444443322 26899999999999999999999999999999999999999999999999999766321
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+... +
T Consensus 156 --~~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------~-------- 216 (256)
T cd05039 156 --QDSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--------Y-------- 216 (256)
T ss_pred --cccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC--------C--------
Confidence 112334567999999875 468899999999999999997 99999877655544433210 0
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. .....+++.+.+||.+||..+|.+|||+.+++.
T Consensus 217 ---~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 ---RM---------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---CC---------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.93 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=200.2
Q ss_pred cEEEeeeeccCceEEEEEEEcCCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENN----KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
|++.+.||.|+||.||++.+...+ ..||+|++..... ......+..|+.+|..++|+||+++++++.. .+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 357789999999999999998766 8999999965432 2355678899999999999999999998877 37899
Q ss_pred EEEeccccchhh-hhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 214 LVFEYMEHDLAG-LAATPGVK-FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 214 LV~Ey~~g~Ll~-~~~~~~~~-l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
++|||+.++.+. .+...... +++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999875444 43332223 8999999999999999999999999999999999999999999999999997765331
Q ss_pred CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------------- 222 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 111112235788999998854 568999999999999999998 8899988776666555432100
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......++..+.+++.+||..||++|||+.++++
T Consensus 223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0011236889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.55 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=199.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|++.+.||.|+||.||++.+. ++..+|+|.+...... ...+.+|+.++++++||||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 47899999999999999999874 4678999998754433 2347789999999999999999998876 4678999
Q ss_pred Eeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 216 FEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||+.++.+..+. .....+++..++.++.||+.+|.|||+.+|+|+||||+|||++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999986555443 334468999999999999999999999999999999999999999999999999997653222111
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.+...
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR----------------- 219 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-----------------
Confidence 222334678999999876 468999999999999999998 9999987776665555432100
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.+ .....+..+.+|+.+||..+|.+|||+.++|+.
T Consensus 220 -----~~------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 -----LY------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----CC------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 012257889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.98 Aligned_cols=240 Identities=28% Similarity=0.405 Sum_probs=201.5
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
...++.||.|+.|.||+|+. .++.||||+++.. -..+|+-|++|+||||+.+.|+|.. ...+|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeee
Confidence 34567899999999999975 5788999998622 1358899999999999999999987 578899999
Q ss_pred ccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccc
Q 005582 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297 (690)
Q Consensus 218 y~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 297 (690)
||..+-+..+++.+..++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++.+.. .....+
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--~STkMS 270 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD--KSTKMS 270 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh--hhhhhh
Confidence 999988888888788899999999999999999999999999999999999999999999999999987643 355678
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~ 377 (690)
++||..|||||++.. .+.+.++|||||||+|||||||.-||..-+ ...-|+- .|+.+ ..
T Consensus 271 FaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd---ssAIIwG-VGsNs------L~---------- 329 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD---SSAIIWG-VGSNS------LH---------- 329 (904)
T ss_pred hhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccc---hheeEEe-ccCCc------cc----------
Confidence 999999999999976 679999999999999999999999986533 2222221 11110 00
Q ss_pred CccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCc
Q 005582 378 QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420 (690)
Q Consensus 378 ~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 420 (690)
..+....|..++-||+.||...|..||+..++|.|-
T Consensus 330 -------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 330 -------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 112345788899999999999999999999999985
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=318.62 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=198.8
Q ss_pred CCCcEEEeeeeccCceEEEEEEEc-------CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEee
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL-------ENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITS 206 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 206 (690)
.++|.+.+.||+|+||.||+|.+. .....||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 358999999999999999999863 235679999987433 344566788999999999 69999999998876
Q ss_pred ccCCeEEEEEeccccchhhhhc-C---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee
Q 005582 207 RVSGSLYLVFEYMEHDLAGLAA-T---------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270 (690)
Q Consensus 207 ~~~~~l~LV~Ey~~g~Ll~~~~-~---------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl 270 (690)
.+.+|+||||+.++.+..+. . ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 46789999999875443332 2 12358899999999999999999999999999999999999
Q ss_pred ccCCceEeeccccccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHH
Q 005582 271 DYNGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQL 348 (690)
Q Consensus 271 d~~g~vKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l 348 (690)
+.++.+||+|||+++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999997654322111 112233467999999876 468999999999999999999 88999887766555
Q ss_pred HHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 349 ~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
..+... .. ......++..+.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREG--HR--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcC--CC--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 544320 00 0112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.70 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=195.8
Q ss_pred CcEEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
+|++...||+|+||.||+|.+.. ....||+|.+.... .......+.+|+.+|+.++||||+++++.+.. .+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998743 33578888886433 33445678899999999999999999998876 467
Q ss_pred EEEEEeccccchhhhhcC------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcc
Q 005582 212 LYLVFEYMEHDLAGLAAT------------------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSN 267 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~------------------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~N 267 (690)
.|+||||+.++.+..++. ....+++..+..++.||+.||.|||+.+|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999999755543321 12358899999999999999999999999999999999
Q ss_pred eeeccCCceEeeccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChH
Q 005582 268 LLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEV 345 (690)
Q Consensus 268 ILld~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~ 345 (690)
|||+.++.+||+|||++..+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765322211 1122344678999998866 468999999999999999998 99999887655
Q ss_pred HHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 346 e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+.... .. .....++..+.+|+..||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGY-------------------RM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCC-------------------CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4433221100 00 011346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=308.99 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=216.1
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 212 (690)
..++.+.+..||.|+.|.||+++...+|...|||.+.... +.+..++++..+.++... ++|.||+.+|+|.. ...+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV 166 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDV 166 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchH
Confidence 3466778889999999999999999999999999998654 345667788888887766 48999999999987 3567
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|-||.|..-+..++..-..+++|..+-.+...++.||.||-+ +||+|||+||+|||+|+.|++||||||++-.+-.+
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 8899998864444444444579999999999999999999987 59999999999999999999999999999776433
Q ss_pred CCCcccccccccCcCCccccC--CCCCCCcceeecchhHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLTSRVVTLWYRPPELLLG--STDYGASVDLWSSGCILAELFAGKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g--~~~ys~~sDIWSlG~iL~ELltG~~pF~g-~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
...+...|.+.|||||-+.- ...|+..+||||||+.|+||.||..||.+ .++.+.+.+|+.... |
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P---------- 313 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-P---------- 313 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-C----------
Confidence 33455678899999999853 35699999999999999999999999998 567888888876211 1
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
++.. -..+++.+.+|+..||..|+.+||.-.++|+|||+..+
T Consensus 314 --------------~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 --------------LLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred --------------CCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 1111 12389999999999999999999999999999999764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.61 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=200.2
Q ss_pred CCCcEEEeeeeccCceEEEEEEEc-------CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEee
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL-------ENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITS 206 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 206 (690)
.++|.+...||+|+||.||+|.+. .++..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 458999999999999999999753 23457999988643 2334556788999999999 89999999999876
Q ss_pred ccCCeEEEEEeccccchhh-hhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceee
Q 005582 207 RVSGSLYLVFEYMEHDLAG-LAAT---------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270 (690)
Q Consensus 207 ~~~~~l~LV~Ey~~g~Ll~-~~~~---------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILl 270 (690)
.+.+|+||||+.++.+. .+.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 46789999999875443 3322 12357888999999999999999999999999999999999
Q ss_pred ccCCceEeeccccccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHH
Q 005582 271 DYNGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQL 348 (690)
Q Consensus 271 d~~g~vKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l 348 (690)
+.++.+||+|||+++.+....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999998764322211 222344678999999876 468999999999999999998 78899887766655
Q ss_pred HHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 349 ~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
..+.... . ......++..+.+||.+||..+|.+|||+.++|+.
T Consensus 250 ~~~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGH--R--------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCC--c--------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5442210 0 00123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=309.44 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=201.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..|++.+.||+|+||.||+|.+..+++ .||||.+... ........+..|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 368999999999999999999876664 6999998643 234556678999999999999999999998865 5678
Q ss_pred EEEEeccccchhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||+.++.+. .+......+++..++.++.|++.||.|||++||+|+||||+||||+.++.+||+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999886554 444444578999999999999999999999999999999999999999999999999997654322
Q ss_pred CCC-ccccc---ccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 292 KQP-LTSRV---VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 292 ~~~-~~~~~---gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
... ..... .+..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL--------- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---------
Confidence 211 11111 2457999999876 468999999999999999886 99999887766655554321100
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+..||..+|.+|||+.+++.
T Consensus 231 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 -------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.82 Aligned_cols=253 Identities=20% Similarity=0.264 Sum_probs=200.4
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcC----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLE----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.++|++.+.||+|+||.||+|.+.. ++..|++|++.. .........+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 4689999999999999999999865 368899998863 33455567789999999999999999999987653 46
Q ss_pred eEEEEEeccccchhhhhc-CC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccc
Q 005582 211 SLYLVFEYMEHDLAGLAA-TP-------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG 282 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~-~~-------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFG 282 (690)
..++++||+.++.+..+. .. ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999865443332 21 1458999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 283 LANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 283 lA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
+++.+....... .....++..|+|||++.+ ..++.++|||||||++|||++ |++||...+..+....+... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRL-- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCC--
Confidence 998654322211 122334677999999876 458999999999999999999 99999877665543333210 000
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....+++.+.+++.+||..||++|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 -------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=305.99 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=194.5
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecccc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
++||+|+||.||+|.+.. ++.||+|++...... .....+.+|+.++++++||||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 368999999999999877 999999998754332 455678899999999999999999998876 4678999999986
Q ss_pred c-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc-cccc
Q 005582 222 D-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL-TSRV 299 (690)
Q Consensus 222 ~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~-~~~~ 299 (690)
+ +...+......+++..+..++.+++.+|.|||+++|+||||||+||||+.++.++|+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 5 4444444445689999999999999999999999999999999999999999999999999976542111111 1122
Q ss_pred ccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCC
Q 005582 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378 (690)
Q Consensus 300 gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~ 378 (690)
.+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.........+......
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 3566999999876 468999999999999999999 88899877655444443211000
Q ss_pred ccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 379 p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+.+||..+|.+|||+.++|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.69 Aligned_cols=243 Identities=20% Similarity=0.364 Sum_probs=195.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
++|++.+.||+|+||.||++.. .|..||+|.+... .....+.+|+.+++.++|+||+++++++... .+.+|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEE
Confidence 4799999999999999999975 4788999998633 2345678999999999999999999976543 4678999
Q ss_pred Eecccc-chhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEH-DLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g-~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+++ ++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999986 454544433 2348899999999999999999999999999999999999999999999999997543221
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
.....+..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.... +
T Consensus 157 --~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~-------------- 217 (256)
T cd05082 157 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--K-------------- 217 (256)
T ss_pred --CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C--------------
Confidence 22334567999998866 468999999999999999997 999998766555444432210 0
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 218 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 ------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=306.73 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=197.1
Q ss_pred eeeeccCceEEEEEEEcC-CC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDLE-NN--KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~-tg--~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
+.||+|+||.||+|.+.. ++ ..||||.+...... .....+.+|+.+|++++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999755 33 36999998765543 556778999999999999999999998875 678999999
Q ss_pred cccc-hhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC--C
Q 005582 219 MEHD-LAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ--P 294 (690)
Q Consensus 219 ~~g~-Ll~~~~~~~-~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~--~ 294 (690)
++++ |...+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9865 444443333 46899999999999999999999999999999999999999999999999999876432211 1
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+...... +
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~---------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----L---------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----C----------
Confidence 122345778999998865 468999999999999999999 99999887777666665431000 0
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.....++..+.+|+..||..+|.+|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 001246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.99 Aligned_cols=248 Identities=30% Similarity=0.440 Sum_probs=194.3
Q ss_pred EEEeeeeccCceEEEEEEEc----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 139 EKLDKIGQGTYSSVYKARDL----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 139 ~~~~~LG~G~fG~Vy~a~~~----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.+.+.||.|.||.||+|... ..+..|+||.++. .........+.+|+.+|++++||||+++++++.. .+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 46789999999999999987 4567899999954 3345557788999999999999999999999984 456999
Q ss_pred EEeccccc-hhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEHD-LAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~-Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.++ |...+... ...+++..+..|+.||+.||.|||+++|+|+||++.||||+.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999865 44444443 46799999999999999999999999999999999999999999999999999977621111
Q ss_pred -CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 293 -QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 -~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
...........|+|||++.+. .++.++||||||+++|||++ |+.||...+..+.+.++.+..-
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 112233456789999998764 48999999999999999999 7899988877776666633100
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......++..+.+||..||..||.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0112357889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.51 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=198.7
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|++.+.||+|+||.||++.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 358999999999999999999854 5567999988643 2334568889999999999999999988765 56899
Q ss_pred EEecccc-chhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEH-DLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g-~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.+ ++...+.. ....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999986 55555443 344688899999999999999999999999999999999999999999999999976643222
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
.......++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------
Confidence 22223344677999999876 468999999999999999999 9999998776655554422100
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......++..+.+++.+||..||.+|||+.+++.
T Consensus 222 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112346789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.23 Aligned_cols=243 Identities=21% Similarity=0.275 Sum_probs=192.9
Q ss_pred eeeccCceEEEEEEEc--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 143 KIGQGTYSSVYKARDL--ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|++++||||+++++++.. ...|+||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999764 456679999986442 34445678899999999999999999998753 56899999998
Q ss_pred cchhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC--ccc
Q 005582 221 HDLAGL-AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--LTS 297 (690)
Q Consensus 221 g~Ll~~-~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~--~~~ 297 (690)
++.+.. +......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....... ...
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 765544 43344579999999999999999999999999999999999999999999999999997654332211 112
Q ss_pred ccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCC
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~ 376 (690)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+... ..
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~------------------ 216 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KR------------------ 216 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CC------------------
Confidence 223578999998875 458999999999999999996 99999887766655444321 00
Q ss_pred CCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 377 ~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.......++++.+||..||..||.+||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 --------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0012346789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=311.31 Aligned_cols=238 Identities=20% Similarity=0.279 Sum_probs=185.9
Q ss_pred eeeccCceEEEEEEEcCC------------------------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 005582 143 KIGQGTYSSVYKARDLEN------------------------NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~t------------------------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv 198 (690)
+||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999974322 2468889886432 23345678899999999999999
Q ss_pred eeeeeEeeccCCeEEEEEeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC---
Q 005582 199 KLEGLITSRVSGSLYLVFEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG--- 274 (690)
Q Consensus 199 ~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g--- 274 (690)
++++++.. ....||||||++++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+||||+..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999876 46789999999987766554 3355789999999999999999999999999999999999998654
Q ss_pred ----ceEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHH-hCCCCCCCCChHHHHH
Q 005582 275 ----ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF-AGKPIMPGRTEVEQLH 349 (690)
Q Consensus 275 ----~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELl-tG~~pF~g~~~~e~l~ 349 (690)
.+||+|||++..... .....++..|+|||++.+...++.++|||||||++|||+ +|.+||.+....+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 489999999854321 123456788999999876567899999999999999994 7899998765543322
Q ss_pred HHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 350 KIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 350 kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
++... .. .....++.+.+||.+||..+|.+|||+.++|++
T Consensus 233 -~~~~~----------~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKK----------HR-------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhc----------cC-------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 11100 00 011234678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.08 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=195.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC----------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE----------------NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMK 199 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~ 199 (690)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 479999999999999999986432 34579999987442 3445567889999999999999999
Q ss_pred eeeeEeeccCCeEEEEEeccccc-hhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcce
Q 005582 200 LEGLITSRVSGSLYLVFEYMEHD-LAGLAATP----------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNL 268 (690)
Q Consensus 200 l~~~~~~~~~~~l~LV~Ey~~g~-Ll~~~~~~----------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NI 268 (690)
+++++.. .+..|+||||+.++ |...+... ...+++..+..++.||+.||.|||+.||+|+||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999876 46789999999864 44433321 12477889999999999999999999999999999999
Q ss_pred eeccCCceEeeccccccccccCCCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh--CCCCCCCCChH
Q 005582 269 LIDYNGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA--GKPIMPGRTEV 345 (690)
Q Consensus 269 Lld~~g~vKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt--G~~pF~g~~~~ 345 (690)
||+.++.++|+|||++..+....... ......++.|+|||++.+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999997654322111 122334678999998776 458999999999999999998 67888776655
Q ss_pred HHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 346 e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+.+..... ++..... .. .......++..+.+|+..||..||.+|||+.++++
T Consensus 241 ~~~~~~~~--------~~~~~~~---~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGE--------FFRDQGR---QV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHH--------HHhhccc---cc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54443321 1110000 00 00112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.28 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=190.1
Q ss_pred eeeeccCceEEEEEEEcC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDLE---NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
+.||+|+||.||+|.+.. ....||||.+... ........+.+|+.+++.++||||+++++++... .+..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998653 3467999987532 2344566788999999999999999999977643 4567999999
Q ss_pred cccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC---CC
Q 005582 219 MEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK---QP 294 (690)
Q Consensus 219 ~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~---~~ 294 (690)
+.++.+ ..+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 987544 44433344577888899999999999999999999999999999999999999999999975532111 11
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
.....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+.. +.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~~--------------- 220 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRR--------------- 220 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCC---------------
Confidence 122345678999998876 468999999999999999999 5678877665554443322 000
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
+ .....++..+.+|+..||..+|++|||+.+++..
T Consensus 221 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --L---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0012357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.38 Aligned_cols=239 Identities=19% Similarity=0.242 Sum_probs=186.2
Q ss_pred eeeeccCceEEEEEEEcC------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 142 DKIGQGTYSSVYKARDLE------------NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~------------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
+.||+|+||.||+|.... ....||+|++.... ......+..|+.+|..++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999998432 23468888875432 3344567889999999999999999999876 3
Q ss_pred CeEEEEEeccccchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCc-------eEeecc
Q 005582 210 GSLYLVFEYMEHDLAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI-------LKIGDF 281 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~-------vKL~DF 281 (690)
...++||||++++.+..+.. ....+++..++.++.||+.||.|||+.+|+||||||+||||+.++. ++|+||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 56799999999877665543 3456999999999999999999999999999999999999987664 899999
Q ss_pred ccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF-AGKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 282 GlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELl-tG~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
|++..+.. .....++..|+|||++.+...++.++|||||||++|||+ +|..||.+....+. ..+... .
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~--~--- 225 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEG--Q--- 225 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhc--C---
Confidence 99865432 223457888999998875567899999999999999998 58888876543322 111110 0
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
. ......+.++.+||.+||..||.+|||+.++|++
T Consensus 226 -------------~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 -------------C-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------c-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0011235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.18 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=198.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC-------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeec
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN-------NKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSR 207 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t-------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~ 207 (690)
.+|.+.+.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 247899988643 2344566788999999999 89999999999876
Q ss_pred cCCeEEEEEeccccchh-hhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeec
Q 005582 208 VSGSLYLVFEYMEHDLA-GLAAT---------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID 271 (690)
Q Consensus 208 ~~~~l~LV~Ey~~g~Ll-~~~~~---------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld 271 (690)
.+.+|+||||+.++.+ ..+.. +...++...+..++.||+.||.|||++||+||||||+||||+
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4679999999987544 33322 123478888999999999999999999999999999999999
Q ss_pred cCCceEeeccccccccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHH
Q 005582 272 YNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLH 349 (690)
Q Consensus 272 ~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~ 349 (690)
.++.+||+|||+++.+...... ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999765432111 1122233567999999876 468999999999999999998 889998877666555
Q ss_pred HHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 350 KIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 350 kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.+..... ......++..+.+||.+||..+|.+|||+.++|.+
T Consensus 248 ~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4432000 00123467789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.12 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=189.2
Q ss_pred eeeccCceEEEEEEEcCCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 143 KIGQGTYSSVYKARDLENNK--LVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.. .+.+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 58999999999999887775 4688877632 2344556788999999999 89999999999876 46789999999
Q ss_pred ccc-hhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccc
Q 005582 220 EHD-LAGLAATP---------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 220 ~g~-Ll~~~~~~---------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGl 283 (690)
.++ |...+... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 864 44443321 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhH
Q 005582 284 ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEY 362 (690)
Q Consensus 284 A~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 362 (690)
+....... .......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------- 228 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 228 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-------
Confidence 86432111 1111223567999998865 568999999999999999997 999998776655444432100
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
. .+....++..+.+|+.+||..||.+|||+.+++.
T Consensus 229 ------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 ------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------C---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 0011246778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.87 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=187.9
Q ss_pred eeeeccCceEEEEEEEcC--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLE--NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999996432 44578888776432 33445567899999999999999999998876 46799999999
Q ss_pred ccchhhhhc-CC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-C
Q 005582 220 EHDLAGLAA-TP----GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-Q 293 (690)
Q Consensus 220 ~g~Ll~~~~-~~----~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-~ 293 (690)
.++.+..++ .. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 875554333 21 12356788899999999999999999999999999999999999999999999865422111 1
Q ss_pred CcccccccccCcCCccccC------CCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 294 PLTSRVVTLWYRPPELLLG------STDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g------~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
......+++.|+|||++.. ...++.++|||||||++|||++ |.+||......+.+.++.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-------- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-------- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc--------
Confidence 1123345677999998742 2357889999999999999999 788998877766666554321110
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
++. ......++..+.+++..|+ .||++|||++++++
T Consensus 230 -~~~--------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 -LPK--------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -CCC--------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000 0012346778888999988 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.66 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=199.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
.+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 479999999999999999999876664 68999876443 24455678899999999999999999998875 57
Q ss_pred EEEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.++||||+.++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 89999999865 44555544556999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCC-cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 291 QKQP-LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~~~-~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.... .....++..|+|||.+.. ..++.++|+|||||++|||++ |.+||.+....+....+... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---------- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERL---------- 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCC----------
Confidence 2211 111223567999998865 468999999999999999998 99999887665554444321 000
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......+..+.+++..||..||..|||+.++++
T Consensus 231 -----------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 -----------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.28 Aligned_cols=239 Identities=18% Similarity=0.247 Sum_probs=186.7
Q ss_pred eeeeccCceEEEEEEEcCCCe-------EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 142 DKIGQGTYSSVYKARDLENNK-------LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~-------~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+.||.|+||.||+|.+..++. .||+|.+.... ......+..|+.+|+.++||||+++++++.. ....++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 368999999999999865544 48888875332 3344567889999999999999999999886 467899
Q ss_pred EEeccccchhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCc--------eEeecccccc
Q 005582 215 VFEYMEHDLAGLAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI--------LKIGDFGLAN 285 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~--------vKL~DFGlA~ 285 (690)
||||+.++.+..+. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999986555444 44446899999999999999999999999999999999999987765 6999999986
Q ss_pred ccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 286 FFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 286 ~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~-~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
.... .....+++.|+|||++.+...++.++|||||||++|+|++|. +||...+...... +... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~------- 221 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--R------- 221 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--c-------
Confidence 5432 223467888999999987566899999999999999999995 6665544433222 1110 0
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
. ......+.++.+||.+||+.||++|||+.++++.
T Consensus 222 -~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 -H-------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -c-------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 0012245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.60 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=201.5
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeec---cCC
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR---VSG 210 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~---~~~ 210 (690)
..++|++.+.||+|||+-||++.+..+++.||+|++.... .+.....++|+...++++||||++++++.... ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3468999999999999999999999999999999998665 45667789999999999999999998875432 134
Q ss_pred eEEEEEeccccc-hhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCcceeeccCCceEeeccccc
Q 005582 211 SLYLVFEYMEHD-LAGLA---ATPGVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 211 ~l~LV~Ey~~g~-Ll~~~---~~~~~~l~e~~i~~i~~qIl~gL~yLHs~g--IvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
..||+++|...+ +++.+ ...+..+++.++..|+.+|++||.+||+.. ++||||||.|||+...+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 689999998865 55433 334557999999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCC--------CCcccccccccCcCCccccCC--CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 005582 285 NFFKCSQK--------QPLTSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 285 ~~~~~~~~--------~~~~~~~gT~~Y~APEvl~g~--~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~ 354 (690)
+...-.-. +.......|..|+|||++.-. ...+.++|||||||+||+|+.|..||. .++..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe---------~~~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE---------RIYQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch---------HHhhc
Confidence 75421100 112233458999999998532 246889999999999999999999985 33333
Q ss_pred hCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 355 ~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.|+..-- ....+..+. . -.-+++.+.+||+.||+.||.+|||+.++|.+
T Consensus 248 GgSlaLA-----------v~n~q~s~P----~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALA-----------VQNAQISIP----N-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEe-----------eeccccccC----C-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 3321100 000000000 0 12278899999999999999999999999874
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.82 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=198.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVS 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~ 209 (690)
++|.+.++||+|+||.||+|.+. .+++.||||+++.... ......+.+|+.+|..+. ||||+++++++.. .
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~ 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK--G 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--C
Confidence 47889999999999999999853 3567899999975432 334456889999999997 9999999999876 4
Q ss_pred CeEEEEEeccccchh-hhhcCC----------------------------------------------------------
Q 005582 210 GSLYLVFEYMEHDLA-GLAATP---------------------------------------------------------- 230 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll-~~~~~~---------------------------------------------------------- 230 (690)
+.+||||||+.++.+ +.+...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 679999999987544 332111
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeec
Q 005582 231 ---------------------------------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID 271 (690)
Q Consensus 231 ---------------------------------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld 271 (690)
...+++..+..|+.||+.||.|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 12367788899999999999999999999999999999999
Q ss_pred cCCceEeeccccccccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHH
Q 005582 272 YNGILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLH 349 (690)
Q Consensus 272 ~~g~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~ 349 (690)
.++.+||+|||+++.+..... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+.+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999986532211 11223456788999999876 458999999999999999998 889998766555544
Q ss_pred HHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 350 KIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 350 kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
..+.. +.. + .....++..+.+||.+||..+|.+||++.++|+.
T Consensus 353 ~~~~~-~~~-----------------~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKR-GYR-----------------M---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHc-CCC-----------------C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43321 000 0 0123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.00 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=201.3
Q ss_pred CcEEEeeeeccCceEEEEEEEcC-CCeEEEEEEeecCC--------CCHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEee
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTN--------MDPESVRFMAREIIILRR-LDHPNIMKLEGLITS 206 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~i~~~~--------~~~~~~~~~~rEi~iL~~-L~HpnIv~l~~~~~~ 206 (690)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999877 68899999886432 123345567789998875 799999999999876
Q ss_pred ccCCeEEEEEeccccchh-hhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeecc
Q 005582 207 RVSGSLYLVFEYMEHDLA-GLA---ATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 207 ~~~~~l~LV~Ey~~g~Ll-~~~---~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DF 281 (690)
.+..|+||||+.+..+ ..+ ......+++..++.++.||+.||.|||+ .+|+|+||+|.|||++.++.++|+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 5789999999987443 332 2344579999999999999999999996 68999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 005582 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361 (690)
Q Consensus 282 GlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~ 361 (690)
|++....... ......++..|+|||++.+ ..++.++|+|||||++|+|++|++||...........+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9998754322 3445678899999999976 4589999999999999999999999987666555444432111000
Q ss_pred HhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 362 ~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
....++..+.+||.+||..||.+|||+.|+..+
T Consensus 234 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.73 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=198.2
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS---P 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---C
Confidence 3579999999999999999999877776 57888876432 23344467899999999999999999998865 3
Q ss_pred eEEEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 211 SLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 211 ~l~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
..++|+||+.++ +...+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 467999999865 5555544445689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 290 SQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 290 ~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.. .+......+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--------- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL--------- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC---------
Confidence 2221 1223345678999999876 468999999999999999997 88999876543332 222210000
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
......+..+.+++..||..||++|||+.++++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.36 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=227.8
Q ss_pred CcCCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 130 ~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
+......+++++..||-|+||.|=++........+|+|++++... +......+..|-.||..++.|.||+||..|.+
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-- 491 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-- 491 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--
Confidence 334456788999999999999999998755555689999887654 45566788999999999999999999988876
Q ss_pred CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
...+||+||-|-|+.+..++...+.|.+..+++|+..+++|+.|||++|||+|||||+|+||+.+|-+||.|||+|+.+.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 58899999999887776666667799999999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
.. ...-++||||.|.|||+++. ...+.++|.||||+++||||+|.|||.+.+...++..|++.+- .|
T Consensus 572 ~g--~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----~i----- 638 (732)
T KOG0614|consen 572 SG--RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----KI----- 638 (732)
T ss_pred cC--CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----hh-----
Confidence 43 34557899999999999997 4689999999999999999999999999999999999987432 11
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC-----HHHHhcCcCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTT 424 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hpwf~~ 424 (690)
+.+..++..+.+||+++-..+|.+|.. +.++-+|.||..
T Consensus 639 -----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 639 -----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred -----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 123457888999999999999999986 899999999965
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.43 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=197.2
Q ss_pred cEEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC-C---
Q 005582 138 FEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS-G--- 210 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~-~--- 210 (690)
|.+.+.||+|+||.||+|.+. .++..||||++............+.+|+.+|+.++||||+++++++..... +
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 357899999997655455566778899999999999999999998765322 1
Q ss_pred eEEEEEeccccchhh-hhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccc
Q 005582 211 SLYLVFEYMEHDLAG-LAAT-----PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~-~~~~-----~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
..++++||+.++.+. .+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247889999865443 2211 1225789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhH
Q 005582 285 NFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEY 362 (690)
Q Consensus 285 ~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 362 (690)
..+...... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRL---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcC----
Confidence 865422211 1222344678999998865 458899999999999999999 88999887765544444321 000
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.....++..+.+|+..||..+|..|||+.+++++
T Consensus 235 -----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.72 Aligned_cols=229 Identities=24% Similarity=0.303 Sum_probs=182.7
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhh
Q 005582 147 GTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGL 226 (690)
Q Consensus 147 G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~ 226 (690)
|.||.||++++..+++.||+|++.... ...+|...+....||||+++++++.. ....|+||||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 999999999999999999999997542 12345555566789999999999876 478999999999765544
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccccCcC
Q 005582 227 AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306 (690)
Q Consensus 227 ~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~A 306 (690)
.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 3333446999999999999999999999999999999999999999999999999988655321 233455778999
Q ss_pred CccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhh
Q 005582 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAE 386 (690)
Q Consensus 307 PEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e 386 (690)
||.+.+ ..++.++|+|||||++|+|++|..+|...... +.. ... ..
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~~---------~~~-------~~ 196 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------INT---------HTT-------LN 196 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------ccc---------ccc-------cC
Confidence 998865 45889999999999999999999876432110 000 000 01
Q ss_pred hcCCCchhHHHHHHHhccCCCCCCCCH-----HHHhcCcCC
Q 005582 387 TFKDIPSSALSLLDILLSTEPEVRGTA-----SSALQNEFF 422 (690)
Q Consensus 387 ~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hpwf 422 (690)
....++..+.+||.+||+.||.+|+|+ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 123467889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.41 Aligned_cols=264 Identities=22% Similarity=0.354 Sum_probs=197.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEc----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
..|.+.+.||+|+||.||+|... .+++.||||++...... .....+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 36888999999999999999864 34889999999755432 34567899999999999999999999887755567
Q ss_pred EEEEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 212 LYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 l~LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.|+||||+.++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999865 44444443336899999999999999999999999999999999999999999999999999876522
Q ss_pred CCCC--cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC----hhHhh
Q 005582 291 QKQP--LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS----EEYWK 364 (690)
Q Consensus 291 ~~~~--~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~----~~~w~ 364 (690)
.... ......+..|+|||.+.+ ..++.++|||||||++|||++|..||....... ....+... ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQMIVTRLL 236 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccccHHHHH
Confidence 1111 112234567999998876 468999999999999999999998876532211 00000000 00000
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
..- ..... ......++..+.+|+.+||..+|.+|||+.++++
T Consensus 237 ~~~-------~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELL-------KEGER-----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHH-------HcCCc-----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 00000 0011345688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.65 Aligned_cols=249 Identities=21% Similarity=0.248 Sum_probs=185.8
Q ss_pred eeeccCceEEEEEEEc--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 143 KIGQGTYSSVYKARDL--ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+ ...+|+||||+.
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCC
Confidence 5899999999999754 3557899999875432 2334467889999999999999999998876 467899999999
Q ss_pred cchhh-hhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC-CC
Q 005582 221 HDLAG-LAAT----PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-QP 294 (690)
Q Consensus 221 g~Ll~-~~~~----~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-~~ 294 (690)
++.+. .+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 75444 3321 123466778888999999999999999999999999999999999999999999965432211 11
Q ss_pred cccccccccCcCCccccCC------CCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 295 LTSRVVTLWYRPPELLLGS------TDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~------~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
.....+++.|+|||++.+. ..++.++|||||||++|||++ |.+||...+..+.+........ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------~~ 229 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ---------LK 229 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc---------CC
Confidence 2234567889999998542 135789999999999999996 9999987665544333221000 00
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
. ..+ ......+..+.+|+..|+ .+|.+|||+++++.
T Consensus 230 ~--------~~~------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 230 L--------PKP------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred C--------CCC------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 000 011235677899999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.99 Aligned_cols=236 Identities=19% Similarity=0.250 Sum_probs=184.9
Q ss_pred eeeeccCceEEEEEEEcCCC----------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe
Q 005582 142 DKIGQGTYSSVYKARDLENN----------KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg----------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
+.||+|+||.||+|.+..++ ..|++|.+..... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36899999999999997776 3578887754321 15668899999999999999999998866 45
Q ss_pred EEEEEeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-------ceEeecccc
Q 005582 212 LYLVFEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-------ILKIGDFGL 283 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-------~vKL~DFGl 283 (690)
.|+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 7999999998766655443 33789999999999999999999999999999999999999888 899999999
Q ss_pred ccccccCCCCCcccccccccCcCCccccCC-CCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 005582 284 ANFFKCSQKQPLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEE 361 (690)
Q Consensus 284 A~~~~~~~~~~~~~~~gT~~Y~APEvl~g~-~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 361 (690)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... .
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~--- 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q--- 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C---
Confidence 976542 1234556789999998764 368999999999999999999 4677765543222111110 0
Q ss_pred HhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 362 ~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. . .......+.+||.+||..+|.+|||+.++|+
T Consensus 223 ----~~----------~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ----HR----------L---------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----CC----------C---------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0 0011268899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.93 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=207.4
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCe---E-EEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNK---L-VALKKVRFT-NMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~---~-VAIK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
..++-.+.++||+|+||.||+|.....+. . ||||..+.. .........+++|..+|+.++|||||+|+|+...
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-- 232 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-- 232 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--
Confidence 34566677999999999999998765422 3 899998853 3567788899999999999999999999999887
Q ss_pred CCeEEEEEeccccchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPG-VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~~-~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
...+|||||+|.|+.+..++... ..++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++.-
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 47799999999986665554443 36999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCCCcc-cccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Q 005582 288 KCSQKQPLT-SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365 (690)
Q Consensus 288 ~~~~~~~~~-~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~ 365 (690)
.. ..... ..-....|+|||.+... .|+.++|||||||++||+++ |..||+|.+..+...+|.......
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~------- 382 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM------- 382 (474)
T ss_pred cc--eeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC-------
Confidence 31 11111 11245779999999764 79999999999999999999 889999999998888885421110
Q ss_pred cCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 366 ~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......|..+..++..|+..||+.|||+.++.+
T Consensus 383 --------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 --------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 011246788899999999999999999999876
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.83 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=191.9
Q ss_pred eeeccCceEEEEEEEcCCC------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 143 KIGQGTYSSVYKARDLENN------KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+|+.++||||+++++++.. ....|+||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 6899999999999976544 789999886432 23345568899999999999999999999876 46789999
Q ss_pred eccccchh-hhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-----ceEeeccccc
Q 005582 217 EYMEHDLA-GLAAT------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-----ILKIGDFGLA 284 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-----~vKL~DFGlA 284 (690)
||+.++.+ ..+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99986544 33322 223478899999999999999999999999999999999999887 8999999999
Q ss_pred cccccCCC-CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhH
Q 005582 285 NFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEY 362 (690)
Q Consensus 285 ~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 362 (690)
..+..... ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~----- 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-R----- 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-c-----
Confidence 76532211 11222345678999999876 458999999999999999998 999998877666554442100 0
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
......++..+.+||.+||..+|.+|||+.++++
T Consensus 232 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 ----------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=334.53 Aligned_cols=266 Identities=27% Similarity=0.456 Sum_probs=217.5
Q ss_pred cCCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeec--
Q 005582 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSR-- 207 (690)
Q Consensus 131 ~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~-- 207 (690)
++..++.|+++..||.|.||.||++++.++++.+|+|++...... ...+.-|+.||+.+ +|||++.++++|...
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 466778999999999999999999999999999999998755432 23466789999988 799999999998653
Q ss_pred -cCCeEEEEEeccccchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccc
Q 005582 208 -VSGSLYLVFEYMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 208 -~~~~l~LV~Ey~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
.++.+|||||||.++....+.+ .+..+.|..+.+|++.++.||.|||.+.++|||||..|||++.+|.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 3578999999999876554432 2567999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcCCccccCC----CCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGS----TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 285 ~~~~~~~~~~~~~~~gT~~Y~APEvl~g~----~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
..++... ..-.+.+|||+|||||++... ..|+..+|+||||++..||.-|.||+-.....-.+-+| .-.|+.
T Consensus 171 aQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPP 246 (953)
T KOG0587|consen 171 AQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPP 246 (953)
T ss_pred eeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCc
Confidence 8776433 334457899999999999642 34788999999999999999999999876655443333 112221
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
.. ..+...+.++.+||..||.+|-++||+..++|+|||++..+
T Consensus 247 kL-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 247 KL-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred cc-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 10 11234567899999999999999999999999999998543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=307.19 Aligned_cols=260 Identities=21% Similarity=0.177 Sum_probs=189.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC---CeEEEEEEeecCCCCH--HH-------HHHHHHHHHHHHhCCCCCeeeeeee
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDP--ES-------VRFMAREIIILRRLDHPNIMKLEGL 203 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~i~~~~~~~--~~-------~~~~~rEi~iL~~L~HpnIv~l~~~ 203 (690)
++|.+.+.||+|+||.||+|.+..+ +..+|+|+........ +. ......++..+..+.|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999998777 6677877654332211 00 0112233445566799999999987
Q ss_pred EeeccCC--eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecc
Q 005582 204 ITSRVSG--SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 204 ~~~~~~~--~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DF 281 (690)
+...... ..+++++++...+...+.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 6553222 3478888887666544432 234678889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 005582 282 GLANFFKCSQK------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355 (690)
Q Consensus 282 GlA~~~~~~~~------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~ 355 (690)
|+|+.+..... .......+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......+....+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~-- 247 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK-- 247 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH--
Confidence 99987643221 11223468999999999876 5689999999999999999999999987743322222111
Q ss_pred CCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 356 g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.+++...... ...++..+..+.++++.|+..+|++||+..++++
T Consensus 248 ----~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 ----CDFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ----HHHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0111110000 0013456788999999999999999999999875
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=300.79 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=194.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+|.+.+.||+|+||.||++. .+++.||+|+++... ....+.+|+.+++.++||||+++++++.. +..|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEE
Confidence 479999999999999999986 478889999986432 23467899999999999999999998765 447999
Q ss_pred Eecccc-chhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEH-DLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g-~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||+.+ ++...+... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999986 455544332 335899999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------- 214 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------- 214 (254)
T ss_pred -CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-----------------
Confidence 122234567999998875 468999999999999999998 999998877655544432200
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.. .....++..+.+|+..||..+|.+|||+.+++.
T Consensus 215 --~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 --RM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --CC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.65 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=207.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.+-+....||+|.||.||+|... .....||||.++... +.....+|.||+.+|..|+|||||+|+|+|.. ++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE--GD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--CC
Confidence 45677889999999999999753 334689999997543 44566789999999999999999999999987 57
Q ss_pred eEEEEEeccccchh-hhhcC---------CCC----CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCce
Q 005582 211 SLYLVFEYMEHDLA-GLAAT---------PGV----KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGIL 276 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll-~~~~~---------~~~----~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~v 276 (690)
.+|||||||.++.| .++.. .+. +|+..+...++.||+.|+.||-++.+|||||-..|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 89999999997544 33321 122 38999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccCCCCCcc-cccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 005582 277 KIGDFGLANFFKCSQKQPLT-SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 277 KL~DFGlA~~~~~~~~~~~~-~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~ 354 (690)
||+||||++..-..+..... .......|||||.|+- ..|+.++|||||||+|||+++ |+.|+.|.++.+.++.|.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999865433333322 3344678999999986 469999999999999999998 88999999999999888651
Q ss_pred hCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHH
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSA 416 (690)
Q Consensus 355 ~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~ 416 (690)
.+-....+.|.++.+|+..|+..+|.+||+..|+
T Consensus 722 ----------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 ----------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ----------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 1223456789999999999999999999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.86 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=186.3
Q ss_pred eeeccCceEEEEEEEcCC--CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccc
Q 005582 143 KIGQGTYSSVYKARDLEN--NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME 220 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~t--g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~ 220 (690)
.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 589999999999975333 2356677665432 23345678999999999999999999999876 467899999999
Q ss_pred cchh-hhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC-CCCc
Q 005582 221 HDLA-GLAATP---GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-KQPL 295 (690)
Q Consensus 221 g~Ll-~~~~~~---~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~-~~~~ 295 (690)
++.+ ..+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 7544 443321 2346777888999999999999999999999999999999999999999999985432111 1112
Q ss_pred ccccccccCcCCccccCC------CCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 296 TSRVVTLWYRPPELLLGS------TDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~------~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
...+++..|+|||++... ..++.++|||||||++|||++ |.+||...+..+.+.+++......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 345678899999987431 235789999999999999997 567888777777766654321100
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.+.+ .....+++.+.+|+..|+ .+|.+|||+.++++
T Consensus 229 ----~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----LFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----cCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000 011236778899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=315.34 Aligned_cols=267 Identities=25% Similarity=0.377 Sum_probs=214.4
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-----CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-----DPESVRFMAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-----~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
-.++|-++..||.|+|+.||+|.|....++||+|+-..... .....+...+|..|-+.|+||.||++|++|.-.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD- 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-
Confidence 34679999999999999999999999999999998654332 234456778999999999999999999999874
Q ss_pred CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCccccCCCcceeecc---CCceEeecccc
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR--GILHRDIKGSNLLIDY---NGILKIGDFGL 283 (690)
Q Consensus 209 ~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~--gIvHrDLKp~NILld~---~g~vKL~DFGl 283 (690)
.+.+|-|+|||+|+.++++++...-+++.+++.|+.||+.||.||.+. -|||-||||.||||.. -|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 578999999999999998888888899999999999999999999987 5999999999999954 57999999999
Q ss_pred ccccccCCCC-----Ccc-cccccccCcCCccccC---CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 005582 284 ANFFKCSQKQ-----PLT-SRVVTLWYRPPELLLG---STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 284 A~~~~~~~~~-----~~~-~~~gT~~Y~APEvl~g---~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~ 354 (690)
+++++.+... .++ ...||.||++||.+.- ....+.++||||+|||+|.+|.|+.||..+-.. ..|+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdILqe 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDILQE 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHHHhh
Confidence 9988654332 122 3468999999999853 345788999999999999999999999654322 122221
Q ss_pred hCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 355 ~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
... .+ ......| .-+.+++++.+||++||.+--+.|....++..||||..
T Consensus 697 NTI-----lk-----AtEVqFP----------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 697 NTI-----LK-----ATEVQFP----------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hch-----hc-----ceeccCC----------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 000 00 0000001 12457899999999999999999999999999999943
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.45 Aligned_cols=277 Identities=25% Similarity=0.416 Sum_probs=220.6
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCC
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 210 (690)
...++|.++.+||.|+|++|.+++...|.+.||+|++++.-. +.+.+.-+..|-.+..+- +||.+|.|+..|.. ..
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--es 324 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ES 324 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cc
Confidence 456799999999999999999999999999999999986533 344556677888888776 79999999999887 57
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.+++|.||++|+-+.+......+|++..+++|...|+.||.|||++|||+||||.+|+|||..|++||+|+|+++.--.
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 8999999999877766666666899999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCC--CC-----ChHHHHHHHHHHhCCCChhHh
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GR-----TEVEQLHKIFKLCGSPSEEYW 363 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~--g~-----~~~e~l~kI~~~~g~p~~~~w 363 (690)
......+.||||.|.|||++.| ..|+.++|+|+|||+++||+.|+.||. |. +..+.+-+++-
T Consensus 404 ~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil---------- 472 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL---------- 472 (593)
T ss_pred CCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh----------
Confidence 2334567899999999999988 579999999999999999999999996 21 22233332221
Q ss_pred hhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCC------HHHHhcCcCCCCC--CCCCCCCCCC
Q 005582 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT------ASSALQNEFFTTK--PLPCDPSSLP 435 (690)
Q Consensus 364 ~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hpwf~~~--p~~~~p~~lp 435 (690)
..+. .....++..+-.+|+..|.+||.+|.. ..++-.|+||... ..-.....+|
T Consensus 473 -----------ekqi-------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~p 534 (593)
T KOG0695|consen 473 -----------EKQI-------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLP 534 (593)
T ss_pred -----------hhcc-------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCC
Confidence 0011 112346777888999999999999974 5889999999753 2222233455
Q ss_pred CCCCCc
Q 005582 436 KYPPSK 441 (690)
Q Consensus 436 ~~p~~~ 441 (690)
+|.|..
T Consensus 535 pf~p~i 540 (593)
T KOG0695|consen 535 PFQPQI 540 (593)
T ss_pred CCCCcc
Confidence 555543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.37 Aligned_cols=202 Identities=32% Similarity=0.486 Sum_probs=172.6
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc----CCeE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SGSL 212 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~~l 212 (690)
.|..-+.||+|+||.||+++++.+|+.||||.++... .....+...+|+++|++|+|+|||+++++-.... ...-
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4667789999999999999999999999999998643 3344566789999999999999999998865543 3456
Q ss_pred EEEEeccccchhhhhcC-C--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeec--cCC--ceEeecccccc
Q 005582 213 YLVFEYMEHDLAGLAAT-P--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID--YNG--ILKIGDFGLAN 285 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~-~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld--~~g--~vKL~DFGlA~ 285 (690)
.+|||||.|+.+.-.+. + ...|++.++..++.++..||.|||++|||||||||.||++- .+| .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 89999999876655443 2 23599999999999999999999999999999999999984 334 67999999999
Q ss_pred ccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCC
Q 005582 286 FFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG 341 (690)
Q Consensus 286 ~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g 341 (690)
.++. +..+++.+||+.|++||++.....|+..+|.|||||++|+++||..||..
T Consensus 173 el~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 173 ELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 8864 44789999999999999987546899999999999999999999998853
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=337.53 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=207.9
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCC-C----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN-N----KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~t-g----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
..-+....||+|.||.||.|....- | ..||||.++... +......|++|..+|+.++|||||+++|++.+ ..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CC
Confidence 4677889999999999999987543 2 349999987543 45667789999999999999999999999987 57
Q ss_pred eEEEEEecccc-chhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccc
Q 005582 211 SLYLVFEYMEH-DLAGLAATP------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 211 ~l~LV~Ey~~g-~Ll~~~~~~------~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGl 283 (690)
..+|++|||+| ||+.++... ...|+..+...++.||+.|+.||+++++|||||...|+||+....|||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 78999999996 666776665 55699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccc-cccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 005582 284 ANFFKCSQKQPLTSR-VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEE 361 (690)
Q Consensus 284 A~~~~~~~~~~~~~~-~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 361 (690)
|+.+-.......... .-...|||||.+.. ..++.++|||||||+|||++| |..||++.+..+.+.-..... ..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL--- 923 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL--- 923 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc---
Confidence 994322222111222 23467999999986 569999999999999999999 789999999888877665421 10
Q ss_pred HhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 362 ~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+....+|..+.+|+..|+..+|++||+...+++
T Consensus 924 ------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 ------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 113458889999999999999999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.08 Aligned_cols=275 Identities=25% Similarity=0.351 Sum_probs=187.6
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEc----------------CCCeEEEEEEeecCCCCH--H----------HHHHHHHH
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDL----------------ENNKLVALKKVRFTNMDP--E----------SVRFMARE 185 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~----------------~tg~~VAIK~i~~~~~~~--~----------~~~~~~rE 185 (690)
..++|++.++||+|+||.||+|... ..++.||||++....... + .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999752 245689999986432110 0 11123457
Q ss_pred HHHHHhCCCCCe-----eeeeeeEeec------cCCeEEEEEeccccchhhhhcCC------------------------
Q 005582 186 IIILRRLDHPNI-----MKLEGLITSR------VSGSLYLVFEYMEHDLAGLAATP------------------------ 230 (690)
Q Consensus 186 i~iL~~L~HpnI-----v~l~~~~~~~------~~~~l~LV~Ey~~g~Ll~~~~~~------------------------ 230 (690)
+.++.++.|.++ ++++++|... ..+..||||||+.++.+..++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 6677776542 12568999999997544332211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccccCcCCccc
Q 005582 231 GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310 (690)
Q Consensus 231 ~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl 310 (690)
...+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 11346678899999999999999999999999999999999999999999999976543222112223447899999988
Q ss_pred cCCCC-------------------CC--CcceeecchhHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 311 LGSTD-------------------YG--ASVDLWSSGCILAELFAGKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 311 ~g~~~-------------------ys--~~sDIWSlG~iL~ELltG~~-pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
..... |+ ...||||+|||+|+|++|.. +|.+...... .++.+. .....|.....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~-~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYD-NDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhcc-chHHHHHhhcc
Confidence 54211 22 24799999999999999874 6643222111 111100 11122322111
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCC---CCCCCHHHHhcCcCCCC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEP---EVRGTASSALQNEFFTT 424 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP---~kRpTa~e~L~hpwf~~ 424 (690)
.. + -...+...++.+++||.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~~---------~---~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QK---------Y---DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cC---------C---CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0 011345678999999999999876 68999999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.22 Aligned_cols=244 Identities=39% Similarity=0.589 Sum_probs=196.0
Q ss_pred CceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhhh
Q 005582 148 TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLA 227 (690)
Q Consensus 148 ~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~ 227 (690)
+||.||+|.+..+++.||+|++........ ...+.+|+.+++.++|+||+++++++.. ....++||||+.++.+...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999975543221 5678899999999999999999999876 4688999999998444433
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccccCcCC
Q 005582 228 ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307 (690)
Q Consensus 228 ~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~AP 307 (690)
......+++..+..++.+|+.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 3333348999999999999999999999999999999999999999999999999998765332 33456678899999
Q ss_pred ccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhh
Q 005582 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAET 387 (690)
Q Consensus 308 Evl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~ 387 (690)
|.+.+ ..++.++||||||+++++|++|..||......+.+...+....... ...
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 209 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------------PPP 209 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------ccc
Confidence 99875 4578899999999999999999999987443333333222110000 000
Q ss_pred cCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 388 FKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 388 ~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
...++..+.+++.+||..+|.+||++.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11167889999999999999999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.99 Aligned_cols=284 Identities=33% Similarity=0.521 Sum_probs=217.4
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeec
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLE---NNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSR 207 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~ 207 (690)
|...+.|..+++||+|+|++||++.+.. ..+.||+|.+..... ...+..|+++|..+ .+.||+++.+.+..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn- 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN- 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc-
Confidence 3445679999999999999999999887 789999999976542 34488999999999 68999999988765
Q ss_pred cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeeccccccc
Q 005582 208 VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANF 286 (690)
Q Consensus 208 ~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~ 286 (690)
.+..++||||+++.-...+.. .++..+++.|++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||||..
T Consensus 107 -nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 107 -NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred -CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 688999999999976665554 4678899999999999999999999999999999999984 57889999999973
Q ss_pred cccCC------------------C-------------------------CCcccccccccCcCCccccCCCCCCCcceee
Q 005582 287 FKCSQ------------------K-------------------------QPLTSRVVTLWYRPPELLLGSTDYGASVDLW 323 (690)
Q Consensus 287 ~~~~~------------------~-------------------------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIW 323 (690)
.+... . .....+.||+.|+|||+++.....++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0 0011246899999999999888889999999
Q ss_pred cchhHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChh----------HhhhcCCCcccc----cC-C-CCccch----
Q 005582 324 SSGCILAELFAGKPIM-PGRTEVEQLHKIFKLCGSPSEE----------YWKRSKLPHATI----FK-P-QQPYKR---- 382 (690)
Q Consensus 324 SlG~iL~ELltG~~pF-~g~~~~e~l~kI~~~~g~p~~~----------~w~~~~l~~~~~----~~-~-~~p~~~---- 382 (690)
|.|||+..+++++.|| ...++.+.+..|....|...-. .|.++..+.... |. . .....+
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999998665 5677788888888877753222 232211110000 00 0 000111
Q ss_pred -hhhhhc-CCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 383 -CVAETF-KDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 383 -~~~e~~-~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
...+.+ ..++..+.+|+++||..||.+|+||+++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 111222 345568999999999999999999999999999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.21 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=208.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~L 214 (690)
++.+-+..||.|+||+|++..++.+|+..|||.++..+.. ....+++.|+....+- +.||||+++|.+.. ++.+||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceee
Confidence 4566678899999999999999999999999999987764 3445567777765554 79999999998776 478999
Q ss_pred EEeccccchhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCceEeecccccccccc
Q 005582 215 VFEYMEHDLAGLAA----TPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~----~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
-||+|+-++-.++. .....++|.-+-.+....+.||.||-. ..||||||||+||||+..|.+||||||++-.+..
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999976554432 233468999888888899999999986 4899999999999999999999999999966542
Q ss_pred CCCCCcccccccccCcCCccccCCC-CCCCcceeecchhHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhcC
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGST-DYGASVDLWSSGCILAELFAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~-~ys~~sDIWSlG~iL~ELltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
+ -..+...|...|||||-+.... .|+..+|+||||++|||+.||+.|+.+-+ ..+++..+.. |-|+--..
T Consensus 221 S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~---- 292 (361)
T KOG1006|consen 221 S--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLF---- 292 (361)
T ss_pred H--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecC----
Confidence 2 2344567788999999986543 49999999999999999999999998744 3455555532 33221100
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
....-+++..+..+|..||.+|-..||...+++++||+...
T Consensus 293 -----------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 293 -----------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -----------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 01112478889999999999999999999999999999765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=303.12 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=198.1
Q ss_pred EeeeeccCceEEEEEEEcCC----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 141 LDKIGQGTYSSVYKARDLEN----NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~t----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
...||.|-||.||.|..... .-.||||..+.. .+++..+.|+.|..+|+.++|||||+|+|+|.. ...||||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wivm 469 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIVM 469 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEEE
Confidence 45799999999999987543 236889987653 345567789999999999999999999999986 5689999
Q ss_pred eccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCc
Q 005582 217 EYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 217 Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|++.-+.+ .++..+...|+......|+.||+.+|.|||+.++|||||-..||||....-|||+||||++.+..+.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 99986554 45555566799999999999999999999999999999999999999999999999999999875544333
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
+..-...-|||||-+.- ..++.++|||.|||++||+|. |..||.|-...+.+..|-+..-
T Consensus 550 S~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR------------------ 610 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER------------------ 610 (974)
T ss_pred cccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC------------------
Confidence 32223566999999864 569999999999999999876 8899998776665544432110
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHH
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSA 416 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~ 416 (690)
....+++|+.+-.|+.+|+++||.+||+..++
T Consensus 611 ----------lP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 611 ----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 11246789999999999999999999987665
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=312.41 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=193.0
Q ss_pred cEEEeeeeccCceE-EEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEE
Q 005582 138 FEKLDKIGQGTYSS-VYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 138 Y~~~~~LG~G~fG~-Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+- .+......+||..|+.- .|||||++++. ..+.+.+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEee--ccCCceEEEE
Confidence 45556789999984 799986 68899999875 35556788999999998 69999999654 4446899999
Q ss_pred EeccccchhhhhcCCCCC--CCH-HHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc---C--CceEeecccccccc
Q 005582 216 FEYMEHDLAGLAATPGVK--FTE-AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY---N--GILKIGDFGLANFF 287 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~--l~e-~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~---~--g~vKL~DFGlA~~~ 287 (690)
.|+|..+|.+++...... +.. ...+..+.|++.||+|||+.+||||||||.||||+. + ..++|+|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999988887663111 111 455788999999999999999999999999999986 3 37899999999988
Q ss_pred ccCCCC--CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 288 KCSQKQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 288 ~~~~~~--~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG-~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
...... ......||-.|+|||++.... -+.++||||||||+|..++| ..||...- +.-.+|+. |.+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~--~~~------ 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILT--GNY------ 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--Hhhhhhhc--Ccc------
Confidence 654332 244567899999999998754 46799999999999999997 68886432 33334433 111
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
++...-+.....+.+||.+||.+||..||||.++|.||||.+.
T Consensus 731 ------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 731 ------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 0111111112289999999999999999999999999999764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=308.12 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=214.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN---KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
....|.++||.|-||.||+|+.+..| ..||||.++... .+.....|+.|..||-+++||||++|.|+.+. ..-+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--Ccee
Confidence 34568889999999999999987666 479999998654 34566779999999999999999999999886 4678
Q ss_pred EEEEeccccchhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCC
Q 005582 213 YLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~ 291 (690)
.||.|||+.+.|+ ++..+.+.|+..++..+++.|+.|++||-++|+|||||...||||+.+-.+|++||||++.+..+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999976655 455566789999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCcccccc--cccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCC
Q 005582 292 KQPLTSRVV--TLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 292 ~~~~~~~~g--T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l 368 (690)
....++.-| ...|.|||.+.. ..++.++||||+||+|||.++ |..||...++.+.+..|-+...-|+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp--------- 855 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP--------- 855 (996)
T ss_pred CccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---------
Confidence 333333333 367999999976 579999999999999999776 8999999999999999876544332
Q ss_pred CcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
..+.|..+-+|+..|+++|-..||+..|++.+
T Consensus 856 -------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 856 -------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 24688999999999999999999999999763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=296.24 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=202.7
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
....+.++||+|-||.|.+|. ...+..||+|+++... .......|.+||++|.+|+||||+.|+++|.. ++.+++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHHH
Confidence 457788999999999999998 4557999999998554 23445679999999999999999999999987 4779999
Q ss_pred Eeccccc-hhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 216 FEYMEHD-LAGLAATPGVK-FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 216 ~Ey~~g~-Ll~~~~~~~~~-l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+|||+.+ |-.++.....+ +.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999965 44444443222 345566779999999999999999999999999999999999999999999865433333
Q ss_pred Cc-ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 294 PL-TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA--GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 294 ~~-~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt--G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.. ...+....|||||.++- ..++.++|+|+||+++||+++ ...||...++.+..+.....+..++.
T Consensus 694 ~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~---------- 762 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR---------- 762 (807)
T ss_pred eeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----------
Confidence 22 23455788999999876 369999999999999999854 67888877776665555443322211
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
..+....+-+|..+.+|+-+|+..|-.+|||.+++-.
T Consensus 763 -----------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 -----------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -----------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1122234567889999999999999999999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=293.74 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=201.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
+..+.++||-|-||.||.|.++.....||||.++-.. -.+..|+.|..+|+.|.|||+|+|+|+|+. +..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEE
Confidence 3456689999999999999999999999999987443 456679999999999999999999999987 46799999
Q ss_pred eccc-cchhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 217 EYME-HDLAGLAATPGV-KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 217 Ey~~-g~Ll~~~~~~~~-~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||. |+|++++...+. .++.....+++.||..|+.||..+++|||||-..|+||.++..|||+||||++++..+....
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9987 678877765443 36666777888899999999999999999999999999999999999999999886544433
Q ss_pred cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccc
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~ 373 (690)
....-...-|.|||-|.- ..++.++|||+|||+|||+.| |-.||+|-+....+..+-+ .
T Consensus 423 HAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-g------------------ 482 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-G------------------ 482 (1157)
T ss_pred ccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-c------------------
Confidence 323333566999998864 568999999999999999988 7789998765443332211 0
Q ss_pred cCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 374 ~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
.-.+....+|+.+..|+..|+.+.|..||+.+|+-+
T Consensus 483 ---------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 483 ---------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ---------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 011234578999999999999999999999988743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=304.69 Aligned_cols=261 Identities=28% Similarity=0.399 Sum_probs=215.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|+.+..||.|+||.||+++++.+++..|+|+++.... ..+.-+.+||-+++..+|||||.+++-+.. .+.+||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 4689999999999999999999999999999999986653 344557899999999999999999998876 367999
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
.||||+++.++.+..-.+++++.++.+..+..+.||.|||+.|=+|||||..|||+++.|.+||+|||.+..+... -..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 9999999988888777779999999999999999999999999999999999999999999999999998665422 223
Q ss_pred cccccccccCcCCcccc--CCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 295 LTSRVVTLWYRPPELLL--GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~--g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
..+..||++|||||+-. ....|...+|||++|+...||-.-++|.........+..+-+....|+.-
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l----------- 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL----------- 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----------
Confidence 45789999999999862 23469999999999999999988887766544444444333322211110
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+.....++.+-+|++.+|.++|.+|||++.+|+|||.+.
T Consensus 238 -------------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 238 -------------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -------------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 011234567888999999999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=297.14 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=205.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC-CC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE-NN--KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~-tg--~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
++....++||+|+||.|++|.+.. +| -.||||.++...... ....|++|+.+|..|+|||+|+|||++.+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chh
Confidence 356677899999999999998864 33 468999998765543 66789999999999999999999999876 467
Q ss_pred EEEEeccccc-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 213 YLVFEYMEHD-LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 213 ~LV~Ey~~g~-Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
.||||++..+ |++-+.+ ....|.......|+.||+.|+.||.++++|||||-..||||-....|||+||||.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 8999999975 4444433 4557889999999999999999999999999999999999999999999999999988654
Q ss_pred CCCC-cc-cccccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcC
Q 005582 291 QKQP-LT-SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 291 ~~~~-~~-~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~ 367 (690)
.... +. ..-....|+|||.|.. ..++.++|||+|||+||||++ |+.||.|.....++++|-+..
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------------ 332 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------------ 332 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc------------
Confidence 3322 11 1223456999999875 569999999999999999999 679999999998888875311
Q ss_pred CCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 368 l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
.....+.++.++.+++..|+..+|..|||...+.+.
T Consensus 333 ----------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 ----------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 011235688999999999999999999999888543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=322.76 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=184.3
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.|.....||+|+||.||+|.+..++..||||++...... ...|+.++++++|||||++++++.. .+..|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 456677899999999999999889999999998643211 2346889999999999999999977 46789999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccccCCCcceeeccCCceEeeccccccccccCCCC
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH---SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLH---s~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||++++.+..+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999766655543 4789999999999999999999 6699999999999999999888876 666543321
Q ss_pred CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC-CChhHhhhcCCCcc
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEV-EQLHKIFKLCGS-PSEEYWKRSKLPHA 371 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~-e~l~kI~~~~g~-p~~~~w~~~~l~~~ 371 (690)
.....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+......... .....|....+
T Consensus 835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 909 (968)
T PLN00113 835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI--- 909 (968)
T ss_pred -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc---
Confidence 123467899999999876 56999999999999999999999998532210 111111110000 00001100000
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
....+ ........+.+|+.+||..||.+|||+.|+++.
T Consensus 910 ---~~~~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 ---RGDVS-------VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---cCCCC-------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000 000122357889999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=256.38 Aligned_cols=215 Identities=27% Similarity=0.454 Sum_probs=180.9
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeE
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 212 (690)
.+++...+..||.|+||.|-+.++..+|...|+|.+...-. ......+++|+.+..+. .+|.+|+++|.+.. .+.+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdv 120 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDV 120 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccE
Confidence 45667788899999999999999999999999999986543 34455678899887776 79999999997665 5789
Q ss_pred EEEEeccccchhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCcceeeccCCceEeeccccccccc
Q 005582 213 YLVFEYMEHDLAGL---AATPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~---~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
||.||.|..++..+ ....+..++|..+-.++..++.||.|||++ .|||||+||+||||+.+|.|||||||.+-.+.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99999999865543 456778899999999999999999999986 89999999999999999999999999997765
Q ss_pred cCCCCCcccccccccCcCCccccC---CCCCCCcceeecchhHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLG---STDYGASVDLWSSGCILAELFAGKPIMP-GRTEVEQLHKIFK 353 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g---~~~ys~~sDIWSlG~iL~ELltG~~pF~-g~~~~e~l~kI~~ 353 (690)
.+- ..+...|...|+|||.+.. ...|+.++||||||+.++||.+++.||+ ..++.+++.++.+
T Consensus 201 dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 332 2233456778999999853 3369999999999999999999999887 4678888888875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=284.38 Aligned_cols=203 Identities=32% Similarity=0.479 Sum_probs=174.8
Q ss_pred CCCCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHH------HHHHHHHHHHHHhCC---CCCeeeeee
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES------VRFMAREIIILRRLD---HPNIMKLEG 202 (690)
Q Consensus 132 ~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~------~~~~~rEi~iL~~L~---HpnIv~l~~ 202 (690)
+....+|..++.||+|+||.|++|.++.+...|+||.+.+...-.+. .-.+-.||+||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 44556799999999999999999999999999999999765432111 112456999999997 999999999
Q ss_pred eEeeccCCeEEEEEecccc--chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeec
Q 005582 203 LITSRVSGSLYLVFEYMEH--DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGD 280 (690)
Q Consensus 203 ~~~~~~~~~l~LV~Ey~~g--~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~D 280 (690)
+|++ .+++||+||--.. +|.+++.. ...++|.+++.+++||+.|+++||+.||||||||-+|+.|+.+|-+||+|
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 9988 5889999998765 44444443 34799999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCC
Q 005582 281 FGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP 340 (690)
Q Consensus 281 FGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~ 340 (690)
||.|.... ..++...+||..|.|||++-|..+.+..-|||+||++||.++....||.
T Consensus 714 fgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99997764 4467788999999999999998888999999999999999998887774
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=274.03 Aligned_cols=266 Identities=24% Similarity=0.286 Sum_probs=194.0
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEeecc--CCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR--LDHPNIMKLEGLITSRV--SGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~~~~~~~--~~~ 211 (690)
.....++.||+|.||.||+|.. +++.||||++. ....+.+..|-.|.+. |.|+||++++++-.... ...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4567788999999999999974 67999999986 3455667778777765 58999999987643321 236
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccccCCCcceeeccCCceEeeccc
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR---------GILHRDIKGSNLLIDYNGILKIGDFG 282 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~---------gIvHrDLKp~NILld~~g~vKL~DFG 282 (690)
++||++|-+.+.+..+++.+ .+++.....++..++.||+|||+- .|+|||||..||||..|+++.|+|||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 89999999877776666554 689999999999999999999973 49999999999999999999999999
Q ss_pred cccccccCCCC-CcccccccccCcCCccccCCCCCC-----CcceeecchhHHHHHHhCCCCCC-CCChHHHHHHHHHHh
Q 005582 283 LANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYG-----ASVDLWSSGCILAELFAGKPIMP-GRTEVEQLHKIFKLC 355 (690)
Q Consensus 283 lA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys-----~~sDIWSlG~iL~ELltG~~pF~-g~~~~e~l~kI~~~~ 355 (690)
||..+.+.... .....+||..|||||+|.|...+. ...||||+|.|||||++.-..+. +....=++----++.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988754332 344589999999999998876665 36899999999999999765443 332222222112223
Q ss_pred CCCChhHhhhcCCCcccccCCCCc-cchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHH
Q 005582 356 GSPSEEYWKRSKLPHATIFKPQQP-YKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSA 416 (690)
Q Consensus 356 g~p~~~~w~~~~l~~~~~~~~~~p-~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~ 416 (690)
..|+-+.++..- ..+...| ++..|... .-...+.+.+..|++-||+.|.||.=+
T Consensus 442 ~hPt~e~mq~~V-----V~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 442 NHPTLEEMQELV-----VRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCCHHHHHHHH-----HhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 344444332210 0011111 11112111 234568899999999999999998543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=239.23 Aligned_cols=213 Identities=39% Similarity=0.634 Sum_probs=179.7
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEecccc-c
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-D 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g-~ 222 (690)
||+|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++.. ....++||||+.+ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999998889999999997554321 34668899999999999999999999876 3788999999995 4
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-CCceEeeccccccccccCCCCCccccccc
Q 005582 223 LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVT 301 (690)
Q Consensus 223 Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~~~~~~~~~~~~~~gT 301 (690)
+...+......++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 44444433246899999999999999999999999999999999999999 89999999999987643321 23345567
Q ss_pred ccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccc
Q 005582 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYK 381 (690)
Q Consensus 302 ~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~ 381 (690)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999986643688999999999999999
Q ss_pred hhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCc
Q 005582 382 RCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420 (690)
Q Consensus 382 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 420 (690)
..+.+++..||..||.+|||+.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3466799999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=287.41 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=196.7
Q ss_pred CcEEEeeeeccCceEEEEEEEc----C---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeecc
Q 005582 137 SFEKLDKIGQGTYSSVYKARDL----E---NNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~----~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
+..+.+.||+|.||.|++|.-. . ....||||.++..... .....+..|+++|+.+ .||||+.|++.+..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 3456669999999999999742 1 1467999998866544 6677899999999999 59999999999987
Q ss_pred CCeEEEEEecccc-chhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc
Q 005582 209 SGSLYLVFEYMEH-DLAGLAATPG---------------VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY 272 (690)
Q Consensus 209 ~~~l~LV~Ey~~g-~Ll~~~~~~~---------------~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~ 272 (690)
.+.+++|+||+.. +|+..+.... ..++..+...++.||+.|++||++..+|||||-..||||..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 5789999999986 4555544433 24899999999999999999999999999999999999999
Q ss_pred CCceEeeccccccccccCCCCCccccc--ccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCC-hHHHH
Q 005582 273 NGILKIGDFGLANFFKCSQKQPLTSRV--VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRT-EVEQL 348 (690)
Q Consensus 273 ~g~vKL~DFGlA~~~~~~~~~~~~~~~--gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~-~~e~l 348 (690)
+..+||+|||+|+.............. ....|||||.+.. ..|+.++|||||||+||||++ |..|+++-. ..+.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999999865433222212222 2345999999987 679999999999999999998 679998854 33333
Q ss_pred HHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 349 ~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
..+.. |. ..+.....+.++.+++..|+..+|++||+..++.+
T Consensus 533 ~~l~~--G~--------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKE--GN--------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhc--CC--------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 32221 10 01123456889999999999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=241.68 Aligned_cols=212 Identities=39% Similarity=0.627 Sum_probs=174.4
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~E 217 (690)
|.+...||.|++|.||++.+..+++.+|||.+...... .....+.+|+..++.++|+||+++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56789999999999999999888999999999765432 246678899999999999999999998776 467899999
Q ss_pred cccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcc
Q 005582 218 YMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296 (690)
Q Consensus 218 y~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~ 296 (690)
|+.+ .|...+......+++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++..+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998 444444333222899999999999999999999999999999999999999999999999999876543211234
Q ss_pred cccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCC-CChH-HHHHHHH
Q 005582 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG-RTEV-EQLHKIF 352 (690)
Q Consensus 297 ~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g-~~~~-e~l~kI~ 352 (690)
...++..|++||.+.+...++.++|+|+||+++++|++|++||.+ .+.. .....|.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 456788999999884445678899999999999999999999987 4444 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=279.06 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=200.4
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
....++||+|+||+||+|.+...|+ +||||++.... .......++.|+.+|..|+|||+++|++++.. ..+-
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCML---STLQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chHH
Confidence 4567899999999999999876664 78999886443 34455678999999999999999999999876 3478
Q ss_pred EEEeccccc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 214 LVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 214 LV~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||++||+++ |++.+......+-......|..||++|+.|||.+++|||||-..||||....++||+|||+|+.+..+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999964 6677777777899999999999999999999999999999999999999999999999999999876655
Q ss_pred CCccccc-ccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 293 QPLTSRV-VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 ~~~~~~~-gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
+...... ..+-|||=|.+.. ..|+.++|||||||++|||+| |..|+.|....+. ..+++... +
T Consensus 854 ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~ge----------R--- 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGE----------R--- 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccc----------c---
Confidence 4433222 2456888888865 579999999999999999988 7888888665443 23332100 0
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
....+..+.++..++.+||..|+..||++.++..
T Consensus 919 --------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 --------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1123557888999999999999999999988754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=301.88 Aligned_cols=203 Identities=19% Similarity=0.246 Sum_probs=147.9
Q ss_pred hCCC-CCeeeeeeeEeec-----cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q 005582 191 RLDH-PNIMKLEGLITSR-----VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIK 264 (690)
Q Consensus 191 ~L~H-pnIv~l~~~~~~~-----~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLK 264 (690)
.++| +||++++++|... ....++++|||++++|...+..+...+++.+++.|+.||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 5788888876221 124678899999998888876666679999999999999999999999999999999
Q ss_pred Ccceeecc-------------------CCceEeeccccccccccCCC---------------CCcccccccccCcCCccc
Q 005582 265 GSNLLIDY-------------------NGILKIGDFGLANFFKCSQK---------------QPLTSRVVTLWYRPPELL 310 (690)
Q Consensus 265 p~NILld~-------------------~g~vKL~DFGlA~~~~~~~~---------------~~~~~~~gT~~Y~APEvl 310 (690)
|+||||+. ++.+||+|||+++....... ......++|++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 44566777777654211000 001124689999999998
Q ss_pred cCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCC
Q 005582 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKD 390 (690)
Q Consensus 311 ~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~ 390 (690)
.+ ..|+.++||||||||||||++|.++|.... ..+..+.... .+ .. +..
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~-~~--------------------------~~~ 236 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LP-PQ--------------------------ILL 236 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cC-hh--------------------------hhh
Confidence 87 458999999999999999999988765321 1111111100 00 00 001
Q ss_pred CchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 391 IPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 391 ~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
..+.+.+++..||..||.+|||+.|+|+||||..
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 1234678899999999999999999999999976
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=254.91 Aligned_cols=251 Identities=25% Similarity=0.298 Sum_probs=183.2
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHH--hCCCCCeeeeeeeEeecc--CCe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR--RLDHPNIMKLEGLITSRV--SGS 211 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~--~L~HpnIv~l~~~~~~~~--~~~ 211 (690)
.+..+.+.||+|.||.||+|.+ .|+.||||+|.... + ..+.+|.+|.+ .|+|+||+.+++.-.... -..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd--E---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD--E---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc--h---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 4678999999999999999988 58899999996332 2 23556666665 469999999987533221 136
Q ss_pred EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccCCCcceeeccCCceEeecccc
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR--------GILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~--------gIvHrDLKp~NILld~~g~vKL~DFGl 283 (690)
+|||++|-+++.+..++.. ..++......++..++.||.|||.. .|.|||||..||||..+|.+.|+|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999998877777766 4799999999999999999999963 399999999999999999999999999
Q ss_pred ccccccCCC---CCcccccccccCcCCccccCCCCC----C-CcceeecchhHHHHHHhC----------CCCCCCCC--
Q 005582 284 ANFFKCSQK---QPLTSRVVTLWYRPPELLLGSTDY----G-ASVDLWSSGCILAELFAG----------KPIMPGRT-- 343 (690)
Q Consensus 284 A~~~~~~~~---~~~~~~~gT~~Y~APEvl~g~~~y----s-~~sDIWSlG~iL~ELltG----------~~pF~g~~-- 343 (690)
|........ .+....+||..|||||+|...... + ..+||||||.|+||++.. ++||.+-.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 987765432 235678999999999998653221 1 258999999999999752 24443311
Q ss_pred --hHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCc--hhHHHHHHHhccCCCCCCCCHHHHh
Q 005582 344 --EVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIP--SSALSLLDILLSTEPEVRGTASSAL 417 (690)
Q Consensus 344 --~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~--~~~~dLI~~mL~~DP~kRpTa~e~L 417 (690)
..+.+.+++ ..+.++..+...|...+ ..+..|++.|+..+|.-|.||--+-
T Consensus 443 DPs~eeMrkVV-----------------------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 443 DPSFEEMRKVV-----------------------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCHHHHhcce-----------------------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 122222111 11112222222333322 2466789999999999999986654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=239.42 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=195.3
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.+.|.+.+.||+|.||.+.+|.++.+...+++|.+.... .....|.+|...--.| .|.||+.-|++-... .+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 468999999999999999999999999999999987543 4456788888877677 589999888764332 56788
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc--CCceEeeccccccccccCC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY--NGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~--~g~vKL~DFGlA~~~~~~~ 291 (690)
+++||++-+.+..-.... .+-|...+.++.|+++||.|||+.++||||||.+||||-. ...+||||||+.+..+.
T Consensus 99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 999999965544443433 4789999999999999999999999999999999999953 34899999999965431
Q ss_pred CCCcccccccccCcCCccccC----CCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhHhhhc
Q 005582 292 KQPLTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQL-HKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g----~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l-~kI~~~~g~p~~~~w~~~ 366 (690)
.....-.+..|.+||++.. .-...+.+|+|.||+|+|.+|||.+||......+.- .+.. .|...
T Consensus 176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~---------~w~~r 244 (378)
T KOG1345|consen 176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE---------QWLKR 244 (378)
T ss_pred --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH---------HHhcc
Confidence 1122233567999998743 223577899999999999999999999743221111 1111 12222
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCC---CCHHHHhcCcCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR---GTASSALQNEFFT 423 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR---pTa~e~L~hpwf~ 423 (690)
+.+ .+...|.-+++.+..+.++-|..+|..| .++.......|..
T Consensus 245 k~~-------------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 245 KNP-------------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cCc-------------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 221 2344567789999999999999999999 7777777777863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-25 Score=223.97 Aligned_cols=263 Identities=36% Similarity=0.506 Sum_probs=207.0
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHH-HHHHHHHHHHHHHhCCCC-CeeeeeeeEeeccCCeEEEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE-SVRFMAREIIILRRLDHP-NIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~Hp-nIv~l~~~~~~~~~~~l~LV 215 (690)
|.+...||.|+|+.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788999999999999999986 7899999876554332 566789999999999988 79999999854 4558999
Q ss_pred EeccccchhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-ceEeeccccccccccCC
Q 005582 216 FEYMEHDLAGLAATPGV---KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~---~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-~vKL~DFGlA~~~~~~~ 291 (690)
++|+.+..+........ .++...+..++.|++.+|.|+|+.+++||||||+|||++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999876654444332 689999999999999999999999999999999999999988 79999999998654332
Q ss_pred CC-----CcccccccccCcCCccccCC--CCCCCcceeecchhHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC-Ch
Q 005582 292 KQ-----PLTSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTE---VEQLHKIFKLCGSP-SE 360 (690)
Q Consensus 292 ~~-----~~~~~~gT~~Y~APEvl~g~--~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~---~e~l~kI~~~~g~p-~~ 360 (690)
.. .....++|.+|+|||.+.+. ..++...|+||+|++++++++|..||..... .......+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 34677899999999999774 4789999999999999999999999887764 33444443333222 00
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
... ..... ......+.+++..++..+|..|.++.+...++|+...
T Consensus 237 ~~~-----------------~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 SPL-----------------SPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccc-----------------Ccccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 000 00000 2234678899999999999999999999999777553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=271.84 Aligned_cols=265 Identities=27% Similarity=0.364 Sum_probs=202.8
Q ss_pred EEEeeeeccCceEEEEEEEcCCCeEEEEEEeec----CCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRF----TNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 139 ~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~----~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.....+|.|+||.|+.+......+.++.|.++. ..........+..|+.+-..|.|||++..+..+... ...+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchh
Confidence 456789999999999988877777777776652 222222233377888888899999998887776653 33444
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC--
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
+||||..+|..++.. ...++..++.+++.||+.||+|||+.||.|||||++|||++.+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 599999966655554 35789999999999999999999999999999999999999999999999999988765444
Q ss_pred -CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcc
Q 005582 293 -QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 -~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~ 371 (690)
......+|+..|+|||++.+..+-....||||.|++++.|++|+.||.-....+....-. . ..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------~--------~~ 541 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------N--------YS 541 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------c--------cc
Confidence 345677899999999999886666678999999999999999999987544332211000 0 00
Q ss_pred cccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCC
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 372 ~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p 426 (690)
..+..... ....+..++...+.+|.+||++||.+|.|++++|+++||+...
T Consensus 542 ~~~~~~~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 542 DQRNIFEG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred cccccccC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 00111111 1223456888999999999999999999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=220.63 Aligned_cols=165 Identities=22% Similarity=0.318 Sum_probs=125.8
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCccccccc
Q 005582 222 DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVT 301 (690)
Q Consensus 222 ~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT 301 (690)
+|...+...+..|++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ...+|
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~ 67 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVD 67 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCc
Confidence 455555544557999999999999999999999999 999999999999999 9999765432 23689
Q ss_pred ccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhcCCCcccccCCCCcc
Q 005582 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPY 380 (690)
Q Consensus 302 ~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~ 380 (690)
+.|+|||++.+ ..|+.++|||||||++|||++|++||....... .+..+....... . +.
T Consensus 68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~----------------~~ 127 (176)
T smart00750 68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---D----------------PR 127 (176)
T ss_pred ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---C----------------cc
Confidence 99999999977 568999999999999999999999997654432 223332211000 0 00
Q ss_pred chhhhhhcCCCch--hHHHHHHHhccCCCCCCCCHHHHhcCcCCC
Q 005582 381 KRCVAETFKDIPS--SALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 381 ~~~~~e~~~~~~~--~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~ 423 (690)
.... ...++. .+.+||..||..||.+|||+.++++|+|+.
T Consensus 128 ~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 DRSN---LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccc---HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0000 011223 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=235.00 Aligned_cols=166 Identities=22% Similarity=0.240 Sum_probs=130.7
Q ss_pred CCCCCcEEEeeeeccCceEEEEEEEcC-CCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhCCCCCeee-eeeeEeec
Q 005582 133 RKADSFEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNM---DPESVRFMAREIIILRRLDHPNIMK-LEGLITSR 207 (690)
Q Consensus 133 ~~~~~Y~~~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~-l~~~~~~~ 207 (690)
...+.|.+.+.||+|+||+||+|.+.. ++..||||++..... .......+.+|+.+|+.|+|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345689999999999999999999876 788889998753211 2334566899999999999999985 4331
Q ss_pred cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC-CCcceeeccCCceEeeccccccc
Q 005582 208 VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDI-KGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 208 ~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDL-Kp~NILld~~g~vKL~DFGlA~~ 286 (690)
+..|||||||+|+.+.... . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 3579999999987665332 1 11 1467899999999999999999999 99999999999999999999987
Q ss_pred cccCCC-------CCcccccccccCcCCcccc
Q 005582 287 FKCSQK-------QPLTSRVVTLWYRPPELLL 311 (690)
Q Consensus 287 ~~~~~~-------~~~~~~~gT~~Y~APEvl~ 311 (690)
+..... ...+..++++.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 653321 1234567788899999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=229.77 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=200.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN-----KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 210 (690)
.+++....+-+|.||.||.|.+.+.. +.|-+|.++. +..+-++..++.|-.+|..+.|||+..+.++.... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cC
Confidence 56888889999999999999775433 3455676653 34556677889999999999999999999998764 45
Q ss_pred eEEEEEecccc-chhhhhc-----CCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccc
Q 005582 211 SLYLVFEYMEH-DLAGLAA-----TPG--VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG 282 (690)
Q Consensus 211 ~l~LV~Ey~~g-~Ll~~~~-----~~~--~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFG 282 (690)
..++++.+++- +|..++. .+. ..++..++..++.||+.|+.|||++||||.||-..|++||+.-.+||+|-.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 66788888874 4444333 221 247778889999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCccccc-ccccCcCCccccCCCCCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 283 LANFFKCSQKQPLTSRV-VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 283 lA~~~~~~~~~~~~~~~-gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
|++.+.+.+...+.... -...||+||.+.. ..|+.++|+|||||+||||+| |+.|+..-++.|...-+.+.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG------ 514 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG------ 514 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc------
Confidence 99987766655444332 2456999999976 579999999999999999988 78888887777776655431
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhc
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 418 (690)
+...+| -+.|+++..++.-|+..+|++||+.+|+..
T Consensus 515 -------------yRlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 -------------YRLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -------------ceecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 112222 368999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=248.68 Aligned_cols=240 Identities=29% Similarity=0.445 Sum_probs=200.4
Q ss_pred eeeccCceEEEEEEE---cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEEEEec
Q 005582 143 KIGQGTYSSVYKARD---LENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~---~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~LV~Ey 218 (690)
.+|+|+||.|++++. .+.|..+|+|++++.............|..++..++ ||.+|+++..|.. ...+|++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 378999999998763 346788999998866543222224567888999997 9999999988877 4789999999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccc
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 298 (690)
..++.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 99987777777777899999999999999999999999999999999999999999999999999987643322 2
Q ss_pred cccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCC
Q 005582 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378 (690)
Q Consensus 299 ~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~ 378 (690)
|||..|||||++.| +..++|.||||+++|||++|..||.+ +.+..|.+..-..+
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------------- 207 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------------- 207 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------------
Confidence 99999999999874 67899999999999999999999988 67777776332222
Q ss_pred ccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCH-----HHHhcCcCCCCC
Q 005582 379 PYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA-----SSALQNEFFTTK 425 (690)
Q Consensus 379 p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hpwf~~~ 425 (690)
..++..+.+++..|+..+|..|.-+ .++++|+||+..
T Consensus 208 ----------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 208 ----------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred ----------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 2356789999999999999999754 899999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-22 Score=216.68 Aligned_cols=255 Identities=24% Similarity=0.228 Sum_probs=190.1
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCC-eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC----CCeeeeeeeEeeccCCe
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENN-KLVALKKVRFTNMDPESVRFMAREIIILRRLDH----PNIMKLEGLITSRVSGS 211 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg-~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H----pnIv~l~~~~~~~~~~~ 211 (690)
+|.+..+||+|+||.||+|.+..++ ..+|+|........... .+..|+.+|..+.. +++..+++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999987774 67888887654322111 46778899988863 68888888774 22467
Q ss_pred EEEEEeccccchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-----CceEeecccccc
Q 005582 212 LYLVFEYMEHDLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-----GILKIGDFGLAN 285 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-----g~vKL~DFGlA~ 285 (690)
-||||+.++.+|.++.... ...|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7999999999999887543 4689999999999999999999999999999999999999865 469999999998
Q ss_pred --ccccCCCC---C----cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 005582 286 --FFKCSQKQ---P----LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG 356 (690)
Q Consensus 286 --~~~~~~~~---~----~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g 356 (690)
.+...... + .....||..|+++.+..+ ...+...|+||++.++.+|+.|..||.+........++.+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 33222211 1 123459999999999887 5689999999999999999999999877654433333322111
Q ss_pred CCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 357 SPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 357 ~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
... ........+..+..++..+-..+...+|....+...
T Consensus 255 ~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLL------------------------TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhc------------------------cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 000 000122345667777777777788888877666443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-23 Score=239.24 Aligned_cols=222 Identities=32% Similarity=0.438 Sum_probs=169.0
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.++|+.++.|..|+||.||+++|+.+.+.+|+ ++++.++ ++| ||+.+- +..++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilR-----------nilt~a--------~npfv 134 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILR-----------NILTFA--------GNPFV 134 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhh-----------cccccc--------CCcce
Confidence 36899999999999999999999999999999 4443321 121 232221 11223
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC--
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
| ||...++... ++++.. ++.+++|||+.||+|||+||+|+||+.-|++|++|||+++.......
T Consensus 135 v-----gDc~tllk~~-g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 135 V-----GDCATLLKNI-GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred e-----chhhhhcccC-CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3 4444444332 244443 37899999999999999999999999999999999999865321110
Q ss_pred -----------C-CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 293 -----------Q-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 293 -----------~-~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
+ .-...|+||.|+|||+++. ..|+..+|+|++|+|+||.+-|..||.|++..+++..++......++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0 0123489999999999976 56999999999999999999999999999999999888764333222
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC---CHHHHhcCcCCCC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG---TASSALQNEFFTT 424 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---Ta~e~L~hpwf~~ 424 (690)
. -..+++++.+||..||..+|..|. .+-++.+|+||+.
T Consensus 280 ~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 E--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred c--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 2 234789999999999999999994 5778889999975
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=196.75 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=189.8
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEeeccCCeEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH-PNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~~~~l~ 213 (690)
...|.++++||.|+||.+|+|....+|..||||+-......+ .+..|..+...|.+ ..|..+..+... ..+-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTE--KDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccc--cccce
Confidence 458999999999999999999999999999999866443333 36778889988865 667777666655 35668
Q ss_pred EEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC---CceEeeccccccccccC
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN---GILKIGDFGLANFFKCS 290 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~---g~vKL~DFGlA~~~~~~ 290 (690)
|||++++.+|.+++......|+...+.-++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+.+...
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 999999999988888777789999999999999999999999999999999999998643 47999999999887543
Q ss_pred CCC------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChh
Q 005582 291 QKQ------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ---LHKIFKLCGSPSEE 361 (690)
Q Consensus 291 ~~~------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~---l~kI~~~~g~p~~~ 361 (690)
... .-....||..|.+--.+.| ..-+...|+=|+|.+|..+.-|..||.|-..... .++|.+.--+.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~--- 243 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST--- 243 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC---
Confidence 322 2334578999998777766 3467889999999999999999999998655443 44443311111
Q ss_pred HhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCC
Q 005582 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411 (690)
Q Consensus 362 ~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp 411 (690)
.+....+.+|.++.-.|.-|=..--++-|
T Consensus 244 ---------------------~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 244 ---------------------PIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred ---------------------CHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 12334567788888888777444333434
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-22 Score=196.90 Aligned_cols=141 Identities=21% Similarity=0.220 Sum_probs=109.1
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHH------------------------HHHHHHHHHHHHhCCCCC
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES------------------------VRFMAREIIILRRLDHPN 196 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~------------------------~~~~~rEi~iL~~L~Hpn 196 (690)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 8999999999754321111 112345999999998887
Q ss_pred eeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccCCCcceeeccCCc
Q 005582 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC-HSRGILHRDIKGSNLLIDYNGI 275 (690)
Q Consensus 197 Iv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yL-Hs~gIvHrDLKp~NILld~~g~ 275 (690)
+.....+... . .+|||||++++.+.........+++..+..++.||+.+|.+| |+.||+||||||+||||+ ++.
T Consensus 81 v~~p~~~~~~---~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK---S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec---C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7443332211 2 389999999865433322335789999999999999999999 799999999999999998 578
Q ss_pred eEeecccccccc
Q 005582 276 LKIGDFGLANFF 287 (690)
Q Consensus 276 vKL~DFGlA~~~ 287 (690)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=196.44 Aligned_cols=208 Identities=24% Similarity=0.317 Sum_probs=172.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCCeEEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.|.+.++||+|+||.++.|.+.-++++||||.-.... ....+..|....+.| ..++|..++.+- +.+.+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhh
Confidence 7999999999999999999999999999999754322 233467788888887 468898886543 335566899
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC-----ceEeeccccccccccC
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-----ILKIGDFGLANFFKCS 290 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g-----~vKL~DFGlA~~~~~~ 290 (690)
+|+++.+|.+++.-.+..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.|+|||+|+.+...
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 99999999988888888999999999999999999999999999999999999997654 6999999999987543
Q ss_pred CCC------CcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCC---hHHHHHHH
Q 005582 291 QKQ------PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT---EVEQLHKI 351 (690)
Q Consensus 291 ~~~------~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~---~~e~l~kI 351 (690)
... ...+..||..||+--..+| ..-+..-|+=|||-+++..|-|..||.|-. ..+.+++|
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 322 2345678999999988888 457889999999999999999999998754 44444444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=189.36 Aligned_cols=141 Identities=21% Similarity=0.265 Sum_probs=111.5
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH----------------------H--HHHHHHHHHHHHHhCCCCC
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP----------------------E--SVRFMAREIIILRRLDHPN 196 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~----------------------~--~~~~~~rEi~iL~~L~Hpn 196 (690)
...||+|+||.||+|.+. +|+.||||+++...... . ....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999986 89999999998652210 0 0123468999999999998
Q ss_pred eeeeeeeEeeccCCeEEEEEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCC
Q 005582 197 IMKLEGLITSRVSGSLYLVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 197 Iv~l~~~~~~~~~~~l~LV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g 274 (690)
|.....+... ..||||||++++.+ .... ....++...+..++.|++.+|.+||+ .||+||||||+||||+ ++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 8555444332 23899999998633 2222 23467888999999999999999999 9999999999999999 89
Q ss_pred ceEeeccccccccc
Q 005582 275 ILKIGDFGLANFFK 288 (690)
Q Consensus 275 ~vKL~DFGlA~~~~ 288 (690)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.8e-21 Score=193.75 Aligned_cols=173 Identities=14% Similarity=0.145 Sum_probs=131.8
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH-HHHHH------HHHHHHHHHhCCCCCeeeeeeeEeecc
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRF------MAREIIILRRLDHPNIMKLEGLITSRV 208 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~~------~~rEi~iL~~L~HpnIv~l~~~~~~~~ 208 (690)
++|++++.||.|+||.||++.+ ++..+|||+++...... ..... +.+|+..+.++.|++|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4899999999999999999754 46689999997544332 22222 578999999999999999998866432
Q ss_pred ------CCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccc
Q 005582 209 ------SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG 282 (690)
Q Consensus 209 ------~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFG 282 (690)
.+..+|||||++|..+.... .+++ ..+.+|+.+|..||..||+||||||+|||++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 24579999999986554432 2333 2456999999999999999999999999999999 9999999
Q ss_pred cccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHH
Q 005582 283 LANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333 (690)
Q Consensus 283 lA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELl 333 (690)
....+.......+ +++. ..|+.++|+||||+++..+.
T Consensus 180 ~~~~~~e~~a~d~-------------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKDR-------------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHHH-------------HHHH-hHhcccccccceeEeehHHH
Confidence 8865532111100 2233 45778999999999987665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=222.38 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=181.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN--MDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
.|...+.||.+.|=+|.+|++ ..|. |+||++-+.. ..-....+.+.|++ ...++|||++.+.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 678889999999999999986 4555 8899986543 22333444456666 666799999988766433 355699
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccc--cccCCC
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF--FKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~--~~~~~~ 292 (690)
|-+|+.++|.+.+..+. .|...+.+.|+.||+.||.-||..||+|+|||.+||||+.=.=+.|+||..-+. +..++.
T Consensus 99 vRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99999999998876653 477778888999999999999999999999999999999888899999986543 222222
Q ss_pred CCccccccc----ccCcCCccccCCC----------CCCCcceeecchhHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 005582 293 QPLTSRVVT----LWYRPPELLLGST----------DYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGS 357 (690)
Q Consensus 293 ~~~~~~~gT----~~Y~APEvl~g~~----------~ys~~sDIWSlG~iL~ELlt-G~~pF~g~~~~e~l~kI~~~~g~ 357 (690)
..++.+..| ..|.|||-+.... ..+++.||||+||+++||++ |+|||. +.++++.-..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHhHhcc
Confidence 333333333 3599999875411 15788999999999999987 789985 2333321000
Q ss_pred CChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 358 p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 419 (690)
- .-....+.+.. -+..++.||..|++.||++|.+|++.|+-
T Consensus 251 ~-------------------~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 N-------------------ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred C-------------------ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 00011112222 23478999999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=197.67 Aligned_cols=237 Identities=22% Similarity=0.321 Sum_probs=150.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCC----------CCeeeeeeeEe
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDH----------PNIMKLEGLIT 205 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~H----------pnIv~l~~~~~ 205 (690)
.+.....||.|+++.||.+.+..||+.+|||++...... ...++.+.+|......+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 567888999999999999999999999999998766532 3345666666654444321 12222222221
Q ss_pred ---------eccC-C-----eEEEEEeccccchhhhhc---C-CCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q 005582 206 ---------SRVS-G-----SLYLVFEYMEHDLAGLAA---T-PGV--KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIK 264 (690)
Q Consensus 206 ---------~~~~-~-----~l~LV~Ey~~g~Ll~~~~---~-~~~--~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLK 264 (690)
...+ . +.+++|+-+.++|..++. . ... .+.......+..|++..+++||+.||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1101 1 347788888888765532 1 111 12223334455899999999999999999999
Q ss_pred CcceeeccCCceEeeccccccccccCCCCCcccccccccCcCCccccCC-------CCCCCcceeecchhHHHHHHhCCC
Q 005582 265 GSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS-------TDYGASVDLWSSGCILAELFAGKP 337 (690)
Q Consensus 265 p~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~-------~~ys~~sDIWSlG~iL~ELltG~~ 337 (690)
|+|+|++.+|.++|+||+....... .......+..|.+||+.... ..++.+.|.|+||+++|.|++|..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999998865432 11113445779999976331 347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCC
Q 005582 338 IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410 (690)
Q Consensus 338 pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR 410 (690)
||........ . .+.+.. +.++|+.++.||..||+.||.+|
T Consensus 249 Pf~~~~~~~~-----------~-----------------~~~f~~-----C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-----------P-----------------EWDFSR-----CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-----------S-----------------GGGGTT-----SS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-----------c-----------------cccchh-----cCCcCHHHHHHHHHHccCCcccC
Confidence 9975432100 0 001122 23789999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-20 Score=184.59 Aligned_cols=190 Identities=16% Similarity=0.131 Sum_probs=139.2
Q ss_pred EEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC--HHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEEE
Q 005582 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD--PESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 139 ~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~LV 215 (690)
.+...|+.|+||+||.+.. .+..++.+.+...... .-....+.+|+.+|++|. |++|++++++ +..|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 3567899999999998764 6778887777644331 112235789999999995 5889999875 236999
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC-CCcceeeccCCceEeeccccccccccCCC--
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDI-KGSNLLIDYNGILKIGDFGLANFFKCSQK-- 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDL-Kp~NILld~~g~vKL~DFGlA~~~~~~~~-- 292 (690)
|||+.|..+..... .. ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 77 meyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999876643221 11 2357889999999999999999999 79999999999999999999986543221
Q ss_pred -----CCcc-----cccccccCcCCccccCCCCCC-CcceeecchhHHHHHHhCCCCCCCCC
Q 005582 293 -----QPLT-----SRVVTLWYRPPELLLGSTDYG-ASVDLWSSGCILAELFAGKPIMPGRT 343 (690)
Q Consensus 293 -----~~~~-----~~~gT~~Y~APEvl~g~~~ys-~~sDIWSlG~iL~ELltG~~pF~g~~ 343 (690)
..+. -...++.|++|+...-....+ ...++++.|+.+|.++|+..++.+++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0000 012467788887543221223 45688899999999999998877654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.7e-20 Score=192.78 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=170.6
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCe-----------------------------------EEEEEEeecCCCC---H
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNK-----------------------------------LVALKKVRFTNMD---P 176 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~-----------------------------------~VAIK~i~~~~~~---~ 176 (690)
.++|++...||+|..+.||.|....+|. +.|||.+-.-..+ .
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 4679999999999999999987532211 2456654322222 2
Q ss_pred HHHHHHHHHHH------HH--------Hh--------CCCCCeeeeeeeEeecc-------------------------C
Q 005582 177 ESVRFMAREII------IL--------RR--------LDHPNIMKLEGLITSRV-------------------------S 209 (690)
Q Consensus 177 ~~~~~~~rEi~------iL--------~~--------L~HpnIv~l~~~~~~~~-------------------------~ 209 (690)
...+.+.+|+- ++ +. -.|||||++.++|.+.. .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 22233334431 11 11 14999999998874421 2
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc--CC--ceEeecccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY--NG--ILKIGDFGLAN 285 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~--~g--~vKL~DFGlA~ 285 (690)
..+|+||.-..+.|..++... ..+....+-++.|+++|+.|||.+||.|||||.+||||.- ++ .+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 468999999999888877665 4677888889999999999999999999999999999853 33 68999999874
Q ss_pred ccccCC-----CCCcccccccccCcCCccccCCCC-----CCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 005582 286 FFKCSQ-----KQPLTSRVVTLWYRPPELLLGSTD-----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355 (690)
Q Consensus 286 ~~~~~~-----~~~~~~~~gT~~Y~APEvl~g~~~-----ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~ 355 (690)
.-+... .......-|.-.-||||+...-.. .-.++|.|+.|.+.||++....||.+.-+...
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------- 465 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------- 465 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--------
Confidence 322110 011122345666899998753111 12378999999999999999999987332111
Q ss_pred CCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHH
Q 005582 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS 414 (690)
Q Consensus 356 g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~ 414 (690)
....+....+ ......+|+.+++|+..+|..||.||+++.
T Consensus 466 ---~~r~Yqe~qL----------------Palp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 466 ---DTRTYQESQL----------------PALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---chhhhhhhhC----------------CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 0001111222 222345789999999999999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-20 Score=204.49 Aligned_cols=176 Identities=31% Similarity=0.447 Sum_probs=125.8
Q ss_pred EEEEEeccccchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccc
Q 005582 212 LYLVFEYMEHDLAGLAAT---PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~~~~~---~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
+||.|++|..+.+..++. .....+......++.||+.|+.| +|.+|+|+||.||+...++.+||.|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 455555655544433332 22235666788899999999999 999999999999999999999999999998765
Q ss_pred cCC-----CCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCChhH
Q 005582 289 CSQ-----KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK-LCGSPSEEY 362 (690)
Q Consensus 289 ~~~-----~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~-~~g~p~~~~ 362 (690)
... ....+..++|+|||+||.|.| ..|+.++||||||+|||||+.- |. +..+.....-. .-|..++.
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f~--T~~er~~t~~d~r~g~ip~~- 480 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---FS--TQFERIATLTDIRDGIIPPE- 480 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---hc--cHHHHHHhhhhhhcCCCChH-
Confidence 433 234667789999999999987 5799999999999999999972 21 11111111100 00111111
Q ss_pred hhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCC
Q 005582 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 363 w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf 422 (690)
+..-.+.-.+||..||...|.+||++.+.--|.|.
T Consensus 481 -------------------------~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 -------------------------FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred -------------------------HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11123456789999999999999988888777775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=181.81 Aligned_cols=144 Identities=20% Similarity=0.163 Sum_probs=112.8
Q ss_pred CcEEEeeeeccCceEEEEEE-EcCCCeEEEEEEeecCCCCH--------------------H--HHHHHHHHHHHHHhCC
Q 005582 137 SFEKLDKIGQGTYSSVYKAR-DLENNKLVALKKVRFTNMDP--------------------E--SVRFMAREIIILRRLD 193 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~-~~~tg~~VAIK~i~~~~~~~--------------------~--~~~~~~rEi~iL~~L~ 193 (690)
-|.+...||+|+||.||+|. +..+|+.||||+++...... . ....+.+|+.+|.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 66799999999997543210 0 1124568999999997
Q ss_pred CCC--eeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccCCCcceee
Q 005582 194 HPN--IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG-ILHRDIKGSNLLI 270 (690)
Q Consensus 194 Hpn--Iv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~g-IvHrDLKp~NILl 270 (690)
+.. ++++++ . ...||||||++++.+.........+....+..++.||+.+|.+||+.| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~---~---~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIA---W---RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeE---e---cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 334433 2 224899999999765443333345677778899999999999999999 9999999999999
Q ss_pred ccCCceEeecccccccc
Q 005582 271 DYNGILKIGDFGLANFF 287 (690)
Q Consensus 271 d~~g~vKL~DFGlA~~~ 287 (690)
+ ++.++|+|||++...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=174.18 Aligned_cols=137 Identities=19% Similarity=0.222 Sum_probs=103.9
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeEeeccC-CeEE
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-----DHPNIMKLEGLITSRVS-GSLY 213 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-----~HpnIv~l~~~~~~~~~-~~l~ 213 (690)
-...||+|+||.||. +..++.. +||++..... .....+.+|+.+++.+ +||||+++++++....+ +.++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 456899999999995 6667665 6999875432 2345689999999999 67999999999987532 3434
Q ss_pred -EEEeccc--cchhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccccCCCcceeeccC----CceEeeccccc
Q 005582 214 -LVFEYME--HDLAGLAATPGVKFTEAQIKCYMKQLLHGL-EHCHSRGILHRDIKGSNLLIDYN----GILKIGDFGLA 284 (690)
Q Consensus 214 -LV~Ey~~--g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL-~yLHs~gIvHrDLKp~NILld~~----g~vKL~DFGlA 284 (690)
+||||++ ++.+..+.... .+++. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 44444443333 46666 36688888888 89999999999999999999743 38999995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-20 Score=213.08 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=208.6
Q ss_pred CCcEEEeeeeccCceEEEEEEEcC-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 213 (690)
..|.+...||+|+|+.|-++.... +...+|+|.+............+..|+.+-..+. |+|++.+++.... ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 468889999999999999887643 4456777777655444555566777999999997 9999999988766 46789
Q ss_pred EEEeccccchhhhhc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCccccCCCcceeeccCC-ceEeecccccccccc
Q 005582 214 LVFEYMEHDLAGLAA-TPGV-KFTEAQIKCYMKQLLHGLEHCH-SRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKC 289 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~-~~~~-~l~e~~i~~i~~qIl~gL~yLH-s~gIvHrDLKp~NILld~~g-~vKL~DFGlA~~~~~ 289 (690)
++++|..|+.+.... .... .++...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998887665555 5544 6788889999999999999999 99999999999999999999 999999999998865
Q ss_pred --CCCCCcccccc-cccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 290 --SQKQPLTSRVV-TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 290 --~~~~~~~~~~g-T~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
.........+| ++.|.|||.+.+.....+..|+||+|+++..+++|..|+.-....... ...|...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeeccc
Confidence 22233556788 999999999988667789999999999999999999887543322200 0011110
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+ ...-...|..++..+.+++.++|..+|..|.+..++-.++|++.
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00012345778899999999999999999999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.8e-18 Score=199.70 Aligned_cols=194 Identities=26% Similarity=0.289 Sum_probs=152.2
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEeeccCC
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD---HPNIMKLEGLITSRVSG 210 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~ 210 (690)
..+.|.|-..||+|+||+||.|.+.. |+.||||+-+..+..+ +.--.+++.+|. -+.|..+...+.. .+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~--~~ 767 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVF--QN 767 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHcc--CC
Confidence 34679999999999999999999765 9999999977554322 222234444444 3445555554444 35
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-------CCceEeecccc
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-------NGILKIGDFGL 283 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-------~g~vKL~DFGl 283 (690)
..+||+||.+.+.+-.+......+++..+..+..|++..|.+||..+|||+||||+|+||.. .--++|+|||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 67899999997655555557778999999999999999999999999999999999999942 33699999999
Q ss_pred ccccccC-CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCC
Q 005582 284 ANFFKCS-QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK 336 (690)
Q Consensus 284 A~~~~~~-~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~ 336 (690)
+-.+.-- ....+...+.|-.+-.+|+..| ..+++.+|.|.|+.+++.||.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 8544321 2345777888999999999987 57999999999999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.6e-17 Score=162.60 Aligned_cols=139 Identities=22% Similarity=0.190 Sum_probs=107.7
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH--------------------HHHHHHHHHHHHHHhCCCCC
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP--------------------ESVRFMAREIIILRRLDHPN 196 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~--------------------~~~~~~~rEi~iL~~L~Hpn 196 (690)
.|.+.+.||+|+||.||++.. .+|+.||||+++...... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 477889999999999999986 489999999976533110 01123567999999998874
Q ss_pred --eeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 197 --IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 197 --Iv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
++.+++ .+..++||||+++..+..+... .....++.+|+.+|.++|+.||+|+||||+||||+.++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444433 1345899999998665443221 34567889999999999999999999999999999999
Q ss_pred ceEeeccccccccc
Q 005582 275 ILKIGDFGLANFFK 288 (690)
Q Consensus 275 ~vKL~DFGlA~~~~ 288 (690)
.++|+|||++..+.
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=162.28 Aligned_cols=136 Identities=20% Similarity=0.236 Sum_probs=108.2
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHH------HHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEE
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE------SVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~------~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV 215 (690)
+.||+|++|.||+|.+ +|..|+||+......... ....+.+|+.++..+.|++|+....++.. ....++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5789999999999986 677899998654322111 12357789999999999998776666554 3567899
Q ss_pred EeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccc
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
|||++|..+....... .. ....++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999986555444322 12 7788999999999999999999999999999999 88999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-17 Score=166.34 Aligned_cols=244 Identities=19% Similarity=0.234 Sum_probs=184.5
Q ss_pred CCCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
..+..++.+|.+...|..|+|++.. ..+++|++..........+.|..|.-.|+.+.||||+.+++.|..+ .++.+
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~ 264 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVI 264 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceE
Confidence 3456677889999999999999854 4566788877666666667788899999999999999999999875 67899
Q ss_pred EEeccccchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCcceeeccCCceEee--ccccccccc
Q 005582 215 VFEYMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLIDYNGILKIG--DFGLANFFK 288 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~g--IvHrDLKp~NILld~~g~vKL~--DFGlA~~~~ 288 (690)
+..||+-+.+.-++. .+.-.+..++..++.+|+.|+.|||+.. |.---|....++||++.+.+|. |--++ +
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--f- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--F- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--e-
Confidence 999999765544333 2334677899999999999999999974 4444688889999998877663 32211 1
Q ss_pred cCCCCCcccccccccCcCCccccCCCC--CCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhc
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGSTD--YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~~--ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~ 366 (690)
........|.|++||.+..... .-.++|+|||+++||||.|...||..-...+--.+|.- .|
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-eg---------- 405 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-EG---------- 405 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-cc----------
Confidence 1123455789999999875432 23479999999999999999999988776665444421 11
Q ss_pred CCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHh
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417 (690)
Q Consensus 367 ~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 417 (690)
.-....+.++..+..|+.-|+..||.+||..+.++
T Consensus 406 ----------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 406 ----------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 11223467888999999999999999999877653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=155.15 Aligned_cols=138 Identities=24% Similarity=0.242 Sum_probs=98.9
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHH----------------------HHHHHHHHHhCCCCC--
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF----------------------MAREIIILRRLDHPN-- 196 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~----------------------~~rEi~iL~~L~Hpn-- 196 (690)
.+.||+|+||.||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999975 8999999998754322111111 135666666665443
Q ss_pred eeeeeeeEeeccCCeEEEEEeccccchhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCC
Q 005582 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 197 Iv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g 274 (690)
+.+++++ ...++||||++++... ...... ... ..+..++.+++.+|.++|. .||+|+||||+|||++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444432 2358999999983221 111110 111 6778899999999999999 9999999999999999 99
Q ss_pred ceEeeccccccccc
Q 005582 275 ILKIGDFGLANFFK 288 (690)
Q Consensus 275 ~vKL~DFGlA~~~~ 288 (690)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=156.33 Aligned_cols=132 Identities=18% Similarity=0.219 Sum_probs=101.1
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH------HHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEE
Q 005582 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP------ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~ 216 (690)
.||+|+||.||++.. ++..|++|+........ .....+.+|+.++..+.|+++....-++.. ....+|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 389999999999984 67889999865332211 123557789999999988875544434433 34568999
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
||++|..+......... .++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99998655544332211 7888999999999999999999999999999 89999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-16 Score=175.95 Aligned_cols=206 Identities=25% Similarity=0.384 Sum_probs=153.6
Q ss_pred HHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccccCCCc
Q 005582 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI-LHRDIKGS 266 (690)
Q Consensus 189 L~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gI-vHrDLKp~ 266 (690)
|+.+.|.|+.+++|.+.+. ..+++|.+||..+.+ +.+......+++-....++++|+.||.|||+..| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578999999999999884 789999999986554 5555557789999999999999999999999876 99999999
Q ss_pred ceeeccCCceEeeccccccccccC-CCCCcccccccccCcCCccccCCCC------CCCcceeecchhHHHHHHhCCCCC
Q 005582 267 NLLIDYNGILKIGDFGLANFFKCS-QKQPLTSRVVTLWYRPPELLLGSTD------YGASVDLWSSGCILAELFAGKPIM 339 (690)
Q Consensus 267 NILld~~g~vKL~DFGlA~~~~~~-~~~~~~~~~gT~~Y~APEvl~g~~~------ys~~sDIWSlG~iL~ELltG~~pF 339 (690)
|+++|....+||+|||+....... .........-..-|.|||++.+... .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999776320 1111111223456999999866311 467799999999999999999999
Q ss_pred CCCCh----HHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHH
Q 005582 340 PGRTE----VEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415 (690)
Q Consensus 340 ~g~~~----~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e 415 (690)
..... .+.+..+.+ .+. .+++..+.... .+++.+..++..|+..+|..||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~--------------------~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGS--------------------NPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCC--------------------CCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHH
Confidence 76322 233333322 111 11111121111 45668999999999999999999998
Q ss_pred Hhc
Q 005582 416 ALQ 418 (690)
Q Consensus 416 ~L~ 418 (690)
+-.
T Consensus 217 i~~ 219 (484)
T KOG1023|consen 217 IRS 219 (484)
T ss_pred HHh
Confidence 844
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.9e-16 Score=175.82 Aligned_cols=139 Identities=17% Similarity=0.155 Sum_probs=106.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-----C-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-----D-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-----~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
..|...+.||+|+||.||++.+... .+++|+...... + ......+.+|+.+|..+.|++|+....++.. .
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--P 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--C
Confidence 3456788999999999999986433 344444321111 1 1123567899999999999999887666555 3
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
...++||||+++..+..... ....++.+|+.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 45789999999866544332 456789999999999999999999999999999 6789999999999653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-14 Score=149.43 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=101.7
Q ss_pred eeee-ccCceEEEEEEEcCCCeEEEEEEeecCCC-----------CHHHHHHHHHHHHHHHhCCCCCe--eeeeeeEeec
Q 005582 142 DKIG-QGTYSSVYKARDLENNKLVALKKVRFTNM-----------DPESVRFMAREIIILRRLDHPNI--MKLEGLITSR 207 (690)
Q Consensus 142 ~~LG-~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-----------~~~~~~~~~rEi~iL~~L~HpnI--v~l~~~~~~~ 207 (690)
..|| .|+.|+||.+.. .+..++||.+..... +......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 899999999875 377899998854221 11223457889999999998875 6677664443
Q ss_pred cCC--eEEEEEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccc
Q 005582 208 VSG--SLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 208 ~~~--~l~LV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
... ..+|||||++| ..+..+... ..+++. .+.+|+.+|.+||++||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 221 23599999997 334333332 245554 3568999999999999999999999999999999999999998
Q ss_pred cc
Q 005582 285 NF 286 (690)
Q Consensus 285 ~~ 286 (690)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.8e-15 Score=137.31 Aligned_cols=132 Identities=24% Similarity=0.255 Sum_probs=108.4
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEeeccCCeEEEEEe
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH--PNIMKLEGLITSRVSGSLYLVFE 217 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~l~LV~E 217 (690)
+++.||.|.++.||++... +..++||.+..... ...+.+|+.++..+.| .++++++.++.. .+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 4578999999999999973 37899998864432 3457889999999976 588888877655 367899999
Q ss_pred ccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccccCCCcceeeccCCceEeeccccccc
Q 005582 218 YMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR---GILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 218 y~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~---gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
|+.+..+..+ +......++.+++.+|.+||.. +|+|+||+|.|||++..+.++|+|||++..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9988655332 5566777889999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.9e-15 Score=172.36 Aligned_cols=261 Identities=24% Similarity=0.290 Sum_probs=190.4
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~L 214 (690)
+.|.+.+-+-.|+++.++.+.-..+|...++|+...... ....++.+..+-.++-...+|-++...--+ .....++|
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L 881 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPL 881 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcch
Confidence 467777788889999999998777887778776654322 122233344444444444556666553332 23467899
Q ss_pred EEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC----
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS---- 290 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~---- 290 (690)
|++|++++-+.-.+......+..-.+.++..+..+++|||+..++|+|++|.|+|+..+|+.+++|||+......-
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999987544444344446777788889999999999999999999999999999999999999999844322100
Q ss_pred -----------------CC---------CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCCh
Q 005582 291 -----------------QK---------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE 344 (690)
Q Consensus 291 -----------------~~---------~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~ 344 (690)
.. ......++|+.|.+||.+++. ..+..+|+|++|++++|.++|.++|...+.
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00 012234679999999999884 578899999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHH---HHhcCcC
Q 005582 345 VEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS---SALQNEF 421 (690)
Q Consensus 345 ~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~---e~L~hpw 421 (690)
......|... ...| .......+..+.+++..+|..+|.+|..+. ++-.|+|
T Consensus 1041 q~~f~ni~~~-----~~~~---------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1041 QQIFENILNR-----DIPW---------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred hhhhhccccC-----CCCC---------------------CCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence 6655554321 0011 122335678899999999999999999988 8899999
Q ss_pred CCCC
Q 005582 422 FTTK 425 (690)
Q Consensus 422 f~~~ 425 (690)
|+..
T Consensus 1095 ~~~~ 1098 (1205)
T KOG0606|consen 1095 FQDV 1098 (1205)
T ss_pred cCCC
Confidence 9874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5e-15 Score=165.00 Aligned_cols=255 Identities=23% Similarity=0.277 Sum_probs=197.0
Q ss_pred CCcEEEeeeec--cCceEEEEEEE--cCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEeeccCC
Q 005582 136 DSFEKLDKIGQ--GTYSSVYKARD--LENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSG 210 (690)
Q Consensus 136 ~~Y~~~~~LG~--G~fG~Vy~a~~--~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 210 (690)
..|.+...+|. |.+|.||.+.. ..++..+|+|+-+.....+..-..-.+|+...+.+ .|+|.++.+..+.. .+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 45778889999 99999999998 88999999998543332222222335666666666 59999998777766 57
Q ss_pred eEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccccCCCcceeeccC-CceEeecccccc
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH----GLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLAN 285 (690)
Q Consensus 211 ~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~----gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~ 285 (690)
.+|+-+|+++..+..........++...++.++.+... ||.++|+.+|+|-|+||.||++..+ ...+++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 89999999999888888887777999999999999999 9999999999999999999999999 899999999998
Q ss_pred ccccCCCCC----cccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCC
Q 005582 286 FFKCSQKQP----LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGR--TEVEQLHKIFKLCGSPS 359 (690)
Q Consensus 286 ~~~~~~~~~----~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~--~~~e~l~kI~~~~g~p~ 359 (690)
.+....... .....+...|++||++.+ -++...|+|+||.++.+..++-.++... +...++..+.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------- 342 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------- 342 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------
Confidence 776543221 112245677999999876 4899999999999999999886554322 1111111110
Q ss_pred hhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 360 EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 360 ~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.-.+.+...+..+...+..|++.+|..|+++..++.|.++..
T Consensus 343 -----------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 -----------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -----------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 011223455666777999999999999999999999999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.1e-12 Score=126.39 Aligned_cols=140 Identities=19% Similarity=0.189 Sum_probs=100.1
Q ss_pred eeeeccCceEEEEEEEcC------CCeEEEEEEeecCCC-----------C---------HHHHHHH----HHHHHHHHh
Q 005582 142 DKIGQGTYSSVYKARDLE------NNKLVALKKVRFTNM-----------D---------PESVRFM----AREIIILRR 191 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~------tg~~VAIK~i~~~~~-----------~---------~~~~~~~----~rEi~iL~~ 191 (690)
..||.|--+.||.|.... .+..+|||+++.... + ......+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 357899998863211 0 0111122 389999999
Q ss_pred CCC--CCeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccCCCcce
Q 005582 192 LDH--PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC-HSRGILHRDIKGSNL 268 (690)
Q Consensus 192 L~H--pnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yL-Hs~gIvHrDLKp~NI 268 (690)
+.. -+++.++++ ..-+|||||++++.+.........+++.....++.+++.+|..| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 843 456666654 22479999998753221111222456667777889999999998 899999999999999
Q ss_pred eeccCCceEeeccccccccc
Q 005582 269 LIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 269 Lld~~g~vKL~DFGlA~~~~ 288 (690)
|++ ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 5789999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=146.18 Aligned_cols=258 Identities=22% Similarity=0.241 Sum_probs=187.9
Q ss_pred CCcCCCCCCcEEEeeeeccCceEEEEEEEc-CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEee
Q 005582 129 GWVPRKADSFEKLDKIGQGTYSSVYKARDL-ENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITS 206 (690)
Q Consensus 129 ~~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~-~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 206 (690)
.|......+|..+..||.|.|+.|+.+... .++..|++|-+...-........-+.|+.+...+ .|.+++.+...|..
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 334455678999999999999999998755 6788999998765443333333445677777777 58888887766554
Q ss_pred ccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccC-CceEeecccccc
Q 005582 207 RVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLAN 285 (690)
Q Consensus 207 ~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~-g~vKL~DFGlA~ 285 (690)
....||-.|||++....+...-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++
T Consensus 338 --~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 --LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred --cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 35678999999887665544434468888999999999999999999999999999999999886 789999999986
Q ss_pred ccccCCCCCcccccccccCc-CCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Q 005582 286 FFKCSQKQPLTSRVVTLWYR-PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 286 ~~~~~~~~~~~~~~gT~~Y~-APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~ 364 (690)
.+.... .....+-++. .+|++.....+..+.|++|||.-+.+.+++.++-...+. |.
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~ 473 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SL 473 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------ce
Confidence 432111 1122233444 366666666789999999999999999999865432111 11
Q ss_pred hcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 365 ~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
.. ........+.....+..+.+.++..|+..|+.+.++..|.=|-.
T Consensus 474 ~i--------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 474 TI--------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ee--------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00 00111112334477888999999999999999999999876643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.2e-12 Score=140.88 Aligned_cols=142 Identities=19% Similarity=0.204 Sum_probs=93.1
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCH----------------------------H----HHH------HHH
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP----------------------------E----SVR------FMA 183 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~----------------------------~----~~~------~~~ 183 (690)
+.||.|++|+||+|.. .+|+.||||+.+...... . ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 689999999986432100 0 000 133
Q ss_pred HHHHHHHhC----CCCCeeeeeeeEeeccCCeEEEEEeccccchhhhhcC-CCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005582 184 REIIILRRL----DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAAT-PGVKFTEAQIKCYMKQLLH-GLEHCHSRG 257 (690)
Q Consensus 184 rEi~iL~~L----~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~-~~~~l~e~~i~~i~~qIl~-gL~yLHs~g 257 (690)
+|...+.++ .|.+-+.+-.++..- ....+|||||++|..+..... ....+. ...++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 444444444 233333333344322 344689999999865433221 111122 2345555555 467899999
Q ss_pred CccccCCCcceeeccCCceEeeccccccccc
Q 005582 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 258 IvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
++|+|+||.|||++.+|.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-12 Score=148.05 Aligned_cols=145 Identities=19% Similarity=0.311 Sum_probs=96.3
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC---------------------------CH-----HHHHHHH
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM---------------------------DP-----ESVRFMA 183 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~---------------------------~~-----~~~~~~~ 183 (690)
..|+. ..||.|++|+||+|+...+|+.||||+++..-. +. +....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999877799999999974310 00 1112233
Q ss_pred HHHHH------HHhC----CCCCeeeeeeeEeeccCCeEEEEEeccccchhhhh---cCCCC---CCCHHHHHHHHHHHH
Q 005582 184 REIII------LRRL----DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLA---ATPGV---KFTEAQIKCYMKQLL 247 (690)
Q Consensus 184 rEi~i------L~~L----~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~---~~~~~---~l~e~~i~~i~~qIl 247 (690)
+|+.+ +.++ .+.+.+.+-.++.+- ....+|||||+.|.-+..+ ...+. .+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 34433 3333 133334443444332 3456899999998654322 12221 245555566666655
Q ss_pred HHHHHHHhCCCccccCCCcceeeccCC----ceEeecccccccccc
Q 005582 248 HGLEHCHSRGILHRDIKGSNLLIDYNG----ILKIGDFGLANFFKC 289 (690)
Q Consensus 248 ~gL~yLHs~gIvHrDLKp~NILld~~g----~vKL~DFGlA~~~~~ 289 (690)
..|++|+|+||.||||+.+| .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999988 999999999977643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.4e-11 Score=137.11 Aligned_cols=169 Identities=22% Similarity=0.335 Sum_probs=127.3
Q ss_pred EEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCC
Q 005582 154 KARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK 233 (690)
Q Consensus 154 ~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~ 233 (690)
.|..+.++.+|.|.+++..+. .......+-++.|+.|+||||+++++.+.. .+++|||+|-+..= ..... .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~Pl--~~~lk---~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRPL--ETVLK---E 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccccH--HHHHH---H
Confidence 455577889999998876543 444557788999999999999999998876 47899999988641 11111 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hCCCccccCCCcceeeccCCceEeeccccccccccCCCCCcccccccccCcCCccccC
Q 005582 234 FTEAQIKCYMKQLLHGLEHCH-SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312 (690)
Q Consensus 234 l~e~~i~~i~~qIl~gL~yLH-s~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g 312 (690)
+....+..-+.||+.||.||| +.+++|++|.-.-|+|+..|..||++|-++........ +......--.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 336677788899999999998 56899999999999999999999999998865432221 1122222233677775532
Q ss_pred CCCCCCcceeecchhHHHHHHhC
Q 005582 313 STDYGASVDLWSSGCILAELFAG 335 (690)
Q Consensus 313 ~~~ys~~sDIWSlG~iL~ELltG 335 (690)
-+...|.|-|||++++++.|
T Consensus 180 ---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 ---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhhHHHHHHHHhCc
Confidence 23568999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-11 Score=119.15 Aligned_cols=127 Identities=19% Similarity=0.165 Sum_probs=93.7
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEeeccCCeEEEEEecc
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI-MKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
++.|+.|.++.||++.. .+..|+||....... ....+.+|+.+++.+.+.++ ++++.+.. ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 46788899999999986 478899998753321 12235789999999865554 44544322 2347999999
Q ss_pred ccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccccCCCcceeeccCCceEeecccccc
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI-----LHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gI-----vHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
+|..+... .. ....++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 74 ~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98654322 01 123456799999999999985 9999999999999 6789999999984
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-11 Score=129.15 Aligned_cols=240 Identities=20% Similarity=0.202 Sum_probs=153.8
Q ss_pred EEEEEEEcCCCeEEEEEEeecCCC-CH-HHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC---CeEEEEEeccccchhh
Q 005582 151 SVYKARDLENNKLVALKKVRFTNM-DP-ESVRFMAREIIILRRLDHPNIMKLEGLITSRVS---GSLYLVFEYMEHDLAG 225 (690)
Q Consensus 151 ~Vy~a~~~~tg~~VAIK~i~~~~~-~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~~l~LV~Ey~~g~Ll~ 225 (690)
.||++.+...|-.|..-.+..... +. ........-..-|-++.|-|||+++.|+.+... ....++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 577887777777665443322111 00 001111112234556679999999999877422 3578899999976554
Q ss_pred hhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCcceeeccCCceEeeccccccccccCCC---CC-c
Q 005582 226 LAA----TPGVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK---QP-L 295 (690)
Q Consensus 226 ~~~----~~~~~l~e~~i~~i~~qIl~gL~yLHs~g--IvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~---~~-~ 295 (690)
..+ .....+.....+.|+-||+.||.|||+.. |+|+++...-|++..+|.+||.---.. .+.+... .. .
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhh
Confidence 332 34556888899999999999999999985 999999999999999998888532211 1111111 00 1
Q ss_pred ccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhHhhhcCCCccccc
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~p-F~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~ 374 (690)
....+-+.|.+||.=.. ...+.++|||+||+...+|..|.-- -.+....+.-..|...+
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 11234578999996432 3467789999999999999887622 22222111111111100
Q ss_pred CCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 375 ~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
+.--..--++++.+||...|..||++.++|.||.+-.
T Consensus 300 -------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 300 -------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred -------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 0111223356899999999999999999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-09 Score=108.08 Aligned_cols=142 Identities=19% Similarity=0.256 Sum_probs=103.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEeecc-CCeEEEEEec
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH--PNIMKLEGLITSRV-SGSLYLVFEY 218 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~-~~~l~LV~Ey 218 (690)
..|+.|.++.||++.. .+|..+++|........ .....+.+|+.++..+.+ .++++++.+..... .+..|+||||
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 5688999999999986 34678999987643321 123457899999999975 34566766654321 1356899999
Q ss_pred cccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 005582 219 MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS------------------------------------------- 255 (690)
Q Consensus 219 ~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs------------------------------------------- 255 (690)
++|..+...... ..+++.+...++.+++..|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998755443321 246777777888888888888874
Q ss_pred -------------CCCccccCCCcceeecc--CCceEeeccccccc
Q 005582 256 -------------RGILHRDIKGSNLLIDY--NGILKIGDFGLANF 286 (690)
Q Consensus 256 -------------~gIvHrDLKp~NILld~--~g~vKL~DFGlA~~ 286 (690)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 67789999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.3e-10 Score=129.70 Aligned_cols=155 Identities=23% Similarity=0.352 Sum_probs=115.8
Q ss_pred HHHHHHHHHHhC-CCccccCCCcceeeccCCceEeeccccccccccCCCCCcc------c--ccccccCcCCccccCCCC
Q 005582 245 QLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT------S--RVVTLWYRPPELLLGSTD 315 (690)
Q Consensus 245 qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~------~--~~gT~~Y~APEvl~g~~~ 315 (690)
+++.||.|+|.. ++||+.|.|++|.++..|.+||+.|+++.........+.. . ..-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 444999999975 8999999999999999999999999988654331111111 1 122567999999987 66
Q ss_pred CCCcceeecchhHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchh
Q 005582 316 YGASVDLWSSGCILAELF-AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSS 394 (690)
Q Consensus 316 ys~~sDIWSlG~iL~ELl-tG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~ 394 (690)
.+.++|+|||||++|.+. .|+++|.+.........-....+.. ....-.++|++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcHH
Confidence 899999999999999999 7778777654433322221111100 00111578999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcCCCCC
Q 005582 395 ALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 395 ~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~ 425 (690)
+++=|.++|..|+..||++.+++..+||++.
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 9999999999999999999999999999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.6e-09 Score=104.69 Aligned_cols=130 Identities=23% Similarity=0.311 Sum_probs=92.2
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCC------CCHH-HHHHHHHHHHHHHhCCC--CCeeeeeeeEeeccCCeE
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTN------MDPE-SVRFMAREIIILRRLDH--PNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~------~~~~-~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~l 212 (690)
..|++|+-+.+|.+.+ -|..+.+|. +... ++.. ...+..+|..+|.++.- -+++.++++ + .+..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D--~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D--PDNG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c--CCCC
Confidence 3578899999999965 344455553 2221 1211 12456789999998853 334444443 3 2456
Q ss_pred EEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccc
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
.|+|||++|.++....... ...++..|-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 7999999998887554433 245677788888899999999999999999997665 99999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-09 Score=102.40 Aligned_cols=143 Identities=16% Similarity=0.213 Sum_probs=98.6
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecC-----CCCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEE
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRFT-----NMDP-ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~-----~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~ 213 (690)
.+..|-+|+-+.|+++.+ .|+.+.||.-... .++. -...+..+|+.+|.++.--.|.--.=+|.+.. .-.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCe
Confidence 678899999999999976 6887777753211 1121 12346788999999885333322211444432 336
Q ss_pred EEEecccc--chhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC---ceEeeccccccc
Q 005582 214 LVFEYMEH--DLAGLAATPGVK-FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANF 286 (690)
Q Consensus 214 LV~Ey~~g--~Ll~~~~~~~~~-l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g---~vKL~DFGlA~~ 286 (690)
|+|||++| .+.+.+...... ....-...+++.|-..|.-||.++|||+||..+||||..+| .+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 88999998 444444332222 22333378889999999999999999999999999998766 458999999953
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=112.64 Aligned_cols=220 Identities=19% Similarity=0.227 Sum_probs=156.6
Q ss_pred ceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeecc--CCeEEEEEecccc--chh
Q 005582 149 YSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV--SGSLYLVFEYMEH--DLA 224 (690)
Q Consensus 149 fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~--~~~l~LV~Ey~~g--~Ll 224 (690)
-.+.|+|....+|..|++|.++...... ......-+++++++.|+|||.+.++|.... ...+++|++|.++ .|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3578999999999999999994322110 111234578899999999999999987321 3468999999875 344
Q ss_pred hhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccC
Q 005582 225 GLAAT--------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 225 ~~~~~--------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~ 290 (690)
+++.. .+...++..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..++|...|....+..+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 43321 2335788999999999999999999999999999999999999889999888887766533
Q ss_pred CCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCc
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~ 370 (690)
.. |.+.+ -.+-|.-.||.+++.|.||..--.-.+.....
T Consensus 447 ~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s---------------------- 485 (655)
T KOG3741|consen 447 PT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS---------------------- 485 (655)
T ss_pred CC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH----------------------
Confidence 21 11222 23568889999999999995321111111000
Q ss_pred ccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcC---cCCCC
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN---EFFTT 424 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h---pwf~~ 424 (690)
.+......++.+++++|..+...+++. -++.++|.+ .||+.
T Consensus 486 ------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~v 529 (655)
T KOG3741|consen 486 ------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTV 529 (655)
T ss_pred ------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHH
Confidence 011223456788899999999999887 678888775 45543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.2e-09 Score=103.69 Aligned_cols=127 Identities=25% Similarity=0.254 Sum_probs=82.5
Q ss_pred EEEEEEEcCCCeEEEEEEeecCCC-----------------------C-HHHHHHHHHHHHHHHhCCCC--CeeeeeeeE
Q 005582 151 SVYKARDLENNKLVALKKVRFTNM-----------------------D-PESVRFMAREIIILRRLDHP--NIMKLEGLI 204 (690)
Q Consensus 151 ~Vy~a~~~~tg~~VAIK~i~~~~~-----------------------~-~~~~~~~~rEi~iL~~L~Hp--nIv~l~~~~ 204 (690)
.||.|.. .+|..+|||+.+.... . .-......+|...|.++..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 5788999998854211 0 01123467899999999765 567776542
Q ss_pred eeccCCeEEEEEeccc--cchhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccccCCCcceeeccCCceEeecc
Q 005582 205 TSRVSGSLYLVFEYME--HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH-CHSRGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 205 ~~~~~~~l~LV~Ey~~--g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~y-LHs~gIvHrDLKp~NILld~~g~vKL~DF 281 (690)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 --~----~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 --R----NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --T----TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred --C----CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1 269999999 6444333322 12244566777888885555 679999999999999999877 8999999
Q ss_pred cccccc
Q 005582 282 GLANFF 287 (690)
Q Consensus 282 GlA~~~ 287 (690)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 998643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=99.50 Aligned_cols=132 Identities=19% Similarity=0.152 Sum_probs=89.3
Q ss_pred EEEEEEEcCCCeEEEEEEeecCCCCHHHHH----------HHHHHHHHHHhCCCCCe--eeeeeeEeecc---CCeEEEE
Q 005582 151 SVYKARDLENNKLVALKKVRFTNMDPESVR----------FMAREIIILRRLDHPNI--MKLEGLITSRV---SGSLYLV 215 (690)
Q Consensus 151 ~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~----------~~~rEi~iL~~L~HpnI--v~l~~~~~~~~---~~~l~LV 215 (690)
.|+++. -.|+.|.||........ ...+ .+.+|...+..|..-+| +.++.+..... ....+||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 355553 35778999976432211 1111 26688888888743333 23344443321 1346899
Q ss_pred Eeccccc--hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeecc-------CCceEeecccccc
Q 005582 216 FEYMEHD--LAGLAAT-PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-------NGILKIGDFGLAN 285 (690)
Q Consensus 216 ~Ey~~g~--Ll~~~~~-~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~-------~g~vKL~DFGlA~ 285 (690)
||++++. +..++.. .....+......++.+|+..+.-||..||+|+||++.||||+. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999984 4444321 1234566778899999999999999999999999999999985 4689999999885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-07 Score=97.72 Aligned_cols=137 Identities=26% Similarity=0.233 Sum_probs=102.3
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCC------------------C--HHHHHHHHHHHHHHHhCCCC--
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM------------------D--PESVRFMAREIIILRRLDHP-- 195 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~------------------~--~~~~~~~~rEi~iL~~L~Hp-- 195 (690)
+.+..+||.|--|.||.|.+ ..|..+|||.=+.... + .-......+|..+|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 44678999999999999996 4788999996432211 0 11123467899999999755
Q ss_pred CeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCc
Q 005582 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI 275 (690)
Q Consensus 196 nIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~ 275 (690)
.|++.+++ +.-.+||||++|-.+.... +.......++..|++-+..+-..||||+|+.+-||||+.+|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 77777664 3447999999995443322 234455566777777777777999999999999999999999
Q ss_pred eEeeccccccc
Q 005582 276 LKIGDFGLANF 286 (690)
Q Consensus 276 vKL~DFGlA~~ 286 (690)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999987754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-06 Score=94.99 Aligned_cols=252 Identities=13% Similarity=0.126 Sum_probs=152.1
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeee-e---eeeEeeccC-CeEEE
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMK-L---EGLITSRVS-GSLYL 214 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~-l---~~~~~~~~~-~~l~L 214 (690)
...||+|+.+.+|-.-.- +- .+.|++...... .. .+-+..|... .||-+-. + .......+. ..+-+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa--~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA--AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCch--HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 457899999999976431 22 244777643321 11 1223334443 5665433 1 011111122 23678
Q ss_pred EEeccccc--hhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeecccccccc
Q 005582 215 VFEYMEHD--LAGLA-----ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 215 V~Ey~~g~--Ll~~~-----~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
.|..+.+- ...++ ......+.+..+....+.|+.+...||..|.+-+|+.++|+||++++.|.|.|=..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88888762 22221 112234788899999999999999999999999999999999999999999984433222
Q ss_pred ccCCCCCcccccccccCcCCcccc-C---CCCCCCcceeecchhHHHHHHhC-CCCCCCCCh----HHHHH-HHHHHhCC
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLL-G---STDYGASVDLWSSGCILAELFAG-KPIMPGRTE----VEQLH-KIFKLCGS 357 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~-g---~~~ys~~sDIWSlG~iL~ELltG-~~pF~g~~~----~e~l~-kI~~~~g~ 357 (690)
.........++...|.+||+.. + .-.-+...|.|.||+++|+||.| +.||.|-.. ..-++ .|-.....
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2233455668899999999753 1 12356789999999999999987 889876321 00000 11111110
Q ss_pred CChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccC--CCCCCCCHHH
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST--EPEVRGTASS 415 (690)
Q Consensus 358 p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~--DP~kRpTa~e 415 (690)
...+ .. ....|-. ..-.|.-+++++..|...|+.. +|.-|||++-
T Consensus 246 ya~~---------~~--~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 246 YASD---------QR--RGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred echh---------cc--CCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0000 00 0000101 1112445789999999999874 3678999753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.3e-06 Score=89.65 Aligned_cols=140 Identities=19% Similarity=0.238 Sum_probs=99.1
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC--------------------HHHH--HHHHHHHHHHHhCC--CCC
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD--------------------PESV--RFMAREIIILRRLD--HPN 196 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~--------------------~~~~--~~~~rEi~iL~~L~--Hpn 196 (690)
...|..|--+.||+|.. .++..||+|+++..... .... .-..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34778899999999984 67899999998643211 1111 12346777888773 445
Q ss_pred eeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCcceeeccCCc
Q 005582 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGI 275 (690)
Q Consensus 197 Iv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIvHrDLKp~NILld~~g~ 275 (690)
+++-+.+.. -.|||||++....-.-......+...++..+..+++..+.-|-. .++||+||..-|||+. ++.
T Consensus 132 vP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 556655532 26999999876222212222344444677888899999988877 8999999999999999 889
Q ss_pred eEeeccccccccc
Q 005582 276 LKIGDFGLANFFK 288 (690)
Q Consensus 276 vKL~DFGlA~~~~ 288 (690)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999996553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.7e-08 Score=110.97 Aligned_cols=248 Identities=17% Similarity=0.144 Sum_probs=167.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEeeccCCeEEE
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN-IMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~~~~l~L 214 (690)
.-|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ ..+...++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC--Ccccccch
Confidence 34667778899999999999987666555 6665422 22456899999999999 44433322 23567899
Q ss_pred EEeccccc--hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccccccccccCCC
Q 005582 215 VFEYMEHD--LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~--Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~~~~~ 292 (690)
+++++.++ ...........|.+.+...+.+.-+.+|++||+.-=+|+| |||..+ +..++.||+.+..+....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999876 2222222223455666777778888999999998889999 887755 789999999987665332
Q ss_pred CCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCccc
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~ 372 (690)
......+|+.++|||+... ..+....|.|++|+-..+|.-|-+|-...-. .....|..+. ..
T Consensus 386 -~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~------~~~~~g~~p~----------s~ 447 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA------VLPMIGNGPN----------SP 447 (829)
T ss_pred -ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcc------ccCCCCCCCC----------cc
Confidence 3445678999999998876 4588899999999987788777766433100 0000111100 00
Q ss_pred ccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCCCCC
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 373 ~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~~p~ 427 (690)
... -...+...+ -.++...||..-|..|+++..++.|.+|..-|+
T Consensus 448 ~L~----~~~aw~~~~------~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 448 MLT----DKSAWSPVF------HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ccc----hhhhcCccc------ccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 000 001111111 115677899999999999999999999987655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-06 Score=88.76 Aligned_cols=105 Identities=24% Similarity=0.268 Sum_probs=77.8
Q ss_pred HHHHHHHHHHhCCCCC--eeeeeeeEeeccC--CeEEEEEecccc--chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005582 181 FMAREIIILRRLDHPN--IMKLEGLITSRVS--GSLYLVFEYMEH--DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254 (690)
Q Consensus 181 ~~~rEi~iL~~L~Hpn--Iv~l~~~~~~~~~--~~l~LV~Ey~~g--~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLH 254 (690)
...+|...+..|..-. ++..+.+...+.. ...+||+|++++ +|...+.. ...++......++.+|+..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~-~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ-WEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh-hcccchhhHHHHHHHHHHHHHHHH
Confidence 4677888777774322 3444555444322 245899999997 34444433 223667778899999999999999
Q ss_pred hCCCccccCCCcceeeccCC---ceEeeccccccc
Q 005582 255 SRGILHRDIKGSNLLIDYNG---ILKIGDFGLANF 286 (690)
Q Consensus 255 s~gIvHrDLKp~NILld~~g---~vKL~DFGlA~~ 286 (690)
.+||+|+|+++.||||+.++ .+.|+||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.4e-06 Score=82.44 Aligned_cols=139 Identities=16% Similarity=0.185 Sum_probs=96.9
Q ss_pred eccCceEEEEEEEcCCCeEEEEEEeecC---CCC-HHHHHHHHHHHHHHHhCCCCC--eeeeeeeEe-ecc--CCeEEEE
Q 005582 145 GQGTYSSVYKARDLENNKLVALKKVRFT---NMD-PESVRFMAREIIILRRLDHPN--IMKLEGLIT-SRV--SGSLYLV 215 (690)
Q Consensus 145 G~G~fG~Vy~a~~~~tg~~VAIK~i~~~---~~~-~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~~-~~~--~~~l~LV 215 (690)
|.||-+.|+.... .|+.+-+|..... ..- +-....+.+|+..|..|..-+ ++++. ++. ... .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4588888988764 3446788876411 000 223456889999999885322 44554 222 111 1235899
Q ss_pred Eecccc--chhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCc--eEeeccccccc
Q 005582 216 FEYMEH--DLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI--LKIGDFGLANF 286 (690)
Q Consensus 216 ~Ey~~g--~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~--vKL~DFGlA~~ 286 (690)
+|-+++ +|...+... -.+.+......++.+|+..|.-||+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 555554332 224577777899999999999999999999999999999987776 99999987653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.6e-06 Score=98.62 Aligned_cols=143 Identities=20% Similarity=0.237 Sum_probs=84.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCC---------------------------CH-HH----HH------HHH
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM---------------------------DP-ES----VR------FMA 183 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~---------------------------~~-~~----~~------~~~ 183 (690)
..|+.++-|+||+|.. .+|+.||||+.+..-. +. .. .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999995 6699999999864211 00 00 01 122
Q ss_pred HHHHHHHhC-----CCCCeeeeeeeEeeccCCeEEEEEeccccchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005582 184 REIIILRRL-----DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257 (690)
Q Consensus 184 rEi~iL~~L-----~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~g 257 (690)
+|..-+.++ +.++| .+=.+|.+ ..+.-.|+|||++|--+ +....+...++...+...+.++ -+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-Eeceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 333333333 12332 22223332 13456899999998322 2211111223433222222111 122333489
Q ss_pred CccccCCCcceeeccCCceEeecccccccccc
Q 005582 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 258 IvHrDLKp~NILld~~g~vKL~DFGlA~~~~~ 289 (690)
++|.|.+|.||+++.+|.+.+.|||+...++.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999976653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.7e-05 Score=79.14 Aligned_cols=139 Identities=19% Similarity=0.218 Sum_probs=87.5
Q ss_pred CCcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHH-HHHH------HHHHHHHHHhCC---CCCeeeeeeeEe
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE-SVRF------MAREIIILRRLD---HPNIMKLEGLIT 205 (690)
Q Consensus 136 ~~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~-~~~~------~~rEi~iL~~L~---HpnIv~l~~~~~ 205 (690)
.+|.+++.+-......|.+.. .+|+.+.+|..+....-.+ .... ..+.+..+..+. .-.+..++-+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 478899999888888888775 3678899998764322111 1111 223444444432 222222222221
Q ss_pred ec---cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCCceEeeccc
Q 005582 206 SR---VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG 282 (690)
Q Consensus 206 ~~---~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g~vKL~DFG 282 (690)
-. .....+|||||++|--+.... .+++ .+...|..+|.-||..|++|+|+.|.|++++.++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 11 123456899999985443221 1233 2445677889999999999999999999998655 9999998
Q ss_pred ccc
Q 005582 283 LAN 285 (690)
Q Consensus 283 lA~ 285 (690)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.7e-05 Score=75.78 Aligned_cols=139 Identities=23% Similarity=0.343 Sum_probs=79.7
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeeEeec-cCCeEEEEEe
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP--NIMKLEGLITSR-VSGSLYLVFE 217 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp--nIv~l~~~~~~~-~~~~l~LV~E 217 (690)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|... .+.+++.+.... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5678999999999998643 47899986532 3455678899998888433 355666544332 2345799999
Q ss_pred ccccchhhh--------------------h-cC--CCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 005582 218 YMEHDLAGL--------------------A-AT--PGVKFTEAQ---------IKCY------------MKQLLH-GLEH 252 (690)
Q Consensus 218 y~~g~Ll~~--------------------~-~~--~~~~l~e~~---------i~~i------------~~qIl~-gL~y 252 (690)
+++|..+.. + .. ....+.... .... +..+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998743322 0 00 111111100 0000 111222 2333
Q ss_pred HHh-------CCCccccCCCcceeec-cCCceEeecccccc
Q 005582 253 CHS-------RGILHRDIKGSNLLID-YNGILKIGDFGLAN 285 (690)
Q Consensus 253 LHs-------~gIvHrDLKp~NILld-~~g~vKL~DFGlA~ 285 (690)
++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 332 3599999999999999 66767899999884
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.3e-05 Score=78.47 Aligned_cols=132 Identities=17% Similarity=0.131 Sum_probs=78.8
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeeEeeccCCeEEEEEecc
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN--IMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~~~~~~~~l~LV~Ey~ 219 (690)
..||+|..+.||+. .+..+++|...... ....+.+|..+++.+..-. +.+.+++... .+..++|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 46899999999984 24457788875322 2234688999999885433 3555555544 45678999999
Q ss_pred ccch-hh---------------h-------hcC---CCCCCCHHHHHHHHH----------HHHHH-HHHHHh----CCC
Q 005582 220 EHDL-AG---------------L-------AAT---PGVKFTEAQIKCYMK----------QLLHG-LEHCHS----RGI 258 (690)
Q Consensus 220 ~g~L-l~---------------~-------~~~---~~~~l~e~~i~~i~~----------qIl~g-L~yLHs----~gI 258 (690)
+|.. .. . +.. +...++.. ...+.. .+... ..+|.. ..+
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 9841 10 0 000 11111110 011100 01111 122221 246
Q ss_pred ccccCCCcceeeccCCceEeecccccc
Q 005582 259 LHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 259 vHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
+|+|+.|.||+++.++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999888 9999999884
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.9e-05 Score=93.29 Aligned_cols=205 Identities=20% Similarity=0.164 Sum_probs=139.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCe--EEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005582 179 VRFMAREIIILRRLDHPNIMKLEGLITSRVSGS--LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256 (690)
Q Consensus 179 ~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~--l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~ 256 (690)
......|+..+..+.|+|++.++.|-..+.... +.+..++|....+......-...+....+.+..++++||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334456777888889999999987755432222 234456666654444445555788899999999999999999999
Q ss_pred CCccccCCCc---ceeeccCCceEee--ccccccccccCCCCCcccccccccCcCCccccCCCCCCC--cceeecchhHH
Q 005582 257 GILHRDIKGS---NLLIDYNGILKIG--DFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGA--SVDLWSSGCIL 329 (690)
Q Consensus 257 gIvHrDLKp~---NILld~~g~vKL~--DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~--~sDIWSlG~iL 329 (690)
...|.-|... +-.++..+.+.++ ||+.+..+.... .......+..|.+||.+.. ..+.. ..|+|.+|.++
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence 7666666555 4445566677777 888887664322 2233344566778887654 23333 36999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcC-CCchhHHHHHHHhccCCCC
Q 005582 330 AELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFK-DIPSSALSLLDILLSTEPE 408 (690)
Q Consensus 330 ~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~ 408 (690)
..+..|..+-.- ...+.. ... .......+++.+|+.-|++
T Consensus 383 ~~~~~~~~i~~~------~~~~~~---------------------------------~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 383 LQLSQGEDISEK------SAVPVS---------------------------------LLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhhcCccccc------ccchhh---------------------------------hhccccchhhhhhhhhhcchhhh
Confidence 999988643210 000000 011 1122678899999999999
Q ss_pred CCCCHHHHhcCcCCCCC
Q 005582 409 VRGTASSALQNEFFTTK 425 (690)
Q Consensus 409 kRpTa~e~L~hpwf~~~ 425 (690)
+|+++.++|.|+|....
T Consensus 424 ~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFP 440 (1351)
T ss_pred hccchhhhhhchhcccc
Confidence 99999999999998653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=6e-05 Score=73.90 Aligned_cols=130 Identities=22% Similarity=0.240 Sum_probs=90.1
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eeeeeEeeccCCeEEEEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM-KLEGLITSRVSGSLYLVF 216 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv-~l~~~~~~~~~~~l~LV~ 216 (690)
-.....|++|.+|.||++.+ .|..+|+|+-+.. .....+..|.++|..+.--++. +++.| +..++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y------g~~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY------GEDFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe------chhhhhh
Confidence 34567899999999999987 5668999987643 3345688999999999766653 45443 2235679
Q ss_pred eccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC-CcceeeccCCceEeeccccccc
Q 005582 217 EYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIK-GSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 217 Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLK-p~NILld~~g~vKL~DFGlA~~ 286 (690)
||+.|--+....... + +.-+..+++.-.-|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 999984433322211 1 2334456666666777899999986 4555555566999999999963
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=9.7e-05 Score=84.27 Aligned_cols=142 Identities=17% Similarity=0.175 Sum_probs=85.0
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-----------------------------HHHHHHHHHHHHHHHh-
Q 005582 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-----------------------------PESVRFMAREIIILRR- 191 (690)
Q Consensus 142 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-----------------------------~~~~~~~~rEi~iL~~- 191 (690)
+.||.-+.|+||+|+- .+|+.||||+.+..-.. .+..+.+..|+..+..
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5799999999999995 56999999987643111 0111122233322222
Q ss_pred ---------CCCCC---eeeeeeeEeeccCCeEEEEEeccccc---hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005582 192 ---------LDHPN---IMKLEGLITSRVSGSLYLVFEYMEHD---LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256 (690)
Q Consensus 192 ---------L~Hpn---Iv~l~~~~~~~~~~~l~LV~Ey~~g~---Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~ 256 (690)
+.|-+ -|.+=.++.+ ....-.|+||||+|- -++.+... .++...+...+.++.. .-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~-~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD-LSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh-cCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHH--HHHHhc
Confidence 23444 1112223332 134568999999982 22333333 2444444333333222 123346
Q ss_pred CCccccCCCcceeecc----CCceEeecccccccccc
Q 005582 257 GILHRDIKGSNLLIDY----NGILKIGDFGLANFFKC 289 (690)
Q Consensus 257 gIvHrDLKp~NILld~----~g~vKL~DFGlA~~~~~ 289 (690)
|++|+|-+|.||||.. ++.+.|.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 67999999999977654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=75.23 Aligned_cols=133 Identities=17% Similarity=0.146 Sum_probs=77.2
Q ss_pred eeccCc-eEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEeeccCCeEEEEEecccc
Q 005582 144 IGQGTY-SSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 144 LG~G~f-G~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
|-.|.+ ..||++.. .+..+.||...... ...+.+|+.+++.+. +--+.+++++... .+..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCC
Confidence 334555 78999864 33577888765322 234678999988883 3445567666544 3557899999987
Q ss_pred chhhhhc---------------------CC--CCCCCHH------HHHHHHH----------------HHHHHHHHHH--
Q 005582 222 DLAGLAA---------------------TP--GVKFTEA------QIKCYMK----------------QLLHGLEHCH-- 254 (690)
Q Consensus 222 ~Ll~~~~---------------------~~--~~~l~e~------~i~~i~~----------------qIl~gL~yLH-- 254 (690)
..+.... .+ ...+... .....+. .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 4332110 00 1111100 0000000 0111122221
Q ss_pred -----hCCCccccCCCcceeeccCCceEeecccccc
Q 005582 255 -----SRGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 255 -----s~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999998888999999884
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=87.05 Aligned_cols=147 Identities=23% Similarity=0.366 Sum_probs=90.1
Q ss_pred EEeeeeccCceEEEEEEEcCCC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCe--eeeeeeEeec-cCCeEE
Q 005582 140 KLDKIGQGTYSSVYKARDLENN--KLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNI--MKLEGLITSR-VSGSLY 213 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg--~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnI--v~l~~~~~~~-~~~~l~ 213 (690)
.+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| ++++.++.+. ..+..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4678899999999998754332 46777775432211 12235789999999995 6665 7777776552 124678
Q ss_pred EEEeccccchhh---------------------h---hcC-C--C-------C--CCCHHHHHHHHHH------------
Q 005582 214 LVFEYMEHDLAG---------------------L---AAT-P--G-------V--KFTEAQIKCYMKQ------------ 245 (690)
Q Consensus 214 LV~Ey~~g~Ll~---------------------~---~~~-~--~-------~--~l~e~~i~~i~~q------------ 245 (690)
+||||++|..+. . +.. . . . .+...++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 999999874211 0 000 0 0 0 0112233332222
Q ss_pred ---HHHHHHHHHh-----------CCCccccCCCcceeeccC--CceEeecccccccc
Q 005582 246 ---LLHGLEHCHS-----------RGILHRDIKGSNLLIDYN--GILKIGDFGLANFF 287 (690)
Q Consensus 246 ---Il~gL~yLHs-----------~gIvHrDLKp~NILld~~--g~vKL~DFGlA~~~ 287 (690)
+...+.+|.. ..+||+|+++.|||++.+ ..+-|.||.++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556633 249999999999999853 34679999998653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00044 Score=69.59 Aligned_cols=130 Identities=26% Similarity=0.332 Sum_probs=90.4
Q ss_pred CCCcEEEeeeeccCc-eEEEEEEEcCCCeEEEEEEeec---CCCC----------H------HHHHHHHHHHHHHHhC--
Q 005582 135 ADSFEKLDKIGQGTY-SSVYKARDLENNKLVALKKVRF---TNMD----------P------ESVRFMAREIIILRRL-- 192 (690)
Q Consensus 135 ~~~Y~~~~~LG~G~f-G~Vy~a~~~~tg~~VAIK~i~~---~~~~----------~------~~~~~~~rEi~iL~~L-- 192 (690)
..+++.++.||.|.- |.||++.- .|+.||||+++. .... . ....-|..|-....+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 368999999999999 99999975 788999999432 1110 0 1122355565555544
Q ss_pred -CCCCe--eeeeeeEeec----------------cCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005582 193 -DHPNI--MKLEGLITSR----------------VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253 (690)
Q Consensus 193 -~HpnI--v~l~~~~~~~----------------~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yL 253 (690)
.+.++ |+++|++.-. ......||.||+.... .++.. -+.+|++-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 56666 8999887321 0112467888877543 23333 345788888899
Q ss_pred HhCCCccccCCCcceeeccCCceEeeccccc
Q 005582 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 254 Hs~gIvHrDLKp~NILld~~g~vKL~DFGlA 284 (690)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999986 3489999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00034 Score=71.86 Aligned_cols=29 Identities=28% Similarity=0.405 Sum_probs=25.6
Q ss_pred CCccccCCCcceeeccCCceEeecccccc
Q 005582 257 GILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 257 gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
.++|+|+.+.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999877667799999884
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=66.72 Aligned_cols=134 Identities=21% Similarity=0.249 Sum_probs=89.6
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecCC--------------CCHHHHHHHHHHHHHHHhCC------CCCeeee
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTN--------------MDPESVRFMAREIIILRRLD------HPNIMKL 200 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~--------------~~~~~~~~~~rEi~iL~~L~------HpnIv~l 200 (690)
...||+|+.=.||.- .......||++.... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999999974 344557889987654 01122445667776666665 8899999
Q ss_pred eeeEeeccCCeEEEEEecccc---c---hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 201 EGLITSRVSGSLYLVFEYMEH---D---LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 201 ~~~~~~~~~~~l~LV~Ey~~g---~---Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
+|+.... ..+-+|+|.+.. . .+..+...+ .+++ .+ ...+-.-..||-+++|+.+||+|.||++....
T Consensus 83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 9998773 557889998753 1 223333222 3555 33 33444555688999999999999999997432
Q ss_pred ----ceEeec-cccc
Q 005582 275 ----ILKIGD-FGLA 284 (690)
Q Consensus 275 ----~vKL~D-FGlA 284 (690)
.+.|+| ||-.
T Consensus 156 ~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEK 170 (199)
T ss_pred CCceEEEEEeCCCCc
Confidence 578888 4544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00041 Score=69.24 Aligned_cols=99 Identities=23% Similarity=0.191 Sum_probs=77.6
Q ss_pred HHHHHHHHhCCC-CCeeeeeeeEeeccCCeEEEEEeccccc-hhhh--hcCCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 005582 183 AREIIILRRLDH-PNIMKLEGLITSRVSGSLYLVFEYMEHD-LAGL--AATPGVKFTEAQIKCYMKQLLHGLEHCHS--- 255 (690)
Q Consensus 183 ~rEi~iL~~L~H-pnIv~l~~~~~~~~~~~l~LV~Ey~~g~-Ll~~--~~~~~~~l~e~~i~~i~~qIl~gL~yLHs--- 255 (690)
..|.-+|+.+.+ +++++++|.|-. ++|.||+... +... ....-...++..+..++.+++..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999976 699999998632 5688999864 3211 01111246899999999999999999998
Q ss_pred CCCccccCCCcceeeccCCceEeecccccccc
Q 005582 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 256 ~gIvHrDLKp~NILld~~g~vKL~DFGlA~~~ 287 (690)
..+.-.|++++|+-|+.+|.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 35788999999999999999999999887554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.30 E-value=2.4e-05 Score=95.59 Aligned_cols=258 Identities=15% Similarity=-0.001 Sum_probs=158.7
Q ss_pred CCCCcEEEeeeeccCceEEEEEEEcCCCe-EEEEEEee---cCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccC
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNK-LVALKKVR---FTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 134 ~~~~Y~~~~~LG~G~fG~Vy~a~~~~tg~-~VAIK~i~---~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
....|++.--||-|.++. +.+..... .+.+|+.+ ..+..+...+-...|...++...|+++.....-......
T Consensus 1227 ~~e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred Hhhhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 345677776676666543 33222111 12444443 222222333344556666777789999887666555555
Q ss_pred CeEEEEEeccccchhhh-hcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccccCCCcceeeccCCceEeec
Q 005582 210 GSLYLVFEYMEHDLAGL-AATP---GVKFTEAQIKCYMKQLLHGLEHCHSRG-----ILHRDIKGSNLLIDYNGILKIGD 280 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~-~~~~---~~~l~e~~i~~i~~qIl~gL~yLHs~g-----IvHrDLKp~NILld~~g~vKL~D 280 (690)
...|++++|+.++-+.. +.+. ...+...-+-+...+.+.+..-+|+.. .+|++||+-|.+|..+..+|+++
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 67799999998765443 3332 223344444444445477777777642 78999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 005582 281 FGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360 (690)
Q Consensus 281 FGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g~~~~e~l~kI~~~~g~p~~ 360 (690)
+|+.+... .........++++.|+.|++... ..++.++|+|..|+.+|++..|.++|. ..+..+++..- .
T Consensus 1384 ~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgii--d- 1453 (2724)
T KOG1826|consen 1384 GGLDKIKN-PVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGII--D- 1453 (2724)
T ss_pred cccccccC-chHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCcc--c-
Confidence 99998432 22333455677889999997754 568888999999999999999887663 23333332110 0
Q ss_pred hHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcCCCC
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 361 ~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpwf~~ 424 (690)
....+. ...-.|.++-.+...+|-+.-..||.-...+.-+.|..
T Consensus 1454 ---------n~tf~s-----------Ie~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1454 ---------NHTFFS-----------IEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred ---------cccccc-----------ccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 000000 00112334444455555566677888888888777743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0023 Score=65.27 Aligned_cols=73 Identities=19% Similarity=0.238 Sum_probs=45.1
Q ss_pred EeeeeccCceEEEEEEEcC-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEeeccCCeEEEEEec
Q 005582 141 LDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN-IMKLEGLITSRVSGSLYLVFEY 218 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~~~~l~LV~Ey 218 (690)
++.|..|-...||++.... .++.|++|+..... .......+|+.++..+...+ +++++..+. + .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEe
Confidence 4567778888999987432 25678899765321 11112357888988885433 344443321 1 379999
Q ss_pred cccc
Q 005582 219 MEHD 222 (690)
Q Consensus 219 ~~g~ 222 (690)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 9873
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00027 Score=75.24 Aligned_cols=136 Identities=17% Similarity=0.181 Sum_probs=93.5
Q ss_pred CcEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCC-------H--------H-----HHHHHHHHHHHHHhCCC--
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-------P--------E-----SVRFMAREIIILRRLDH-- 194 (690)
Q Consensus 137 ~Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~-------~--------~-----~~~~~~rEi~iL~~L~H-- 194 (690)
-+.+.++||-|.-+.||.+-+ ..|.+.++|.-+..... . . ..-...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999986 56888898854322110 0 0 01124578888888843
Q ss_pred CCeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCcceeeccCC
Q 005582 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 195 pnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHrDLKp~NILld~~g 274 (690)
=-|++.+++ +.-++|||++.+-.+..... + ..+..+...++.-+.-|-.+|+||+|..-=||+|++++
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~----v--~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRH----V--EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeee----c--CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 224455443 34589999998744332221 1 11223444566666778899999999999999999999
Q ss_pred ceEeecccccc
Q 005582 275 ILKIGDFGLAN 285 (690)
Q Consensus 275 ~vKL~DFGlA~ 285 (690)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999997653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0035 Score=67.96 Aligned_cols=142 Identities=21% Similarity=0.265 Sum_probs=96.9
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecCC----------------------CCHHH-HH-HHHHHHHHHHhCCCC
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN----------------------MDPES-VR-FMAREIIILRRLDHP 195 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~----------------------~~~~~-~~-~~~rEi~iL~~L~Hp 195 (690)
+-..|.-|--+.||.|. ..+|..+|||+++-.- ..+.. ++ ....|+.-|.+|+.-
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44567778999999998 4778889999875210 01111 22 134677778888654
Q ss_pred CeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccCCCcceeeccCC
Q 005582 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC-HSRGILHRDIKGSNLLIDYNG 274 (690)
Q Consensus 196 nIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yL-Hs~gIvHrDLKp~NILld~~g 274 (690)
.|..-.-+.. ..-.|||+|++.+-+-........++...+..+-.|++.-+.-| |..++||.||.--|+|+ .+|
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence 4432211111 12369999999754444444455788888888888888777765 56799999999999998 578
Q ss_pred ceEeecccccccc
Q 005582 275 ILKIGDFGLANFF 287 (690)
Q Consensus 275 ~vKL~DFGlA~~~ 287 (690)
.+.|+|.+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999999877543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.002 Score=66.95 Aligned_cols=132 Identities=21% Similarity=0.223 Sum_probs=74.3
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEeeccCCeEEEEEeccccc
Q 005582 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI-MKLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 144 LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
+..|-...+|+.. .++..+++|........- . -...+|..+|+.+....+ .+++.+. . -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCc
Confidence 4457778899886 356678888754321110 0 124678999998854333 3444332 1 26899999874
Q ss_pred hhhh------------------hc-C--CCCCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCCccccC
Q 005582 223 LAGL------------------AA-T--PGVKFTE-AQIKCYMKQL---------LHGLEHCHS--------RGILHRDI 263 (690)
Q Consensus 223 Ll~~------------------~~-~--~~~~l~e-~~i~~i~~qI---------l~gL~yLHs--------~gIvHrDL 263 (690)
.+.. +. . ...++.. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 3211 00 0 1111221 1222222222 111222222 14899999
Q ss_pred CCcceeeccCCceEeeccccccc
Q 005582 264 KGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 264 Kp~NILld~~g~vKL~DFGlA~~ 286 (690)
.|.|||++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998843
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0013 Score=73.80 Aligned_cols=172 Identities=24% Similarity=0.322 Sum_probs=116.1
Q ss_pred HHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 005582 182 MAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261 (690)
Q Consensus 182 ~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIvHr 261 (690)
++--..+|+.+.|+|.-..+++.... .....+|||+++.++.+...... +-.. +++ .+++.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~- 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLH- 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchh-------hhc-------ccccce-
Confidence 55668899999999999998876654 34588999999988877765533 1111 111 222222
Q ss_pred cCCCcceeeccCCceEeeccccccccccCCCCCcccccccccCcCCccccCCCCCCCcceeecchhHHHHHHhCCCCCCC
Q 005582 262 DIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG 341 (690)
Q Consensus 262 DLKp~NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~~sDIWSlG~iL~ELltG~~pF~g 341 (690)
-|| ++++| -++.. | | ...++++||||+|.++.++..|..++..
T Consensus 91 ----~~~-------~~~td-~~~t~-----------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 ----LNI-------IYITD-HFLTK-----------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ----ehh-------hhccc-ccccc-----------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 122 23333 11100 0 1 1122599999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCChhHhhhcCCCcccccCCCCccchhhhhhcCCCchhHHHHHHHhccCCCCCCCCHHHHhcCcC
Q 005582 342 RTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421 (690)
Q Consensus 342 ~~~~e~l~kI~~~~g~p~~~~w~~~~l~~~~~~~~~~p~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hpw 421 (690)
.+..+++..|.+....+.+..- ..+.......++..+++++..|+...|..||...++++++-
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i 196 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS 196 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence 8888998888875444332211 01111223456788999999999999999999999999999
Q ss_pred CCCC
Q 005582 422 FTTK 425 (690)
Q Consensus 422 f~~~ 425 (690)
|+..
T Consensus 197 ~~ev 200 (725)
T KOG1093|consen 197 FTEV 200 (725)
T ss_pred HHHH
Confidence 9764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.01 Score=63.57 Aligned_cols=78 Identities=15% Similarity=0.175 Sum_probs=53.2
Q ss_pred EEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC---CCeeeeeeeEeec-cCCeEEE
Q 005582 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH---PNIMKLEGLITSR-VSGSLYL 214 (690)
Q Consensus 139 ~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H---pnIv~l~~~~~~~-~~~~l~L 214 (690)
.....||.|..+.||.... .++ .+.+|..+. .. ....+..|...|+.|.- -.|+++++++... ..+..+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3467899999999999864 334 466676432 11 12357889999998843 3677888776542 2356799
Q ss_pred EEeccccc
Q 005582 215 VFEYMEHD 222 (690)
Q Consensus 215 V~Ey~~g~ 222 (690)
|||++++.
T Consensus 91 VmE~i~G~ 98 (297)
T PRK10593 91 LLERLRGV 98 (297)
T ss_pred EEeccCCE
Confidence 99998864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.013 Score=62.89 Aligned_cols=30 Identities=30% Similarity=0.481 Sum_probs=26.3
Q ss_pred CCCccccCCCcceeeccCCceEeecccccc
Q 005582 256 RGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 256 ~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999976666899999884
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.014 Score=61.71 Aligned_cols=139 Identities=17% Similarity=0.158 Sum_probs=80.2
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeeE----eeccCCeEE
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN--IMKLEGLI----TSRVSGSLY 213 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~----~~~~~~~l~ 213 (690)
-+..|..|....+|+... .+..+++|+... . ....+..|+.++..|.+.+ +++++... .....+..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356777788889999864 334688898753 1 1234667888888774322 44443311 111235678
Q ss_pred EEEeccccchhhh---------------hcC--CCC-------CC-CHHHH--H--------HHHHHHHHHHHHHHh---
Q 005582 214 LVFEYMEHDLAGL---------------AAT--PGV-------KF-TEAQI--K--------CYMKQLLHGLEHCHS--- 255 (690)
Q Consensus 214 LV~Ey~~g~Ll~~---------------~~~--~~~-------~l-~e~~i--~--------~i~~qIl~gL~yLHs--- 255 (690)
+|++|++|..... +.. ... .. .+... . .....+...+.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998732210 000 000 00 00000 0 011112334444443
Q ss_pred ----CCCccccCCCcceeeccCCceEeecccccc
Q 005582 256 ----RGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 256 ----~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998888999999884
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0055 Score=65.13 Aligned_cols=73 Identities=25% Similarity=0.301 Sum_probs=44.5
Q ss_pred EeeeeccCceEEEEEEEcC------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEeeccCCeEE
Q 005582 141 LDKIGQGTYSSVYKARDLE------NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN-IMKLEGLITSRVSGSLY 213 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~~~~l~ 213 (690)
++.|..|-...||++.... +++.|++|+..... .......+|+.++..+.... ..++++++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 3455557677899887432 25788999865432 12233578888888885333 3455544421 3
Q ss_pred EEEeccccc
Q 005582 214 LVFEYMEHD 222 (690)
Q Consensus 214 LV~Ey~~g~ 222 (690)
+|+||++|.
T Consensus 74 ~v~e~i~G~ 82 (302)
T cd05156 74 RIEEFIPSR 82 (302)
T ss_pred chhheeCCC
Confidence 588998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.018 Score=64.05 Aligned_cols=77 Identities=19% Similarity=0.137 Sum_probs=52.6
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEeeccCCeE
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFT-----NMDPESVRFMAREIIILRRLD---HPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~-----~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~l 212 (690)
.+.||.|.+..||++.+...++.|.||.-... ..-+-...+...|...|+.+. -.++++++.+. ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 46789999999999997544468999975311 100223456677888888863 35677787652 2446
Q ss_pred EEEEecccc
Q 005582 213 YLVFEYMEH 221 (690)
Q Consensus 213 ~LV~Ey~~g 221 (690)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.015 Score=62.13 Aligned_cols=142 Identities=18% Similarity=0.163 Sum_probs=80.6
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeeE----eeccCCe
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN--IMKLEGLI----TSRVSGS 211 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~----~~~~~~~ 211 (690)
...+..|+.|....||++.. .+| .+.+|+..... . ...+..|+.++..|.... +++++... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34566777788789999863 444 57788875421 1 223456777777773222 34443311 1112356
Q ss_pred EEEEEeccccchhh---------------hhcC--CCC--------CCCH-HH--HH----------HHHHHHHHHHHHH
Q 005582 212 LYLVFEYMEHDLAG---------------LAAT--PGV--------KFTE-AQ--IK----------CYMKQLLHGLEHC 253 (690)
Q Consensus 212 l~LV~Ey~~g~Ll~---------------~~~~--~~~--------~l~e-~~--i~----------~i~~qIl~gL~yL 253 (690)
.++||+|++|.... .+.. .+. .+.. .. .. .....+...+.++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999872110 0000 110 0110 00 00 0011233345555
Q ss_pred Hh-------CCCccccCCCcceeeccCCceEeecccccc
Q 005582 254 HS-------RGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 254 Hs-------~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 579999999999999998878999999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.035 Score=60.33 Aligned_cols=147 Identities=19% Similarity=0.260 Sum_probs=79.8
Q ss_pred CCcCCCCCCcEEEeeeeccCceEEEEEEEcCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeeE
Q 005582 129 GWVPRKADSFEKLDKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI-MKLEGLI 204 (690)
Q Consensus 129 ~~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~ 204 (690)
+|-....+...+.. |..|-...+|++..... +..|.+++..... +..-.-.+|+.+++.+..-++ +++++++
T Consensus 8 ~w~~~~~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~ 83 (330)
T PLN02421 8 GWSDLDDSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVF 83 (330)
T ss_pred ccccCCcCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEe
Confidence 34333333444444 44477778998864322 2378888875321 111123578899988865444 4555554
Q ss_pred eeccCCeEEEEEeccccchhhh------------------hcC---CCC-CC-CHHHHHHHHHHH---------------
Q 005582 205 TSRVSGSLYLVFEYMEHDLAGL------------------AAT---PGV-KF-TEAQIKCYMKQL--------------- 246 (690)
Q Consensus 205 ~~~~~~~l~LV~Ey~~g~Ll~~------------------~~~---~~~-~l-~e~~i~~i~~qI--------------- 246 (690)
. .+ +|.+|+++..+.. +.. +.. .+ ....+..|+.++
T Consensus 84 ~---~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~ 157 (330)
T PLN02421 84 G---NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYE 157 (330)
T ss_pred C---Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhc
Confidence 2 12 5888887632210 001 110 01 122333333222
Q ss_pred -------HHHHHH---HH-hCC----CccccCCCcceeecc-CCceEeecccccc
Q 005582 247 -------LHGLEH---CH-SRG----ILHRDIKGSNLLIDY-NGILKIGDFGLAN 285 (690)
Q Consensus 247 -------l~gL~y---LH-s~g----IvHrDLKp~NILld~-~g~vKL~DFGlA~ 285 (690)
..-+.. +. ..+ ++|.||.+.|||++. ++.++|+||..|.
T Consensus 158 ~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 158 TISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111111 21 112 689999999999975 5789999999884
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.045 Score=57.97 Aligned_cols=30 Identities=23% Similarity=0.347 Sum_probs=25.3
Q ss_pred CCccccCCCcceeeccCCc-eEeeccccccc
Q 005582 257 GILHRDIKGSNLLIDYNGI-LKIGDFGLANF 286 (690)
Q Consensus 257 gIvHrDLKp~NILld~~g~-vKL~DFGlA~~ 286 (690)
.++|+|++|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997554 56999999854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.087 Score=57.58 Aligned_cols=140 Identities=15% Similarity=0.172 Sum_probs=79.3
Q ss_pred cEEEeeeeccCceEEEEEEEcC----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEeeccCCeE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLE----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI-MKLEGLITSRVSGSL 212 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~l 212 (690)
..-+..|-.|-.-.+|++.... .++.|.+|+..... ...+ ...+|+.+++.+..-++ .++++.+.. +
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~---g-- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN---G-- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECC---c--
Confidence 3344556558888999986432 24678899875432 1122 23678999888854333 345554422 2
Q ss_pred EEEEeccccchhhh------------------hcC---CCC--CCCHHHHHHHHHHHH-----------------HHHHH
Q 005582 213 YLVFEYMEHDLAGL------------------AAT---PGV--KFTEAQIKCYMKQLL-----------------HGLEH 252 (690)
Q Consensus 213 ~LV~Ey~~g~Ll~~------------------~~~---~~~--~l~e~~i~~i~~qIl-----------------~gL~y 252 (690)
.|.+|+++..+.. +.. +.. ......+..|+.++. ..+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 5788887632210 000 111 111233334432221 11111
Q ss_pred H----H----hCCCccccCCCcceeecc-CCceEeeccccccc
Q 005582 253 C----H----SRGILHRDIKGSNLLIDY-NGILKIGDFGLANF 286 (690)
Q Consensus 253 L----H----s~gIvHrDLKp~NILld~-~g~vKL~DFGlA~~ 286 (690)
| . ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 2 125899999999999986 47899999998854
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.075 Score=56.45 Aligned_cols=29 Identities=28% Similarity=0.433 Sum_probs=25.6
Q ss_pred CCCccccCCCcceeeccCCceEeecccccc
Q 005582 256 RGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 256 ~gIvHrDLKp~NILld~~g~vKL~DFGlA~ 285 (690)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678899999774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.16 Score=54.89 Aligned_cols=148 Identities=19% Similarity=0.248 Sum_probs=84.6
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEeeccCCeEEEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH--PNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~l~LV 215 (690)
..++..+-.|..-.+|...+ +++.++|. ...............+|+.+|+.+.- --+...+++|....-+..|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455553344444555543 37778877 22112233455667889999998853 223344555554322466999
Q ss_pred Eeccccch----------h-hhhc-----------C------C--C--CCCCHHHHHHHHHHH--------------HHH
Q 005582 216 FEYMEHDL----------A-GLAA-----------T------P--G--VKFTEAQIKCYMKQL--------------LHG 249 (690)
Q Consensus 216 ~Ey~~g~L----------l-~~~~-----------~------~--~--~~l~e~~i~~i~~qI--------------l~g 249 (690)
|+|++|.. . .... . + + ..+...++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998721 0 0000 0 0 0 001222333333322 223
Q ss_pred HHHHHhC--------CCccccCCCcceeeccCCceEeeccccccccc
Q 005582 250 LEHCHSR--------GILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 250 L~yLHs~--------gIvHrDLKp~NILld~~g~vKL~DFGlA~~~~ 288 (690)
..+|+.+ .++|+|+.+.||||+..+-+=|.||+++..-+
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 4455543 48999999999999999889999999997543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.088 Score=57.79 Aligned_cols=74 Identities=18% Similarity=0.219 Sum_probs=48.0
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEee----c-CCCCHHHHHHHHHHHHHHHhCC--CC-CeeeeeeeEeeccCCeEEE
Q 005582 143 KIGQGTYSSVYKARDLENNKLVALKKVR----F-TNMDPESVRFMAREIIILRRLD--HP-NIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg~~VAIK~i~----~-~~~~~~~~~~~~rEi~iL~~L~--Hp-nIv~l~~~~~~~~~~~l~L 214 (690)
.||.|...-||++.+...++-|+||.-. . ....+-...+...|...|+... -| .+++++.+ + .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D--~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D--TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c--ccccee
Confidence 4788999999999975444679998643 1 1111333445667888887763 24 56666544 2 244569
Q ss_pred EEeccc
Q 005582 215 VFEYME 220 (690)
Q Consensus 215 V~Ey~~ 220 (690)
|||+++
T Consensus 78 vMEdL~ 83 (370)
T TIGR01767 78 VMEDLS 83 (370)
T ss_pred hHhhCc
Confidence 999985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.088 Score=56.42 Aligned_cols=30 Identities=23% Similarity=0.197 Sum_probs=27.7
Q ss_pred CCccccCCCcceeeccCCceEeeccccccc
Q 005582 257 GILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 257 gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
+++|+|+.+.|||++.++.+-|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998854
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.32 Score=51.92 Aligned_cols=75 Identities=13% Similarity=0.194 Sum_probs=44.7
Q ss_pred cEEEeeeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEeeccCCeEEE
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD---HPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 138 Y~~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~l~L 214 (690)
-+....|+-|....+|+.. .+++.+.||+-... ....+..|..-|+.|. --.+++++.+.... +.-||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceE
Confidence 3456778889999999986 67788999987522 2234667888887773 34567777766553 34599
Q ss_pred EEecccc
Q 005582 215 VFEYMEH 221 (690)
Q Consensus 215 V~Ey~~g 221 (690)
||||++.
T Consensus 90 lle~l~~ 96 (288)
T PF03881_consen 90 LLEFLEM 96 (288)
T ss_dssp EEE----
T ss_pred EEEeecC
Confidence 9999874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.15 Score=56.62 Aligned_cols=76 Identities=22% Similarity=0.219 Sum_probs=51.0
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEe----ecCCCCHHHHHHHHHHHHHHHhCC--CC-CeeeeeeeEeeccCCeEE
Q 005582 141 LDKIGQGTYSSVYKARDLENNKLVALKKV----RFTNMDPESVRFMAREIIILRRLD--HP-NIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 141 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i----~~~~~~~~~~~~~~rEi~iL~~L~--Hp-nIv~l~~~~~~~~~~~l~ 213 (690)
...||.|.-.-||++.+...++-|+||.- +.....+-...+...|..+|+.+. .| .+++++.+ + .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D--~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D--SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C--cHHhh
Confidence 67889999999999997433567888864 222112334556677888888763 24 56667544 2 24457
Q ss_pred EEEeccc
Q 005582 214 LVFEYME 220 (690)
Q Consensus 214 LV~Ey~~ 220 (690)
+|||+++
T Consensus 110 ~vMEdL~ 116 (409)
T PRK12396 110 CVMEDLS 116 (409)
T ss_pred HHHHhCc
Confidence 8999985
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.3 Score=54.54 Aligned_cols=76 Identities=16% Similarity=0.168 Sum_probs=50.1
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeec-----CCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEeeccCCe
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRF-----TNMDPESVRFMAREIIILRRLD---HPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~-----~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~ 211 (690)
..+.||.|....||+..+ .+..|+||.-.. ....+....+...|...|+.+. ..++++++.++. +.
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC----CC
Confidence 467889999999999886 345688887541 1101123444556677777663 357888877654 33
Q ss_pred EEEEEecccc
Q 005582 212 LYLVFEYMEH 221 (690)
Q Consensus 212 l~LV~Ey~~g 221 (690)
.++||||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5789999965
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.28 Score=54.56 Aligned_cols=74 Identities=22% Similarity=0.288 Sum_probs=42.9
Q ss_pred EEeeeeccCceEEEEEEEcCC-CeE-----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEeeccCCeE
Q 005582 140 KLDKIGQGTYSSVYKARDLEN-NKL-----VALKKVRFTNMDPESVRFMAREIIILRRLDHPNI-MKLEGLITSRVSGSL 212 (690)
Q Consensus 140 ~~~~LG~G~fG~Vy~a~~~~t-g~~-----VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~l 212 (690)
.+..|..|-...+|++..... +.. |.+.... . .....-.-.+|+.+++.|...++ .++++.+..
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------ 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--T-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------ 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--C-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence 344555588889999974332 122 3433321 1 11111123579999999965554 456555432
Q ss_pred EEEEeccccc
Q 005582 213 YLVFEYMEHD 222 (690)
Q Consensus 213 ~LV~Ey~~g~ 222 (690)
++|.||++|.
T Consensus 125 g~l~efIeGr 134 (383)
T PTZ00384 125 FTIQEWVEGN 134 (383)
T ss_pred EEEEEEeccc
Confidence 5899999874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.21 Score=51.21 Aligned_cols=115 Identities=18% Similarity=0.157 Sum_probs=73.0
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeeEeeccCCeEEEEEeccccchhhh
Q 005582 147 GTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGL 226 (690)
Q Consensus 147 G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l~LV~Ey~~g~Ll~~ 226 (690)
|+.++...+...- | +..+|++......- ....+..+..++.++. .|++|.. .+.-.+-+++|+|-.-
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~---- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKI---- 139 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCc----
Confidence 4555555554322 3 34567765433221 2234578889998876 6888762 2344567899988621
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCccccCCCcceeeccCCceEeecccc
Q 005582 227 AATPGVKFTEAQIKCYMKQLLHGLEHCHS--RGILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 227 ~~~~~~~l~e~~i~~i~~qIl~gL~yLHs--~gIvHrDLKp~NILld~~g~vKL~DFGl 283 (690)
. -++. .++..=+..|.-+|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 140 ----~-i~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 140 ----K-INFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ----c-cchh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 1 1111 122223567888894 3699999999999999999999999653
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.18 Score=55.05 Aligned_cols=71 Identities=23% Similarity=0.299 Sum_probs=54.6
Q ss_pred CeEEEEEeccccchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCcceeeccCCceEeeccccccc
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 210 ~~l~LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~-gIvHrDLKp~NILld~~g~vKL~DFGlA~~ 286 (690)
-.+|++|++-.+.+...-. -...++..|+.+.+..|.-+... .+-|||+.-.||||+ .|.+-|+||-+++.
T Consensus 299 ~y~yl~~kdhgt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDHGTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecCCceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4567888877665543221 24667778888887777666655 588999999999999 99999999999984
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.49 Score=53.59 Aligned_cols=92 Identities=13% Similarity=0.173 Sum_probs=53.7
Q ss_pred hhhhccccCCcCCCCCCcEEEeeeeccCceEEEEEEEcC--------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC
Q 005582 121 AVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLE--------NNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192 (690)
Q Consensus 121 ~~~~e~~~~~~~~~~~~Y~~~~~LG~G~fG~Vy~a~~~~--------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L 192 (690)
....+.+.+|.....++. .+..|..|-.-.+|++.... .++.|.+++.-... +..-.-..|..+++.+
T Consensus 91 ~i~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~l 166 (442)
T PTZ00296 91 KICLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTM 166 (442)
T ss_pred HHHHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHH
Confidence 344444556653333445 56677668888899987432 14678888864321 1111335688888887
Q ss_pred CCCCee-eeeeeEeeccCCeEEEEEeccccc
Q 005582 193 DHPNIM-KLEGLITSRVSGSLYLVFEYMEHD 222 (690)
Q Consensus 193 ~HpnIv-~l~~~~~~~~~~~l~LV~Ey~~g~ 222 (690)
..-+|- ++++.+.. +.|.||++|.
T Consensus 167 s~~gi~P~l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 167 SKYRIAPQLLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred HHCCCCCceEEEeCC------CEEEEeeCCc
Confidence 654443 45554421 4678898864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.32 E-value=0.31 Score=53.09 Aligned_cols=136 Identities=22% Similarity=0.302 Sum_probs=77.6
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCC---eeeeeeeEeeccCC--eEEE
Q 005582 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD---HPN---IMKLEGLITSRVSG--SLYL 214 (690)
Q Consensus 143 ~LG~G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---Hpn---Iv~l~~~~~~~~~~--~l~L 214 (690)
.|.+ .-..||+... .+|.. ++|+.+.. ... ..+.-|+..|..|. .+- |..+-|-......+ ..+-
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEe-cCCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 3444 4567898874 44554 88988755 332 33566788888773 211 33333322222234 6788
Q ss_pred EEeccccchhhh----------------hc--CCCC---------CCCHH----HH---------HHHHHHHHHHHHHHH
Q 005582 215 VFEYMEHDLAGL----------------AA--TPGV---------KFTEA----QI---------KCYMKQLLHGLEHCH 254 (690)
Q Consensus 215 V~Ey~~g~Ll~~----------------~~--~~~~---------~l~e~----~i---------~~i~~qIl~gL~yLH 254 (690)
|++|++|..+.. +. ..+. ...+. .. .....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999998743331 00 0000 01111 00 112234445555555
Q ss_pred h--------CC--CccccCCCcceeeccCC-ceEeecccccc
Q 005582 255 S--------RG--ILHRDIKGSNLLIDYNG-ILKIGDFGLAN 285 (690)
Q Consensus 255 s--------~g--IvHrDLKp~NILld~~g-~vKL~DFGlA~ 285 (690)
+ .+ |||+|+.|.|||++.+. .+-++||+-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 4 24 99999999999999887 48999999873
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.18 E-value=1.4 Score=55.13 Aligned_cols=31 Identities=29% Similarity=0.487 Sum_probs=26.1
Q ss_pred CCCccccCCCcceeeccCC--ceE-eeccccccc
Q 005582 256 RGILHRDIKGSNLLIDYNG--ILK-IGDFGLANF 286 (690)
Q Consensus 256 ~gIvHrDLKp~NILld~~g--~vK-L~DFGlA~~ 286 (690)
.+|||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 455 999998843
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.07 E-value=2.3 Score=46.09 Aligned_cols=71 Identities=17% Similarity=0.168 Sum_probs=40.3
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eee---eeeeEeeccCCeEEEEEecccc
Q 005582 147 GTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN--IMK---LEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 147 G~fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~---l~~~~~~~~~~~l~LV~Ey~~g 221 (690)
+.-..||+... .++..+++|+.+..... ...+..|+.++..|.... |+. .-+-.....++..+.|+++++|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 34457899874 55677999987643322 234566777777663211 222 1121111124567889999886
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.07 E-value=0.24 Score=53.48 Aligned_cols=52 Identities=23% Similarity=0.206 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHHHHHHHHHh----CCCccccCCCcceeeccCC------------------ceEeecccccccc
Q 005582 236 EAQIKCYMKQLLHGLEHCHS----RGILHRDIKGSNLLIDYNG------------------ILKIGDFGLANFF 287 (690)
Q Consensus 236 e~~i~~i~~qIl~gL~yLHs----~gIvHrDLKp~NILld~~g------------------~vKL~DFGlA~~~ 287 (690)
..-++.++.||+.-.-.+-+ .+++|-||||+||||-... .++|.||.++...
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 35677788888765544433 4699999999999984332 4677777777543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.39 E-value=0.91 Score=50.52 Aligned_cols=59 Identities=24% Similarity=0.250 Sum_probs=35.0
Q ss_pred EEEEEecccc-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccccCCCcceeecc
Q 005582 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEH-CHSRGILHRDIKGSNLLIDY 272 (690)
Q Consensus 212 l~LV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~y-LHs~gIvHrDLKp~NILld~ 272 (690)
..||-+|+.| ++...+... ..++...+.++.-...||.- |--.+++|.|+.|.|||+-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 4555566665 333333332 24454555555544555543 33468999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 690 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-57 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-57 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-57 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-56 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-54 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-53 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-53 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-52 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-52 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-52 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-52 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-52 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-52 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-52 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-52 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-52 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-52 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-52 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-52 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-52 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-52 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-52 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-52 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-52 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-52 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-52 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-51 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-51 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-51 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-51 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-51 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-51 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-51 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-51 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-51 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-51 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-51 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-51 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-51 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-51 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-51 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-51 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-50 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-50 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-48 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-48 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-48 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-48 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-46 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-46 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-45 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-45 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-45 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-45 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-45 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-45 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-40 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-40 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-40 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-40 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-40 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-40 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-39 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-39 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-39 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-39 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-39 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-39 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-39 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-39 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-39 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-39 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-39 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-39 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-38 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-38 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-38 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-38 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-38 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-38 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-37 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-37 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-37 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-37 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-37 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-37 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-37 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-37 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-37 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-37 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-37 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-37 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-37 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-37 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-37 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-37 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-36 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-36 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-36 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-36 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-36 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-36 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-36 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-36 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-36 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-36 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-36 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-36 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-36 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-36 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-35 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-35 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-35 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-35 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-34 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-34 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-34 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-34 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-33 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-33 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-33 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-33 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-33 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-33 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-33 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-33 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-33 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-33 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-33 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-33 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-33 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-33 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-33 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-33 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-33 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-33 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-33 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-33 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-33 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-33 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-33 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-33 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-33 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-33 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-33 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-33 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-33 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-33 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-33 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-33 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-33 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-33 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-33 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-33 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-33 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-33 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-33 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-33 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-33 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-33 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-33 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-33 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-33 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-33 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-33 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-33 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-33 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-32 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-32 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-32 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-32 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-32 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-32 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-32 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-32 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-32 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-32 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-32 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-31 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-31 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-30 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-30 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-30 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-30 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-30 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-30 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-30 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-30 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-30 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-30 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-30 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-30 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-30 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-30 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-30 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-30 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-30 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-30 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-30 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-30 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-29 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-29 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-29 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-29 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-29 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-28 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-27 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-26 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-26 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-25 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-25 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-25 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-25 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-25 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-25 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-25 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-25 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-25 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-25 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-24 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-24 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-21 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-21 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-20 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-17 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-16 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-16 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-09 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-07 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 529 bits (1365), Expect = 0.0
Identities = 139/343 (40%), Positives = 192/343 (55%), Gaps = 14/343 (4%)
Query: 125 EAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA- 183
+++ + +EKL KIGQGT+ V+KAR + + VALKKV N + E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 184 REIIILRRLDHPNIMKLEGLITSRVS------GSLYLVFEYMEHDLAGLAATPGVKFTEA 237
REI IL+ L H N++ L + ++ S GS+YLVF++ EHDLAGL + VKFT +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC---SQKQP 294
+IK M+ LL+GL + H ILHRD+K +N+LI +G+LK+ DFGLA F SQ
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354
T+RVVTLWYRPPELLLG DYG +DLW +GCI+AE++ PIM G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 355 CGSPSEEYWKR-SKLPHATIFKPQQPYKRCVAETFKDIPSS--ALSLLDILLSTEPEVRG 411
CGS + E W + + KR V + K AL L+D LL +P R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 412 TASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
+ AL ++FF + P+P D + + F+ +
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHH 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 475 bits (1226), Expect = e-165
Identities = 127/348 (36%), Positives = 185/348 (53%), Gaps = 14/348 (4%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD--PESVRFMA-REII 187
V +A +EKLD +G+G +++VYKARD N++VA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLL 247
+L+ L HPNI+ L + ++ LVF++ME DL + + T + IK YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
GLE+ H ILHRD+K +NLL+D NG+LK+ DFGLA F S + T +VVT WYR P
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAP 181
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-S 366
ELL G+ YG VD+W+ GCILAEL P +PG ++++QL +IF+ G+P+EE W
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426
LP FK + F L L+ L P R TA+ AL+ ++F+ +P
Sbjct: 242 SLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
Query: 427 LPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESK 474
P LP+ E ++ R + G K
Sbjct: 300 GPTPGCQLPRPNCPVE-----TLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-138
Identities = 114/324 (35%), Positives = 172/324 (53%), Gaps = 8/324 (2%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+++ KLDK+G+GTY++VYK + + LVALK++R + + + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
NI+ L +I + SL LVFEY++ DL G +K ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
+ +LHRD+K NLLI+ G LK+ DFGLA + + VVTLWYRPP++LLGSTD
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATIF 374
Y +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+EE W +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSL 434
+ + + S LL LL E R +A A+++ FF + L
Sbjct: 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK--L 295
Query: 435 PKYPPSKE-FDVKLRDDDRRRGGG 457
P +++L+ + R
Sbjct: 296 PDTTSIFALKEIQLQKEASLRSAH 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-137
Identities = 117/397 (29%), Positives = 182/397 (45%), Gaps = 42/397 (10%)
Query: 128 NGWVPRKADSFEKLD-KIGQGTYSSVYKARDLE--NNKLVALKKVRFTNMDPESVRFMAR 184
+ R D FE K+G+GTY VYKA+ + ++K ALK++ T + + R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---- 67
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGL--------AATPGVKFTE 236
EI +LR L HPN++ L+ + S ++L+F+Y EHDL + A V+
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQK 292
+K + Q+L G+ + H+ +LHRD+K +N+L+ G +KI D G A F K
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 293 Q--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEV----- 345
L VVT WYR PELLLG+ Y ++D+W+ GCI AEL +PI R E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 346 ----EQLHKIFKLCGSPSEEYWKR-SKLPHATIFKP---QQPYKRC-----VAETFKDIP 392
+QL +IF + G P+++ W+ K+P + + Y C + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 393 SSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLP---KYPPSKEFDVKLRD 449
S A LL LL+ +P R T+ A+Q+ +F PLP YP + + D
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
Query: 450 DDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAELQ 486
D + + +G G + L+
Sbjct: 368 DKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-136
Identities = 116/321 (36%), Positives = 168/321 (52%), Gaps = 18/321 (5%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-VRFMA-REIIILRR 191
+ F++L+K+G GTY++VYK + VALK+V+ +D E A REI +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKE 59
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK-----FTEAQIKCYMKQL 246
L H NI++L +I + L LVFE+M++DL + V +K + QL
Sbjct: 60 LKHENIVRLYDVIHTE--NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L GL CH ILHRD+K NLLI+ G LK+GDFGLA F +S VVTLWYR
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVVTLWYRA 176
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR- 365
P++L+GS Y S+D+WS GCILAE+ GKP+ PG + EQL IF + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 366 SKLPHATIFKPQQPY----KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
+KLP Q+P + T + + + + L LL P++R +A AL + +
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 422 FTTKPLPCDPSSLPKYPPSKE 442
F +
Sbjct: 297 FAEYYHHASMGGSRSHHHHHH 317
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-134
Identities = 122/296 (41%), Positives = 177/296 (59%), Gaps = 8/296 (2%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
+EKL+KIG+GTY +V+KA++ E +++VALK+VR + D E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI++L ++ S L LVFE+ + DL + +K ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
SR +LHRD+K NLLI+ NG LK+ +FGLA F + ++ VVTLWYRPP++L G+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 315 DYGASVDLWSSGCILAELF-AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHAT 372
Y S+D+WS+GCI AEL AG+P+ PG +QL +IF+L G+P+EE W +KLP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
+ P P + + ++ LL LL P R +A ALQ+ +F+ P
Sbjct: 238 PY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-134
Identities = 117/307 (38%), Positives = 160/307 (52%), Gaps = 17/307 (5%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF---MAREIIIL 189
+E + +IG G Y +VYKARD + VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 190 RRL---DHPNIMKLEGLITSR---VSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCY 242
RRL +HPN+++L + + + LVFE+++ DL L P IK
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
M+Q L GL+ H+ I+HRD+K N+L+ G +K+ DFGLA + S + LT VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTL 183
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
WYR PE+LL ST Y VD+WS GCI AE+F KP+ G +E +QL KIF L G P E+
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 363 WKR-SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
W R LP F P+ P R V ++ S LL +L+ P R +A ALQ+ +
Sbjct: 243 WPRDVSLPRGA-FPPRGP--RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 422 FTTKPLP 428
Sbjct: 300 LHKDEGN 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-133
Identities = 99/311 (31%), Positives = 154/311 (49%), Gaps = 7/311 (2%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
+ +EK+ KIG+G+Y V+K R+ + ++VA+KK + D ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
PN++ L + R L+LVFEY +H + E +K Q L + CH
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
+HRD+K N+LI + ++K+ DFG A V T WYR PELL+G T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATI 373
YG VD+W+ GC+ AEL +G P+ PG+++V+QL+ I K G + + S + +
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 374 FK-PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPS 432
K P + F +I AL LL L +P R T L + +F D +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298
Query: 433 SLPKYPPSKEF 443
P +
Sbjct: 299 KEHDKPAENLY 309
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-133
Identities = 120/301 (39%), Positives = 172/301 (57%), Gaps = 7/301 (2%)
Query: 128 NGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REI 186
N + + ++KL+K+G+GTY VYKA+D ++VALK++R + + E + A REI
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRL-DAEDEGIPSTAIREI 70
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+L+ L HPNI+ L +I S L LVFE+ME DL + ++QIK Y+ QL
Sbjct: 71 SLLKELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L G+ HCH ILHRD+K NLLI+ +G LK+ DFGLA F + T VVTLWYR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRA 187
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR- 365
P++L+GS Y SVD+WS GCI AE+ GKP+ PG T+ +QL KIF + G+P+ W +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425
+LP Q K+ + + LL +L +P R +A A+ + +F
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 426 P 426
Sbjct: 308 D 308
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-133
Identities = 88/313 (28%), Positives = 163/313 (52%), Gaps = 7/313 (2%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRR 191
+ + +E L +G+G+Y V K R+ + ++VA+KK ++ D + V+ +A REI +L++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQ 80
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
L H N++ L + + YLVFE+++H + ++ Y+ Q+++G+
Sbjct: 81 LRHENLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
CHS I+HRDIK N+L+ +G++K+ DFG A + + V T WYR PELL+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLV 197
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPH 370
G YG +VD+W+ GC++ E+F G+P+ PG ++++QL+ I G+ + + +K P
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 371 ATIFK-PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
+ P+ + + + + + L L +P+ R + L ++FF
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317
Query: 430 DPSSLPKYPPSKE 442
S + K+
Sbjct: 318 RFSQELQLKVQKD 330
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-132
Identities = 121/327 (37%), Positives = 170/327 (51%), Gaps = 19/327 (5%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDL-ENNKLVALKKVRFTNMDPESVRFMA-REII 187
+ R +E + +IG+G Y V+KARDL + VALK+VR E + RE+
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVA 63
Query: 188 ILRRL---DHPNIMKLEGLITSRVS---GSLYLVFEYMEHDLAG-LAATPGVKFTEAQIK 240
+LR L +HPN+++L + T + L LVFE+++ DL L P IK
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
M QLL GL+ HS ++HRD+K N+L+ +G +K+ DFGLA + S + LTS VV
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV 181
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSE 360
TLWYR PE+LL S+ Y VDLWS GCI AE+F KP+ G ++V+QL KI + G P E
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 361 EYWKR-SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
E W R LP + + + DI LL L+ P R +A SAL +
Sbjct: 241 EDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 420 EFFTTKPLPCD--PSSLPKYPPSKEFD 444
+F + S LP + E +
Sbjct: 298 PYFQDLERCKENLDSHLPPSQNTSELN 324
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-132
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 12/306 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIII 188
D + ++ K+G+GTY VYKA D N+ VA+K++R + + E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
L+ L H NI++L+ +I L+L+FEY E+DL + IK ++ QL++
Sbjct: 87 LKELQHRNIIELKSVIHHN--HRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLIN 143
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYN-----GILKIGDFGLANFFKCSQKQPLTSRVVTLW 303
G+ CHSR LHRD+K NLL+ + +LKIGDFGLA F + T ++TLW
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLW 202
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363
YRPPE+LLGS Y SVD+WS CI AE+ P+ PG +E++QL KIF++ G P + W
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 364 KR-SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ LP P+ K + L LL +L +P R +A +AL++ +F
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
Query: 423 TTKPLP 428
+
Sbjct: 323 SHNDFD 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 384 bits (990), Expect = e-130
Identities = 110/290 (37%), Positives = 163/290 (56%), Gaps = 8/290 (2%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
+ + L+KIG+GTY VYKA++ + ALKK+R + E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+KL +I ++ L LVFE+++ DL L K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
R +LHRD+K NLLI+ G LKI DFGLA F + T +VTLWYR P++L+GS
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR-SKLPHATI 373
Y ++D+WS GCI AE+ G P+ PG +E +QL +IF++ G+P+ + W ++LP
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
K + S + LL +L +P R TA AL++ +F
Sbjct: 237 NFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-102
Identities = 116/339 (34%), Positives = 168/339 (49%), Gaps = 19/339 (5%)
Query: 116 PSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD 175
S +T V G + S+ IG G++ VY+A+ ++ +LVA+KKV D
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QD 90
Query: 176 PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLA---A 228
RF RE+ I+R+LDH NI++L S L LV +Y+ + +A +
Sbjct: 91 K---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 147
Query: 229 TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFF 287
+K YM QL L + HS GI HRDIK NLL+D + +LK+ DFG A
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ 347
+ +P S + + +YR PEL+ G+TDY +S+D+WS+GC+LAEL G+PI PG + V+Q
Sbjct: 208 --VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265
Query: 348 LHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETF-KDIPSSALSLLDILLSTE 406
L +I K+ G+P+ E R P+ T FK Q + F P A++L LL
Sbjct: 266 LVEIIKVLGTPTREQI-REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 407 PEVRGTASSALQNEFFTTKPLP-CDPSSLPKYPPSKEFD 444
P R T A + FF P + P F
Sbjct: 325 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 363
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 9e-98
Identities = 109/337 (32%), Positives = 171/337 (50%), Gaps = 24/337 (7%)
Query: 118 WLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE 177
+ +A + G ++ ++ IG G++ V++A+ +E+++ VA+KKV D
Sbjct: 24 VIKVLASDGKTGE--QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL---QDK- 76
Query: 178 SVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLA---ATP 230
RF RE+ I+R + HPN++ L+ S L LV EY+ + + A
Sbjct: 77 --RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL 134
Query: 231 GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFKC 289
IK YM QLL L + HS GI HRDIK NLL+D G+LK+ DFG A
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-- 192
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLH 349
+P S + + +YR PEL+ G+T+Y ++D+WS+GC++AEL G+P+ PG + ++QL
Sbjct: 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 350 KIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETF-KDIPSSALSLLDILLSTEPE 408
+I K+ G+PS E ++ P+ K Q ++ F P A+ L+ LL P
Sbjct: 253 EIIKVLGTPSREQI-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311
Query: 409 VRGTASSALQNEFFTTKPLPCDPSSLPKYPP-SKEFD 444
R TA AL + FF L + +P F+
Sbjct: 312 ARLTAIEALCHPFF--DELRTGEARMPNGRELPPLFN 346
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 3e-92
Identities = 100/350 (28%), Positives = 155/350 (44%), Gaps = 29/350 (8%)
Query: 114 GWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN 173
G S ++ A A + ++ D F+ GQGT+ +V ++ VA+KKV
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--- 57
Query: 174 MDPESVRFMAREIIILRRL---DHPNIMKLEGLITSRVSGS-----LYLVFEYMEHDLAG 225
+ RF RE+ I++ L HPNI++L+ + L +V EY+ L
Sbjct: 58 ---QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114
Query: 226 LA---ATPGVKFTEAQIKCYMKQLLHGLE--HCHSRGILHRDIKGSNLLIDY-NGILKIG 279
V IK ++ QL+ + H S + HRDIK N+L++ +G LK+
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 280 DFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIM 339
DFG A S +P + + + +YR PEL+ G+ Y +VD+WS GCI AE+ G+PI
Sbjct: 175 DFGSAKKL--SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 340 PGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ---QPYKRCVAETFKDIPSSAL 396
G QLH+I ++ G PS E ++ H + P+ ++ A
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 397 SLLDILLSTEPEVRGTASSALQNEFFTT--KPLPCDPSSLPKYPPSKEFD 444
LL LL PE R AL + +F P P++ P F
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDL--PEDLFR 340
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 8e-89
Identities = 100/360 (27%), Positives = 156/360 (43%), Gaps = 55/360 (15%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
+ + +G G++ V + D+E+ K ALKKV DP R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---QDP---RYKNRELDIMKV 56
Query: 192 LDHPNIMKLEGLITSRVSGS------------------------------------LYLV 215
LDH NI+KL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 216 FEYMEHDLAGLA---ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY 272
EY+ L + G I Y+ QL + HS GI HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 273 N-GILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAE 331
LK+ DFG A +P + + + +YR PEL+LG+T+Y S+DLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 332 LFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK-PQQPYKRCVAETF-K 389
L GKP+ G T ++QL +I ++ G+P++E R PH T + P + + +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLK-AKDWRKILPE 292
Query: 390 DIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRD 449
PS A+ LL+ +L EP++R A+ + FF L + S ++
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPHGVNQN 349
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-88
Identities = 94/299 (31%), Positives = 153/299 (51%), Gaps = 23/299 (7%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DH 194
D ++ + K+G+G YS V++A ++ NN+ V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 195 PNIMKLEGLITSRVSGSLYLVFEY-MEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
PNI+ L ++ VS + LVFE+ D L T T+ I+ YM ++L L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 146
Query: 254 HSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
HS GI+HRD+K N++ID+ + L++ D+GLA F+ Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVD 204
Query: 313 STDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEE-YWKRSKLPH 370
Y S+D+WS GC+LA + K P G +QL +I K+ G+ Y + +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 371 ATIFKPQQPYKRCV-------AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
F +E + AL LD LL + + R TA A+++ +F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 2e-84
Identities = 109/387 (28%), Positives = 168/387 (43%), Gaps = 67/387 (17%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+P + +E IG G+Y V +A D ++VA+KK+ D + + REI IL
Sbjct: 51 IPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 191 RLDHPNIMKLEGLITSRVSGS---LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLL 247
RL+H +++K+ ++ + LY+V E + D L TP V TE IK + LL
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLL 166
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA----------------------- 284
G+++ HS GILHRD+K +N L++ + +K+ DFGLA
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 285 ---NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF-------- 333
+ K+ LT VVT WYR PEL+L +Y ++D+WS GCI AEL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 334 ---AGKPIMPG--------------------RTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
P+ PG R +QL+ IF + G+PSEE + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 371 ATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
A + P + AE F + A+ LL +L P R T + L + FF +
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
Query: 429 CD-PSSLPKYPPSKEFDVKLRDDDRRR 454
++ K + + + R
Sbjct: 407 EVETNATEKVRLPFNDWMNMDEPQLRY 433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 2e-84
Identities = 96/338 (28%), Positives = 144/338 (42%), Gaps = 27/338 (7%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVR-FMA------ 183
+ + I G+Y +V D E VA+K+V T D +V
Sbjct: 20 MQSP---YTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 184 --REIIILRRLDHPNIMKLEGLITSRVSGS---LYLVFEYMEHDLAGLAATPGVKFTEAQ 238
REI +L HPNI+ L + + LYLV E M DLA + + +
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298
I+ +M +L GL H G++HRD+ N+L+ N + I DF LA + + T
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHY 193
Query: 299 VVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP 358
V WYR PEL++ + VD+WS+GC++AE+F K + G T QL+KI ++ G+P
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 359 SEEYWKRSKLPHATIF----KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS 414
E P A + P R AL L+ +L P+ R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 415 SALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDR 452
AL++ +F + L DP L S+ F D
Sbjct: 313 QALRHPYF--ESL-FDPLDLT-EGLSERFHFDESVTDV 346
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 4e-84
Identities = 115/327 (35%), Positives = 163/327 (49%), Gaps = 18/327 (5%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIIL 189
V + + L IG+G Y V A D N VA+KK+ F + + REI IL
Sbjct: 25 VGPR---YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKIL 79
Query: 190 RRLDHPNIMKLEGLITSRVSGS---LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
R H NI+ + +I + +Y+V + ME DL L T + I ++ Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQI 137
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA--NFFKCSQKQPLTSRVVTLWY 304
L GL++ HS +LHRD+K SNLL++ LKI DFGLA LT V T WY
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
R PE++L S Y S+D+WS GCILAE+ + +PI PG+ ++QL+ I + GSPS+E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 365 RSKLPHATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
A + P+K V F + S AL LLD +L+ P R AL + +
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 423 TTKPLPCDPSSLPKYPPSKEFDVKLRD 449
+ DPS P +FD++L D
Sbjct: 318 --EQY-YDPSDEPIAEAPFKFDMELDD 341
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 9e-84
Identities = 97/320 (30%), Positives = 157/320 (49%), Gaps = 19/320 (5%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+P+ + +G G Y SV A D + + VA+KK+ + RE+++L+
Sbjct: 22 LPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 191 RLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+ H N++ L + T S YLV +M+ DL + F+E +I+ + Q+
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQM 135
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L GL++ HS G++HRD+K NL ++ + LKI DFGLA +T VVT WYR
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRA 191
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE++L Y +VD+WS GCI+AE+ GK + G+ ++QL +I K+ G P E+ ++
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251
Query: 367 KLPHATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424
A + P + F A LL+ +L + + R TA+ AL + FF
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF-- 309
Query: 425 KPLPCDPSSLPKYPPSKEFD 444
+P DP + +
Sbjct: 310 EPF-RDPEEETEAQQPFDDS 328
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 5e-82
Identities = 103/330 (31%), Positives = 159/330 (48%), Gaps = 16/330 (4%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
V + L +G G Y +V A D VA+KK+ + RE+ +L+
Sbjct: 23 VRAV---YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79
Query: 191 RLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+ H N++ L + T + YLV +M DL L K E +I+ + Q+
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQM 137
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L GL + H+ GI+HRD+K NL ++ + LKI DFGLA +T VVT WYR
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRA 193
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE++L Y +VD+WS GCI+AE+ GK + G ++QL +I K+ G+P E+ +R
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 367 KLPHATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424
+ A + P A + A++LL+ +L + E R TA AL + +F +
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
Query: 425 KPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
D + KY S + DV D+ +R
Sbjct: 314 LHDTEDEPQVQKYDDSFD-DVDRTLDEWKR 342
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 9e-82
Identities = 103/327 (31%), Positives = 156/327 (47%), Gaps = 21/327 (6%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
VP + ++ L +G G Y SV A D + VA+KK+ + RE+ +L+
Sbjct: 27 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 191 RLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+ H N++ L + T S +YLV M DL + K T+ ++ + Q+
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQI 141
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L GL++ HS I+HRD+K SNL ++ + LKI DFGLA +T V T WYR
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE++L Y +VD+WS GCI+AEL G+ + PG ++QL I +L G+P E K+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 367 KLPHATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424
A + + A F A+ LL+ +L + + R TA+ AL + +F
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF-- 315
Query: 425 KPLPCDPSSLPKYPPSKEFDVKLRDDD 451
DP P P +D L D
Sbjct: 316 AQY-HDPDDEPVADP---YDQSLESRD 338
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-81
Identities = 105/309 (33%), Positives = 160/309 (51%), Gaps = 25/309 (8%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+ + + L +G G V+ A D + +K VA+KK+ T+ P+SV+ REI I+R
Sbjct: 9 LGSR---YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIR 63
Query: 191 RLDHPNIMKLEGLITSRVSGS------------LYLVFEYMEHDLAGLAATPGVKFTEAQ 238
RLDH NI+K+ ++ S +Y+V EYME DLA + E
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEH 121
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID-YNGILKIGDFGLA--NFFKCSQKQPL 295
+ +M QLL GL++ HS +LHRD+K +NL I+ + +LKIGDFGLA S K L
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355
+ +VT WYR P LLL +Y ++D+W++GCI AE+ GK + G E+EQ+ I +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 356 GSPSEEYWKR--SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA 413
EE + S +P +P + + + I A+ L+ +L+ P R TA
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 414 SSALQNEFF 422
AL + +
Sbjct: 301 EEALSHPYM 309
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-81
Identities = 102/337 (30%), Positives = 157/337 (46%), Gaps = 24/337 (7%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-FTNMDPESVRFMAREIIIL 189
+ F+ +G+G Y V A ++VA+KK+ F P REI IL
Sbjct: 9 ISSD---FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKIL 63
Query: 190 RRLDHPNIMKLEGLITSRVSGS---LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
+ H NI+ + + + +Y++ E M+ DL + +T ++ I+ ++ Q
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQT 121
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA---------NFFKCSQKQPLTS 297
L ++ H ++HRD+K SNLLI+ N LK+ DFGLA N Q+ +
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357
V T WYR PE++L S Y ++D+WS GCILAELF +PI PGR QL IF + G+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 358 P-SEEYWKRSKLPHATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTAS 414
P S+ + + P A + P + F + + LL +L +P R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 415 SALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDD 451
AL++ + T P D PPS F+ +
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSF-FEFDHYKEA 337
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 1e-80
Identities = 109/364 (29%), Positives = 168/364 (46%), Gaps = 45/364 (12%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
V RK +E + K+G+G Y V+K+ D ++VA+KK+ + + REI+IL
Sbjct: 7 VLRK---YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 191 RL-DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L H NI+ L ++ + +YLVF+YME DL + + + QL+
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKV 121
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA--------------------NFFKC 289
+++ HS G+LHRD+K SN+L++ +K+ DFGL+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLH 349
+ LT V T WYR PE+LLGST Y +D+WS GCIL E+ GKPI PG + + QL
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 350 KIFKLCGSPSEEYW----------------KRSKLPHATIFKPQQPYKRCVAETF--KDI 391
+I + PS E ++ ++ + +K + + D
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 392 PSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD-PSSLPKYPPSKEFDVKLRDD 450
AL LLD LL P R +A+ AL++ F + P + P+ +VK D
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSID 361
Query: 451 DRRR 454
D R
Sbjct: 362 DYRN 365
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-76
Identities = 92/346 (26%), Positives = 161/346 (46%), Gaps = 35/346 (10%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
V ++ ++ L IG G V A D + VA+KK+ + + RE+++++
Sbjct: 23 VLKR---YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 191 RLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
++H NI+ L + T + S +Y+V E M+ +L + ++ + Q+
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQM 136
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L G++H HS GI+HRD+K SN+++ + LKI DFGLA +T VVT +YR
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 194
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR- 365
PE++LG Y +VD+WS GCI+ E+ G + PG ++Q +K+ + G+P E+ K+
Sbjct: 195 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 366 --------SKLPHATIFKPQQPYKR--------CVAETFKDIPSSALSLLDILLSTEPEV 409
P +++ +E K S A LL +L +
Sbjct: 254 QPTVRTYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 410 RGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFD-VKLRDDDRRR 454
R + ALQ+ + P + + P P K+ D + ++ +
Sbjct: 310 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 355
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 252 bits (644), Expect = 1e-76
Identities = 101/411 (24%), Positives = 181/411 (44%), Gaps = 47/411 (11%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
V ++ ++ L IG G V A D ++ VA+KK+ + + RE+++++
Sbjct: 60 VLKR---YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 191 RLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
++H NI+ L + T + + +YLV E M+ +L + ++ + Q+
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQM 173
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L G++H HS GI+HRD+K SN+++ + LKI DFGLA +T VVT +YR
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 231
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR- 365
PE++L Y +VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P E+ K+
Sbjct: 232 PEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 366 --------SKLPHATIFKPQQPYKR--------CVAETFKDIPSSALSLLDILLSTEPEV 409
P + + +E K S A LL +L +P
Sbjct: 291 QPTVRNYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346
Query: 410 RGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFD-VKLRDDD------------RRRGG 456
R + ALQ+ + P + + P K+ D + ++ +
Sbjct: 347 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTK 406
Query: 457 GGKGRGLESIRKAGKESKAVPAPDANAELQTSIQKRQNQSNPKATSEQFNS 507
G +G S A S P ++ +S+ Q ++ +S + ++
Sbjct: 407 NGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASA 457
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-76
Identities = 107/368 (29%), Positives = 157/368 (42%), Gaps = 61/368 (16%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
VP + IG+G+Y VY A D K VA+KKV D + + REI IL
Sbjct: 24 VPDN---YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 191 RLDHPNIMKLEGLITSRVSGS---LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLL 247
RL I++L LI LY+V E + DL L TP + TE IK + LL
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLL 139
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA---------------------NF 286
G H GI+HRD+K +N L++ + +K+ DFGLA
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 287 FKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG----------- 335
+ K+ LTS VVT WYR PEL+L +Y S+D+WS+GCI AEL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 336 KPIMPG-----------------RTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQ 378
P+ PG ++ +QL+ IF + G+P+E+ K P +
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 379 PYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPK 436
P+++ + + + I ++LL+ +L P R T AL + + K +
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL--KDV-RKKKLENF 376
Query: 437 YPPSKEFD 444
Sbjct: 377 STKKIILP 384
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-66
Identities = 73/315 (23%), Positives = 130/315 (41%), Gaps = 55/315 (17%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
R A FE++ +GQG + V KAR+ +++ A+KK+R T ++ E+++L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 193 DHPNIMKL-----------EGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIK 240
+H +++ + + + +L++ EY E L L + + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP------ 294
+Q+L L + HS+GI+HRD+K N+ ID + +KIGDFGLA S
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 295 -------LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ 347
LTS + T Y E+L G+ Y +D++S G I E+ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 348 LHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEP 407
L K+ + ++ + ++ +L+ +P
Sbjct: 238 LKKLRSVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDP 272
Query: 408 EVRGTASSALQNEFF 422
R A + L + +
Sbjct: 273 NKRPGARTLLNSGWL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-66
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 46/312 (14%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN- 196
+ L +IG G S V++ + E ++ A+K V D +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 197 -IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
I++L + +Y+V E DL + K Y K +L + H
Sbjct: 89 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGS- 313
GI+H D+K +N LI +G+LK+ DFG+AN + S+V T+ Y PPE +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 314 ---------TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
+ D+WS GCIL + GK P + + Q+ K+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA----------- 251
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPS-SALSLLDILLSTEPEVRGTASSALQNEFFT 423
I P + F DIP +L L +P+ R + L + +
Sbjct: 252 --------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
Query: 424 TKPLPCDPSSLP 435
+ P + +
Sbjct: 298 IQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-64
Identities = 78/352 (22%), Positives = 132/352 (37%), Gaps = 46/352 (13%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN- 196
+ L +IG G S V++ + E ++ A+K V D +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 197 -IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
I++L + +Y+V E DL + K Y K +L + H
Sbjct: 70 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP-LTSRVVTLWYRPPELLLGS- 313
GI+H D+K +N LI +G+LK+ DFG+AN + S+V T+ Y PPE +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 314 ---------TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
+ D+WS GCIL + GK P + + Q+ K+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA----------- 232
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPS-SALSLLDILLSTEPEVRGTASSALQNEFFT 423
I P + F DIP +L L +P+ R + L + +
Sbjct: 233 --------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
Query: 424 TKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKA 475
+ P + + K +L + + L G+ +
Sbjct: 279 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-63
Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 38/296 (12%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
SF++L ++G G+Y V+K R E+ +L A+K+ P+ E+ +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 192 L-DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+ HP ++LE G LYL E L G EAQ+ Y++ L L
Sbjct: 113 VGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
H HS+G++H D+K +N+ + G K+GDFGL + Y PELL
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQEGDPRYMAPELL 228
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
G YG + D++S G + E+ +P E ++ +
Sbjct: 229 QG--SYGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG---------------- 267
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426
P+ + S S+L ++L +P++R TA + L +P
Sbjct: 268 --YLPPEFT---------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL-RQP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-63
Identities = 82/304 (26%), Positives = 127/304 (41%), Gaps = 47/304 (15%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
P +A+ +E L IG G+Y K R + K++ K++ + +M + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLL 247
L HPNI++ I R + +LY+V EY E DLA + E + M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 248 HGLEHCHSRG-----ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
L+ CH R +LHRD+K +N+ +D +K+GDFGLA + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
+Y PE + Y D+WS GC+L EL A P ++ E KI
Sbjct: 181 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------- 228
Query: 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIP---SSAL-SLLDILLSTEPEVRGTASSALQ 418
F+ IP S L ++ +L+ + R + L+
Sbjct: 229 ---------------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
Query: 419 NEFF 422
N
Sbjct: 268 NPLI 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 81/379 (21%), Positives = 140/379 (36%), Gaps = 53/379 (13%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+ K + L +IG G S V++ + E ++ A+K V D +++ EI L
Sbjct: 51 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 191 RLDHPN--IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
+L + I++L + +Y+V E DL + K Y K +L
Sbjct: 110 KLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLE 166
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPP 307
+ H GI+H D+K +N LI +G+LK+ DFG+AN + S+V + Y PP
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 308 ELLLGSTD----------YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357
E + + D+WS GCIL + GK P + + Q+ K+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA---- 279
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPS-SALSLLDILLSTEPEVRGTASSA 416
I P + F DIP +L L +P+ R +
Sbjct: 280 ---------------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 417 LQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAV 476
L + + + P + + K +L + + K E +
Sbjct: 319 LAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLN-------SPNSILKAAKTLYEHYSG 371
Query: 477 PAPDANAELQTSIQKRQNQ 495
++ +T +KR +
Sbjct: 372 GESHNSSSSKTFEKKRGKK 390
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-61
Identities = 85/363 (23%), Positives = 142/363 (39%), Gaps = 42/363 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + +L KIG+G++ + E+ + +K++ + M + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHC 253
NI++ GSLY+V +Y E DL + A GV F E QI + Q+ L+H
Sbjct: 84 NIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
H R ILHRDIK N+ + +G +++GDFG+A S + + + T +Y PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENK 200
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y D+W+ GC+L EL K + + KI
Sbjct: 201 -PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---------------------- 237
Query: 374 FKPQQPYKRCVAETFKDIP---SSAL-SLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
++ +F + S L SL+ L P R + +S L+ F +
Sbjct: 238 ----------ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287
Query: 430 DPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAELQTSI 489
L + K G+ S+ A K +K +
Sbjct: 288 LSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYG 347
Query: 490 QKR 492
K+
Sbjct: 348 DKK 350
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-60
Identities = 74/311 (23%), Positives = 120/311 (38%), Gaps = 60/311 (19%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
R F++++ IG G + V+KA+ + K +K+V++ N RE+ L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 192 LDHPNIMKL--------------EGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFT 235
LDH NI+ + + L++ E+ + L + G K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 236 EAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295
+ +Q+ G+++ HS+ +++RD+K SN+ + +KIGDFGL K K
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355
T TL Y PE + DYG VDL++ G ILAEL + +
Sbjct: 179 TRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCD--TAFETSKFFTDL---- 231
Query: 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSAL-SLLDILLSTEPEVRGTAS 414
+ + DI +LL LLS +PE R S
Sbjct: 232 --------RDGIIS--------------------DIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 415 SALQNEFFTTK 425
L+ K
Sbjct: 264 EILRTLTVWKK 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-60
Identities = 72/320 (22%), Positives = 127/320 (39%), Gaps = 56/320 (17%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
R FE + +G+G + V++A++ ++ A+K++R N + + M RE+ L +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 193 DHPNIMK----------LEGLITSRVSGSLYLVFEYMEH-DLAGL--AATPGVKFTEAQI 239
+HP I++ E L S LY+ + +L + +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 240 KCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-----------NFFK 288
Q+ +E HS+G++HRD+K SN+ + ++K+GDFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQL 348
T +V T Y PE + G+ Y VD++S G IL EL + P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL-----LYPFSTQMERV 234
Query: 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE 408
+ + + K P F ++ +LS P
Sbjct: 235 RTLTDV---------RNLKFPP----------------LFTQKYPCEYVMVQDMLSPSPM 269
Query: 409 VRGTASSALQNEFFTTKPLP 428
R A + ++N F P
Sbjct: 270 ERPEAINIIENAVFEDLDFP 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-59
Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 44/293 (15%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDH 194
+F KIG+G +S VY+A L + VALKKV+ + MD ++ +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLLHGL 250
PN++K L +V E + DL+ + E + Y QL L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
EH HSR ++HRDIK +N+ I G++K+GD GL FF S+ S V T +Y PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
+ Y D+WS GC+L E+ A + P + L+ +
Sbjct: 209 HEN-GYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLC------------------ 247
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALS-----LLDILLSTEPEVRGTASSALQ 418
K+ + +PS S L+++ ++ +PE R +
Sbjct: 248 ----------KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-59
Identities = 62/301 (20%), Positives = 115/301 (38%), Gaps = 25/301 (8%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ D +GQG ++V++ R + L A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPG--VKFTEAQIKCYMKQLLHGLEH 252
NI+KL + + L+ E+ L + P E++ ++ ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 253 CHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
GI+HR+IK N++ D + K+ DFG A + + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPD 185
Query: 309 LLLGSTD-------YGASVDLWSSGCILAELFAGKP----IMPGRTEVEQLHKIFKLCGS 357
+ + YGA+VDLWS G G R E ++KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417
+ ++++ + P ++ + + +L +L + E
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQFF 301
Query: 418 Q 418
Sbjct: 302 A 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 64/305 (20%), Positives = 119/305 (39%), Gaps = 30/305 (9%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ D +GQG ++V++ R + L A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPG--VKFTEAQIKCYMKQLLHGLEH 252
NI+KL + + L+ E+ L + P E++ ++ ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 253 CHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
GI+HR+IK N++ D + K+ DFG A + + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPD 185
Query: 309 LLLGSTD-------YGASVDLWSSGCILAELFAGKP----IMPGRTEVEQLHKIFKLCGS 357
+ + YGA+VDLWS G G R E ++KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417
+ ++++ + P ++ + + +L +L + E
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGF---- 297
Query: 418 QNEFF 422
++FF
Sbjct: 298 -DQFF 301
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 204 bits (519), Expect = 8e-57
Identities = 80/416 (19%), Positives = 137/416 (32%), Gaps = 36/416 (8%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
+ +E +++G G + V + + + VA+K+ R + P++ EI I+++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKK 68
Query: 192 LDHPNIMKL----EGLITSRVSGSLYLVFEYMEH-DLAGLAATPG--VKFTEAQIKCYMK 244
L+HPN++ +GL + L EY E DL E I+ +
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCSQKQPLTSRVVT 301
+ L + H I+HRD+K N+++ I KI D G A Q + T V T
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGT 186
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361
L Y PELL Y +VD WS G + E G + Q H + +
Sbjct: 187 LQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
+ P K L +L RGT
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLER-----WLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 422 FT--TKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAP 479
F L S+ + + +++ L++++ ++ +P
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENEN----------LQNLKSWLQQDTGIPEE 350
Query: 480 DANAELQTSIQKRQNQSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQTMKPT 535
+ Q +Q N Q+ D G E + +P
Sbjct: 351 E-----QELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQ 401
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-55
Identities = 84/326 (25%), Positives = 136/326 (41%), Gaps = 37/326 (11%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF-MAREIIILR 190
PR + + +G+G ++ ++ D + ++ A K V + + R M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L H +++ G +++V E L L TE + + Y++Q++ G
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 153
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
++ H ++HRD+K NL ++ + +KIGDFGLA + + T Y PE+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEV 212
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
L + VD+WS GCI+ L GKP E +I K EY +P
Sbjct: 213 LSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 261
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
K I A SL+ +L T+P R T + L +EFFT+ +P
Sbjct: 262 -------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
Query: 430 D-PSSLPKYPPSKEFDVKLRDDDRRR 454
P + PP D R+
Sbjct: 303 RLPITCLTIPPRFSIAPSSLDPSNRK 328
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 82/311 (26%), Positives = 133/311 (42%), Gaps = 37/311 (11%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF-MAREIIILR 190
PR + + +G+G ++ ++ D + ++ A K V + + R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L H +++ G +++V E L L TE + + Y++Q++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
++ H ++HRD+K NL ++ + +KIGDFGLA + + T Y PE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEV 186
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
L + VD+WS GCI+ L GKP E +I K EY +P
Sbjct: 187 LSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 235
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
K I A SL+ +L T+P R T + L +EFFT+ +P
Sbjct: 236 -------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276
Query: 430 D-PSSLPKYPP 439
P + PP
Sbjct: 277 RLPITCLTIPP 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 65/313 (20%), Positives = 112/313 (35%), Gaps = 46/313 (14%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ + K+G+G +S V L + ALK++ + RE + R +HPNI
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNI 88
Query: 198 MKLEGLITSRVSGS--LYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLLHGLE 251
++L +L+ + + L G TE QI + + GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF--------KCSQKQPLTSRVVTLW 303
H++G HRD+K +N+L+ G + D G N + Q ++ T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 304 YRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361
YR PEL D+WS GC+L + G+ P + + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDS 255
Query: 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSAL-SLLDILLSTEPEVRGTASSALQNE 420
+ + + SSAL LL+ +++ +P R L
Sbjct: 256 V--ALAVQNQLSIPQSPRH------------SSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 421 FFTTKPLPCDPSS 433
P P ++
Sbjct: 302 EALQPPAPGQHTT 314
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 35/300 (11%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF-MAREIIIL 189
+ K + F+ + +G+G+++ VY+A + VA+K + M + + E+ I
Sbjct: 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH 248
+L HP+I++L S +YLV E + ++ F+E + + +M Q++
Sbjct: 66 CQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
G+ + HS GILHRD+ SNLL+ N +KI DFGLA K ++ T T Y PE
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPE 182
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
+ S +G D+WS GC+ L G+P T L+K+ +Y ++
Sbjct: 183 IATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY----EM 231
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
P + A L+ LL P R + SS L + F +
Sbjct: 232 P-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 73/330 (22%), Positives = 130/330 (39%), Gaps = 46/330 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK-----------KVRFTNMDPESVRFMA- 183
+ + + + QG ++ + ++NK ALK +N D S++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 184 ---REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME--------HDLAGLAATPGV 232
E+ I+ + + + EG+IT+ +Y+++EYME L
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 233 KFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291
IKC +K +L+ + H+ + I HRD+K SN+L+D NG +K+ DFG + + +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 292 KQPLTSRVVTLWYRPPELLLGSTDY-GASVDLWSSGCILAELFAGK-PIMPGRTEVEQLH 349
+ T + PPE + Y GA VD+WS G L +F P + VE +
Sbjct: 207 ---IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 350 KIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV 409
I + + P + + + + + L + L P
Sbjct: 264 NIRT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 410 RGTASSALQNEFFT---TKPLPCDPSSLPK 436
R T+ AL++E+ + L L K
Sbjct: 314 RITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-53
Identities = 57/313 (18%), Positives = 109/313 (34%), Gaps = 62/313 (19%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
R F +L+KIG G + SV+K + + A+K+ + + RE+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 193 -DHPNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLL 247
H ++++ + + EY D F EA++K + Q+
Sbjct: 68 GQHSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGIL-------------------KIGDFGLANFFK 288
GL + HS ++H DIK SN+ I I KIGD G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---- 181
Query: 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQL 348
++ + E+L + + D+++ + +P +P +Q
Sbjct: 182 -TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQW 237
Query: 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE 408
H+I + G +P + + LL +++ +PE
Sbjct: 238 HEIRQ--GRLPR-------IP-------------------QVLSQEFTELLKVMIHPDPE 269
Query: 409 VRGTASSALQNEF 421
R +A + +++
Sbjct: 270 RRPSAMALVKHSV 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 8e-52
Identities = 52/375 (13%), Positives = 102/375 (27%), Gaps = 64/375 (17%)
Query: 81 LQRRSTINVQVAQPRMTRIVSVSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEK 140
L+R + + + ++ + + ++ + +
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLS--------QGERKLKL 66
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPN--- 196
++ + G S V+ RD+E + ALK + + RL +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 197 ---------------------IMKLEGLITSRVSGSLYLVFEYMEHDLAGL------AAT 229
+L + L+ DL L
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 230 PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289
+ QL+ + S+G++H NL I +G L +GD
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---- 242
Query: 290 SQKQPLTSRVVTLWYRPPELLLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQL 348
+ V + Y P E L S + +++ W G + ++ P
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P-------- 292
Query: 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE 408
F L + WKR L + C +P +L+ L+ +
Sbjct: 293 ---FGLVTPGIKGSWKRPSL--RVPGTDSLAFGSC-----TPLPDFVKTLIGRFLNFDRR 342
Query: 409 VRGTASSALQNEFFT 423
R A++ F
Sbjct: 343 RRLLPLEAMETPEFL 357
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-51
Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 58/305 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + + +G+G++ V K +D + A+K + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCYMKQ 245
NIMKL ++ S Y+V E G +F+E +KQ
Sbjct: 82 NIMKLFEILEDS--SSFYIVGELYT----------GGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ G+ + H I+HRD+K N+L+ + + +KI DFGL+ F+ Q + R+ T
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA 187
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS--E 360
+Y PE+L G+ Y D+WS+G IL L +G P G+ E + L ++ G +
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDL 243
Query: 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
W + I A L+ +L+ P +R TA+ L++
Sbjct: 244 PQW-------------------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 421 FFTTK 425
+
Sbjct: 279 WIQKY 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-51
Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 36/292 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ ++++ K+G G Y V RD + A+K +R T++ S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NIMKL + + YLV E + +L KF E +KQ+L G+ + H
Sbjct: 97 NIMKLYDFFEDK--RNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH 153
Query: 255 SRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
I+HRD+K NLL+ + + ++KI DFGL+ F+ ++ + R+ T +Y PE+L
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLR 211
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y D+WS G IL L AG P G+T+ E L K+ K + W
Sbjct: 212 KK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW-------- 261
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
K++ A L+ +L + + R +A AL++ +
Sbjct: 262 -----------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 58/303 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + + +G+G++ V K +D + A+K + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCYMKQ 245
NIMKL ++ S Y+V E G +F+E +KQ
Sbjct: 82 NIMKLFEILEDS--SSFYIVGELYT----------GGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ G+ + H I+HRD+K N+L+ + + +KI DFGL+ F+ Q + R+ T
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA 187
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS--E 360
+Y PE+L G+ Y D+WS+G IL L +G P G+ E + L ++ G +
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDL 243
Query: 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
W + I A L+ +L+ P +R TA+ L++
Sbjct: 244 PQW-------------------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 421 FFT 423
+
Sbjct: 279 WIQ 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 67/310 (21%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
D+++ +++G+G +S V + A K + + D + + RE I R+L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKL 62
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCY 242
HPNI++L I YLVF+ + G ++EA
Sbjct: 63 QHPNIVRLHDSIQEE--SFHYLVFDLVT----------GGELFEDIVAREFYSEADASHC 110
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRV 299
++Q+L + +CHS GI+HR++K NLL+ +K+ DFGLA +
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFA 168
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFKLCGS 357
T Y PE+L Y VD+W+ G IL L G P P + +I G+
Sbjct: 169 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGA 223
Query: 358 PS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415
W + A SL+D +L+ P+ R TA
Sbjct: 224 YDYPSPEW-------------------------DTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 416 ALQNEFFTTK 425
AL+ + +
Sbjct: 259 ALKVPWICNR 268
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-50
Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK-----KVRFTNMDPESVRFMAREIIILR 190
+ FE +G+G + +VY AR+ ++ ++ALK ++ ++ +R RE+ I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLR---REVEIQS 64
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L HPNI++L G +YL+ EY + KF E + Y+ +L +
Sbjct: 65 HLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANA 121
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
L +CHS+ ++HRDIK NLL+ G LKI DFG + S++ L TL Y PPE+
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEM 178
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
+ G + VDLWS G + E GKP T E +I ++ E+ P
Sbjct: 179 IEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP 227
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
+ A L+ LL P R L++ + T
Sbjct: 228 -------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 38/290 (13%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE 201
+IG+G++ +VYK D E VA +++ + + E +L+ L HPNI++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 202 G--LITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG- 257
T + + LV E M L ++ + +Q+L GL+ H+R
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 258 -ILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
I+HRD+K N+ I G +KIGD GLA + + + T + PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPE--MYEEK 205
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375
Y SVD+++ G + E+ + P +E + +I++ S K
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV---------------K 247
Query: 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425
P K + E K+I ++ + + R + L + FF +
Sbjct: 248 PASFDKVAIPE-VKEI-------IEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-50
Identities = 81/307 (26%), Positives = 137/307 (44%), Gaps = 41/307 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
D ++ +G+G++ V +D + A+K + + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
PNIMKL + G YLV E +L + +F+E ++Q+L G+ +
Sbjct: 86 PNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM 142
Query: 254 HSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
H I+HRD+K NLL+ + ++I DFGL+ F+ + + ++ T +Y PE+L
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVL 200
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKRSKL 368
G+ Y D+WS+G IL L +G P G E + L K+ K G + W
Sbjct: 201 HGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQW----- 251
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
K + SA L+ +L+ P +R +A AL +E+ T
Sbjct: 252 --------------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291
Query: 429 CDPSSLP 435
+P
Sbjct: 292 QISVDVP 298
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-50
Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 45/300 (15%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HP 195
SF D +G G ++ R + +N+ VA+K+ + PE F RE+ +LR D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKR-----ILPECFSFADREVQLLRESDEHP 78
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
N+++ R Y+ E L + ++Q GL H HS
Sbjct: 79 NVIRYFCTEKDR--QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 256 RGILHRDIKGSNLLIDYNG-----ILKIGDFGLANFFKCSQK--QPLTSRVVTLWYRPPE 308
I+HRD+K N+LI I DFGL + + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 309 LLLGSTD--YGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
+L +VD++S+GC+ + + G + + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425
++ L++ +++ +P+ R +A L++ FF +
Sbjct: 257 D-------------------VIARE-------LIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 64/300 (21%), Positives = 106/300 (35%), Gaps = 49/300 (16%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++G+G++ V++ +D + A+KKVR E E++ L P I
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 198 MKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L G R + + E +E L E + Y+ Q L GLE+
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYL 166
Query: 254 HSRGILHRDIKGSNLLIDYNGIL-KIGDFG----LANFFKCSQKQPLTSRVVTLWYRPPE 308
H+R ILH D+K N+L+ +G + DFG L T + PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
+++G A VD+WSS C++ + G P T+ + K+ P
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP---------- 272
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
P + A + L EP R +A + + +
Sbjct: 273 ------PPIREIPPSCAPLTAQ-------AIQEGLRKEPVHRASAMELRRKVGKALQEVG 319
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-50
Identities = 81/331 (24%), Positives = 129/331 (38%), Gaps = 78/331 (23%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNM------DPESVRFMAREI 186
D + +G G V A + + K VA+K K +F +V EI
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 66
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTE 236
IL++L+HP I+K++ + Y+V E ME G + E
Sbjct: 67 EILKKLNHPCIIKIKNFFDAE---DYYIVLELME----------GGELFDKVVGNKRLKE 113
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQ 293
A K Y Q+L +++ H GI+HRD+K N+L+ + + ++KI DFG + +
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 171
Query: 294 PLTSRVVTLWYRPPELLLGSTD--YGASVDLWSSGCILAELFAGKPIMP---GRTEVEQL 348
+ + T Y PE+L+ Y +VD WS G IL +G P P RT+V
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLK 229
Query: 349 HKIFKLCGS---PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST 405
+I G E W ++ AL L+ LL
Sbjct: 230 DQI--TSGKYNFIP-EVW-------------------------AEVSEKALDLVKKLLVV 261
Query: 406 EPEVRGTASSALQNEFFTTKPLPCDPSSLPK 436
+P+ R T AL++ + + + L
Sbjct: 262 DPKARFTTEEALRHPWLQDEDMKRKFQDLLS 292
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-50
Identities = 70/339 (20%), Positives = 124/339 (36%), Gaps = 80/339 (23%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
+ IGQG+Y V A + + + A+K K + ++P+ V + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYME-------------------------------- 220
HPNI +L + + LV E
Sbjct: 86 HHPNIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 221 --------HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI-- 270
+ G + E I M+Q+ L + H++GI HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 271 DYNGILKIGDFGLANFF---KCSQKQPLTSRVVTLWYRPPELLLGSTD-YGASVDLWSSG 326
+ + +K+ DFGL+ F + +T++ T ++ PE+L + + YG D WS+G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 327 CILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKRSKLPHATIFKPQQPYKRCV 384
+L L G PG + + + ++ +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNY--------------------- 300
Query: 385 AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
+ A LL LL+ + R A ALQ+ + +
Sbjct: 301 ----NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-49
Identities = 75/313 (23%), Positives = 127/313 (40%), Gaps = 66/313 (21%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK------KVRFTNMDPESVRFM-AREIII 188
+++E + +G+G S V + K A+K F+ + + +R +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 189 LRRLD-HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
LR++ HPNI++L+ + +LVF+ M+ V +E
Sbjct: 77 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMK----------KGELFDYLTEKVTLSEK 124
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297
+ + M+ LL + H I+HRD+K N+L+D + +K+ DFG + + L
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLRE 182
Query: 298 RVVTLWYRPPELLLGSTD-----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIF 352
T Y PE++ S + YG VD+WS+G I+ L AG P R ++ L I
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI- 241
Query: 353 KLCGSPS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
+ G+ W D + L+ L +P+ R
Sbjct: 242 -MSGNYQFGSPEW-------------------------DDYSDTVKDLVSRFLVVQPQKR 275
Query: 411 GTASSALQNEFFT 423
TA AL + FF
Sbjct: 276 YTAEEALAHPFFQ 288
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-49
Identities = 74/308 (24%), Positives = 120/308 (38%), Gaps = 63/308 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
D+++ +++G+G +S V + A K + + D + + RE I R+L
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKL 85
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCY 242
HPNI++L I YLVF+ + G ++EA
Sbjct: 86 QHPNIVRLHDSIQEE--SFHYLVFDLVT----------GGELFEDIVAREFYSEADASHC 133
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRV 299
++Q+L + +CHS GI+HR++K NLL+ +K+ DFGLA +
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFA 191
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS 359
T Y PE+L Y VD+W+ G IL L G P + +I G+
Sbjct: 192 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYD 248
Query: 360 --EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417
W + A SL+D +L+ P+ R TA AL
Sbjct: 249 YPSPEW-------------------------DTVTPEAKSLIDSMLTVNPKKRITADQAL 283
Query: 418 QNEFFTTK 425
+ + +
Sbjct: 284 KVPWICNR 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-49
Identities = 80/312 (25%), Positives = 131/312 (41%), Gaps = 49/312 (15%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK-----KVRFTNMDPESVRFMAREIIILR 190
D F+ +G+G + +VY AR+ +N ++ALK ++ ++ +R REI I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLR---REIEIQS 69
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L HPNI+++ R +YL+ E+ +L G +F E + +M++L
Sbjct: 70 HLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADA 126
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
L +CH R ++HRDIK NLL+ Y G LKI DFG + + + TL Y PPE+
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPPEM 183
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
+ G T + VDLW +G + E G P + E +I + + K P
Sbjct: 184 IEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL----KFP 232
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
+ + L+ LL P R +++ +
Sbjct: 233 -------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273
Query: 430 DPSSLPKYPPSK 441
P P Y ++
Sbjct: 274 LP---PVYQSTQ 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-49
Identities = 67/293 (22%), Positives = 119/293 (40%), Gaps = 46/293 (15%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKV--RFTNMDPESVRFMAREIIILRRLD 193
D F K+G G + V+ + + +K + + + E + EI +L+ LD
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLD 78
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYME-----HDLAGLAATPGVKFTEAQIKCYMKQLLH 248
HPNI+K+ + ++Y+V E E + A +E + MKQ+++
Sbjct: 79 HPNIIKIFEVFEDY--HNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMN 135
Query: 249 GLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
L + HS+ ++H+D+K N+L + +KI DFGLA FK + T+ T Y
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTALYM 193
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PE+ D+WS+G ++ L G G + E K
Sbjct: 194 APEVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------------TY 239
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+ + + + + A+ LL +L+ +PE R +A+ L
Sbjct: 240 KEP----NYAVE----------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-48
Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 66/310 (21%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
+ ++ +++G+G +S V + + + A + + D + + RE I R L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLL 67
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCY 242
HPNI++L I+ G YL+F+ + G ++EA
Sbjct: 68 KHPNIVRLHDSISEE--GHHYLIFDLVT----------GGELFEDIVAREYYSEADASHC 115
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRV 299
++Q+L + HCH G++HR++K NLL+ +K+ DFGLA + ++Q
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFA 174
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFKLCGS 357
T Y PE+L YG VDLW+ G IL L G P P + +I G+
Sbjct: 175 GTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGA 229
Query: 358 PS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415
W + A L++ +L+ P R TA+
Sbjct: 230 YDFPSPEW-------------------------DTVTPEAKDLINKMLTINPSKRITAAE 264
Query: 416 ALQNEFFTTK 425
AL++ + + +
Sbjct: 265 ALKHPWISHR 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 16/212 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
+ D +G+GTY VY RDL N +A+K++ D + + EI + + L
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLK 77
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPG-VKFTEAQIKCYMKQLLH 248
H NI++ G + +G + + E + L L + G +K E I Y KQ+L
Sbjct: 78 HKNIVQYLG--SFSENGFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILE 133
Query: 249 GLEHCHSRGILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRP 306
GL++ H I+HRDIKG N+LI+ Y+G+LKI DFG + + + P T TL Y
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMA 191
Query: 307 PELLLGSTD-YGASVDLWSSGCILAELFAGKP 337
PE++ YG + D+WS GC + E+ GKP
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 95/372 (25%), Positives = 137/372 (36%), Gaps = 73/372 (19%)
Query: 82 QRRSTINVQVAQPRMTRIVSVSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKL 141
QRR+ I P + + + G + G A F +
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95
Query: 142 ----DKIGQGTYSSVYKARDLENNKLVALK-----KVRFTNMDPESVRFM-AREIIILRR 191
D IG+G S V + A+K R + E VR RE ILR+
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 192 L-DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIK 240
+ HP+I+ L S ++LVF+ M V +E + +
Sbjct: 156 VAGHPHIITLIDSYESS--SFMFLVFDLMR----------KGELFDYLTEKVALSEKETR 203
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
M+ LL + H+ I+HRD+K N+L+D N +++ DFG + + + L
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCG 261
Query: 301 TLWYRPPELLLGSTD-----YGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFK 353
T Y PE+L S D YG VDLW+ G IL L AG P P R ++ L I
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQILMLRMI-- 317
Query: 354 LCGSPS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411
+ G W D S+ L+ LL +PE R
Sbjct: 318 MEGQYQFSSPEW-------------------------DDRSSTVKDLISRLLQVDPEARL 352
Query: 412 TASSALQNEFFT 423
TA ALQ+ FF
Sbjct: 353 TAEQALQHPFFE 364
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 83/315 (26%), Positives = 131/315 (41%), Gaps = 46/315 (14%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK-----KVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
+G+G+Y V + D E A+K K+R +V+ +EI +LRRL H N++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 199 KLEGLITSRVSGSLYLVFEYMEHDLAGL-AATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
+L ++ + +Y+V EY + + + P +F Q Y QL+ GLE+ HS+G
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKC-SQKQPLTSRVVTLWYRPPELLLGSTDY 316
I+H+DIK NLL+ G LKI G+A + + + ++PPE+ G +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 317 -GASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
G VD+WS+G L + G P G + I K Y +P
Sbjct: 190 SGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK------GSY----AIP---- 233
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSS 433
D LL +L EP R + Q+ +F K P +
Sbjct: 234 ---------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP--AEA 276
Query: 434 LPKYPPSKEFDVKLR 448
PPS + + R
Sbjct: 277 PVPIPPSPDTKDRWR 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-48
Identities = 82/324 (25%), Positives = 130/324 (40%), Gaps = 65/324 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR-----------FTNMDPESVRFMAR 184
+S+ K+ K+G G Y V ++ + A+K ++ + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKF 234
EI +L+ LDHPNI+KL + + YLV E+ E G KF
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDK--KYFYLVTEFYE----------GGELFEQIINRHKF 143
Query: 235 TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQ 291
E MKQ+L G+ + H I+HRDIK N+L+ + +KI DFGL++FF +
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--K 201
Query: 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
L R+ T +Y PE+L Y D+WS G I+ L G P G+ + + + K+
Sbjct: 202 DYKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 352 FKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG 411
K W K+I A L+ ++L+ + R
Sbjct: 260 EKGKYYFDFNDW-------------------------KNISDEAKELIKLMLTYDYNKRC 294
Query: 412 TASSALQNEFFTTKPLPCDPSSLP 435
TA AL + + + S
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQK 318
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-48
Identities = 78/319 (24%), Positives = 128/319 (40%), Gaps = 58/319 (18%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---------KVRFTNMDPESVRFMAREI 186
D + +G G V A + + K VA++ +V EI
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE---TEI 191
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQ 245
IL++L+HP I+K++ + Y+V E ME +L + EA K Y Q
Sbjct: 192 EILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 247
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+L +++ H GI+HRD+K N+L+ + + ++KI DFG + + + + T
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 305
Query: 303 WYRPPELLLGSTD--YGASVDLWSSGCILAELFAGKPIMP---GRTEVEQLHKIFKLCGS 357
Y PE+L+ Y +VD WS G IL +G P P RT+V +I G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGK 361
Query: 358 PS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415
+ E W ++ AL L+ LL +P+ R T
Sbjct: 362 YNFIPEVW-------------------------AEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 416 ALQNEFFTTKPLPCDPSSL 434
AL++ + + + L
Sbjct: 397 ALRHPWLQDEDMKRKFQDL 415
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-48
Identities = 80/313 (25%), Positives = 128/313 (40%), Gaps = 66/313 (21%)
Query: 133 RKADSFEKL----DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREII 187
+ + IG+G++ V A A KK+ + D + + +EI
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIE 58
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
I++ LDHPNI++L +YLV E G F E+
Sbjct: 59 IMKSLDHPNIIRLYETFEDN--TDIYLVMELCT----------GGELFERVVHKRVFRES 106
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQP 294
MK +L + +CH + HRD+K N L + LK+ DFGLA FK +
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKM 164
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354
+ ++V T +Y P++L G YG D WS+G ++ L G P T+ E + KI
Sbjct: 165 MRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--R 220
Query: 355 CGSPS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT 412
G+ + E+ W ++ A SL+ LL+ P+ R T
Sbjct: 221 EGTFTFPEKDW-------------------------LNVSPQAESLIRRLLTKSPKQRIT 255
Query: 413 ASSALQNEFFTTK 425
+ AL++E+F +
Sbjct: 256 SLQALEHEWFEKQ 268
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-48
Identities = 90/348 (25%), Positives = 151/348 (43%), Gaps = 66/348 (18%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAR----EIIILRRL- 192
+E L IG+G++ V KA D + ++ VALK VR + + R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 193 -----DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQL 246
+ N++ + T R + + FE + +L + F+ ++ + +
Sbjct: 152 KQDKDNTMNVIHMLENFTFR--NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNG--ILKIGDFGLANFFKCSQKQPLTSRVVTLWY 304
L L+ H I+H D+K N+L+ G +K+ DFG + C + Q + + + + +Y
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFY 265
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE--- 361
R PE++LG YG +D+WS GCILAEL G P++PG E +QL + +L G PS++
Sbjct: 266 RAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 362 ----------------YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSA---------- 395
Y + L ++ +R + P S
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK---LRGPPESREWGNALKGCD 381
Query: 396 ----LSLLDILLSTEPEVRGTASSALQNEFFT---TKPLPCDPSSLPK 436
L L L +P VR T AL++ + KP + +S+ +
Sbjct: 382 DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-48
Identities = 73/363 (20%), Positives = 127/363 (34%), Gaps = 53/363 (14%)
Query: 135 ADSFEKLDKIGQG--TYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
+E L IG+G +V AR + V ++++ E V F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 193 DHPNIMKLEGLITSRVSGS-LYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLL 247
+HPNI+ + ++ + L++V +M DL + E I ++ +L
Sbjct: 84 NHPNIVPY---RATFIADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVL 138
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFG-LANFFKCSQKQ-----PLTSRVVT 301
L++ H G +HR +K S++LI +G + + + Q+Q V
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 302 LWYRPPELLLGSTD-YGASVDLWSSGCILAELFAGKP----------------------- 337
L + PE+L + Y A D++S G EL G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 338 -IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSAL 396
E + + S + S + P PY R + F
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH------ 312
Query: 397 SLLDILLSTEPEVRGTASSALQNEFFT-TKPLPCD--PSSLPKYPPSKEFDVKLRDDDRR 453
++ L P+ R +AS+ L + FF K + P L P F+ D
Sbjct: 313 -FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSG 371
Query: 454 RGG 456
G
Sbjct: 372 IFG 374
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 69/306 (22%), Positives = 116/306 (37%), Gaps = 40/306 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + + +G+G + V++ + + K K V+ D V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+ L S L ++FE++ D+ T + E +I Y+ Q+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 255 SRGILHRDIKGSNLLI--DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
S I H DI+ N++ + +KI +FG A K Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQH 177
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
+ D+WS G ++ L +G P T + + I + EE +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAF------- 227
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430
K+I A+ +D LL E + R TAS ALQ+ + K
Sbjct: 228 ------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
Query: 431 PSSLPK 436
+
Sbjct: 270 TKVIRT 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-47
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 62/306 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
+F ++ +G G +S V+ + KL ALK ++ + S+ EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCYMK 244
NI+ LE + S YLV + + G +TE ++
Sbjct: 66 ENIVTLEDIYEST--THYYLVMQLVS----------GGELFDRILERGVYTEKDASLVIQ 113
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVT 301
Q+L +++ H GI+HRD+K NLL + N + I DFGL+ + +++ T
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGT 170
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPS-- 359
Y PE+L Y +VD WS G I L G P TE + KI + G
Sbjct: 171 PGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFE 227
Query: 360 EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
+W DI SA + LL +P R T AL +
Sbjct: 228 SPFW-------------------------DDISESAKDFICHLLEKDPNERYTCEKALSH 262
Query: 420 EFFTTK 425
+
Sbjct: 263 PWIDGN 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-47
Identities = 69/320 (21%), Positives = 115/320 (35%), Gaps = 62/320 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-H 194
+ +G G+ +V + VA+K+ M + EI +L D H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALMEIKLLTESDDH 68
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLA------GLAATPGVKFTEAQIKCYMKQLLH 248
PN+++ T+ LY+ E +L ++ E ++Q+
Sbjct: 69 PNVIRYYCSETTD--RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 249 GLEHCHSRGILHRDIKGSNLLID-------------YNGILKIGDFGLANFFK---CSQK 292
G+ H HS I+HRD+K N+L+ N + I DFGL S +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 293 QPLTSRVVTLWYRPPELLLGSTD------YGASVDLWSSGCILAE-LFAGKPIMPGRTEV 345
L + T +R PELL S + S+D++S GC+ L GK P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKY 244
Query: 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST 405
+ I + G S + K + + A L+ ++
Sbjct: 245 SRESNIIR--GIFSLDEMKCLHDRS--------------------LIAEATDLISQMIDH 282
Query: 406 EPEVRGTASSALQNEFFTTK 425
+P R TA L++ F K
Sbjct: 283 DPLKRPTAMKVLRHPLFWPK 302
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 80/326 (24%), Positives = 135/326 (41%), Gaps = 48/326 (14%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-------- 192
+ K+G G +S+V+ A+D+ NN VA+K VR + E+ EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 193 ---DHPNIMKLEG--LITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQL 246
+I+KL + +VFE + +L + +K KQL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 247 LHGLEHCHSR-GILHRDIKGSNLLIDY------NGILKIGDFGLANFFKCSQKQPLTSRV 299
L GL++ H R GI+H DIK N+L++ +KI D G A C + T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT------EVEQLHKIFK 353
T YR PE+LLG+ +G D+WS+ C++ EL G + + + + +I +
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 354 LCGSP----------SEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDIL- 402
L G + ++ L P + + E +K A + D L
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 403 --LSTEPEVRGTASSALQNEFFTTKP 426
L +P R A + + +
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTL 341
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 88/335 (26%), Positives = 137/335 (40%), Gaps = 58/335 (17%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
D +E + IG+G +S V + + E + A+K +FT+ S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH----DLAGLAATPGVKFTEAQIKCYMKQLLH 248
HP+I++L +S G LY+VFE+M+ A G ++EA YM+Q+L
Sbjct: 84 KHPHIVELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 249 GLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
L +CH I+HRD+K +L+ + + +K+G FG+A S RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFM 200
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFK--LCGSPS-- 359
PE++ YG VD+W G IL L +G P G E ++F+ + G
Sbjct: 201 APEVVKREP-YGKPVDVWGCGVILFILLSGCL--PFYGTKE-----RLFEGIIKGKYKMN 252
Query: 360 EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
W I SA L+ +L +P R T AL +
Sbjct: 253 PRQW-------------------------SHISESAKDLVRRMLMLDPAERITVYEALNH 287
Query: 420 EFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
+ + E +LR + RR
Sbjct: 288 PWL------KERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 80/310 (25%), Positives = 128/310 (41%), Gaps = 59/310 (19%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMA--------------- 183
D+IG+G+Y V A + +N A+K K + R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 184 ------REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTE 236
+EI IL++LDHPN++KL ++ LY+VFE + + + +E
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSE 136
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296
Q + Y + L+ G+E+ H + I+HRDIK SNLL+ +G +KI DFG++N FK S L+
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LS 195
Query: 297 SRVVTLWYRPPELLLGST-DY-GASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFK 353
+ V T + PE L + + G ++D+W+ G L G+ P M + KI
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-DERIMCLHSKIKS 254
Query: 354 LCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTA 413
+ + P DI L+ +L PE R
Sbjct: 255 ------QAL----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRIVV 287
Query: 414 SSALQNEFFT 423
+ + T
Sbjct: 288 PEIKLHPWVT 297
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 1e-46
Identities = 50/349 (14%), Positives = 104/349 (29%), Gaps = 85/349 (24%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRR 191
+ + + +GQ + +A D E + + FT P +++ M E++ LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 192 L-------------------------DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGL 226
L ++++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 227 ------AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGD 280
++ Q++ L H G++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 281 FGLANFFKCSQKQPLTSRVVTLWYRPPELL----------LGSTDYGASVDLWSSGCILA 330
F + V+ + PPEL T S D W+ G ++
Sbjct: 250 FEHL-----VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 331 ELFAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETF 388
++ P + IF+ C
Sbjct: 305 WIWCADL--PITKDAALGGSEWIFRSC--------------------------------- 329
Query: 389 KDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKY 437
K+IP +LL+ L E R A++ + ++LP Y
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 55/298 (18%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+G+G Y V A + + VA+K R + PE+++ +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPG---------VKFTEAQIKCYMKQLLHGLE 251
G YL EY + G + E + + QL+ G+
Sbjct: 71 YGHRREG--NIQYLFLEY---------CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC-SQKQPLTSRVVTLWYRPPELL 310
+ H GI HRDIK NLL+D LKI DFGLA F+ ++++ L TL Y PELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
+ VD+WS G +L + AG+ +P + +EY +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE--- 223
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
+ +K I S+ L+LL +L P R T ++ ++ KPL
Sbjct: 224 KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLK 270
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-46
Identities = 81/321 (25%), Positives = 126/321 (39%), Gaps = 55/321 (17%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
+G+G Y V A + + VA+K R + PE+++ +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPG---------VKFTEAQIKCYMKQLLHGLE 251
G YL EY + G + E + + QL+ G+
Sbjct: 71 YGHRREG--NIQYLFLEY---------CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC-SQKQPLTSRVVTLWYRPPELL 310
+ H GI HRDIK NLL+D LKI DFGLA F+ ++++ L TL Y PELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
+ VD+WS G +L + AG+ +P + +EY +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE--- 223
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430
+ +K I S+ L+LL +L P R T ++ ++ KPL
Sbjct: 224 KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLKKG 272
Query: 431 PSSLPKYPPSKEFDVKLRDDD 451
Sbjct: 273 AKRPRVTSGGVSESPSGFSKH 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 74/347 (21%), Positives = 124/347 (35%), Gaps = 64/347 (18%)
Query: 129 GWVPRKADSFEKL----DKIGQGTYSSVYKARDLENNKLVALK-------KVRFTNMDPE 177
G P K E +++G G ++ V K R+ A K + + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 178 SVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVK 233
+ RE+ ILR++ H N++ L + +R + L+ E + D
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFD----FLAQKES 111
Query: 234 FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKC 289
+E + ++KQ+L G+ + H++ I H D+K N+++ +K+ DFGLA+ +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQ 347
+ T + PE++ G D+WS G I L +G P G T+ E
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQET 226
Query: 348 LHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEP 407
L I + EE++ A + LL E
Sbjct: 227 LANITSVSYDFDEEFF-------------------------SHTSELAKDFIRKLLVKET 261
Query: 408 EVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
R T AL++ + T D S R RR
Sbjct: 262 RKRLTIQEALRHPWITPV----DNQQAMVRRESVVNLENFRKQYVRR 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-45
Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 37/287 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
D ++ L+++G G + V++ + ++ K + D +V+ EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P ++ L + + L+ E++ +L A K +EA++ YM+Q GL+H
Sbjct: 108 PKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 254 HSRGILHRDIKGSNLLI--DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
H I+H DIK N++ +KI DFGLA + + T + PE++
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVD 223
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
G D+W+ G + L +G G ++E L + + E+ +
Sbjct: 224 REP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF-------- 274
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+ A + LL EP R T AL+
Sbjct: 275 -----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 63/298 (21%), Positives = 104/298 (34%), Gaps = 56/298 (18%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKL 200
+G G V + + ALK + D R +E+ + P+I+ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 201 EGLI--TSRVSGSLYLVFEYMEHDLAG------LAATPGVKFTEAQIKCYMKQLLHGLEH 252
+ L ++ E ME G + FTE + M+ + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 253 CHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
HS I HRD+K NLL + + +LK+ DFG A + L + T +Y PE+
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNALQTPCYTPYYVAPEV 200
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKR 365
L Y S D+WS G I+ L G P T + + G W
Sbjct: 201 LGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW-- 257
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
++ A L+ +LL T+P R T + + + +
Sbjct: 258 -----------------------SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 86/337 (25%), Positives = 150/337 (44%), Gaps = 42/337 (12%)
Query: 140 KLDK-IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
+L K IG+G ++ V AR + + VA+K + T ++P S++ + RE+ I++ L+HPNI+
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 199 KLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
KL +I + +LYL+ EY ++ G + E + + +Q++ +++CH +
Sbjct: 78 KLFEVIETE--KTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYG 317
I+HRD+K NLL+D + +KI DFG +N F L + Y PEL G G
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 318 ASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQ 377
VD+WS G IL L +G G+ E ++ + G ++
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY-------------- 236
Query: 378 QPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKY 437
+ + +LL L P RGT +++ + +
Sbjct: 237 -------------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE------DEL 277
Query: 438 PPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESK 474
P E ++ + D R G G E I+++ + K
Sbjct: 278 KPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMK 314
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 30/250 (12%)
Query: 116 PSWLTAVAGEAINGWVPRKAD----SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRF 171
P L +G + +V + + + +G ++ VY+A+D+ + + ALK++
Sbjct: 4 PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 172 TNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEY---MEHDLAGL- 226
+ E R + +E+ +++L HPNI++ + S E+ E L
Sbjct: 64 --NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV 121
Query: 227 ----AATPGVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLIDYNGILKIGD 280
+ + Q ++H H + I+HRD+K NLL+ G +K+ D
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181
Query: 281 FGLANFF-----------KCSQKQPLTSRVVTLWYRPPEL--LLGSTDYGASVDLWSSGC 327
FG A + + + +R T YR PE+ L + G D+W+ GC
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241
Query: 328 ILAELFAGKP 337
IL L +
Sbjct: 242 ILYLLCFRQH 251
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 68/306 (22%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK-------KVRFTNMDPESVRFMAREIII 188
D +E +++G G ++ V K R K A K + E + RE+ I
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE---REVNI 61
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQ 238
LR + HPNI+ L + ++ + L+ E + G TE +
Sbjct: 62 LREIRHPNIITLHDIFENK--TDVVLILELVS----------GGELFDFLAEKESLTEDE 109
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQP 294
++KQ+L G+ + HS+ I H D+K N+++ N +K+ DFG+A+ +
Sbjct: 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNE 167
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIF 352
+ T + PE++ G D+WS G I L +G P G T+ E L I
Sbjct: 168 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNIS 224
Query: 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT 412
+ EEY+ + A + LL +P+ R T
Sbjct: 225 AVNYDFDEEYF-------------------------SNTSELAKDFIRRLLVKDPKRRMT 259
Query: 413 ASSALQ 418
+ +L+
Sbjct: 260 IAQSLE 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 82/329 (24%), Positives = 125/329 (37%), Gaps = 66/329 (20%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKL 200
+G+G++S K ++N+ A+K + + + +EI L+ + HPNI+KL
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQ---KEITALKLCEGHPNIVKL 71
Query: 201 EGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCYMKQLLHGL 250
+ + +LV E + G F+E + M++L+ +
Sbjct: 72 HEVFHDQ--LHTFLVMELLN----------GGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 251 EHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
H H G++HRD+K NLL + N +KI DFG A QPL + TL Y P
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAP 178
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---VEQLHKIFK--LCGSPS--E 360
ELL + Y S DLWS G IL + +G+ +I K G S
Sbjct: 179 ELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
E W K++ A L+ LL+ +P R S NE
Sbjct: 238 EAW-------------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
Query: 421 FFTTK-PLPCDPSSLPKYPPSKEFDVKLR 448
+ L +P P S V
Sbjct: 273 WLQDGSQLSSNPLMTPDILGSSGAAVHTC 301
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 74/308 (24%), Positives = 121/308 (39%), Gaps = 67/308 (21%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DH 194
D +E + IG G+YS + N A+K + + DP EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQH 75
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCYMK 244
PNI+ L+ + +Y+V E M+ G F+E + +
Sbjct: 76 PNIITLKDVYDDG--KYVYVVTELMK----------GGELLDKILRQKFFSEREASAVLF 123
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+ +E+ H++G++HRD+K SN+L ++I DFG A + ++ L +
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCY 182
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP---IMPGRTEVEQLHKIFKLCGS 357
T + PE+L Y A+ D+WS G +L + G P T E L +I G
Sbjct: 183 TANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI--GSGK 239
Query: 358 PS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415
S YW + +A L+ +L +P R TA+
Sbjct: 240 FSLSGGYW-------------------------NSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 416 ALQNEFFT 423
L++ +
Sbjct: 275 VLRHPWIV 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 68/306 (22%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK-------KVRFTNMDPESVRFMAREIII 188
D ++ +++G G ++ V K R+ A K K + E + RE+ I
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE---REVSI 67
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQ 238
L+ + HPN++ L + ++ + L+ E + G TE +
Sbjct: 68 LKEIQHPNVITLHEVYENK--TDVILILELVA----------GGELFDFLAEKESLTEEE 115
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQP 294
++KQ+L+G+ + HS I H D+K N+++ +KI DFGLA+
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIF 352
+ T + PE++ G D+WS G I L +G P G T+ E L +
Sbjct: 174 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVS 230
Query: 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT 412
+ +EY+ + + A + LL +P+ R T
Sbjct: 231 AVNYEFEDEYF-------------------------SNTSALAKDFIRRLLVKDPKKRMT 265
Query: 413 ASSALQ 418
+LQ
Sbjct: 266 IQDSLQ 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-44
Identities = 69/315 (21%), Positives = 121/315 (38%), Gaps = 55/315 (17%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALK-----KVRFTNMDPESVRFMAREIIILRRL 192
+ +G+G + +V+ L + VA+K +V + +SV E+ +L ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 193 D----HPNIMKLEGLITSRVSGSLYLVFEYMEH--DLAGLAATPGVKFTEAQIKCYMKQL 246
HP +++L ++ LV E DL G E +C+ Q+
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG--FMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQV 148
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
+ ++HCHSRG++HRDIK N+LID G K+ DFG +P T T Y
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGTRVYS 205
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PPE + + +WS G +L ++ G +P E+ +I + E
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD--IP----FERDQEILE------AELHFP 253
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425
+ + +L+ L+ +P R + L + +
Sbjct: 254 AHV-----------------------SPDCCALIRRCLAPKPSSRPSLEEILLDPWM-QT 289
Query: 426 PLPCDPSSLPKYPPS 440
P P + K P+
Sbjct: 290 PAEDVPLNPSKGGPA 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-44
Identities = 81/315 (25%), Positives = 126/315 (40%), Gaps = 68/315 (21%)
Query: 132 PRKADSFEKL----DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREII 187
D+ ++G+G S VY+ + K ALK ++ +D + VR EI
Sbjct: 45 GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIG 100
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
+L RL HPNI+KL+ + + + LV E + G ++E
Sbjct: 101 VLLRLSHPNIIKLKEIFETP--TEISLVLELVT----------GGELFDRIVEKGYYSER 148
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQP 294
+KQ+L + + H GI+HRD+K NLL + LKI DFGL+ + +
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVL 206
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK- 353
+ + T Y PE+L G YG VD+WS G I L G P E +F+
Sbjct: 207 MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRR 262
Query: 354 -LCGSPS--EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
L +W ++ +A L+ L+ +P+ R
Sbjct: 263 ILNCEYYFISPWW-------------------------DEVSLNAKDLVRKLIVLDPKKR 297
Query: 411 GTASSALQNEFFTTK 425
T ALQ+ + T K
Sbjct: 298 LTTFQALQHPWVTGK 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP-ESVRFMAREIIILRRLD 193
F L +IG G++ +VY ARD+ N+++VA+KK+ ++ E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
HPN ++ G + +LV EY + L E +I L GL +
Sbjct: 113 HPNTIQYRG--CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS ++HRD+K N+L+ G++K+GDFG S P S V T ++ PE++L
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGS-----ASIMAPANSFVGTPYWMAPEVILAM 225
Query: 314 TD--YGASVDLWSSGCILA-ELFAGKP 337
+ Y VD+WS G I EL KP
Sbjct: 226 DEGQYDGKVDVWSLG-ITCIELAERKP 251
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 80/339 (23%), Positives = 137/339 (40%), Gaps = 64/339 (18%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAR----EIIILR 190
D +E IG+G++ V KA D + VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 191 RL------DHPNIMKLEGLITSRVSGSLYLVFEYMEHDL-AGLAATPGVKFTEAQIKCYM 243
+ I+ L+ R L LVFE + ++L L T + + +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFR--NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 244 KQLLHGLEHCHSR--GILHRDIKGSNLLI--DYNGILKIGDFGLANFFKCSQKQPLTSRV 299
+Q+ L + I+H D+K N+L+ +KI DFG + C Q + +
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYI 219
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSP- 358
+ +YR PE+LLG Y ++D+WS GCIL E+ G+P+ G EV+Q++KI ++ G P
Sbjct: 220 QSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278
Query: 359 --------------------------SEEYWKRSKLPHATIFK------PQQPYKRCVAE 386
+++ + K P P R E
Sbjct: 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGE 338
Query: 387 TFKDIPSSA--LSLLDILLSTEPEVRGTASSALQNEFFT 423
+ + L+ +L +P+ R ALQ+ FF
Sbjct: 339 SGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 19/220 (8%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
D +E + IG G + V A + VA+K++ + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 192 LDHPNIMKLEGLITSRVSGS-LYLVFEYME---------HDLAGLAATPGVKFTEAQIKC 241
HPNI+ TS V L+LV + + H +A GV E+ I
Sbjct: 70 CHHPNIVSY---YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIAT 125
Query: 242 YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVT 301
++++L GLE+ H G +HRD+K N+L+ +G ++I DFG++ F T
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 302 LWYRP----PELLLGSTDYGASVDLWSSGCILAELFAGKP 337
P PE++ Y D+WS G EL G
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 37/295 (12%)
Query: 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHP 195
+ K + +G G + V+K + +A K ++ M D E V+ EI ++ +LDH
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHA 146
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
N+++L S+ + LV EY++ +L TE +MKQ+ G+ H H
Sbjct: 147 NLIQLYDAFESK--NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 255 SRGILHRDIKGSNLLI--DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
ILH D+K N+L +KI DFGLA +K ++ L T + PE++
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTPEFLAPEVVNY 262
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372
D+WS G I L +G G + E L+ I +E +
Sbjct: 263 DF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF--------- 312
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427
+DI A + LL E R +AS AL++ + + L
Sbjct: 313 ----------------QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 73/327 (22%), Positives = 129/327 (39%), Gaps = 64/327 (19%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKV------RFTNMDPESVRFMAREIIILRR 191
+ + +G G + V+ A D E NK V +K + ++ + + EI IL R
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG------LAATPGVKFTEAQIKCYMKQ 245
++H NI+K+ + ++ G LV ME +G + P + E +Q
Sbjct: 86 VEHANIIKVLDIFENQ--GFFQLV---MEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQ 138
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
L+ + + + I+HRDIK N++I + +K+ DFG A + + + + + T+ Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFCGTIEYC 196
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS-PSEEYWK 364
PE+L+G+ G +++WS G L L + P E +
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCELEE 235
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424
+ A I P + +SL+ LL PE R T + + + T
Sbjct: 236 TVE---AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280
Query: 425 KPLPCDPSSLPKYPPSKEFDVKLRDDD 451
P +L Y + F V +
Sbjct: 281 ------PVNLADYTWEEVFRVNKPESG 301
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 69/331 (20%), Positives = 121/331 (36%), Gaps = 68/331 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK-------KVRFTNMDPESVRFMAREIII 188
D ++ +++G G ++ V K R+ A K + + E + RE+ I
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSI 68
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQ 238
LR++ HPNI+ L + +R + L+ E + G +E +
Sbjct: 69 LRQVLHPNIITLHDVYENR--TDVVLILELVS----------GGELFDFLAQKESLSEEE 116
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI----DYNGILKIGDFGLANFFKCSQKQP 294
++KQ+L G+ + H++ I H D+K N+++ +K+ DFGLA+ +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVE 174
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIF 352
+ T + PE++ G D+WS G I L +G P G T+ E L I
Sbjct: 175 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANIT 231
Query: 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT 412
+ EE++ A + LL E R T
Sbjct: 232 AVSYDFDEEFF-------------------------SQTSELAKDFIRKLLVKETRKRLT 266
Query: 413 ASSALQNEFFTTKPLPCDPSSLPKYPPSKEF 443
AL++ + T + F
Sbjct: 267 IQEALRHPWITPVDTQQAMVRRESVVNLENF 297
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 72/317 (22%), Positives = 120/317 (37%), Gaps = 54/317 (17%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA----REIIILRRLD 193
++ +G G + SVY + +N VA+K V + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 194 H--PNIMKLEGLITSRVSGSLYLVFEYMEH--DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+++L S L+ E E DL G E + + Q+L
Sbjct: 105 SGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEA 161
Query: 250 LEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
+ HCH+ G+LHRDIK N+LID N G LK+ DFG K T T Y PPE
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPE 218
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
+ +G S +WS G +L ++ G +P + +I + + + R ++
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHD----EEIIR------GQVFFRQRV 266
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
S L+ L+ P R T + + LP
Sbjct: 267 -----------------------SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
Query: 429 CDPSSLPKYP----PSK 441
+ + + + PSK
Sbjct: 304 QETAEIHLHSLSPGPSK 320
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 79/377 (20%), Positives = 132/377 (35%), Gaps = 63/377 (16%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKL 200
+G G V + + + ALK ++ D R RE+ + R P+I+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 120
Query: 201 EGLI--TSRVSGSLYLVFEYMEHDLAG------LAATPGVKFTEAQIKCYMKQLLHGLEH 252
+ L +V E ++ G + FTE + MK + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 253 CHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
HS I HRD+K NLL N ILK+ DFG A LT+ T +Y PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPE- 233
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKR 365
+LG Y S D+WS G I+ L G P + + G W
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-- 291
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425
++ L+ LL TEP R T + + + +
Sbjct: 292 -----------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI--- 325
Query: 426 PLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAEL 485
+ +P+ P +K + L ++R ++ K DA+ L
Sbjct: 326 ---MQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 382
Query: 486 QTSIQKRQNQSNPKATS 502
++R+ +A +
Sbjct: 383 LL--KRRKKARALEAAA 397
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 62/306 (20%), Positives = 103/306 (33%), Gaps = 55/306 (17%)
Query: 131 VPRKADSFEKL-----DKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFM 182
+ ++F ++G+G ++ V + + A K K R +
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-- 76
Query: 183 AREIIILRRLDH-PNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEA 237
EI +L P ++ L + + + L+ EY L +E
Sbjct: 77 -HEIAVLELAKSCPRVINLHEVYENT--SEIILILEYAAGGEIFSL--CLPELAEMVSEN 131
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQP 294
+ +KQ+L G+ + H I+H D+K N+L+ G +KI DFG++
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACE 189
Query: 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIF 352
L + T Y PE+L + D+W+ G I L P G E I
Sbjct: 190 LREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNIS 246
Query: 353 KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT 412
++ SEE + + A + LL PE R T
Sbjct: 247 QVNVDYSEETF-------------------------SSVSQLATDFIQSLLVKNPEKRPT 281
Query: 413 ASSALQ 418
A L
Sbjct: 282 AEICLS 287
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 70/355 (19%), Positives = 127/355 (35%), Gaps = 65/355 (18%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNMDPESVRFMAR----EIIIL 189
+ +E + +G+GT+ V + D VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 190 RRL------DHPNIMKLEGLITSRVSGSLYLVFEYME---HDLAGLAATPGVKFTEAQIK 240
+++ + + + G + + FE + + L + ++
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFH--GHMCIAFELLGKNTFEF--LKENNFQPYPLPHVR 126
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI-------------------LKIGDF 281
QL H L H + H D+K N+L + +++ DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG 341
G A + T+ V T YRPPE++L + D+WS GCIL E + G +
Sbjct: 187 GSA----TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 342 RTEVEQLHKIFKLCGSPSEEYWKRSK------------LPHATIFKPQQPYKRCVAETFK 389
E L + K+ G R++ +++ + + + +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 390 DIPSSALSLLDIL---LSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSK 441
+ L D++ L +P R T + AL + FF P + S PS+
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT-PEERSFHTSRNPSR 355
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 69/327 (21%), Positives = 113/327 (34%), Gaps = 76/327 (23%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRL-DHPNIMK 199
D +G+G ++ V +L ++ A+K + V RE+ +L + H N+++
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLE 75
Query: 200 LEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCYMKQLLHG 249
L YLVFE M G F E + ++ +
Sbjct: 76 LIEFFEEE--DRFYLVFEKMR----------GGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 250 LEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQ------KQPLTSRVV 300
L+ H++GI HRD+K N+L + +KI DF L + K + L +
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 301 TLWYRPPELLLGSTD----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG 356
+ Y PE++ ++ Y DLWS G IL I+ L G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-------IL--------------LSG 222
Query: 357 SP---SEEYWKRSKLPHATIFKPQQPYKRCVAE---TF-----KDIPSSALSLLDILLST 405
P Q + E F I +A L+ LL
Sbjct: 223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVR 282
Query: 406 EPEVRGTASSALQNEFFT----TKPLP 428
+ + R +A+ LQ+ + LP
Sbjct: 283 DAKQRLSAAQVLQHPWVQGCAPENTLP 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-42
Identities = 64/287 (22%), Positives = 109/287 (37%), Gaps = 37/287 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
D ++ +++G G + V++ + A K V + D E+VR +EI + L H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRH 213
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P ++ L + +++E+M +L A K +E + YM+Q+ GL H
Sbjct: 214 PTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 254 HSRGILHRDIKGSNLLI--DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
H +H D+K N++ + LK+ DFGL KQ + T + PE+
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAE 329
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
G G D+WS G + L +G G + E L + + + +
Sbjct: 330 G-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-------- 380
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
I + LL +P R T AL+
Sbjct: 381 -----------------SGISEDGKDFIRKLLLADPNTRMTIHQALE 410
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 83/306 (27%), Positives = 139/306 (45%), Gaps = 50/306 (16%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + +KIGQG +VY A D+ + VA++++ + + + EI+++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK---FTEAQIKCYMKQLLHGLEH 252
NI+ + V L++V EY+ G + T V E QI ++ L LE
Sbjct: 78 NIVNYLD--SYLVGDELWVVMEYLA----GGSLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVTLWYRPPE 308
HS ++HRDIK N+L+ +G +K+ DFG C+Q P S+ V T ++ PE
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-----CAQITPEQSKRSTMVGTPYWMAPE 186
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
++ YG VD+WS G + E+ G+P P L ++ + + +
Sbjct: 187 VVTRK-AYGPKVDIWSLGIMAIEMIEGEP--P-YLNENPLRALYLIATNGT--------- 233
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
P + Q P K ++ F+D L+ L + E RG+A LQ++F
Sbjct: 234 P-----ELQNPEK--LSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLKI---A 276
Query: 429 CDPSSL 434
SSL
Sbjct: 277 KPLSSL 282
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 67/340 (19%), Positives = 120/340 (35%), Gaps = 66/340 (19%)
Query: 138 FEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNMDPESVRFMAR----EIIILRRL 192
+E +D +G+G + V + D + + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 193 ------DHPNIMKLEGLITSRVSGSLYLVFEYME---HDLAGLAATPGVKFTEAQIKCYM 243
+++ G + +VFE + +D + + F I+
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHH--GHICIVFELLGLSTYDF--IKENGFLPFRLDHIRKMA 124
Query: 244 KQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI-------------------LKIGDFGLA 284
Q+ + HS + H D+K N+L + +K+ DFG A
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE 344
+ ++ V T YR PE++L + D+WS GCIL E + G + P
Sbjct: 185 ----TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 345 VEQLHKIFKLCGSPSEEY----------------WKRSKLPHATIFKPQQPYKRCVAETF 388
E L + ++ G + W + + +P K +
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 389 KDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
+ L+ +L +P R T AL++ FF
Sbjct: 300 VEHE-RLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 69/339 (20%), Positives = 128/339 (37%), Gaps = 70/339 (20%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAR----EIIILRRL- 192
F + K+G GT+ V + ++N K A+K VR +++ R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 193 ----DHPNIMKLEGLITSRVSGSLYLVFEYME---HDLAGLAATPGVKFTEAQIKCYMKQ 245
++ NI+K G + L+FE + +++ + F IK Y +
Sbjct: 90 NDDINNNNIVKYHGKFMYY--DHMCLIFEPLGPSLYEI--ITRNNYNGFHIEDIKLYCIE 145
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGI-------------------------LKIGD 280
+L L + + H D+K N+L+D +K+ D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 281 FGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMP 340
FG A + S + T YR PE++L + S D+WS GC+LAEL+ G +
Sbjct: 206 FGCA----TFKSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 341 GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF------KPQQPYKRCVAETFKDIPSS 394
+E L + + + + + + + K P + K +
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 395 A-----------LSLLDILLSTEPEVRGTASSALQNEFF 422
L +L +P +R + + L+++F
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 48/353 (13%), Positives = 100/353 (28%), Gaps = 72/353 (20%)
Query: 144 IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-VRFMAREIIILRRL---------- 192
+GQ + +A D E + + FT P + ++ M E++ LR L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 193 ---------------DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGL------AATPG 231
++++ S + ++ M+ +L ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 232 VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291
Q++ L H G++H ++ ++++D G + + F S
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 292 KQPLTSRVVTLWYRPPELLLGS----TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQ 347
P+ +L T + D W+ G + ++ +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 348 LHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEP 407
IF+ C K+IP +LL+ L
Sbjct: 326 SEWIFRSC---------------------------------KNIPQPVRALLEGFLRYPK 352
Query: 408 EVRGTASSALQNEFFT---TKPLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGG 457
E R A++ + T+ P P++E + G
Sbjct: 353 EDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAG 405
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 14/207 (6%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
+ F KL+KIG+G++ V+K D K+VA+K + + E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 195 PNIMKLEGLITSRVSGS-LYLVFEYMEHDLAGLAA---TPGVKFTEAQIKCYMKQLLHGL 250
P + K G S + + L+++ EY+ G A PG E QI ++++L GL
Sbjct: 80 PYVTKYYG---SYLKDTKLWIIMEYLG---GGSALDLLEPG-PLDETQIATILREILKGL 132
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
++ HS +HRDIK +N+L+ +G +K+ DFG+A +Q + T V T ++ PE++
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVI 191
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKP 337
S Y + D+WS G EL G+P
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 78/319 (24%), Positives = 129/319 (40%), Gaps = 51/319 (15%)
Query: 140 KLDK-IGQGTYSSVYKARDLENNKLVALK---KVRFTNMD-PESVRFMAREIIILRRLDH 194
+ + +G+G++ V A + + VALK + D V REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
P+I+KL +IT+ + +V EY +L + TE + + + +Q++ +E+CH
Sbjct: 69 PHIIKLYDVITTP--TDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH 125
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
I+HRD+K NLL+D N +KI DFGL+N L + + Y PE++ G
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVINGKL 183
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
G VD+WS G +L + G+ K+ Y +P
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY----VMP----- 228
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSL 434
+ A SL+ ++ +P R T ++ +F +L
Sbjct: 229 --------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV--------NL 266
Query: 435 PKY-PPSKEFDVKLRDDDR 452
P Y P +E D
Sbjct: 267 PDYLRPMEEVQGSYADSRI 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES---VRFMAREIIILRR 191
+ +E + ++G G + VYKA++ E L A K ++ +S + EI IL
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-----IETKSEEELEDYIVEIEILAT 72
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
DHP I+KL G G L+++ E+ + + TE QI+ +Q+L L
Sbjct: 73 CDHPYIVKLLG--AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
HS+ I+HRD+K N+L+ G +++ DFG++ Q S + T ++ PE++
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSFIGTPYWMAPEVV 189
Query: 311 LGST----DYGASVDLWSSGCILAELFAGKP 337
+ T Y D+WS G L E+ +P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 75/306 (24%), Positives = 135/306 (44%), Gaps = 50/306 (16%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ KIG+G+ V AR+ + + VA+K + + + E++I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHF 102
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVK---FTEAQIKCYMKQLLHGLEH 252
N++++ + V L+++ E+++ G A T V E QI + +L L +
Sbjct: 103 NVVEMYK--SYLVGEELWVLMEFLQ----GGALTDIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVTLWYRPPE 308
H++G++HRDIK ++L+ +G +K+ DFG C+Q + V T ++ PE
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGF-----CAQISKDVPKRKSLVGTPYWMAPE 211
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
++ S Y VD+WS G ++ E+ G+P P + + +L SP
Sbjct: 212 VISRS-LYATEVDIWSLGIMVIEMVDGEP--P-YFSDSPVQAMKRLRDSPP--------- 258
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
P K + +K V+ +D L+ +L +P+ R TA L + F
Sbjct: 259 P-----KLKNSHK--VSPVLRD-------FLERMLVRDPQERATAQELLDHPFLLQ---T 301
Query: 429 CDPSSL 434
P L
Sbjct: 302 GLPECL 307
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+ +D ++ + IG G + RD +LVA+K + E+V+ REII R
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHR 71
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L HPNI++ + +I + L ++ EY +L G +F+E + + + +QLL G
Sbjct: 72 SLRHPNIVRFKEVILTP--THLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSG 128
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGI--LKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
+ +CHS I HRD+K N L+D + LKI DFG + S V T Y P
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPAYIAP 186
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAG 335
E+LL G D+WS G L + G
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 144 IGQGTYSSVYKARDLENNKLVALK---KVRFTNMD-PESVRFMAREIIILRRLDHPNIMK 199
+G GT+ V VA+K + + ++D ++ REI L+ HP+I+K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIK 75
Query: 200 LEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
L +I++ ++V EY+ +L G + E + + +Q+L +++CH +
Sbjct: 76 LYQVISTP--TDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGA 318
+HRD+K N+L+D + KI DFGL+N + L + + Y PE++ G G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 319 SVDLWSSGCILAELFAGK 336
VD+WS G IL L G
Sbjct: 191 EVDIWSCGVILYALLCGT 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +G+G + K E +++ +K++ D E+ R +E+ ++R L+HP
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHP 67
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
N++K G++ L + EY++ L G+ + ++ +Q + K + G+ + H
Sbjct: 68 NVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLA-------------NFFKCSQKQPLTSRVVT 301
S I+HRD+ N L+ N + + DFGLA K ++ + V
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG 341
++ PE++ G Y VD++S G +L E+ P
Sbjct: 186 PYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 62/305 (20%), Positives = 100/305 (32%), Gaps = 77/305 (25%)
Query: 136 DSFEKLDK-IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-D 193
D ++ + +G G V + + + ALK ++ D R RE+ + R
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQ 69
Query: 194 HPNIMKLEGLI--TSRVSGSLYLVFEYMEHDLAG------LAATPGVKFTEAQIKCYMKQ 245
P+I+++ + L +V E ++ G + FTE + MK
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ +++ HS I HRD+K NLL N ILK+ DFG A
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------ 167
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK--LCGSPS- 359
E Y S D+WS G I+ L G P + + G
Sbjct: 168 ----KETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 360 -EEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
W ++ L+ LL TEP R T + +
Sbjct: 222 PNPEW-------------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
Query: 419 NEFFT 423
+ +
Sbjct: 257 HPWIM 261
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-D 193
A FE ++ +G GTY VYK R ++ +L A+K + ++ + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 194 HPNIMKLEG----LITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQ 245
H NI G + L+LV E+ DL + T G E I ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
+L GL H H ++HRDIKG N+L+ N +K+ DFG+ +Q R T
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNTFIGT 192
Query: 306 P----PELLLGSTD----YGASVDLWSSGCILAELFAGKP 337
P PE++ + Y DLWS G E+ G P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 81/330 (24%), Positives = 139/330 (42%), Gaps = 53/330 (16%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ F+ L+K+G+G+Y SVYKA E ++VA+K+V + D + + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
+++K G + + L++V EY D+ L TE +I ++ L GLE
Sbjct: 85 HVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLE 139
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR----VVTLWYRPP 307
+ H +HRDIK N+L++ G K+ DFG+ Q ++ + T ++ P
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGV-----AGQLTDTMAKRNTVIGTPFWMAP 194
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367
E++ Y D+WS G E+ GKP + + I P
Sbjct: 195 EVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------T 244
Query: 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427
++ F D + L PE R TA+ LQ+ F +
Sbjct: 245 FRKPELWSDN----------FTD-------FVKQCLVKSPEQRATATQLLQHPFVRS--- 284
Query: 428 PCDPSSL-PKYPPSKEFDVKLRDDDRRRGG 456
S L + + +K ++ +R G
Sbjct: 285 AKGVSILRDLINEAMDVKLKRQESQQREEG 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 43/253 (16%), Positives = 86/253 (33%), Gaps = 30/253 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+G+G ++ VY+A D +N + LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHD-----LAGLAATPGVKFTEAQIKCYMKQ 245
MK + LV E + + TP + + + +
Sbjct: 123 PSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLI-----------DYNGILKIGDFGLANFFKCSQK-Q 293
+L+ +E H I+H DIK N ++ D + L + D G + K K
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPI-MPGRTEVEQLHKIF 352
T++ T ++ E+L + +D + + + G + + + +F
Sbjct: 241 IFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 353 KLCGSPSEEYWKR 365
+ P + W
Sbjct: 300 R--RLPHLDMWNE 310
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-38
Identities = 85/424 (20%), Positives = 151/424 (35%), Gaps = 46/424 (10%)
Query: 140 KLDK-IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF-MAREIIILRRLDHPNI 197
L +G GT+ V + VA+K + + V + REI L+ HP+I
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 198 MKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
+KL +I++ +++V EY+ +L G + E + + +Q+L G+++CH
Sbjct: 79 IKLYQVISTP--SDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH 135
Query: 257 GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
++HRD+K N+L+D + KI DFGL+N + L + + Y PE++ G
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 317 GASVDLWSSGCILAELFAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
G VD+WSSG IL L G +P KI + P
Sbjct: 194 GPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------GIF----YTP----- 236
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSL 434
+ + S +SLL +L +P R T ++E+F + LP
Sbjct: 237 --------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF-KQDLPKYLFPE 281
Query: 435 PKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAELQTSIQKRQN 494
S D + + + + L + + L ++ N
Sbjct: 282 DPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLA----VAYHLIIDNRRIMN 337
Query: 495 QSNPKATSEQFNSDEDSGSGFPIEPPKGIGRNAGGQTMKPTTVGASLNMTMDSDRNSRSY 554
++ + P+ + T+ ++
Sbjct: 338 EAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAK 397
Query: 555 MHPG 558
H G
Sbjct: 398 WHLG 401
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 25/307 (8%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K D FEK+ ++G G V+K + ++A K + + P + RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 89
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
P I+ G S G + + E+M+ L + G + E + ++ GL +
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 146
Query: 253 CHSRG-ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ I+HRD+K SN+L++ G +K+ DFG++ S S V T Y PE L
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 203
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
G+ Y D+WS G L E+ G+ +P E + E R + P
Sbjct: 204 GTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 372 TIFKPQQPYKRCVA--ETFKDIPSSALSLL-------------DILLSTEPEVRGTASSA 416
+ K + +A E I + L + L P R
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 417 LQNEFFT 423
+ + F
Sbjct: 323 MVHAFIK 329
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+IG G++ +VYK + + VA+K + T P+ ++ E+ +LR+ H
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+ G T+ L +V ++ E L KF ++ +Q G+++ H
Sbjct: 81 NILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFF-KCSQKQPLTSRVVTLWYRPPELLLG- 312
++ I+HRD+K +N+ + + +KIGDFGLA + S ++ + PE++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 313 -STDYGASVDLWSSGCILAELFAGK 336
S Y D+++ G +L EL G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 65/361 (18%), Positives = 113/361 (31%), Gaps = 103/361 (28%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLE------------NNKLVALKKVR---------- 170
R FE + +G+G + V++A++ N+ +A +KV
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 171 ----------------------------------FTNMDPESVRFMAREIIILRRLDHPN 196
+ P + + +I + N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEH-DLAGL--AATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L S LY+ + +L Q+ +E
Sbjct: 123 TVG--QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLA-----------NFFKCSQKQPLTSRVVTL 302
HS+G++HRD+K SN+ + ++K+GDFGL T +V T
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
Y PE + G+ Y VD++S G IL EL T++E++ I +
Sbjct: 241 LYMSPEQIHGNN-YSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV-------- 286
Query: 363 WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
+ K P F ++ +LS P R A+ ++N F
Sbjct: 287 -RNLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
Query: 423 T 423
Sbjct: 330 E 330
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILR 190
+ + F+ +G+G++S+V AR+L ++ A+K K + V ++ RE ++
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMS 85
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
RLDHP +KL T + LY Y ++ +L G F E + Y +++
Sbjct: 86 RLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSA 142
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPE 308
LE+ H +GI+HRD+K N+L++ + ++I DFG A KQ + V T Y PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKP 337
LL S DLW+ GCI+ +L AG P
Sbjct: 203 LLTEK-SACKSSDLWALGCIIYQLVAGLP 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 13/233 (5%)
Query: 127 INGWV-PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMARE 185
I G + + E L ++G GT V+K R + ++A+K++R + + E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMD 73
Query: 186 IIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMK 244
+ ++ + D P I++ G + + +++ E M L E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 245 QLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLW 303
++ L + G++HRD+K SN+L+D G +K+ DFG++ + +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAA 189
Query: 304 YRPPE----LLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKI 351
Y PE DY D+WS G L EL G+ P +T+ E L K+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREI-IILRRL 192
A+ + L +IG+G Y SV K + +++A+K++R T D + + + ++ +++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSS 78
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYM----EHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
D P I++ G + G ++ E M + + + E + +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 249 GLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
L H I+HRDIK SN+L+D +G +K+ DFG++ S + T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAP 194
Query: 308 ELLLGSTD---YGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKI 351
E + S Y D+WS G L EL G+ P + +QL ++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 138 FEKLD---KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
+ L+ KIG G++ +V++A + VA+K + + E V RE+ I++RL H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL--AATPGVKFTEAQIKCYMKQLLHGLE 251
PNI+ G +T +L +V EY+ L L + + E + + G+
Sbjct: 94 PNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 252 HCHSRG--ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
+ H+R I+HR++K NLL+D +K+ DFGL+ K S S T + PE+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEV 210
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGK 336
L D++S G IL EL +
Sbjct: 211 LRDEP-SNEKSDVYSFGVILWELATLQ 236
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 37/210 (17%), Positives = 77/210 (36%), Gaps = 21/210 (10%)
Query: 138 FEKLD---KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
F++L+ K+ + ++K R + +K ++ + R E LR H
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
PN++ + G S + L+ +M +++ L ++Q + + G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGM 124
Query: 251 EHCHSRG--ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
H+ I + +++ID + +I + F+ R+ + PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPE 178
Query: 309 LLLG--STDYGASVDLWSSGCILAELFAGK 336
L S D+WS +L EL +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-----VRFMAREIIILR 190
+ E +IG+G + V+K R +++ +VA+K + + + E+ + RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
L+HPNI+KL GL+ + +V E++ DL + M + G
Sbjct: 79 NLNHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 250 LEHCHSRG--ILHRDIKGSNLLIDYNG-----ILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+E+ ++ I+HRD++ N+ + K+ DFGL+ ++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNF 190
Query: 303 WYRPPELLLG-STDYGASVDLWSSGCILAELFAGK 336
+ PE + Y D +S IL + G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
E + +G+G + V KA+ K VA+K++ + F+ E+ L R++HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKA---FI-VELRQLSRVNHP 61
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL--AATPGVKFTEAQIKCYMKQLLHGLEH 252
NI+KL G + + LV EY E L + A P +T A + Q G+ +
Sbjct: 62 NIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 253 CHSR---GILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
HS ++HRD+K NLL+ G +LKI DFG A C + +T+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPE 173
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGK 336
+ GS Y D++S G IL E+ +
Sbjct: 174 VFEGSN-YSEKCDVFSWGIILWEVITRR 200
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 47/215 (21%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 138 FEKLD---KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
FE+L+ IG+G + VY R + VA++ + + + ++ RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
N++ G S L ++ + L + + + + ++++ G+ +
Sbjct: 89 ENVVLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLA----NFFKCSQKQPLTSRVVTLWYRPPEL 309
H++GILH+D+K N+ D NG + I DFGL ++ L + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 310 LLGSTD--------YGASVDLWSSGCILAELFAGK 336
+ + + D+++ G I EL A +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 14/227 (6%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREI-IILRRL 192
KAD E + ++G+G Y V K R + + +++A+K++R T + + + + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTV 63
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYME---HDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
D P + G + G +++ E M+ G E + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 250 LEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
LEH HS ++HRD+K SN+LI+ G +K+ DFG++ + + Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPE 179
Query: 309 LLLGSTD---YGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKI 351
+ + Y D+WS G + EL + P T +QL ++
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 82/365 (22%), Positives = 140/365 (38%), Gaps = 90/365 (24%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-----DHP 195
+ K+G G +S+V+ + D++ K VA+K V+ E+ EI +L+ + + P
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDP 98
Query: 196 NIMKLEGLITS-RVSGS----LYLVFEYMEHDLAGL-AATPGVKFTEAQIKCYMKQLLHG 249
N + L+ ++SG + +VFE + H L + +K ++Q+L G
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 250 LEHCHSR-GILHRDIKGSNLLIDYN----------------------------------- 273
L++ H++ I+H DIK N+L+ N
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 274 --------------GILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGAS 319
+KI D G A C + T + T YR E+L+GS Y
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTP 273
Query: 320 VDLWSSGCILAELFAGKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKRSK------ 367
D+WS+ C+ EL G + + + + + I +L G + K
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 368 -----LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDIL---LSTEPEVRGTASSALQN 419
L H T KP ++ V E ++ A D L L PE R TA+ L++
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLV-EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 420 EFFTT 424
+ +
Sbjct: 393 PWLNS 397
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 69/287 (24%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRR 191
+ D FE L IG+G +S V + + ++ A+K + +M E F E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE-ERDVLVN 117
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
D I +L LYLV EY DL L + G + + Y+ +++ +
Sbjct: 118 GDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
+ H G +HRDIK N+L+D G +++ DFG + V T Y PE+L
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 311 LG------STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
+ YG D W+ G E+F G+ + E KI
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI------------- 282
Query: 365 RSKLPHATIFK-PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
+ + P + +P A + LL PE R
Sbjct: 283 ---VHYKEHLSLPLVD---------EGVPEEARDFIQRLL-CPPETR 316
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 138 FEKLD---KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFM--AREIIILRRL 192
F +L IG G + VY+A VA+K R + S +E + L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
HPNI+ L G+ +L LV E+ L + + + + + Q+ G+
Sbjct: 64 KHPNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMN 119
Query: 252 HCHSRG---ILHRDIKGSNLLID--------YNGILKIGDFGLANFFKCSQKQPLTSRVV 300
+ H I+HRD+K SN+LI N ILKI DFGLA + + K S
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAG 176
Query: 301 TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK 336
+ PE++ S + D+WS G +L EL G+
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 10/225 (4%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRR 191
+ FE L IG+G + V + +K+ A+K + M E+ F E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-ERDVLVN 130
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
D I L +LYLV +Y DL L + + E + Y+ +++ +
Sbjct: 131 GDSKWITTLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
+ H +HRDIK N+L+D NG +++ DFG + V T Y PE+L
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 311 LGSTD----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
YG D WS G + E+ G+ + VE KI
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 11/224 (4%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM--DPESVRFMAREIIILRR 191
KA+ +E + IG+G + V R K+ A+K + M +S F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMAF 125
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+ P +++L + LY+V EYM DL L + E + Y +++ L
Sbjct: 126 ANSPWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLAL 181
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
+ HS G +HRD+K N+L+D +G LK+ DFG + V T Y PE+L
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 311 L---GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
G YG D WS G L E+ G + V KI
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 67/306 (21%), Positives = 119/306 (38%), Gaps = 64/306 (20%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILRRL 192
D FE L IG+G++ V + + K+ A+K K + + VR + +E+ I++ L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN--EVRNVFKELQIMQGL 72
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCY 242
+HP ++ L + + +++V + + G V F E +K +
Sbjct: 73 EHPFLVNLWY--SFQDEEDMFMVVDLL----------LGGDLRYHLQQNVHFKEETVKLF 120
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ +L+ L++ ++ I+HRD+K N+L+D +G + I DF +A ++ +T+ T
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTK 178
Query: 303 WYRPPELLL--GSTDYGASVDLWSSGCILAELFAGKP---IMPGRTEVEQLHKIFKLCGS 357
Y PE+ Y +VD WS G EL G+ I + E +H
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---- 234
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-GTASSA 416
P +SLL LL P+ R S
Sbjct: 235 ------TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269
Query: 417 LQNEFF 422
+
Sbjct: 270 QNFPYM 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALK--KVRFTNMDPESV-RFMAREIIILRRLDH 194
++ +DK+G G S+VY A D N VA+K + E++ RF RE+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-KEETLKRF-EREVHNSSQLSH 70
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
NI+ + + YLV EY+E L+ + G + + Q+L G++H
Sbjct: 71 QNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA 127
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT--SRVV-TLWYRPPELL 310
H I+HRDIK N+LID N LKI DFG+A K + LT + V+ T+ Y PE
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIA---KALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 311 LGSTDYGASVDLWSSGCILAELFAGKP 337
G D++S G +L E+ G+P
Sbjct: 185 KGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALK--KVRFTNMDPESV-RFMAREIIILRRLDH 194
+E + +G G S V+ ARDL +++ VA+K + DP RF RE L+H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRF-RREAQNAAALNH 71
Query: 195 PNIMKL--EGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
P I+ + G + Y+V EY++ L + T G T + + L
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALN 130
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT--SRVV-TLWYRPPE 308
H GI+HRD+K +N++I +K+ DFG+A +T + V+ T Y PE
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPE 189
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKP 337
G + S D++S GC+L E+ G+P
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEP 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 29/220 (13%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLE-NNKLVALKKVRFTNMDPESV-RFMAREIIILRRL 192
A +E I G +Y A D N + V LK + + D E+ M E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAM-AERQFLAEV 136
Query: 193 DHPNIMKL-----EGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQL 246
HP+I+++ Y+V EY+ L A+ Y+ ++
Sbjct: 137 VHPSIVQIFNFVEHT--DRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEI 191
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR---VVTLW 303
L L + HS G+++ D+K N+++ + K+ D G + S T
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV--------SRINSFGYLYGTPG 242
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT 343
++ PE++ A+ D+++ G LA L P GR
Sbjct: 243 FQAPEIVRTGPT-VAT-DIYTVGRTLAALTLDLPTRNGRY 280
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALK--KVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
+G+G VY+A D ++VALK ++ DP M RE RL P++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHV- 96
Query: 199 KLEGLITSRVS--------GSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
V G LY+ + DLA + G + ++Q+
Sbjct: 97 ---------VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSA 146
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVV-TLWYRP 306
L+ H+ G HRD+K N+L+ + + DFG+A + + LT V TL+Y
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYMA 203
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKP 337
PE S + D+++ C+L E G P
Sbjct: 204 PERFSESHATYRA-DIYALTCVLYECLTGSP 233
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-29
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILRRL 192
D F +G+G + V+ + KL A L K R + E IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMVEKKILAKV 242
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYME------HDLAGLAATPGVKFTEAQIKCYMKQL 246
I+ L ++ L LV M H + + F E + Y Q+
Sbjct: 243 HSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQI 298
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
+ GLEH H R I++RD+K N+L+D +G ++I D GLA K Q + T +
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMA 357
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
PELLLG +Y SVD ++ G L E+ A + R E + ++ +
Sbjct: 358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-29
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 16/225 (7%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRLDH 194
++F + +G+G + V + K+ A KK+ + E IL +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYME------HDLAGLAATPGVKFTEAQIKCYMKQLLH 248
++ L ++ +L LV M H + F EA+ Y ++
Sbjct: 244 RFVVSLAYAYETK--DALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYAAEICC 297
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
GLE H I++RD+K N+L+D +G ++I D GLA + Q + RV T+ Y PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRVGTVGYMAPE 355
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
++ Y S D W+ GC+L E+ AG+ R + + ++ +
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/235 (25%), Positives = 89/235 (37%), Gaps = 26/235 (11%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
A + + +IG+G Y V+ + + VA+K F + S F EI + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRH 90
Query: 195 PNIMKLEGLITSRVSGS--LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
NI+ LYL+ +Y E+ L + + +K + GL
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-LKL-AYSSVSGLC 148
Query: 252 HCHSR--------GILHRDIKGSNLLIDYNGILKIGDFGLANFF---KCSQKQPLTSRVV 300
H H+ I HRD+K N+L+ NG I D GLA F P +RV
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 301 TLWYRPPELLLGST-----DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHK 350
T Y PPE+L S D++S G IL E+ E + +
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMA-REIIILRRLDH 194
D+ + L+ IG+G Y +VYK + + VA+K F+ + ++ F+ + I + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEH 66
Query: 195 PNIMKLEG---LITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
NI + +T+ LV EY + L + + + + + GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH--SVTRGL 124
Query: 251 EHCHS---------RGILHRDIKGSNLLIDYNGILKIGDFGLANFF-------KCSQKQP 294
+ H+ I HRD+ N+L+ +G I DFGL+ +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 295 LTSRVVTLWYRPPELLLGSTD------YGASVDLWSSGCILAELFAGK 336
S V T+ Y PE+L G+ + VD+++ G I E+F
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 64/254 (25%), Positives = 104/254 (40%), Gaps = 49/254 (19%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ L+ +G + V+KA+ N+ VA+K F D +S + E+ L + H NI
Sbjct: 26 LQLLEVKARGRFGCVWKAQ--LLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMKHENI 80
Query: 198 MKLEG--LITSRVSGSLYLVFEYMEH----------------------DLA-GLAATPGV 232
++ G + V L+L+ + E +A GLA
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA----- 135
Query: 233 KFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292
Y+ + + GL+ H I HRDIK N+L+ N I DFGLA F+ +
Sbjct: 136 ---------YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 293 QPLTSRVV-TLWYRPPELLLGSTDYGAS----VDLWSSGCILAELFAGKPIMPGRTEVEQ 347
T V T Y PE+L G+ ++ +D+++ G +L EL + G +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 348 LHKIFKLCGSPSEE 361
L ++ PS E
Sbjct: 247 LPFEEEIGQHPSLE 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 41/224 (18%)
Query: 132 PR-KADSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREII 187
P+ F+ L +G G++ V+ R N + A LKK + V E +
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERL 58
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
+L + HP I+++ G T + + ++++ +Y+ G +F
Sbjct: 59 MLSIVTHPFIIRMWG--TFQDAQQIFMIMDYI----------EGGELFSLLRKSQRFPNP 106
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297
K Y ++ LE+ HS+ I++RD+K N+L+D NG +KI DFG A K +
Sbjct: 107 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-------KY-VPD 158
Query: 298 RVVTLW----YRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337
TL Y PE++ Y S+D WS G ++ E+ AG
Sbjct: 159 VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYT 201
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 58/223 (26%), Positives = 86/223 (38%), Gaps = 32/223 (14%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
A L+ +G+G Y V++ + VA+K F++ D +S F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS--WQGENVAVKI--FSSRDEKSW-FRETELYNTVMLRH 61
Query: 195 PNIMKLEG--LITSRVSGSLYLVFEYME----HDLAGLAATPGVKFTEAQIKCYMKQLLH 248
NI+ + + S L+L+ Y E +D L T + +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY--LQLTT---LDTVSCLRIVLSIAS 116
Query: 249 GLEHCHSR--------GILHRDIKGSNLLIDYNGILKIGDFGLANFF---KCSQKQPLTS 297
GL H H I HRD+K N+L+ NG I D GLA
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 298 RVVTLWYRPPELLLGST-----DYGASVDLWSSGCILAELFAG 335
RV T Y PE+L + D VD+W+ G +L E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTN-MDPESVRFMAREIIILRRL 192
+ D F+++ +G G++ V + E+ A+K + + + + E IL+ +
Sbjct: 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKCY 242
+ P ++KLE + + + +LY+V EY+ G +F+E + Y
Sbjct: 99 NFPFLVKLEF--SFKDNSNLYMVMEYV----------AGGEMFSHLRRIGRFSEPHARFY 146
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
Q++ E+ HS +++RD+K NLLID G +++ DFG A K+ + R TL
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-------KR-VKGRTWTL 198
Query: 303 ----WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKP 337
PE++L Y +VD W+ G ++ E+ AG P
Sbjct: 199 CGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYP 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 54/225 (24%), Positives = 81/225 (36%), Gaps = 26/225 (11%)
Query: 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
+ IG+G + V++ + + VA+K F++ + S F EI L H NI+
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENIL 99
Query: 199 KLEGLITSRVSGS--LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
L+LV +Y EH L T + GL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHM 157
Query: 256 R--------GILHRDIKGSNLLIDYNGILKIGDFGLANFF---KCSQKQPLTSRVVTLWY 304
I HRD+K N+L+ NG I D GLA + RV T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 305 RPPELLLGST-----DYGASVDLWSSGCILAELFAGKPIMPGRTE 344
PE+L S + D+++ G + E+ I +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 47/340 (13%), Positives = 92/340 (27%), Gaps = 78/340 (22%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD------PESVRFMAREIIIL 189
+ ++ +KIG+G + V++ ++ VA+K + D ++ + EIII
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 190 RRL---------DHPNIMKLEG----------------------------LITSRVSGSL 212
+ L + L L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR-GILHRDIKGSNLLID 271
++V E E L + A K + QL L + HRD+ N+L+
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 272 YNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAE 331
+ K+ P V++ DY S + +
Sbjct: 197 KTSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 332 LFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH---------ATIFKPQQPYKR 382
+ + + G + + I++L + W + K +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 383 CVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
C K I +L+ +A+ L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 136 DSFEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
+++ +G+G + V R + VA+K ++ + +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
L H NI+K +G+ T + L+ E++ L K Q Y Q+ G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---------KQPLTSRVVT 301
++ SR +HRD+ N+L++ +KIGDFGL + + P+
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----- 194
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
WY PE L+ S Y AS D+WS G L EL
Sbjct: 195 -WY-APECLMQSKFYIAS-DVWSFGVTLHELL 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIIL--- 189
+ F IG+G + VY R + K+ A L K R E I+L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLV 246
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH 248
D P I+ + L + + M DL + G F+EA ++ Y +++
Sbjct: 247 STGDCPFIVCMSY--AFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIIL 303
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
GLEH H+R +++RD+K +N+L+D +G ++I D GLA K+ + V T Y PE
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPE 360
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKP 337
+L Y +S D +S GC+L +L G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
+ L ++G+G + SV R ++VA+KK++ + + F REI IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKS 67
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
L H NI+K +G+ S +L L+ EY+ + L + ++ Y Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---------KQPLTSRVVT 301
E+ ++ +HRD+ N+L++ +KIGDFGL + + P+
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----- 182
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
WY PE L S AS D+WS G +L ELF
Sbjct: 183 -WY-APESLTESKFSVAS-DVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
+ L ++G+G + SV R ++VA+KK++ + + F REI IL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKS 98
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
L H NI+K +G+ S +L L+ EY+ + L + ++ Y Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---------KQPLTSRVVT 301
E+ ++ +HRD+ N+L++ +KIGDFGL + + P+
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----- 213
Query: 302 LWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
WY PE L S AS D+WS G +L ELF
Sbjct: 214 -WY-APESLTESKFSVAS-DVWSFGVVLYELF 242
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W + + ++IG+G + V+ R +N LVA+K R T +F+ +E I
Sbjct: 109 WVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARI 165
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
L++ HPNI++L G+ T + +Y+V E ++ D T G + + +
Sbjct: 166 LKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
G+E+ S+ +HRD+ N L+ +LKI DFG++
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 49/251 (19%), Positives = 98/251 (39%), Gaps = 22/251 (8%)
Query: 110 QVVAGWPSWLTAVAGEAINGW-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKK 168
+ W + R K+G G Y VY+ + + VA+K
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT 252
Query: 169 VRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-L 226
++ M+ E F+ E +++ + HPN+++L G+ T Y++ E+M + +L L
Sbjct: 253 LKEDTMEVEE--FLK-EAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYL 307
Query: 227 AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-- 284
+ + + Q+ +E+ + +HR++ N L+ N ++K+ DFGL+
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 285 ---NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMP 340
+ + + W P L + D+W+ G +L E+ G P
Sbjct: 368 MTGDTYTAHAGAKFPIK----WTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYP 421
Query: 341 GRTEVEQLHKI 351
G + +
Sbjct: 422 GIDLSQVYELL 432
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREIIIL 189
+ + + ++G+G + SV R LVA+K+++ + P+ R REI IL
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREIQIL 78
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH 248
+ L I+K G+ SL LV EY+ L + +++ Y Q+
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---------KQPLTSRV 299
G+E+ SR +HRD+ N+L++ +KI DFGLA + + P+
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF--- 195
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
WY PE L + S D+WS G +L ELF
Sbjct: 196 ---WY-APESLSDNIFSRQS-DVWSFGVVLYELF 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 70/296 (23%), Positives = 112/296 (37%), Gaps = 70/296 (23%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILR 190
+ F+ L +G+GT+ V R+ + A L+K D V E +L+
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQ 60
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIK 240
HP + L+ + L V EY G FTE + +
Sbjct: 61 NTRHPFLTALKY--AFQTHDRLCFVMEYA----------NGGELFFHLSRERVFTEERAR 108
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
Y +++ LE+ HSR +++RDIK NL++D +G +KI DFGL K+ ++
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGAT 161
Query: 301 ------TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKL 354
T Y PE+L DYG +VD W G ++ E+ G+ + I
Sbjct: 162 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM- 219
Query: 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
+ + P + + A SLL LL +P+ R
Sbjct: 220 ---------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 136 DSFEKLDKIGQGTYSSVYKAR---DLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
IG G V R + + VA+K ++ + + F+ E I+ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQF 107
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
DHPNI++LEG++T +V EYME+ L T +FT Q+ ++ + G+
Sbjct: 108 DHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---WYRPPE 308
+ G +HRD+ N+L+D N + K+ DFGL+ + T+ + W PE
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APE 224
Query: 309 LLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
+ + AS D+WS G ++ E+ A G+ T + + +
Sbjct: 225 AIA----FRTFSSAS-DVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 31/215 (14%), Positives = 61/215 (28%), Gaps = 36/215 (16%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVRFT-NMDPESVRFMAREIIILRRLDHPNIMK 199
L G ++A D ++ VAL V + + ++ + L R+D P + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 200 LEGLITSRVSGSLYLVFEYME-HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGI 258
+ L +V E++ L +A T + M+ L + H G+
Sbjct: 96 V--LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAGV 150
Query: 259 LHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGA 318
S + + +G + + P
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--------NP 181
Query: 319 SVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
D+ G L L + +P L +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDPESVRFMAREI 186
+ + + IG+G + VY D + K+ A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQ 245
II++ HPN++ L G+ R GS +V YM+H DL T + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ G+++ S+ +HRD+ N ++D +K+ DFGLA
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 43/242 (17%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDL---ENNKLVA---LKKVRFTNMDPESVRFMAREII 187
+ + FE L +G+G Y V++ R + K+ A LKK ++ A E
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA-ERN 73
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
IL + HP I+ L + G LYL+ EY+ G F E
Sbjct: 74 ILEEVKHPFIVDLIYAFQT--GGKLYLILEYL----------SGGELFMQLEREGIFMED 121
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297
Y+ ++ L H H +GI++RD+K N+++++ G +K+ DFGL K+ +
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIHD 174
Query: 298 RVV------TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
V T+ Y PE+L+ + + +VD WS G ++ ++ G P G + + KI
Sbjct: 175 GTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233
Query: 352 FK 353
K
Sbjct: 234 LK 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 15/225 (6%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR +S K+GQG + V+ VA+K ++ M PE F+ +E +++
Sbjct: 181 IPR--ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE--AFL-QEAQVMK 234
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLH 248
+L H +++L +++ +Y+V EYM L L G Q+ Q+
Sbjct: 235 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL-WYRPP 307
G+ + +HRD++ +N+L+ N + K+ DFGLA + ++ + W P
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-DLENNK---LVALKKVRFTNMDPESVRFMAREI 186
+ +K+ +G+G + V D N+ +VA+K ++ + +EI
Sbjct: 28 FHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEI 84
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQ 245
ILR L H +I+K +G + SL LV EY+ L P AQ+ + +Q
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQ 142
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---------KQPLT 296
+ G+ + H++ +HRD+ N+L+D + ++KIGDFGLA P+
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
WY PE L Y AS D+WS G L EL
Sbjct: 203 ------WY-APECLKEYKFYYAS-DVWSFGVTLYELL 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 45/242 (18%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR---DLENNKLVA---LKKVRFTNMDPESVRFMAREII 187
FE L +GQG++ V+ + + +L A LKK D VR E
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTKM-ERD 78
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
IL ++HP I+KL + G LYL+ +++ G V FTE
Sbjct: 79 ILVEVNHPFIVKLHYAFQT--EGKLYLILDFL----------RGGDLFTRLSKEVMFTEE 126
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297
+K Y+ +L L+H HS GI++RD+K N+L+D G +K+ DFGL+ K+ +
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDH 179
Query: 298 RVV------TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
T+ Y PE++ + S D WS G ++ E+ G G+ E + I
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238
Query: 352 FK 353
K
Sbjct: 239 LK 240
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILR 190
K + F +G+G++ V+ A + N+ A LKK D + M + ++
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECTMVEKRVLSL 73
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIK 240
+HP + + T + +L+ V EY+ G KF ++
Sbjct: 74 AWEHPFLTHMFC--TFQTKENLFFVMEYL----------NGGDLMYHIQSCHKFDLSRAT 121
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
Y +++ GL+ HS+GI++RD+K N+L+D +G +KI DFG+ K+ +
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGDAK 174
Query: 301 TLW------YRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
T Y PE+LLG Y SVD WS G +L E+ G+ G+ E E H I
Sbjct: 175 TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/234 (26%), Positives = 115/234 (49%), Gaps = 30/234 (12%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W VPR ++ + ++++G G + V+ + VA+K ++ +M P++ F+A E +
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA--FLA-EANL 61
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQL 246
+++L H +++L ++T +Y++ EYME+ L L G+K T ++ Q+
Sbjct: 62 MKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---- 302
G+ R +HRD++ +N+L+ KI DFGLA + ++ T+R
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIK 175
Query: 303 WYRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
W PE + YG S D+WS G +L E+ G+ PG T E + +
Sbjct: 176 WT-APEAIN----YGTFTIKS-DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR---DLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
A + +G G + V R + VA+K ++ + + F+ E I+
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMG 101
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+ DHPNI++LEG++T S + +V EYME+ L +FT Q+ ++ + G
Sbjct: 102 QFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---WYRP 306
+++ G +HRD+ N+LI+ N + K+ DFGL + + T+R + W
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-S 218
Query: 307 PELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
PE + Y AS D+WS G +L E+ + G+ + + + +
Sbjct: 219 PEAIA----YRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 63/293 (21%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILR 190
+ FE L +G+GT+ V ++ + A LKK D V E +L+
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQ 203
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIK 240
HP + L+ + L V EY G F+E + +
Sbjct: 204 NSRHPFLTALKYSFQT--HDRLCFVMEYA----------NGGELFFHLSRERVFSEDRAR 251
Query: 241 CYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299
Y +++ L++ HS + +++RD+K NL++D +G +KI DFGL K K T +
Sbjct: 252 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKT 308
Query: 300 V--TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357
T Y PE+L DYG +VD W G ++ E+ G+ + + I
Sbjct: 309 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---- 363
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
+ + P + + A SLL LL +P+ R
Sbjct: 364 ------EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 58/242 (23%), Positives = 106/242 (43%), Gaps = 28/242 (11%)
Query: 121 AVAGEAINGW-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESV 179
+ AG W + L ++G G + V + VA+K ++ +M +
Sbjct: 10 STAGLGYGSWEIDP--KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE- 65
Query: 180 RFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQ 238
F+ E ++ L H +++L G+ T ++++ EYM + L +F Q
Sbjct: 66 -FI-EEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR 298
+ K + +E+ S+ LHRD+ N L++ G++K+ DFGL+ + + TS
Sbjct: 122 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSS 178
Query: 299 VVTL----WYRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLH 349
V + W PPE+L+ Y S D+W+ G ++ E+++ GK T E
Sbjct: 179 VGSKFPVRWS-PPEVLM----YSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
Query: 350 KI 351
I
Sbjct: 233 HI 234
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W + + +IG G + V+ N VA+K +R M E F+ E +
Sbjct: 3 WVIDP--SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEED--FI-EEAEV 56
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
+ +L HP +++L G+ + LV E+MEH L+ T F + +
Sbjct: 57 MMKLSHPKLVQLYGVCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL----W 303
G+ + ++HRD+ N L+ N ++K+ DFG+ F Q TS T W
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKW 171
Query: 304 YRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
PE+ + S D+WS G ++ E+F+ GK R+ E + I
Sbjct: 172 A-SPEVFS----FSRYSSKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 24/234 (10%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR----DLENNKLVALKKVRFTNMDPESVRFMAREI 186
+ + IG G + VYK + VA+K ++ + + V F+ E
Sbjct: 41 IHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEA 97
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQ 245
I+ + H NI++LEG+I+ + ++ EYME+ L +F+ Q+ ++
Sbjct: 98 GIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL--- 302
+ G+++ + +HRD+ N+L++ N + K+ DFGL+ + + T+ +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 303 WYRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
W PE + Y AS D+WS G ++ E+ G+ + E + I
Sbjct: 216 WT-APEAIS----YRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR----FTNMDPESVRFMAREIIIL 189
K F L +G+G++ V + ++L A+K ++ + D E M + ++
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT--MVEKRVLA 396
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH 248
P + +L + LY V EY+ DL G +F E Y ++
Sbjct: 397 LPGKPPFLTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAI 453
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV------TL 302
GL S+GI++RD+K N+++D G +KI DFG+ K+ + V T
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFCGTP 506
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
Y PE++ YG SVD W+ G +L E+ AG+ G E E I
Sbjct: 507 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKAR---DLENNKLVALK--KVRFTNMDPESVRFMAR 184
+P + IG+G + VY +N A+K E+ F+ R
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA--FL-R 71
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYM 243
E +++R L+HPN++ L G++ G +++ YM H DL +P T + +
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 244 KQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
Q+ G+E+ + +HRD+ N ++D + +K+ DFGLA
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
+ R + L ++G G + V + + VA+K ++ +M + F +E
Sbjct: 3 MELKR--EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSED--EFF-QEAQT 56
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
+ +L HP ++K G+ + +Y+V EY+ + L + G +Q+ +
Sbjct: 57 MMKLSHPKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL----W 303
G+ S +HRD+ N L+D + +K+ DFG+ + S V T W
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKW 171
Query: 304 YRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
PE+ Y S D+W+ G ++ E+F+ GK T E + K+
Sbjct: 172 S-APEVFH----YFKYSSKS-DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W + R K+G G Y VY+ + + VA+K ++ M+ E F+ +E +
Sbjct: 8 WEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAV 62
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQL 246
++ + HPN+++L G+ T Y++ E+M + +L L + + + Q+
Sbjct: 63 MKEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---- 302
+E+ + +HRD+ N L+ N ++K+ DFGL+ T+
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIK 177
Query: 303 WYRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
W PE L Y S D+W+ G +L E+ G PG + +
Sbjct: 178 WT-APESLA----YNKFSIKS-DVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 58/295 (19%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRR 191
F+ L IG+G+Y+ V R + +++ A+K V+ N D + + + +
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKC 241
+HP ++ L + L+ V EY+ G K E +
Sbjct: 67 SNHPFLVGLHSCFQT--ESRLFFVIEYV----------NGGDLMFHMQRQRKLPEEHARF 114
Query: 242 YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV- 300
Y ++ L + H RGI++RD+K N+L+D G +K+ D+G+ K+ L
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTT 167
Query: 301 -----TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355
T Y PE+L G DYG SVD W+ G ++ E+ AG+ P F +
Sbjct: 168 STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIV 213
Query: 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
GS I + Q R + A S+L L+ +P+ R
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIPRS-------LSVKAASVLKSFLNKDPKER 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 40/237 (16%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVA---LKKVRFTNMDPESVRFMAREIIILR 190
K F L IG+G++ V AR A L+K E M+ ++L+
Sbjct: 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKHIMSERNVLLK 94
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIK 240
+ HP ++ L + + LY V +Y+ G F E + +
Sbjct: 95 NVKHPFLVGLHFSFQT--ADKLYFVLDYI----------NGGELFYHLQRERCFLEPRAR 142
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV 300
Y ++ L + HS I++RD+K N+L+D G + + DFGL K+ +
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNST 195
Query: 301 ------TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKI 351
T Y PE+L Y +VD W G +L E+ G P R E I
Sbjct: 196 TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 42/240 (17%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR----FTNMDPESVRFMAREIIIL 189
D+FE + +G+G++ V AR E L A+K ++ + D E M + I+
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT--MTEKRILS 78
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQI 239
+HP + +L + L+ V E++ G +F EA+
Sbjct: 79 LARNHPFLTQLFCCFQT--PDRLFFVMEFV----------NGGDLMFHIQKSRRFDEARA 126
Query: 240 KCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRV 299
+ Y +++ L H +GI++RD+K N+L+D+ G K+ DFG+ K+ + + V
Sbjct: 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNGV 179
Query: 300 VTLW------YRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFK 353
T Y PE+L YG +VD W+ G +L E+ G E + I
Sbjct: 180 TTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDPESVRFMAREI 186
+ + + IG+G + VY D + K+ A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 187 IILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQ 245
II++ HPN++ L G+ R GS +V YM+H DL T + + Q
Sbjct: 142 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ G++ S+ +HRD+ N ++D +K+ DFGLA
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 15/225 (6%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR +S K+GQG + V+ VA+K ++ M PE F+ +E +++
Sbjct: 264 IPR--ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE--AFL-QEAQVMK 317
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLH 248
+L H +++L +++ +Y+V EYM L L G Q+ Q+
Sbjct: 318 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL-WYRPP 307
G+ + +HRD++ +N+L+ N + K+ DFGLA + ++ + W P
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 435 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 58/295 (19%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRR 191
F+ L IG+G+Y+ V R + +++ A++ V+ N D + + + +
Sbjct: 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEAQIKC 241
+HP ++ L + L+ V EY+ G K E +
Sbjct: 110 SNHPFLVGLHSCFQT--ESRLFFVIEYV----------NGGDLMFHMQRQRKLPEEHARF 157
Query: 242 YMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV- 300
Y ++ L + H RGI++RD+K N+L+D G +K+ D+G+ K+ L
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTT 210
Query: 301 -----TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLC 355
T Y PE+L G DYG SVD W+ G ++ E+ AG+ P F +
Sbjct: 211 STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIV 256
Query: 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
GS I + Q R + A S+L L+ +P+ R
Sbjct: 257 GSSDNPDQNTEDYLFQVILEKQIRIPRS-------LSVKAASVLKSFLNKDPKER 304
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 24/232 (10%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR---DLENNKLVALKKVRFTNMDPESVR--FMAREIII 188
L+K+G G++ V + VA+K ++ + F+ RE+
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNA 74
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
+ LDH N+++L G++ + + +V E L F + Y Q+
Sbjct: 75 MHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---WY 304
G+ + S+ +HRD+ NLL+ ++KIGDFGL + + + W
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 305 RPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
PE L AS D W G L E+F G+ G + LHKI
Sbjct: 192 -APESLK----TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 37/249 (14%)
Query: 121 AVAGEAINGW-VPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDP 176
G + + + R + E IG+G + V++ EN L VA+K + D
Sbjct: 1 GAMGSSTRDYEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS 58
Query: 177 ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFT 235
+F+ +E + +R+ DHP+I+KL G+IT ++++ E +L
Sbjct: 59 VREKFL-QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLD 114
Query: 236 EAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ---- 291
A + Y QL L + S+ +HRDI N+L+ N +K+GDFGL+ + + S
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174
Query: 292 ---KQPLTSRVVTLWYRPPELLLGSTDYG----ASVDLWSSGCILAELF--AGKPIMPGR 342
K P+ W PE + + AS D+W G + E+ KP G
Sbjct: 175 SKGKLPI------KWM-APESIN----FRRFTSAS-DVWMFGVCMWEILMHGVKP-FQGV 221
Query: 343 TEVEQLHKI 351
+ + +I
Sbjct: 222 KNNDVIGRI 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 68/294 (23%), Positives = 113/294 (38%), Gaps = 65/294 (22%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR----FTNMDPESVRFMAREIIIL 189
K F L +G+G++ V + ++L A+K ++ + D E M + ++
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT--MVEKRVLA 75
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL------AGLAATPGVKFTEAQIKCY 242
P + +L + LY V EY+ DL G +F E Y
Sbjct: 76 LPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVG-------RFKEPHAVFY 126
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-- 300
++ GL S+GI++RD+K N+++D G +KI DFG+ K+ + V
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTK 179
Query: 301 ----TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG 356
T Y PE++ YG SVD W+ G +L E+ AG+ G E E I +
Sbjct: 180 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--- 235
Query: 357 SPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
P K + A+++ L++ P R
Sbjct: 236 -------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 51/236 (21%), Positives = 97/236 (41%), Gaps = 29/236 (12%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDPESVRFMARE 185
+ + R + +G+G + VY+ + + K+ VA+K + +FM E
Sbjct: 7 YGIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SE 63
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMK 244
+I++ LDHP+I+KL G+I +++ E + +L + Y
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL-- 302
Q+ + + S +HRDI N+L+ +K+GDFGL+ + + + VT
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLP 177
Query: 303 --WYRPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
W PE + + AS D+W + E+ + GK + + +
Sbjct: 178 IKWM-SPESIN----FRRFTTAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 52/230 (22%), Positives = 96/230 (41%), Gaps = 22/230 (9%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR---DLENNKL-VALKKVRFTNMDPESVRFMAREIIIL 189
K F+K+ +G G + +VYK + E K+ VA+K++R + + E ++
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVM 71
Query: 190 RRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLH 248
+D+P++ +L G+ + ++ L+ + M L + + Q+
Sbjct: 72 ASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYRP 306
G+ + R ++HRD+ N+L+ +KI DFGLA +K+ +V W
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-A 187
Query: 307 PELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
E +L + S D+WS G + EL G G E +
Sbjct: 188 LESIL----HRIYTHQS-DVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 33/166 (19%), Positives = 70/166 (42%), Gaps = 14/166 (8%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR---DLENNKLVALKKVRFTNMDPESVRFMAREII 187
+ R + +G+G + SV + + + VA+K ++ N + E
Sbjct: 31 IDR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA 88
Query: 188 ILRRLDHPNIMKLEGLIT---SRVSGSLYLVFEYMEH-DL-----AGLAATPGVKFTEAQ 238
++ HPN+++L G+ S+ ++ +M++ DL T
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ +M + G+E+ +R LHRD+ N ++ + + + DFGL+
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 39/169 (23%), Positives = 70/169 (41%), Gaps = 12/169 (7%)
Query: 119 LTAVAGEAINGW-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPE 177
+ A +GW + + L IG+G + V VA+K ++
Sbjct: 5 VAAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA 60
Query: 178 SVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFT 235
F+ E ++ +L H N+++L G+I G LY+V EYM L L +
Sbjct: 61 ---FL-AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 236 EAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ + + +E+ +HRD+ N+L+ + + K+ DFGL
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 50/232 (21%), Positives = 91/232 (39%), Gaps = 22/232 (9%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
+ R + ++G G + SV + R + VA+K ++ ++ M RE I
Sbjct: 6 LKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQI 63
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
+ +LD+P I++L G+ + +L LV E L + + + + Q+
Sbjct: 64 MHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---WY 304
G+++ + +HRD+ N+L+ KI DFGL+ WY
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 305 RPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
PE + + S D+WS G + E + G+ E + I
Sbjct: 181 -APECIN----FRKFSSRS-DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 63/303 (20%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILR 190
+PR +S + K+G G + V+ A + VA+K ++ +M E+ F+ E +++
Sbjct: 185 IPR--ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEA--FL-AEANVMK 238
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLH 248
L H ++KL ++T +Y++ E+M L L + G K ++ + Q+
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL----WY 304
G+ R +HRD++ +N+L+ + + KI DFGLA + ++ T+R W
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWT 352
Query: 305 RPPELLLGSTDYG----ASVDLWSSGCILAELFA-GK---PIMPGRTEVEQLHKIFKL-- 354
PE + +G S D+WS G +L E+ G+ P M + L + +++
Sbjct: 353 -APEAIN----FGSFTIKS-DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406
Query: 355 ---CGSPSEEY------WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST 405
C P E Y WK +P +R TF+ I S L D +T
Sbjct: 407 PENC--PEELYNIMMRCWK------------NRPEER---PTFEYIQS---VLDDFYTAT 446
Query: 406 EPE 408
E +
Sbjct: 447 ESQ 449
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 33/169 (19%), Positives = 72/169 (42%), Gaps = 20/169 (11%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMARE 185
V R + ++GQG++ VY+ E VA+K V E + F+ E
Sbjct: 22 VAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 78
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG--LAATPGVKFTEAQIKCY 242
+++ + ++++L G+++ ++ E M DL + P +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 243 MKQLLH-------GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ +++ G+ + ++ +HRD+ N ++ + +KIGDFG+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 54/294 (18%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDL---ENNKLVA---LKKVRFTNMDPESVRFMAREII 187
++FE L +G G Y V+ R + + KL A LKK + +
Sbjct: 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPG----------VKFTEA 237
+ P ++ L + L+L+ +Y+ G +FTE
Sbjct: 112 LEHIRQSPFLVTLHYAFQT--ETKLHLILDYI----------NGGELFTHLSQRERFTEH 159
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS 297
+++ Y+ +++ LEH H GI++RDIK N+L+D NG + + DFGL+ F + +
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 298 RVVTLWYRPPELLLGSTD-YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCG 356
T+ Y P+++ G + +VD WS G ++ EL G E +I +
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-- 277
Query: 357 SPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR 410
I K + PY + ++ + A L+ LL +P+ R
Sbjct: 278 ----------------ILKSEPPYPQ-------EMSALAKDLIQRLLMKDPKKR 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 36/167 (21%), Positives = 71/167 (42%), Gaps = 15/167 (8%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR---DLENNKLVALKKVRFTNMDPESVRFMAREII 187
+P F +G+G + SV +A+ + + VA+K ++ + + RE
Sbjct: 20 IPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA 77
Query: 188 ILRRLDHPNIMKLEGLIT----SRVSGSLYLVFEYMEH-DL-----AGLAATPGVKFTEA 237
++ DHP++ KL G+ ++ +M+H DL A
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 238 QIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ +M + G+E+ SR +HRD+ N ++ + + + DFGL+
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 63/342 (18%), Positives = 121/342 (35%), Gaps = 62/342 (18%)
Query: 136 DSFEKLDKIGQGTYSSVYKAR---DLENNKL-VALKKVRFTNMDPESVRFMAREIIILRR 191
F+K+ +G G + +VYK + E K+ VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
+D+P++ +L G+ + ++ L+ + M L + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYRPPE 308
+ R ++HRD+ N+L+ +KI DFGLA +K+ +V W E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189
Query: 309 LLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFK--------LC 355
+L + S D+WS G + EL G G E + K +C
Sbjct: 190 SIL----HRIYTHQS-DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 356 GSPSEEY------WKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEV 409
+ Y W R F+++ + +
Sbjct: 245 --TIDVYMIMVKCWM------------IDADSR---PKFREL----IIEFSKMARDPQRY 283
Query: 410 RGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDD 451
+Q + P P D + ++ D + D+
Sbjct: 284 L-----VIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 320
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 20/237 (8%)
Query: 120 TAVAGEAINGW-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES 178
A +GW + + L IG+G + V VA+K ++
Sbjct: 178 AAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA- 232
Query: 179 VRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTE 236
F+ E ++ +L H N+++L G+I G LY+V EYM L L +
Sbjct: 233 --FL-AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGG 288
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA-NFFKCSQKQPL 295
+ + + +E+ +HRD+ N+L+ + + K+ DFGL L
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
+ W PE L S D+WS G +L E+++ G+ P + + ++
Sbjct: 349 PVK----WT-APEALREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-22
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKL-VALKKVRFTNMDPESVRFMAREII 187
+ R + E IG+G + V++ EN + VA+K + D +F+ +E +
Sbjct: 387 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEAL 443
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQL 246
+R+ DHP+I+KL G+IT ++++ E +L A + Y QL
Sbjct: 444 TMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ-------KQPLTSRV 299
L + S+ +HRDI N+L+ N +K+GDFGL+ + + S K P+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---- 556
Query: 300 VTLWYRPPELLLGSTDYGASVDLWSSGCILAELF--AGKPIMPGRTEVEQLHKI 351
W P + + ++ D+W G + E+ KP G + + +I
Sbjct: 557 --KWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 26/175 (14%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMARE 185
+ A F + ++G+ + VYK E + VA+K ++ P F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HE 62
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------AGLAAT 229
++ RL HPN++ L G++T L ++F Y H DL T
Sbjct: 63 AMLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 230 PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ Q+ G+E+ S ++H+D+ N+L+ +KI D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 61/244 (25%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D+F + +G+G + VYK R L + LVA+K+++ ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 196 NIMKLEGLITSRVSGSLYLVFEYME--------HDLA--------------------GLA 227
N+++L G + LV+ YM + GLA
Sbjct: 88 NLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 228 ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287
Y LH +HC + I+HRD+K +N+L+D +GDFGLA
Sbjct: 146 --------------Y----LH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 288 KCSQKQPLTSRVV-TLWYRPPE-LLLG-STDYGASVDLWSSGCILAELFAG-KPIMPGRT 343
+ +T+ V T+ + PE L G S++ D++ G +L EL G + R
Sbjct: 185 -DYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARL 240
Query: 344 EVEQ 347
+
Sbjct: 241 ANDD 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR--DLENNKLVALKKVRFTNMDPESVRFMAREIII 188
+ + + D IG+G + V KAR A+K+++ + F E+ +
Sbjct: 22 LDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEV 78
Query: 189 LRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------AGLAATPG 231
L +L HPNI+ L G G LYL EY H +L +A +
Sbjct: 79 LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 232 VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ Q+ + + G+++ + +HRD+ N+L+ N + KI DFGL+
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 37/240 (15%), Positives = 80/240 (33%), Gaps = 32/240 (13%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-------DLENNKLVALKKVRFTNMDPESVRFMA 183
+ + + +GQGT++ ++K + V LK + + + F
Sbjct: 5 IRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF- 60
Query: 184 REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCY 242
++ +L H +++ G+ LV E+++ L
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLID--------YNGILKIGDFGLANFFKCSQ--K 292
KQL + ++H ++ N+L+ +K+ D G++ +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
+ + W PPE + + + D WS G L E+ + G + +L
Sbjct: 179 ERIP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 21/220 (9%)
Query: 143 KIGQGTYSSVYKARDLENNKL--VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
++G G + +V K + VA+K ++ DP + E ++++LD+P I+++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 201 EGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
G+ + S LV E E L + I + Q+ G+++ +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---WYRPPELLLGSTDY 316
HRD+ N+L+ KI DFGL+ + + WY PE + Y
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECIN----Y 194
Query: 317 G----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
S D+WS G ++ E F+ G+ G E +
Sbjct: 195 YKFSSKS-DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 40/185 (21%), Positives = 74/185 (40%), Gaps = 35/185 (18%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMA 183
W PR + +G+G + V KA VA+K ++ E +
Sbjct: 18 WEFPR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL- 74
Query: 184 REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL------------------- 223
E +L++++HP+++KL G + G L L+ EY ++ L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 224 ----AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIG 279
+ L T + + Q+ G+++ ++HRD+ N+L+ +KI
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 280 DFGLA 284
DFGL+
Sbjct: 193 DFGLS 197
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 26/232 (11%)
Query: 134 KADSFEKLDKIGQGTYSSVYKAR---DLENNKL-VALK--KVRFTNMDPESVRFMAREII 187
K KL +G G + +V+K + E+ K+ V +K + + ++ ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VT-DHML 67
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQL 246
+ LDH +I++L GL SL LV +Y+ L + + Q+
Sbjct: 68 AIGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWY 304
G+ + G++HR++ N+L+ +++ DFG+A+ KQ L S + W
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 305 RPPELLLGSTDYG----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
E + +G S D+WS G + EL G G E +
Sbjct: 185 -ALESIH----FGKYTHQS-DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 27/178 (15%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMA 183
W PR D + +G+G + V +A + VA+K ++ E M
Sbjct: 22 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM- 78
Query: 184 REIIILRRLD-HPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------AGL 226
E+ IL + H N++ L G T + G L ++ E+ + +L
Sbjct: 79 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 227 AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
T + CY Q+ G+E SR +HRD+ N+L+ ++KI DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-20
Identities = 47/220 (21%), Positives = 89/220 (40%), Gaps = 21/220 (9%)
Query: 143 KIGQGTYSSVYKAR-DLENNKL-VALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKL 200
++G G + SV + + ++ VA+K ++ ++ M RE I+ +LD+P I++L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 201 EGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGIL 259
G+ + +L LV E L + + + + Q+ G+++ + +
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 260 HRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL---WYRPPELLLGSTDY 316
HR++ N+L+ KI DFGL+ WY PE + +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECIN----F 513
Query: 317 G----ASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKI 351
S D+WS G + E + G+ E + I
Sbjct: 514 RKFSSRS-DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-------DLENNKLVALKKVRFTNMDPESVRF 181
W PR D +G+G + V A + VA+K ++ + +
Sbjct: 30 WEFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 182 MAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------A 224
+ E+ +++ + H NI+ L G T G LY++ EY +L
Sbjct: 88 V-SEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 225 GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ P + T + QL G+E+ S+ +HRD+ N+L+ N ++KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 59/256 (23%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYK--ARDLENNK---LVALKKVRFTNMDPESVRFMARE 185
VPR + + +G G + VY+ + N+ VA+K + + + + F+ E
Sbjct: 27 VPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 83
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL------AGLAATPGVKFTEAQ 238
+I+ + +H NI++ G+ S +++ E M DL +
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCSQKQPL 295
+ + + G ++ +HRDI N L+ G + KIGDFG+A
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----------- 190
Query: 296 TSRVV--TLWYR------------PPELLLGSTDYG----ASVDLWSSGCILAELF--AG 335
R + +YR PPE + G + D WS G +L E+F
Sbjct: 191 --RDIYRASYYRKGGCAMLPVKWMPPEAFM----EGIFTSKT-DTWSFGVLLWEIFSLGY 243
Query: 336 KPIMPGRTEVEQLHKI 351
P P ++ E L +
Sbjct: 244 MPY-PSKSNQEVLEFV 258
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 34/183 (18%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMARE 185
PR + + IG+G + V++AR E +VA+K ++ F RE
Sbjct: 44 YPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 100
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL----------------AGLAA 228
++ D+PNI+KL G+ V + L+FEYM + DL +
Sbjct: 101 AALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 229 TPGVKFTEAQIKCYMKQLLH-------GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281
T + + L G+ + R +HRD+ N L+ N ++KI DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 282 GLA 284
GL+
Sbjct: 219 GLS 221
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-------DLENNKLVALKKVRFTNMDPESVRF 181
W PR D +G+G + V A + VA+K ++ + +
Sbjct: 76 WEFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 182 MAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------A 224
+ E+ +++ + H NI+ L G T G LY++ EY +L
Sbjct: 134 V-SEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 225 GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ P + T + QL G+E+ S+ +HRD+ N+L+ N ++KI DFGLA
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 27/175 (15%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMARE 185
+ R+ ++ ++G+G + V+ A ++ LVA+K ++ + F RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQ-RE 67
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL--------AGLAATPGVKFTE 236
+L L H +I+K G+ L +VFEYM+H DL + +
Sbjct: 68 AELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 237 AQIKCYMKQLLH-------GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
A+ + + Q+LH G+ + S+ +HRD+ N L+ N ++KIGDFG++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMARE 185
+ R+ + ++G+G + V+ A ++ LVA+K ++ + F RE
Sbjct: 38 IKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQ-RE 93
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL--------------AGLAATP 230
+L L H +I++ G+ T L +VFEYM H DL AG
Sbjct: 94 AELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 231 GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
Q+ Q+ G+ + +HRD+ N L+ ++KIGDFG++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 59/259 (22%), Positives = 94/259 (36%), Gaps = 62/259 (23%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMA 183
W PR + +G G + V +A + VA+K ++ + E M
Sbjct: 18 WEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM- 74
Query: 184 REIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL-----------------A 224
E+ +L L +H NI+ L G T + G ++ EY + DL
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 225 GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ + + + Q+ G+ S+ +HRD+ N+L+ + I KI DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 285 NFFKCSQKQPLTSRVV--TLWYR------------PPELLLGSTDYGASVDLWSSGCILA 330
R + Y PE + Y D+WS G L
Sbjct: 193 -------------RDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLW 238
Query: 331 ELFA-GK---PIMPGRTEV 345
ELF+ G P MP ++
Sbjct: 239 ELFSLGSSPYPGMPVDSKF 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVR----FMAREIIILRR 191
++F+ IG G + VYK L + VALK+ PES + F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSF 91
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHD-----LAGLAATPGVKFTEAQIKCYMKQL 246
HP+++ L G R + L+++YME+ L G + P + + Q ++
Sbjct: 92 CRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQ---RLEIC 145
Query: 247 L---HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TL 302
+ GL + H+R I+HRD+K N+L+D N + KI DFG++ + L++ V TL
Sbjct: 146 IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 303 WYRPPE------LLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQ 347
Y PE L S D++S G +L E+ + I+
Sbjct: 206 GYIDPEYFIKGRLTEKS-------DVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 59/256 (23%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYK--ARDLENNK---LVALKKVRFTNMDPESVRFMARE 185
VPRK + + +G G + VY+ + N+ VA+K + + + + F+ E
Sbjct: 68 VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 124
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL------AGLAATPGVKFTEAQ 238
+I+ + +H NI++ G+ S +++ E M DL +
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 239 IKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCSQKQPL 295
+ + + G ++ +HRDI N L+ G + KIGDFG+A
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----------- 231
Query: 296 TSRVV--TLWYR------------PPELLLGSTDYG----ASVDLWSSGCILAELF--AG 335
R + +YR PPE + G + D WS G +L E+F
Sbjct: 232 --RDIYRAGYYRKGGCAMLPVKWMPPEAFM----EGIFTSKT-DTWSFGVLLWEIFSLGY 284
Query: 336 KPIMPGRTEVEQLHKI 351
P P ++ E L +
Sbjct: 285 MPY-PSKSNQEVLEFV 299
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-------DLENNKLVALKKVRFTNMDPESVRF 181
W +PR D +G+G + V A VA+K ++ + +
Sbjct: 64 WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 182 MAREIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------A 224
+ E+ +++ + H NI+ L G T G LY++ EY +L
Sbjct: 122 I-SEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 225 GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ P + + + Q+ G+E+ S+ +HRD+ N+L+ + ++KI DFGLA
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 63/234 (26%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVR----FMAREIIILRRLDHPNIM 198
K+G+G + VYK + NN VA+KK+ +D + F EI ++ + H N++
Sbjct: 38 KMGEGGFGVVYKGY-V-NNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKVMAKCQHENLV 93
Query: 199 KLEGLITSRVSGSLY--------LVFEYM-----EHDLAGLAATP------------GVK 233
+L G + LV+ YM L+ L TP G
Sbjct: 94 ELLG----------FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA- 142
Query: 234 FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293
A G+ H +HRDIK +N+L+D KI DFGLA + +
Sbjct: 143 ---AN----------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 294 PLTSRVV-TLWYRPPELLLG-STDYGASVDLWSSGCILAELFAG-KPIMPGRTE 344
+TSR+V T Y PE L G T D++S G +L E+ G + R
Sbjct: 190 VMTSRIVGTTAYMAPEALRGEITP---KSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 26/176 (14%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKA-----RDLENNKLVALKKVRFTNMDPESVRFMA 183
W PR F K +G G + V +A + VA+K ++ T E M
Sbjct: 41 WEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM- 97
Query: 184 REIIILRRLD-HPNIMKLEGLITSRVSGSLYLVFEYMEH-DL-------------AGLAA 228
E+ I+ L H NI+ L G T G + ++ EY + DL A
Sbjct: 98 SELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 229 TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+ + + Q+ G+ S+ +HRD+ N+L+ + KIGDFGLA
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 58/261 (22%), Positives = 101/261 (38%), Gaps = 44/261 (16%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
+ + KIG G++ +Y D+ + VA+K P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 195 -PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
I + +V E + L L KF+ + Q++ +E+
Sbjct: 64 GVGIPTIRWC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 254 HSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELL 310
HS+ +HRD+K N L+ ++ I DFGLA ++ ++ T + + YR + L
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR----THQHIP--YRENKNL 175
Query: 311 LGSTDYGASV------------DLWSSGCILAELFAGK---PIMPGRTEVEQLHKIFK-- 353
G+ Y AS+ DL S G +L G + T+ ++ +I +
Sbjct: 176 TGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234
Query: 354 -------LC-GSPSE--EYWK 364
LC G PSE Y
Sbjct: 235 MSTPIEVLCKGYPSEFATYLN 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 35/185 (18%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMA 183
W PR+ F K +G G + V A + VA+K ++ E M
Sbjct: 40 WEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM- 96
Query: 184 REIIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DL---------------AGL 226
E+ ++ +L H NI+ L G T +SG +YL+FEY + DL
Sbjct: 97 SELKMMTQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 227 AATPGVKFTEAQIKCYMKQLLH-------GLEHCHSRGILHRDIKGSNLLIDYNGILKIG 279
++ E + LL G+E + +HRD+ N+L+ + ++KI
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 280 DFGLA 284
DFGLA
Sbjct: 215 DFGLA 219
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 54/255 (21%), Positives = 100/255 (39%), Gaps = 46/255 (18%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH-PNIMKLE 201
+IG+G++ +++ +L NN+ VA+K + P+ + E + L I +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVY 72
Query: 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHR 261
+ LV + + L L G KF+ + KQ+L ++ H + +++R
Sbjct: 73 YF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 130
Query: 262 DIKGSNLLIDYNG-----ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDY 316
DIK N LI ++ + DFG+ F++ T + + YR + L G+ Y
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV----TKQHIP--YREKKNLSGTARY 184
Query: 317 GASV------------DLWSSGCILAELFAGK---PIMPGRTEVEQLHKIFK-------- 353
S+ DL + G + G + T ++ +I +
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 354 -LC-GSPSE--EYWK 364
LC G P E +Y
Sbjct: 244 ELCAGFPEEFYKYMH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 43/225 (19%), Positives = 81/225 (36%), Gaps = 42/225 (18%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL---------- 192
KIG G + +Y A + A V+ + + + E+ +R+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 193 -----DHPNIMKLEGLITSRVSGSLY--LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQ 245
D+ I G + G Y +V E + DL ++ G F ++ + +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKI--GDFGLANFFKCSQKQPLTSRVVTLW 303
+L LE+ H +H DIK +NLL+ Y ++ D+GL+ + +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH------KQYQ 213
Query: 304 YRPPELLLGSTDYGASV------------DLWSSGCILAELFAGK 336
P + G+ ++ S+ D+ G + GK
Sbjct: 214 ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 35/219 (15%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRF--MAREIIILRRLDH- 194
F KIG G + + ++L N+ VA+K ++P R + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
I ++ +V E + L L F+ + QL+ +E+ H
Sbjct: 65 DGIPQVYYF--GPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 255 SRGILHRDIKGSNLLIDYNG-----ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
S+ +++RD+K N LI G ++ I DF LA + + T + + YR +
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE----TKKHIP--YREHKS 176
Query: 310 LLGSTDYGASV------------DLWSSGCILAELFAGK 336
L G+ Y S+ DL + G + G
Sbjct: 177 LTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 42/258 (16%)
Query: 132 PRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR 191
PR + F KIG G++ +Y +++ N+ VA+K P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 192 L-DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
L I + LV + + L L K + + Q+++ +
Sbjct: 59 LQGGTGIPNVRWF--GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 251 EHCHSRGILHRDIKGSNLLIDYNG---ILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
E HS+ LHRDIK N L+ + I DFGLA ++ + T + + YR
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS----THQHIP--YREN 170
Query: 308 ELLLGSTDYGASV------------DLWSSGCILAELFAGK---PIMPGRTEVEQLHKIF 352
+ L G+ Y ASV DL S G +L G + T+ ++ KI
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
Query: 353 K---------LC-GSPSE 360
+ LC G P+E
Sbjct: 230 EKKVATSIEALCRGYPTE 247
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 40/225 (17%), Positives = 76/225 (33%), Gaps = 39/225 (17%)
Query: 143 KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLE- 201
IGQG + +Y A +++ V ++P + E+ +R P ++
Sbjct: 42 PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 202 ----------------GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQ 245
GL +++ + DL + +F+ + +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKI--GDFGLANFFKCSQKQPLTSRVVTLW 303
+L LE+ H +H DIK SNLL++Y ++ D+GLA +
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH------KAYA 214
Query: 304 YRPPELLLGSTDYGASV------------DLWSSGCILAELFAGK 336
P G+ ++ S+ DL G + + G
Sbjct: 215 ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 34/230 (14%), Positives = 67/230 (29%), Gaps = 49/230 (21%)
Query: 143 KIGQGTYSSVYKARDL--------ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
+ +Y+A + +LK +D + R + R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKP 102
Query: 195 PNIMKLEGLITSRVSG--SLY-----------LVFEYMEHDLAGL-AATPGVKFTEAQIK 240
+ K + L ++ + + LV + L +P +E +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 241 CYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKI--GDFGLANFFKCSQKQPLTSR 298
+LL LE H +H ++ N+ +D ++ +G A + S K
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH----- 217
Query: 299 VVTLWYRPPELLLGSTDYGASV------------DLWSSGCILAELFAGK 336
V G ++ S+ DL S G + + G
Sbjct: 218 -VAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 5e-10
Identities = 65/477 (13%), Positives = 130/477 (27%), Gaps = 136/477 (28%)
Query: 36 FKKENVTVVVETDGIGNESTTRLI------NDQSVADDDVGSSDDGEKKVKLQRRSTINV 89
KE + ++ + S T + + + V K + T
Sbjct: 46 LSKEEIDHIIMSKD--AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR 103
Query: 90 QVAQPRMTRIVSVSNGERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTY 149
Q + I QV A + V R + K+ Q
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQVFAKYN--------------VSRL----QPYLKLRQALL 145
Query: 150 SSVYKARDLENNKLVAL-------KKV------RFTNMDPESVRFMAREI--IILRRLDH 194
L K V + K + M +I + L+ +
Sbjct: 146 E-------LRPAKNVLIDGVLGSGKTWVALDVCL----SYKVQCKMDFKIFWLNLKNCNS 194
Query: 195 PN--IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
P + L+ L + + ++ K I+ +++LL +
Sbjct: 195 PETVLEMLQ---------KLLYQIDPNWTSRSDHSSNI--KLRIHSIQAELRRLLKSKPY 243
Query: 253 CHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR--VVTLWYRPPELL 310
+ +L +++ + F C K LT+R VT + L
Sbjct: 244 ENCLLVL-LNVQNAK-------AWN--AFN----LSC--KILLTTRFKQVT------DFL 281
Query: 311 LGSTDYGASVDLWSSGCILAE---LFA---GKPI--MPGRTEVEQLHKIF----KLCGS- 357
+T S+D S E L +P ++ +
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-----REVLTTNPRRLSIIAES 336
Query: 358 ----PSE-EYWKR---SKLPHA-----TIFKP---QQPYKRCVAETFKD---IPSSALSL 398
+ + WK KL + +P ++ + R F IP+ LSL
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTILLSL 394
Query: 399 L-DILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
+ ++ ++ V + N+ + P PS ++K++ ++
Sbjct: 395 IWFDVIKSDVMV-------VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 6e-04
Identities = 49/393 (12%), Positives = 105/393 (26%), Gaps = 115/393 (29%)
Query: 55 TTRLINDQSVADDDVGSSDDGEKKVKLQRRSTINVQVAQPRMT---------RIVSVSNG 105
TTR + V D + + I++ +T + +
Sbjct: 271 TTR---FKQVTDF-----------LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 106 ERGAQVVAGWPSWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVA 165
+ +V+ P ++ E+I + D+++ ++ +KL
Sbjct: 317 DLPREVLTTNP-RRLSIIAESIRDGLAT-WDNWKHVN-----------------CDKLTT 357
Query: 166 LKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG 225
+ + ++P R M + + + I + + L L++ +
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFP--PSAH-------IPTIL---LSLIWFDVIKS--- 402
Query: 226 LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLAN 285
+ + H ++ + K + I L
Sbjct: 403 ---------DVMVV----------VNKLHKYSLVEKQPK--------ESTISIPSIYLEL 435
Query: 286 FFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG---KPIMPGR 342
K + L +V Y P+ + D + + + G K I
Sbjct: 436 KVKLENEYALHRSIVD-HYNIPK----TFDSDDLIPPYLDQYFYS--HIGHHLKNIEHPE 488
Query: 343 TEVEQLHKIF--------KLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSS 394
+ +F K+ + S L K YK + + D
Sbjct: 489 -RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK---FYKPYICD--NDPKYE 542
Query: 395 AL--SLLDILLSTEPE-VRGTASS----ALQNE 420
L ++LD L E + + AL E
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIALMAE 575
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 12/106 (11%)
Query: 234 FTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA------NFF 287
T + CY Q+ G+E SR +HRD+ N+L+ ++KI DFGLA +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELF 333
L + W PE + Y D+WS G +L E+F
Sbjct: 250 VRKGDARLPLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMA 183
W PR D + +G+G + V +A + VA+K ++ E M
Sbjct: 17 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM- 73
Query: 184 REIIILRRLD-HPNIMKLEGLITSRVSGSLYLVFEYMEH 221
E+ IL + H N++ L G T + G L ++ E+ +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 29/160 (18%), Positives = 56/160 (35%), Gaps = 31/160 (19%)
Query: 141 LDKIGQGTYSSVYKARDLENNKLVALKKVR-----FTNM----DPESVRFM-------AR 184
+G+G S+V+ E +K + F + D + F
Sbjct: 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153
Query: 185 EIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMK 244
E L++L + K+ + ++ E ++ L V+ +
Sbjct: 154 EFRALQKLQGLAVPKVYAWEGN------AVLMELIDAK--ELYR---VRVENPD--EVLD 200
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLA 284
+L + + RGI+H D+ N+L+ GI I DF +
Sbjct: 201 MILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 690 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-87 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-84 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-77 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-76 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-75 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-75 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-73 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-72 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-70 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-69 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-69 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-68 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-67 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-66 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-65 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-65 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-27 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (700), Expect = 4e-87
Identities = 137/311 (44%), Positives = 182/311 (58%), Gaps = 12/311 (3%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
+ +EKL KIGQGT+ V+KAR + + VALKKV N REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 193 DHPNIMKLEGLITSRVS------GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQL 246
H N++ L + ++ S GS+YLVF++ EHDLAGL + VKFT ++IK M+ L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF---KCSQKQPLTSRVVTLW 303
L+GL + H ILHRD+K +N+LI +G+LK+ DFGLA F K SQ T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363
YRPPELLLG DYG +DLW +GCI+AE++ PIM G TE QL I +LCGS + E W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 364 KR-SKLPHATIFKPQQPYKRCVAETFKDIPSS--ALSLLDILLSTEPEVRGTASSALQNE 420
+ + KR V + K AL L+D LL +P R + AL ++
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 421 FFTTKPLPCDP 431
FF + P+P D
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (680), Expect = 2e-84
Identities = 118/301 (39%), Positives = 170/301 (56%), Gaps = 7/301 (2%)
Query: 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM---DPESVRFMAREIIILRRLDHP 195
EKLD +G+G +++VYKARD N++VA+KK++ + R REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
NI+ L + ++ LVF++ME DL + + T + IK YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
ILHRD+K +NLL+D NG+LK+ DFGLA F S + T +VVT WYR PELL G+
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375
YG VD+W+ GCILAEL P +PG ++++QL +IF+ G+P+EE W +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLP 435
P + F L L+ L P R TA+ AL+ ++F+ +P P LP
Sbjct: 238 KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
Query: 436 K 436
+
Sbjct: 297 R 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 5e-77
Identities = 114/327 (34%), Positives = 159/327 (48%), Gaps = 13/327 (3%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
+ L IG+G Y V A D N VA+KK+ R + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 195 PNIMKLEGLITSRVS---GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
NI+ + +I + +YLV M DL L T + I ++ Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--LTSRVVTLWYRPPEL 309
+ HS +LHRD+K SNLL++ LKI DFGLA LT V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
+L S Y S+D+WS GCILAE+ + +PI PG+ ++QL+ I + GSPS+E
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 370 HATIFKPQQPYKRCV--AETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427
A + P+K V F + S AL LLD +L+ P R AL + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 428 PCDPSSLPKYPPSKEFDVKLRDDDRRR 454
DPS P +FD++L D + +
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 8e-76
Identities = 117/296 (39%), Positives = 168/296 (56%), Gaps = 6/296 (2%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
++F+K++KIG+GTY VYKAR+ ++VALKK+R REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+KL +I + LYLVFE++ DL + A+ IK Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S +LHRD+K NLLI+ G +K+ DFGLA F + T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
Y +VD+WS GCI AE+ + + PG +E++QL +IF+ G+P E W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT--TKPLP 428
+ ++ ++ + SLL +L +P R +A +AL + FF TKP+P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (620), Expect = 7e-75
Identities = 110/335 (32%), Positives = 163/335 (48%), Gaps = 18/335 (5%)
Query: 117 SWLTAVAGEAINGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP 176
S +T V G + S+ IG G++ VY+A+ ++ +LVA+KKV
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------ 54
Query: 177 ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS----LYLVFEYMEHDLAGLA---AT 229
+ RF RE+ I+R+LDH NI++L S L LV +Y+ + +A +
Sbjct: 55 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 230 PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFK 288
+K YM QL L + HS GI HRDIK NLL+D + +LK+ DFG A
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL- 173
Query: 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQL 348
+ +P S + + +YR PEL+ G+TDY +S+D+WS+GC+LAEL G+PI PG + V+QL
Sbjct: 174 -VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE 408
+I K+ G+P+ E + + PQ P A++L LL P
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 409 VRGTASSALQNEFFTTKPLPCDPSSLPKYPPSKEF 443
R T A + FF L LP +
Sbjct: 293 ARLTPLEACAHSFF--DELRDPNVKLPNGRDTPAL 325
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 8e-75
Identities = 103/325 (31%), Positives = 160/325 (49%), Gaps = 13/325 (4%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ L +G G Y +V A D VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 196 NIMKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
N++ L + T + YLV +M DL L K E +I+ + Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+ H+ GI+HRD+K NL ++ + LKI DFGLA +T VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVIL 191
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +VD+WS GCI+AE+ GK + G ++QL +I K+ G+P E+ +R + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 372 TIFKPQQPY--KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPC 429
+ P K+ A + A++LL+ +L + E R TA AL + +F +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 430 DPSSLPKYPPSKEFDVKLRDDDRRR 454
D + KY S + DV D+ +R
Sbjct: 312 DEPQVQKYDDSFD-DVDRTLDEWKR 335
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 1e-74
Identities = 105/333 (31%), Positives = 159/333 (47%), Gaps = 12/333 (3%)
Query: 127 INGWVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREI 186
+N + + ++ L +G G Y SV A D + VA+KK+ + RE+
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 187 IILRRLDHPNIMKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCY 242
+L+ + H N++ L + T S +YLV M DL + K T+ ++
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFL 126
Query: 243 MKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTL 302
+ Q+L GL++ HS I+HRD+K SNL ++ + LKI DFGLA T V T
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATR 182
Query: 303 WYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 362
WYR PE++L Y +VD+WS GCI+AEL G+ + PG ++QL I +L G+P E
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 363 WKR--SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
K+ S+ I Q K A F A+ LL+ +L + + R TA+ AL +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 421 FFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRR 453
+F P D Y S E L D+ +
Sbjct: 303 YFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 7e-73
Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 31/294 (10%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ ++ + +G+G Y V A + + VA+K V +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHE 63
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
N++K G R YL EY P + E + + QL+ G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGST 314
GI HRDIK NLL+D LKI DFGLA F+ + ++ L +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
+ VD+WS G +L + AG+ ++ Q + +K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428
+K I S+ L+LL +L P R T ++ ++ KPL
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLK 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 234 bits (596), Expect = 2e-72
Identities = 107/287 (37%), Positives = 157/287 (54%), Gaps = 4/287 (1%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + L+KIG+GTY VYKA++ + ALKK+R D REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
NI+KL +I ++ L LVFE+++ DL L K ++ QLL+G+ +CH
Sbjct: 61 NIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
R +LHRD+K NLLI+ G LKI DFGLA F ++ +VTLWYR P++L+GS
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375
Y ++D+WS GCI AE+ G P+ PG +E +QL +IF++ G+P+ + W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
K + S + LL +L +P R TA AL++ +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (591), Expect = 1e-71
Identities = 112/289 (38%), Positives = 164/289 (56%), Gaps = 4/289 (1%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+EKL+KIG+GTY +V+KA++ E +++VALK+VR + D REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
NI++L ++ S LVFE+ + DL + +K ++ QLL GL CHS
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
R +LHRD+K NLLI+ NG LK+ +FGLA F + ++ VVTLWYRPP++L G+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 316 YGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
Y S+D+WS+GCI AEL P+ PG +QL +IF+L G+P+EE W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
P P + + ++ LL LL P R +A ALQ+ +F+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 231 bits (591), Expect = 9e-71
Identities = 70/313 (22%), Positives = 119/313 (38%), Gaps = 37/313 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
D ++ +++G G + V++ + A K V + D E+VR +EI + L H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRH 82
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P ++ L + +++E+M +L A K +E + YM+Q+ GL H
Sbjct: 83 PTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 254 HSRGILHRDIKGSNLLI--DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
H +H D+K N++ + LK+ DFGL KQ + T + PE+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAE 198
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
G G D+WS G + L +G G + E L + + + +
Sbjct: 199 GKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-------- 249
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDP 431
I + LL +P R T AL++ + T P
Sbjct: 250 -----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
Query: 432 SSLPKYPPSKEFD 444
S +P +K D
Sbjct: 293 SQIPSSRYTKIRD 305
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 2e-70
Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 23/306 (7%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
K D FEK+ ++G G V+K + ++A K + + P + RE+ +L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN 62
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
P I+ G S G + + E+M+ + E + ++ GL +
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 254 HSR-GILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
+ I+HRD+K SN+L++ G +K+ DFG++ S S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG 177
Query: 313 STDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
+ Y D+WS G L E+ G+ PI P + +L ++ G +E +
Sbjct: 178 T-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 372 TI---------FKPQQPYKRCVAETFKDIPSSALS-----LLDILLSTEPEVRGTASSAL 417
+ V E +PS S ++ L P R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 418 QNEFFT 423
+ F
Sbjct: 297 VHAFIK 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 228 bits (582), Expect = 6e-70
Identities = 80/322 (24%), Positives = 138/322 (42%), Gaps = 39/322 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
F L +IG G++ +VY ARD+ N+++VA+KK+ ++ E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
PN ++ G + +LV EY + L E +I L GL + H
Sbjct: 75 PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S ++HRD+K N+L+ G++K+GDFG A+ P S V T ++ PE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMD 187
Query: 315 D--YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372
+ Y VD+WS G EL KP + + L+ I + + L
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------NESPALQS-- 236
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPS 432
+ +D L P+ R T+ L++ F + P
Sbjct: 237 ----------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280
Query: 433 SLPKYPPSKEFDVKLRDDDRRR 454
L + +K+ +L + R+
Sbjct: 281 DLIQR--TKDAVRELDNLQYRK 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-69
Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 39/297 (13%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD 193
+A+ +E L IG G+Y K R + K++ K++ + +M + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL---AATPGVKFTEAQIKCYMKQLLHG 249
HPNI++ I R + +LY+V EY E DLA + E + M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 250 LEHCHSRG-----ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWY 304
L+ CH R +LHRD+K +N+ +D +K+GDFGLA + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYY 180
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE + + Y D+WS GC+L EL A P ++ E KI + K
Sbjct: 181 MSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
++P+ ++ +L+ + R + L+N
Sbjct: 231 FRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 7e-69
Identities = 79/301 (26%), Positives = 123/301 (40%), Gaps = 39/301 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D +E + ++G G + VYKA++ E + L A K + E + EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHP 69
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+KL +L+++ E+ + + TE+QI+ KQ L L + H
Sbjct: 70 NIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
I+HRD+K N+L +G +K+ DFG++ Q S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 315 D----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370
Y D+WS G L E+ +P + L KI K P+ R
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT---KPL 427
S+ L L + R T S LQ+ F T KP+
Sbjct: 241 --------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
Query: 428 P 428
Sbjct: 281 R 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 226 bits (577), Expect = 1e-68
Identities = 68/321 (21%), Positives = 127/321 (39%), Gaps = 40/321 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D ++ L+++G G + V++ + ++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 86
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
++ L + + L+ E++ +L A K +EA++ YM+Q GL+H H
Sbjct: 87 KLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 255 SRGILHRDIKGSNLLIDY--NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
I+H DIK N++ + +KI DFGLA + + + T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 202
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372
G D+W+ G + L +G G ++E L + + E+ +
Sbjct: 203 E-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPS 432
+ A + LL EP R T AL++ + D S
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHS 291
Query: 433 SLPKYPPSKEFDVKLRDDDRR 453
+L PS ++ + +
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEK 312
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 2e-68
Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 37/308 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + +KIGQG +VY A D+ + VA++++ + EI+++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNP 77
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS 255
NI+ L++V EY+ E QI ++ L LE HS
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 256 RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTD 315
++HRDIK N+L+ +G +K+ DFG Q + ++ V T ++ PE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKA- 192
Query: 316 YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375
YG VD+WS G + E+ G+P + L+ I G+P +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP------------ 239
Query: 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF-TTKPLPCDPSSL 434
+ + + L+ L + E RG+A LQ++F KPL S
Sbjct: 240 -------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL---SSLT 283
Query: 435 PKYPPSKE 442
P +KE
Sbjct: 284 PLIAAAKE 291
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-67
Identities = 78/289 (26%), Positives = 123/289 (42%), Gaps = 36/289 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
+ FE +G+G + +VY AR+ ++ ++ALK + + + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
PNI++L G + +YL+ EY KF E + Y+ +L + L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S+ ++HRDIK NLL+ G LKI DFG + + T+ TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
+ VDLWS G + E GKP T E +I ++ + +
Sbjct: 181 -HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423
+ A L+ LL P R L++ + T
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 4e-67
Identities = 115/298 (38%), Positives = 160/298 (53%), Gaps = 13/298 (4%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLEN-NKLVALKKVRFTNMDPESVRFMAREIIILRR 191
R +E + +IG+G Y V+KARDL+N + VALK+VR + RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 192 L---DHPNIMKLEGLITSRVS---GSLYLVFEYMEHD-LAGLAATPGVKFTEAQIKCYMK 244
L +HPN+++L + T + L LVFE+++ D L P IK M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 245 QLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWY 304
QLL GL+ HS ++HRD+K N+L+ +G +K+ DFGLA S + LTS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWY 181
Query: 305 RPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
R PE+LL S+ Y VDLWS GCI AE+F KP+ G ++V+QL KI + G P EE W
Sbjct: 182 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
R F + + + DI LL L+ P R +A SAL + +F
Sbjct: 241 RDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-66
Identities = 71/335 (21%), Positives = 124/335 (37%), Gaps = 36/335 (10%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ + + +G+G + V++ + + K K V+ D V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+ L S L ++FE++ D+ T + E +I Y+ Q+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 255 SRGILHRDIKGSNLLIDY--NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLG 312
S I H DI+ N++ + +KI +FG A K Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 313 STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372
+ D+WS G ++ L +G T + + I + EE +
Sbjct: 178 DV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPS 432
K+I A+ +D LL E + R TAS ALQ+ + K
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 433 SLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIR 467
+ + + ++ D + +IR
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIR 306
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-65
Identities = 92/334 (27%), Positives = 159/334 (47%), Gaps = 23/334 (6%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
++ L IG G V A D ++ VA+KK+ + + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 198 MKLEGLITSRVS----GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
+ L + T + + +YLV E M+ L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS GI+HRD+K SN+++ + LKI DFGLA +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG- 192
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y +VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P E+ K+ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 374 FKPQQPYKR-------------CVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
+ + Y +E K S A LL +L +P R + ALQ+
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 421 FFTTKPLPCDPSSLPKYPPSKEFDVKLRDDDRRR 454
+ P + + P K+ D + + +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 216 bits (550), Expect = 5e-65
Identities = 94/304 (30%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
D ++ + K+G+G YS V++A ++ NN+ V +K + P + + REI IL L
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKREIKILENL 86
Query: 193 -DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
PNI+ L ++ VS + LVFE++ + D L T+ I+ YM ++L L
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKAL 142
Query: 251 EHCHSRGILHRDIKGSNLLIDY-NGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
++CHS GI+HRD+K N++ID+ + L++ D+GLA F+ Q+ RV + +++ PEL
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKLCGSPS-EEYWKRSK 367
L+ Y S+D+WS GC+LA + K P G +QL +I K+ G+ +Y +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 368 LPHATIFKPQQPY-------KRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420
+ F + +E + AL LD LL + + R TA A+++
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 421 FFTT 424
+F T
Sbjct: 321 YFYT 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 71/240 (29%), Positives = 117/240 (48%), Gaps = 7/240 (2%)
Query: 132 PRK--ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIII 188
PRK + F+ +G+G++S+V AR+L ++ A+K + ++ V ++ RE +
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
+ RLDHP +KL LY Y ++ F E + Y +++
Sbjct: 62 MSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPP 307
LE+ H +GI+HRD+K N+L++ + ++I DFG A KQ + V T Y P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367
ELL + S DLW+ GCI+ +L AG P E KI KL E+++ +++
Sbjct: 180 ELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 3e-63
Identities = 82/317 (25%), Positives = 126/317 (39%), Gaps = 36/317 (11%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
D ++ D +G G +S V A D KLVA+K + ++ + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
NI+ L+ + S G LYL+ + + +L G +TE + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 255 SRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
GI+HRD+K NLL D + + I DFGL+ L++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLA 182
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +VD WS G I L G P + + +I K YW
Sbjct: 183 QK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDP 431
DI SA + L+ +PE R T ALQ+ +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 432 SSLPKYPPSKEFDVKLR 448
K+ K +
Sbjct: 277 IHQSVSEQIKKNFAKSK 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 207 bits (528), Expect = 2e-62
Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 44/301 (14%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPES-------VRFMAREIII 188
+++E + +G+G S V + K A+K + T S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 189 LRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQL 246
LR++ HPNI++L+ + +LVF+ M+ +L +E + + M+ L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRAL 119
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L + H I+HRD+K N+L+D + +K+ DFG + +K L T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 307 PELLLGSTD-----YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361
PE++ S + YG VD+WS+G I+ L AG P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
W D + L+ L +P+ R TA AL + F
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 422 F 422
F
Sbjct: 273 F 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 60/294 (20%), Positives = 118/294 (40%), Gaps = 36/294 (12%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W +P +IG G++ +VYK + + VA+K + T P+ ++ E+ +
Sbjct: 3 WEIPD--GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLL 247
LR+ H NI+ G T+ L +V ++ E L KF ++ +Q
Sbjct: 58 LRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF-KCSQKQPLTSRVVTLWYRP 306
G+++ H++ I+HRD+K +N+ + + +KIGDFGLA + S ++ +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 307 PELLLGSTD--YGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE++ Y D+++ G +L EL G+ +Q+ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------- 223
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+ +++ + P + L+ L + + R L
Sbjct: 224 ------------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-60
Identities = 66/312 (21%), Positives = 124/312 (39%), Gaps = 40/312 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM----DPESVRFMAREIIILRR 191
D ++ +++G G ++ V K R+ A K ++ S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
+ HPN++ L + ++ + L+ E + TE + ++KQ+L+G+
Sbjct: 70 IQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 252 HCHSRGILHRDIKGSNLLIDYNGI----LKIGDFGLANFFKCSQKQPLTSRVVTLWYRPP 307
+ HS I H D+K N+++ + +KI DFGLA+ + + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367
E++ G D+WS G I L +G G T+ E L + + +EY+
Sbjct: 186 EIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427
+ + A + LL +P+ R T +LQ+ + KP
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI--KPK 277
Query: 428 PCDPSSLPKYPP 439
+ +
Sbjct: 278 DTQQALSSAWSH 289
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-59
Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 37/291 (12%)
Query: 138 FEKLD-KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN 196
F K D +IG+G++ +VYK D E VA +++ + + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 197 IMKLEGLITSRVSG--SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
I++ S V G + LV E M ++ + +Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 255 SRG--ILHRDIKGSNLLI-DYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
+R I+HRD+K N+ I G +KIGD GLA + S + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y SVD+++ G + E+ + Q+++ P+
Sbjct: 187 EK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--------- 235
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422
K +++ + + R + L + FF
Sbjct: 236 -----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 3e-57
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 31/292 (10%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLD 193
+D +E + +G G S V+ ARDL ++ VA+K +R DP RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 194 HPNIMKLEGLITSR--VSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
HP I+ + + Y+V EY++ T + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP--LTSRVVTLWYRPPEL 309
H GI+HRD+K +N++I +K+ DFG+A S + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 310 LLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369
G + A D++S GC+L E+ G+P G + V ++ + P
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEF 421
+ + + +++ L+ PE R ++ ++ +
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 193 bits (491), Expect = 3e-56
Identities = 84/400 (21%), Positives = 153/400 (38%), Gaps = 77/400 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREII----ILRR 191
+ F IG+G + VY R + K+ A+K + + + +A ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
D P I+ + + L + + M + F+EA ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLL 311
H H+R +++RD+K +N+L+D +G ++I D GLA F + + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 312 GSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371
Y +S D +S GC+L +L G ++ H+I ++ + + E
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-----GTASSALQNEFFTTKP 426
SLL+ LL + R A ++ FF +
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF--RS 270
Query: 427 LPCDPSSLPKYPP-----------SKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKA 475
L L KYPP + FD+ D++ ++K
Sbjct: 271 LDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEE--------------------DTKG 310
Query: 476 VPAPDANAEL----QTSIQKRQNQSNPKATSEQFNSDEDS 511
+ D++ EL +I +R Q + + N++ D
Sbjct: 311 IKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDR 350
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-56
Identities = 68/309 (22%), Positives = 116/309 (37%), Gaps = 50/309 (16%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM----DPESVRFMAREIIILR 190
++ +G G + SVY + +N VA+K V + + + + E+++L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 191 RLD--HPNIMKLEGLITSRVSGSLYLVFEYME--HDLAGLAATPGVKFTEAQIKCYMKQL 246
++ +++L S L+ E E DL G E + + Q+
Sbjct: 63 KVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQV 119
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
L + HCH+ G+LHRDIK N+LID N G LK+ DFG K + T T Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYS 176
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PPE + +G S +WS G +L ++ G E+ + F+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------ 224
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425
+ + S L+ L+ P R T + +
Sbjct: 225 -----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 426 PLPCDPSSL 434
LP + + +
Sbjct: 262 LLPQETAEI 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-55
Identities = 66/300 (22%), Positives = 124/300 (41%), Gaps = 44/300 (14%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIII 188
W VPR ++ + ++++G G + V+ + VA+K ++ +M P++ E +
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL---AEANL 61
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG--LAATPGVKFTEAQIKCYMKQL 246
+++L H +++L ++T +Y++ EYME+ L G+K T ++ Q+
Sbjct: 62 MKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
G+ R +HRD++ +N+L+ KI DFGLA + ++ + +
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PE + T + D+WS G +L E+ G+ PG T E + + + R
Sbjct: 179 PEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------GYR 228
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ--NEFFT 423
P + P L+ + PE R T +FFT
Sbjct: 229 MVRP-------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 72/373 (19%), Positives = 132/373 (35%), Gaps = 62/373 (16%)
Query: 136 DSFEKLDK-IGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-D 193
D ++ + +G G V + + + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 194 HPNIMKLEGLITSRVSG--SLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQLLHG 249
P+I+++ + + +G L +V E ++ +L + FTE + MK +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 250 LEHCHSRGILHRDIKGSNLLID---YNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
+++ HS I HRD+K NLL N ILK+ DFG A + T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
PE+L Y S D+WS G I+ L G P + + E+
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-- 238
Query: 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT-TK 425
+ ++ L+ LL TEP R T + + + + +
Sbjct: 239 -------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
Query: 426 PLPCDPSSLPKYPPSKEFDVKLRDDDRRRGGGGKGRGLESIRKAGKESKAVPAPDANAEL 485
+P P + + + ++ ++ + +
Sbjct: 280 KVPQTPLHTSRVLKEDKERWEDVKEEMT----------SALATMRVDYE----------- 318
Query: 486 QTSIQKRQNQSNP 498
Q I+K ++ SNP
Sbjct: 319 QIKIKKIEDASNP 331
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 187 bits (477), Expect = 9e-55
Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 42/293 (14%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
F+ L +G G++ V+ R N + A+K ++ + + V E ++L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
P I+++ G ++++ +Y+E +F K Y ++ LE+ H
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S+ I++RD+K N+L+D NG +KI DFG A + + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKP 177
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
Y S+D WS G ++ E+ AG ++ KI
Sbjct: 178 -YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------------------A 216
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-----GTASSALQNEFF 422
+ + P LL L++ + R + +F
Sbjct: 217 ELRFP---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 36/290 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVR--FTNMDPESVRFMAREIIILRRLD 193
+ F +G+G++ V+ A + N+ A+K ++ MD + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 194 HPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
HP + + ++ +L+ V EY+ KF ++ Y +++ GL+
Sbjct: 62 HPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
HS+GI++RD+K N+L+D +G +KI DFG+ + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ 178
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y SVD WS G +L E+ G+ G+ E E H I
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------------- 217
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSA-LQNEFF 422
P P + + A LL L EPE R Q+ F
Sbjct: 218 DNPFYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 39/293 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDH 194
+ F+ L +G+GT+ V R+ + A+K +R + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 195 PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
P + L+ + L V EY + FTE + + Y +++ LE+ H
Sbjct: 65 PFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
SR +++RDIK NL++D +G +KI DFGL S + + T Y PE+L +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDN- 180
Query: 315 DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374
DYG +VD W G ++ E+ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------E 220
Query: 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-----GTASSALQNEFF 422
+ + P + + A SLL LL +P+ R A +++ FF
Sbjct: 221 EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-53
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 41/303 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+S K+GQG + V+ VA+K ++ M PE+ +E ++++L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEHDLAGLA--ATPGVKFTEAQIKCYMKQLLHGLEHC 253
+++L +++ +Y+V EYM G Q+ Q+ G+ +
Sbjct: 73 KLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
+HRD++ +N+L+ N + K+ DFGLA + ++ + + PE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 314 TDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372
+ D+WS G +L EL G+ PG E L ++ +
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------- 229
Query: 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ--NEFFTTKPLPCD 430
++ P + P S L+ EPE R T ++FT+
Sbjct: 230 GYRMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
Query: 431 PSS 433
P
Sbjct: 281 PGE 283
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-53
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 37/290 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNK---LVALKKVRFTNM-DPESVRFMAREIIILRR 191
L+K+G G++ V + + VA+K ++ + PE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGL 250
LDH N+++L G++ + + +V E L F + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPEL 309
+ S+ +HRD+ NLL+ ++KIGDFGL + + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 310 LLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
L + + + D W G L E+F G+ G + LHKI K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------------- 229
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+ +P +D P +++ + +PE R T +
Sbjct: 230 ---EGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (456), Expect = 5e-52
Identities = 58/323 (17%), Positives = 107/323 (33%), Gaps = 41/323 (12%)
Query: 133 RKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRL 192
R + + KIG G++ +Y D+ + VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEH 252
+ + +V E + L L KF+ + Q++ +E+
Sbjct: 60 QGGVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 253 CHSRGILHRDIKGSNLLI---DYNGILKIGDFGLANFFK------CSQKQPLTSRVVTLW 303
HS+ +HRD+K N L+ ++ I DFGLA ++ + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 304 YRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363
Y LG + DL S G +L G G + K ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229
Query: 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ--NEF 421
++ + K PS + L+ S + + S Q
Sbjct: 230 -------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 422 FTTKPLPCDPS---SLPKYPPSK 441
F + D ++ K+ S+
Sbjct: 277 FHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-52
Identities = 54/294 (18%), Positives = 109/294 (37%), Gaps = 46/294 (15%)
Query: 129 GW-VPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREII 187
GW + + L IG+G + V VA+K ++ + + + E
Sbjct: 1 GWALNM--KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEAS 52
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAG-LAATPGVKFTEAQIKCYMKQ 245
++ +L H N+++L G+I G LY+V EYM L L + + +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYR 305
+ +E+ +HRD+ N+L+ + + K+ DFGL +Q + + + +
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE L + D+WS G +L E+++ G+ P + + ++ K
Sbjct: 168 APEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+K P P + ++ + +R + +
Sbjct: 216 --------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 9e-52
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 37/285 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
+ +IG G + V+ L N VA+K +R M E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
+++L G+ + LVFE+MEH L+ T F + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
++HRD+ N L+ N ++K+ DFG+ F Q T + + PE+ S
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS- 177
Query: 315 DYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
Y + D+WS G ++ E+F+ GK R+ E + I +T
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STG 218
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
F+ +P + + +++ PE R S L+
Sbjct: 219 FRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 56/286 (19%), Positives = 110/286 (38%), Gaps = 37/286 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
L ++G G + V + VA+K ++ +M + E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH 254
+++L G+ T ++++ EYM + L +F Q+ K + +E+
Sbjct: 60 KLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 255 SRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGST 314
S+ LHRD+ N L++ G++K+ DFGL+ + + + + PPE+L+ S
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS- 176
Query: 315 DYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
+ + D+W+ G ++ E+++ GK T E I + R PH
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------GLRLYRPH--- 224
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419
+++ + + R T L N
Sbjct: 225 ----------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-50
Identities = 59/301 (19%), Positives = 118/301 (39%), Gaps = 41/301 (13%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKA--RDLENNKLVALKKVRFTNMDPESVRFMAREII 187
++ RK + E ++G G + +V K + + K VA+K ++ DP + E
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLL 247
++++LD+P I+++ G+ + S LV E E + I + Q+
Sbjct: 61 VMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 248 HGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK--CSQKQPLTSRVVTLWYR 305
G+++ +HRD+ N+L+ KI DFGL+ + + + T + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364
PE + + + D+WS G ++ E F+ G+ G E + K +
Sbjct: 178 APECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------GE 227
Query: 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS---ALQNEF 421
R P P L+++ + + E R ++ L+N +
Sbjct: 228 RMGCP-------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 422 F 422
+
Sbjct: 269 Y 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 73/328 (22%), Positives = 137/328 (41%), Gaps = 43/328 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILR 190
++FE L +G G Y V+ R + + KL A+K ++ + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 191 RLDH-PNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+ P ++ L + L+L+ +Y+ + +FTE +++ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPEL 309
LEH H GI++RDIK N+L+D NG + + DFGL+ F + + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 310 LLGS-TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
+ G + + +VD WS G ++ EL G E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVR-----GTASSALQNEFFT 423
+++ + A L+ LL +P+ R A ++ FF
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF- 295
Query: 424 TKPLPCDPSSLPKYPPSKEFDVKLRDDD 451
+ + D + K P F +RD+
Sbjct: 296 -QKINWDDLAAKKVPAP--FKPVIRDEL 320
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (444), Expect = 2e-50
Identities = 47/293 (16%), Positives = 94/293 (32%), Gaps = 40/293 (13%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH-PN 196
++ +IG+G++ +++ +L NN+ VA+K + P+ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 197 IMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSR 256
I + LV + + L L G KF+ + KQ+L ++ H +
Sbjct: 63 IPNVYYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 257 GILHRDIKGSNLLID-----YNGILKIGDFGLANFF------KCSQKQPLTSRVVTLWYR 305
+++RDIK N LI ++ + DFG+ F+ + + + T Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 306 PPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
LG + DL + G + G G K ++
Sbjct: 181 SINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG---------- 229
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
++ + E P + + +
Sbjct: 230 -----------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-50
Identities = 60/293 (20%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREII 187
+ R + E IG+G + V++ + VA+K + D +F+ +E +
Sbjct: 4 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 60
Query: 188 ILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQL 246
+R+ DHP+I+KL G+IT ++++ E +L A + Y QL
Sbjct: 61 TMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 247 LHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRP 306
L + S+ +HRDI N+L+ N +K+GDFGL+ + + S + + + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 307 PELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365
PE + + ++ D+W G + E+ G G + + +I +R
Sbjct: 178 PESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GER 227
Query: 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+P + P + SL+ + +P R +
Sbjct: 228 LPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 7e-50
Identities = 61/308 (19%), Positives = 124/308 (40%), Gaps = 45/308 (14%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRL 192
+ IG G + V K VA+K ++ + + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
DHPN++ LEG++T S + ++ E+ME+ L +FT Q+ ++ + G++
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV----TLWYRPP 307
+ +HRD+ N+L++ N + K+ DFGL+ F + P + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
E + + ++ D+WS G ++ E+ + G+ T + ++ I +
Sbjct: 203 EAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------------- 248
Query: 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426
++ P D PS+ L+ + R + T
Sbjct: 249 ------DYRLPPP---------MDCPSALHQLMLDCWQKDRNHRPKFGQIVN----TLDK 289
Query: 427 LPCDPSSL 434
+ +P+SL
Sbjct: 290 MIRNPNSL 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (438), Expect = 1e-49
Identities = 51/285 (17%), Positives = 109/285 (38%), Gaps = 35/285 (12%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHP 195
K+G G Y VY+ + + VA+K ++ M+ E +E +++ + HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 196 NIMKLEGLITSRVSGSLYLVFEYMEH--DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHC 253
N+++L G+ T Y++ E+M + L L + + + Q+ +E+
Sbjct: 74 NLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 254 HSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGS 313
+ +HRD+ N L+ N ++K+ DFGL+ + + PE L +
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 314 TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
+ D+W+ G +L E+ ++ Q++++ +
Sbjct: 192 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------------KD 232
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
++ ++P + P L+ P R + + Q
Sbjct: 233 YRMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (438), Expect = 6e-49
Identities = 59/301 (19%), Positives = 113/301 (37%), Gaps = 42/301 (13%)
Query: 130 WVPRKADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIII 188
+ D F+++ +G G++ V + E+ A+K + + + + E I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 189 LRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLH 248
L+ ++ P ++KLE + + + + + L +F+E + Y Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVL 152
Query: 249 GLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPE 308
E+ HS +++RD+K NLLID G +++ DFG A K + T PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPE 208
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
++L Y +VD W+ G ++ E+ AG P ++ KI
Sbjct: 209 IILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH------- 260
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPE-----VRGTASSALQNEFFT 423
S LL LL + ++ + +++F
Sbjct: 261 ----------------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 424 T 424
T
Sbjct: 299 T 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-49
Identities = 57/300 (19%), Positives = 110/300 (36%), Gaps = 43/300 (14%)
Query: 134 KADSFEKLD-KIGQGTYSSVYKARDLENNK--LVALKKVRFTNMDPESVRFMAREIIILR 190
K D+ D ++G G + SV + K VA+K ++ ++ M RE I+
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMH 64
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+LD+P I++L G+ + +L LV E L + + + + Q+ G
Sbjct: 65 QLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV--TLWYRPP 307
+++ + +HRD+ N+L+ KI DFGL+ L + P
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 308 ELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366
E + + + D+WS G + E + G+ E + I + KR
Sbjct: 182 ECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRM 231
Query: 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS---ALQNEFFT 423
+ P + P +L+ + E R + ++ +++
Sbjct: 232 ECP-------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-48
Identities = 67/314 (21%), Positives = 114/314 (36%), Gaps = 62/314 (19%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKL-----VALKKVRFTNMDPESVRFMAREIIILR 190
++ E +G G + V A +K VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 191 RL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKF-------------- 234
+L H NI+ L G T SG +YL+FEY + DL + KF
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 235 --------TEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286
T + C+ Q+ G+E + +HRD+ N+L+ + ++KI DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 287 FKCSQKQPL-TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTE 344
+ + + + + PE L Y D+WS G +L E+F+ G PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 345 VEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLS 404
+K+ + FK QP ++ +
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 405 TEPEVRGTASSALQ 418
+ R + +
Sbjct: 306 FDSRKRPSFPNLTS 319
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (432), Expect = 6e-48
Identities = 75/342 (21%), Positives = 133/342 (38%), Gaps = 51/342 (14%)
Query: 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNI 197
+ + K+G G +S+V+ A+D+ NN VA+K VR + E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 198 MKLEGLITSRVSGSLYLVFEYMEHD---------------LAGLAATPGVKFTEAQIKCY 242
K + + + + L F + + LA + +K
Sbjct: 72 TKEDSMGANHIL-KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 243 MKQLLHGLEHC-HSRGILHRDIKGSNLLIDYNGI------LKIGDFGLANFFKCSQKQPL 295
KQLL GL++ GI+H DIK N+L++ +KI D G A ++ +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT------EVEQLH 349
+R YR PE+LLG+ +G D+WS+ C++ EL G + + + +
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 350 KIFKLCGSPSEEYWKRSKLPHATI-------------FKPQQPYKRCVAETFKDIPSSAL 396
+I +L G + K F P + + KD
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 397 SLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPKYP 438
L +L +P R A + + + L + +P
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRE 346
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (425), Expect = 1e-47
Identities = 66/318 (20%), Positives = 115/318 (36%), Gaps = 63/318 (19%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKAR-----DLENNKLVALKKVRFTNMDPESVRFMARE 185
PR ++ E + IG+G + V++AR E +VA+K ++ F RE
Sbjct: 10 YPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 66
Query: 186 IIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGL------------------ 226
++ D+PNI+KL G V + L+FEYM + DL
Sbjct: 67 AALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 227 -----AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281
++ + A+ C +Q+ G+ + R +HRD+ N L+ N ++KI DF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMP 340
GL+ + P + Y D+W+ G +L E+F+ G
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 341 GRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLD 400
G E ++ + P ++ P +L+
Sbjct: 245 GMAHEEVIYYVRD---------GNILACP-------------------ENCPLELYNLMR 276
Query: 401 ILLSTEPEVRGTASSALQ 418
+ S P R + S +
Sbjct: 277 LCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 57/330 (17%), Positives = 110/330 (33%), Gaps = 44/330 (13%)
Query: 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALK---KVRFTNMDPESVRFMAREIIILR 190
K F+K+ +G G + +VYK + + V + K P++ + + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 191 RLDHPNIMKLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHG 249
+D+P++ +L G+ + ++ L+ + M L + + Q+ G
Sbjct: 67 SVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 250 LEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSRVV-TLWYRPPE 308
+ + R ++HRD+ N+L+ +KI DFGLA +K+ + + E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 309 LLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367
+L Y D+WS G + EL G G E + K +R
Sbjct: 184 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---------GERLP 233
Query: 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN-EFFTTKP 426
P ++ + + R + P
Sbjct: 234 QP-------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 427 ---LPCDPSSLPKYPPSKE--FDVKLRDDD 451
L P + F L D++
Sbjct: 275 QRYLVIQGDERMHLPSPTDSNFYRALMDEE 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 39/285 (13%)
Query: 142 DKIGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIM 198
+ IG+G + VY L+N+ A+K + E +F+ E II++ HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 199 KLEGLITSRVSGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG 257
L G I R GS +V YM+H DL T + + Q+ G++ S+
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 258 ILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL---TSRVVTLWYRPPELLLGST 314
+HRD+ N ++D +K+ DFGLA + + T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 315 DYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373
+ D+WS G +L EL G P P + + + +R P
Sbjct: 211 -FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP---- 256
Query: 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
+ P ++ + E+R + S +
Sbjct: 257 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 63/301 (20%), Positives = 102/301 (33%), Gaps = 29/301 (9%)
Query: 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH 194
A + + IG+G + V++ + + VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 195 PNIMKLEGLITSR--VSGSLYLVFEYMEH-DLA------GLAATPGVKFTEAQIKCYMKQ 245
NI+ L+LV +Y EH L + +K +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 246 LLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ---PLTSRVVTL 302
+ + I HRD+K N+L+ NG I D GLA + RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 303 WYRPPELLLGS-----TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357
Y PE+L S + D+++ G + E+ I G E QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSD 235
Query: 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSAL 417
PS E ++ +P P + E + + ++ R TA
Sbjct: 236 PSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIK 289
Query: 418 Q 418
+
Sbjct: 290 K 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 61/313 (19%), Positives = 104/313 (33%), Gaps = 57/313 (18%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMARE 185
PR + +G G + V +A + VA+K ++ + E M E
Sbjct: 20 FPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SE 76
Query: 186 IIILRRL-DHPNIMKLEGLITSRVSGSLYLVFEYMEH------------------DLAGL 226
+ +L L +H NI+ L G T G ++ EY + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 227 AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286
+ + + Q+ G+ S+ +HRD+ N+L+ + I KI DFGLA
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 287 FKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEV 345
K + + + Y D+WS G L ELF+ G PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST 405
+ +K+ K F+ P + P+ ++
Sbjct: 255 SKFYKMIK------------------EGFRMLSP---------EHAPAEMYDIMKTCWDA 287
Query: 406 EPEVRGTASSALQ 418
+P R T +Q
Sbjct: 288 DPLKRPTFKQIVQ 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 67/324 (20%), Positives = 123/324 (37%), Gaps = 56/324 (17%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENNKL--VALKKVRFTNMDPESVRFMAREIIILRRL- 192
+ + D IG+G + V KAR ++ A+K+++ + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 193 DHPNIMKLEGLITSRVSGSLYLVFEYMEH----------------DLAGLAATPGVKFTE 236
HPNI+ L G R G LYL EY H +A + +
Sbjct: 69 HHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 237 AQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLT 296
Q+ + + G+++ + +HRD+ N+L+ N + KI DFGL+ + K+ T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 297 SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLC 355
+ + + E L S Y + D+WS G +L E+ + G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 356 GSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS 415
++ ++P + L+ +P R + +
Sbjct: 242 -----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 416 ALQ--NEFFTTKPLPCDPSSLPKY 437
L N + + + K+
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 57/290 (19%), Positives = 113/290 (38%), Gaps = 38/290 (13%)
Query: 136 DSFEKLDKIGQGTYSSVYKARDLENN----KLVALKKVRFTNMDPESVRFMAREIIILRR 191
+ IG G + VYK ++ VA+K ++ + + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 192 LDHPNIMKLEGLITSRVSGSLYLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGL 250
H NI++LEG+I+ + ++ EYME+ +F+ Q+ ++ + G+
Sbjct: 66 FSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 251 EHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTS--RVVTLWYRPPE 308
++ + +HRD+ N+L++ N + K+ DFGL+ + + T+ + + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 309 LLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368
+ AS D+WS G ++ E+ ++ K
Sbjct: 184 AISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227
Query: 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418
F+ P D PS+ L+ E R + +
Sbjct: 228 ---DGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-42
Identities = 64/313 (20%), Positives = 103/313 (32%), Gaps = 55/313 (17%)
Query: 130 W-VPRKADSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKVRFTNMDPESVRFMA 183
W PR D + +G+G + V +A + VA+K ++ E M+
Sbjct: 8 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 184 REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEHDL----------------AGLA 227
I++ H N++ L G T G L ++ E+ +
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 228 ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287
T + CY Q+ G+E SR +HRD+ N+L+ ++KI DFGLA
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 288 KCSQKQPLTSRVV-TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEV 345
L + PE + Y D+WS G +L E+F+ PG
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 346 EQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLST 405
E+ + K R + P +
Sbjct: 244 EEFCRRLK--------EGTRMRAP-------------------DYTTPEMYQTMLDCWHG 276
Query: 406 EPEVRGTASSALQ 418
EP R T S ++
Sbjct: 277 EPSQRPTFSELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-41
Identities = 60/312 (19%), Positives = 110/312 (35%), Gaps = 56/312 (17%)
Query: 131 VPRKADSFEKLDKIGQGTYSSVYKARDLENNK-------LVALKKVRFTNMDPESVRFMA 183
+PR D +G+G + V A + +K VA+K ++ + + ++
Sbjct: 10 LPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 67
Query: 184 REIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYMEH----------------DLAGLA 227
++ H NI+ L G T G LY++ EY +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 228 ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287
P + + + Q+ G+E+ S+ +HRD+ N+L+ + ++KI DFGLA
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 288 KCSQKQPLT-SRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE 346
T + + + + PE L Y D+WS G +L E+F VE
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244
Query: 347 QLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTE 406
+L K+ K + +P + + ++
Sbjct: 245 ELFKLLK------------------EGHRMDKP---------SNCTNELYMMMRDCWHAV 277
Query: 407 PEVRGTASSALQ 418
P R T ++
Sbjct: 278 PSQRPTFKQLVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 50/321 (15%), Positives = 113/321 (35%), Gaps = 52/321 (16%)
Query: 116 PSWLTAVAGEAINGW-VPRKADSFEKLDKIGQGTYSSVYKARD-----LENNKLVALKKV 169
P + +A + W V R + ++GQG++ VY+ E VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58
Query: 170 RFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYME--------- 220
E + F+ E +++ + ++++L G+++ ++ E M
Sbjct: 59 NEAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLR 115
Query: 221 -HDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIG 279
A + +++ ++ G+ + ++ +HRD+ N ++ + +KIG
Sbjct: 116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175
Query: 280 DFGLANFFKCSQKQPLTSRVV-TLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KP 337
DFG+ + + + + + PE L + D+WS G +L E+ +
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQ 234
Query: 338 IMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALS 397
G + + L + + P + P
Sbjct: 235 PYQGLSNEQVLRFVME---------GGLLDKP-------------------DNCPDMLFE 266
Query: 398 LLDILLSTEPEVRGTASSALQ 418
L+ + P++R + +
Sbjct: 267 LMRMCWQYNPKMRPSFLEIIS 287
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 107 bits (269), Expect = 1e-27
Identities = 32/203 (15%), Positives = 69/203 (33%), Gaps = 30/203 (14%)
Query: 142 DKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFM--------AREIIILRRLD 193
+G+G S+V+ E +K + + + V+ + I R +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 194 HPNIMKLEGLITSRV--SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLE 251
+ KL+GL +V ++ E ++ + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 252 HCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPLTSR---VVTLWYRPPE 308
+ RGI+H D+ N+L+ GI I DF + + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 309 LLLGSTDYGASVDLWSSGCILAE 331
Y D+ S+ + +
Sbjct: 174 -----RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.16 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=447.05 Aligned_cols=294 Identities=40% Similarity=0.677 Sum_probs=250.8
Q ss_pred EEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 79736511696489999995899399999950479997---889999999999993899971025424763058939999
Q 005582 139 EKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP---ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 139 ~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
+.+++||+|+||+||+|++..+|+.||||+++...... .....+.+|+.+|+.++|||||++++++.. .+.+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCEEEH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225--8740220
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 94242133565408999889999999999999999999968985445777662550589347601465322346899986
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
|||+.++++..+......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+... ....
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCC
T ss_pred HHHHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC-CCCC
T ss_conf 455345077655412667789999999999999998863163550357762588537784114657610005787-5543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCCCC
Q ss_conf 44545666769833339989998311443046899998389999999949999999987099995675315899666568
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~~ 375 (690)
...++|++|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++.+|++.+|.|+.+.|............
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred CCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHH
T ss_conf 30204733363999726778880564363042899998596999999999999999985189972545210002134430
Q ss_pred CCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 9885101122111799545999999962479898899998862947899999999999999
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSLPK 436 (690)
Q Consensus 376 ~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~~~p~~lp~ 436 (690)
...+ ...+...+..+++.+++||.+||++||.+||||.|+|+||||++.|.|+.++.+|+
T Consensus 238 ~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 238 KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred CCCC-CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCCCCCCC
T ss_conf 3478-98867856568999999999976389456908999967996578999989888999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=425.10 Aligned_cols=290 Identities=39% Similarity=0.679 Sum_probs=246.5
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|++++.||+|+||+||+|.+..+++.||||+++...........+.+|+.+|+.++|||||++++++.+ .+.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322--4320378
Q ss_pred EECCCCCHHHHH-CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 942421335654-0899988999999999999999999996898544577766255058934760146532234689998
Q 005582 216 FEYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||+.++++... ......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-~~~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-CSBC
T ss_pred EEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCC-CCCC
T ss_conf 862377445554420256888899999999999999986528899213571140113467621035786134368-8641
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCCC
Q ss_conf 64454566676983333998999831144304689999838999999994999999998709999567531589966656
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~ 374 (690)
....++|+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++.+++...+.+.+..|...........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCC
T ss_conf 00103652154112213665777422103333134279668799898899999999998328983331444222421243
Q ss_pred CCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf 898851011221117995459999999624798988999988629478999999
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 375 ~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~ 428 (690)
.............+..++..+.+||.+||..||.+|||+.|+|+||||++.+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred CCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf 454322220444166789999999999763995579189999678701469999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=424.03 Aligned_cols=268 Identities=24% Similarity=0.376 Sum_probs=229.8
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEE
T ss_conf 657589889840768199999988999899999984524--3169999999999986799799929999998--999999
Q ss_pred EEECCCCCH-HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC--CCCEEEECCCCCCCCCCCC
Q ss_conf 994242133-5654089998899999999999999999999689854457776625505--8934760146532234689
Q 005582 215 VFEYMEHDL-AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY--NGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 215 V~Ey~~g~L-l~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~--~g~vKL~DFGlA~~~~~~~ 291 (690)
|||||+++. ...+......+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|..+..
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred EEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC--
T ss_conf 998579988999997623789999999999999999999975697600015467364168898699954521044256--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 99864454566676983333998999831144304689999838999999994999999998709999567531589966
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++...
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 248 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA--------- 248 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG---------
T ss_pred CCCCCEECCCCCCCCHHHHCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------
T ss_conf 543200068624218899758-9987267655465999999859899899799999999984788989422---------
Q ss_pred CCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 656898851011221117995459999999624798988999988629478999999999999
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCDPSSL 434 (690)
Q Consensus 372 ~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~~~p~~l 434 (690)
+..+++.+.+||.+||..||.+|||++|+|+||||+....+..+..+
T Consensus 249 ----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~ 295 (350)
T d1koaa2 249 ----------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295 (350)
T ss_dssp ----------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred ----------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCCCCCHHHC
T ss_conf ----------------35899999999999756896679089998629132889888754238
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=425.48 Aligned_cols=262 Identities=29% Similarity=0.419 Sum_probs=220.8
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 89980797365116964899999958993999999504799978899999999999938999710254247630589399
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
..++|++++.||+|+||+||+|.++.+++.||||++..... .+....+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ 79 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQY 79 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEEE
T ss_conf 87460899897217480999999999997999999845664-1279999999999985799888469654046--74367
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC-
Q ss_conf 9994242133565408999889999999999999999999968985445777662550589347601465322346899-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~- 292 (690)
|||||++++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 98864589808999753799999999999999999999999759835754689978878998798323142240468865
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCC
Q ss_conf 98644545666769833339989998311443046899998389999999949999999987099995675315899666
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~ 372 (690)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+.......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC--------------
T ss_conf 311132557474287286189999971016173799999982997888898599999998638887--------------
Q ss_pred CCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 5689885101122111799545999999962479898899998862947899
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 373 ~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~ 424 (690)
...+..+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 226 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf ------------8864469999999999976799668909999961984585
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=420.20 Aligned_cols=297 Identities=44% Similarity=0.713 Sum_probs=246.2
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-----
Q ss_conf 899807973651169648999999589939999995047999788999999999999389997102542476305-----
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----- 208 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----- 208 (690)
..++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 62798899997227482999999989997999999842224637899999999999983599966067654024654444
Q ss_pred -CCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf -8939999942421335654089998899999999999999999999689854457776625505893476014653223
Q 005582 209 -SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFF 287 (690)
Q Consensus 209 -~~~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~ 287 (690)
.+.+|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEEC
T ss_conf 57638999853578741012220344330899999999999998852299885676722203668996876313500223
Q ss_pred CCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHH
Q ss_conf 4689---9986445456667698333399899983114430468999983899999999499999999870999956753
Q 005582 288 KCSQ---KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 288 ~~~~---~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~ 364 (690)
.... .......++|++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+.+..+....+.++.+.+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCC
T ss_conf 55444321135660249787428997079998917870067864661744879989989999999999841899825534
Q ss_pred HCCCCCCCC-CCCCCCCCHHHHHHC--CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf 158996665-689885101122111--799545999999962479898899998862947899999999
Q 005582 365 RSKLPHATI-FKPQQPYKRCVAETF--KDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430 (690)
Q Consensus 365 ~~~~~~~~~-~~~~~p~~~~~~~~~--~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~~~ 430 (690)
......... ............+.+ ...++.+++||.+||++||++|+||.|+|+||||+..|.|.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred CCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf 432034443320133445550334044459989999999987389658909999974950156999978
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=420.79 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=225.9
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.+.|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|+.++|||||+++++|.+ .+.+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEE
T ss_conf 403599899931778299999998999799999988726--4679999999999986799798919999998--999999
Q ss_pred EEECCCCCHH-HHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC--CCCCEEEECCCCCCCCCCCC
Q ss_conf 9942421335-65408999889999999999999999999968985445777662550--58934760146532234689
Q 005582 215 VFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID--YNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 215 V~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid--~~g~vKL~DFGlA~~~~~~~ 291 (690)
|||||+++.+ ..+......|++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|..+..
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred EEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC--
T ss_conf 998289980888898638998999999999999999999997792651314455311346788489952563034378--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 99864454566676983333998999831144304689999838999999994999999998709999567531589966
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
.......++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 251 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA--------- 251 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST---------
T ss_pred CCCEEECCCCCCCCCHHHHCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------
T ss_conf 872010047645348999747-9989763338989999999968899899799999999984788989300---------
Q ss_pred CCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 656898851011221117995459999999624798988999988629478999
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
+..+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 252 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 ----------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf ----------------24799999999999756996689189999609734888
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=418.53 Aligned_cols=290 Identities=33% Similarity=0.524 Sum_probs=244.9
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----CC
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305----89
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|+++++||+|+||+||+|.+..+|+.||||+++...........+.+|+.+|+.++|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 39999942421335654089998899999999999999999999689854457776625505893476014653223468
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
.+||||||++.++...... ..|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~-- 172 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-- 172 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEEECCCCCHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECCC--
T ss_conf 5999984055218999874--022699999999999999999873787645668511112100122113431022068--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCC
Q ss_conf 99986445456667698333399899983114430468999983899999999499999999870999956753158996
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~ 370 (690)
...+..++|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.++|.......
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred --CCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHH
T ss_conf --763102455333588998178789965010300389999997869988897689999998503788488886530003
Q ss_pred CCCCC--CCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf 66568--9885101122111799545999999962479898899998862947899999999
Q 005582 371 ATIFK--PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430 (690)
Q Consensus 371 ~~~~~--~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~~~ 430 (690)
..... ........+...+..+++.+++||.+||.+||.+||||.|+|+||||+....+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf 44331157866655667755689999999999977299557929999963962375877664
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=415.54 Aligned_cols=281 Identities=36% Similarity=0.552 Sum_probs=235.3
Q ss_pred CCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC----CCCEE
Q ss_conf 80797365116964899999958993999999504799978899999999999938999710254247630----58939
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR----VSGSL 212 (690)
Q Consensus 137 ~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~~l 212 (690)
+|..+++||+|+||+||+|++..+++.||||++...... ..+|+.+|+.++||||++++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 767516982176839999999999979999998816068------99999999866898987387899744765773189
Q ss_pred EEEEECCCCCHHHHH---CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEEECCCCCCCCC
Q ss_conf 999942421335654---08999889999999999999999999968985445777662550589-34760146532234
Q 005582 213 YLVFEYMEHDLAGLA---ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFK 288 (690)
Q Consensus 213 yLV~Ey~~g~Ll~~~---~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g-~vKL~DFGlA~~~~ 288 (690)
|||||||++++...+ ......+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCC
T ss_conf 99984168860788886310368999999999999999999999866876457886037873589711673366054404
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCC
Q ss_conf 68999864454566676983333998999831144304689999838999999994999999998709999567531589
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~ 368 (690)
. .......++|+.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+++.+|++.+|.+..+.|.....
T Consensus 175 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 R--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp T--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred C--CCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 7--76532002555556827764046888210002465277855028799898799999999999748981776543062
Q ss_pred CCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 966656898851011221117995459999999624798988999988629478999
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
.......+..............+++.+.+||.+||.+||.+||||.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 101103554456744443156899999999999765895579299999669845246
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.92 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=221.7
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|+++++||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+ .+.+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEEE
T ss_conf 0538878981285829999999899989999998430172--79999999999986799988058577988--9998999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 94242133565408999889999999999999999999968985445777662550589347601465322346899986
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||||+++.+..+...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... ....
T Consensus 96 mEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCCB
T ss_pred EEECCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC-CCCC
T ss_conf 9703798089886415-9999999999999999999999879722677688868878996864251564132136-6644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCCCC
Q ss_conf 44545666769833339989998311443046899998389999999949999999987099995675315899666568
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~~ 375 (690)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..... +..
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~--------------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PEL--------------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCC---------------
T ss_pred CCCCCCCCCCCHHHHCC-CCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-CCC---------------
T ss_conf 44444777368266447-9988012031372999998048899899799999999985799-988---------------
Q ss_pred CCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 9885101122111799545999999962479898899998862947899
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~ 424 (690)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf ----------885537999999999986699668909999964996577
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.35 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=224.4
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 9980797365116964899999958993999999504799-978899999999999938999710254247630589399
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
.++|++++.||+|+||.||+|++..+++.||||++++... .......+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCCC
T ss_conf 4742898898317684999999989998999999815654497999999999999986799988778764035--64211
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99942421335654089998899999999999999999999689854457776625505893476014653223468999
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+|||||.++.+.........+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC-CC
T ss_conf 10003579860555532567759999999999965211343159622464777847658998888205652003567-86
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCC
Q ss_conf 86445456667698333399899983114430468999983899999999499999999870999956753158996665
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~ 373 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~----------------- 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred CCCCCEECHHHHHHHHCCC-CCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC-----------------
T ss_conf 2055100889966665048-9888333102230678899878999999699999999852899-----------------
Q ss_pred CCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 68988510112211179954599999996247989889-----99988629478999
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRp-----Ta~eiL~Hpwf~~~ 425 (690)
..+..+++.+.+||.+||++||.+|+ +++++|+||||...
T Consensus 223 ------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf ------------898668999999998666389344225652349999729150369
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=426.79 Aligned_cols=284 Identities=24% Similarity=0.334 Sum_probs=220.3
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 89980797365116964899999958993999999504799978899999999999938999710254247630589399
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
..++|+++++||+|+||.||+|++..+++.||+|+++... .......+.+|+.+|+.++|||||+++++|.+ ...+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEE
T ss_conf 7568889789712778099999998999699999987540-97899999999999986799999949999998--99999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 999424213356540899988999999999999999999996-8985445777662550589347601465322346899
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|||||+.++.+..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC--
T ss_conf 999767998689987424999999999999999999999998599971445779946878998999548776256788--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCHHHHHHC----C
Q ss_conf 986445456667698333399899983114430468999983899999999499-99999987099995675315----8
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKRS----K 367 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e-~l~kI~~~~G~p~~e~~~~~----~ 367 (690)
...+.+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+..+ ....+....+.+........ .
T Consensus 159 -~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CCCCCCCCCCCCCCHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf -6211137714119468758-99894888998999999999888998998878999999887517754577421233322
Q ss_pred CCC-CCCCCCCCCCCHHH----HHH-----CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 996-66568988510112----211-----1799545999999962479898899998862947899
Q 005582 368 LPH-ATIFKPQQPYKRCV----AET-----FKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 368 ~~~-~~~~~~~~p~~~~~----~~~-----~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~ 424 (690)
... .....+........ ... ...++.++.+||.+||++||.+||||+|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 1111222354134778876650268766764448999999999986899467908999960986476
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=417.13 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=222.6
Q ss_pred CCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 807973651169648999999589939999995047999-7889999999999993899971025424763058939999
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
.|+.++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++|||||++++++.+ .+.+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998--9988999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 94242133565408999889999999999999999999968985445777662550589347601465322346899986
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
||||.++++.........+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC-----C
T ss_conf 98069994578997379999999999999999999999868976667884217987999789844365334677-----8
Q ss_pred CCCCCCCCCCCCCCCCCC--CCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCC
Q ss_conf 445456667698333399--899983114430468999983899999999499999999870999956753158996665
Q 005582 296 TSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~--~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~ 373 (690)
...+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+.+.++......+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 233 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------- 233 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC---------------
T ss_conf 73134766368899834678886721454558999999987889999979999999998289998---------------
Q ss_pred CCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 6898851011221117995459999999624798988999988629478999
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
.....+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 234 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf ------------8878889999999999773796579189999719975378
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=416.30 Aligned_cols=285 Identities=38% Similarity=0.648 Sum_probs=243.4
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|+++++||+|+||+||+|.+. +++.||||+++...........+.+|+.+|+.++||||+++++.+.. .+.+|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CCCEEEE
T ss_conf 99634318722778189999968-99999999981232685899999999999986799868766012046--7731589
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 94242133565408999889999999999999999999968985445777662550589347601465322346899986
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
+||+.++++..+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|...... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCC-CCCC
T ss_conf 974004567899860477514456899999999999860574882678775056868997873236643011467-6541
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCCCC
Q ss_conf 44545666769833339989998311443046899998389999999949999999987099995675315899666568
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFK 375 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~~ 375 (690)
...++++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.+++...+.+....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred CEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 01024311013788717888884100211175899997797998988989999999986389971104212333221433
Q ss_pred CCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 9885101122111799545999999962479898899998862947899
Q 005582 376 PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 376 ~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~ 424 (690)
............+..+++.+.+||.+||++||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 3335676466651258999999999986689668909999856922074
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=418.50 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=221.5
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
+.|++.+.||+|+||+||+|++..+++.||||++....... ....+.+|+.+|+.++|||||++++++.+ .+.+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEEE
T ss_conf 66699889940658399999999999899999981577312-89999999999986799899919899998--9988898
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC---CCCCEEEECCCCCCCCCCCCC
Q ss_conf 94242133565408999889999999999999999999968985445777662550---589347601465322346899
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLID---YNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid---~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC--
T ss_conf 852689848886530367887899999999999987524130556870463001104688824998315435872589--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCC
Q ss_conf 98644545666769833339989998311443046899998389999999949999999987099995675315899666
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~ 372 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|......++.
T Consensus 164 ~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 230 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------ 230 (307)
T ss_dssp ---------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT------------
T ss_pred CEEEEEEECCCCCCCHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC------------
T ss_conf 70440032842259188737-99980787345159999998597999998999999998616877787------------
Q ss_pred CCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 56898851011221117995459999999624798988999988629478999
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 231 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 -------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf -------------6666789999999999760897579189998629844799
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=412.92 Aligned_cols=289 Identities=39% Similarity=0.645 Sum_probs=237.3
Q ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCC-CEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEEC
Q ss_conf 78899807973651169648999999589-93999999504799978899999999999938---999710254247630
Q 005582 132 PRKADSFEKLDKIGQGTYSSVYKARDLEN-NKLVALKKVRFTNMDPESVRFMAREIIILRRL---DHPNIMKLEGLITSR 207 (690)
Q Consensus 132 ~~~~~~Y~~~~~IG~G~fG~Vy~a~~~~~-g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~ 207 (690)
++..++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||++++++|...
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 88758979888992155869999999888998999999802324516799999999999987425898802366322146
Q ss_pred ---CCCEEEEEEECCCCCHHHHH-CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf ---58939999942421335654-08999889999999999999999999968985445777662550589347601465
Q 005582 208 ---VSGSLYLVFEYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGL 283 (690)
Q Consensus 208 ---~~~~lyLV~Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGl 283 (690)
....+|++|||++++++.+. ......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 66667469999974058714444430378999899999999999999999758898357986278985899754210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 32234689998644545666769833339989998311443046899998389999999949999999987099995675
Q 005582 284 ANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 363 (690)
Q Consensus 284 A~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~ 363 (690)
+..... .......+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+++.+|+..++.+....|
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred HHHHCC--CCCCCCCCCCHHHCCCCHHCC-CCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCC
T ss_conf 011002--345777654851148310017-98881110003289999998787998998989999999984079961105
Q ss_pred HHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 31589966656898851011221117995459999999624798988999988629478999
Q 005582 364 KRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 364 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
..........+... ........+..+++.+++||.+||++||.+||||.|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHCCC--CCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 32111103330223--4564544044589999999999874896679189999669634075
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=420.40 Aligned_cols=255 Identities=31% Similarity=0.471 Sum_probs=220.4
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 99807973651169648999999589939999995047999-78899999999999938999710254247630589399
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-PESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEE
T ss_conf 5376998898517785899999989994999999816885676899999999999985688888859999998--99989
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99942421335654089998899999999999999999999689854457776625505893476014653223468999
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
||||||+++.+...+.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---S 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---C
T ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCC---C
T ss_conf 9985047985898875048999999999999999999999988946522023441466899871155563354488---8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCC
Q ss_conf 86445456667698333399899983114430468999983899999999499999999870999956753158996665
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~ 373 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|.+.-..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred CCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC----------------
T ss_conf 5235578876349999758-99893144046759999983299998889999999999718999----------------
Q ss_pred CCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 689885101122111799545999999962479898899998862947899
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTT 424 (690)
Q Consensus 374 ~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~ 424 (690)
....+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 223 -------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf -------------98668999999999976479768909999971907078
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=418.41 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=224.2
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 89980797365116964899999958993999999504799978899999999999938999710254247630589399
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
+.++|++++.||+|+||.||+|+++.+|+.||+|++............+.+|+.+|+.++|||||++++++.+.....+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CCHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 73337996798308891999999999997999999874657979999999999999977899982489999917899899
Q ss_pred EEEECCCCCHHHHHC----CCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 999424213356540----89998899999999999999999999689-----854457776625505893476014653
Q 005582 214 LVFEYMEHDLAGLAA----TPGVKFTEAQIKCYMKQLLHGLEHCHSRG-----ILHRDIKGSNLLIDYNGILKIGDFGLA 284 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~----~~~~~l~e~~i~~i~~qIl~gL~yLHs~g-----IiHrDIKp~NILid~~g~vKL~DFGlA 284 (690)
||||||+++.+..+. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHH
Q ss_conf 22346899986445456667698333399899983114430468999983899999999499999999870999956753
Q 005582 285 NFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 364 (690)
Q Consensus 285 ~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~ 364 (690)
+.+... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.+|...--
T Consensus 162 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-------- 231 (269)
T d2java1 162 RILNHD-TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-------- 231 (269)
T ss_dssp HHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred EECCCC-CCCCCCCCCCCCCCCHHHHCC-CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--------
T ss_conf 322457-775566778823279999839-9999389887527899998018899899899999999971899--------
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 1589966656898851011221117995459999999624798988999988629478
Q 005582 365 RSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFF 422 (690)
Q Consensus 365 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf 422 (690)
......+++.+.+||.+||+.||.+|||+.|+|+|||+
T Consensus 232 --------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf --------------------88974359999999999767995579189999729819
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=412.15 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=225.0
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCH----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 98079736511696489999995899399999950479997----88999999999999389997102542476305893
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP----ESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
++|++++.||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.+|+.++|||||++++++.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 677982798117895999999999998999999875663213406899999999999986799899938899997--998
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC----CEEEECCCCCCCC
Q ss_conf 999994242133565408999889999999999999999999968985445777662550589----3476014653223
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG----ILKIGDFGLANFF 287 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g----~vKL~DFGlA~~~ 287 (690)
+|||||||+++.+..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHC
T ss_conf 99999867786431001035642155789999999999876662542211333012798258986664696433442105
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCC
Q ss_conf 46899986445456667698333399899983114430468999983899999999499999999870999956753158
Q 005582 288 KCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 288 ~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~ 367 (690)
... ......++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++...
T Consensus 168 ~~~--~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~----- 239 (293)
T d1jksa_ 168 DFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY----- 239 (293)
T ss_dssp TTS--CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH-----
T ss_pred CCC--CCCCCCCCCCCCCCHHHHCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHH-----
T ss_conf 777--63122477774309999818-9999766522140999999708899889999999999981688887010-----
Q ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99666568988510112211179954599999996247989889999886294789999
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 368 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p 426 (690)
+..++..+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 240 --------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 240 --------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp --------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred --------------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf --------------------478899999999998638966891999996190418887
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=416.71 Aligned_cols=259 Identities=29% Similarity=0.382 Sum_probs=219.7
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
+.|++++.||+|+||.||+|++..++..||+|++.... ....+.+.+|+.+|+.++|||||++++++.+ .+.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEE
T ss_conf 37598479930778199999999999399999987289--9999999999999986799998849889800--9958999
Q ss_pred EECCCCCHHHHH-CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 942421335654-0899988999999999999999999996898544577766255058934760146532234689998
Q 005582 216 FEYMEHDLAGLA-ATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~~~-~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
||||+++.+..+ ......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-CCC
T ss_conf 9627998188999862899999999999999999999999889887140700314878999899716123035778-641
Q ss_pred CCCCCCCCCCCCCCCCCC----CCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCC
Q ss_conf 644545666769833339----9899983114430468999983899999999499999999870999956753158996
Q 005582 295 LTSRVVTLWYRPPELLLG----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g----~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~ 370 (690)
....+||+.|+|||++.+ ...|+.++|||||||++|+|++|++||.+.+..+.+.+|.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------------ 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------------
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC------------
T ss_conf 00102562647999983202578888806657878999999820889999989999999997079987------------
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 6656898851011221117995459999999624798988999988629478999
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
......+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 235 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 235 --------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred --------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf --------------77656699999999999766996689199999629231889
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=417.84 Aligned_cols=259 Identities=29% Similarity=0.407 Sum_probs=221.7
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 9980797365116964899999958993999999504799-978899999999999938999710254247630589399
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEE
T ss_conf 9877898898508790999999989997999999865775577789999999999987688886179999998--99889
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC-
Q ss_conf 9994242133565408999889999999999999999999968985445777662550589347601465322346899-
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~- 292 (690)
|||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC
T ss_conf 99970489877776531599999999999999999997621650884767741236688853886032102422567764
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCC
Q ss_conf 98644545666769833339989998311443046899998389999999949999999987099995675315899666
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~ 372 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|.+....
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------------- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------------
T ss_pred CCCCCCCCCCCCCCCEEECC-CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC---------------
T ss_conf 33355567755258440026-89896662304569999980388998995999999999718999---------------
Q ss_pred CCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHH------HHCCCCCCCC
Q ss_conf 5689885101122111799545999999962479898899998------8629478999
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASS------ALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~e------iL~Hpwf~~~ 425 (690)
....+++.+.+||.+||+.||.+|||++| +++||||+..
T Consensus 229 --------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 229 --------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp --------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred --------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCC
T ss_conf --------------985479999999999855797689197897377898769764789
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=414.94 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=222.3
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
Q ss_conf 89980797365116964899999958993999999504799-97889999999999993899971025424763058939
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
..++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||++++++.. ...+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC--CCCC
T ss_conf 72370898896117680899999989998999999826774588999999999999997487727403444432--2222
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99994242133565408999889999999999999999999968985445777662550589347601465322346899
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 yLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|+||||+.++.+...+.....+++..++.|+.||+.||.|||+++|+||||||+||||+.+|.+||+|||+|+.+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred CCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC---
T ss_conf 32222334662266675158989999999999999989999859986176799993607789788610103332256---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCC
Q ss_conf 98644545666769833339989998311443046899998389999999949999999987099995675315899666
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~ 372 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+.+|......+
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 257 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-------------- 257 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred -CCCCCCCCCCCCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC--------------
T ss_conf -6643367635678899717-998853311450078999975889989959999999986179889--------------
Q ss_pred CCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 568988510112211179954599999996247989889-----99988629478999
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRp-----Ta~eiL~Hpwf~~~ 425 (690)
...+++.+.+||..||..||.+|+ |++++|+||||+..
T Consensus 258 ---------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 258 ---------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---------------CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf ---------------7668999999999983409986065534549999719051589
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=407.24 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=214.9
Q ss_pred CEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC--CCEEEEE
Q ss_conf 07973651169648999999589939999995047999788999999999999389997102542476305--8939999
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV--SGSLYLV 215 (690)
Q Consensus 138 Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~--~~~lyLV 215 (690)
|++..+||+|+||+||+|.+..++..||+|++............+.+|+.+|+.++|||||++++++.+.. ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEC-CCCCEEEECCCCCCCCCCCCC
Q ss_conf 942421335654089998899999999999999999999689--85445777662550-589347601465322346899
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRG--ILHRDIKGSNLLID-YNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~g--IiHrDIKp~NILid-~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|||++++.+..++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~---~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---A 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---T
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC---C
T ss_conf 9578989489997513554699999999999999999997899799687674351166799988980057654236---8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCC
Q ss_conf 98644545666769833339989998311443046899998389999999949999999987099995675315899666
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~ 372 (690)
......+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+......+.+.+.. +.++..
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~----------- 233 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS----------- 233 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG-----------
T ss_pred CCCCCCCCCCCCCCHHHHCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCC-----------
T ss_conf 76677553813008988478--9998671100799999998788999876559999999973-899865-----------
Q ss_pred CCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 568988510112211179954599999996247989889999886294789
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 373 ~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~ 423 (690)
.....++++.+||.+||+.||.+|||++|+|+||||+
T Consensus 234 --------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 --------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf --------------6755789999999997637975892999996775409
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=411.86 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=213.0
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 899807973651169648999999589939999995047999----7889999999999993899971025424763058
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD----PESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
..++|++++.||+|+||.||+|++..+|+.||||++...... .........++.+++.++|||||++++++.+ .
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--C
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998--9
Q ss_pred CEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf 93999994242133565408999889999999999999999999968985445777662550589347601465322346
Q 005582 210 GSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKC 289 (690)
Q Consensus 210 ~~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~ 289 (690)
+.+|||||||.++.+..++.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf 98899999148983899987325532789999999999999999977962204442216785889679822010233378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCC
Q ss_conf 89998644545666769833339989998311443046899998389999999949999999987099995675315899
Q 005582 290 SQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 290 ~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~ 369 (690)
. .....+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+....+.. .....
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~---------- 225 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMA---------- 225 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCC----------
T ss_pred C---CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-CCCCC----------
T ss_conf 8---643311345542168760389998441046778999999859998888998999999986-04688----------
Q ss_pred CCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCC-----HHHHHCCCCCCCC
Q ss_conf 6665689885101122111799545999999962479898899-----9988629478999
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGT-----ASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpT-----a~eiL~Hpwf~~~ 425 (690)
...+..+++.+.+||.+||+.||.+||| |+++|+||||+..
T Consensus 226 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 ---------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ---------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred ---------------CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf ---------------8788778999999999985669888088743579999749102378
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=411.59 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=223.3
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 9980797365116964899999958993999999504799-978899999999999938999710254247630589399
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE--CCEEE
T ss_conf 5470888897207680899999989997999999845775488999999999999986369675330356852--88005
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99942421335654089998899999999999999999999689854457776625505893476014653223468999
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
+|||||.++.+.........+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECC----
T ss_conf 6765037863223432222111007999999998765541247677055681050386899889831752167124----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCC
Q ss_conf 86445456667698333399899983114430468999983899999999499999999870999956753158996665
Q 005582 294 PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 294 ~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~ 373 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|......
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 219 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------------- 219 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------------
T ss_pred CCCCCCCCCCCCCHHHHCC-CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC----------------
T ss_conf 5643457634359999838-99980430465333689997598999996999999999708988----------------
Q ss_pred CCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 68988510112211179954599999996247989889-----99988629478999
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 374 ~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRp-----Ta~eiL~Hpwf~~~ 425 (690)
....+++.+.+||.+||..||.+|+ |++++|+||||+..
T Consensus 220 -------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 220 -------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------------CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf -------------99778999999999995449976664310219999819351467
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=410.85 Aligned_cols=289 Identities=30% Similarity=0.499 Sum_probs=241.0
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC----CCCE
Q ss_conf 980797365116964899999958993999999504799978899999999999938999710254247630----5893
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSR----VSGS 211 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~~ 211 (690)
++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++||||++++++|... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99999424213356540899988999999999999999999996898544577766255058934760146532234689
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~ 291 (690)
+|+||||+.++++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-- 171 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 171 (355)
T ss_dssp EEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEECCCHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCCC--
T ss_conf 699984144677876503---899999999999999999886522112456776321136544313201023211466--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 99864454566676983333998999831144304689999838999999994999999998709999567531589966
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
....+..++|+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+...++.+++...+.+..++|........
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred CCCCCCCCCCCCCCCHHHHCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHH
T ss_conf 655332214655558133147-7778774333566257898659899888977889999997205898799987656677
Q ss_pred C-----CCCCCCCCCHH--------HHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf 6-----56898851011--------22111799545999999962479898899998862947899999999
Q 005582 372 T-----IFKPQQPYKRC--------VAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLPCD 430 (690)
Q Consensus 372 ~-----~~~~~~p~~~~--------~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~~~ 430 (690)
. ........... ........++.+++||.+||.+||++||||+|+|+||||+....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~ 322 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE 322 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHH
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCCCCC
T ss_conf 776417543566642126433354321013337999999999987699457908999966942087888100
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=407.25 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=225.1
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.++|++++.||+|+||+||+|.+..+++.||+|+++... .....+.+|+.+|+.++|||||+++++|.+ .+.+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
T ss_conf 010588789831778399999998999699999975786---659999999999985799798909899988--998899
Q ss_pred EEECCCCC-HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEEECCCCCCCCCCCC
Q ss_conf 99424213-356540899988999999999999999999996898544577766255058--934760146532234689
Q 005582 215 VFEYMEHD-LAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN--GILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 215 V~Ey~~g~-Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~--g~vKL~DFGlA~~~~~~~ 291 (690)
|||||+++ |...+...+..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC--
T ss_conf 995389980889987538999999999999999999999987699751355444344378851899764411100346--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 99864454566676983333998999831144304689999838999999994999999998709999567531589966
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
.......++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......++...|
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred CCCCCCCCCCCCCCCCHHCCC-CCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHC--------
T ss_conf 775321223322234021048-77784011302799999998289999998999999999838999880223--------
Q ss_pred CCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 656898851011221117995459999999624798988999988629478999
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf -----------------6789999999999866996689099999639965667
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.37 Aligned_cols=287 Identities=39% Similarity=0.675 Sum_probs=245.7
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|+++++||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444--4311588
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 94242133565408999889999999999999999999968985445777662550589347601465322346899986
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQPL 295 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~~ 295 (690)
++++.++++..+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.|...... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-CSCC
T ss_pred EEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC-CCCC
T ss_conf 630233222112123565403678999999999987743399860014676121133782665204601104688-7510
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCCC
Q ss_conf 4454566676983333998999831144304689999838999-999994999999998709999567531589966656
Q 005582 296 TSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIF 374 (690)
Q Consensus 296 ~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~p-F~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~ 374 (690)
....+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCC
T ss_conf 01034431014667506988880444026541889985189999889999999999986118997355134432221133
Q ss_pred CCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 898851011221117995459999999624798988999988629478999
Q 005582 375 KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 375 ~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
....+...........+++.+.+||.+||++||.+||||+|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred CCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 444544310433065689999999999864996689099999649534079
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.49 Aligned_cols=291 Identities=35% Similarity=0.519 Sum_probs=239.3
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC---CC
Q ss_conf 899807973651169648999999589939999995047999788999999999999389997102542476305---89
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV---SG 210 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~ 210 (690)
..++|+++++||+|+||+||+|.+..+++.||||++.... .......+++|+.+|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 3898599789940648099999999999499999980310-958999999999999976898988588899505645541
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 39999942421335654089998899999999999999999999689854457776625505893476014653223468
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+++++++++|...+... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 49999962598656644058--9999999999999999999999789867778764378879997787545705650477
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCC
Q ss_conf 99--9864454566676983333998999831144304689999838999999994999999998709999567531589
Q 005582 291 QK--QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~--~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~ 368 (690)
.. ......++|+.|+|||++.....|+.++||||+||++|+|++|++||.+.+..++...+...++.+..........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 76410101102652000387860478887410100467013377669799788888999998765206997566423433
Q ss_pred CCCCCCC--CCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 9666568--9885101122111799545999999962479898899998862947899999
Q 005582 369 PHATIFK--PQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPL 427 (690)
Q Consensus 369 ~~~~~~~--~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~ 427 (690)
.....+. ........+...+..+++.+++||.+||+.||.+||||.|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 2222024467755778777837899999999999976489567908999861986555889
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.86 Aligned_cols=288 Identities=33% Similarity=0.541 Sum_probs=238.5
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----CC
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305----89
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRV----SG 210 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 210 (690)
.++|+++++||+|+||+||+|++..+|+.||||+++....+......+.+|+.+|+.++|||||++++++.... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 39999942421335654089998899999999999999999999689854457776625505893476014653223468
Q 005582 211 SLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 211 ~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
.+|+++++++++|..++. . ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~-~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-T-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred EEEEEEEECCCCHHHHCC-C-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC--
T ss_conf 499999625886232002-2-453099999999999999999973887651667763345543220013210001257--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCC
Q ss_conf 99986445456667698333399899983114430468999983899999999499999999870999956753158996
Q 005582 291 QKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 291 ~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~ 370 (690)
.......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......|....+.+..+.+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHH
T ss_conf --544443454355583553377567855124320589999976889978898899999999730799757732001024
Q ss_pred CCCC--CCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf 6656--898851011221117995459999999624798988999988629478999999
Q 005582 371 ATIF--KPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKPLP 428 (690)
Q Consensus 371 ~~~~--~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p~~ 428 (690)
...+ .........+...+..+++.+++||.+||..||.+||||.|+|+||||+....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred HHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf 454443035578755566267899999999999775883459389998559954879998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=397.34 Aligned_cols=262 Identities=28% Similarity=0.399 Sum_probs=222.6
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE
Q ss_conf 99807973651169648999999589939999995047999-------788999999999999389-9971025424763
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD-------PESVRFMAREIIILRRLD-HPNIMKLEGLITS 206 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~-------~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~ 206 (690)
.++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 05893999994242133565408999889999999999999999999968985445777662550589347601465322
Q 005582 207 RVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 207 ~~~~~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~ 286 (690)
.+.+|||||||+++.+..++.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf --760599997689866899998659999999999999999999999875994323462548986899838712403167
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
Q ss_conf 34689998644545666769833339-----9899983114430468999983899999999499999999870999956
Q 005582 287 FKCSQKQPLTSRVVTLWYRPPELLLG-----STDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEE 361 (690)
Q Consensus 287 ~~~~~~~~~~~~~gT~~Y~APEvl~g-----~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e 361 (690)
+... ...+..+||+.|+|||++.+ ...|+.++||||+||++|+|++|++||.+.+..+.+..|......++.
T Consensus 160 ~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 236 (277)
T d1phka_ 160 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 236 (277)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred CCCC--CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCC-
T ss_conf 2688--7213452467888988860534456788992331856560231032288898899999999999818988898-
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 7531589966656898851011221117995459999999624798988999988629478999
Q 005582 362 YWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 362 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
..+.++++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus 237 ------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 237 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHHH
T ss_conf ------------------------5434689999999999765896689199999739787975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.67 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=219.5
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCCCEE
Q ss_conf 9980797365116964899999958993999999504799-9788999999999999-3899971025424763058939
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILR-RLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~-~L~HpnIv~l~~~~~~~~~~~l 212 (690)
.++|++++.||+|+||+||+|++..+++.||||++++... .......+.+|+.++. .++||||+++++++.+ .+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704--9831
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99994242133565408999889999999999999999999968985445777662550589347601465322346899
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 213 yLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||||++++.+..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~ 157 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-D 157 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC-C
T ss_conf 677750379808998640478999999999999999999998689340347654044448996301555302323566-5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCC
Q ss_conf 98644545666769833339989998311443046899998389999999949999999987099995675315899666
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHAT 372 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~ 372 (690)
...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|... .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------------- 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------------- 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--------------
T ss_pred CCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC--CC--------------
T ss_conf 33454578777689999827-99883232011227898987388999998999999999718--99--------------
Q ss_pred CCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHH-HHHCCCCCCCC
Q ss_conf 568988510112211179954599999996247989889999-88629478999
Q 005582 373 IFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS-SALQNEFFTTK 425 (690)
Q Consensus 373 ~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~-eiL~Hpwf~~~ 425 (690)
.....+++.+.+||.+||+.||.+|||+. ++++||||+..
T Consensus 221 -------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 -------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCCC
T ss_conf -------------89756799999999996544898783889999809013158
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=394.09 Aligned_cols=282 Identities=32% Similarity=0.519 Sum_probs=228.2
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCCEE
Q ss_conf 899807973651169648999999589939999995047999788999999999999389-9971025424763058939
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l 212 (690)
..++|+++++||+|+||+||+|++..+++.||||+++... ...+.+|+.+|+.+. ||||++++++|.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCE
T ss_conf 9867189789831748199999988999799999988899-----99999999999851579987679999981687712
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEEECCCCCCCCCCCC
Q ss_conf 99994242133565408999889999999999999999999968985445777662550589-34760146532234689
Q 005582 213 YLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNG-ILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 yLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g-~vKL~DFGlA~~~~~~~ 291 (690)
|+||||+.++.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..+...
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred EEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC-
T ss_conf 6888631798589974---689999999999999999988764334434564412377489983664156542664688-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCC-CCHHHHHHHHHHHHCCCCHHHHHH-CCCC
Q ss_conf 99864454566676983333998999831144304689999838999999-994999999998709999567531-5899
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKR-SKLP 369 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g-~~~~e~l~kI~~~~G~p~~e~~~~-~~~~ 369 (690)
......++|+.|+|||++.+...|+.++||||+||++|+|++|+.||.. .+..++...+...+|.+....|.. ....
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCC
T ss_conf -7444322486424761026888888452323354555876048899988760189999999987884155555422544
Q ss_pred CCCCC------CCCCCCCHH-HHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 66656------898851011-221117995459999999624798988999988629478999
Q 005582 370 HATIF------KPQQPYKRC-VAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 370 ~~~~~------~~~~p~~~~-~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
....+ ......... .......+++++++||.+||.+||.+||||+|+|+||||++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred CCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 474300000333433112115521124489999999999866995689089999649355887
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.42 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=210.3
Q ss_pred CCCCEEEE-EEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHH-CCCCCEEEEEEEEEEC--CCC
Q ss_conf 99807973-6511696489999995899399999950479997889999999999993-8999710254247630--589
Q 005582 135 ADSFEKLD-KIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRR-LDHPNIMKLEGLITSR--VSG 210 (690)
Q Consensus 135 ~~~Y~~~~-~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~-L~HpnIv~l~~~~~~~--~~~ 210 (690)
.++|+++. .||+|+||.||+|++..+++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+. ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCC
T ss_conf 148798107965454869999998899989999998974-------7799999999986699997829899950346897
Q ss_pred EEEEEEECCCC-CHHHHHCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEECCCCCC
Q ss_conf 39999942421-335654089-998899999999999999999999689854457776625505---8934760146532
Q 005582 211 SLYLVFEYMEH-DLAGLAATP-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY---NGILKIGDFGLAN 285 (690)
Q Consensus 211 ~lyLV~Ey~~g-~Ll~~~~~~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~---~g~vKL~DFGlA~ 285 (690)
.+|||||||++ +|...+... ...|++.+++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 89999977899849999986278775799999999999999999997698644410022011355556631135455123
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHH
Q ss_conf 23468999864454566676983333998999831144304689999838999999994999999998709999567531
Q 005582 286 FFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365 (690)
Q Consensus 286 ~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~ 365 (690)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 163 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~------- 232 (335)
T d2ozaa1 163 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------- 232 (335)
T ss_dssp ECCCC--CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-------
T ss_pred ECCCC--CCCCCCCCCCCCCCCHHHCC-CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCC-------
T ss_conf 33688--86432267756379277748-988888888764516778865889988988778899999998538-------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 589966656898851011221117995459999999624798988999988629478999
Q 005582 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTK 425 (690)
Q Consensus 366 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~ 425 (690)
...+ ....+..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 233 -----------~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 233 -----------QYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -----------SSSC---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -----------CCCC---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf -----------8888---985434699999999999756996579099999709876178
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=384.00 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=222.3
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC--CE
Q ss_conf 9980797365116964899999958993999999504799-97889999999999993899971025424763058--93
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS--GS 211 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~--~~ 211 (690)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... +......+.+|+.+|+.++||||+++++++..... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99999424213356540899988999999999999999999996898544577766255058934760146532234689
Q 005582 212 LYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~ 291 (690)
+||||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++..+|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCC
T ss_conf 99999778898710112035899999999999999999999985795276346755665754320100344432212354
Q ss_pred C--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCC
Q ss_conf 9--98644545666769833339989998311443046899998389999999949999999987099995675315899
Q 005582 292 K--QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 292 ~--~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~ 369 (690)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+..+.+.++......++.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 235 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------
T ss_pred CCCCCCCCCCCCCCCCCHHHHCC-CCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC---------
T ss_conf 43333464257624369999839-99996632026528999997697998996999999999846999971---------
Q ss_pred CCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 666568988510112211179954599999996247989889999886294789
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFT 423 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~ 423 (690)
.....+|+.+.+||.+||+.||.+||+..+.|.|+|++
T Consensus 236 ----------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf ----------------00347899999999998667976777399999999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.46 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=207.9
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCH----HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf 998079736511696489999995899399999950479997----88999999999999389--997102542476305
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDP----ESVRFMAREIIILRRLD--HPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE--
T ss_conf 883799679840878399999999999799999985688443345567999999999999743589881279999830--
Q ss_pred CCEEEEEEECCCC-CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC-CCEEEECCCCCCC
Q ss_conf 8939999942421-3356540899988999999999999999999996898544577766255058-9347601465322
Q 005582 209 SGSLYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN-GILKIGDFGLANF 286 (690)
Q Consensus 209 ~~~lyLV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~-g~vKL~DFGlA~~ 286 (690)
.+.+|+||||+.+ +++.........+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf 99689999833686228999861589999999999999999999998779755667611147744788489775465353
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHC
Q ss_conf 34689998644545666769833339989998311443046899998389999999949999999987099995675315
Q 005582 287 FKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 287 ~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~ 366 (690)
... ...+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ .+... ..
T Consensus 161 ~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~-------- 221 (273)
T d1xwsa_ 161 LKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QV-------- 221 (273)
T ss_dssp CCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CC--------
T ss_pred CCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHC--CC--------
T ss_conf 244---455665658774799998489978865332554034536756889988736------77615--44--------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 899666568988510112211179954599999996247989889999886294789999
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNEFFTTKP 426 (690)
Q Consensus 367 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hpwf~~~p 426 (690)
.....+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 222 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 222 -------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp -------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf -------------------77877999999999997608975893999985398667887
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.35 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=213.9
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.++|++.+.||+|+||.||+|+.. ..||||+++...........+.+|+.+|++++|||||++++++.. ..+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEEEE
T ss_conf 451899889830788589999999---989999997346998999999999999984799878645679715---58999
Q ss_pred EEECCCCCHH-HHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC-
Q ss_conf 9942421335-65408999889999999999999999999968985445777662550589347601465322346899-
Q 005582 215 VFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK- 292 (690)
Q Consensus 215 V~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~- 292 (690)
|||||+++.+ ..+......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 99658998889998523578999999999999999988875099951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCCCC--CCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCC
Q ss_conf 986445456667698333399--899983114430468999983899999999499999999870999956753158996
Q 005582 293 QPLTSRVVTLWYRPPELLLGS--TDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~--~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~ 370 (690)
.......||+.|+|||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+......++.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD---------- 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC----------
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC----------
T ss_conf 3125665574317999995056899995315163599999999788998998969999999965888986----------
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCC
Q ss_conf 66568988510112211179954599999996247989889999886294
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hp 420 (690)
+.....++++.+.+|+.+||..||.+|||+.+++++-
T Consensus 231 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 231 -------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp -------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------------CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf -------------0003655549999999997588976892999999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=380.02 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=206.2
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.++|++.+.||+|+||+||+|.+..+++.||||+++..... .+.+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH---HHHHHHHHHHHHHCCCCCEECCCCCEEE--CCEEEE
T ss_conf 79939865982088808999999999969999997776103---9999999999986799988267752745--785478
Q ss_pred EEECCCCCHHH-HHC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99424213356-540-8999889999999999999999999968985445777662550589347601465322346899
Q 005582 215 VFEYMEHDLAG-LAA-TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll~-~~~-~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~ 292 (690)
|||||+++.+. .+. .....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 76314676067775303554157999999999999978889878930576045768998999289832445465378872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 9864454566676983333998999831144304689999838999-999994999999998709999567531589966
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~p-F~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
...+...+++.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.... .+++.....+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~-~~~i~~~~~~------------- 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRM------------- 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHTTCCC-------------
T ss_pred EEECCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHCCCCC-------------
T ss_conf 21035566546669278727-99981043021789999998679988774259999-9998558888-------------
Q ss_pred CCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 65689885101122111799545999999962479898899998862
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 372 ~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
.....+++.+.+||..||+.||.+|||+.++++
T Consensus 236 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --------------887433099999999975779768939999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.69 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=208.6
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCC-----EEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 998079736511696489999995899-----3999999504799978899999999999938-9997102542476305
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENN-----KLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g-----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.+.||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.+|..+ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--
T ss_conf 89939701983078819999998578855420499999966335-878999999999999971589968687788862--
Q ss_pred CCEEEEEEECCCCCHHH-HHCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 89399999424213356-540899----------------------9889999999999999999999968985445777
Q 005582 209 SGSLYLVFEYMEHDLAG-LAATPG----------------------VKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKG 265 (690)
Q Consensus 209 ~~~lyLV~Ey~~g~Ll~-~~~~~~----------------------~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp 265 (690)
.+.+|||||||+++.+. .+.... ..+++..++.|+.||+.||.|||+++|+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCH
T ss_conf 99589999727999599999862577751022100001222001257789999999999999999999739905052703
Q ss_pred CCEEECCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCC
Q ss_conf 6625505893476014653223468999-86445456667698333399899983114430468999983-899999999
Q 005582 266 SNLLIDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRT 343 (690)
Q Consensus 266 ~NILid~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~ 343 (690)
+|||++.++.+||+|||+|+........ ......+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCC-CCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 214434598289851422220457786156234357876578388727-9999633030003999999838999999989
Q ss_pred HHHHHHHHHHHHCCCCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 4999999998709999567531589966656898851011221117995459999999624798988999988629
Q 005582 344 EVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 344 ~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
....+.++......+ .....+++.+.+||..||+.||.+|||++|+++|
T Consensus 272 ~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCC---------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 899999998569989---------------------------9887678999999999758896689399999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=372.89 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=211.3
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCE---EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 9980797365116964899999958993---9999995047999788999999999999389997102542476305893
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNK---LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
.++|++.+.||+|+||+||+|.+..+++ .||||++.... .....+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 004278569802788299999995799788999999978445-98999999999999985799888618999962--887
Q ss_pred EEEEEECCCCCHHHH-HCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 999994242133565-4089998899999999999999999999689854457776625505893476014653223468
Q 005582 212 LYLVFEYMEHDLAGL-AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~-~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+|||||+++.+.. +......+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 79999722798530021045679999999999999999889885279835761504489889991998884431575677
Q ss_pred CCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHH
Q ss_conf 999----86445456667698333399899983114430468999983-8999999994999999998709999567531
Q 005582 291 QKQ----PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKR 365 (690)
Q Consensus 291 ~~~----~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~ 365 (690)
... ......+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+......+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------- 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred CCCCEEEECCCCCCCCCCCCHHHHHC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC-------
T ss_conf 77653650256668830038788836-9978612144535789999867999999999999999997378899-------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 589966656898851011221117995459999999624798988999988629
Q 005582 366 SKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 366 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
....++..+.+|+..||+.||.+|||+.+++++
T Consensus 254 ---------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ---------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ---------------------974226999999999758797689299999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.03 Aligned_cols=264 Identities=25% Similarity=0.417 Sum_probs=217.1
Q ss_pred CCCCEEEEEEECCCCEEEEEEEEC---CCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECC
Q ss_conf 998079736511696489999995---8993999999504799--97889999999999993899-97102542476305
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL---ENNKLVALKKVRFTNM--DPESVRFMAREIIILRRLDH-PNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~---~~g~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~ 208 (690)
.++|++++.||+|+||+||+|.+. .+|+.||||+++.... +......+.+|+.+|++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--
T ss_conf 102599989832878399999987658879489999983677210168999999999999864679839996200024--
Q ss_pred CCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 89399999424213356540899988999999999999999999996898544577766255058934760146532234
Q 005582 209 SGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFK 288 (690)
Q Consensus 209 ~~~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~ 288 (690)
...+|+||||+.++.+.........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf 87300123123411799998730454378888889999999988514998965477320124699988874132022203
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCC
Q ss_conf 68999864454566676983333998-99983114430468999983899999999499999999870999956753158
Q 005582 289 CSQKQPLTSRVVTLWYRPPELLLGST-DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 289 ~~~~~~~~~~~gT~~Y~APEvl~g~~-~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~ 367 (690)
...........+++.|++||++.+.. .++.++|||||||+||+|++|++||.+.+..+....+.+....+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC--------
T ss_conf 444432212223333310687605776887132517777999999768999888877779999998335689--------
Q ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 99666568988510112211179954599999996247989889-----99988629478999
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRG-----TASSALQNEFFTTK 425 (690)
Q Consensus 368 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRp-----Ta~eiL~Hpwf~~~ 425 (690)
......+++.+.+||.+||++||.+|+ |++|+|+||||+..
T Consensus 253 -----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 253 -----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -----------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCC
T ss_conf -----------------9886547999999999974458988199974509999749723489
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.44 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=212.2
Q ss_pred CCCCEEEEE-EECCCCEEEEEEEECC--CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 998079736-5116964899999958--9939999995047999788999999999999389997102542476305893
Q 005582 135 ADSFEKLDK-IGQGTYSSVYKARDLE--NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 135 ~~~Y~~~~~-IG~G~fG~Vy~a~~~~--~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
.++|.+.+. ||+|+||.||+|.+.. ++..||||+++... .......+.+|+.+|++++|||||++++++.. +.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---CE
T ss_conf 447188784873060809999999608976899999988203-97899999999999986799888068656036---80
Q ss_pred EEEEEECCCCCHHHH-HCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 999994242133565-4089998899999999999999999999689854457776625505893476014653223468
Q 005582 212 LYLVFEYMEHDLAGL-AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~-~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
+|||||||+++.+.. +......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 79999807899689975212569999999999999999878998688105767646604546885420331342115543
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCC
Q ss_conf 99--986445456667698333399899983114430468999983-899999999499999999870999956753158
Q 005582 291 QK--QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 291 ~~--~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~ 367 (690)
.. .......+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..|.+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----------- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----------
T ss_conf 432113562113743358688727-99995412322017899999389999999799999999981899-----------
Q ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf 9966656898851011221117995459999999624798988999988---6294789
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSA---LQNEFFT 423 (690)
Q Consensus 368 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~ei---L~Hpwf~ 423 (690)
.+....+++.+.+||..||+.||.+|||+.++ |+|.|+.
T Consensus 231 -----------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -----------------999976789999999997577976890999999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.06 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=211.4
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.++|++.+.||+|+||.||+|.+. ++..||||+++..... .+.+.+|+.+|++++|||||++++++.. +.+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEECC---CCEEE
T ss_conf 899388679810798289999999-9999999998647688---8999999999986799988578731045---97699
Q ss_pred EEECCCCCHHHHHCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 9942421335654089--99889999999999999999999968985445777662550589347601465322346899
Q 005582 215 VFEYMEHDLAGLAATP--GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~--~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||++++.+...... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC
T ss_conf 99957898288887514789887889999999999999999748954675642251562024404234101477358864
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 9864454566676983333998999831144304689999838-999999994999999998709999567531589966
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG-~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
.......+|+.|+|||++.+ ..|+.++|||||||++|||+|| .++|...+..+.+..+....-.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------------- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred CCCCCCCCCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC--------------
T ss_conf 42035677444458289837-999824564525799999996898888888999999999706888--------------
Q ss_pred CCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 65689885101122111799545999999962479898899998862--947899
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ--NEFFTT 424 (690)
Q Consensus 372 ~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~--Hpwf~~ 424 (690)
.....+++.+.+|+..||+.||.+|||+.++++ |+||+.
T Consensus 230 --------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --------------89655719999999997588976893999999986113213
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.01 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=210.3
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|++++.||+|+||.||+|.+. ++..||||+++..... ...+.+|+.+++.++|||||++++++.. .+.+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCCCCEECC--CCCEEEE
T ss_conf 99588889820888299999988-9999999998788676---8999999999996689975653524315--9933799
Q ss_pred EECCCCCHHH-HHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 9424213356-540899988999999999999999999996898544577766255058934760146532234689998
Q 005582 216 FEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||++++.+. .+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEE
T ss_conf 98369991899752013478899999999999998776531643104431532666688776865532100236887335
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCC
Q ss_conf 6445456667698333399899983114430468999983-899999999499999999870999956753158996665
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~ 373 (690)
.....+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||...+..+.+..+......
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------------- 221 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------- 221 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC----------------
T ss_pred ECCEECCCCCCCHHHHCC-CCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC----------------
T ss_conf 043001766678578607-999840332105999999987898887789999999999806888----------------
Q ss_pred CCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 6898851011221117995459999999624798988999988629
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 374 ~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
......++.+.+|+..||+.||.+|||++++|+|
T Consensus 222 ------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ------------9954367999999999765797689199999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.05 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=207.3
Q ss_pred EEEECCCCEEEEEEEEC--CCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEECC
Q ss_conf 36511696489999995--8993999999504799978899999999999938999710254247630589399999424
Q 005582 142 DKIGQGTYSSVYKARDL--ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 142 ~~IG~G~fG~Vy~a~~~--~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV~Ey~ 219 (690)
++||+|+||.||+|.+. .+++.||||+++....+....+.+.+|+.+|++++|||||++++++.. +.+||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---CCEEEEEECC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505---9779999747
Q ss_pred CCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC--CCCC
Q ss_conf 21335654089998899999999999999999999689854457776625505893476014653223468999--8644
Q 005582 220 EHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ--PLTS 297 (690)
Q Consensus 220 ~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~--~~~~ 297 (690)
+++.+..+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...... ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCC
T ss_conf 88968999752257899999999999999976687479556777611310235675123413453313432344322445
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCCCCC
Q ss_conf 5456667698333399899983114430468999983-899999999499999999870999956753158996665689
Q 005582 298 RVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKP 376 (690)
Q Consensus 298 ~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~~~ 376 (690)
..+|+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....|.+. ..
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~------------------ 228 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER------------------ 228 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC------------------
T ss_pred CCCCCEECCCHHHCC-CCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC--CC------------------
T ss_conf 677842039166537-999843443034031328965899999998999999999828--99------------------
Q ss_pred CCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf 8851011221117995459999999624798988999988---6294789
Q 005582 377 QQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSA---LQNEFFT 423 (690)
Q Consensus 377 ~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~ei---L~Hpwf~ 423 (690)
......+|..+.+|+..||+.||.+|||+.++ |+|+|+.
T Consensus 229 --------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf --------999865679999999997588976890989999985288750
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.99 Aligned_cols=249 Identities=20% Similarity=0.339 Sum_probs=214.6
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|++.++||+|+||.||+|++ .++..||||+++...... ..+.+|+.+++.++||||+++++++.+ .+.+|+|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCEEEEEEEEEE--CCCEEEE
T ss_conf 9979968982078839999998-899899999987475778---999999999996689860158899850--7816999
Q ss_pred EECCCCCH-HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 94242133-56540899988999999999999999999996898544577766255058934760146532234689998
Q 005582 216 FEYMEHDL-AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQP 294 (690)
Q Consensus 216 ~Ey~~g~L-l~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~~ 294 (690)
|||++++. ..........+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEE
T ss_conf 97048993888641024677689999999999999998754684346654135887699847988614420235787225
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCCCC
Q ss_conf 6445456667698333399899983114430468999983-899999999499999999870999956753158996665
Q 005582 295 LTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHATI 373 (690)
Q Consensus 295 ~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~ 373 (690)
.....+|+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+...+|......+
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------------
T ss_pred ECCCCCCCCCCCCHHHCC-CCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC---------------
T ss_conf 246578877578078637-9988521033643246739755999988999999999998079789---------------
Q ss_pred CCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 6898851011221117995459999999624798988999988629
Q 005582 374 FKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 374 ~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
.....+..+.+||.+||+.||.+|||+.++|+|
T Consensus 222 -------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 -------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -------------965465999999999766897689399999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.00 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=208.0
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCE----EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 980797365116964899999958993----9999995047999788999999999999389997102542476305893
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNK----LVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
++|++++.||+|+||+||+|.+..+|+ .||+|+++... .....+.+.+|+.+|+.++|||||++++++.. +.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CC
T ss_conf 999783198208992999999958998898999999965134-97999999999999986799888158999961---98
Q ss_pred EEEEEECCCC-CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 9999942421-335654089998899999999999999999999689854457776625505893476014653223468
Q 005582 212 LYLVFEYMEH-DLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 lyLV~Ey~~g-~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
.++++||+.+ +++..+......+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCC
T ss_conf 36999842687401011133457999999999999999999998769504762120311679987586025522233544
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCC
Q ss_conf 999-86445456667698333399899983114430468999983-8999999994999999998709999567531589
Q 005582 291 QKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKL 368 (690)
Q Consensus 291 ~~~-~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~ 368 (690)
... ......+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+.... .+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~---------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL---------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC----------
T ss_pred CCCCCCCCCCCCCCCCCHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-CC----------
T ss_conf 45322365105864467088746-9998356544079999999977999999999899999997599-89----------
Q ss_pred CCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCC
Q ss_conf 9666568988510112211179954599999996247989889999886294
Q 005582 369 PHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQNE 420 (690)
Q Consensus 369 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~Hp 420 (690)
.....+++.+.+|+..||..||.+|||+.++++|-
T Consensus 233 -----------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 233 -----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp -----------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf -----------------99855689999999984789934691999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.79 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=213.0
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 99807973651169648999999589939999995047999788999999999999389997102542476305893999
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
.++|++.+.||+|+||+||+|++.. +..||||+++..... ...+.+|+.+++.++|||||++++++.+ +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEEC---CCEEE
T ss_conf 7997984699307980999999999-999999998804488---8999999999986666788689999823---97599
Q ss_pred EEECCCCCHHHHHCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 994242133565408--999889999999999999999999968985445777662550589347601465322346899
Q 005582 215 VFEYMEHDLAGLAAT--PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~--~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~ 292 (690)
||||+.++.+..... ....+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 99944799435420000355305999999999999999987541143353123079998999299844255542568873
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCC
Q ss_conf 9864454566676983333998999831144304689999838-999999994999999998709999567531589966
Q 005582 293 QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPHA 371 (690)
Q Consensus 293 ~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG-~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~~ 371 (690)
.......+|+.|+|||++.. ..++.++|||||||++|||++| .++|.+....+.+..+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred EEECCCCCCCCCCCHHHHHC-CCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC--------------
T ss_conf 35245455665458089837-998917741323589999986899999888899999999826899--------------
Q ss_pred CCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCCC
Q ss_conf 65689885101122111799545999999962479898899998862--9478999
Q 005582 372 TIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ--NEFFTTK 425 (690)
Q Consensus 372 ~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~--Hpwf~~~ 425 (690)
.....+++.+.+||..||+.||++|||+.+++. ++||+..
T Consensus 234 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf --------------998323799999999975669758919999999876662389
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.06 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=211.9
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCC---CEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
Q ss_conf 9807973651169648999999589---9399999950479997889999999999993899971025424763058939
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN---NKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSL 212 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 212 (690)
++|++.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.+|+.++||||+++++++.. +.+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEE
T ss_conf 99698779930788299999993699644999999936566-87999999999999986899998569889953---747
Q ss_pred EEEEECCCCCHHH-HHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 9999424213356-540899988999999999999999999996898544577766255058934760146532234689
Q 005582 213 YLVFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 213 yLV~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~ 291 (690)
|+||||+.++.+. ........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCCC
T ss_conf 99998406980776542247899999999999999877523022674414102655320678967876503421336776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCC
Q ss_conf 9986445456667698333399899983114430468999983-899999999499999999870999956753158996
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~ 370 (690)
....+...+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+.++......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred CEECCCEECCCCCCHHHHHCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-------------
T ss_conf 233054005831032667516-998874524442478999982699998889999999999818999-------------
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 6656898851011221117995459999999624798988999988629
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
..++.+++.+.+||..||..||.+|||+.++++|
T Consensus 229 ---------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ---------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ---------------8987779999999999768797689299999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.73 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=205.9
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCC----EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 98079736511696489999995899----39999995047999788999999999999389997102542476305893
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENN----KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
+.|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+|+.++|||||++++++.. ...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCC
T ss_conf 996861598117790999999968998787999999988445-96899999999999985689878323677833--880
Q ss_pred EEEEEECCCCCHHHH-HCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 999994242133565-4089998899999999999999999999689854457776625505893476014653223468
Q 005582 212 LYLVFEYMEHDLAGL-AATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~-~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+||||+.++++.. .......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCC
T ss_conf 38999721357402221023454208999999999998541212123425765644278889984998455103003578
Q ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCC
Q ss_conf 999--864454566676983333998999831144304689999838-99999999499999999870999956753158
Q 005582 291 QKQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 291 ~~~--~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG-~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~ 367 (690)
... ......+|+.|+|||++.+ ..|+.++|||||||++|||+++ .++|.+.+..+.+..+....-
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----------- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----------- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred CCCCEEECCCCCCCCCCCHHHHCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----------
T ss_conf 765267426777734348888704-99997355634489899999679886556899999999863578-----------
Q ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 996665689885101122111799545999999962479898899998862
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 368 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
.....+++..+.+||..||..||.+|||+.++++
T Consensus 232 -----------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 -----------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -----------------9985045799999999977679768939999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.87 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=205.0
Q ss_pred CCCEEEEEEECCCCEEEEEEEECC-----CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 980797365116964899999958-----993999999504799978899999999999938-99971025424763058
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVS 209 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~-----~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~ 209 (690)
++|++.++||+|+||.||+|.+.. +++.||||+++... .......+.+|+.++.++ +|+||+.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC-C
T ss_conf 9979844984167839999998677755578399999986001-7178999999999988614998499741154047-9
Q ss_pred CEEEEEEECCCCCHHHHHCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
Q ss_conf 93999994242133565408----------------99988999999999999999999996898544577766255058
Q 005582 210 GSLYLVFEYMEHDLAGLAAT----------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYN 273 (690)
Q Consensus 210 ~~lyLV~Ey~~g~Ll~~~~~----------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~ 273 (690)
..+|+|||||+++.+..++. ....+++..+..|+.||+.||.|||+++|+||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
T ss_conf 75799998458992999998536666653222023321468999999999999999998873797178677310657799
Q ss_pred CCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHC-CCCCCCCCHHHHHHHH
Q ss_conf 93476014653223468999-864454566676983333998999831144304689999838-9999999949999999
Q 005582 274 GILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEVEQLHKI 351 (690)
Q Consensus 274 g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG-~~pF~g~~~~e~l~kI 351 (690)
+.+||+|||+|+........ .....+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+....+.+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 8289845752001135665222475166721020368646-889966322136789999986889999899989999999
Q ss_pred HHHHCCCCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 98709999567531589966656898851011221117995459999999624798988999988629
Q 005582 352 FKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 352 ~~~~G~p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
+.....+ .....+++.+.+||..||+.||.+|||+.++|+|
T Consensus 250 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCC---------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9638988---------------------------8886578999999999767796679199999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=353.56 Aligned_cols=282 Identities=27% Similarity=0.420 Sum_probs=220.9
Q ss_pred CCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEE
Q ss_conf 807973651169648999999589939999995047999788999999999999389-----------997102542476
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-----------HPNIMKLEGLIT 205 (690)
Q Consensus 137 ~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIv~l~~~~~ 205 (690)
+|+++++||+|+||+||+|++..+|+.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 579989975077818999999999979999998343---13368999999999984014555554227676478998763
Q ss_pred ECCCCEEEEEEECCCC--CH-HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCC------C
Q ss_conf 3058939999942421--33-56540899988999999999999999999996-8985445777662550589------3
Q 005582 206 SRVSGSLYLVFEYMEH--DL-AGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS-RGILHRDIKGSNLLIDYNG------I 275 (690)
Q Consensus 206 ~~~~~~lyLV~Ey~~g--~L-l~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs-~gIiHrDIKp~NILid~~g------~ 275 (690)
.......+++++++.. +. ..........+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCE
T ss_conf 12565202343200035420000012234678689999999999999888764058646567705705630576564430
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCC------HHHHHH
Q ss_conf 47601465322346899986445456667698333399899983114430468999983899999999------499999
Q 005582 276 LKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRT------EVEQLH 349 (690)
Q Consensus 276 vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~------~~e~l~ 349 (690)
++|+|||.|..... .....++|+.|+|||++.+ ..|+.++||||+||++++|++|++||.+.. ..+.+.
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEEECCCCCCCCC----CCCCCCCCCCCCCHHHCCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 56753144212344----5422366521057132146-677764320123789999987889989875543210268999
Q ss_pred HHHHHHCCCCHHHHHHCCCCC----------CCCCCCCCCCCHHHHHHC---CCCCHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 999870999956753158996----------665689885101122111---7995459999999624798988999988
Q 005582 350 KIFKLCGSPSEEYWKRSKLPH----------ATIFKPQQPYKRCVAETF---KDIPSSALSLLDILLSTEPEVRGTASSA 416 (690)
Q Consensus 350 kI~~~~G~p~~e~~~~~~~~~----------~~~~~~~~p~~~~~~~~~---~~~~~~~~dLL~~lL~~DP~kRpTa~ei 416 (690)
.++..+|.++.+.+....... ........+........+ ...++.+++||.+||.+||.+||||.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 99998379987886245322000132012202432357764442100015674358999999999877994579089999
Q ss_pred HCCCCCCCCC
Q ss_conf 6294789999
Q 005582 417 LQNEFFTTKP 426 (690)
Q Consensus 417 L~Hpwf~~~p 426 (690)
|+||||++.+
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred HCCCCCCCCC
T ss_conf 6693407898
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=355.79 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=209.4
Q ss_pred CCCCEEEEEEECCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 998079736511696489999995-----899399999950479997889999999999993899971025424763058
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~-----~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.++|++++.||+|+||+||+|++. .++..||||+++... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC--C
T ss_conf 88938867982078839999998887657788299999988210-85799999999999996689976552466605--9
Q ss_pred CEEEEEEECCCCCHHHHHCC------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 93999994242133565408------------------------999889999999999999999999968985445777
Q 005582 210 GSLYLVFEYMEHDLAGLAAT------------------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKG 265 (690)
Q Consensus 210 ~~lyLV~Ey~~g~Ll~~~~~------------------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp 265 (690)
..+++||||+.++.+..++. ....+++..+..++.||+.||.|||+++|+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECC
T ss_conf 80389998158992999998527554210000111001210346788989999999999999985541357868548840
Q ss_pred CCEEECCCCCEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCC-CCCCCCC
Q ss_conf 662550589347601465322346899-98644545666769833339989998311443046899998389-9999999
Q 005582 266 SNLLIDYNGILKIGDFGLANFFKCSQK-QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRT 343 (690)
Q Consensus 266 ~NILid~~g~vKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~-~pF~g~~ 343 (690)
+|||++.++.+||+|||+|+....... ...+...+|+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf 116898999289833144211367764111577776767679899726-8898056302523629999806899999989
Q ss_pred HHHHHHHHHHHHCCCCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 499999999870999956753158996665689885101122111799545999999962479898899998862
Q 005582 344 EVEQLHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 344 ~~e~l~kI~~~~G~p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
..+.+..+..... ......+++.+.+||..||+.||.+|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHCCCC----------------------------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999999973997----------------------------8887325299999999974889657939999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=350.28 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=210.1
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058939999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 215 (690)
++|++.+.||+|+||.||+|++..+++.||||++....... .+.+|+.+++.+.|++++.++..+... ....|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEEC-CCEEEEE
T ss_conf 88999689850788099999998899899999972100588----899999999970389960179999951-9877899
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEECCCCCCCCCCCCC
Q ss_conf 942421335654089998899999999999999999999689854457776625505---89347601465322346899
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY---NGILKIGDFGLANFFKCSQK 292 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~---~g~vKL~DFGlA~~~~~~~~ 292 (690)
|||+++++..........+++..+..++.||+.||.|||++||+||||||+|||++. +..++|+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCC
T ss_conf 98738713332443068876899999999999999999979944266787660643357776156504675134255445
Q ss_pred ------CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHC
Q ss_conf ------98644545666769833339989998311443046899998389999999949999999987099995675315
Q 005582 293 ------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRS 366 (690)
Q Consensus 293 ------~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~ 366 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.........+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--------- 231 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--------- 231 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---------
T ss_pred CCCEECCCCCCCCCCCCCCCHHHHHC-CCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC---------
T ss_conf 54100013577678735329999918-99898321886177899998498766553057799999985235---------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHH---HHHCCCCCCC
Q ss_conf 899666568988510112211179954599999996247989889999---8862947899
Q 005582 367 KLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTAS---SALQNEFFTT 424 (690)
Q Consensus 367 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~---eiL~Hpwf~~ 424 (690)
............+|+++.+|+..||..||.+||++. ++|+|+|.+.
T Consensus 232 ------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 232 ------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------CCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf ------------6789835753478899999999984399557919999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.16 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=208.7
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCC-C--EEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 9807973651169648999999589-9--3999999504799-9788999999999999389997102542476305893
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLEN-N--KLVALKKVRFTNM-DPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~-g--~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 211 (690)
++|++++.||+|+||.||+|..... + ..||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---CC
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740---10
Q ss_pred EEEEEECCCCCHH-HHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 9999942421335-654089998899999999999999999999689854457776625505893476014653223468
Q 005582 212 LYLVFEYMEHDLA-GLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCS 290 (690)
Q Consensus 212 lyLV~Ey~~g~Ll-~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~ 290 (690)
+|+||||++++.+ .........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred HHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCC
T ss_conf 01146542386125444212689999999999999999998752178752056688815655654332561155530358
Q ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCC
Q ss_conf 999--86445456667698333399899983114430468999983-899999999499999999870999956753158
Q 005582 291 QKQ--PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSK 367 (690)
Q Consensus 291 ~~~--~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~ 367 (690)
... ......++..|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+.+|.+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--------- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---------
T ss_pred CCCCEECCCCCCCCCCCCHHHHHC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC---------
T ss_conf 875265476325731079999837-9999421566148999999968999999969999999998479999---------
Q ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 996665689885101122111799545999999962479898899998862
Q 005582 368 LPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 368 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
+....+++.+.+||..||..||.+|||+.++++
T Consensus 235 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ------------------985445399999999976889667929999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.31 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=209.0
Q ss_pred CCCCEEEEEEECCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 998079736511696489999995-----8993999999504799978899999999999938-9997102542476305
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDL-----ENNKLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRV 208 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~-----~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 208 (690)
.++|++.++||+|+||.||+|... .+++.||||+++... .......+.+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--
T ss_conf 89969854982068829999998066447788699999987424-877999999999998762699988789989831--
Q ss_pred CCEEEEEEECCCCCHHHHHCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 893999994242133565408------------------99988999999999999999999996898544577766255
Q 005582 209 SGSLYLVFEYMEHDLAGLAAT------------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLI 270 (690)
Q Consensus 209 ~~~lyLV~Ey~~g~Ll~~~~~------------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILi 270 (690)
...+|||||||+++.+..++. ....+++..+..|+.||+.||.|||+++|+||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCC
T ss_conf 99789999737998799999853566544444533222334588999999999999999998875792666241021000
Q ss_pred CCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHH
Q ss_conf 05893476014653223468999-86445456667698333399899983114430468999983-89999999949999
Q 005582 271 DYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQL 348 (690)
Q Consensus 271 d~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l 348 (690)
+.++.+||+|||+++........ ..+..++|+.|+|||++.+ ..++.++|||||||++|||+| |.++|.+.+..+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 0257521023401023367886158620135968767788617-999974001025899999985899887789989999
Q ss_pred HHHHHHHCCCCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9999870999956753158996665689885101122111799545999999962479898899998862
Q 005582 349 HKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 349 ~kI~~~~G~p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
.++......+ .....++..+.+||.+||+.||.+|||+.++|+
T Consensus 258 ~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCC---------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9998668988---------------------------985436599999999975779657929999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.97 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=208.4
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCC-------EEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEE
Q ss_conf 8998079736511696489999995899-------3999999504799978899999999999938-9997102542476
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENN-------KLVALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLIT 205 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g-------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~ 205 (690)
..++|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|..++.++ +|||||++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf 58996970098516782899999857875556675499999988112-86889999999999998139996973465220
Q ss_pred ECCCCEEEEEEECCCCCHHHHHCC-C---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 305893999994242133565408-9---------------998899999999999999999999689854457776625
Q 005582 206 SRVSGSLYLVFEYMEHDLAGLAAT-P---------------GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLL 269 (690)
Q Consensus 206 ~~~~~~lyLV~Ey~~g~Ll~~~~~-~---------------~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NIL 269 (690)
+ .+.+|+||||++++.+..++. . ...+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 90 ~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 Q--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp S--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C--CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEE
T ss_conf 1--88689999736999099999860677643222334574346799999999999999998766379786302210224
Q ss_pred ECCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHH
Q ss_conf 505893476014653223468999-86445456667698333399899983114430468999983-8999999994999
Q 005582 270 IDYNGILKIGDFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQ 347 (690)
Q Consensus 270 id~~g~vKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~ 347 (690)
++.++.+||+|||++......... .....++|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf 54789767622111011355555431466788846632667517-98882555477588888740179898999999999
Q ss_pred HHHHHHHHCCCCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 99999870999956753158996665689885101122111799545999999962479898899998862
Q 005582 348 LHKIFKLCGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 348 l~kI~~~~G~p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
...+... ..+ .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 247 ~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCC-CCC---------------------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999728-888---------------------------987435299999999976679767939999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.60 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=209.1
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCEE--EEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCCCE
Q ss_conf 99807973651169648999999589939--99999504799978899999999999938-9997102542476305893
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLENNKL--VALKKVRFTNMDPESVRFMAREIIILRRL-DHPNIMKLEGLITSRVSGS 211 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~--VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 211 (690)
.++|++.+.||+|+||.||+|.+..++.. ||||++.... .....+.+.+|+.+|..+ +|||||++++++.. .+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--CCE
T ss_conf 79968877982078828999999899969999999978233-857999999999999862289988367888841--873
Q ss_pred EEEEEECCCCCHHHHHCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC
Q ss_conf 999994242133565408----------------9998899999999999999999999689854457776625505893
Q 005582 212 LYLVFEYMEHDLAGLAAT----------------PGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGI 275 (690)
Q Consensus 212 lyLV~Ey~~g~Ll~~~~~----------------~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~ 275 (690)
+|+||||++++.+..++. ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCC
T ss_conf 69999802898699998640355555123101234578999999999999999987663089545550520489868876
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCC-CCCCCCCHHHHHHHHHHH
Q ss_conf 4760146532234689998644545666769833339989998311443046899998389-999999949999999987
Q 005582 276 LKIGDFGLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGK-PIMPGRTEVEQLHKIFKL 354 (690)
Q Consensus 276 vKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~-~pF~g~~~~e~l~kI~~~ 354 (690)
+||+|||+|+....... .....+|..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+...
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEECCCCCCCCCCCCCC--CCCEECCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf 38743443224442234--553013775555387526-999962215313889999983689999999999999999826
Q ss_pred HCCCCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC--CCCCC
Q ss_conf 09999567531589966656898851011221117995459999999624798988999988629--47899
Q 005582 355 CGSPSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN--EFFTT 424 (690)
Q Consensus 355 ~G~p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H--pwf~~ 424 (690)
.- .+....+++.+.+||.+||+.||++|||+.++|++ .++..
T Consensus 243 ~~----------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 243 YR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC----------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 88----------------------------888766789999999997678966894999999999999861
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.03 Aligned_cols=252 Identities=16% Similarity=0.243 Sum_probs=208.5
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECC-----CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 9980797365116964899999958-----99399999950479997889999999999993899971025424763058
Q 005582 135 ADSFEKLDKIGQGTYSSVYKARDLE-----NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS 209 (690)
Q Consensus 135 ~~~Y~~~~~IG~G~fG~Vy~a~~~~-----~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 209 (690)
.++|++.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.++++++||||+++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--C
T ss_conf 89918835982078818999998786447789689999987012-86899999999999997699988412547842--8
Q ss_pred CEEEEEEECCCCCHHHHHC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 9399999424213356540----------899988999999999999999999996898544577766255058934760
Q 005582 210 GSLYLVFEYMEHDLAGLAA----------TPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIG 279 (690)
Q Consensus 210 ~~lyLV~Ey~~g~Ll~~~~----------~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~ 279 (690)
..+++||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEE
T ss_conf 81067776048998899987503321134446887999999999999999998764796543286775403599649994
Q ss_pred CCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 14653223468999-864454566676983333998999831144304689999838-9999999949999999987099
Q 005582 280 DFGLANFFKCSQKQ-PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAG-KPIMPGRTEVEQLHKIFKLCGS 357 (690)
Q Consensus 280 DFGlA~~~~~~~~~-~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG-~~pF~g~~~~e~l~kI~~~~G~ 357 (690)
|||+|+.+...... .....++|+.|+|||.+.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+.+..-
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~- 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-
T ss_conf 2454202357763031340231632378888736-99883334443789999999689999999899999999980888-
Q ss_pred CCHHHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9956753158996665689885101122111799545999999962479898899998862
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 358 p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
......+++.+.+||..||+.||.+|||+.++++
T Consensus 254 ---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ---------------------------8886335399999999975779658939999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.25 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=201.0
Q ss_pred CEEEEEEECCCCEEEEEEEECCCC---EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 079736511696489999995899---39999995047999788999999999999389997102542476305893999
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENN---KLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 138 Y~~~~~IG~G~fG~Vy~a~~~~~g---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 214 (690)
+.+.++||+|+||+||+|.+..++ ..||||+++.. ........+.+|+.+|++++||||+++++++... .+.+|+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEE
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEE
T ss_conf 52666981368809999999779987999999998843-6978999999999999867899986786789806-994389
Q ss_pred EEECCCCCHHH-HHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99424213356-54089998899999999999999999999689854457776625505893476014653223468999
Q 005582 215 VFEYMEHDLAG-LAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQKQ 293 (690)
Q Consensus 215 V~Ey~~g~Ll~-~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~~~ 293 (690)
|||||+++.+. +.......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 99874067414421013454048999999999887652003367625776687576779998899106523225566555
Q ss_pred ---CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHHCCCCHHHHHHCCCC
Q ss_conf ---8644545666769833339989998311443046899998389999999-949999999987099995675315899
Q 005582 294 ---PLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKRSKLP 369 (690)
Q Consensus 294 ---~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~-~~~e~l~kI~~~~G~p~~e~~~~~~~~ 369 (690)
......+|+.|+|||++.+ ..++.++|||||||++|||++|..||... +..+....+.. |..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~----------- 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRR----------- 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCC-----------
T ss_pred CCEECCCCCCCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCC-----------
T ss_conf 3100256555645567688743-79997457466199999999789999888999999999980--898-----------
Q ss_pred CCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 66656898851011221117995459999999624798988999988629
Q 005582 370 HATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 370 ~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
+ .....+++.+.+|+..||..||.+|||+.|+++|
T Consensus 253 ------~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 ------L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------C---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ------8---------9964475999999999768897689399999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.20 Aligned_cols=246 Identities=19% Similarity=0.331 Sum_probs=203.7
Q ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 89980797365116964899999958993999999504799978899999999999938999710254247630589399
Q 005582 134 KADSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVSGSLY 213 (690)
Q Consensus 134 ~~~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 213 (690)
..++|++++.||+|+||.||+|.+ .|..||||+++... ..+.+.+|+.++++++||||+++++++.+. .+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred CHHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCHH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEE
T ss_conf 789948857982079808999999--99099999988577----799999999999867898985498788723-89289
Q ss_pred EEEECCCCCHHHHHCC-C-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 9994242133565408-9-9988999999999999999999996898544577766255058934760146532234689
Q 005582 214 LVFEYMEHDLAGLAAT-P-GVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDFGLANFFKCSQ 291 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~-~-~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DFGlA~~~~~~~ 291 (690)
|||||++++.+..++. . ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf 9996369998999987457888899999999999985232113376553666567601468997763245600344787-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCC
Q ss_conf 9986445456667698333399899983114430468999983-899999999499999999870999956753158996
Q 005582 292 KQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKRSKLPH 370 (690)
Q Consensus 292 ~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELlt-G~~pF~g~~~~e~l~kI~~~~G~p~~e~~~~~~~~~ 370 (690)
.....+++.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..|....
T Consensus 157 ---~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------- 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 217 (262)
T ss_dssp --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred ---CCCCCCCCCCCCHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC---------------
T ss_conf ---765566646778178727-9888588777579999999978999999999999999998089---------------
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 6656898851011221117995459999999624798988999988629
Q 005582 371 ATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 371 ~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
..+....+++.+.+||..||+.||.+|||+.+++++
T Consensus 218 -------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 -------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -------------999976579999999999756697689399999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=330.51 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=205.9
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCCCEEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899-97102542476305893999
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH-PNIMKLEGLITSRVSGSLYL 214 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~~~~lyL 214 (690)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..+.| +||+.+++++.. ....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCCCEE
T ss_conf 8069979984178829999999889979999997502582----9999999999996489998779999601--881179
Q ss_pred EEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC-----CCCEEEECCCCCCCCCC
Q ss_conf 9942421335654089998899999999999999999999689854457776625505-----89347601465322346
Q 005582 215 VFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDY-----NGILKIGDFGLANFFKC 289 (690)
Q Consensus 215 V~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~-----~g~vKL~DFGlA~~~~~ 289 (690)
||||+++++...+...+..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEECCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCC
T ss_conf 99964888799997520311068999999999999999997796626677131523475434479568723660577146
Q ss_pred CCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHHCCCCH
Q ss_conf 899------9864454566676983333998999831144304689999838999999994---9999999987099995
Q 005582 290 SQK------QPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCILAELFAGKPIMPGRTE---VEQLHKIFKLCGSPSE 360 (690)
Q Consensus 290 ~~~------~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL~ELltG~~pF~g~~~---~e~l~kI~~~~G~p~~ 360 (690)
... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+... ...+.++....-.+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CCCCCCEEECCCCCEEECHHHCCHHHHCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC--
T ss_conf 76654111024676277510267989648-888869998983199999986987678853021999999997056799--
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 6753158996665689885101122111799545999999962479898899998862
Q 005582 361 EYWKRSKLPHATIFKPQQPYKRCVAETFKDIPSSALSLLDILLSTEPEVRGTASSALQ 418 (690)
Q Consensus 361 e~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~ 418 (690)
...+..+++|+++.+++..|+..+|.+||+...+.+
T Consensus 236 ----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 ----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ----------------------958965799899999999984399300859999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.31 Aligned_cols=269 Identities=22% Similarity=0.227 Sum_probs=190.5
Q ss_pred CCCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC--CEEE
Q ss_conf 98079736511696489999995899399999950479997889999999999993899971025424763058--9399
Q 005582 136 DSFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPNIMKLEGLITSRVS--GSLY 213 (690)
Q Consensus 136 ~~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~--~~ly 213 (690)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... ........|+..+..++||||+++++++..... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 6899988982078819999999--99899999987200---467999999999962799868326889983798604899
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf 999424213356540899988999999999999999999996--------898544577766255058934760146532
Q 005582 214 LVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHS--------RGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 214 LV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs--------~gIiHrDIKp~NILid~~g~vKL~DFGlA~ 285 (690)
+|||||+++.+..++... .+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 999646698989998658-9998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCCCCCCCCC-----CCCCCCEEECCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 23468999---864454566676983333998-----9998311443046899998389999999949999999987099
Q 005582 286 FFKCSQKQ---PLTSRVVTLWYRPPELLLGST-----DYGASVDLWSSGCILAELFAGKPIMPGRTEVEQLHKIFKLCGS 357 (690)
Q Consensus 286 ~~~~~~~~---~~~~~~gT~~Y~APEvl~g~~-----~ys~ksDIWSlGviL~ELltG~~pF~g~~~~e~l~kI~~~~G~ 357 (690)
.+...... .....+||+.|+|||++.+.. .++.++|||||||++|||+||.+||............ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSS
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH-CCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012-25564
Q ss_pred CCHHHHHHCCCCCCCCCCCCCCCCHHHHHHC--CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9956753158996665689885101122111--7995459999999624798988999988629
Q 005582 358 PSEEYWKRSKLPHATIFKPQQPYKRCVAETF--KDIPSSALSLLDILLSTEPEVRGTASSALQN 419 (690)
Q Consensus 358 p~~e~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~dLL~~lL~~DP~kRpTa~eiL~H 419 (690)
+.......... ...+.+. +...+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~--~~~~~p~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVC--EQKLRPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHT--TSCCCCC------CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHH--CCCCCCC------CCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 30999999875--0246888------77655776899999999999760698589599999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=9.7e-28 Score=178.75 Aligned_cols=172 Identities=16% Similarity=0.123 Sum_probs=120.9
Q ss_pred CEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCC----------------HHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 07973651169648999999589939999995047999----------------78899999999999938999710254
Q 005582 138 FEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMD----------------PESVRFMAREIIILRRLDHPNIMKLE 201 (690)
Q Consensus 138 Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~----------------~~~~~~~~rEi~iL~~L~HpnIv~l~ 201 (690)
+.+.++||+|+||.||+|.+ .+|+.||||+++..... ........+|..++..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 02277802485659999997-99999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCCCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECC
Q ss_conf 24763058939999942421335654089998899999999999999999999689854457776625505893476014
Q 005582 202 GLITSRVSGSLYLVFEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCHSRGILHRDIKGSNLLIDYNGILKIGDF 281 (690)
Q Consensus 202 ~~~~~~~~~~lyLV~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLHs~gIiHrDIKp~NILid~~g~vKL~DF 281 (690)
++. . .++||||+++..... ++...+..++.||+.+|.|||++||+||||||+|||++.+ .++|+||
T Consensus 81 ~~~----~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWE----G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEE----T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EEC----C--CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEEC
T ss_conf 862----8--889999504565420-------0157899999999999999826888983689036114289-8999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCHHHH
Q ss_conf 653223468999864454566676983333998999831144304689
Q 005582 282 GLANFFKCSQKQPLTSRVVTLWYRPPELLLGSTDYGASVDLWSSGCIL 329 (690)
Q Consensus 282 GlA~~~~~~~~~~~~~~~gT~~Y~APEvl~g~~~ys~ksDIWSlGviL 329 (690)
|+|..........+...-.+ .-.+.+ . ..|+..+|+||+.--+
T Consensus 147 G~a~~~~~~~~~~~l~rd~~---~~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILERDVR---NIITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHHHHHH---HHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHH---HHHHHH-C-CCCCCCCCHHHHHHHH
T ss_conf 88430899870999987799---999997-5-7899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=1.3e-06 Score=54.33 Aligned_cols=139 Identities=14% Similarity=0.110 Sum_probs=82.4
Q ss_pred CCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCCEEEEE
Q ss_conf 807973651169648999999589939999995047999788999999999999389-9971025424763058939999
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLD-HPNIMKLEGLITSRVSGSLYLV 215 (690)
Q Consensus 137 ~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLV 215 (690)
.|+.....+.++.+.||+.. .++..+.+|....... .....+.+|..++..+. +--+.+++.+... .+..|+|
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv 88 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL 88 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred CEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCC--CCHHHHHHHHHHHHHHHCCCCCCCEEEEEEC--CCCEEEE
T ss_conf 52799767899877189999--0898699998488765--3255699999999987606998728999750--8964999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q ss_conf 942421335654089998899999999999999999999-----------------------------------------
Q 005582 216 FEYMEHDLAGLAATPGVKFTEAQIKCYMKQLLHGLEHCH----------------------------------------- 254 (690)
Q Consensus 216 ~Ey~~g~Ll~~~~~~~~~l~e~~i~~i~~qIl~gL~yLH----------------------------------------- 254 (690)
|++++|..+....... ... ..++.++...|..||
T Consensus 89 ~~~l~G~~~~~~~~~~--~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC--SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEECCCCCCCCCCCCC--CCH---HHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 9860433435433440--269---99999899999998556842143576446565557789987765555430332320
Q ss_pred ------------HC------CCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf ------------68------985445777662550589347601465322
Q 005582 255 ------------SR------GILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 255 ------------s~------gIiHrDIKp~NILid~~g~vKL~DFGlA~~ 286 (690)
.. .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 05799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.34 E-value=1.3e-05 Score=48.41 Aligned_cols=136 Identities=13% Similarity=0.093 Sum_probs=76.2
Q ss_pred EEECCC-CEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC--CCEEEEEEEEEECCCCEEEEEEECC
Q ss_conf 651169-6489999995899399999950479997889999999999993899--9710254247630589399999424
Q 005582 143 KIGQGT-YSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH--PNIMKLEGLITSRVSGSLYLVFEYM 219 (690)
Q Consensus 143 ~IG~G~-fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~lyLV~Ey~ 219 (690)
.+..|. .+.||++.. ..+..+.+|....... ..+..|...|+.+.. -.+.+++.+..+ .+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCC--CCCEEEEEEEE
T ss_conf 7678654775899993-8987899995896677-----68999999999998659998861322245--66159998744
Q ss_pred CCCHHHHH------------------CC---CCCCC--CHHHHHHHHH--------------------HHHHHHHHHHHC
Q ss_conf 21335654------------------08---99988--9999999999--------------------999999999968
Q 005582 220 EHDLAGLA------------------AT---PGVKF--TEAQIKCYMK--------------------QLLHGLEHCHSR 256 (690)
Q Consensus 220 ~g~Ll~~~------------------~~---~~~~l--~e~~i~~i~~--------------------qIl~gL~yLHs~ 256 (690)
+|..+... .. ....+ .......... .....+..+...
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred ECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 13554322126899999999999987368854488755412468899999987541101134011213799999999871
Q ss_pred -------CCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf -------985445777662550589347601465322
Q 005582 257 -------GILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 257 -------gIiHrDIKp~NILid~~g~vKL~DFGlA~~ 286 (690)
.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 8765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=8.1e-06 Score=49.53 Aligned_cols=78 Identities=19% Similarity=0.191 Sum_probs=48.8
Q ss_pred EEEEEECCCCEEEEEEEECCCCEEEEEEEEECC-----CCCHHHHHHHHHHHHHHHHCC-C--CCEEEEEEEEEECCCCE
Q ss_conf 973651169648999999589939999995047-----999788999999999999389-9--97102542476305893
Q 005582 140 KLDKIGQGTYSSVYKARDLENNKLVALKKVRFT-----NMDPESVRFMAREIIILRRLD-H--PNIMKLEGLITSRVSGS 211 (690)
Q Consensus 140 ~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~-----~~~~~~~~~~~rEi~iL~~L~-H--pnIv~l~~~~~~~~~~~ 211 (690)
..+.||.|....||++.+..+++.|.+|.-... ...+-...+...|...|..+. + ..+++++.+ +. ..
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~--~~ 105 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EM 105 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TT
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CC--CC
T ss_conf 699807985276899995799848999617713034677788877899999999998650579885528998--59--88
Q ss_pred EEEEEECCCC
Q ss_conf 9999942421
Q 005582 212 LYLVFEYMEH 221 (690)
Q Consensus 212 lyLV~Ey~~g 221 (690)
.++|||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEECCCC
T ss_conf 7798713577
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.79 E-value=0.00015 Score=42.01 Aligned_cols=75 Identities=19% Similarity=0.237 Sum_probs=47.5
Q ss_pred CCEEEEEEECCCCEEEEEEEECC-------CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCC-EEEEEEEEEECC
Q ss_conf 80797365116964899999958-------9939999995047999788999999999999389997-102542476305
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLE-------NNKLVALKKVRFTNMDPESVRFMAREIIILRRLDHPN-IMKLEGLITSRV 208 (690)
Q Consensus 137 ~Y~~~~~IG~G~fG~Vy~a~~~~-------~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~ 208 (690)
.+ .+..|+.|-.-.+|++.... ....|.+++.-.. . . .....+|..+++.+.-.+ ..++++++.+
T Consensus 44 ~l-~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 44 HL-RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp GE-EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred CE-EEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC--C-H-HHHHHHHHHHHHHHHHCCCCCEEEEECCC--
T ss_conf 16-9999178533434899968877544578981799965996--1-1-65899999999999757999808998189--
Q ss_pred CCEEEEEEECCCCC
Q ss_conf 89399999424213
Q 005582 209 SGSLYLVFEYMEHD 222 (690)
Q Consensus 209 ~~~lyLV~Ey~~g~ 222 (690)
.+|+||++|.
T Consensus 117 ----g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ----GRLEEYIPSR 126 (395)
T ss_dssp ----EEEECCCCEE
T ss_pred ----CEEEEEECCC
T ss_conf ----5699973455
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.71 E-value=0.00048 Score=39.13 Aligned_cols=134 Identities=16% Similarity=0.133 Sum_probs=71.5
Q ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC---C--CEEEEEEEEEECCCCEEEEEEECCCC
Q ss_conf 696489999995899399999950479997889999999999993899---9--71025424763058939999942421
Q 005582 147 GTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH---P--NIMKLEGLITSRVSGSLYLVFEYMEH 221 (690)
Q Consensus 147 G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H---p--nIv~l~~~~~~~~~~~lyLV~Ey~~g 221 (690)
+..-.||++.. .+|..|++|+.+..... ...+..|+..+..|.. | ..+..-+-......+..+.+++++.|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CCCCEEEEEEC-CCCCEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf 61202699983-89997999984787788---999999999999998559987875206898056653479999865277
Q ss_pred CHHH----------------HH--CC-----CCCCCC-------------------HHHHHHHHHHHHHHHHHHHH----
Q ss_conf 3356----------------54--08-----999889-------------------99999999999999999996----
Q 005582 222 DLAG----------------LA--AT-----PGVKFT-------------------EAQIKCYMKQLLHGLEHCHS---- 255 (690)
Q Consensus 222 ~Ll~----------------~~--~~-----~~~~l~-------------------e~~i~~i~~qIl~gL~yLHs---- 255 (690)
.... +. .. ....+. ......+...+-..+..+..
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 68899999999998999999886303578655677897887665689998747699889899999999999999984545
Q ss_pred ---CCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf ---8985445777662550589347601465322
Q 005582 256 ---RGILHRDIKGSNLLIDYNGILKIGDFGLANF 286 (690)
Q Consensus 256 ---~gIiHrDIKp~NILid~~g~vKL~DFGlA~~ 286 (690)
.++||+|+.+.|||++. + ..++||+-+..
T Consensus 189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 68712024788804287838-9-35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.16 E-value=0.0037 Score=33.86 Aligned_cols=143 Identities=15% Similarity=0.185 Sum_probs=73.6
Q ss_pred CCEEEEEEECCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-----CCEEEEE-EEEEECCCC
Q ss_conf 8079736511696489999995899399999950479997889999999999993899-----9710254-247630589
Q 005582 137 SFEKLDKIGQGTYSSVYKARDLENNKLVALKKVRFTNMDPESVRFMAREIIILRRLDH-----PNIMKLE-GLITSRVSG 210 (690)
Q Consensus 137 ~Y~~~~~IG~G~fG~Vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-----pnIv~l~-~~~~~~~~~ 210 (690)
...-...|..|.--+.|.+.. .+|+ +.+|++.... +.. .+..|+.++..|.. |..+... |........
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t-~~g~-yVLri~~~~~-~~~---~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT-TKDP-LILTLYEKRV-EKN---DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE-SSCC-EEEEEECC----CC---HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CCEEEECCCCCCCCCEEEEEE-CCCC-EEEEECCCCC-CHH---HHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEEC
T ss_conf 856852378885267389997-8972-8999807899-988---999999998754302555455641048976213412
Q ss_pred EEEEEEECCCCCHH---------------H---HHCC-----CCCCCCHH------------------HHHHHHHHHHHH
Q ss_conf 39999942421335---------------6---5408-----99988999------------------999999999999
Q 005582 211 SLYLVFEYMEHDLA---------------G---LAAT-----PGVKFTEA------------------QIKCYMKQLLHG 249 (690)
Q Consensus 211 ~lyLV~Ey~~g~Ll---------------~---~~~~-----~~~~l~e~------------------~i~~i~~qIl~g 249 (690)
....++.++.+... . .... ........ .....+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred CCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_conf 55024531146553332046788888998764544432024531011101200245677776531141279999999876
Q ss_pred HHHHHH----CCCCCCCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf 999996----898544577766255058934760146532
Q 005582 250 LEHCHS----RGILHRDIKGSNLLIDYNGILKIGDFGLAN 285 (690)
Q Consensus 250 L~yLHs----~gIiHrDIKp~NILid~~g~vKL~DFGlA~ 285 (690)
+..... .|+||+|+.++|||++.+...-|.||+.+.
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 4204855454503337863656402045412674222123
|